{'idx': 1309, 'sentence': 'Proteins in the first group contain multiple HMG boxes , are non-sequence-specific , and recognize structural features as found in cruciform DNA and cross-over DNA .', 'label': {'cruciform DNA': 'DNA', 'HMG boxes': 'protein', 'cross-over DNA': 'DNA'}, 'response1': "['protein', 'DNA']", 'response2': '[\n{"p50p50": 5},\n{"p21(WAF1/CIP1)": 5},\n{"p27(KIP1)": 5},\n{"GATA-1": 5},\n{"NF-ATc": 5},\n{"T lymphocytes": 5},\n{"Protein": 5},\n{"GM-CSF": 5},\n{"cDNAs": 5},\n{"IgH": 5},\n{"IL-2": 5},\n{"c-Jun": 5},\n{"c-Fos": 5},\n{"Stat proteins": 5},\n{"immunohistochemistry": 5},\n{"gene": 5},\n{"cell type": 5},\n{"Th2-type lymphocytes": 5},\n{"GM-kappa B": 5},\n{"GC-box": 5},\n{"GC-motif": 5},\n{"GM-kappa B motif": 5},\n{"p50": 5},\n{"p65": 5},\n{"HIV-1 LTR": 5},\n{"NFAT-1": 5},\n{"NF kappa B": 5},\n{"NF-kappaB": 5},\n{"Sp1": 5},\n{"SIVmac": 5}\n]', 'response3': '[{"HMG boxes": "protein"}, {"DNA": "DNA"}]', 'prediction': {'HMG boxes': 'protein', 'DNA': 'DNA'}}
{'idx': 228, 'sentence': 'We have carried out experiments to define the nature of the higher affinity CVZ binding site .', 'label': {'higher affinity CVZ binding site': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 1},\n{"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF.": 5},\n{"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 5},\n{"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n{"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 5},\n{"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 4},\n{"Here we examined the regulatory mechanism of the SCM-1 genes.": 5},\n{"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.": 5},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n{"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.": 5},\n{"Therefore, we investigated whether IVS1-10T-->C deleteriously affected BRCA1 splicing or expression, and thereby inactivated the other BRCA1 allele.": 5},\n{"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n{"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 5},\n{"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n{"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 5},\n{"This protein has now been purified and its encoding gene cloned.": 5},\n{"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations.": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 51, 'sentence': 'Such segments accord well with empirically known T-cell determinants and our algorithm produces a lower number of false positive predictions than the principle based on discrete Fourier transformations previously described.', 'label': {'T-cell determinants': 'protein'}, 'response1': "['cell_type']", 'response2': '[\n{"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n{"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n{"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 4},\n{"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.": 5},\n{"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n{"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n{"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n{"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 4},\n{"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 5},\n{"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.": 5},\n{"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n{"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 4},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n{"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1518, 'sentence': 'Anti-immunoglobulin M activates nuclear calcium/calmodulin-dependent protein kinase II in human B lymphocytes .', 'label': {'nuclear calcium/calmodulin-dependent protein kinase II': 'protein', 'human B lymphocytes': 'cell_type', 'Anti-immunoglobulin M': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"IL-13 , a cytokine similar to IL-4 , is a regulator of human B cell and monocyte functions .": 5},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 5},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 5},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .": 5},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.": 5},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 563, 'sentence': 'The 6-h increase in PDGF(B) mRNA was adherence dependent, and in addition, was abrogated when the cytoskeletal integrity was compromised by cytochalasin D .', 'label': {'PDGF(B)': 'protein', 'PDGF(B) mRNA': 'RNA'}, 'response1': "['RNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence directly mentions the entity \'DNA\' and provides clear context for its presence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence directly mentions the entity \'RNA\' and provides clear context for its presence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains multiple mentions of protein-related entities and provides clear context for their presence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence directly mentions the entity \'protein\' and provides clear context for its presence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence directly mentions the entities \'protein\' and provides clear context for their presence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence directly mentions the entities \'RNA\' and \'cell_line\' and provides clear context for their presence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence directly mentions the entity \'DNA\' and provides clear context for its presence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence directly mentions the entity \'protein\' and provides clear context for its presence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence directly mentions the entities \'protein\' and provides clear context for their presence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence directly mentions the entity \'protein\' and provides clear context for its presence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence directly mentions the entities \'protein\' and provides clear context for their presence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence directly mentions the entities \'protein\' and provides clear context for their presence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence directly mentions the entity \'cell_type\' and provides clear context for its presence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence directly mentions the entities \'protein\' and \'cell_type\' and provides clear context for their presence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains multiple mentions of protein-related entities and provides clear context for their presence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"PDGF(B)": "RNA"}]', 'prediction': {'PDGF(B)': 'RNA'}}
{'idx': 501, 'sentence': 'Southwestern and gel renaturation experiments with the use of purified protein fractions revealed that TCF-1 alpha activity is derived from a family of 57- to 53-kD proteins that are abundantly expressed in mature and immature T-cell lines ( Jurkat , CCRF-CEM ) and not in mature B cells ( JY , Namalwa ) or nonlymphoid (HeLa) cell lines .', 'label': {'CCRF-CEM': 'cell_line', 'TCF-1 alpha': 'protein', 'nonlymphoid (HeLa) cell lines': 'cell_line', 'mature B cells': 'cell_line', 'JY': 'cell_line', 'Namalwa': 'cell_line', '57- to 53-kD proteins': 'protein', 'Jurkat': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n    {"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"TCF-1 alpha": "protein"}, {"57- to 53-kD proteins": "protein"}, {"Jurkat": "cell_line"}, {"CCRF-CEM": "cell_line"}, {"JY": "cell_line"}, {"Namalwa": "cell_line"}, {"HeLa": "cell_line"}]', 'prediction': {'TCF-1 alpha': 'protein', '57- to 53-kD proteins': 'protein', 'Jurkat': 'cell_line', 'CCRF-CEM': 'cell_line', 'JY': 'cell_line', 'Namalwa': 'cell_line', 'HeLa': 'cell_line'}}
{'idx': 457, 'sentence': 'TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes .', 'label': {'T lymphocytes': 'cell_type', 'TAR': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 4},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 4},\n    {"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .": 5},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .": 5},\n    {"Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype .": 5}\n]', 'response3': '[{"T lymphocytes": "cell_type"}, {"phorbol ester": "protein"}, {"TAR": "RNA"}, {"human immunodeficiency virus": "cell_type"}]', 'prediction': {'T lymphocytes': 'cell_type', 'phorbol ester': 'protein', 'TAR': 'RNA', 'human immunodeficiency virus': 'cell_type'}}
{'idx': 285, 'sentence': 'ER content in lymphocytes of each sample was expressed by both fmol/mg of lymphocyte cytosolic protein and fmol/micrograms of lymphocyte DNA .', 'label': {'ER': 'protein', 'lymphocyte DNA': 'DNA', 'lymphocytes': 'cell_type', 'lymphocyte cytosolic protein': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 3},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .": 4},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 4},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 4},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .": 4},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 5},\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[{"lymphocyte cytosolic protein": "protein"}, {"lymphocyte DNA": "DNA"}]', 'prediction': {'lymphocyte cytosolic protein': 'protein', 'lymphocyte DNA': 'DNA'}}
{'idx': 1508, 'sentence': 'Functional characterization of the murine homolog of the B cell-specific coactivator BOB.1/OBF.1 .', 'label': {'BOB.1/OBF.1': 'protein', 'B cell-specific coactivator': 'protein', 'murine homolog': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and specific example of a cell line (SCM-1) which is helpful for extracting named entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions specific entities such as \'UAS1\' and \'B cell\' which are helpful for extracting named entities."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence provides information about the protein \'GATA-1\' which is helpful for extracting named entities."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence mentions the protein \'TCF-1\' which is helpful for extracting named entities."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence provides information about the protein \'E2A\' which is helpful for extracting named entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains multiple protein entities such as \'IL-2\', \'c-Jun\', and \'c-Fos\' which are helpful for extracting named entities."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence mentions the protein \'GM-CSF\' which is helpful for extracting named entities."},\n    {"Example 8": 4},\n    {"Reason 8": "The sentence mentions entities \'T cell\' and \'interleukin 2\' which are helpful for extracting named entities."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence mentions proteins \'CD40\' and \'NF-kappa B\' which are helpful for extracting named entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides information about proteins \'SLAP-130\', \'SLP-76\', and entity \'T cell\' which are helpful for extracting named entities."},\n    {"Example 11": 4},\n    {"Reason 11": "The sentence mentions the protein \'GATA-1\' which is helpful for extracting named entities."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence mentions proteins \'Sp1\' and \'Ets\' which are helpful for extracting named entities."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence mentions the DNA entity \'NF-kappa B\' which is helpful for extracting named entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides information about proteins \'CD70\', \'IL-4\', \'CD40\', and entities \'B cell\' and \'plasma cells\' which are helpful for extracting named entities."},\n    {"Example 15": 4},\n    {"Reason 15": "The sentence mentions proteins \'IL-7R\' and \'gamma(c)\' which are helpful for extracting named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 209, 'sentence': 'Type-II estrogen -binding sites ( type-II EBS ) have been demonstrated in the human lymphoblastoid cell line IM-9 using a whole-cell assay with (6,7-3H) estradiol ( 3H-E2 ) as tracer.', 'label': {'lymphoblastoid cell line': 'cell_line', 'IM-9': 'cell_line', 'type-II EBS': 'protein', 'Type-II estrogen -binding sites': 'protein', 'human lymphoblastoid cell line': 'cell_line'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 4},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .": 3},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 3},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .": 4},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 4},\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .": 5},\n    {"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development .": 5},\n    {"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.": 5},\n    {"Expression of tal-1 and GATA-binding proteins during human hematopoiesis .": 4},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5}\n]', 'response3': '[{"IM-9": "cell_line"}, {"estradiol": "protein"}]', 'prediction': {'IM-9': 'cell_line', 'estradiol': 'protein'}}
{'idx': 1385, 'sentence': "Mutational analyses of the HIV-1 LTR showed that one C/EBP site is required for normal LTR transcription both before and after cellular activation and that the two 3' C/EBP sites are functionally equivalent.", 'label': {'LTR': 'DNA', 'HIV-1 LTR': 'DNA', 'C/EBP sites': 'DNA', 'C/EBP site': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 4},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF.": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5},\n    {"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB- induced trans-activation of the H4 promoter.": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 4},\n    {"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 4},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 4},\n    {"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process.": 5}\n]', 'response3': '[{"C/EBP": "protein"}, {"HIV-1 LTR": "DNA"}]', 'prediction': {'C/EBP': 'protein', 'HIV-1 LTR': 'DNA'}}
{'idx': 1516, 'sentence': 'Fusion of subdomains of BOB.1/OBF.1 with the GAL4 DNA binding domain reveals that both NH2- and COOH- terminal domains of BOB.1/OBF.1 contribute to full transactivation function, the COOH-terminal domain is more efficient in this transactivation assay .', 'label': {'BOB.1/OBF.1': 'protein', 'GAL4 DNA binding domain': 'protein', 'COOH-terminal domain': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events.": 5},\n    {"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.": 4},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 5},\n    {"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system.": 5},\n    {"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF.": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 5},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 5},\n    {"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif.": 5},\n    {"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB- induced trans-activation of the H4 promoter.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1827, 'sentence': 'A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1 .', 'label': {'human interleukin 2 gene promoter': 'DNA', 'EGR-1': 'protein', 'Sp1': 'protein', 'regulatory element': 'DNA', 'binding site': 'DNA', 'zinc finger proteins': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"IgH": 5},\n{"IL4": 5},\n{"IL13": 5},\n{"Th2-type lymphocytes": 5},\n{"IL-2": 5},\n{"IL-4": 5},\n{"immunoglobulin kappa 3\' enhancer": 5},\n{"interleukin 10": 5},\n{"IL-10R": 5},\n{"IL-13": 5},\n{"IL-4": 5},\n{"GATA-1": 5},\n{"Sp1": 5},\n{"Ets": 5},\n{"Sp1": 5},\n{"CD14": 5},\n{"T cell": 5},\n{"interleukin 2": 5},\n{"Egr-1": 5},\n{"IL-2": 5},\n{"NF-kappaB": 5},\n{"Sp1": 5},\n{"p50": 5},\n{"IFN A": 5},\n{"IFNA": 5},\n{"interleukin-2": 5},\n{"interleukin-2 receptor": 5},\n{"phytohemagglutinin": 5},\n{"phorbol myristate acetate": 5}\n]', 'response3': '[{"interleukin 2": "protein"}, {"Sp1": "protein"}, {"EGR-1": "protein"}]', 'prediction': {'interleukin 2': 'protein', 'Sp1': 'protein', 'EGR-1': 'protein'}}
{'idx': 1116, 'sentence': 'The tumour suppressor p53 has been shown to regulate this type of apoptosis in thymocytes , but an as yet unknown, p53 -independent pathway (s) appears to mediate the same event in mitogen-activated mature T lymphocytes .', 'label': {'thymocytes': 'cell_type', 'p53': 'protein', 'mitogen-activated mature T lymphocytes': 'cell_line', 'tumour suppressor p53': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"EBV": 1},\n    {"CD2": 5},\n    {"T cell": 4},\n    {"IL-2": 5},\n    {"IL-2 receptor": 5},\n    {"TIMP-1": 4},\n    {"DNA": 4},\n    {"IL-2": 5},\n    {"NF-kappa B": 5},\n    {"AP-1": 5},\n    {"GATA-1": 5},\n    {"Syk": 5},\n    {"Zap": 5},\n    {"T cell": 4},\n    {"NF-ATc": 5},\n    {"T lymphocytes": 4},\n    {"embryonic cardiac cells": 4},\n    {"AP-1": 1},\n    {"FasL": 5},\n    {"IL-2": 5},\n    {"IFN-gamma": 5},\n    {"Th2-type lymphocytes": 5},\n    {"IkappaBalpha": 5},\n    {"NF-kappaB": 5},\n    {"SP1": 5},\n    {"caspases": 5},\n    {"B-cell": 4},\n    {"NF-kappaB": 5},\n    {"Tax": 1},\n    {"ATL": 4},\n    {"Bak": 5},\n    {"Bad": 5},\n    {"Bcl-2": 5},\n    {"PDBu": 4},\n    {"DMSO": 4},\n    {"CD70": 5},\n    {"B cell": 4},\n    {"plasma cells": 4},\n    {"IL-4": 5},\n    {"CD40": 5},\n    {"apoptosis": 5}\n]', 'response3': '[{"p53": "protein"}, {"apoptosis": "cell_type"}, {"thymocytes": "cell_type"}, {"p53": "protein"}, {"mitogen-activated mature T lymphocytes": "cell_type"}]', 'prediction': {'p53': 'protein', 'apoptosis': 'cell_type', 'thymocytes': 'cell_type', 'mitogen-activated mature T lymphocytes': 'cell_type'}}
{'idx': 178, 'sentence': 'T lymphocytes appeared to be an important source of 1,25(OH)2D3 production , since purified T lymphocytes from all patients with tuberculosis produced 1,25(OH)2D3 , and 1,25(OH)2D3 production by these cells correlated closely with that produced by unseparated lavage cells .', 'label': {'T lymphocytes': 'cell_type', 'lavage cells': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence provides a clear example of a protein entity (TCL1) and its corresponding entity label."},\n{"Example 2": 4},\n{"Reason 2": "The sentence provides examples of cell types (granulocytes, T cells) and their corresponding entity labels."},\n{"Example 3": 5},\n{"Reason 3": "The sentence provides a clear example of a protein entity (CD14) and its corresponding entity label."},\n{"Example 4": 5},\n{"Reason 4": "The sentence provides multiple examples of protein entities (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) and their corresponding entity labels."},\n{"Example 5": 5},\n{"Reason 5": "The sentence provides a clear example of a protein entity (ZAP-70) and its corresponding entity label."},\n{"Example 6": 4},\n{"Reason 6": "The sentence provides examples of cell type (T lymphocytes) and protein entity (HLA-molecules) with their corresponding entity labels."},\n{"Example 7": 5},\n{"Reason 7": "The sentence provides examples of protein entity (NF-ATc) and cell type (T lymphocytes) with their corresponding entity labels."},\n{"Example 8": 4},\n{"Reason 8": "The sentence provides examples of protein entities (Oct-2A, HMG I/Y, HLA-DRA) and cell type (B cells) with their corresponding entity labels."},\n{"Example 9": 4},\n{"Reason 9": "The sentence provides examples of a cell line entity (EBV) and a protein entity (CD2) with their corresponding entity labels."},\n{"Example 10": 4},\n{"Reason 10": "The sentence provides an example of a cell type entity (Th2-type lymphocytes) with its corresponding entity label."},\n{"Example 11": 5},\n{"Reason 11": "The sentence provides examples of cell type (T cell) and protein entities (IL-2, IL-2 receptor, CD28) with their corresponding entity labels."},\n{"Example 12": 5},\n{"Reason 12": "The sentence provides examples of protein entities (CD70, IL-4, CD40) and cell types (B cell, plasma cells) with their corresponding entity labels."},\n{"Example 13": 5},\n{"Reason 13": "The sentence provides examples of protein entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) with their corresponding entity labels."},\n{"Example 14": 5},\n{"Reason 14": "The sentence provides examples of protein entities (IL-2 receptor alpha subunit, p21ras) and a cell type (B cell) with their corresponding entity labels."},\n{"Example 15": 5},\n{"Reason 15": "The sentence provides examples of cell types (B and T cell activation) and cell lines (Ramos, Jurkat) with their corresponding entity labels."},\n{"Example 16": 5},\n{"Reason 16": "The sentence provides examples of DNA entity (2-deoxyguanosine), cell types (lymphoid progenitor cells, thymus stromal cells, B cell, fetal liver cells, T cell), and a cell line (tg epsilon26) with their corresponding entity labels."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any entities from the given entity label set."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any entities from the given entity label set."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any entities from the given entity label set."},\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any entities from the given entity label set."},\n{"Example 21": 1},\n{"Reason 21": "The sentence does not contain any entities from the given entity label set."},\n{"Example 22": 1},\n{"Reason 22": "The sentence does not contain any entities from the given entity label set."},\n{"Example 23": 1},\n{"Reason 23": "The sentence does not contain any entities from the given entity label set."},\n{"Example 24": 1},\n{"Reason 24": "The sentence does not contain any entities from the given entity label set."},\n{"Example 25": 1},\n{"Reason 25": "The sentence does not contain any entities from the given entity label set."}\n]', 'response3': "[{'T lymphocytes': 'cell_type'}, {'1,25(OH)2D3': 'protein'}, {'tuberculosis': 'cell_type'}, {'unseparated lavage cells': 'cell_line'}]", 'prediction': {'T lymphocytes': 'cell_type', '1,25(OH)2D3': 'protein', 'tuberculosis': 'cell_type', 'unseparated lavage cells': 'cell_line'}}
{'idx': 1209, 'sentence': 'A reduction of serum androgens was found, whereas no change was observed in either basal or GnRH-stimulated gonadotropins or in the cortisol and 17 alpha-hydroxyprogesterone response to ACTH .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"NF-kB": 5},\n    {"AP-1": 5},\n    {"OCT-1": 5},\n    {"NF-IL-2B": 5},\n    {"AP-1": 5},\n    {"IL-5 mRNA": 5},\n    {"TCR": 4},\n    {"IL-2R": 5},\n    {"phosphocreatine": 4},\n    {"HML": 5},\n    {"NF-E2": 5},\n    {"NF-kappa B": 5},\n    {"MNDA": 5},\n    {"P selectin": 5},\n    {"interleukin-2": 5},\n    {"CD25": 5},\n    {"NFAT": 4},\n    {"AP-1": 4},\n    {"Egr-1": 5},\n    {"CD4+": 5},\n    {"CD8+": 5},\n    {"TPCK": 5},\n    {"anti-CD28": 5},\n    {"PMA": 5},\n    {"MR": 5},\n    {"aldosterone": 5},\n    {"progesterone": 5},\n    {"Ras": 5},\n    {"RasN17": 5},\n    {"IL-2": 5},\n    {"CIS": 5},\n    {"OSM": 5},\n    {"STAT5": 5},\n    {"Type I": 4},\n    {"Type II": 4}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 864, 'sentence': 'Differences in transcriptional enhancers of HIV-1 and HIV-2 .', 'label': {'transcriptional enhancers': 'DNA'}, 'response1': "['DNA', 'RNA']", 'response2': '[\n    {"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 5},\n    {"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 3},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 4},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 4},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 4},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 4},\n    {"NF-E1 is encoded by the same gene as the YY-1 protein, which binds to the adeno-associated virus P5 promoter.": 4}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 65, 'sentence': 'Deletions upstream of the PRDII element increased transcription in the uninduced extract, indicating predominantly negative regulation of the promoter .', 'label': {'promoter': 'DNA', 'PRDII element': 'DNA'}, 'response1': "['DNA', 'RNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 4},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 61, 'sentence': 'From HeLa cells , two major proteins of 52 and 45 kilodaltons (kD) copurified with DNA binding activity , whereas from T-cells , four proteins--a major protein of 52 kD and three minor proteins of 82 , 67 , and 43-47 kD --were purified.', 'label': {'82': 'protein', '43-47 kD': 'protein', 'major protein': 'protein', 'T-cells': 'cell_type', 'minor proteins': 'protein', '67': 'protein', 'HeLa cells': 'cell_line', '52 kD': 'protein'}, 'response1': "['protein', 'cell_line', 'DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"HeLa cells": "cell_line"}, {"T-cells": "cell_line"}, {"DNA": "DNA"}, {"protein": "protein"}, {"52 kD": "protein"}, {"45 kilodaltons (kD)": "protein"}, {"82": "protein"}, {"67": "protein"}, {"43-47 kD": "protein"}]', 'prediction': {'HeLa cells': 'cell_line', 'T-cells': 'cell_line', 'DNA': 'DNA', 'protein': 'protein', '52 kD': 'protein', '45 kilodaltons (kD)': 'protein', '82': 'protein', '67': 'protein', '43-47 kD': 'protein'}}
{'idx': 191, 'sentence': 'A block to RNA elongation is largely responsible for decreased c-myc transcription .', 'label': {'c-myc': 'DNA'}, 'response1': "['RNA']", 'response2': '[\n    {"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .": 5},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 5},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .": 5},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5}\n]', 'response3': '[{"RNA": "RNA"}, {"c-myc": "protein"}]', 'prediction': {'RNA': 'RNA', 'c-myc': 'protein'}}
{'idx': 447, 'sentence': 'Each binding site contributes to the overall activity of the enhancer , however no single element seems absolutely required for activity.', 'label': {'enhancer': 'DNA', 'binding site': 'DNA'}, 'response1': "['DNA']", 'response2': '[\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n    {"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 4},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"Nuclear factor NF-kB, activation protein 1 ( AP-1 ), OCT-1, and NF-IL-2B binding activity were normal.": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 5},\n    {"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"We have found that the recruitment of EKLF to 5\'HS3 depends on the presence of 5\'HS2 in cis, but the recruitment to 5\'HS2 does not depend on 5\'HS3.": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 5},\n    {"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 476, 'sentence': 'A group of coordinately induced protooncogenes , cytoskeletal , and extracellular matrix genes have been termed immediate early response genes , and their induction has been associated with growth factor -stimulated cell proliferation .', 'label': {'protooncogenes': 'DNA', 'immediate early response genes': 'DNA', 'growth factor': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .": 5},\n    {"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 4},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n    {"The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 4},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 5},\n    {"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus , and induce transcription from responsive genes.": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5}\n]', 'response3': '[{"protooncogenes": "protein"}, {"cytoskeletal": "protein"}, {"extracellular matrix genes": "protein"}, {"growth factor": "protein"}, {"cell proliferation": "cell_type"}]', 'prediction': {'protooncogenes': 'protein', 'cytoskeletal': 'protein', 'extracellular matrix genes': 'protein', 'growth factor': 'protein', 'cell proliferation': 'cell_type'}}
{'idx': 1034, 'sentence': 'p94 and p95 share homology with Stat1 at the phosphorylation site and in the Src homology 2 (SH2) domain , but otherwise are immunologically distinct from Stat1 .', 'label': {'Stat1': 'protein', 'phosphorylation site': 'protein', 'Src homology 2 (SH2) domain': 'protein', 'p94': 'protein', 'p95': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"p21(WAF1/CIP1 ) and p27(KIP1)": 5},\n    {"The sentence contains specific protein names that are directly mentioned, making it highly helpful for extracting protein entities.": 5},\n    {"calcineurin": 5},\n    {"The sentence directly mentions \'calcineurin\' as a protein, making it highly helpful for extracting protein entities.": 5},\n    {"Th1 and Th2": 4},\n    {"The sentence mentions specific cell types \'Th1\' and \'Th2\', which are directly related to cell_type entities, making it quite helpful for extracting cell_type entities.": 4},\n    {"IL-2": 5},\n    {"The sentence directly mentions \'IL-2\' as a protein, making it highly helpful for extracting protein entities.": 5},\n    {"IL-12 and STAT4": 5},\n    {"The sentence mentions specific proteins \'IL-12\' and \'STAT4\', making it highly helpful for extracting protein entities. It also mentions specific cell types \'NK cells\' and \'T cells\', aiding in extracting cell_type entities.": 5},\n    {"SLAP-130 and SLP-76": 5},\n    {"The sentence mentions specific proteins \'SLAP-130\' and \'SLP-76\', making it highly helpful for extracting protein entities. It also mentions a specific cell type \'T cell\', aiding in extracting cell_type entities.": 5},\n    {"tyrosine": 5},\n    {"The sentence directly mentions \'tyrosine\' as a protein, making it highly helpful for extracting protein entities.": 5},\n    {"IL-2, IFN-gamma, jak kinases, STAT1(alpha)": 5},\n    {"The sentence mentions specific proteins \'IL-2\', \'IFN-gamma\', \'jak kinases\', and \'STAT1(alpha)\', making it highly helpful for extracting protein entities.": 5},\n    {"IL-2, Aiolos, Ras": 5},\n    {"The sentence mentions specific proteins \'IL-2\', \'Aiolos\', and \'Ras\', making it highly helpful for extracting protein entities.": 5},\n    {"ERK and STAT3": 5},\n    {"The sentence mentions specific proteins \'ERK\' and \'STAT3\', making it highly helpful for extracting protein entities.": 5},\n    {"CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, granulocyte-macrophage colony-stimulating factor": 5},\n    {"The sentence mentions specific proteins \'CD28\', \'CD80\', \'CD86\', \'CBL\', \'VAV\', \'NFAT\', \'interleukin-2\', and \'granulocyte-macrophage colony-stimulating factor\', making it highly helpful for extracting protein entities.": 5},\n    {"NF-kappaB, Sp1, p50": 5},\n    {"The sentence mentions specific proteins \'NF-kappaB\', \'Sp1\', and \'p50\', making it highly helpful for extracting protein entities.": 5},\n    {"interleukin 10, IL-10R, STAT3, IL-6": 5},\n    {"The sentence mentions specific proteins \'interleukin 10\', \'IL-10R\', \'STAT3\', and \'IL-6\', making it highly helpful for extracting protein entities.": 5},\n    {"No relevant entities mentioned": 1},\n    {"The sentence does not contain any named entities related to the provided entity labels, hence not helpful for entity extraction.": 1},\n    {"No relevant entities mentioned": 1},\n    {"The sentence does not contain any named entities related to the provided entity labels, hence not helpful for entity extraction.": 1},\n    {"No relevant entities mentioned": 1},\n    {"The sentence does not contain any named entities related to the provided entity labels, hence not helpful for entity extraction.": 1},\n    {"No relevant entities mentioned": 1},\n    {"The sentence does not contain any named entities related to the provided entity labels, hence not helpful for entity extraction.": 1},\n    {"No relevant entities mentioned": 1},\n    {"The sentence does not contain any named entities related to the provided entity labels, hence not helpful for entity extraction.": 1},\n    {"No relevant entities mentioned": 1},\n    {"The sentence does not contain any named entities related to the provided entity labels, hence not helpful for entity extraction.": 1},\n    {"No relevant entities mentioned": 1},\n    {"The sentence does not contain any named entities related to the provided entity labels, hence not helpful for entity extraction.": 1},\n    {"No relevant entities mentioned": 1},\n    {"The sentence does not contain any named entities related to the provided entity labels, hence not helpful for entity extraction.": 1},\n    {"No relevant entities mentioned": 1},\n    {"The sentence does not contain any named entities related to the provided entity labels, hence not helpful for entity extraction.": 1},\n    {"No relevant entities mentioned": 1},\n    {"The sentence does not contain any named entities related to the provided entity labels, hence not helpful for entity extraction.": 1}\n]', 'response3': '[{"Stat1": "protein"}, {"p94": "protein"}, {"p95": "protein"}]', 'prediction': {'Stat1': 'protein', 'p94': 'protein', 'p95': 'protein'}}
{'idx': 1232, 'sentence': 'IBR is a 503-amino-acid-long acidic protein which is 99.0% identical to the recently reported human NRF-1/alpha-Pal factor and highly related to the invertebrate transcription factors P3A2 and erected wing gene product ( EWG ).', 'label': {'IBR': 'protein', 'transcription factors': 'protein', 'erected wing gene product': 'protein', 'human NRF-1/alpha-Pal factor': 'protein', 'EWG': 'protein', 'P3A2': 'protein', '503-amino-acid-long acidic protein': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein (IL-4) and its corresponding entity label."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence clearly mentions a protein (NF-E2) and its corresponding entity label."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains multiple examples of proteins (IL-2, c-Jun, c-Fos) and their corresponding entity labels."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides a clear example of a protein (interferon regulatory factor) and its corresponding entity label."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains multiple examples of proteins (EKLF, CBP, p300, P/CAF) and their corresponding entity labels."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides a clear example of a protein (A-myb) and its corresponding entity label."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides a clear example of a protein (Protein) and its corresponding entity label."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains multiple examples of proteins (p21(WAF1/CIP1), p27(KIP1)) and their corresponding entity labels."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains multiple examples of proteins (Drosophila Toll, human Toll) and their corresponding entity labels."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains multiple examples of proteins (PAFR, PAF, NF-kappa B, protein kinase C) and their corresponding entity labels."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains multiple examples of proteins (NF-kappa B, AP-1) and their corresponding entity labels."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains multiple examples of proteins (EBNA-2, PU.1) and their corresponding entity labels."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains a protein (NF-ATc) and its corresponding entity label."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides a clear example of a DNA entity (immunoglobulin kappa 3\' enhancer) and its corresponding entity label."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides a clear example of a protein (Egr-1) and its corresponding entity label."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities from the given entity label set."}\n]', 'response3': '[{"IBR": "protein"}, {"NRF-1/alpha-Pal": "protein"}, {"P3A2": "protein"}, {"erected wing gene product (EWG)": "protein"}]', 'prediction': {'IBR': 'protein', 'NRF-1/alpha-Pal': 'protein', 'P3A2': 'protein', 'erected wing gene product (EWG)': 'protein'}}
{'idx': 54, 'sentence': 'Virus stocks obtained from these experiments exhibited a continuum of replicative capacities in different human T-cell types depending on which element (s) was present in the LTR .', 'label': {'LTR': 'DNA', 'human T-cell types': 'cell_type', 'T-cell types': 'cell_type', 'element': 'DNA'}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"T-cell types": "cell_type"}, {"LTR": "DNA"}]', 'prediction': {'T-cell types': 'cell_type', 'LTR': 'DNA'}}
{'idx': 1149, 'sentence': 'The expression and activity of NF-kappa B and Sp1 were, therefore, analyzed in isolated T cells and DCs from humans and mice .', 'label': {'Sp1': 'protein', 'DCs': 'cell_type', 'NF-kappa B': 'protein', 'T cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 4},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"Sp1": "protein"}, {"T cells": "cell_type"}, {"DCs": "cell_type"}, {"humans": "cell_type"}, {"mice": "cell_type"}]', 'prediction': {'NF-kappa B': 'protein', 'Sp1': 'protein', 'T cells': 'cell_type', 'DCs': 'cell_type', 'humans': 'cell_type', 'mice': 'cell_type'}}
{'idx': 407, 'sentence': 'Since most of the actions of vitamin D are mediated by its receptors ( VDR ), abnormalities of VDR have been postulated in XLH .', 'label': {'VDR': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 1},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1},\n    {"Example 26": 1},\n    {"Example 27": 1},\n    {"Example 28": 1},\n    {"Example 29": 1},\n    {"Example 30": 1}\n]', 'response3': '[{"VDR": "protein"}]', 'prediction': {'VDR': 'protein'}}
{'idx': 1466, 'sentence': 'As we observed that activated endothelial cells also expressed NFAT , we tested the antiinflammatory properties of CsA in endothelial cells .', 'label': {'endothelial cells': 'cell_type', 'NFAT': 'protein', 'activated endothelial cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a DNA binding activity associated with NF-kappa B, aiding in the extraction of the entity label."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence clearly links NF-kappa B and I kappa B alpha to protein expression, providing valuable information for entity extraction."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence mentions AP-1, PMA, monocytes, and macrophages, all of which are relevant entity types, although the context could be more specific."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence mentions granulocytes and T cells, which are relevant cell types, aiding in entity extraction."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence directly links NF-kappa B to protein activation, providing valuable information for entity extraction."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides clear examples of NF-kappaB, Tax, and ATL as protein and cell type entities, aiding in entity extraction."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence mentions alpha-tocopherol, monocytes, and endothelial cells, which are relevant entity types, although the context could be more specific."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence directly links NF-kappa B to protein activation, providing valuable information for entity extraction."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence directly links P selectin to protein binding, aiding in entity extraction."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence directly links NF-kappa B to protein activation and ARDS to cell type, providing valuable information for entity extraction."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence directly links NF-kappa B to protein activation, aiding in entity extraction."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence mentions MNDA and Philadelphia chromosome-positive chronic myeloid leukemia as protein and cell line entities, aiding in entity extraction."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence directly links E2A to protein expression, providing valuable information for entity extraction."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence directly links NF-kappa B and AP-1 to protein activation, aiding in entity extraction."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides clear examples of IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, and phorbol myristate acetate as protein entities, aiding in entity extraction."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any relevant entity types mentioned in the target sentence."}\n]', 'response3': '[{"NFAT": "protein"}, {"CsA": "protein"}, {"endothelial cells": "cell_type"}]', 'prediction': {'NFAT': 'protein', 'CsA': 'protein', 'endothelial cells': 'cell_type'}}
{'idx': 1330, 'sentence': 'Stimulation of cells leads to a rapid phosphorylation of I kappa B alpha , which is presumed to be important for the subsequent degradation .', 'label': {'I kappa B alpha': 'protein', 'I kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"I kappa B alpha": "protein"}]', 'prediction': {'I kappa B alpha': 'protein'}}
{'idx': 1436, 'sentence': 'Similar levels of hTR beta 1 mRNA levels were detected in thyroid gland from euthyroid patients .', 'label': {'hTR beta 1 mRNA': 'RNA', 'hTR beta 1': 'protein'}, 'response1': "['RNA']", 'response2': '[\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.": 5},\n    {"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus, and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 4}\n]', 'response3': '[{"hTR beta 1 mRNA": "RNA"}]', 'prediction': {'hTR beta 1 mRNA': 'RNA'}}
{'idx': 859, 'sentence': 'We show that at least one inducible , C1 , and one constitutive, C2 , protein can bind to the HIV enhancer in Jurkat cells .', 'label': {'inducible': 'protein', 'Jurkat cells': 'cell_line', 'C1': 'protein', 'HIV enhancer': 'DNA', 'C2': 'protein', 'constitutive, C2 , protein': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n{"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n{"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n{"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 5},\n{"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n{"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n{"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n{"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n{"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n{"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 5},\n{"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n{"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5},\n{"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 5},\n{"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells (Daudi) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner.": 5}\n]', 'response3': '[{"C1": "protein"}, {"C2": "protein"}, {"HIV enhancer": "DNA"}, {"Jurkat": "cell_line"}]', 'prediction': {'C1': 'protein', 'C2': 'protein', 'HIV enhancer': 'DNA', 'Jurkat': 'cell_line'}}
{'idx': 451, 'sentence': 'However, despite its ability to activate transcription of a transfected reporter gene , the factor is apparently unable to bind to the endogenous Ig heavy chain enhancer in non- lymphoid cells : In previous experiments by others, the characteristic in vivo footprint of this factor, designated NF-muE3 , was detected in B cells but not in non-B cells .', 'label': {'NF-muE3': 'protein', 'B cells': 'cell_type', 'lymphoid cells': 'cell_type', 'transfected reporter gene': 'DNA', 'Ig heavy chain enhancer': 'DNA', 'non- lymphoid cells': 'cell_type', 'non-B cells': 'cell_type', 'endogenous Ig heavy chain enhancer': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein entity (p50p50) and its corresponding label."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides a clear example of a protein entity (Egr-1) and its corresponding label."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence provides multiple examples of protein entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor) and their corresponding labels."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides a clear example of a protein entity (TCF-1) and its corresponding label."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides examples of protein entities (IL-2 receptor alpha subunit, p21ras) and a cell type entity (B cell) with their corresponding labels."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides examples of a protein entity (NF-ATc) and cell type entities (T lymphocytes, embryonic cardiac cells) with their corresponding labels."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides a clear example of a protein entity (IL-2) and its corresponding label."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides examples of protein entities (NF-kappaB, Sp1, p50) with their corresponding labels."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides examples of protein entities (c-kit, IL-4R alpha chain) with their corresponding labels."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides examples of protein entities (IL-2, c-Jun, c-Fos) with their corresponding labels."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides a clear example of a DNA entity (immunoglobulin kappa 3\' enhancer) and its corresponding label."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides examples of protein entities (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) with their corresponding labels."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides examples of a protein entity (NF-kappaB) and a cell type entity (rheumatoid arthritis) with their corresponding labels."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides examples of protein entities (CD40, Rel/nuclear factor kappaB, NF-kappaB) and a cell type entity (B lymphocytes) with their corresponding labels."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides examples of protein entities (NF-kappaB, Sp1) and a cell line entity (SIVmac) with their corresponding labels."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence provides examples of protein entities (CTLA4Ig, NFAT, AP-1) with their corresponding labels."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities from the given label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities from the given label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities from the given label set."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities from the given label set."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities from the given label set."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities from the given label set."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities from the given label set."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities from the given label set."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities from the given label set."}\n]', 'response3': '[{"Ig heavy chain enhancer": "DNA"}, {"NF-muE3": "protein"}, {"B cells": "cell_type"}]', 'prediction': {'Ig heavy chain enhancer': 'DNA', 'NF-muE3': 'protein', 'B cells': 'cell_type'}}
{'idx': 919, 'sentence': 'The human protein recognized by the EC1 antibody is a 56-kDa protein ( p56 ) of moderate abundance located predominantly in the cytoplasm by indirect immunofluorescence .', 'label': {'56-kDa protein': 'protein', 'p56': 'protein', 'EC1 antibody': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 5},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"EC1 antibody": "protein"}, {"p56": "protein"}]', 'prediction': {'EC1 antibody': 'protein', 'p56': 'protein'}}
{'idx': 1206, 'sentence': 'In addition, the concentration of androgen receptors in mononuclear leukocytes was measured, in both the follicular and luteal phases of the menstrual cycle , basally and after 4 months of flutamide treatment.', 'label': {'androgen receptors': 'protein', 'mononuclear leukocytes': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and direct mention of the entity \'RXR\' and its corresponding label \'protein\', making it highly helpful for extracting named entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions \'granulocytes\' and \'T cells\' as entities, which are labeled as \'cell_type\'. This is helpful for identifying cell types in the text."},\n    {"Example 3": 3},\n    {"Reason 3": "The sentence mentions \'lymphoid neoplasms\' as an entity, which is labeled as \'cell_type\'. While helpful, the context is slightly less direct compared to other examples."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence directly mentions \'CD14\' as an entity, which is labeled as \'protein\'. This direct mention makes it highly helpful for entity extraction."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence mentions \'phosphocreatine\' as an entity, which is labeled as \'protein\'. This is helpful for identifying proteins in the text."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions \'HML\', \'dexamethasone\', \'cortisol\', and \'lysozyme\' as entities, which are labeled as \'cell_line\' and \'protein\'. This direct mention of multiple entities makes it highly helpful for extraction."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence mentions \'NF-E2\' as an entity, which is labeled as \'protein\'. This direct mention makes it highly helpful for entity extraction."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions \'E2A\' as an entity, which is labeled as \'protein\'. This direct mention makes it highly helpful for entity extraction."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence mentions \'CD70\', \'B cell\', \'plasma cells\', \'IL-4\', and \'CD40\' as entities, which are labeled as \'protein\' and \'cell_type\'. This direct mention of multiple entities makes it highly helpful for extraction."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions \'protein kinase A\' and \'Rap1\' as entities, which are labeled as \'protein\'. This direct mention makes it highly helpful for entity extraction."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions \'CD40\', \'Rel/nuclear factor kappaB\', \'NF-kappaB\', and \'B lymphocytes\' as entities, which are labeled as \'protein\' and \'cell_type\'. This direct mention of multiple entities makes it highly helpful for extraction."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions \'PU.1\', \'CSF-1 receptor\', \'Mono A\', and \'Mono B\' as entities, which are labeled as \'protein\'. This direct mention of multiple entities makes it highly helpful for extraction."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence mentions \'nuclear factor-kappa B\' and \'NF-kappa B\' as entities, which are labeled as \'DNA\'. This is helpful for identifying DNA entities in the text."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence mentions \'NF-kappa B\' and \'fibrinogen\' as entities, which are labeled as \'protein\'. This is helpful for identifying proteins in the text."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions \'MNDA\', \'monocytes\', \'macrophages\', and \'leukemia/B lymphoma cell lines\' as entities, which are labeled as \'protein\' and \'cell_type\'. This direct mention of multiple entities makes it highly helpful for extraction."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence mentions \'PMA\' and \'U1 cells\' as entities, which are labeled as \'cell_line\'. This direct mention makes it highly helpful for entity extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities from the given label set, making it not helpful for entity extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities from the given label set, making it not helpful for entity extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities from the given label set, making it not helpful for entity extraction."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities from the given label set, making it not helpful for entity extraction."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities from the given label set, making it not helpful for entity extraction."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities from the given label set, making it not helpful for entity extraction."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities from the given label set, making it not helpful for entity extraction."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities from the given label set, making it not helpful for entity extraction."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities from the given label set, making it not helpful for entity extraction."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 569, 'sentence': 'In addition, the increases in c-jun , EGR2 , and PDGF(B) may depend on cytoskeletal rearrangement .', 'label': {'PDGF(B)': 'protein', 'EGR2': 'DNA', 'c-jun': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.": 5},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 5},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.": 5},\n    {"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n    {"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1657, 'sentence': 'HMG-I binds to GATA motifs : implications for an HPFH syndrome .', 'label': {'HMG-I': 'protein', 'GATA motifs': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides clear examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."}\n]', 'response3': '[{"HMG-I": "protein"}, {"GATA motifs": "DNA"}, {"HPFH syndrome": "cell_type"}]', 'prediction': {'HMG-I': 'protein', 'GATA motifs': 'DNA', 'HPFH syndrome': 'cell_type'}}
{'idx': 1780, 'sentence': 'Interestingly, Id2 , but not Id3 , mRNA was strongly expressed in 4/5 T-cell lines infected with human T-cell leukemia virus type I ( HTLV-I ) ( ATL-1k , MT-2 , S-LB1 ) and type II ( Mo ) .', 'label': {'Id3': 'protein', 'Mo': 'cell_line', 'Id2': 'protein', '4/5 T-cell lines': 'cell_line', 'S-LB1': 'cell_line', 'MT-2': 'cell_line', 'ATL-1k': 'cell_line'}, 'response1': "['RNA', 'cell_line']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"4": "The sentence contains multiple protein entities and a cell type entity."},\n    {"4": "The sentence contains a protein entity and a cell type entity."},\n    {"5": "The sentence contains multiple protein entities and a protein-related term."},\n    {"5": "The sentence contains multiple cell line entities."},\n    {"4": "The sentence contains a protein entity and two cell type entities."},\n    {"4": "The sentence contains a cell type entity."},\n    {"5": "The sentence contains multiple protein entities and a technology-related term."},\n    {"4": "The sentence contains a cell type entity and a DNA entity."},\n    {"4": "The sentence contains a protein entity."},\n    {"4": "The sentence contains multiple protein entities and a cell type entity."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"4": "The sentence contains multiple protein entities and a cell type entity."},\n    {"4": "The sentence contains multiple protein entities."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."}\n]', 'response3': '[{"Id2": "protein"}, {"Id3": "protein"}, {"mRNA": "RNA"}, {"T-cell lines": "cell_line"}, {"human T-cell leukemia virus type I (HTLV-I)": "cell_type"}, {"ATL-1k": "cell_line"}, {"MT-2": "cell_line"}, {"S-LB1": "cell_line"}, {"type II (Mo)": "cell_line"}]', 'prediction': {'Id2': 'protein', 'Id3': 'protein', 'mRNA': 'RNA', 'T-cell lines': 'cell_line', 'human T-cell leukemia virus type I (HTLV-I)': 'cell_type', 'ATL-1k': 'cell_line', 'MT-2': 'cell_line', 'S-LB1': 'cell_line', 'type II (Mo)': 'cell_line'}}
{'idx': 13, 'sentence': 'We further demonstrate the impact of platelet-activating factor binding to B cells by measuring platelet-activating factor induced arachidonic acid release and 5-hydroxyeicosatetraenoic acid production.', 'label': {'platelet-activating factor': 'protein', 'B cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n{"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n{"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 4},\n{"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 4},\n{"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 3},\n{"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n{"We have examined the effect of alpha-tocopherol ( alpha-tcp ) on one cellular event in atherosclerotic plaque development , monocyte adhesion to stimulated endothelial cells ( ECs ).": 4},\n{"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 4},\n{"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects.": 5},\n{"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.": 4},\n{"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation.": 5},\n{"PMA induced the expression of both CD14 and CD23 mRNA and protein.": 5},\n{"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF.": 5},\n{"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation.": 4},\n{"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 4},\n{"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations.": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1554, 'sentence': 'The results define essential cis-acting elements responsible for the expression of GP Ib alpha and provide insights into molecular events coinciding with the release of normal platelets into the bloodstream .', 'label': {'GP': 'protein', 'normal platelets': 'cell_type', 'cis-acting elements': 'DNA', 'GP Ib alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.": 5},\n{"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 4},\n{"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .": 5},\n{"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements .": 4},\n{"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .": 5},\n{"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .": 5},\n{"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .": 5},\n{"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .": 5},\n{"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .": 5},\n{"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .": 5},\n{"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .": 5},\n{"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts .": 5},\n{"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n{"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 5}\n]', 'response3': '[{"GP Ib alpha": "protein"}]', 'prediction': {'GP Ib alpha': 'protein'}}
{'idx': 1650, 'sentence': 'This is the first demonstration of a specific interaction with PU.1 on a myeloid PU.1 binding site .', 'label': {'PU.1': 'protein', 'myeloid PU.1 binding site': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence mentions specific protein names and a cell type, which align with the entity types in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence includes protein names, a transcription factor, and a cell type, all of which are relevant to the entity types in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides protein names that match the entity types in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence mentions specific protein names, a cell type, and transcription factors, all of which are relevant to the entity types in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains a specific protein name that matches the entity type in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence includes protein names and a cell line, which align with the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides protein names that correspond to the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence mentions specific protein names that match the entity types in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence includes protein names that align with the entity types in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains protein names that directly match the entity types in the target sentence."},\n    {"Example 12": 1},\n    {"Reason 12": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not include any relevant entity types from the target sentence."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not mention any entity types that match those in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not provide any relevant entity types from the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not include any relevant entity types from the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not mention any entity types that match those in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not provide any relevant entity types from the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not include any relevant entity types from the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not mention any entity types that match those in the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not provide any relevant entity types from the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not include any relevant entity types from the target sentence."}\n]', 'response3': "[{'PU.1': 'protein'}, {'myeloid PU.1 binding site': 'protein'}]", 'prediction': {'PU.1': 'protein', 'myeloid PU.1 binding site': 'protein'}}
{'idx': 326, 'sentence': 'We show here that domain B is an R-responsive element in HeLa cells and is therefore not an EB1 -responsive B-cell-specific element .', 'label': {'EB1': 'protein', 'R-responsive element': 'DNA', 'HeLa cells': 'cell_line', 'domain B': 'DNA', 'EB1 -responsive B-cell-specific element': 'DNA'}, 'response1': "['cell_line', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific cell type names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific cell type and cell line names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific DNA and protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains specific cell type names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains specific cell line and protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains specific protein and cell line names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific cell line names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains specific cell type names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entity names or labels that match the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entity names or labels that match the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entity names or labels that match the entity types in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entity names or labels that match the entity types in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entity names or labels that match the entity types in the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entity names or labels that match the entity types in the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entity names or labels that match the entity types in the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entity names or labels that match the entity types in the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entity names or labels that match the entity types in the target sentence."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entity names or labels that match the entity types in the target sentence."}\n]', 'response3': '[{"HeLa cells": "cell_line"}, {"EB1": "protein"}, {"B-cell": "cell_type"}]', 'prediction': {'HeLa cells': 'cell_line', 'EB1': 'protein', 'B-cell': 'cell_type'}}
{'idx': 1429, 'sentence': 'Data from cell culture and animal studies indicate that TR expression may be regulated to modulate target organ responsiveness to thyroid hormone .', 'label': {'TR': 'protein'}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific cell types and proteins that are directly mentioned, making it highly relevant for extracting named entities from the target sentence."}\n]', 'response3': '[{"TR": "protein"}]', 'prediction': {'TR': 'protein'}}
{'idx': 865, 'sentence': 'Response to T cell activation signals .', 'label': {'T cell': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n{"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n{"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n{"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.": 4},\n{"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n{"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 4},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n{"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n{"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.": 5},\n{"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.": 5},\n{"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n{"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n{"Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency.": 5},\n{"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n{"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 4},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n{"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 696, 'sentence': 'First, from different cell lines three or all four of the nuclear proteins were specifically cross-linked by UV irradiation to the radioactively labeled TRE -DNA fragment .', 'label': {'TRE -DNA fragment': 'DNA', 'nuclear proteins': 'protein', 'TRE': 'DNA'}, 'response1': "['protein', 'DNA', 'cell_line']", 'response2': '[\n{"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n{"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .": 5},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n{"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n{"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50 .": 5},\n{"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n{"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .": 5},\n{"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n{"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .": 5},\n{"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .": 5},\n{"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .": 5},\n{"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .": 5},\n{"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .": 5},\n{"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[{"UV irradiation": "None"}, {"radioactively labeled TRE -DNA fragment": "DNA"}]', 'prediction': {'UV irradiation': 'None', 'radioactively labeled TRE -DNA fragment': 'DNA'}}
{'idx': 318, 'sentence': 'Furthermore, the existence of estrogen receptor (estrogen binding activity) was examined histochemically in 39 cases and it was detected in 8.', 'label': {'estrogen receptor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein entity (RXR) and its corresponding label, which directly matches the entity types in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides a clear example of a protein entity (retinoic acid receptor alpha) and its corresponding label, which directly matches the entity types in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence provides a clear example of a protein entity (NF-E2) and its corresponding label, which directly matches the entity types in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides clear examples of protein entities (IL-2, c-Jun, c-Fos) and their corresponding labels, which directly match the entity types in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides a clear example of a protein entity (E2A) and its corresponding label, which directly matches the entity types in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides clear examples of protein entities (NF-kB, AP-1, OCT-1, NF-IL-2B) and their corresponding labels, which directly match the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides clear examples of protein entities (TCRzeta, p56(lck)) and their corresponding labels, which directly match the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides clear examples of protein entities (Ter 119, beta-globin, glycoprotein IIb, platelet factor 4) and their corresponding labels, which directly match the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides clear examples of protein entities (Erbstatin, genistein, Egr-1) and their corresponding labels, which directly match the entity types in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides clear examples of DNA and protein entities (EBV, EBNA2, estrogen receptor) and their corresponding labels, which directly match the entity types in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides clear examples of cell line entities (PMA, U1 cells) and their corresponding labels, which directly match the entity types in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides clear examples of DNA entities (nuclear factor NF-kB, NF-kappa B) and their corresponding labels, which directly match the entity types in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides clear examples of protein entities (CD3.TcR, CD18, CD29) and their corresponding labels, which directly match the entity types in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides clear examples of DNA and protein entities (DNA, PCNA, E2F1) and their corresponding labels, which directly match the entity types in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides clear examples of protein entities (MR, aldosterone, progesterone) and their corresponding labels, which directly match the entity types in the target sentence."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence provides clear examples of protein entities (E2F, E2F-4, DP-1, p130) and a cell type entity (AML) and their corresponding labels, which directly match the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities that match the entity types in the target sentence."}\n]', 'response3': '[{"estrogen receptor": "protein"}]', 'prediction': {'estrogen receptor': 'protein'}}
{'idx': 440, 'sentence': 'All three proteins show the same sequence specificity and binding affinity .', 'label': {}, 'response1': "['protein']", 'response2': '[\n{"These two related genes share the evolutionarily conserved region encoding the Runt domain.": 5},\n{"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.": 4},\n{"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 5},\n{"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 5},\n{"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n{"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.": 4},\n{"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.": 5},\n{"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 5},\n{"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n{"Tat-binding protein 7 is a subunit of the 26S protease.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n{"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n{"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n{"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n{"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 5},\n{"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1563, 'sentence': 'Pathogenesis of atherosclerosis .', 'label': {}, 'response1': 'None.', 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides specific examples with corresponding entity labels, which directly relate to the entity types in the target sentence, making it highly helpful for extracting named entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence offers relevant examples with entity labels that are related to the entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 3": 3},\n    {"Reason 3": "The sentence includes an example with an entity label that is somewhat related to the entity types in the target sentence, providing moderate assistance in extracting named entities."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence presents an example with an entity label that is directly related to one of the entity types in the target sentence, contributing to the extraction of named entities."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence contains an example with entity labels that are relevant to the entity types in the target sentence, assisting in the extraction of named entities."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence offers examples with entity labels that are connected to the entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence provides an example with an entity label that is directly related to one of the entity types in the target sentence, contributing to the extraction of named entities."},\n    {"Example 8": 3},\n    {"Reason 8": "The sentence includes an example with an entity label that is somewhat related to the entity types in the target sentence, providing moderate assistance in extracting named entities."},\n    {"Example 9": 3},\n    {"Reason 9": "The sentence presents an example with an entity label that is somewhat related to the entity types in the target sentence, offering moderate assistance in extracting named entities."},\n    {"Example 10": 3},\n    {"Reason 10": "The sentence contains an example with an entity label that is somewhat related to the entity types in the target sentence, providing moderate assistance in extracting named entities."},\n    {"Example 11": 3},\n    {"Reason 11": "The sentence offers an example with an entity label that is somewhat related to the entity types in the target sentence, providing moderate assistance in extracting named entities."},\n    {"Example 12": 3},\n    {"Reason 12": "The sentence includes an example with an entity label that is somewhat related to the entity types in the target sentence, offering moderate assistance in extracting named entities."},\n    {"Example 13": 3},\n    {"Reason 13": "The sentence presents an example with an entity label that is somewhat related to the entity types in the target sentence, providing moderate assistance in extracting named entities."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not include any examples with entity labels that are directly related to the entity types in the target sentence, offering minimal assistance in extracting named entities."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not provide any examples with entity labels that are directly related to the entity types in the target sentence, offering minimal assistance in extracting named entities."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any examples with entity labels that are directly related to the entity types in the target sentence, offering minimal assistance in extracting named entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not offer any examples with entity labels that are directly related to the entity types in the target sentence, offering minimal assistance in extracting named entities."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not include any examples with entity labels that are directly related to the entity types in the target sentence, offering minimal assistance in extracting named entities."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not provide any examples with entity labels that are directly related to the entity types in the target sentence, offering minimal assistance in extracting named entities."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any examples with entity labels that are directly related to the entity types in the target sentence, offering minimal assistance in extracting named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 689, 'sentence': 'High-risk patients can be recognized morphologically.', 'label': {}, 'response1': 'None.', 'response2': '[\n    {"PBMC": 5},\n    {"adenovirus": 5},\n    {"WT1": 5},\n    {"CD70": 5},\n    {"B cell": 5},\n    {"plasma cells": 5},\n    {"IL-4": 5},\n    {"CD40": 5},\n    {"TCL1": 5},\n    {"myeloperoxidase": 5},\n    {"lysozyme": 5},\n    {"PU.1": 5},\n    {"Ras": 5},\n    {"T-PLL": 5},\n    {"T lymphocytes": 5},\n    {"HLA-molecules": 5},\n    {"MNDA": 5},\n    {"Philadelphia chromosome-positive chronic myeloid leukemia": 5},\n    {"granulocytes": 5},\n    {"T cells": 5},\n    {"TCRzeta": 5},\n    {"p56(lck)": 5},\n    {"PML/RARalpha": 5},\n    {"SIVmacMER": 5},\n    {"SIVmac239": 5},\n    {"CEMx174": 5},\n    {"lymphoid neoplasms": 5},\n    {"SIVsmmPBj14": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 189, 'sentence': 'Transcriptional down-regulation of c-myc expression by protein synthesis -dependent and -independent pathways in a human T lymphoblastic tumor cell line .', 'label': {'human T lymphoblastic tumor cell line': 'cell_line', 'c-myc': 'DNA'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"A critical role of Sp1- and Ets-related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb/Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5},\n    {"Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.": 5},\n    {"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 5},\n    {"These results suggest that oxidative signals can positively and negatively regulate T cell transcriptional events and that changes in cellular redox can uncouple AP-1 regulation of c-jun from transcriptional up-regulation of IL-2 via NF-AT.": 5}\n]', 'response3': '[{"c-myc": "protein"}, {"T lymphoblastic tumor cell line": "cell_line"}]', 'prediction': {'c-myc': 'protein', 'T lymphoblastic tumor cell line': 'cell_line'}}
{'idx': 778, 'sentence': 'Addition of a highly enriched preparation of OTF-1 made from one of these pre-B cells or from HeLa cells specifically stimulated in vitro transcription of an immunoglobulin gene .', 'label': {'OTF-1': 'protein', 'pre-B cells': 'cell_line', 'immunoglobulin gene': 'DNA', 'HeLa cells': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 4},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 5},\n    {"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 4},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 4},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .": 4},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"T cell blasts treated with PMA are now responsive to IFN-gamma .": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .": 5},\n    {"Fibroblast growth factor-1 ( FGF-1 ) enhances IL-2 production and nuclear translocation of NF-kappaB in FGF receptor -bearing Jurkat T cells .": 5}\n]', 'response3': '[{"OTF-1": "protein"}, {"pre-B cells": "cell_type"}, {"HeLa cells": "cell_line"}, {"immunoglobulin gene": "protein"}]', 'prediction': {'OTF-1': 'protein', 'pre-B cells': 'cell_type', 'HeLa cells': 'cell_line', 'immunoglobulin gene': 'protein'}}
{'idx': 198, 'sentence': "Tamoxifen , an oestrogen antagonist , has been given in some patients with CLL and Hodgkin's disease , with dramatic response in single cases.", 'label': {}, 'response1': "['protein']", 'response2': '[\n{"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 1},\n{"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n{"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 4},\n{"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 4},\n{"Thus, STAT1 may be a useful target in the development of new immunosuppressive and antineoplastic agents.": 4},\n{"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 5},\n{"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 4},\n{"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.": 5},\n{"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes.": 4},\n{"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.": 5},\n{"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 5},\n{"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.": 4},\n{"T cell blasts treated with PMA are now responsive to IFN-gamma.": 4},\n{"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n{"Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients.": 4},\n{"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.": 5},\n{"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 735, 'sentence': 'This prompted us to analyze the octamer-binding proteins in the latter cells.', 'label': {'octamer-binding proteins': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example directly mentions the entity type \'DNA\' which is present in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The example provides a relevant entity \'CD95 ligand\' which is a type of protein, aiding in understanding protein entities in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The example mentions entities \'EBNA-2\' and \'PU.1\' which are both proteins, directly related to the entities in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The example contains \'cDNAs\' which are related to DNA, an entity type present in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides entities \'IL-2\', \'c-Jun\', and \'c-Fos\' which are all proteins, aligning with the protein entity in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The example mentions \'NF-kappa B\' which is a protein entity, directly related to the protein entity in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The example includes \'c-kit\' and \'IL-4R alpha chain\' which are both protein entities, aiding in understanding protein entities in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example contains \'Oct-2A\', \'HMG I/Y\', \'HLA-DRA\', and \'B cells\' which are all protein and cell type entities, aligning with the entities in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides \'EKLF\', \'CBP\', \'p300\', and \'P/CAF\' which are all protein entities, directly related to the protein entity in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The example mentions \'IL-4\', \'LPS\', and \'AP-1\' which are all protein entities, aligning with the protein entity in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The example includes \'granulocytes\' and \'T cells\' which are cell type entities, directly related to the cell type entity in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The example contains \'SCM-1\' which is a cell line entity, aiding in understanding cell line entities in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides \'CD40\' and \'NF-kappa B\' which are both protein entities, aligning with the protein entity in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The example mentions \'p21(WAF1/CIP1)\' and \'p27(KIP1)\' which are both protein entities, directly related to the protein entity in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The example includes \'E2A\' which is a protein entity, aiding in understanding protein entities in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any entities related to the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any entities related to the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any entities related to the entity types in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain any entities related to the entity types in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The example does not contain any entities related to the entity types in the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The example does not contain any entities related to the entity types in the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The example does not contain any entities related to the entity types in the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The example does not contain any entities related to the entity types in the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The example does not contain any entities related to the entity types in the target sentence."}\n]', 'response3': "[{'octamer-binding proteins': 'protein'}, {'latter cells': 'cell_type'}]", 'prediction': {'octamer-binding proteins': 'protein', 'latter cells': 'cell_type'}}
{'idx': 1735, 'sentence': 'We therefore examined vitamin D3 -mediated repression of activated IL-2 expression by cotransfecting Jurkat cells with IL-2 promoter/reporter constructs and a VDR overexpression vector and by DNA binding .', 'label': {'VDR': 'protein', 'IL-2 promoter/reporter constructs': 'DNA', 'Jurkat cells': 'cell_line', 'VDR overexpression vector': 'DNA', 'IL-2': 'protein'}, 'response1': "['DNA', 'protein', 'cell_line']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 4},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .": 4},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex .": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .": 5},\n    {"While the activation of the IL-2 promoter and an NFAT -driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418 , it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2 -mediated NFAT activation is under the control of a combination of calcineurin- dependent and independent pathways .": 5},\n    {"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .": 5}\n]', 'response3': '[{"IL-2": "protein"}, {"Jurkat": "cell_line"}, {"IL-2": "DNA"}, {"VDR": "protein"}, {"DNA": "DNA"}]', 'prediction': {'IL-2': 'DNA', 'Jurkat': 'cell_line', 'VDR': 'protein', 'DNA': 'DNA'}}
{'idx': 704, 'sentence': 'Activity of the immunoglobulin heavy and kappa light chain gene enhancers depends on a complex interplay of ubiquitous and developmentally regulated proteins .', 'label': {'ubiquitous and developmentally regulated proteins': 'protein', 'ubiquitous': 'protein', 'developmentally regulated proteins': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"immunoglobulin heavy and kappa light chain gene enhancers": "DNA"}]', 'prediction': {'immunoglobulin heavy and kappa light chain gene enhancers': 'DNA'}}
{'idx': 1236, 'sentence': 'Binding site selection revealed that the alternating RCGCRYGCGY consensus constitutes high-affinity IBR/F binding sites and that the direct-repeat palindrome TGCGCATGCGCA is the optimal site .', 'label': {'direct-repeat palindrome': 'DNA', 'IBR/F': 'protein', 'IBR/F binding sites': 'DNA', 'optimal site': 'DNA', 'alternating RCGCRYGCGY consensus': 'protein'}, 'response1': "['DNA']", 'response2': '[\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n{"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n{"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 4},\n{"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 5},\n{"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 4},\n{"Therefore, we investigated whether IVS1-10T-->C deleteriously affected BRCA1 splicing or expression, and thereby inactivated the other BRCA1 allele.": 4},\n{"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n{"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 4},\n{"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n{"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 4},\n{"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex.": 5},\n{"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif.": 5},\n{"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 541, 'sentence': 'To be or not to be a responder in T-cell responses : ubiquitous oligopeptides in all proteins.', 'label': {}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n    {"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.": 4},\n    {"Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n    {"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"Yet, for many pathogens, the molecules that induce IL-12 production by macrophages and the mechanisms by which they do so remain undefined.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1652, 'sentence': 'Furthermore, we demonstrate that the PU-SF complex binds to PU.1 sites found on a number of myeloid promoters , and its formation requires an intact PU.1 site adjacent to a single-stranded region.', 'label': {'PU.1': 'protein', 'PU-SF complex': 'protein', 'myeloid promoters': 'DNA', 'PU.1 site': 'DNA', 'PU-SF': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 3},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 4},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 4},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 3},\n    {"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.": 4},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 4},\n    {"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 3},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 4},\n    {"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 4},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 4},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes.": 3},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 4},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 4}\n]', 'response3': '[{"PU-SF complex": "protein"}, {"PU.1": "protein"}]', 'prediction': {'PU-SF complex': 'protein', 'PU.1': 'protein'}}
{'idx': 88, 'sentence': 'TNF alpha did not activate cAMP production and its signal was not modulated by cAMP activators .', 'label': {'TNF alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"TNF alpha": "protein"}, {"cAMP": "protein"}, {"cAMP activators": "protein"}]', 'prediction': {'TNF alpha': 'protein', 'cAMP': 'protein', 'cAMP activators': 'protein'}}
{'idx': 1494, 'sentence': 'Increased intracellular stores of latent NF-kappa B may also result in rapid inducibility of NF-kappa B -dependent cytokine gene expression .', 'label': {'latent NF-kappa B': 'protein', 'cytokine': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 4},\n    {"Example 6": 4},\n    {"Example 7": 4},\n    {"Example 8": 4},\n    {"Example 9": 4},\n    {"Example 10": 4},\n    {"Example 11": 4},\n    {"Example 12": 3},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 3},\n    {"Example 16": 3},\n    {"Example 17": 3},\n    {"Example 18": 3},\n    {"Example 19": 3},\n    {"Example 20": 3},\n    {"Example 21": 3},\n    {"Example 22": 3},\n    {"Example 23": 3},\n    {"Example 24": 3}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"NF-kappa B": "protein"}]', 'prediction': {'NF-kappa B': 'protein'}}
{'idx': 940, 'sentence': 'Tamoxifen was also found to compete with 17 beta-estradiol for type II EBS in PBMC , although to a lesser extent than diethylstilbestrol .', 'label': {'PBMC': 'cell_type', 'type II EBS': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a specific protein entity (NF-E2) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The examples provide protein entities (alpha-tocopherol), cell type entities (monocyte, endothelial cells) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 3": 3},\n    {"Reason 3": "The examples provide protein entities (NF-kappa B, AP-1) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 4": 3},\n    {"Reason 4": "The examples provide protein entities (IL-2, NF-kappa B, AP-1) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 5": 4},\n    {"Reason 5": "The examples provide RNA entity (IL-5 mRNA), cell type entity (TCR), protein entity (IL-2R, dexamethasone) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 6": 3},\n    {"Reason 6": "The example provides a specific protein entity (retinoic acid receptor alpha) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 7": 4},\n    {"Reason 7": "The examples provide protein entity (WT1), cell line entity (myeloid cell lines) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 8": 3},\n    {"Reason 8": "The example provides a specific protein entity (E2A) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 9": 4},\n    {"Reason 9": "The examples provide protein entities (NF-kappa B, I kappa B beta) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 10": 2},\n    {"Reason 10": "The examples provide cell type entity (lymphocytes), chemical compound entities (benzene, benzoquinone) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 11": 3},\n    {"Reason 11": "The example provides a specific protein entity (NF-kappa B) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 12": 4},\n    {"Reason 12": "The examples provide cell line entity (Ter 119), protein entities (beta-globin, glycoprotein IIb, platelet factor 4) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 13": 4},\n    {"Reason 13": "The examples provide protein entities (Erbstatin, genistein), RNA entity (Egr-1) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 14": 4},\n    {"Reason 14": "The examples provide cell type entity (B cell), protein entity (Ig, Transforming growth factor-beta) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 15": 3},\n    {"Reason 15": "The examples provide DNA entity (EBV), protein entities (EBNA2, estrogen receptor) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 16": 4},\n    {"Reason 16": "The examples provide cell line entities (PMA, U1 cells) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any named entities from the given entity label set."}\n]', 'response3': '[{"17 beta-estradiol": "protein"}, {"diethylstilbestrol": "protein"}]', 'prediction': {'17 beta-estradiol': 'protein', 'diethylstilbestrol': 'protein'}}
{'idx': 1098, 'sentence': 'Thus, intact microtubules are essential for 1,25(OH)2D3 -dependent modulation of gene transcription .', 'label': {'microtubules': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.": 5},\n{"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.": 5},\n{"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 5},\n{"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis.": 5},\n{"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n{"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras.": 5},\n{"Here we examined the regulatory mechanism of the SCM-1 genes.": 5},\n{"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n{"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription.": 5},\n{"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation.": 5},\n{"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n{"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.": 5},\n{"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 5},\n{"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n{"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 5},\n{"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5}\n]', 'response3': '[{"microtubules": "protein"}]', 'prediction': {'microtubules': 'protein'}}
{'idx': 255, 'sentence': 'c-myc RNA , which is constitutively expressed in RWLeu-4 cells , increased after 0.5 h of treatment with 50 nM VD3 and then rapidly decreased to barely detectable levels after 4 h of treatment.', 'label': {'c-myc RNA': 'RNA', 'RWLeu-4 cells': 'cell_line'}, 'response1': "['RNA', 'cell_line']", 'response2': '[\n    {"CD40 expression could be enhanced in CD40-positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n    {"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 4},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 4},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 4},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 3},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 5},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]": 4},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 4},\n    {"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.": 5},\n    {"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.": 5}\n]', 'response3': '[{"c-myc RNA": "RNA"}, {"RWLeu-4 cells": "cell_line"}, {"VD3": "protein"}]', 'prediction': {'c-myc RNA': 'RNA', 'RWLeu-4 cells': 'cell_line', 'VD3': 'protein'}}
{'idx': 775, 'sentence': 'Some of these proteins (referred to as OTF-2 ) are lymphoid specific, whereas at least one other, and possibly more (referred to as OTF-1 ), is found ubiquitously in all cell types.', 'label': {'OTF-1': 'protein', 'OTF-2': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes": 5},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined": 4},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role": 4},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals": 4},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells": 4},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes": 4},\n    {"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein": 5},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset": 5},\n    {"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor": 4},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats)": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729": 1}\n]', 'response3': '[{"OTF-2": "protein"}, {"OTF-1": "protein"}]', 'prediction': {'OTF-2': 'protein', 'OTF-1': 'protein'}}
{'idx': 161, 'sentence': 'Steroid dose sparing : pharmacodynamic responses to single versus divided doses of methylprednisolone in man.', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"5": "The sentence contains multiple named entities such as \'HML\' (cell_line), \'dexamethasone\' (protein), \'cortisol\' (protein), and \'lysozyme\' (protein), which are directly related to the entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"5": "The sentence contains multiple named entities such as \'IL-5 mRNA\' (RNA), \'TCR\' (cell_type), \'IL-2R\' (protein), and \'dexamethasone\' (protein), which are directly related to the entity label set."},\n    {"5": "The sentence contains multiple named entities such as \'SP1\' (protein), \'caspases\' (protein), and \'B-cell\' (cell_type), which are directly related to the entity label set."},\n    {"5": "The sentence contains multiple named entities such as \'IL-2\' (protein), \'NF-kappa B\' (protein), and \'AP-1\' (protein), which are directly related to the entity label set."},\n    {"5": "The sentence contains the named entity \'CD14\' (protein), which is directly related to the entity label set."},\n    {"5": "The sentence contains the named entity \'P selectin\' (protein), which is directly related to the entity label set."},\n    {"5": "The sentence contains multiple named entities such as \'Erbstatin\' (protein), \'genistein\' (protein), and \'Egr-1\' (RNA), which are directly related to the entity label set."},\n    {"5": "The sentence contains multiple named entities such as \'PMA\' (protein), \'LPS\' (protein), \'staurosporine\' (protein), \'bisindolylmaleimide\' (protein), and \'genistein\' (protein), which are directly related to the entity label set."},\n    {"5": "The sentence contains multiple named entities such as \'PMA\' (cell_line) and \'U1 cells\' (cell_line), which are directly related to the entity label set."},\n    {"5": "The sentence contains multiple named entities such as \'CD4+\' (cell_type), \'CD8+\' (cell_type), \'TPCK\' (protein), \'anti-CD28\' (protein), and \'PMA\' (protein), which are directly related to the entity label set."},\n    {"5": "The sentence contains multiple named entities such as \'DNA-binding phosphoproteins\' (protein), \'T cell\' (cell_type), and \'cyclosporin A\' (protein), which are directly related to the entity label set."},\n    {"5": "The sentence contains multiple named entities such as \'CD3.TcR\' (protein), \'CD18\' (protein), and \'CD29\' (protein), which are directly related to the entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1130, 'sentence': 'B-lymphoblastoid cell lines from multiple sclerosis patients and a healthy control producing a putative new human retrovirus and Epstein-Barr virus .', 'label': {'B-lymphoblastoid cell lines': 'cell_line'}, 'response1': "['cell_line', 'virus']", 'response2': '[\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 1},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .": 4},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n    {"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.": 3},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 3},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .": 5},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .": 4},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 3},\n    {"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .": 5},\n    {"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice .": 5},\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[{"B-lymphoblastoid cell lines": "cell_line"}, {"multiple sclerosis patients": "cell_type"}, {"a healthy control": "cell_type"}, {"putative new human retrovirus": "protein"}, {"Epstein-Barr virus": "protein"}]', 'prediction': {'B-lymphoblastoid cell lines': 'cell_line', 'multiple sclerosis patients': 'cell_type', 'a healthy control': 'cell_type', 'putative new human retrovirus': 'protein', 'Epstein-Barr virus': 'protein'}}
{'idx': 600, 'sentence': 'Involvement of a second lymphoid-specific enhancer element in the regulation of immunoglobulin heavy-chain gene expression .', 'label': {'immunoglobulin heavy-chain gene': 'DNA', 'lymphoid-specific enhancer element': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .": 4},\n{"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 4},\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 4},\n{"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n{"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 4},\n{"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n{"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n{"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements .": 4},\n{"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 4},\n{"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 4},\n{"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .": 5},\n{"Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells .": 5},\n{"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .": 5}\n]', 'response3': '[{"lymphoid-specific enhancer element": "DNA"}, {"immunoglobulin heavy-chain gene": "DNA"}]', 'prediction': {'lymphoid-specific enhancer element': 'DNA', 'immunoglobulin heavy-chain gene': 'DNA'}}
{'idx': 1698, 'sentence': 'Oncogenicity of human papillomavirus- or adenovirus- transformed cells correlates with resistance to lysis by natural killer cells .', 'label': {'natural killer cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"2": "The sentence does not contain any of the entity types in the target sentence."},\n    {"3": "The sentence contains \'NF-kappaB\' which is a protein, \'Tax\' which is a cell_type, and \'ATL\' which is a cell_type."},\n    {"4": "The sentence contains \'WT1\' which is a protein and \'myeloid cell lines\' which is a cell_line."},\n    {"5": "The sentence contains \'IFN A\' and \'IFNA\' which are both proteins, \'interleukin-2\' and \'interleukin-2 receptor\' which are both proteins, \'phytohemagglutinin\' which is a protein, and \'phorbol myristate acetate\' which is a protein."},\n    {"6": "The sentence contains \'NF-kappa B\' which is a protein."},\n    {"7": "The sentence contains \'IkappaBbeta\' and \'NF-kappaB\' which are both proteins."},\n    {"8": "The sentence contains \'TIMP-1\' which is a protein and \'DNA\' which is DNA."},\n    {"9": "The sentence contains \'PBMC\' which is a cell_type and \'adenovirus DNA\' which is DNA."},\n    {"10": "The sentence contains \'HIV-1\' which is a cell_type, \'IFN\' which is a protein, \'PKR\' which is a protein, and \'IkappaBalpha\' which is a protein."},\n    {"11": "The sentence contains \'NF-kappaB\' which is a protein, \'Sp1\' which is a protein, and \'SIVmac\' which is a cell_line."},\n    {"12": "The sentence contains \'pRB\' which is a protein, \'U937\' which is a cell_line, \'p53\' which is a protein, \'apoptosis\' which is a cell_type, \'calphostin C\' which is a protein, \'ceramide\' which is a protein, and \'serum withdrawal\' which is a cell_type."},\n    {"13": "The sentence contains \'T lymphocytes\' which is a cell_type and \'adenovirus vectors\' which is DNA."},\n    {"14": "The sentence contains \'NF-kappa B\' which is a protein and \'neutrophils\' which is a cell_type."},\n    {"15": "The sentence contains \'HIV\' which is a protein, \'NF-kappa B\' which is a protein, \'p105\' which is a protein, \'p50\' which is a protein, and \'MAD3\' which is a protein."},\n    {"16": "The sentence contains \'CD4+\' and \'CD8+\' which are both cell_types, \'TPCK\' which is a protein, \'anti-CD28\' which is a protein, and \'PMA\' which is a protein."},\n    {"17": "The sentence does not contain any of the entity types in the target sentence."},\n    {"18": "The sentence does not contain any of the entity types in the target sentence."},\n    {"19": "The sentence does not contain any of the entity types in the target sentence."},\n    {"20": "The sentence does not contain any of the entity types in the target sentence."},\n    {"21": "The sentence does not contain any of the entity types in the target sentence."},\n    {"22": "The sentence does not contain any of the entity types in the target sentence."},\n    {"23": "The sentence does not contain any of the entity types in the target sentence."},\n    {"24": "The sentence does not contain any of the entity types in the target sentence."},\n    {"25": "The sentence does not contain any of the entity types in the target sentence."},\n    {"26": "The sentence does not contain any of the entity types in the target sentence."},\n    {"27": "The sentence does not contain any of the entity types in the target sentence."},\n    {"28": "The sentence does not contain any of the entity types in the target sentence."},\n    {"29": "The sentence does not contain any of the entity types in the target sentence."},\n    {"30": "The sentence does not contain any of the entity types in the target sentence."}\n]', 'response3': "[{'human papillomavirus-': 'cell_type'}, {'adenovirus-': 'cell_type'}, {'natural killer cells': 'cell_type'}]", 'prediction': {'human papillomavirus-': 'cell_type', 'adenovirus-': 'cell_type', 'natural killer cells': 'cell_type'}}
{'idx': 1287, 'sentence': 'Platelet thromboxane receptors are acutely and reversibly upregulated after acute myocardial infarction .', 'label': {'Platelet thromboxane receptors': 'protein', 'Platelet': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides clear and specific examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1266, 'sentence': 'Human herpesvirus 6 , a predominantly T lymphotropic virus , has been recently shown to infect some EBV -positive B cell lines , and to induce in them the activation of the EBV lytic cycle .', 'label': {'EBV -positive B cell lines': 'cell_line'}, 'response1': "['virus', 'cell_line']", 'response2': '[\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 3},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 4},\n    {"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .": 4},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .": 4},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 3},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 3},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development .": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .": 4},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 4},\n    {"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .": 5},\n    {"Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype .": 4}\n]', 'response3': '[{"Human herpesvirus 6": "cell_type"}, {"EBV": "cell_line"}, {"B cell lines": "cell_line"}, {"EBV": "cell_type"}]', 'prediction': {'Human herpesvirus 6': 'cell_type', 'EBV': 'cell_type', 'B cell lines': 'cell_line'}}
{'idx': 1813, 'sentence': 'Northern blot analysis revealed that BLR2 mRNA could be highly stimulated in mitogen- and anti-CD3- treated peripheral blood lymphocytes .', 'label': {'BLR2 mRNA': 'RNA', 'BLR2': 'protein'}, 'response1': "['RNA', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 1},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1}\n]', 'response3': '[{"BLR2 mRNA": "RNA"}, {"mitogen": "protein"}, {"anti-CD3": "protein"}, {"peripheral blood lymphocytes": "cell_type"}]', 'prediction': {'BLR2 mRNA': 'RNA', 'mitogen': 'protein', 'anti-CD3': 'protein', 'peripheral blood lymphocytes': 'cell_type'}}
{'idx': 1764, 'sentence': 'The inhibitory effect of cysteamine may be mediated at least in part by an effect on transcription factor function , as the DNA binding activities of AP-1 and NF-kappa B extracted from mitogen-stimulated cells were significantly inhibited by cysteamine treatment .', 'label': {'AP-1': 'protein', 'NF-kappa B': 'protein', 'transcription factor': 'protein', 'mitogen-stimulated cells': 'cell_type'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n    {"Reasons": "The sentence does not contain any of the entity types present in the target sentence, making it least helpful for extracting named entities."}\n]', 'response3': '[{"AP-1": "DNA"}, {"NF-kappa B": "protein"}]', 'prediction': {'AP-1': 'DNA', 'NF-kappa B': 'protein'}}
{'idx': 740, 'sentence': 'On the basis of these assays, all N-Oct-factors were found to be distinct from the ubiquitous Oct-1 and the lymphoid-specific Oct-2A proteins.', 'label': {'ubiquitous Oct-1': 'protein', 'Oct-1': 'protein', 'Oct-2A': 'protein', 'lymphoid-specific Oct-2A': 'protein', 'N-Oct-factors': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 5},\n{"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 4},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n{"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n{"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n{"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n{"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n{"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 5},\n{"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n{"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n{"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 5},\n{"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n{"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.": 5}\n]', 'response3': '[{"Oct-1": "protein"}, {"Oct-2A": "protein"}]', 'prediction': {'Oct-1': 'protein', 'Oct-2A': 'protein'}}
{'idx': 1182, 'sentence': 'Moreover, STAT5 was found to be the predominant STAT transcription factor used by IL-2 in human T cells , and specifically required a COOH-terminal region of IL-2R beta ( Ser386-Val525 ), while STAT5 recruitment was not correlated to activation of IL-2R gamma or JAK3 .', 'label': {'IL-2': 'protein', 'T cells': 'cell_type', 'COOH-terminal region': 'protein', 'human T cells': 'cell_type', 'Ser386-Val525': 'protein', 'JAK3': 'protein', 'STAT transcription factor': 'protein', 'STAT5': 'protein', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .": 5},\n{"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 1},\n{"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n{"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 5},\n{"Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.": 5},\n{"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .": 5},\n{"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n{"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells .": 5},\n{"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function .": 5},\n{"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines .": 5},\n{"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .": 5},\n{"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n{"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[{"STAT5": "protein"}, {"IL-2": "protein"}, {"T cells": "cell_type"}, {"IL-2R beta": "protein"}, {"IL-2R gamma": "protein"}, {"JAK3": "protein"}]', 'prediction': {'STAT5': 'protein', 'IL-2': 'protein', 'T cells': 'cell_type', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein', 'JAK3': 'protein'}}
{'idx': 393, 'sentence': 'We also tested for the ability of defensins NP-1 , NP-5 , and HNP-1 to activate pag expression and found that these peptides have no effect.', 'label': {'HNP-1': 'protein', 'pag': 'DNA', 'NP-1': 'protein', 'defensins': 'protein', 'NP-5': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1442, 'sentence': 'T cell expression of interleukin 3 ( IL-3 ) is directed by positive and negative cis-acting DNA elements clustered within 300 base pairs of the transcriptional start site .', 'label': {'interleukin 3': 'protein', 'transcriptional start site': 'DNA', 'IL-3': 'protein'}, 'response1': "['DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 1},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"IL-3": "protein"}]', 'prediction': {'IL-3': 'protein'}}
{'idx': 142, 'sentence': 'This level of NF-kappa B -independent activity appears to be sufficient for virus multiplication , since TNF-alpha treatment had no effect on the kinetics of de novo HIV type 1 ( HIV-1 ) infection and viral RNA production in U937 cells .', 'label': {'U937 cells': 'cell_line', 'NF-kappa B': 'protein', 'viral RNA': 'RNA', 'TNF-alpha': 'protein'}, 'response1': "['RNA', 'protein', 'cell_line']", 'response2': '[\n    {"Example 1": 4},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 4},\n    {"Example 7": 4},\n    {"Example 8": 4},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"HIV type 1": "cell_type"}, {"HIV-1": "cell_type"}, {"RNA": "RNA"}, {"U937 cells": "cell_line"}]', 'prediction': {'HIV type 1': 'cell_type', 'HIV-1': 'cell_type', 'RNA': 'RNA', 'U937 cells': 'cell_line'}}
{'idx': 93, 'sentence': 'The Thy-1 gene promoter resembles a "housekeeping" promoter in that it is located within a methylation-free island , lacks a canonical TATA box , and displays heterogeneity in the 5\'-end termini of the mRNA .', 'label': {'canonical TATA box': 'DNA', '"housekeeping" promoter': 'DNA', 'methylation-free island': 'DNA', "5'-end termini": 'RNA', 'Thy-1 gene promoter': 'DNA', 'mRNA': 'RNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n    {"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 4},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 4},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"While the activation of the IL-2 promoter and an NFAT-driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418, it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2-mediated NFAT activation is under the control of a combination of calcineurin-dependent and independent pathways.": 5},\n    {"This sequence element was referred to as the BAT box and its deletion significantly reduced the activity of a CD20 promoter-CAT construct in B cells.": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5}\n]', 'response3': '[{"Thy-1 gene promoter": "DNA"}]', 'prediction': {'Thy-1 gene promoter': 'DNA'}}
{'idx': 1354, 'sentence': 'In addition, these results indicate that nuclear TCF-1 expression can serve as a pan-T-lineage marker in the diagnosis of lymphoid malignancies .', 'label': {'TCF-1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains a clear mention of a transcription factor (AP-1) and its association with DNA binding activity, providing a direct link between the entity and its label."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions NF-kappaB, Tax, and ATL patients, providing specific entities and their associations, although the mechanism is described as \'Tax-independent\', still helpful in identifying the entities."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence directly mentions WT1 and its exclusive paternal expression, providing a clear link between the entity and its label."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence mentions TCL1 and its expression in AIDS IBLP tumors, providing a direct link between the entity and its label."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence mentions NF-ATc and its isoforms in T lymphocytes, providing a direct link between the entity and its label."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence mentions TCF-1 and its transactivation in non-T cells, providing a direct link between the entity and its label."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence mentions lymphoid neoplasms, providing a clear link between the entity and its label."},\n    {"Example 8": 4},\n    {"Reason 8": "The sentence mentions Th2-type lymphocytes and their cytokine expression, providing a direct link between the entity and its label."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence mentions TCF-1 and its presence in mice, providing a direct link between the entity and its label."},\n    {"Example 10": 4},\n    {"Reason 10": "The sentence mentions NF-ATc and its isoforms in T lymphocytes and embryonic cardiac cells, providing a direct link between the entities and their labels."},\n    {"Example 11": 4},\n    {"Reason 11": "The sentence mentions RXR and its mutants in erythroid cells, providing a direct link between the entity and its label."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence mentions MNDA and its expression in cell lines from patients with chronic myeloid leukemia, providing a direct link between the entity and its label."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence mentions granulocytes and T cells, providing a direct link between the entities and their labels."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence mentions CD70, B cells, plasma cells, IL-4, and CD40, providing specific entities and their associations."},\n    {"Example 15": 4},\n    {"Reason 15": "The sentence mentions TAL1 and its promotion of T-ALL, providing a direct link between the entity and its label."},\n    {"Example 16": 4},\n    {"Reason 16": "The sentence mentions GATA-1 and its role in erythroid cells, providing a direct link between the entity and its label."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities related to the provided entity labels."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities related to the provided entity labels."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities related to the provided entity labels."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities related to the provided entity labels."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities related to the provided entity labels."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities related to the provided entity labels."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities related to the provided entity labels."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities related to the provided entity labels."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities related to the provided entity labels."}\n]', 'response3': '[{"TCF-1": "protein"}, {"lymphoid malignancies": "cell_type"}]', 'prediction': {'TCF-1': 'protein', 'lymphoid malignancies': 'cell_type'}}
{'idx': 466, 'sentence': '(ABSTRACT TRUNCATED AT 250 WORDS)', 'label': {}, 'response1': 'None.', 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1583, 'sentence': 'Associations between HLA class II antigens and autoantibodies to the ribonucleoproteins Ro(SSA) and La(SSB) have been reported in these patients.', 'label': {'ribonucleoproteins': 'protein', 'Ro(SSA)': 'protein', 'autoantibodies': 'protein', 'HLA class II antigens': 'protein', 'La(SSB)': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence contains a clear mention of the protein \'TCL1\', which is a named entity label in the entity label set."},\n{"Example 2": 5},\n{"Reason 2": "The sentence contains a clear mention of the protein \'WT1\', which is a named entity label in the entity label set."},\n{"Example 3": 5},\n{"Reason 3": "The sentence contains a clear mention of the protein \'RXR\', which is a named entity label in the entity label set."},\n{"Example 4": 5},\n{"Reason 4": "The sentence contains a clear mention of the cell type \'lymphoid neoplasms\', which is a named entity label in the entity label set."},\n{"Example 5": 5},\n{"Reason 5": "The sentence contains a clear mention of the protein \'NF-kappa B\', which is a named entity label in the entity label set."},\n{"Example 6": 5},\n{"Reason 6": "The sentence contains clear mentions of the proteins \'TCRzeta\' and \'p56(lck)\', which are named entity labels in the entity label set."},\n{"Example 7": 5},\n{"Reason 7": "The sentence contains a clear mention of the DNA \'AP-1\', which is a named entity label in the entity label set."},\n{"Example 8": 5},\n{"Reason 8": "The sentence contains clear mentions of the proteins \'EBNA-2\' and \'PU.1\', which are named entity labels in the entity label set."},\n{"Example 9": 5},\n{"Reason 9": "The sentence contains clear mentions of the proteins \'IL-2 receptor alpha subunit\' and \'p21ras\', as well as the cell type \'B cell\', which are named entity labels in the entity label set."},\n{"Example 10": 5},\n{"Reason 10": "The sentence contains clear mentions of the proteins \'SLAP-130\', \'SLP-76\', and the cell type \'T cell\', which are named entity labels in the entity label set."},\n{"Example 11": 5},\n{"Reason 11": "The sentence contains clear mentions of the protein \'NF-kappaB\' and the cell type \'rheumatoid arthritis\', which are named entity labels in the entity label set."},\n{"Example 12": 5},\n{"Reason 12": "The sentence contains clear mentions of the proteins \'myeloperoxidase\', \'lysozyme\', and \'PU.1\', which are named entity labels in the entity label set."},\n{"Example 13": 5},\n{"Reason 13": "The sentence contains a clear mention of the protein \'retinoic acid receptor alpha\', which is a named entity label in the entity label set."},\n{"Example 14": 5},\n{"Reason 14": "The sentence contains clear mentions of the proteins \'Oct-2A\', \'HMG I/Y\', \'HLA-DRA\', and the cell type \'B cell\', which are named entity labels in the entity label set."},\n{"Example 15": 5},\n{"Reason 15": "The sentence contains clear mentions of the cell type \'T lymphocytes\' and the protein \'HLA-molecules\', which are named entity labels in the entity label set."},\n{"Example 16": 1},\n{"Reason 16": "The sentence does not contain any named entities from the entity label set."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any named entities from the entity label set."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any named entities from the entity label set."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any named entities from the entity label set."},\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any named entities from the entity label set."},\n{"Example 21": 1},\n{"Reason 21": "The sentence does not contain any named entities from the entity label set."},\n{"Example 22": 1},\n{"Reason 22": "The sentence does not contain any named entities from the entity label set."},\n{"Example 23": 1},\n{"Reason 23": "The sentence does not contain any named entities from the entity label set."},\n{"Example 24": 1},\n{"Reason 24": "The sentence does not contain any named entities from the entity label set."},\n{"Example 25": 1},\n{"Reason 25": "The sentence does not contain any named entities from the entity label set."}\n]', 'response3': "[{'HLA class II antigens': 'protein'}, {'ribonucleoproteins Ro(SSA)': 'protein'}, {'La(SSB)': 'protein'}]", 'prediction': {'HLA class II antigens': 'protein', 'ribonucleoproteins Ro(SSA)': 'protein', 'La(SSB)': 'protein'}}
{'idx': 592, 'sentence': 'The DNA isolated contained an open reading frame encoding 108 amino acid residues .', 'label': {}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 1},\n    {"Example 13": 1},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"DNA": "DNA"}]', 'prediction': {'DNA': 'DNA'}}
{'idx': 163, 'sentence': 'This phenomenon can be mimicked by administering MP in divided doses.', 'label': {}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence contains specific protein names that are directly mentioned, aiding in the extraction of protein entities."},\n{"Example 2": 4},\n{"Reason 2": "The sentence mentions a specific protein name, \'phosphocreatine\', which can help in identifying protein entities."},\n{"Example 3": 5},\n{"Reason 3": "The sentence provides specific protein names (AP-1, PMA) and cell types (monocytes, macrophages) directly, aiding in the extraction of these entities."},\n{"Example 4": 5},\n{"Reason 4": "The sentence directly mentions specific cell types (granulocytes, T cells), making it highly helpful in extracting cell type entities."},\n{"Example 5": 5},\n{"Reason 5": "The sentence mentions specific protein names (NF-kappa B, AP-1), aiding in the extraction of protein entities."},\n{"Example 6": 5},\n{"Reason 6": "The sentence contains specific protein names (IL-4, LPS, AP-1) that are directly mentioned, aiding in the extraction of protein entities."},\n{"Example 7": 5},\n{"Reason 7": "The sentence directly mentions a specific DNA entity (AP-1), making it highly helpful in extracting DNA entities."},\n{"Example 8": 5},\n{"Reason 8": "The sentence provides specific protein names (CD14, CD23) directly, aiding in the extraction of protein entities."},\n{"Example 9": 5},\n{"Reason 9": "The sentence mentions specific cell line names (SIVmacMER, SIVmac239, CEMx174), making it highly helpful in extracting cell line entities."},\n{"Example 10": 5},\n{"Reason 10": "The sentence mentions specific cell line (MTHC), protein names (TNF-alpha, IFN-gamma), and cell type (DC), aiding in the extraction of these entities."},\n{"Example 11": 5},\n{"Reason 11": "The sentence directly mentions a specific cell type (T lymphocytes), making it highly helpful in extracting cell type entities."},\n{"Example 12": 5},\n{"Reason 12": "The sentence contains specific protein names (SP1, caspases) and cell type (B-cell) directly, aiding in the extraction of these entities."},\n{"Example 13": 5},\n{"Reason 13": "The sentence mentions specific protein names (Tip, Tap) and a cell line (Jurkat-T cells), aiding in the extraction of these entities."},\n{"Example 14": 5},\n{"Reason 14": "The sentence provides specific protein names (PMA, LPS, staurosporine, bisindolylmaleimide, genistein) directly, aiding in the extraction of protein entities."},\n{"Example 15": 5},\n{"Reason 15": "The sentence mentions specific RNA (interleukin-1beta) and protein (inhibitor-kappaB alpha) entities directly, aiding in the extraction of these entities."},\n{"Example 16": 5},\n{"Reason 16": "The sentence mentions specific cell line names (PMA-stimulated U1 cells), aiding in the extraction of cell line entities."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any entity types mentioned in the target sentence, hence not helpful for extraction."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any entity types mentioned in the target sentence, hence not helpful for extraction."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any entity types mentioned in the target sentence, hence not helpful for extraction."},\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any entity types mentioned in the target sentence, hence not helpful for extraction."},\n{"Example 21": 1},\n{"Reason 21": "The sentence does not contain any entity types mentioned in the target sentence, hence not helpful for extraction."},\n{"Example 22": 1},\n{"Reason 22": "The sentence does not contain any entity types mentioned in the target sentence, hence not helpful for extraction."},\n{"Example 23": 1},\n{"Reason 23": "The sentence does not contain any entity types mentioned in the target sentence, hence not helpful for extraction."},\n{"Example 24": 1},\n{"Reason 24": "The sentence does not contain any entity types mentioned in the target sentence, hence not helpful for extraction."},\n{"Example 25": 1},\n{"Reason 25": "The sentence does not contain any entity types mentioned in the target sentence, hence not helpful for extraction."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1751, 'sentence': 'This effect is thought to be largely mediated through inactivation of the phosphatase calcineurin , which in turn inhibits translocation of an NFAT component to the nucleus.', 'label': {'NFAT': 'protein', 'calcineurin': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence 1": 5},\n    {"Sentence 2": 5},\n    {"Sentence 3": 5},\n    {"Sentence 4": 5},\n    {"Sentence 5": 5},\n    {"Sentence 6": 5},\n    {"Sentence 7": 5},\n    {"Sentence 8": 5},\n    {"Sentence 9": 5},\n    {"Sentence 10": 5},\n    {"Sentence 11": 5},\n    {"Sentence 12": 5},\n    {"Sentence 13": 5},\n    {"Sentence 14": 5},\n    {"Sentence 15": 5},\n    {"Sentence 16": 1},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1},\n    {"Sentence 20": 1},\n    {"Sentence 21": 1},\n    {"Sentence 22": 1},\n    {"Sentence 23": 1},\n    {"Sentence 24": 1},\n    {"Sentence 25": 1}\n]', 'response3': '[{"calcineurin": "protein"}, {"NFAT": "protein"}]', 'prediction': {'calcineurin': 'protein', 'NFAT': 'protein'}}
{'idx': 1774, 'sentence': 'Further studies are needed to elucidate if this sex difference in PBMC receptors for 1.25 Dihydroxyvitamin D3 is of any pathophysiological relevance .', 'label': {'PBMC': 'cell_type', 'PBMC receptors': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 3},\n    {"An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage.": 4},\n    {"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).": 5},\n    {"These results indicate that the monocyte/B-cell-specific transcription factor PU.1 and the Mono A and Mono B protein complexes act in concert to regulate monocyte-specific transcription of the CSF-1 receptor.": 5},\n    {"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.": 5},\n    {"A 3-bp mutation at the distal Sp1-binding site not only eliminates Sp1 interaction, but also abolishes most of the VitD3 induction of CD14 expression.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 206, 'sentence': 'It is concluded that (i) patients with CLL rarely express ER and (ii) immunocytochemical staining of cytospin preparations is a valid technique for the measurement of ER .', 'label': {'ER': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor )": 5},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 4},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL .": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 5},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n    {"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 5},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms .": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 928, 'sentence': 'A mouse ets-1 cDNA clone was obtained by screening a mouse thymus cDNA expression library with a double-stranded oligonucleotide probe representing 20 bp of the Moloney murine sarcoma virus ( MSV ) long terminal repeat ( LTR ).', 'label': {'ets-1': 'protein', 'long terminal repeat': 'DNA', 'double-stranded oligonucleotide probe': 'DNA', 'mouse thymus cDNA expression library': 'DNA', 'mouse ets-1 cDNA clone': 'DNA', 'LTR': 'DNA'}, 'response1': "['DNA', 'RNA']", 'response2': '[\n    {"SIVsmmPBj14": 5},\n    {"SIVmacMER": 5},\n    {"SIVmac239": 5},\n    {"CEMx174": 5},\n    {"GM-CSF": 5},\n    {"PML/RARalpha": 5},\n    {"Th2-type lymphocytes": 5},\n    {"protein": 5},\n    {"Sp1": 5},\n    {"Ets": 5},\n    {"c-kit": 5},\n    {"IL-4R alpha chain": 5},\n    {"TCF-1": 5},\n    {"MIP-1 alpha": 5},\n    {"GOS19": 5},\n    {"LD78": 5},\n    {"AT464": 5},\n    {"CD14": 5},\n    {"IFN A": 5},\n    {"IFNA": 5},\n    {"interleukin-2": 5},\n    {"interleukin-2 receptor": 5},\n    {"phytohemagglutinin": 5},\n    {"phorbol myristate acetate": 5},\n    {"SLAP-130": 5},\n    {"SLP-76": 5},\n    {"Egr-1": 5},\n    {"E2A": 5},\n    {"CD95 ligand": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1301, 'sentence': 'It was found that the most significant variable predicting NK activity at follow-up was tumor ER concentration , with higher NK activity associated with ER -status .', 'label': {'ER': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 1},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"ER": "protein"}, {"NK": "cell_type"}, {"ER": "protein"}]', 'prediction': {'ER': 'protein', 'NK': 'cell_type'}}
{'idx': 1708, 'sentence': 'The Ca(2+) -dependent phosphatase calcineurin , a target of FK506 and CsA , synergizes with PKC -induced activation of nuclear factor (NF)-kappa B in T cell lines .', 'label': {'nuclear factor (NF)-kappa B': 'protein', 'T cell lines': 'cell_line', 'Ca(2+) -dependent phosphatase': 'protein', 'PKC': 'protein', 'calcineurin': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of the entity \'calcineurin\' and its corresponding label \'protein\', making it highly helpful for extracting named entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence clearly mentions \'IkappaBalpha\' and \'NF-kappaB\' as entities with the label \'protein\', aiding in the extraction of named entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains \'IkappaBbeta\' and \'NF-kappaB\' as entities labeled as \'protein\', making it very helpful for named entity extraction."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides \'NF-kappa B\' and \'AP-1\' as entities labeled as \'protein\', aiding in the extraction of named entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence includes multiple entities such as \'PAFR\', \'PAF\', \'NF-kappa B\', and \'protein kinase C\' with the label \'protein\', making it highly helpful for named entity extraction."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions \'CD40\' and \'NF-kappa B\' as entities labeled as \'protein\', providing valuable examples for named entity extraction."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence contains \'NF-kappaB\', \'Tax\', and \'ATL\' as entities, with \'NF-kappaB\' labeled as \'protein\' and \'Tax\' and \'ATL\' as \'cell_type\', providing helpful examples for named entity extraction."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides \'NF-kappa B\' and \'I kappa B beta\' as entities labeled as \'protein\', aiding in the extraction of named entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence includes \'NF-kappa B\' and \'I kappa B alpha\' as entities labeled as \'protein\', making it very helpful for named entity extraction."},\n    {"Example 10": 4},\n    {"Reason 10": "The sentence mentions \'NF-kappa B\' as an entity labeled as \'protein\', providing a helpful example for named entity extraction."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains \'RelA\' and \'NF-kappa B\' as entities labeled as \'protein\', aiding in the extraction of named entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides \'Syk\', \'Zap\', and \'T cell\' as entities labeled as \'protein\' and \'cell_type\', offering valuable examples for named entity extraction."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence mentions \'NF-kappa B\' as an entity labeled as \'protein\', providing a helpful example for named entity extraction."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence includes \'SP1\', \'caspases\', and \'B-cell\' as entities labeled as \'protein\' and \'cell_type\', making it highly helpful for named entity extraction."},\n    {"Example 15": 4},\n    {"Reason 15": "The sentence contains \'NF-kappa B\' as an entity labeled as \'protein\', providing a helpful example for named entity extraction."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entities related to the provided entity labels, making it not helpful for named entity extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities related to the provided entity labels, making it not helpful for named entity extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities related to the provided entity labels, making it not helpful for named entity extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities related to the provided entity labels, making it not helpful for named entity extraction."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities related to the provided entity labels, making it not helpful for named entity extraction."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities related to the provided entity labels, making it not helpful for named entity extraction."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities related to the provided entity labels, making it not helpful for named entity extraction."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities related to the provided entity labels, making it not helpful for named entity extraction."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities related to the provided entity labels, making it not helpful for named entity extraction."}\n]', 'response3': '[{"calcineurin": "protein"}, {"FK506": "protein"}, {"CsA": "protein"}, {"PKC": "protein"}, {"NF-kappa B": "protein"}, {"T cell lines": "cell_line"}]', 'prediction': {'calcineurin': 'protein', 'FK506': 'protein', 'CsA': 'protein', 'PKC': 'protein', 'NF-kappa B': 'protein', 'T cell lines': 'cell_line'}}
{'idx': 747, 'sentence': 'Protein kinase inhibitor H-7 blocks accumulation of unspliced mRNA of human T-cell leukemia virus type I ( HTLV-I ).', 'label': {'unspliced mRNA': 'RNA'}, 'response1': "['protein', 'RNA']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .": 5},\n    {"Control of NF-kappa B activity by the I kappa B beta inhibitor .": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Tat-binding protein 7 is a subunit of the 26S protease .": 5},\n    {"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells .": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 333, 'sentence': 'These protoenhancers alone are weakly or not responsive to R .', 'label': {'protoenhancers': 'DNA', 'R': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5},\n    {"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .": 4},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50 .": 4},\n    {"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements .": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 4},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .": 5},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 5},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 758, 'sentence': 'Cell proliferation of CEM-C7 cells cultured in both serum-free media has been sustained for 3 mo.', 'label': {'CEM-C7': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[\n{"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.": 5},\n{"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 4},\n{"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 4},\n{"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 4},\n{"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 3},\n{"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n{"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 4},\n{"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n{"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 5},\n{"Thus, we were able to derive a hematopoietic cell line, called 47.10, that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.": 5},\n{"Notably, the lack of pRB in these U937-derived clones renders these p53-null cells highly resistant to apoptosis induced by serum withdrawal, calphostin C, and ceramide.": 5},\n{"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.": 5},\n{"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.": 5},\n{"We isolated a novel subline, UT-7/GMT, from the human leukemia cell line UT-7/GM (N. Komatsu, et al., Blood, 89: 4021-4033, 1997).": 5},\n{"The modified vectors were used to transduce human hematopoietic cell lines, cord blood-derived CD34(+) stem/progenitor cells, and murine bone marrow repopulating stem cells.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 727, 'sentence': 'The importance of the internal ATGs to Rex function is not known.', 'label': {'Rex': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and direct mention of the entity with its corresponding label, making it highly helpful for extracting named entities from the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 429, 'sentence': 'As shown by mobility-shift , methylation interference , and mutational analyses , the mammalian protein BSAP recognizes all four sea urchin binding sites in a manner indistinguishable from TSAP ; however, the two proteins differ in molecular weight.', 'label': {'TSAP': 'protein', 'mammalian protein': 'protein', 'sea urchin binding sites': 'DNA', 'BSAP': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.": 5},\n    {"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n    {"Tat-binding protein 7 is a subunit of the 26S protease.": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 5},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 5},\n    {"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1372, 'sentence': 'The TCL1 oncogene on human chromosome 14q32.1 is involved in chromosome translocations [ t(14;14)(q11;q32.1) and t(7;14)(q35;q32.1) ] and inversions [ inv14(q11;q32.1) ] with TCR alpha/beta loci in T-cell leukemias , such as T-prolymphocytic ( T-PLL ).', 'label': {'14q32.1': 'DNA', 'TCR alpha/beta loci': 'DNA', 't(14;14)(q11;q32.1)': 'DNA', 'TCL1 oncogene': 'DNA', 'human chromosome': 'DNA', 't(7;14)(q35;q32.1)': 'DNA', 'inv14(q11;q32.1)': 'DNA'}, 'response1': "['DNA', 'cell_type']", 'response2': '[\n{"Therefore, we investigated whether IVS1-10T-->C deleteriously affected BRCA1 splicing or expression, and thereby inactivated the other BRCA1 allele.": 5},\n{"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.": 4},\n{"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n{"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 4},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n{"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 4},\n{"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 4},\n{"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.": 5},\n{"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n{"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 4},\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n{"Here we examined the regulatory mechanism of the SCM-1 genes.": 3},\n{"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 5},\n{"By the time of diagnosis of T-PLL, the clone contains many more genetic changes in the form of additional translocations.": 5},\n{"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n{"SCL is expressed in erythroid, megakaryocyte and mast cell populations (the same cell lineages as GATA-1, a zinc-finger transcription factor).": 4}\n]', 'response3': '[{"TCL1": "protein"}, {"TCR alpha/beta": "protein"}, {"T-cell": "cell_type"}, {"T-PLL": "cell_type"}]', 'prediction': {'TCL1': 'protein', 'TCR alpha/beta': 'protein', 'T-cell': 'cell_type', 'T-PLL': 'cell_type'}}
{'idx': 546, 'sentence': 'Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin .', 'label': {'T lymphocytes': 'cell_type', 'immunophilin': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein entity (calcineurin) and its corresponding label."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides a clear example of a protein entity (NF-kappa B) and its corresponding label."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence provides multiple examples of protein entities (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) and their corresponding labels."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides multiple examples of protein entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) and their corresponding labels."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides multiple examples of protein entities (IL-2, IL-2 receptor, CD28) and their corresponding labels, as well as a cell type entity (T cell)."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides multiple examples of protein entities (IL-5 mRNA, TCR, IL-2R, dexamethasone) and their corresponding labels, as well as an RNA entity (IL-5 mRNA)."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides multiple examples of protein entities (NF-kappa B, I kappa B alpha) and their corresponding labels."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides a clear example of a protein entity (IL-2) and its corresponding label."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides multiple examples of protein entities (CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, granulocyte-macrophage colony-stimulating factor) and their corresponding labels."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides multiple examples of protein entities (NF-ATc, T lymphocytes) and their corresponding labels."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides multiple examples of protein entities (IkappaBbeta, NF-kappaB) and their corresponding labels."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides multiple examples of protein entities (IL-2 receptor alpha subunit, p21ras) and their corresponding labels, as well as a cell type entity (B cell)."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides multiple examples of protein entities (Syk, Zap, T cell) and their corresponding labels."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides multiple examples of protein entities (IL-2, NF-kappa B, AP-1) and their corresponding labels."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides multiple examples of protein entities (IL-2, Aiolos, Ras) and their corresponding labels."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence provides multiple examples of protein entities (IkappaBalpha, NF-kappaB) and their corresponding labels."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities from the given label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities from the given label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities from the given label set."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities from the given label set."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities from the given label set."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities from the given label set."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities from the given label set."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities from the given label set."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities from the given label set."}\n]', 'response3': "[{'T lymphocytes': 'cell_type'}, {'immunophilin': 'protein'}, {'FK506': 'protein'}, {'rapamycin': 'protein'}]", 'prediction': {'T lymphocytes': 'cell_type', 'immunophilin': 'protein', 'FK506': 'protein', 'rapamycin': 'protein'}}
{'idx': 1437, 'sentence': 'In summary, we developed an assay for the quantitative determination of hTR beta 1 mRNA levels in small human tissue samples , containing as little as 50 ng of total RNA.', 'label': {'hTR beta 1': 'protein', 'hTR beta 1 mRNA': 'RNA'}, 'response1': "['RNA']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 4},\n    {"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 3},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 4},\n    {"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.": 4},\n    {"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 4},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 4},\n    {"To evaluate the PML/RARalpha role in myelopoiesis, transgenic mice expressing PML/RARalpha were engineered.": 4},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 4},\n    {"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 4},\n    {"Thus, we were able to derive a hematopoietic cell line, called 47.10, that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.": 4},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 4}\n]', 'response3': '[{"hTR beta 1 mRNA": "RNA"}]', 'prediction': {'hTR beta 1 mRNA': 'RNA'}}
{'idx': 1399, 'sentence': 'To investigate the role of NF-M in hematopoietic cell lineage commitment, we constructed a conditional form of the protein by fusing it to the hormone binding domain of the human estrogen receptor .', 'label': {'hematopoietic cell lineage': 'cell_line', 'human estrogen receptor': 'protein', 'NF-M': 'protein', 'hormone binding domain': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n{"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n{"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 5},\n{"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n{"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.": 5},\n{"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 5},\n{"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events.": 5},\n{"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n{"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n{"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n{"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.": 5},\n{"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 5},\n{"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5}\n]', 'response3': '[{"NF-M": "protein"}, {"hormone binding domain": "protein"}, {"human estrogen receptor": "protein"}]', 'prediction': {'NF-M': 'protein', 'hormone binding domain': 'protein', 'human estrogen receptor': 'protein'}}
{'idx': 1327, 'sentence': 'Our results demonstrate that NF-IL6 is involved in transcriptional activation of the human IL-4 promoter in T cells .', 'label': {'human IL-4': 'protein', 'human IL-4 promoter': 'DNA', 'NF-IL6': 'protein', 'T cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a clear mapping between the entity \'IL-4\' and its corresponding label \'protein\' in the sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The example provides multiple mappings between entities and their corresponding labels in the sentence, aiding in the extraction of named entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides mappings between entities and their corresponding labels, helping in identifying named entities related to proteins and cell types in the sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The example provides mappings between entities and their corresponding labels, aiding in the extraction of named entities related to proteins and cell types in the sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides mappings between entities and their corresponding labels, aiding in the extraction of named entities related to proteins in the sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The example provides mappings between entities and their corresponding labels, aiding in the extraction of named entities related to proteins and cell types in the sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides mappings between entities and their corresponding labels, aiding in the extraction of named entities related to proteins in the sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides mappings between entities and their corresponding labels, aiding in the extraction of named entities related to proteins and cell types in the sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides mappings between entities and their corresponding labels, aiding in the extraction of named entities related to proteins in the sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides mappings between entities and their corresponding labels, aiding in the extraction of named entities related to proteins in the sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides mappings between entities and their corresponding labels, aiding in the extraction of named entities related to proteins in the sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The example provides mappings between entities and their corresponding labels, aiding in the extraction of named entities related to proteins and cell types in the sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides mappings between entities and their corresponding labels, aiding in the extraction of named entities related to proteins in the sentence."},\n    {"Example 14": 1},\n    {"Reason 14": "The example does not contain any entities that match the entity labels provided in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The example does not contain any entities that match the entity labels provided in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any entities that match the entity labels provided in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any entities that match the entity labels provided in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any entities that match the entity labels provided in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain any entities that match the entity labels provided in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The example does not contain any entities that match the entity labels provided in the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The example does not contain any entities that match the entity labels provided in the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The example does not contain any entities that match the entity labels provided in the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The example does not contain any entities that match the entity labels provided in the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The example does not contain any entities that match the entity labels provided in the target sentence."}\n]', 'response3': '[{"NF-IL6": "protein"}, {"IL-4": "protein"}, {"T cells": "cell_type"}]', 'prediction': {'NF-IL6': 'protein', 'IL-4': 'protein', 'T cells': 'cell_type'}}
{'idx': 146, 'sentence': 'Unlike other class II promoters , the HLA-DR alpha (DRA) promoter also contains one element identical to the "octamer" motif of immunoglobulin variable region promoters that is responsible for B cell-specific transcription .', 'label': {'"octamer" motif': 'DNA', 'HLA-DR alpha (DRA) promoter': 'DNA', 'class II promoters': 'DNA', 'immunoglobulin variable region promoters': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n{"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 5},\n{"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 4},\n{"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.": 5},\n{"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n{"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n{"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n{"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n{"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 4},\n{"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 4},\n{"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n{"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 4},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5}\n]', 'response3': '[{"HLA-DR alpha (DRA)": "protein"}, {"octamer": "protein"}, {"immunoglobulin variable region": "protein"}, {"B cell-specific": "cell_type"}]', 'prediction': {'HLA-DR alpha (DRA)': 'protein', 'octamer': 'protein', 'immunoglobulin variable region': 'protein', 'B cell-specific': 'cell_type'}}
{'idx': 1247, 'sentence': 'The Janus family tyrosine kinase Jak3 is the only signaling molecule known to be associated with gamma c , so it was hypothesized that defects in Jak3 might cause an XSCID -like phenotype .', 'label': {'Janus family tyrosine kinase': 'protein', 'Jak3': 'protein', 'gamma c': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 3},\n    {"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.": 4},\n    {"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.": 4},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 4},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n    {"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/thrombopoiesis or possibly a mature platelet function such as aggregation.": 4},\n    {"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n    {"SCL is expressed in erythroid, megakaryocyte and mast cell populations (the same cell lineages as GATA-1, a zinc-finger transcription factor).": 4},\n    {"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine (IL-2 and IFN-gamma) production is normal.": 5},\n    {"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 3}\n]', 'response3': '[{"Jak3": "protein"}, {"gamma c": "protein"}, {"XSCID": "cell_type"}]', 'prediction': {'Jak3': 'protein', 'gamma c': 'protein', 'XSCID': 'cell_type'}}
{'idx': 1300, 'sentence': 'As considerable evidence has accumulated that social support in both animal and human populations may have survival value, we sought to test the reliability of this regression model , using coping and perceived support factor values obtained at 3 months after surgery to account for concurrent follow-up NK activity in this serially assessed group of patients .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 5},\n    {"Because relatively little is known about these events in nonhuman primates , our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates .": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .": 4},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes .": 4},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements .": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .": 5},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .": 4},\n    {"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .": 5},\n    {"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 350, 'sentence': 'Induction of 24,25-(OH)2D3 synthesis by 1,25(OH)2D3 was observed in the fifth cell line , designated Ro-VDR , although the sensitivity to hormone treatment was lower than in the control cell line from a normal donor .', 'label': {'control cell line': 'cell_line', 'cell line': 'cell_line', 'Ro-VDR': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .": 5},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .": 4},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .": 4},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]": 4},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .": 4},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 4},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex .": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"Protein kinase B ( c-Akt ), phosphatidylinositol 3-kinase , and STAT5 are activated by erythropoietin ( EPO ) in HCD57 erythroid cells but are constitutively active in an EPO -independent, apoptosis -resistant subclone ( HCD57-SREI cells ).": 5},\n    {"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice .": 5},\n    {"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development .": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 4},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[{"Ro-VDR": "cell_line"}]', 'prediction': {'Ro-VDR': 'cell_line'}}
{'idx': 1093, 'sentence': 'The genomic actions of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) are mediated by the intracellular vitamin D receptor ( VDR ).', 'label': {'VDR': 'protein', 'vitamin D receptor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains multiple protein names and a cell type, which are all present in the entity label set."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any entities from the entity label set."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains a protein name that is present in the entity label set."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains a protein name that is present in the entity label set."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains a protein name that is present in the entity label set."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains multiple protein names and a cell type, which are all present in the entity label set."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains a protein name that is present in the entity label set."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains a protein name that is present in the entity label set."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains a protein name that is present in the entity label set."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains multiple protein names that are present in the entity label set."},\n    {"Example 11": 1},\n    {"Reason 11": "The sentence does not contain any entities from the entity label set."},\n    {"Example 12": 1},\n    {"Reason 12": "The sentence does not contain any entities from the entity label set."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not contain any entities from the entity label set."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not contain any entities from the entity label set."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any entities from the entity label set."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entities from the entity label set."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities from the entity label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities from the entity label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities from the entity label set."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities from the entity label set."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1493, 'sentence': 'Chronic HIV-1 infection of myeloid cells leads to constitutive NF-kappa B DNA-binding activity and provides an intranuclear environment capable of perpetuating HIV-1 replication .', 'label': {'myeloid cells': 'cell_type', 'NF-kappa B': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and direct mention of the entity with its corresponding label, making it highly helpful for extracting named entities from the target sentence."}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"DNA": "DNA"}, {"HIV-1": "cell_type"}]', 'prediction': {'NF-kappa B': 'protein', 'DNA': 'DNA', 'HIV-1': 'cell_type'}}
{'idx': 334, 'sentence': "One of the protoenhancers contains the overlapping palindromes 5'-TTGTCCcgtGGACAAaTGTCC-3' .", 'label': {'protoenhancers': 'DNA', 'overlapping palindromes': 'DNA'}, 'response1': "['DNA']", 'response2': '```json\n[\n    {"IgH": 5},\n    {"BRCA1": 5},\n    {"EBNA2": 4, "TP1": 4},\n    {"GM-CSF": 5},\n    {"Protein": 5},\n    {"IL-2": 4, "c-Jun": 4, "c-Fos": 4},\n    {"p50p50": 5},\n    {"EKLF": 5},\n    {"TCF-1": 5},\n    {"ZEBRA": 5},\n    {"immunoglobulin kappa 3\' enhancer": 5},\n    {"Egr-1": 5},\n    {"T cell": 4, "interleukin 2": 5},\n    {"Th2-type lymphocytes": 5},\n    {"CD95 ligand": 5},\n    {"GM-kappa B": 5, "GC-box": 5, "GC-motif": 5, "GM-kappa B motif": 5}\n]\n```', 'response3': '```json\n[{"TTGTCCcgtGGACAAaTGTCC": "DNA"}]\n```', 'prediction': {'TTGTCCcgtGGACAAaTGTCC': 'DNA'}}
{'idx': 946, 'sentence': 'Compared to the control group , fewer depressed subjects down-regulated Bmax after DEX .', 'label': {}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 3": 5},\n{"Reason 3": "The sentence contains multiple named entities such as \'Bak\', \'Bad\', \'Bcl-2\', \'PDBu\', and \'DMSO\' which are all proteins or cell lines from the given entity label set."},\n{"Example 4": 4},\n{"Reason 4": "The sentence contains named entities \'IL-5 mRNA\', \'TCR\', \'IL-2R\', and \'dexamethasone\' which are RNA, cell type, protein, and protein respectively from the given entity label set."},\n{"Example 5": 1},\n{"Reason 5": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 6": 3},\n{"Reason 6": "The sentence contains named entities \'UAS1\' and \'B cell\' which are cell line and cell type respectively from the given entity label set."},\n{"Example 7": 2},\n{"Reason 7": "The sentence contains named entity \'AP-1\' which is not part of the given entity label set."},\n{"Example 8": 5},\n{"Reason 8": "The sentence contains multiple named entities such as \'cAMP-dependent protein kinase\' and \'Rap1\' which are proteins from the given entity label set."},\n{"Example 9": 3},\n{"Reason 9": "The sentence contains named entities \'MNDA\' and \'myeloid cell lines\' which are RNA and cell line respectively from the given entity label set."},\n{"Example 10": 2},\n{"Reason 10": "The sentence contains named entities \'CCAAT box\' and \'EKLF binding site\' which are not part of the given entity label set."},\n{"Example 11": 4},\n{"Reason 11": "The sentence contains named entity \'DNA\' which is part of the given entity label set."},\n{"Example 12": 3},\n{"Reason 12": "The sentence contains named entities \'NDP kinase\', \'KA\', \'SCC\', and \'BCC\' which are proteins and cell types from the given entity label set."},\n{"Example 13": 3},\n{"Reason 13": "The sentence contains named entities \'granulocytes\' and \'T cells\' which are cell types from the given entity label set."},\n{"Example 14": 1},\n{"Reason 14": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 15": 5},\n{"Reason 15": "The sentence contains multiple named entities such as \'VDR\', \'RXR\', \'GRIP-1\', \'DRIP205\', and \'DRIP\' which are all proteins from the given entity label set."},\n{"Example 16": 4},\n{"Reason 16": "The sentence contains multiple named entities such as \'interleukin-2\', \'alpha chain\', \'CD25\', and \'IL-2 receptor\' which are all proteins from the given entity label set."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 21": 1},\n{"Reason 21": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 22": 1},\n{"Reason 22": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 23": 1},\n{"Reason 23": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 24": 1},\n{"Reason 24": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 25": 1},\n{"Reason 25": "The sentence does not contain any named entities from the given entity label set."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 777, 'sentence': 'We have identified two human pre-B-cell lines that contain extremely low levels of OTF-2 yet still express high levels of steady-state immunoglobulin heavy-chain mRNA in vivo and efficiently transcribe an immunoglobulin gene in vitro.', 'label': {'OTF-2': 'protein', 'immunoglobulin gene': 'DNA', 'steady-state immunoglobulin heavy-chain mRNA': 'RNA', 'human pre-B-cell lines': 'cell_line', 'immunoglobulin heavy-chain': 'protein'}, 'response1': "['cell_line', 'RNA', 'protein']", 'response2': '[\n    {"This protein has now been purified and its encoding gene cloned.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 5},\n    {"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 5},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 5},\n    {"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 552, 'sentence': 'Similarly, an excess of FK506 is needed to revert rapamycin -mediated inhibition of IL-2 -induced proliferation .', 'label': {'IL-2': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"FK506": "protein"}, {"rapamycin": "protein"}, {"IL-2": "protein"}]', 'prediction': {'FK506': 'protein', 'rapamycin': 'protein', 'IL-2': 'protein'}}
{'idx': 1310, 'sentence': 'The abundant chromosomal protein HMG-1 belongs to this subgroup.', 'label': {'HMG-1': 'protein', 'chromosomal protein': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 3},\n{"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n{"This protein has now been purified and its encoding gene cloned.": 5},\n{"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.": 3},\n{"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 4},\n{"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n{"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 4},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 4},\n{"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 3},\n{"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n{"Tat-binding protein 7 is a subunit of the 26S protease.": 4},\n{"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.": 4},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n{"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n{"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.": 5},\n{"Here we examined the regulatory mechanism of the SCM-1 genes.": 3},\n{"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1409, 'sentence': 'We investigated the ability of PRL and IL-2 to activate Stat proteins in different T cell lines .', 'label': {'IL-2': 'protein', 'T cell lines': 'cell_line', 'PRL': 'protein', 'Stat proteins': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains the entity \'IL-2\' which is labeled as \'protein\' in the entity label set, making it highly relevant for named entity extraction."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains multiple entities such as \'T cell\', \'IL-2\', \'IL-2 receptor\', and \'CD28\' which are labeled as \'cell_type\' and \'protein\' in the entity label set, providing good context for named entity extraction."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains multiple entities such as \'IL4\', \'IL13\', \'STAT6\', \'STAT3\', \'STAT5\', and \'B cells\' which are labeled as \'protein\' and \'cell_type\' in the entity label set, making it highly relevant for named entity extraction."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence contains entities like \'AP-1\', \'PMA\', \'monocytes\', and \'macrophages\' which are labeled as \'protein\' and \'cell_type\' in the entity label set, providing good context for named entity extraction."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence contains entities like \'IL-2 receptor alpha subunit\', \'p21ras\', and \'B cell\' which are labeled as \'protein\' and \'cell_type\' in the entity label set, providing good context for named entity extraction."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains entities like \'IL-2\', \'IFN-gamma\', \'jak kinases\', and \'STAT1(alpha)\' which are labeled as \'protein\' in the entity label set, making it highly relevant for named entity extraction."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains the entity \'IL-2\' which is labeled as \'protein\' in the entity label set, making it highly relevant for named entity extraction."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains entities like \'IL-2\', \'c-Jun\', and \'c-Fos\' which are labeled as \'protein\' in the entity label set, making it highly relevant for named entity extraction."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains entities like \'CD70\', \'B cell\', \'plasma cells\', \'IL-4\', and \'CD40\' which are labeled as \'protein\' and \'cell_type\' in the entity label set, making it highly relevant for named entity extraction."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains the entity \'NF-kappa B\' which is labeled as \'protein\' in the entity label set, making it highly relevant for named entity extraction."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains entities like \'Stat3\', \'Stat5\', and \'c-Mpl\' which are labeled as \'protein\' in the entity label set, making it highly relevant for named entity extraction."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains entities like \'IL-2\', \'Aiolos\', and \'Ras\' which are labeled as \'protein\' in the entity label set, making it highly relevant for named entity extraction."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains entities like \'IL-4\', \'LPS\', and \'AP-1\' which are labeled as \'protein\' in the entity label set, making it highly relevant for named entity extraction."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains entities like \'IFN A\', \'IFNA\', \'interleukin-2\', \'interleukin-2 receptor\', \'phytohemagglutinin\', and \'phorbol myristate acetate\' which are labeled as \'protein\' in the entity label set, making it highly relevant for named entity extraction."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains entities like \'IL-12\', \'STAT4\', \'NK cells\', \'T cells\', and \'IL-12 receptor\' which are labeled as \'protein\' and \'cell_type\' in the entity label set, making it highly relevant for named entity extraction."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence contains the entity \'E2A\' which is labeled as \'protein\' in the entity label set, making it highly relevant for named entity extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities that match the entity labels in the entity label set, hence not helpful for named entity extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities that match the entity labels in the entity label set, hence not helpful for named entity extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities that match the entity labels in the entity label set, hence not helpful for named entity extraction."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities that match the entity labels in the entity label set, hence not helpful for named entity extraction."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities that match the entity labels in the entity label set, hence not helpful for named entity extraction."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities that match the entity labels in the entity label set, hence not helpful for named entity extraction."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities that match the entity labels in the entity label set, hence not helpful for named entity extraction."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities that match the entity labels in the entity label set, hence not helpful for named entity extraction."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities that match the entity labels in the entity label set, hence not helpful for named entity extraction."}\n]', 'response3': "[{'PRL': 'protein'}, {'IL-2': 'protein'}, {'Stat proteins': 'protein'}, {'T cell lines': 'cell_line'}]", 'prediction': {'PRL': 'protein', 'IL-2': 'protein', 'Stat proteins': 'protein', 'T cell lines': 'cell_line'}}
{'idx': 1140, 'sentence': 'The conserved cis-acting sequence , GGAAAA , and transcription factors binding to this sequence are involved in the response to increased intracellular Ca2+ concentrations .', 'label': {'transcription factors': 'protein', 'conserved cis-acting sequence': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a transcription factor (AP-1) binding to DNA, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides examples of two proteins (Jun and ATF-2) involved in transcription, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence mentions Th2-type lymphocytes, which are a specific type of cell, related to the \'cell_type\' entity label in the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence mentions proteins involved in transcription, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides a clear example of a protein (Egr-1) which is a transcription factor, directly related to the entity types mentioned in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides examples of proteins (IL-2, c-Jun, c-Fos) involved in transcription, directly related to the entity types mentioned in the target sentence."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence mentions GM-CSF, which is a protein, directly related to the entity types mentioned in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides a clear example of a protein (GATA-1) which is a transcription factor, directly related to the entity types mentioned in the target sentence."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence mentions TCF-1, which is a protein involved in transcription, directly related to the entity types mentioned in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides a clear example of proteins (Stat proteins) involved in transcription, directly related to the entity types mentioned in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides examples of proteins (EKLF, CBP, p300, P/CAF) involved in transcription, directly related to the entity types mentioned in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides examples of proteins (SCL, GATA-1) which are transcription factors, directly related to the entity types mentioned in the target sentence."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence mentions G-CSF, which is a protein, directly related to the entity types mentioned in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides examples of proteins (VDR, RXR, GRIP-1, DRIP205, DRIP) involved in transcription, directly related to the entity types mentioned in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides examples of proteins (ZEB, c-Myb, Ets) and mentions hematopoietic cells, which are cell types, directly related to the entity types mentioned in the target sentence."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence provides examples of proteins (tal-1, GATA-binding proteins) and mentions hematopoiesis, which is a cell type, directly related to the entity types mentioned in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entity types mentioned in the target sentence."}\n]', 'response3': '[{"GGAAAA": "DNA"}]', 'prediction': {'GGAAAA': 'DNA'}}
{'idx': 449, 'sentence': 'We find that the factor that binds to the E3 enhancer motif , CATGTGGC , is a ubiquitous transcription factor .', 'label': {'ubiquitous transcription factor': 'protein', 'E3 enhancer motif': 'DNA'}, 'response1': "['DNA']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with their corresponding entity labels, which can aid in understanding the types of entities present in the sentence and how they are labeled."}\n]', 'response3': '[{"E3 enhancer motif": "DNA"}]', 'prediction': {'E3 enhancer motif': 'DNA'}}
{'idx': 1402, 'sentence': 'At the same time, we observed a down-regulation of progenitor-specific surface markers and the up-regulation of differentiation markers restricted to the eosinophil and myeloid lineages .', 'label': {'eosinophil': 'cell_type', 'myeloid lineages': 'cell_type', 'differentiation markers': 'protein', 'progenitor-specific surface markers': 'protein'}, 'response1': "['cell_type']", 'response2': '[\n{"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 5},\n{"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n{"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n{"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]": 5},\n{"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 5},\n{"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 5},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n{"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n{"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 5},\n{"PMA induced the expression of both CD14 and CD23 mRNA and protein.": 5},\n{"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n{"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 5},\n{"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 5},\n{"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n{"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n{"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n{"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta- herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"eosinophil": "cell_type"}, {"myeloid": "cell_type"}]', 'prediction': {'eosinophil': 'cell_type', 'myeloid': 'cell_type'}}
{'idx': 664, 'sentence': 'Interferon-gamma and the sexual dimorphism of autoimmunity .', 'label': {'Interferon-gamma': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 5},\n    {"In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine (IFN-gamma) in combination with allergy-driven overproduction of T helper 2-type cytokines.": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n    {"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency.": 5},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"The role of the transcription factor NF-kappaB in the pathogenesis of rheumatoid arthritis has long been a subject of controversy.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 5},\n    {"CD40 expression could be enhanced in CD40-positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1726, 'sentence': 'It is tempting to speculate that enhanced NF-kappa B expression caused by free radical production/oxidative stress may modulate liver injury , perhaps through an effect on cytotoxic cytokine synthesis .', 'label': {'NF-kappa B': 'protein', 'cytotoxic cytokine': 'protein'}, 'response1': "['protein']", 'response2': '```json\n[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains the entity \'NF-kappa B\' which is labeled as \'protein\' in the entity label set. The example provides a clear match between the entity in the sentence and its corresponding label."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains the entities \'NF-kappa B\' and \'ARDS\' which are labeled as \'protein\' and \'cell_type\' respectively in the entity label set. The example provides a match between the entities in the sentence and their corresponding labels."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains the entities \'PAFR\', \'PAF\', \'NF-kappa B\', and \'protein kinase C\' which are labeled as \'protein\' in the entity label set. The example provides clear matches between the entities in the sentence and their corresponding labels."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains the entities \'NF-kappa B\' and \'I kappa B alpha\' which are labeled as \'protein\' in the entity label set. The example provides clear matches between the entities in the sentence and their corresponding labels."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains the entity \'NF-kappa B\' which is labeled as \'protein\' in the entity label set. The example provides a clear match between the entity in the sentence and its corresponding label."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains the entities \'IkappaBalpha\' and \'NF-kappaB\' which are labeled as \'protein\' in the entity label set. The example provides clear matches between the entities in the sentence and their corresponding labels."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains the entity \'NF-kappa B\' which is labeled as \'protein\' in the entity label set. The example provides a clear match between the entity in the sentence and its corresponding label."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains the entity \'NF-kappa B\' which is labeled as \'protein\' in the entity label set. The example provides a clear match between the entity in the sentence and its corresponding label."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence contains the entities \'NF-kappaB\' and \'rheumatoid arthritis\' which are labeled as \'protein\' and \'cell_type\' respectively in the entity label set. The example provides a match between the entities in the sentence and their corresponding labels."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains the entities \'IkappaBbeta\' and \'NF-kappaB\' which are labeled as \'protein\' in the entity label set. The example provides clear matches between the entities in the sentence and their corresponding labels."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains the entities \'NF-kappaB\', \'Tax\', and \'ATL\' which are labeled as \'protein\' and \'cell_type\' respectively in the entity label set. The example provides clear matches between the entities in the sentence and their corresponding labels."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains the entities \'NF-kappa B\' and \'I kappa B alpha\' which are labeled as \'protein\' in the entity label set. The example provides clear matches between the entities in the sentence and their corresponding labels."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains the entities \'NF-kappa B\' and \'I kappa B beta\' which are labeled as \'protein\' in the entity label set. The example provides clear matches between the entities in the sentence and their corresponding labels."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains the entities \'CD40\', \'Rel/nuclear factor kappaB\', and \'NF-kappaB\' which are labeled as \'protein\' in the entity label set. The example provides clear matches between the entities in the sentence and their corresponding labels."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains the entities \'HIV-1\', \'IFN\', \'PKR\', and \'IkappaBalpha\' which are labeled as \'cell_type\' and \'protein\' respectively in the entity label set. The example provides clear matches between the entities in the sentence and their corresponding labels."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entities that match the entity labels in the entity label set."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities that match the entity labels in the entity label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities that match the entity labels in the entity label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities that match the entity labels in the entity label set."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities that match the entity labels in the entity label set."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities that match the entity labels in the entity label set."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities that match the entity labels in the entity label set."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities that match the entity labels in the entity label set."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities that match the entity labels in the entity label set."}\n]\n```', 'response3': '```json\n[]\n```', 'prediction': {}}
{'idx': 1573, 'sentence': 'Immunofluorescence colocalization of both estrogen and progesterone receptors with eosinophil cationic protein showed that approximately 70% of positive cells were eosinophils .', 'label': {'estrogen': 'protein', 'eosinophil cationic protein': 'protein', 'positive cells': 'cell_type', 'progesterone receptors': 'protein', 'eosinophils': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 4},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 4},\n    {"Eosinophils play an important role in the effector phase of allergic inflammation.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n    {"PMA induced the expression of both CD14 and CD23 mRNA and protein.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).": 5},\n    {"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.": 5},\n    {"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.": 5},\n    {"To study the regulatory mechanism of gp91phox gene expression in eosinophils, we transiently transfected eosinophil-committed HL-60-C15 cells with gp91phox promoter constructs, and identified a negative element from bp -267 to -246 of the gp91phox gene, the deletion of which caused an 83% increase in promoter activity.": 5}\n]', 'response3': '[{"estrogen": "protein"}, {"progesterone": "protein"}, {"eosinophil cationic protein": "protein"}, {"eosinophils": "cell_type"}]', 'prediction': {'estrogen': 'protein', 'progesterone': 'protein', 'eosinophil cationic protein': 'protein', 'eosinophils': 'cell_type'}}
{'idx': 1589, 'sentence': 'Inhibition of NF-AT -dependent transcription by NF-kappa B : implications for differential gene expression in T helper cell subsets .', 'label': {'NF-kappa B': 'protein', 'T helper cell subsets': 'cell_type', 'NF-AT': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence directly mentions the entity \'NF-kappa B\' which is a protein, making it highly relevant for named entity extraction."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence directly mentions the entities \'NF-kappa B\' and \'I kappa B alpha\' which are proteins, making it highly relevant for named entity extraction."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence mentions the entity \'NF-ATc\' which is a protein and \'T lymphocytes\' which is a cell type, aiding in named entity extraction."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence mentions the entities \'NF-kappaB\', \'Tax\', and \'ATL\' which are proteins and cell types, making it highly relevant for named entity extraction."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence directly mentions the entity \'NF-kappa B\' which is a protein, making it highly relevant for named entity extraction."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions the entities \'NF-kappa B\' and \'I kappa B alpha\' which are proteins, aiding in named entity extraction."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence mentions the entities \'NF-ATc\', \'T lymphocytes\', and \'embryonic cardiac cells\' which are proteins and cell types, aiding in named entity extraction."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence directly mentions the entity \'GATA-1\' which is a protein, making it highly relevant for named entity extraction."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence directly mentions the entity \'NF-kappa B\' which is a protein, making it highly relevant for named entity extraction."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions the entities \'NF-kappa B\' and \'I kappa B beta\' which are proteins, aiding in named entity extraction."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions the entities \'PAFR\', \'PAF\', \'NF-kappa B\', and \'protein kinase C\' which are proteins, aiding in named entity extraction."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence mentions the entities \'Sp1\' and \'Ets\' which are proteins, aiding in named entity extraction."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence mentions the entities \'Th1\' and \'Th2\' which are cell types, aiding in named entity extraction."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence mentions the entity \'Th2-type lymphocytes\' which is a cell type, aiding in named entity extraction."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions the entities \'IL-2\', \'NF-kappa B\', and \'AP-1\' which are proteins, aiding in named entity extraction."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence mentions \'NF-kappa B\' as DNA, which is incorrect and not helpful for named entity extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any relevant entities for named entity extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any relevant entities for named entity extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any relevant entities for named entity extraction."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any relevant entities for named entity extraction."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any relevant entities for named entity extraction."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any relevant entities for named entity extraction."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any relevant entities for named entity extraction."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any relevant entities for named entity extraction."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any relevant entities for named entity extraction."}\n]', 'response3': '[{"NF-AT": "protein"}, {"NF-kappa B": "protein"}, {"T helper cell subsets": "cell_type"}]', 'prediction': {'NF-AT': 'protein', 'NF-kappa B': 'protein', 'T helper cell subsets': 'cell_type'}}
{'idx': 114, 'sentence': 'These results indicate that in monocytic cell lineage , HIV-1 could mimic some differentiation/activation stimuli allowing nuclear NF-KB expression .', 'label': {'NF-KB': 'protein', 'monocytic cell lineage': 'cell_line'}, 'response1': "['cell_line', 'cell_type']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with their corresponding entity labels, providing clear and direct guidance for entity extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains a clear example of a named entity with its corresponding entity label, aiding in entity extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of named entities with their corresponding entity labels, providing guidance for entity extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains a clear example of a named entity with its corresponding entity label, aiding in entity extraction."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides a comprehensive list of named entities with their corresponding entity labels, offering significant assistance in entity extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains a clear example of a named entity with its corresponding entity label, aiding in entity extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of named entities with their corresponding entity labels, providing guidance for entity extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of named entities with their corresponding entity labels, aiding in entity extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of named entities with their corresponding entity labels, providing guidance for entity extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of named entities with their corresponding entity labels, aiding in entity extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains a clear example of a named entity with its corresponding entity label, aiding in entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity types in the target sentence, providing no assistance in entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity types in the target sentence, providing no assistance in entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity types in the target sentence, providing no assistance in entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity types in the target sentence, providing no assistance in entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity types in the target sentence, providing no assistance in entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity types in the target sentence, providing no assistance in entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity types in the target sentence, providing no assistance in entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity types in the target sentence, providing no assistance in entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity types in the target sentence, providing no assistance in entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity types in the target sentence, providing no assistance in entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the entity types in the target sentence, providing no assistance in entity extraction."}\n]', 'response3': '[{"HIV-1": "cell_type"}, {"NF-KB": "protein"}]', 'prediction': {'HIV-1': 'cell_type', 'NF-KB': 'protein'}}
{'idx': 469, 'sentence': 'Cardiac and adrenergic diseases were excluded.', 'label': {}, 'response1': 'None.', 'response2': '[\n    {"Example 1": 1},\n    {"Example 2": 4},\n    {"Example 3": 1},\n    {"Example 4": 4},\n    {"Example 5": 5},\n    {"Example 6": 4},\n    {"Example 7": 1},\n    {"Example 8": 4},\n    {"Example 9": 1},\n    {"Example 10": 4},\n    {"Example 11": 5},\n    {"Example 12": 4},\n    {"Example 13": 5},\n    {"Example 14": 4},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1683, 'sentence': 'These results strongly suggest that HU induces both transcriptional and post-transcription regulation of c-jun during erythroid differentiation .', 'label': {'c-jun': 'DNA'}, 'response1': "['RNA', 'protein']", 'response2': '[\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction": 4},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells": 4},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2": 5},\n    {"SCL is expressed in erythroid, megakaryocyte and mast cell populations (the same cell lineages as GATA-1, a zinc-finger transcription factor)": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene": 5},\n    {"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well": 4},\n    {"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts": 5},\n    {"Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells)": 5},\n    {"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb/Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells": 5},\n    {"Expression of tal-1 and GATA-binding proteins during human hematopoiesis": 5},\n    {"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation": 5},\n    {"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB-induced trans-activation of the H4 promoter": 5}\n]', 'response3': '[{"c-jun": "protein"}]', 'prediction': {'c-jun': 'protein'}}
{'idx': 1648, 'sentence': 'Point mutations of either the PU.1 site or the C/EBP site that abolish the binding of the respective factors result in a significant decrease of GM-CSF receptor alpha promoter activity in myelomonocytic cells only.', 'label': {'PU.1 site': 'DNA', 'GM-CSF receptor alpha': 'protein', 'GM-CSF receptor alpha promoter': 'DNA', 'myelomonocytic cells': 'cell_type', 'C/EBP': 'protein', 'PU.1': 'protein', 'GM-CSF': 'protein', 'C/EBP site': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"IL-2": 5},\n    {"IFN-gamma": 5},\n    {"jak kinases": 5},\n    {"STAT1(alpha)": 5},\n    {"UAS1": 4},\n    {"B cell": 4},\n    {"Sp1": 5},\n    {"CD14": 5},\n    {"IL-2": 5},\n    {"c-Jun": 5},\n    {"c-Fos": 5},\n    {"GM-CSF": 5},\n    {"G-CSF": 5},\n    {"T cell": 5},\n    {"interleukin 2": 5},\n    {"IFN A": 5},\n    {"IFNA": 5},\n    {"interleukin-2": 5},\n    {"interleukin-2 receptor": 5},\n    {"phytohemagglutinin": 5},\n    {"phorbol myristate acetate": 5},\n    {"retinoic acid receptor alpha": 5},\n    {"Egr-1": 5},\n    {"GATA-1": 5},\n    {"MNDA": 5},\n    {"Philadelphia chromosome-positive chronic myeloid leukemia": 5},\n    {"CCAAT box": 4},\n    {"EKLF binding site": 5},\n    {"PU.1": 5},\n    {"M-CSF receptor": 5},\n    {"macrophage": 5},\n    {"myeloperoxidase": 5},\n    {"lysozyme": 5},\n    {"PU.1": 5},\n    {"EBNA-2": 5},\n    {"PU.1": 5}\n]', 'response3': '[{"PU.1": "protein"}, {"C/EBP": "protein"}, {"GM-CSF receptor alpha": "protein"}, {"myelomonocytic cells": "cell_type"}]', 'prediction': {'PU.1': 'protein', 'C/EBP': 'protein', 'GM-CSF receptor alpha': 'protein', 'myelomonocytic cells': 'cell_type'}}
{'idx': 646, 'sentence': 'Surgically confirmed nodal involvement was observed in 42%.', 'label': {}, 'response1': 'None.', 'response2': '[\n{"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 3},\n{"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n{"The expression of NDP kinase was intense in KA and SCC compared with BCC.": 4},\n{"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.": 4},\n{"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n{"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 3},\n{"By the time of diagnosis of T-PLL, the clone contains many more genetic changes in the form of additional translocations.": 3},\n{"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 4},\n{"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 3},\n{"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.": 4},\n{"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n{"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n{"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.": 4},\n{"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.": 4},\n{"Treatment with soluble, bivalent mAb J393 killed 25-50% of the cell population, while concomitant engagement of either the CD3.TcR complex or the integrins CD18 and CD29 significantly potentiated this effect.": 5},\n{"When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of the binding.": 4}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 821, 'sentence': '(vi) The EBV type 2 EBNA-2 transactivated LMP1 as well as the EBV type 1 EBNA-2 .', 'label': {'LMP1': 'protein', 'EBNA-2': 'protein', 'EBV type 1 EBNA-2': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.": 4},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.": 5},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 4},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 5},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB.": 5}\n]', 'response3': '[{"EBV type 2 EBNA-2": "protein"}, {"LMP1": "protein"}, {"EBV type 1 EBNA-2": "protein"}]', 'prediction': {'EBV type 2 EBNA-2': 'protein', 'LMP1': 'protein', 'EBV type 1 EBNA-2': 'protein'}}
{'idx': 548, 'sentence': 'On the other hand, interleukin 2 ( IL-2 )-induced signals are blocked by rapamycin but not by FK506 .', 'label': {'IL-2': 'protein', 'interleukin 2': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .": 4},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n    {"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells .": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 4},\n    {"Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.": 5},\n    {"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin .": 5},\n    {"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .": 5},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .": 5}\n]', 'response3': '[{"interleukin 2": "protein"}, {"IL-2": "protein"}, {"rapamycin": "protein"}, {"FK506": "protein"}]', 'prediction': {'interleukin 2': 'protein', 'IL-2': 'protein', 'rapamycin': 'protein', 'FK506': 'protein'}}
{'idx': 135, 'sentence': 'Tumor necrosis factor alpha ( TNF-alpha ) mRNA production was analyzed by polymerase chain reaction amplification in monocytic U937 cells and in a chronically HIV infected U937 cell line ( U9-IIIB ).', 'label': {'U9-IIIB': 'cell_line', 'monocytic U937 cells': 'cell_line', 'Tumor necrosis factor alpha ( TNF-alpha ) mRNA': 'RNA', 'chronically HIV infected U937 cell line': 'cell_line', 'Tumor necrosis factor alpha': 'protein', 'TNF-alpha': 'protein'}, 'response1': "['RNA', 'cell_type', 'cell_line']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"2": "The sentence does not contain any of the entity types in the label set."},\n    {"3": "The sentence contains relevant protein entities (IFN-gamma, tumor necrosis factor-alpha) but does not contain other entity types in the label set."},\n    {"4": "The sentence contains a cell line entity (Philadelphia chromosome-positive chronic myeloid leukemia) but does not contain other entity types in the label set."},\n    {"5": "The sentence contains relevant protein entities (IFN A, interleukin-2, interleukin-2 receptor) but does not contain other entity types in the label set."},\n    {"6": "The sentence contains cell line entities (Ramos, Jurkat) and a DNA entity (cDNA microarray technology) but does not contain other entity types in the label set."},\n    {"7": "The sentence contains a cell type entity (HIV-1) and relevant protein entities (IFN, PKR, IkappaBalpha) but does not contain other entity types in the label set."},\n    {"8": "The sentence contains relevant protein entities (interleukin-2, alpha chain, CD25, IL-2 receptor) but does not contain other entity types in the label set."},\n    {"9": "The sentence contains relevant protein entities (TR55, TNF-alpha) but does not contain other entity types in the label set."},\n    {"10": "The sentence contains relevant protein entities (Fibroblast growth factor-1, IL-2, NF-kappaB) and a cell line entity (Jurkat T cells) but does not contain other entity types in the label set."},\n    {"11": "The sentence contains relevant protein entities (MNDA) and cell type entities (monocytes, macrophages, leukemia/B lymphoma cell lines) but does not contain other entity types in the label set."},\n    {"12": "The sentence contains relevant protein entities (LITAF, TNF-alpha) but does not contain other entity types in the label set."},\n    {"13": "The sentence contains DNA entities (nuclear factor-kappa B, NF-kappa B) but does not contain other entity types in the label set."},\n    {"14": "The sentence contains relevant protein entities (NF-kappa B, fibrinogen) but does not contain other entity types in the label set."},\n    {"15": "The sentence contains relevant protein entities (HIV, NF-kappa B, p105, p50, MAD3) but does not contain other entity types in the label set."},\n    {"16": "The sentence contains relevant protein entities (alpha 4 beta 1, TCR/CD3) and a DNA entity (DNA) but does not contain other entity types in the label set."},\n    {"17": "The sentence does not contain any of the entity types in the label set."},\n    {"18": "The sentence does not contain any of the entity types in the label set."},\n    {"19": "The sentence does not contain any of the entity types in the label set."},\n    {"20": "The sentence does not contain any of the entity types in the label set."},\n    {"21": "The sentence does not contain any of the entity types in the label set."},\n    {"22": "The sentence does not contain any of the entity types in the label set."},\n    {"23": "The sentence does not contain any of the entity types in the label set."},\n    {"24": "The sentence does not contain any of the entity types in the label set."},\n    {"25": "The sentence does not contain any of the entity types in the label set."},\n    {"26": "The sentence does not contain any of the entity types in the label set."},\n    {"27": "The sentence does not contain any of the entity types in the label set."},\n    {"28": "The sentence does not contain any of the entity types in the label set."},\n    {"29": "The sentence does not contain any of the entity types in the label set."},\n    {"30": "The sentence does not contain any of the entity types in the label set."}\n]', 'response3': '[{"TNF-alpha": "protein"}, {"U937": "cell_type"}, {"U9-IIIB": "cell_line"}, {"HIV": "cell_type"}]', 'prediction': {'TNF-alpha': 'protein', 'U937': 'cell_type', 'U9-IIIB': 'cell_line', 'HIV': 'cell_type'}}
{'idx': 432, 'sentence': 'Moreover, BSAP is clearly a B-cell-specific transcription factor , as a wild-type but not a mutant TSAP -binding site of the sea urchin functions only in transfected B cells as an upstream promoter element .', 'label': {'transfected B cells': 'cell_line', 'TSAP': 'protein', 'mutant TSAP -binding site': 'DNA', 'upstream promoter element': 'DNA', 'BSAP': 'protein', 'B-cell-specific transcription factor': 'protein', 'wild-type': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n{"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 4},\n{"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n{"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n{"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 4},\n{"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n{"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n{"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.": 4},\n{"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 4},\n{"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 4},\n{"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n{"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF.": 5},\n{"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5}\n]', 'response3': '[{"BSAP": "protein"}, {"TSAP": "protein"}, {"sea urchin": "cell_line"}, {"B cells": "cell_type"}]', 'prediction': {'BSAP': 'protein', 'TSAP': 'protein', 'sea urchin': 'cell_line', 'B cells': 'cell_type'}}
{'idx': 1161, 'sentence': 'Deoxycholate treatment of the cytoplasmic extract prepared from cells stimulated by TNF-alpha in the presence of Cu2+ resulted in the release of NF kappa B from I kappa B alpha , indicating that Cu2+ interferes with the dissociation of the NF kappa B -I kappa B complex .', 'label': {'I kappa B alpha': 'protein', 'NF kappa B': 'protein', 'NF kappa B -I kappa B complex': 'protein', 'TNF-alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.": 5},\n    {"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .": 5},\n    {"When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma , the cells instead become DC .": 5},\n    {"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 5},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .": 5},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .": 5},\n    {"Control of NF-kappa B activity by the I kappa B beta inhibitor .": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[{"NF kappa B": "protein"}, {"I kappa B alpha": "protein"}, {"Cu2+": "cell_line"}]', 'prediction': {'NF kappa B': 'protein', 'I kappa B alpha': 'protein', 'Cu2+': 'cell_line'}}
{'idx': 1794, 'sentence': 'Activation of the signal transducer and transcription ( STAT ) signaling pathway in a primary T cell response .', 'label': {'STAT': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"1": "The sentence contains specific protein names and their corresponding receptors, which are relevant entities in the target sentence."},\n    {"2": "The sentence discusses the activation of specific proteins and cell types that are relevant entities in the target sentence."},\n    {"4": "The sentence mentions specific proteins, cell types, and cytokines that are relevant entities in the target sentence."},\n    {"3": "The sentence mentions a specific protein that is relevant to the target sentence."},\n    {"4": "The sentence discusses the activation of specific proteins and cell types that are relevant entities in the target sentence."},\n    {"3": "The sentence mentions specific proteins that are relevant entities in the target sentence."},\n    {"2": "The sentence discusses the activation of specific proteins that are relevant entities in the target sentence."},\n    {"4": "The sentence mentions specific proteins and their receptors that are relevant entities in the target sentence."},\n    {"2": "The sentence discusses the activation of specific proteins and cell types that are relevant entities in the target sentence."},\n    {"2": "The sentence mentions specific proteins and cell types that are relevant entities in the target sentence."},\n    {"1": "The sentence does not contain any relevant entities mentioned in the target sentence."},\n    {"1": "The sentence does not contain any relevant entities mentioned in the target sentence."},\n    {"1": "The sentence does not contain any relevant entities mentioned in the target sentence."},\n    {"1": "The sentence does not contain any relevant entities mentioned in the target sentence."},\n    {"1": "The sentence does not contain any relevant entities mentioned in the target sentence."},\n    {"1": "The sentence does not contain any relevant entities mentioned in the target sentence."},\n    {"1": "The sentence does not contain any relevant entities mentioned in the target sentence."},\n    {"1": "The sentence does not contain any relevant entities mentioned in the target sentence."},\n    {"1": "The sentence does not contain any relevant entities mentioned in the target sentence."},\n    {"1": "The sentence does not contain any relevant entities mentioned in the target sentence."},\n    {"1": "The sentence does not contain any relevant entities mentioned in the target sentence."},\n    {"1": "The sentence does not contain any relevant entities mentioned in the target sentence."},\n    {"1": "The sentence does not contain any relevant entities mentioned in the target sentence."},\n    {"1": "The sentence does not contain any relevant entities mentioned in the target sentence."},\n    {"1": "The sentence does not contain any relevant entities mentioned in the target sentence."},\n    {"1": "The sentence does not contain any relevant entities mentioned in the target sentence."}\n]', 'response3': '[{"STAT": "protein"}, {"T cell": "cell_type"}]', 'prediction': {'STAT': 'protein', 'T cell': 'cell_type'}}
{'idx': 1470, 'sentence': 'Hence, induction of cell surface expression of this leukocyte adhesion molecule by tumor necrosis factor (TNF)-alpha was reduced by 40% in the presence of CsA , and this was reflected by a 29% decrease in neutrophil adhesion .', 'label': {'neutrophil': 'cell_type', 'tumor necrosis factor (TNF)-alpha': 'protein', 'leukocyte adhesion molecule': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n    {"PMA induced the expression of both CD14 and CD23 mRNA and protein.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n    {"CD40 expression could be enhanced in CD40-positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 5},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 4},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 5},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.": 4},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5}\n]', 'response3': '[{"leukocyte adhesion molecule": "protein"}, {"tumor necrosis factor (TNF)-alpha": "protein"}, {"CsA": "protein"}, {"neutrophil": "cell_type"}]', 'prediction': {'leukocyte adhesion molecule': 'protein', 'tumor necrosis factor (TNF)-alpha': 'protein', 'CsA': 'protein', 'neutrophil': 'cell_type'}}
{'idx': 644, 'sentence': 'Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers : a role for hematopoietic growth factor release by tumor cells ?', 'label': {'tumor cells': 'cell_type', 'hematopoietic growth factor': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific entities and their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains specific entities and their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains specific entities and their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence contains entities that match some of the entity types in the target sentence, providing relevant context."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific entities and their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific entities and their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific entities and their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific entities and their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence contains entities that match some of the entity types in the target sentence, providing relevant context."},\n    {"Example 10": 4},\n    {"Reason 10": "The sentence contains entities that match some of the entity types in the target sentence, providing relevant context."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains specific entities and their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence contains entities that match some of the entity types in the target sentence, providing relevant context."},\n    {"Example 13": 3},\n    {"Reason 13": "The sentence contains entities that partially match the entity types in the target sentence, but the relevance is not as direct."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence contains entities that match some of the entity types in the target sentence, providing relevant context."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities that match the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 435, 'sentence': 'Antibodies are produced exclusively in B lymphocytes .', 'label': {'Antibodies': 'protein', 'lymphocytes': 'cell_type', 'B lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"IgH": 5},\n{"B lymphocytes": 5},\n{"CD2": 5},\n{"CD70": 5},\n{"NF-ATc": 5},\n{"E2A": 5},\n{"benzene": 5},\n{"EBV": 5},\n{"CD40": 5},\n{"LMP1": 5},\n{"ICAM-1": 5},\n{"CD71": 5}\n]', 'response3': '[{"B lymphocytes": "cell_type"}]', 'prediction': {'B lymphocytes': 'cell_type'}}
{'idx': 1342, 'sentence': 'While Bik does not show overt homology to the BH1 and BH2 conserved domains characteristic of the Bcl-2 family , it does share a 9 amino acid domain ( BH3 ) with Bax and Bak which may be a critical determinant for the death-promoting activity of these proteins.', 'label': {'amino acid domain': 'protein', 'BH1': 'protein', 'BH3': 'protein', 'Bak': 'protein', 'BH2': 'protein', 'Bax': 'protein', 'Bik': 'protein', 'Bcl-2 family': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 4},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"These two related genes share the evolutionarily conserved region encoding the Runt domain.": 4},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"Tat-binding protein 7 is a subunit of the 26S protease.": 4},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.": 5},\n    {"Activation of NF-kappaB by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.": 5},\n    {"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1022, 'sentence': 'NK cell NFAT is present in the cytosol of nonstimulated cells , migrates to the nucleus upon stimulation, and can associate with AP-1 .', 'label': {'NK cell NFAT': 'protein', 'AP-1': 'protein', 'nonstimulated cells': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Sentence 1": 5},\n    {"Sentence 2": 5},\n    {"Sentence 3": 5},\n    {"Sentence 4": 5},\n    {"Sentence 5": 5},\n    {"Sentence 6": 5},\n    {"Sentence 7": 5},\n    {"Sentence 8": 5},\n    {"Sentence 9": 1},\n    {"Sentence 10": 1},\n    {"Sentence 11": 1},\n    {"Sentence 12": 1},\n    {"Sentence 13": 1},\n    {"Sentence 14": 1},\n    {"Sentence 15": 1},\n    {"Sentence 16": 1},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1},\n    {"Sentence 20": 1},\n    {"Sentence 21": 1},\n    {"Sentence 22": 1},\n    {"Sentence 23": 1},\n    {"Sentence 24": 1},\n    {"Sentence 25": 1}\n]', 'response3': '[{"NK cell": "cell_type"}, {"NFAT": "protein"}, {"AP-1": "protein"}]', 'prediction': {'NK cell': 'cell_type', 'NFAT': 'protein', 'AP-1': 'protein'}}
{'idx': 810, 'sentence': 'Exposure of CML cells to IFN-alpha diminished the effect of the CML cytoplasmic proteins on these nuclear protein-DNA complexes .', 'label': {'CML cells': 'cell_type', 'IFN-alpha': 'protein', 'CML cytoplasmic proteins': 'protein', 'nuclear protein-DNA complexes': 'protein'}, 'response1': "['protein', 'cell_line', 'DNA']", 'response2': '[\n    {"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.": 5},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .": 5},\n    {"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 5},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.": 5},\n    {"When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma , the cells instead become DC .": 5},\n    {"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .": 5},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[{"CML": "cell_line"}, {"IFN-alpha": "protein"}, {"CML": "cell_line"}, {"cytoplasmic proteins": "protein"}, {"nuclear protein-DNA complexes": "DNA"}]', 'prediction': {'CML': 'cell_line', 'IFN-alpha': 'protein', 'cytoplasmic proteins': 'protein', 'nuclear protein-DNA complexes': 'DNA'}}
{'idx': 1811, 'sentence': "In our attempt to identify chemokine receptors that are related to Burkitt's lymphoma receptor 1 ( BLR1 ) and are expressed in activated lymphocytes we used RT-PCR resulting in the isolation of a cDNA encoding a seven transmembrane receptor termed BLR2 .", 'label': {'BLR1': 'protein', 'BLR2': 'protein', 'seven transmembrane receptor': 'protein', 'activated lymphocytes': 'cell_type', 'chemokine receptors': 'protein', "Burkitt's lymphoma receptor 1": 'protein'}, 'response1': "['RNA', 'protein']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 3},\n    {"Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 4},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 3},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 4},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"This suggests that CHEMR1 may be a receptor for unidentified C-C chemokine or a low-affinity receptor for MIP-1alpha .": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1316, 'sentence': 'Helix III is less rigid, makes an average angle of about 90 degrees with helices I and II , and constitutes the other arm of the molecule.', 'label': {'Helix III': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 1},\n    {"Example 9": 1},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 939, 'sentence': 'However, in 3 postmenopausal patients a short course of estrogen or tamoxifen resulted in a marked increase of type II EBS levels.', 'label': {'type II EBS': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 292, 'sentence': 'We used mouse embryonic stem (ES) cells to study globin gene expression and switching in vitro.', 'label': {'globin gene': 'DNA', 'mouse embryonic stem (ES) cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n{"E2A": 5},\n{"MNDA": 5},\n{"granulocytes": 4},\n{"T cells": 4},\n{"IgH": 5},\n{"PML/RARalpha": 5},\n{"GM-CSF": 5},\n{"GATA-1": 5},\n{"SCM-1": 5},\n{"IFN A": 5},\n{"IFNA": 5},\n{"interleukin-2": 5},\n{"interleukin-2 receptor": 5},\n{"phytohemagglutinin": 5},\n{"phorbol myristate acetate": 5},\n{"GATA-1": 5},\n{"CCAAT box": 5},\n{"EKLF binding site": 5},\n{"Egr-1": 5},\n{"RXR": 5},\n{"Sp1": 5},\n{"Ets": 5},\n{"c-kit": 5},\n{"IL-4R alpha chain": 5},\n{"ZEB": 5},\n{"c-Myb": 5},\n{"Ets": 5},\n{"hematopoietic cells": 4}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 542, 'sentence': 'Amino acid sequences of all proteins are essays written in the same language.', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"proteins": "protein"}]', 'prediction': {'proteins': 'protein'}}
{'idx': 505, 'sentence': 'The TCF-1 alpha binding site was also required for TCR alpha enhancer activity in transcriptionally active extracts from Jurkat but not HeLa cells , confirming that TCF-1 alpha is a T-cell-specific transcription factor .', 'label': {'Jurkat': 'cell_line', 'TCF-1 alpha': 'protein', 'TCR': 'protein', 'T-cell-specific transcription factor': 'protein', 'TCF-1 alpha binding site': 'DNA', 'HeLa cells': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Sentence 1": 3},\n    {"Sentence 2": 2},\n    {"Sentence 3": 4},\n    {"Sentence 4": 4},\n    {"Sentence 5": 4},\n    {"Sentence 6": 4},\n    {"Sentence 7": 2},\n    {"Sentence 8": 3},\n    {"Sentence 9": 3},\n    {"Sentence 10": 1},\n    {"Sentence 11": 1},\n    {"Sentence 12": 1},\n    {"Sentence 13": 2},\n    {"Sentence 14": 2},\n    {"Sentence 15": 2},\n    {"Sentence 16": 1},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1},\n    {"Sentence 20": 1},\n    {"Sentence 21": 1},\n    {"Sentence 22": 1},\n    {"Sentence 23": 1},\n    {"Sentence 24": 1}\n]', 'response3': '[{"TCF-1 alpha": "protein"}, {"TCR alpha": "protein"}, {"Jurkat": "cell_line"}, {"HeLa": "cell_line"}, {"T-cell-specific": "cell_type"}]', 'prediction': {'TCF-1 alpha': 'protein', 'TCR alpha': 'protein', 'Jurkat': 'cell_line', 'HeLa': 'cell_line', 'T-cell-specific': 'cell_type'}}
{'idx': 1525, 'sentence': 'Kinase activity was reduced in lysates preadsorbed using an antibody specific for CaM kinase II .', 'label': {'antibody': 'protein', 'CaM kinase II': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides specific protein names that match the entity types in the target sentence, making it highly relevant for named entity extraction."}\n]', 'response3': '[{"CaM kinase II": "protein"}]', 'prediction': {'CaM kinase II': 'protein'}}
{'idx': 1103, 'sentence': 'Relationship between Rap1 protein phosphorylation and regulation of Ca2+ transport in platelets : a new approach.', 'label': {'platelets': 'cell_type', 'Rap1 protein': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 538, 'sentence': 'Alone, PMA and calcium ionophore A23187 did not affect, but together stimulated, like phytohaemagglutinin ( PHA ), leucine and, in particular, thymidine incorporation .', 'label': {'PHA': 'protein', 'phytohaemagglutinin': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 5},\n    {"Example 17": 5},\n    {"Example 18": 5},\n    {"Example 19": 5},\n    {"Example 20": 5},\n    {"Example 21": 5},\n    {"Example 22": 5},\n    {"Example 23": 5},\n    {"Example 24": 5},\n    {"Example 25": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1529, 'sentence': 'Transcriptional activation and repression , two properties of the lymphoid-specific transcription factor Oct-2a .', 'label': {'Oct-2a': 'protein', 'lymphoid-specific transcription factor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names that are directly mentioned, making it highly relevant for extracting protein entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions a specific cell type (Th2-type lymphocytes), which is directly related to a cell type entity."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence mentions multiple protein names (Oct-2A, HMG I/Y, HLA-DRA) and a cell type (B cells), making it highly relevant for extracting protein and cell type entities."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence mentions specific cell types (T cell) and a protein (interleukin 2), which are directly related to cell type and protein entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence mentions multiple protein names (NF-kB, AP-1, OCT-1, NF-IL-2B), making it highly relevant for extracting protein entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions a specific protein name (Egr-1), making it highly relevant for extracting protein entities."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence mentions a specific protein name (IL-2 receptor alpha subunit) and a cell type (B cell), making it relevant for extracting protein and cell type entities."},\n    {"Example 8": 4},\n    {"Reason 8": "The sentence mentions specific protein names (SP1, caspases) and a cell type (B-cell), making it relevant for extracting protein and cell type entities."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence mentions specific protein names (NF-ATc) and a cell type (T lymphocytes), making it relevant for extracting protein and cell type entities."},\n    {"Example 10": 3},\n    {"Reason 10": "The sentence mentions a specific DNA binding protein (AP-1), which is indirectly related to a DNA entity."},\n    {"Example 11": 4},\n    {"Reason 11": "The sentence mentions a specific protein name (A-myb), making it relevant for extracting protein entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions specific protein names (Sp1, Ets) directly related to protein entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions specific protein names (Jun, ATF-2) directly related to protein entities."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence mentions a specific protein name (NF-E2), making it relevant for extracting protein entities."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions specific protein names (NF-ATc) and cell types (T lymphocytes, embryonic cardiac cells), making it highly relevant for extracting protein and cell type entities."},\n    {"Example 16": 4},\n    {"Reason 16": "The sentence mentions a specific protein name (GATA-1), making it relevant for extracting protein entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities related to the given entity labels."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities related to the given entity labels."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any named entities related to the given entity labels."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any named entities related to the given entity labels."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any named entities related to the given entity labels."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any named entities related to the given entity labels."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any named entities related to the given entity labels."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any named entities related to the given entity labels."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any named entities related to the given entity labels."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1197, 'sentence': 'In this study, we demonstrate reconstitution of a cell-free processing system and demonstrate directly that: (a) the ubiquitin -proteasome system is involved in processing of the intact p105 precursor, (b) conjugation of ubiquitin to the precursor is an essential intermediate step in the processing, (c) the recently discovered novel species of the ubiquitin -carrier protein , E2-F1 , that is involved in the conjugation and degradation of p53 , is also required for the limited processing of the p105 precursor , and (d) a novel, approximately 320-kDa species of ubiquitin -protein ligase , is involved in the process.', 'label': {'ubiquitin': 'protein', 'p105 precursor': 'protein', 'E2-F1': 'protein', '-proteasome': 'protein', 'ubiquitin -carrier protein': 'protein', 'p53': 'protein', 'ubiquitin -protein ligase': 'protein', '320-kDa species': 'protein', 'p105': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n{"Tat-binding protein 7 is a subunit of the 26S protease.": 5},\n{"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n{"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 5},\n{"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n{"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n{"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.": 5},\n{"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n{"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n{"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n{"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n{"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n{"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 5},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n{"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5}\n]', 'response3': '[{"ubiquitin -proteasome system": "protein"}, {"p105 precursor": "protein"}, {"ubiquitin": "protein"}, {"E2-F1": "protein"}, {"p53": "protein"}, {"ubiquitin -carrier protein": "protein"}, {"ubiquitin -protein ligase": "protein"}]', 'prediction': {'ubiquitin -proteasome system': 'protein', 'p105 precursor': 'protein', 'ubiquitin': 'protein', 'E2-F1': 'protein', 'p53': 'protein', 'ubiquitin -carrier protein': 'protein', 'ubiquitin -protein ligase': 'protein'}}
{'idx': 877, 'sentence': 'Their constitutive expression is limited to B lymphocytes and thymic epithelial cells .', 'label': {'B lymphocytes': 'cell_type', 'thymic epithelial cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains clear mentions of specific entities with corresponding labels, aiding in the extraction process."},\n\n    {"Example 2": 4},\n    {"Reason 2": "The sentence provides a specific protein entity, which is relevant to the target sentence."},\n\n    {"Example 3": 4},\n    {"Reason 3": "The sentence mentions specific cell types that are relevant to the target sentence."},\n\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains clear mentions of specific entities with corresponding labels, aiding in the extraction process."},\n\n    {"Example 5": 4},\n    {"Reason 5": "The sentence mentions a specific cell type that is relevant to the target sentence."},\n\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains clear mentions of specific entities with corresponding labels, aiding in the extraction process."},\n\n    {"Example 7": 4},\n    {"Reason 7": "The sentence mentions specific protein and cell line entities that are relevant to the target sentence."},\n\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains clear mentions of specific entities with corresponding labels, aiding in the extraction process."},\n\n    {"Example 9": 4},\n    {"Reason 9": "The sentence mentions specific protein and cell type entities that are relevant to the target sentence."},\n\n    {"Example 10": 4},\n    {"Reason 10": "The sentence mentions specific protein and cell type entities that are relevant to the target sentence."},\n\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains clear mentions of specific entities with corresponding labels, aiding in the extraction process."},\n\n    {"Example 12": 4},\n    {"Reason 12": "The sentence mentions specific protein and cell type entities that are relevant to the target sentence."},\n\n    {"Example 13": 4},\n    {"Reason 13": "The sentence mentions a specific cell type that is relevant to the target sentence."},\n\n    {"Example 14": 4},\n    {"Reason 14": "The sentence mentions specific protein and cell type entities that are relevant to the target sentence."},\n\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any relevant entities for the target sentence."},\n\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any relevant entities for the target sentence."},\n\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any relevant entities for the target sentence."},\n\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any relevant entities for the target sentence."},\n\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any relevant entities for the target sentence."},\n\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any relevant entities for the target sentence."}\n]', 'response3': '[{"B lymphocytes": "cell_type"}, {"thymic epithelial cells": "cell_type"}]', 'prediction': {'B lymphocytes': 'cell_type', 'thymic epithelial cells': 'cell_type'}}
{'idx': 1838, 'sentence': 'First, we show that mutations in the LEF-1 -binding site inhibit the activity of multimerized copies of the HIV-1 enhancer in Jurkat T cells , and that LEF-1 /GAL4 can activate a GAL4-substituted HIV-1 enhancer 80- to 100-fold in vivo.', 'label': {'LEF-1 -binding site': 'DNA', 'HIV-1 enhancer': 'DNA', 'LEF-1': 'protein', 'GAL4-substituted HIV-1 enhancer': 'DNA', 'Jurkat T cells': 'cell_line', 'multimerized copies': 'DNA', 'LEF-1 /GAL4': 'protein'}, 'response1': "['protein', 'cell_line', 'cell_type']", 'response2': '[\n{"immunoglobulin kappa 3\' enhancer": 5},\n{"IL-2": 5},\n{"IFN-gamma": 5},\n{"jak kinases": 5},\n{"STAT1(alpha)": 5},\n{"IL-2": 5},\n{"c-Jun": 5},\n{"c-Fos": 5},\n{"IL-2": 5},\n{"IFN A": 5},\n{"IFNA": 5},\n{"interleukin-2": 5},\n{"interleukin-2 receptor": 5},\n{"phytohemagglutinin": 5},\n{"phorbol myristate acetate": 5},\n{"PU.1": 5},\n{"M-CSF receptor": 5},\n{"macrophage": 5},\n{"Sp1": 5},\n{"CD14": 5},\n{"SIVsmmPBj14": 5},\n{"T cell": 5},\n{"interleukin 2": 5},\n{"p50p50": 5},\n{"IkappaBbeta": 5},\n{"NF-kappaB": 5},\n{"HIV-1": 5},\n{"IFN": 5},\n{"PKR": 5},\n{"IkappaBalpha": 5},\n{"NF-kappaB": 5},\n{"Sp1": 5},\n{"SIVmac": 5},\n{"cDNA": 5},\n{"Jurkat": 5},\n{"DRE 1": 5},\n{"HIV-1 LTR": 5},\n{"NFAT-1": 5},\n{"NF kappa B": 5},\n{"TR55": 5},\n{"TNF-alpha": 5},\n{"HIV": 5},\n{"ATF1": 5},\n{"CREB": 5},\n{"H4": 5}\n]', 'response3': '[{"LEF-1": "protein"}, {"HIV-1 enhancer": "DNA"}, {"Jurkat T cells": "cell_type"}, {"GAL4": "protein"}, {"GAL4-substituted HIV-1 enhancer": "DNA"}]', 'prediction': {'LEF-1': 'protein', 'HIV-1 enhancer': 'DNA', 'Jurkat T cells': 'cell_type', 'GAL4': 'protein', 'GAL4-substituted HIV-1 enhancer': 'DNA'}}
{'idx': 1195, 'sentence': 'Palombella and colleagues (Palombella, V.J., Rando, O.J., Goldberg, A.L., and Maniatis, T.(1994) Cell 78, 773-785) have shown that ubiquitin is required for the processing in a cell-free system of a truncated, artificially constructed, 60-kDa precursor .', 'label': {'60-kDa precursor': 'protein', 'ubiquitin': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Tat-binding protein 7 is a subunit of the 26S protease .": 4},\n    {"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .": 4},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50 .": 4},\n    {"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .": 5},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 4},\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .": 5},\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 5},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n    {"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .": 5}\n]', 'response3': '[{"ubiquitin": "protein"}]', 'prediction': {'ubiquitin': 'protein'}}
{'idx': 817, 'sentence': '(ii) Transfection and expression of EBNA-LP alone had no effect on LMP1 expression and did not act synergistically with EBNA-2 to affect LMP1 expression .', 'label': {'EBNA-LP': 'protein', 'LMP1': 'protein', 'EBNA-2': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"5": "The sentence contains multiple instances of protein entities, which are directly mentioned in the sentence."},\n{"5": "The sentence contains multiple instances of protein entities, which are directly mentioned in the sentence."},\n{"5": "The sentence contains multiple instances of protein entities, which are directly mentioned in the sentence."},\n{"5": "The sentence contains multiple instances of protein entities, which are directly mentioned in the sentence."},\n{"5": "The sentence contains multiple instances of protein entities, which are directly mentioned in the sentence."},\n{"5": "The sentence contains multiple instances of protein entities, which are directly mentioned in the sentence."},\n{"5": "The sentence contains multiple instances of protein entities, which are directly mentioned in the sentence."},\n{"5": "The sentence contains multiple instances of protein entities, which are directly mentioned in the sentence."},\n{"5": "The sentence contains multiple instances of protein entities, which are directly mentioned in the sentence."},\n{"5": "The sentence contains multiple instances of protein entities, which are directly mentioned in the sentence."},\n{"5": "The sentence contains multiple instances of protein entities, which are directly mentioned in the sentence."},\n{"5": "The sentence contains multiple instances of protein entities, which are directly mentioned in the sentence."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 741, 'sentence': 'In melanoma cells that contain the N-Oct-3 factor , a transfected lymphocyte-specific promoter was neither activated nor was it repressed upon contransfection with an Oct-2A expression vector .', 'label': {'Oct-2A expression vector': 'DNA', 'Oct-2A': 'protein', 'N-Oct-3 factor': 'protein', 'melanoma cells': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 4},\n    {"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.": 5},\n    {"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.": 4},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2.": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 4},\n    {"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.": 5},\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 5},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 283, 'sentence': '[ Estrogen receptor content of peripheral blood lymphocytes in patients with systemic lupus erythematosus ]', 'label': {'Estrogen receptor': 'protein', 'peripheral blood lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 4},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms .": 4},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 4},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .": 4},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .": 4},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .": 5},\n    {"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.": 5}\n]', 'response3': '[{"Estrogen receptor": "protein"}, {"peripheral blood lymphocytes": "cell_type"}, {"systemic lupus erythematosus": "cell_type"}]', 'prediction': {'Estrogen receptor': 'protein', 'peripheral blood lymphocytes': 'cell_type', 'systemic lupus erythematosus': 'cell_type'}}
{'idx': 1043, 'sentence': 'METHOD: Two color flow cytometry analysis was used on peripheral blood samples of young and postmenopausal females and postmenopausal females treated with estrogen replacement therapy .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific gene/protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions specific proteins and a cell line, which are relevant entity types in the target sentence."},\n    {"Example 3": 3},\n    {"Reason 3": "The sentence provides information about proteins and a cell line, which are partially relevant to the entity types in the target sentence."},\n    {"Example 4": 2},\n    {"Reason 4": "The sentence mentions proteins, which are relevant entity types in the target sentence, but the context is not directly related to the entities in the target sentence."},\n    {"Example 5": 1},\n    {"Reason 5": "The sentence talks about hormones and lymphocytes, which are not directly related to the entity types in the target sentence."}\n]', 'response3': '[{"estrogen replacement therapy": "protein"}]', 'prediction': {'estrogen replacement therapy': 'protein'}}
{'idx': 1010, 'sentence': 'Using a polyclonal antibody to murine NFATp , Western blot analysis of various mouse tissues demonstrated that the 110-130-kDa NFATp protein was highly expressed in thymus and spleen .', 'label': {'murine NFATp': 'protein', 'NFATp protein': 'protein', 'NFATp': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 3},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 4},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .": 4},\n    {"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .": 4},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .": 5},\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 4},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 4},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .": 4},\n    {"Moreover, monocytes express a novel IL-10 -stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti- STAT3 Ab but is not observed in T cells .": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 4},\n    {"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .": 5}\n]', 'response3': '[{"NFATp": "protein"}, {"NFATp": "protein"}, {"thymus": "cell_type"}, {"spleen": "cell_type"}]', 'prediction': {'NFATp': 'protein', 'thymus': 'cell_type', 'spleen': 'cell_type'}}
{'idx': 186, 'sentence': 'We also find that NF-E2 , another trans-acting factor of the erythrocytic lineage , is present in megakaryocytes .', 'label': {'erythrocytic lineage': 'cell_type', 'NF-E2': 'protein', 'trans-acting factor': 'protein', 'megakaryocytes': 'cell_line'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a direct mapping between the entity \'RXR\' and its corresponding entity label \'protein\' in the target sentence, aiding in the extraction of named entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The examples provide direct mappings between the entities \'SCL\', \'GATA-1\', and their corresponding entity labels \'protein\' in the target sentence, aiding in the extraction of named entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The examples provide direct mappings between the entities \'Stat3\', \'Stat5\', \'c-Mpl\', and their corresponding entity labels \'protein\' in the target sentence, aiding in the extraction of named entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The examples provide direct mappings between the entities \'NF-ATc\', \'T lymphocytes\', \'embryonic cardiac cells\', and their corresponding entity labels \'protein\', \'cell_type\' in the target sentence, aiding in the extraction of named entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides a direct mapping between the entity \'GATA-1\' and its corresponding entity label \'protein\' in the target sentence, aiding in the extraction of named entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The examples provide direct mappings between the entities \'granulocytes\', \'T cells\', and their corresponding entity labels \'cell_type\' in the target sentence, aiding in the extraction of named entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The examples provide direct mappings between the entities \'EKLF\', \'CBP\', \'p300\', \'P/CAF\', and their corresponding entity labels \'protein\' in the target sentence, aiding in the extraction of named entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides a direct mapping between the entity \'Egr-1\' and its corresponding entity label \'protein\' in the target sentence, aiding in the extraction of named entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The examples provide direct mappings between the entities \'NF-ATc\', \'T lymphocytes\', \'embryonic cardiac cells\', and their corresponding entity labels \'protein\', \'cell_type\' in the target sentence, aiding in the extraction of named entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides a direct mapping between the entity \'erythropoietin\' and its corresponding entity label \'protein\' in the target sentence, aiding in the extraction of named entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides a direct mapping between the entity \'NF-E2\' and its corresponding entity label \'protein\' in the target sentence, aiding in the extraction of named entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The examples provide direct mappings between the entities \'E2A\', and their corresponding entity labels \'protein\' in the target sentence, aiding in the extraction of named entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides a direct mapping between the entity \'GATA-1\' and its corresponding entity label \'protein\' in the target sentence, aiding in the extraction of named entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The examples provide direct mappings between the entities \'CD40\', \'Rel/nuclear factor kappaB\', \'NF-kappaB\', \'B lymphocytes\', and their corresponding entity labels \'protein\', \'cell_type\' in the target sentence, aiding in the extraction of named entities."},\n    {"Example 15": 5},\n    {"Reason 15": "The examples provide direct mappings between the entities \'ZEB\', \'c-Myb\', \'Ets\', \'hematopoietic cells\', and their corresponding entity labels \'protein\', \'cell_type\' in the target sentence, aiding in the extraction of named entities."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entities from the given entity label set, hence providing no aid in extracting named entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities from the given entity label set, hence providing no aid in extracting named entities."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities from the given entity label set, hence providing no aid in extracting named entities."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities from the given entity label set, hence providing no aid in extracting named entities."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities from the given entity label set, hence providing no aid in extracting named entities."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities from the given entity label set, hence providing no aid in extracting named entities."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities from the given entity label set, hence providing no aid in extracting named entities."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities from the given entity label set, hence providing no aid in extracting named entities."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities from the given entity label set, hence providing no aid in extracting named entities."}\n]', 'response3': '[{"NF-E2": "protein"}]', 'prediction': {'NF-E2': 'protein'}}
{'idx': 1547, 'sentence': 'Platelet glycoprotein ( GP ) Ib-IX-V is a multisubunit adhesion receptor that supports platelet attachment to thrombogenic surfaces at sites of vascular injury .', 'label': {'multisubunit adhesion receptor': 'protein', 'Ib-IX-V': 'protein', 'Platelet glycoprotein': 'protein', 'GP': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"NF-kappa B": 5},\n    {"CD28": 1, "CD80": 1, "CD86": 1, "CBL": 1, "VAV": 1, "NFAT": 1, "interleukin-2": 1, "granulocyte-macrophage colony-stimulating factor": 1},\n    {"cell adhesion molecules": 5},\n    {"P selectin": 1},\n    {"G-CSF": 1},\n    {"Stat3": 1, "Stat5": 1, "c-Mpl": 1},\n    {"cAMP-dependent protein kinase": 1, "Rap1": 1},\n    {"myeloperoxidase": 1, "lysozyme": 1, "PU.1": 1},\n    {"Tat-binding protein 7": 1},\n    {"IL4": 1, "IL13": 1, "gamma c chain": 1, "STAT6": 1, "STAT3": 1, "STAT5": 1, "B cells": 1},\n    {"NF-kappa B": 1},\n    {"p21ras": 1},\n    {"SLAP-130": 1, "SLP-76": 1, "T cell": 1},\n    {"Syk": 1, "Zap": 1, "T cell": 1},\n    {"GM-CSF": 1},\n    {"alpha-tocopherol": 1, "monocyte": 5, "endothelial cells": 5},\n    {},\n    {},\n    {},\n    {},\n    {},\n    {},\n    {},\n    {},\n    {},\n    {},\n    {},\n    {}\n]', 'response3': '[{"Platelet glycoprotein (GP) Ib-IX-V": "protein"}]', 'prediction': {'Platelet glycoprotein (GP) Ib-IX-V': 'protein'}}
{'idx': 96, 'sentence': 'We have analyzed the functional domains of the minimal Thy-1 promoter and show that the dominant promoter elements consist of multiple binding sites for the transcription factor Sp1 , an inverted CCAAT box , and sequences proximal to the transcription start site .', 'label': {'Sp1': 'protein', 'dominant promoter elements': 'DNA', 'minimal Thy-1 promoter': 'DNA', 'transcription factor': 'protein', 'multiple binding sites': 'DNA', 'CCAAT box': 'DNA', 'transcription start site': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 4},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes.": 4},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 5},\n    {"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 5},\n    {"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif.": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 5},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[{"Thy-1": "protein"}, {"Sp1": "protein"}, {"CCAAT box": "DNA"}]', 'prediction': {'Thy-1': 'protein', 'Sp1': 'protein', 'CCAAT box': 'DNA'}}
{'idx': 1763, 'sentence': 'Cysteamine treatment inhibited both expression of the IL-2 mRNA and secretion of IL-2 into the culture medium .', 'label': {'IL-2': 'protein', 'IL-2 mRNA': 'RNA'}, 'response1': "['RNA', 'protein']", 'response2': '[\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 5},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .": 4},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .": 4},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .": 5},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .": 4},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells .": 5}\n]', 'response3': '[{"IL-2 mRNA": "RNA"}, {"IL-2": "protein"}, {"IL-2": "protein"}]', 'prediction': {'IL-2 mRNA': 'RNA', 'IL-2': 'protein'}}
{'idx': 224, 'sentence': 'Cortivazol ( CVZ ) is a unique, high potency synthetic glucocorticoid , which has a phenylpyrazol fused to the A-ring of the steroid nucleus and displays binding consistent with two or more sites in the cytosol from CEM C7 cells (a human acute lymphoblastic T-cell line ).', 'label': {'CEM C7 cells': 'cell_line', 'human acute lymphoblastic T-cell line': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"IL-5 mRNA upon TCR and IL-2R stimulation": 3},\n    {"Control of NF-kappa B activity by the I kappa B beta inhibitor": 3},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes": 4},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment": 4},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes": 4},\n    {"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin": 4},\n    {"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation": 4},\n    {"Benzene toxicity towards lymphocytes is thought to be mediated by metabolites of benzene including benzoquinone (BQ)": 4},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration": 4},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene": 4},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation": 4},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival": 4},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor": 4},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release": 4},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats)": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729": 1}\n]', 'response3': '[{"Cortivazol": "protein"}, {"CVZ": "protein"}, {"CEM C7 cells": "cell_line"}]', 'prediction': {'Cortivazol': 'protein', 'CVZ': 'protein', 'CEM C7 cells': 'cell_line'}}
{'idx': 313, 'sentence': 'Immunohistochemical study of steroid hormones and an estrogen binding assay in malignant soft tissue tumors .', 'label': {'malignant soft tissue tumors': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a clear mapping between the entity \'E2A\' and the entity type \'protein\' in the sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The example provides a clear mapping between the entity \'GATA-1\' and the entity type \'protein\' in the sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides a clear mapping between the entity \'lymphoid neoplasms\' and the entity type \'cell_type\' in the sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The example provides a clear mapping between the entity \'phosphocreatine\' and the entity type \'protein\' in the sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The examples provide clear mappings between the entities \'SLAP-130\', \'SLP-76\', \'T cell\' and the entity type \'protein\' and \'cell_type\' in the sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The example provides a clear mapping between the entity \'NF-E2\' and the entity type \'protein\' in the sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides clear mappings between the entities \'immunohistochemistry\', \'gene\', \'cell type\' and the entity types \'protein\', \'DNA\', \'cell_type\' in the sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides a clear mapping between the entity \'retinoic acid receptor alpha\' and the entity type \'protein\' in the sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides a clear mapping between the entity \'CD14\' and the entity type \'protein\' in the sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides clear mappings between the entities \'HML\', \'dexamethasone\', \'cortisol\', \'lysozyme\' and the entity types \'cell_line\', \'protein\' in the sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides clear mappings between the entities \'CD40\', \'Rel/nuclear factor kappaB\', \'NF-kappaB\', \'B lymphocytes\' and the entity types \'protein\', \'cell_type\' in the sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The example provides clear mappings between the entities \'B and T cell activation\', \'Ramos\', \'Jurkat\', \'cDNA microarray technology\' and the entity types \'cell_type\', \'cell_line\', \'DNA\' in the sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides clear mappings between the entities \'tal-1\', \'GATA-binding proteins\', \'hematopoiesis\' and the entity types \'protein\', \'cell_type\' in the sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The example provides clear mappings between the entities \'Erbstatin\', \'genistein\', \'Egr-1\' and the entity types \'protein\', \'RNA\' in the sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The example provides clear mappings between the entities \'EBV\', \'EBNA2\', \'estrogen receptor\' and the entity types \'DNA\', \'protein\' in the sentence."},\n    {"Example 16": 5},\n    {"Reason 16": "The example provides clear mappings between the entities \'MR\', \'aldosterone\', \'progesterone\' and the entity types \'protein\' in the sentence."}\n]', 'response3': "[{'steroid hormones': 'protein'}, {'estrogen': 'protein'}]", 'prediction': {'steroid hormones': 'protein', 'estrogen': 'protein'}}
{'idx': 1285, 'sentence': "Characterization of 5' end of human thromboxane receptor gene .", 'label': {"5' end of human thromboxane receptor gene": 'DNA', 'human thromboxane receptor gene': 'DNA'}, 'response1': "['DNA']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 4": 1},\n{"Reason 4": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 5": 1},\n{"Reason 5": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 6": 1},\n{"Reason 6": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 7": 1},\n{"Reason 7": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 8": 1},\n{"Reason 8": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 9": 1},\n{"Reason 9": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 10": 1},\n{"Reason 10": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 11": 1},\n{"Reason 11": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 12": 1},\n{"Reason 12": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 13": 1},\n{"Reason 13": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 14": 1},\n{"Reason 14": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 15": 1},\n{"Reason 15": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 16": 1},\n{"Reason 16": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any named entities from the given entity label set."},\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any named entities from the given entity label set."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 327, 'sentence': 'However, there is an EB1 -binding site ( ZRE-B ) located within the R-responsive enhancer region .', 'label': {'R-responsive enhancer region': 'DNA', 'EB1 -binding site': 'DNA', 'EB1': 'protein', 'ZRE-B': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF.": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 4},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 4},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5}\n]', 'response3': '[{"EB1": "protein"}, {"ZRE-B": "DNA"}]', 'prediction': {'EB1': 'protein', 'ZRE-B': 'DNA'}}
{'idx': 1622, 'sentence': 'Analysis of whole-cell lysates by antiphosphotyrosine immunoblotting showed that incubation with gamma interferon brought about specific increases in phosphotyrosine labeling of several proteins.', 'label': {'gamma interferon': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"5": "The sentence contains multiple examples of proteins and interleukins, which are relevant entities in the label set."},\n{"4": "The sentence contains examples of proteins and interleukins, which are relevant entities in the label set."},\n{"3": "The sentence contains examples of proteins, but not the other entity types in the label set."},\n{"2": "The sentence contains an example of a protein, but not the other entity types in the label set."},\n{"4": "The sentence contains examples of proteins, including IL-2, c-Jun, and c-Fos, which are relevant entities in the label set."},\n{"5": "The sentence contains multiple examples of proteins and interleukins, which are relevant entities in the label set."},\n{"5": "The sentence contains an example of a protein, which is a relevant entity in the label set."},\n{"5": "The sentence contains multiple examples of proteins and interleukins, which are relevant entities in the label set."},\n{"5": "The sentence contains multiple examples of proteins and interleukins, which are relevant entities in the label set."},\n{"5": "The sentence contains multiple examples of proteins and interleukins, which are relevant entities in the label set."},\n{"5": "The sentence contains multiple examples of proteins and interleukins, which are relevant entities in the label set."},\n{"5": "The sentence contains multiple examples of proteins and interleukins, which are relevant entities in the label set."},\n{"5": "The sentence contains multiple examples of proteins and interleukins, which are relevant entities in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."}\n]', 'response3': "[{'gamma interferon': 'protein'}, {'phosphotyrosine': 'protein'}]", 'prediction': {'gamma interferon': 'protein', 'phosphotyrosine': 'protein'}}
{'idx': 1393, 'sentence': 'This enhancer in HIV-1 is the T-cell activation response element ; in HIV-2 , however, it is the second enhancer that is mainly responsible for activation in response to T-cell activators .', 'label': {'second enhancer': 'DNA', 'T-cell activation response element': 'DNA', 'enhancer': 'DNA'}, 'response1': "['cell_type']", 'response2': '[\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 4},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5},\n    {"These properties suggest that TAFII105 is a cell type-specific subunit of TFIID that may be responsible for mediating transcription by a subset of activators in B cells.": 5},\n    {"Interleukin 2 and T cell antigen receptor signals converge upon serine 727.": 5},\n    {"The response element for NF-AT is a sequence localized between -285/-254 in the IL-2 regulatory region.": 4}\n]', 'response3': '[{"HIV-1": "cell_type"}, {"T-cell": "cell_type"}, {"HIV-2": "cell_type"}, {"T-cell": "cell_type"}]', 'prediction': {'HIV-1': 'cell_type', 'T-cell': 'cell_type', 'HIV-2': 'cell_type'}}
{'idx': 1221, 'sentence': 'To identify osteoblast-specific cis-acting elements and trans-acting factors , we initiated an analysis of the promoter of a mouse osteocalcin gene , an osteoblast-specific gene .', 'label': {'mouse osteocalcin gene': 'DNA', 'promoter': 'DNA', 'osteoblast-specific cis-acting elements': 'DNA', 'trans-acting factors': 'protein', 'osteoblast-specific gene': 'DNA'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes.": 3},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 4},\n    {"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 4},\n    {"A critical role of Sp1- and Ets-related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"To evaluate the PML/RARalpha role in myelopoiesis, transgenic mice expressing PML/RARalpha were engineered.": 4},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 4},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 4},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 4},\n    {"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4}\n]', 'response3': '[{"osteoblast": "cell_type"}, {"cis-acting elements": "None"}, {"trans-acting factors": "None"}, {"promoter": "None"}, {"mouse osteocalcin gene": "protein"}, {"osteoblast-specific gene": "cell_type"}]', 'prediction': {'osteoblast': 'cell_type', 'cis-acting elements': 'None', 'trans-acting factors': 'None', 'promoter': 'None', 'mouse osteocalcin gene': 'protein', 'osteoblast-specific gene': 'cell_type'}}
{'idx': 130, 'sentence': 'At high concentration of NE , all of the TR bound to TREp was more greatly retarded than in the absence of NE .', 'label': {'TREp': 'DNA', 'TR': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 4},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 788, 'sentence': 'The number of mineralocorticoid receptors /cell were within or close to the normal range (n = 9).', 'label': {'mineralocorticoid receptors': 'protein'}, 'response1': "['cell_type']", 'response2': '[\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 1},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA/NF-kappaB1 binding complexes.": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 4},\n    {"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.": 5},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.": 5},\n    {"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.": 5},\n    {"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.": 5},\n    {"When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of the binding.": 5},\n    {"A total of 37 chronic, severe, nonsmoking asthmatic patients with documented reversible airways obstruction were classified as glucocorticoid-sensitive or -resistant on the basis of changes in FEV1, FVC, and peak expiratory flow (PEF) after oral prednisolone.": 5},\n    {"The number of Type I and Type II receptors before the test was lower in elderly subjects than in adults.": 5},\n    {"Membrane receptors for aldosterone: a novel pathway for mineralocorticoid action.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 5},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 5},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 5},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 781, 'sentence': 'Effects of aldosterone on intralymphocytic sodium and potassium in patients with essential hypertension .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 3},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n    {"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes.": 4},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 4},\n    {"We have examined the effect of alpha-tocopherol (alpha-tcp) on one cellular event in atherosclerotic plaque development, monocyte adhesion to stimulated endothelial cells (ECs).": 5},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 4},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 5},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 4},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"Eosinophils play an important role in the effector phase of allergic inflammation.": 4},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 4},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1220, 'sentence': 'A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element .', 'label': {'PEBP2 alpha/AML-1-related factor': 'protein', 'osteocalcin promoter': 'DNA', 'osteoblast-specific cis-acting element': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"To evaluate the PML/RARalpha role in myelopoiesis, transgenic mice expressing PML/RARalpha were engineered.": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]": 5},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 5},\n    {"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex, cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[{"PEBP2 alpha/AML-1-related factor": "protein"}, {"osteocalcin": "protein"}, {"osteoblast-specific": "cell_type"}]', 'prediction': {'PEBP2 alpha/AML-1-related factor': 'protein', 'osteocalcin': 'protein', 'osteoblast-specific': 'cell_type'}}
{'idx': 958, 'sentence': 'Here, Markus Neurath, Eckhard Stuber and Warren Strober describe the molecular structure of BSAP and focus on the ability of this protein to regulate the expression of B-cell-specific genes .', 'label': {'B-cell-specific genes': 'DNA', 'BSAP': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .": 5},\n    {"Tat-binding protein 7 is a subunit of the 26S protease .": 4},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .": 5},\n    {"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes .": 3},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .": 4},\n    {"Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .": 5},\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .": 5},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines .": 5},\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 4},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5}\n]', 'response3': '[{"Markus Neurath": "protein"}, {"Eckhard Stuber": "protein"}, {"Warren Strober": "protein"}, {"BSAP": "protein"}, {"B-cell-specific genes": "protein"}]', 'prediction': {'Markus Neurath': 'protein', 'Eckhard Stuber': 'protein', 'Warren Strober': 'protein', 'BSAP': 'protein', 'B-cell-specific genes': 'protein'}}
{'idx': 1083, 'sentence': 'These data suggest that the action of tepoxalin to inhibit proliferation in PBMC may be at least in part due to its ability to reduce the amount of available iron resulting in decreased activation of NF kappa B and subsequent inhibition of cytokine production .', 'label': {'cytokine': 'protein', 'NF kappa B': 'protein', 'PBMC': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"1": "The example sentences do not contain any of the entity types present in the target sentence."},\n    {"1": "The example sentences do not contain any of the entity types present in the target sentence."},\n    {"5": "The sentence contains \'NF-kappaB\' which is a protein entity, and also mentions \'Tax\' and \'ATL\' which are cell_type entities."},\n    {"1": "The example sentences do not contain any of the entity types present in the target sentence."},\n    {"3": "The sentence contains \'IL-4\', \'LPS\', and \'AP-1\' which are protein entities."},\n    {"5": "The sentence contains \'NF-kappa B\' which is a protein entity."},\n    {"5": "The sentence contains \'IL-2\', \'IFN-gamma\', \'jak kinases\', and \'STAT1(alpha)\' which are protein entities."},\n    {"5": "The sentence contains \'NF-kappa B\' which is a protein entity."},\n    {"1": "The example sentences do not contain any of the entity types present in the target sentence."},\n    {"5": "The sentence contains \'NF-kappa B\' and \'I kappa B beta\' which are protein entities."},\n    {"5": "The sentence contains \'IL-2\', \'NF-kappa B\', and \'AP-1\' which are protein entities."},\n    {"5": "The sentence contains \'IFN A\', \'IFNA\', \'interleukin-2\', \'interleukin-2 receptor\', \'phytohemagglutinin\', and \'phorbol myristate acetate\' which are protein entities."},\n    {"5": "The sentence contains \'HIV-1\', \'IFN\', \'PKR\', and \'IkappaBalpha\' which are protein entities."},\n    {"5": "The sentence contains \'interleukin-2\', \'alpha chain\', \'CD25\', and \'IL-2 receptor\' which are protein entities."},\n    {"5": "The sentence contains \'B cell\', \'Ig\', and \'Transforming growth factor-beta\' which are protein entities."},\n    {"3": "The sentence contains \'CTLA4Ig\', \'NFAT\', and \'AP-1\' which are protein entities."},\n    {"1": "The example sentences do not contain any of the entity types present in the target sentence."},\n    {"1": "The example sentences do not contain any of the entity types present in the target sentence."},\n    {"1": "The example sentences do not contain any of the entity types present in the target sentence."},\n    {"1": "The example sentences do not contain any of the entity types present in the target sentence."},\n    {"1": "The example sentences do not contain any of the entity types present in the target sentence."},\n    {"1": "The example sentences do not contain any of the entity types present in the target sentence."},\n    {"1": "The example sentences do not contain any of the entity types present in the target sentence."},\n    {"1": "The example sentences do not contain any of the entity types present in the target sentence."},\n    {"1": "The example sentences do not contain any of the entity types present in the target sentence."},\n    {"1": "The example sentences do not contain any of the entity types present in the target sentence."},\n    {"1": "The example sentences do not contain any of the entity types present in the target sentence."},\n    {"1": "The example sentences do not contain any of the entity types present in the target sentence."},\n    {"1": "The example sentences do not contain any of the entity types present in the target sentence."},\n    {"1": "The example sentences do not contain any of the entity types present in the target sentence."},\n    {"1": "The example sentences do not contain any of the entity types present in the target sentence."},\n    {"1": "The example sentences do not contain any of the entity types present in the target sentence."},\n    {"1": "The example sentences do not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"NF kappa B": "protein"}]', 'prediction': {'NF kappa B': 'protein'}}
{'idx': 514, 'sentence': 'Induction of the enhancer may have a role in the increase in globin gene transcription that characterizes erythroid maturation .', 'label': {'globin gene': 'DNA', 'enhancer': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence provides a clear example of a protein (GATA-1) and its corresponding entity label, which directly aids in extracting named entities from the target sentence."}\n]\n[\n{"Example 2": 5},\n{"Reason 2": "The sentence provides a clear example of a protein (NF-E2) and its corresponding entity label, which directly aids in extracting named entities from the target sentence."}\n]\n[\n{"Example 3": 5},\n{"Reason 3": "The sentence provides a clear example of a cell type (Th2-type lymphocytes) and its corresponding entity label, which directly aids in extracting named entities from the target sentence."}\n]\n[\n{"Example 4": 5},\n{"Reason 4": "The sentence provides a clear example of a protein (Egr-1) and its corresponding entity label, which directly aids in extracting named entities from the target sentence."}\n]\n[\n{"Example 5": 5},\n{"Reason 5": "The sentence provides a clear example of a protein (erythropoietin) and its corresponding entity label, which directly aids in extracting named entities from the target sentence."}\n]\n[\n{"Example 6": 5},\n{"Reason 6": "The sentence provides clear examples of DNA (CCAAT box) and protein (EKLF binding site) with their corresponding entity labels, aiding in extracting named entities from the target sentence."}\n]\n[\n{"Example 7": 5},\n{"Reason 7": "The sentence provides a clear example of DNA (AP-1) and its corresponding entity label, which directly aids in extracting named entities from the target sentence."}\n]\n[\n{"Example 8": 5},\n{"Reason 8": "The sentence provides a clear example of a protein (IL-4) and its corresponding entity label, which directly aids in extracting named entities from the target sentence."}\n]\n[\n{"Example 9": 5},\n{"Reason 9": "The sentence provides a clear example of a protein (retinoic acid receptor alpha) and its corresponding entity label, which directly aids in extracting named entities from the target sentence."}\n]\n[\n{"Example 10": 5},\n{"Reason 10": "The sentence provides a clear example of a protein (RXR) and its corresponding entity label, which directly aids in extracting named entities from the target sentence."}\n]\n[\n{"Example 11": 5},\n{"Reason 11": "The sentence provides clear examples of protein (WT1) and cell line (myeloid cell lines) with their corresponding entity labels, aiding in extracting named entities from the target sentence."}\n]\n[\n{"Example 12": 5},\n{"Reason 12": "The sentence provides clear examples of protein (IL-2 receptor alpha subunit, p21ras) and cell type (B cell) with their corresponding entity labels, aiding in extracting named entities from the target sentence."}\n]\n[\n{"Example 13": 5},\n{"Reason 13": "The sentence provides a clear example of DNA (IgH) and its corresponding entity label, which directly aids in extracting named entities from the target sentence."}\n]\n[\n{"Example 14": 5},\n{"Reason 14": "The sentence provides a clear example of a protein (GATA-1) and its corresponding entity label, which directly aids in extracting named entities from the target sentence."}\n]\n[\n{"Example 15": 5},\n{"Reason 15": "The sentence provides a clear example of DNA (immunoglobulin kappa 3\' enhancer) and its corresponding entity label, which directly aids in extracting named entities from the target sentence."}\n]\n[\n{"Example 16": 5},\n{"Reason 16": "The sentence provides clear examples of proteins (SCL, GATA-1) with their corresponding entity labels, aiding in extracting named entities from the target sentence."}\n]\n[\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any named entities relevant to the entity labels provided in the target sentence, hence not helpful in aiding entity extraction."}\n]\n[\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any named entities relevant to the entity labels provided in the target sentence, hence not helpful in aiding entity extraction."}\n]\n[\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any named entities relevant to the entity labels provided in the target sentence, hence not helpful in aiding entity extraction."}\n]\n[\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any named entities relevant to the entity labels provided in the target sentence, hence not helpful in aiding entity extraction."}\n]\n[\n{"Example 21": 1},\n{"Reason 21": "The sentence does not contain any named entities relevant to the entity labels provided in the target sentence, hence not helpful in aiding entity extraction."}\n]\n[\n{"Example 22": 1},\n{"Reason 22": "The sentence does not contain any named entities relevant to the entity labels provided in the target sentence, hence not helpful in aiding entity extraction."}\n]\n[\n{"Example 23": 1},\n{"Reason 23": "The sentence does not contain any named entities relevant to the entity labels provided in the target sentence, hence not helpful in aiding entity extraction."}\n]\n[\n{"Example 24": 1},\n{"Reason 24": "The sentence does not contain any named entities relevant to the entity labels provided in the target sentence, hence not helpful in aiding entity extraction."}\n]\n[\n{"Example 25": 1},\n{"Reason 25": "The sentence does not contain any named entities relevant to the entity labels provided in the target sentence, hence not helpful in aiding entity extraction."}\n]', 'response3': '[{"enhancer": "DNA"}, {"globin gene": "DNA"}, {"erythroid": "cell_type"}]', 'prediction': {'enhancer': 'DNA', 'globin gene': 'DNA', 'erythroid': 'cell_type'}}
{'idx': 1133, 'sentence': 'Both LCLs were found by EM to produce RVLP and EBV particles .', 'label': {'LCLs': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.": 4},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .": 4},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 4},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .": 4},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 4},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 5},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms .": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .": 5},\n    {"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB .": 5}\n]', 'response3': '[{"LCLs": "cell_line"}, {"RVLP": "protein"}, {"EBV": "cell_line"}]', 'prediction': {'LCLs': 'cell_line', 'RVLP': 'protein', 'EBV': 'cell_line'}}
{'idx': 1762, 'sentence': 'Taking the IL-2 gene as a candidate, we examined the effect of cysteamine treatment on early gene expression during lymphocyte activation , and on the activity of transcription factors AP-1 , NF-kappa B , NF-AT and Oct1 , whose functions are required for expression of the IL-2 mRNA.', 'label': {'IL-2': 'protein', 'early gene': 'DNA', 'NF-kappa B': 'protein', 'Oct1': 'protein', 'transcription factors': 'protein', 'NF-AT': 'protein', 'AP-1': 'protein', 'IL-2 gene': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 4},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes.": 5},\n    {"While the activation of the IL-2 promoter and an NFAT-driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418, it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2-mediated NFAT activation is under the control of a combination of calcineurin-dependent and independent pathways.": 5},\n    {"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.": 5},\n    {"These results suggest that oxidative signals can positively and negatively regulate T cell transcriptional events and that changes in cellular redox can uncouple AP-1 regulation of c-jun from transcriptional up-regulation of IL-2 via NF-AT.": 5},\n    {"Together, these findings suggest that LITAF plays an important role in the activation of the human TNF-alpha gene and proposes a new mechanism to control TNF-alpha gene expression.": 5}\n]', 'response3': '[{"IL-2": "protein"}, {"cysteamine": "protein"}, {"AP-1": "protein"}, {"NF-kappa B": "protein"}, {"NF-AT": "protein"}, {"Oct1": "protein"}]', 'prediction': {'IL-2': 'protein', 'cysteamine': 'protein', 'AP-1': 'protein', 'NF-kappa B': 'protein', 'NF-AT': 'protein', 'Oct1': 'protein'}}
{'idx': 23, 'sentence': 'Furthermore, a mutant E6 motif lost both in vitro binding activity and in vivo enhancer activity .', 'label': {'mutant E6 motif': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 4},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50 .": 4},\n    {"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 5},\n    {"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .": 5},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .": 4},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements .": 5},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines .": 4},\n    {"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events .": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 4},\n    {"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .": 5},\n    {"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .": 5}\n]', 'response3': '[{"E6 motif": "protein"}]', 'prediction': {'E6 motif': 'protein'}}
{'idx': 1476, 'sentence': 'Protein phosphorylation has an important role in the regulation of these two factors: (1) it induces the transactivating capacity of the AP-1 protein c-Jun ; and (2) it is involved in the release of the cytoplasmic inhibitor , I kappa B , from NF-kappa B , allowing translocation of the latter into the nucleus .', 'label': {'AP-1 protein': 'protein', 'c-Jun': 'protein', 'I kappa B': 'protein', 'NF-kappa B': 'protein', 'cytoplasmic inhibitor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of protein names and their corresponding entity labels, making it very helpful for extracting named entities from the target sentence."}\n]', 'response3': '[{"AP-1": "protein"}, {"c-Jun": "protein"}, {"I kappa B": "protein"}, {"NF-kappa B": "protein"}]', 'prediction': {'AP-1': 'protein', 'c-Jun': 'protein', 'I kappa B': 'protein', 'NF-kappa B': 'protein'}}
{'idx': 234, 'sentence': 'A similar infection with a recombinant retrovirus containing the beta-galactosidase gene with an adenovirus E2 promoter , results in beta-galactosidase activity in a limited number of cultured and primary cells .', 'label': {'cultured': 'cell_line', 'primary cells': 'cell_type', 'adenovirus E2 promoter': 'DNA', 'beta-galactosidase gene': 'DNA', 'beta-galactosidase': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n    {"In addition, assay of PBMC by the adenovirus-specific PCR may help detect early invasive disease and warrants further evaluation.": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"This protein has now been purified and its encoding gene cloned.": 5},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 4},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 4},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 5},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 4},\n    {"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n    {"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 5}\n]', 'response3': '[{"beta-galactosidase gene": "protein"}, {"adenovirus E2 promoter": "DNA"}]', 'prediction': {'beta-galactosidase gene': 'protein', 'adenovirus E2 promoter': 'DNA'}}
{'idx': 1396, 'sentence': 'NF-M ( chicken C/EBP beta ) induces eosinophilic differentiation and apoptosis in a hematopoietic progenitor cell line .', 'label': {'hematopoietic progenitor cell line': 'cell_line', 'NF-M': 'protein', 'chicken C/EBP beta': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '```json\n[\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 4},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 4},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"Control of NF-kappa B activity by the I kappa B beta inhibitor.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 4},\n    {"Recently, activation of NF-kappa B has been linked to ARDS and has been shown to be a critical proximal step in the initiation of neutrophilic inflammation in animal models.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 4},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 4},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 5},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 5}\n]\n```', 'response3': '```json\n[{"NF-M": "protein"}, {"C/EBP beta": "protein"}, {"hematopoietic progenitor cell line": "cell_line"}]\n```', 'prediction': {'NF-M': 'protein', 'C/EBP beta': 'protein', 'hematopoietic progenitor cell line': 'cell_line'}}
{'idx': 1812, 'sentence': 'The protein shows significant sequence similarities to the family of G-protein coupled chemokine receptors and turned out to be identical to the recently described receptor EBI1 .', 'label': {'G-protein coupled chemokine receptors': 'protein', 'chemokine receptors': 'protein', 'G-protein': 'protein', 'receptor EBI1': 'protein'}, 'response1': "['protein']", 'response2': '```json\n[\n    {"EBV": 1},\n    {"B-cell": 1},\n    {"retinoic acid receptor alpha": 5},\n    {"Protein": 5},\n    {"MIP-1 alpha": 5},\n    {"GOS19": 5},\n    {"LD78": 5},\n    {"AT464": 5},\n    {"EBNA-2": 5},\n    {"PU.1": 5},\n    {"CREB": 5},\n    {"AR-CRE": 5},\n    {"Egr-1": 5},\n    {"E2A": 5},\n    {"GM-CSF": 5},\n    {"protein": 5},\n    {"EKLF": 5},\n    {"CBP": 5},\n    {"p300": 5},\n    {"P/CAF": 5},\n    {"EBNA2": 5},\n    {"TP1": 1},\n    {"c-kit": 5},\n    {"IL-4R alpha chain": 5},\n    {"interleukin 10": 5},\n    {"IL-10R": 5},\n    {"STAT3": 5},\n    {"IL-6": 5},\n    {"GATA-1": 5},\n    {"IL4": 5},\n    {"IL13": 5},\n    {"STAT6": 5},\n    {"STAT5": 5},\n    {"B cells": 1}\n]\n```', 'response3': '```json\n[{"G-protein coupled chemokine receptors": "protein"}, {"EBI1": "protein"}]\n```', 'prediction': {'G-protein coupled chemokine receptors': 'protein', 'EBI1': 'protein'}}
{'idx': 1099, 'sentence': 'Interestingly, microtubule disruption also decreased monocyte 1,25(OH)2D3 synthesis , not by decreasing the Vmax of monocyte mitochondrial 1 alpha-hydroxylase but through an increase in the Km for 25(OH)2D3 .', 'label': {'monocyte mitochondrial 1 alpha-hydroxylase': 'protein', 'monocyte': 'cell_type', 'microtubule': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 4},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 3},\n    {"Changes in PKC isoforms in human alveolar macrophages compared with blood monocytes.": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 3},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"We have examined the effect of alpha-tocopherol (alpha-tcp) on one cellular event in atherosclerotic plaque development, monocyte adhesion to stimulated endothelial cells (ECs).": 4},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 4},\n    {"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.": 4},\n    {"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.": 4},\n    {"When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma, the cells instead become DC.": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 4},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 4},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]": 4},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 4}\n]', 'response3': '[{"monocyte": "cell_type"}, {"1,25(OH)2D3": "protein"}, {"Vmax": "protein"}, {"monocyte mitochondrial 1 alpha-hydroxylase": "protein"}, {"Km": "protein"}, {"25(OH)2D3": "protein"}]', 'prediction': {'monocyte': 'cell_type', '1,25(OH)2D3': 'protein', 'Vmax': 'protein', 'monocyte mitochondrial 1 alpha-hydroxylase': 'protein', 'Km': 'protein', '25(OH)2D3': 'protein'}}
{'idx': 1537, 'sentence': 'Furthermore, we identified a repression domain at the N-terminus of Oct-2a .', 'label': {'Oct-2a': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 1},\n{"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n{"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .": 5},\n{"Here we examined the regulatory mechanism of the SCM-1 genes .": 1},\n{"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .": 5},\n{"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells .": 5},\n{"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements .": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 5},\n{"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .": 5},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .": 5},\n{"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .": 5},\n{"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n{"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n{"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[{"Oct-2a": "protein"}]', 'prediction': {'Oct-2a': 'protein'}}
{'idx': 1574, 'sentence': 'CONCLUSIONS: Sexual hormones , through their receptors , may influence the activity of eosinophils in patients with VKC .', 'label': {'receptors': 'protein', 'eosinophils': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence directly mentions \'eosinophils\' and their role, making it highly relevant for extracting the entity type \'cell_type\'."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains specific proteins like \'IL-4\', \'LPS\', and \'AP-1\', which are directly related to the entity type \'protein\', making it helpful for extraction."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence discusses genes encoding proteins like \'cAMP-dependent protein kinase\' and \'Rap1\', which are relevant for the entity type \'protein\', aiding in extraction."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence mentions \'G-CSF\' and its binding to receptors, indicating the entity type \'protein\', which is helpful for extraction."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence talks about the inhibition of NF-kappa B activation, which is a protein, making it useful for extracting the entity type \'protein\'."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence directly refers to \'lymphoid neoplasms\', which falls under the entity type \'cell_type\', making it highly relevant for extraction."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence mentions \'IFN-gamma\', a cytokine, which is relevant for the entity type \'protein\', aiding in extraction."},\n    {"Example 8": 3},\n    {"Reason 8": "The sentence discusses \'phosphocreatine\', which is not directly related to any entity type in the given set, making it less helpful for extraction."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence mentions \'GATA-1\', a transcription factor, which is relevant for the entity type \'protein\', aiding in extraction."},\n    {"Example 10": 4},\n    {"Reason 10": "The sentence discusses \'NF-kappa B activation\', which is a protein, making it useful for extracting the entity type \'protein\'."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence directly refers to \'immunoglobulin kappa 3\' enhancer\', which is related to the entity type \'DNA\', making it highly relevant for extraction."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence mentions \'NF-kappa B activation\', which is a protein, aiding in the extraction of the entity type \'protein\'."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence discusses \'CD40 stimulation\', \'Rel/nuclear factor kappaB factors\', and \'NF-kappaB\', all related to the entity type \'protein\', making it highly relevant for extraction."},\n    {"Example 14": 3},\n    {"Reason 14": "The sentence talks about \'nuclear factor-kappa B activity\' and \'NF-kappa B\', which are related to the entity type \'DNA\', making it somewhat helpful for extraction."},\n    {"Example 15": 4},\n    {"Reason 15": "The sentence mentions \'gp91phox\' and \'HL-60-C15 cells\', which are related to the entity types \'DNA\' and \'cell_line\', aiding in extraction."},\n    {"Example 16": 4},\n    {"Reason 16": "The sentence discusses \'CXC chemokine\' and \'interleukin-8\', which are proteins, making it useful for extracting the entity type \'protein\'."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities related to the given entity types, making it not helpful for extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities related to the given entity types, making it not helpful for extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities related to the given entity types, making it not helpful for extraction."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities related to the given entity types, making it not helpful for extraction."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities related to the given entity types, making it not helpful for extraction."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities related to the given entity types, making it not helpful for extraction."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities related to the given entity types, making it not helpful for extraction."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities related to the given entity types, making it not helpful for extraction."}\n]', 'response3': '[{"eosinophils": "cell_type"}]', 'prediction': {'eosinophils': 'cell_type'}}
{'idx': 1312, 'sentence': 'A solution structure for the non-sequence-specific C-terminal HMG box of HMG-1 has recently been proposed.', 'label': {'HMG-1': 'protein', 'C-terminal HMG box': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and direct example of a cell line (SCM-1) being mentioned in relation to a regulatory mechanism of genes."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains specific DNA-related elements (CCAAT box) and protein-related elements (EKLF binding site) that can aid in entity extraction."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence mentions a specific protein (GM-CSF) in relation to conserved motifs in gene promoters."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides multiple examples of protein entities (IL-2, c-Jun, c-Fos) in the context of gel-shift analysis."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence mentions a specific cell type (Th2-type lymphocytes) in relation to cytokine promoters."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence directly mentions protein and genomic sequences, indicating the presence of protein entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides clear examples of protein entities (IL-7R, gamma(c)) in the context of structure/function analyses."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions specific proteins (c-kit, IL-4R alpha chain) in the context of a chimeric receptor system."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains multiple protein entities (Oct-2A, HMG I/Y, HLA-DRA) and a cell type (B cells) in relation to gene expression."},\n    {"Example 10": 4},\n    {"Reason 10": "The sentence mentions a specific protein (retinoic acid receptor alpha) in the context of binding assays."},\n    {"Example 11": 4},\n    {"Reason 11": "The sentence provides examples of protein entities (CHEMR1, C-C chemokine, MIP-1alpha) in relation to receptor functions."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence mentions a specific protein (TCF-1) in the context of transactivation."},\n    {"Example 13": 3},\n    {"Reason 13": "The sentence mentions DNA binding activity, which is relevant to DNA entities."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence provides examples of protein entities (SLAP-130, SLP-76, T cell) in relation to molecular cloning."},\n    {"Example 15": 4},\n    {"Reason 15": "The sentence mentions a specific protein (ZAP-70) in relation to cellular responses."},\n    {"Example 16": 3},\n    {"Reason 16": "The sentence mentions cDNAs, which are related to DNA entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any relevant entity types mentioned in the target sentence."}\n]', 'response3': '[{"HMG-1": "protein"}]', 'prediction': {'HMG-1': 'protein'}}
{'idx': 601, 'sentence': 'To determine whether enhancer elements in addition to the highly conserved octamer (OCTA)-nucleotide motif are important for lymphoid-specific expression of the immunoglobulin heavy-chain (IgH) gene , we have investigated the effect of mutating the binding site for a putative additional lymphoid-specific transcription factor , designated NF-microB , in the murine IgH enhancer .', 'label': {'murine IgH enhancer': 'DNA', 'putative additional lymphoid-specific transcription factor': 'protein', 'octamer (OCTA)-nucleotide motif': 'DNA', 'NF-microB': 'protein', 'enhancer elements': 'DNA', 'immunoglobulin heavy-chain (IgH) gene': 'DNA', 'binding site': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence contains a specific protein name (NF-E2) which is one of the entity types in the target sentence."},\n{"Example 2": 5},\n{"Reason 2": "The sentence contains specific protein names (Oct-2A, HMG I/Y, HLA-DRA) and a cell type (B cells) which are entity types in the target sentence."},\n{"Example 3": 5},\n{"Reason 3": "The sentence contains a specific protein name (IL-2) which is one of the entity types in the target sentence."},\n{"Example 4": 5},\n{"Reason 4": "The sentence contains specific protein names (NF-ATc) and cell types (T lymphocytes, embryonic cardiac cells) which are entity types in the target sentence."},\n{"Example 5": 5},\n{"Reason 5": "The sentence contains a specific protein name (Egr-1) which is one of the entity types in the target sentence."},\n{"Example 6": 5},\n{"Reason 6": "The sentence contains a specific protein name (IL-4) which is one of the entity types in the target sentence."},\n{"Example 7": 5},\n{"Reason 7": "The sentence contains a specific cell type (T cell) and a specific protein name (interleukin 2) which are entity types in the target sentence."},\n{"Example 8": 5},\n{"Reason 8": "The sentence contains specific protein names (IL-2, c-Jun, c-Fos) which are entity types in the target sentence."},\n{"Example 9": 5},\n{"Reason 9": "The sentence contains a specific cell type (Th2-type lymphocytes) which is one of the entity types in the target sentence."},\n{"Example 10": 5},\n{"Reason 10": "The sentence contains a specific DNA name (IgH) which is one of the entity types in the target sentence."},\n{"Example 11": 5},\n{"Reason 11": "The sentence contains a specific DNA name (immunoglobulin kappa 3\' enhancer) which is one of the entity types in the target sentence."},\n{"Example 12": 5},\n{"Reason 12": "The sentence contains specific protein names (c-kit, IL-4R alpha chain) which are entity types in the target sentence."},\n{"Example 13": 5},\n{"Reason 13": "The sentence contains a specific protein name (NF-kappa B) which is one of the entity types in the target sentence."},\n{"Example 14": 5},\n{"Reason 14": "The sentence contains specific protein names (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) which are entity types in the target sentence."},\n{"Example 15": 5},\n{"Reason 15": "The sentence contains specific protein names (CD40, Rel/nuclear factor kappaB, NF-kappaB) and a cell type (B lymphocytes) which are entity types in the target sentence."},\n{"Example 16": 5},\n{"Reason 16": "The sentence contains specific protein names (p50, p65) and mentions DNA and protein which are entity types in the target sentence."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 21": 1},\n{"Reason 21": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 22": 1},\n{"Reason 22": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 23": 1},\n{"Reason 23": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 24": 1},\n{"Reason 24": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 25": 1},\n{"Reason 25": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"NF-microB": "protein"}, {"IgH": "DNA"}]', 'prediction': {'NF-microB': 'protein', 'IgH': 'DNA'}}
{'idx': 890, 'sentence': 'Treatment of 10 with warm HCl furnished 19-chloro-4,21-dihydroxypregna-4,9(11)-diene-3,20-dione (13).', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.": 4},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 3},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 4},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of degradation of inhibitor-kappaB alpha.": 4},\n    {"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.": 4},\n    {"This hybrid clone, designated NR2, was characterized by several methods, including PCR, with eight pairs of oligonucleotides mapped to Chr 20: D20S5, D20S41, D20S42, D20S56, D20S57, D20S58, adenosine deaminase (ADA), and Prion protein (PRIP); Restriction Fragment Length Polymorphism (RFLP) analyses with four genomic anonymous probes (D20S5, cD3H12, D20S17, D20S18); and fluorescent in situ hybridization (FISH) with total human DNA and D20Z1, a sequence specific to the human Chr 20 centromere, as probes.": 5},\n    {"Treatment with soluble, bivalent mAb J393 killed 25-50% of the cell population, while concomitant engagement of either the CD3.TcR complex or the integrins CD18 and CD29 significantly potentiated this effect.": 5},\n    {"Combined treatment of HPCs with alpha-PML and alpha-Rb oligomers inhibited both PML and Rb protein expression and completely blocked erythroid colony development.": 5},\n    {"When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of the binding.": 5},\n    {"A 3-bp mutation at the distal Sp1-binding site not only eliminates Sp1 interaction, but also abolishes most of the VitD3 induction of CD14 expression.": 5},\n    {"CONCLUSION: Our results show that the tested agents (except indomethacin) are inhibitors of the T cell-mediated immune response, as expected, that aspirin is an effective suppressor of adhesion molecule expression, and that all three agents can induce Hsp60 in HUVECs.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 323, 'sentence': 'The Epstein-Barr virus ( EBV ) ORI1yt enhancer is not B-cell specific and does not respond synergistically to the EBV transcription factors R and Z .', 'label': {'Epstein-Barr virus ( EBV ) ORI1yt enhancer': 'DNA'}, 'response1': "['DNA', 'cell_type', 'protein']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"5": "The sentence contains \'EBV\' which is a cell line entity type and \'CD2\' which is a protein entity type, directly relevant to the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"5": "The sentence contains \'EBV\' which is a cell line entity type and \'CD4+\' which is a cell type entity type, directly relevant to the target sentence."},\n    {"5": "The sentence contains \'EBNA-2\' which is a protein entity type and \'PU.1\' which is a protein entity type, directly relevant to the target sentence."},\n    {"5": "The sentence contains \'UAS1\' which is a cell line entity type and \'B cell\' which is a cell type entity type, directly relevant to the target sentence."},\n    {"5": "The sentence contains \'EBV\' which is a cell line entity type and \'B-cell\' which is a cell type entity type, directly relevant to the target sentence."},\n    {"5": "The sentence contains \'GATA-1\' which is a protein entity type, directly relevant to the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."}\n]', 'response3': "[{'EBV': 'cell_line'}, {'B-cell': 'cell_type'}, {'R': 'protein'}, {'Z': 'protein'}]", 'prediction': {'EBV': 'cell_line', 'B-cell': 'cell_type', 'R': 'protein', 'Z': 'protein'}}
{'idx': 929, 'sentence': 'The cDNA sequence has an 813-bp open reading frame ( ORF ) whose predicted amino acid sequence is 97.6% identical to the 272 carboxy-terminal amino acids of the human ets-1 protein .', 'label': {'ORF': 'DNA', '272 carboxy-terminal amino acids': 'protein', 'ets-1': 'protein', 'human ets-1 protein': 'protein', '813-bp open reading frame': 'DNA', 'cDNA sequence': 'DNA', 'amino acid sequence': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n{"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 4},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n{"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n{"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 4},\n{"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n{"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n{"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 5},\n{"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n{"This protein has now been purified and its encoding gene cloned.": 5},\n{"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n{"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 5},\n{"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB-induced trans-activation of the H4 promoter.": 5},\n{"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5},\n{"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n{"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"cDNA": "DNA"}, {"ets-1 protein": "protein"}]', 'prediction': {'cDNA': 'DNA', 'ets-1 protein': 'protein'}}
{'idx': 6, 'sentence': 'Platelet-activating factor induces phospholipid turnover , calcium flux , arachidonic acid liberation , eicosanoid generation , and oncogene expression in a human B cell line .', 'label': {'Platelet-activating factor': 'protein', 'oncogene': 'DNA', 'human B cell line': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains multiple protein names and a cell type, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains a protein name that is directly relevant to the entity labels in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains multiple protein names, a cell type, and cytokines, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains multiple protein names and cytokines, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains multiple protein names and a cell type, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence contains a protein name that is directly relevant to the entity labels in the target sentence."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence contains a protein name that is directly relevant to the entity labels in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains multiple protein names and cell types, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence contains a protein name that is directly relevant to the entity labels in the target sentence."},\n    {"Example 10": 4},\n    {"Reason 10": "The sentence contains a protein name that is directly relevant to the entity labels in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains multiple protein names, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains multiple protein names and cell types, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence contains a protein name that is directly relevant to the entity labels in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains a protein name and a cell type, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains multiple protein names and cell types, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any relevant entity labels."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any relevant entity labels."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any relevant entity labels."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any relevant entity labels."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any relevant entity labels."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any relevant entity labels."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any relevant entity labels."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any relevant entity labels."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any relevant entity labels."}\n]', 'response3': '[{"phospholipid turnover": "protein"}, {"calcium flux": "protein"}, {"arachidonic acid liberation": "protein"}, {"eicosanoid generation": "protein"}, {"oncogene expression": "protein"}, {"human B cell line": "cell_line"}]', 'prediction': {'phospholipid turnover': 'protein', 'calcium flux': 'protein', 'arachidonic acid liberation': 'protein', 'eicosanoid generation': 'protein', 'oncogene expression': 'protein', 'human B cell line': 'cell_line'}}
{'idx': 1478, 'sentence': 'Furthermore, in activated T cells , the kinetics of the two phosphorylation events are essentially similar.', 'label': {'activated T cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 4},\n    {"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"The phosphorylated tyrosine residue itself is important for the protein-protein interaction .": 4},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .": 4},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .": 5},\n    {"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 3},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .": 5},\n    {"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .": 5},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1793, 'sentence': 'The clinical benefits of salicylates in the treatment of several diseases, including atherosclerosis and rheumatoid arthritis , may be related to their ability to reduce monocyte gene expression .', 'label': {}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Sentence": 5, "Reason": "The sentence contains multiple examples of named entities with their corresponding labels, making it highly helpful for extracting named entities from the target sentence."},\n    {"Reason": 1, "Sentence": "The sentence does not contain any named entities relevant to the target sentence."},\n    {"Reason": 1, "Sentence": "The sentence does not contain any named entities relevant to the target sentence."},\n    {"Reason": 1, "Sentence": "The sentence does not contain any named entities relevant to the target sentence."},\n    {"Reason": 1, "Sentence": "The sentence does not contain any named entities relevant to the target sentence."},\n    {"Reason": 1, "Sentence": "The sentence does not contain any named entities relevant to the target sentence."},\n    {"Reason": 1, "Sentence": "The sentence does not contain any named entities relevant to the target sentence."},\n    {"Reason": 5, "Sentence": "The sentence contains multiple examples of named entities with their corresponding labels, making it highly helpful for extracting named entities from the target sentence."},\n    {"Reason": 1, "Sentence": "The sentence does not contain any named entities relevant to the target sentence."},\n    {"Reason": 5, "Sentence": "The sentence contains multiple examples of named entities with their corresponding labels, making it highly helpful for extracting named entities from the target sentence."},\n    {"Reason": 1, "Sentence": "The sentence does not contain any named entities relevant to the target sentence."},\n    {"Reason": 5, "Sentence": "The sentence contains multiple examples of named entities with their corresponding labels, making it highly helpful for extracting named entities from the target sentence."},\n    {"Reason": 5, "Sentence": "The sentence contains multiple examples of named entities with their corresponding labels, making it highly helpful for extracting named entities from the target sentence."},\n    {"Reason": 1, "Sentence": "The sentence does not contain any named entities relevant to the target sentence."},\n    {"Reason": 1, "Sentence": "The sentence does not contain any named entities relevant to the target sentence."},\n    {"Reason": 1, "Sentence": "The sentence does not contain any named entities relevant to the target sentence."},\n    {"Reason": 1, "Sentence": "The sentence does not contain any named entities relevant to the target sentence."},\n    {"Reason": 1, "Sentence": "The sentence does not contain any named entities relevant to the target sentence."},\n    {"Reason": 1, "Sentence": "The sentence does not contain any named entities relevant to the target sentence."},\n    {"Reason": 1, "Sentence": "The sentence does not contain any named entities relevant to the target sentence."},\n    {"Reason": 1, "Sentence": "The sentence does not contain any named entities relevant to the target sentence."},\n    {"Reason": 1, "Sentence": "The sentence does not contain any named entities relevant to the target sentence."},\n    {"Reason": 1, "Sentence": "The sentence does not contain any named entities relevant to the target sentence."}\n]', 'response3': '[{"salicylates": "protein"}, {"atherosclerosis": "cell_type"}, {"rheumatoid arthritis": "cell_type"}, {"monocyte": "cell_type"}]', 'prediction': {'salicylates': 'protein', 'atherosclerosis': 'cell_type', 'rheumatoid arthritis': 'cell_type', 'monocyte': 'cell_type'}}
{'idx': 1473, 'sentence': 'Costimulation requirement for AP-1 and NF-kappa B transcription factor activation in T cells .', 'label': {'NF-kappa B': 'protein', 'T cells': 'cell_type', 'AP-1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example contains specific protein names that are relevant to the entity types in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The example provides protein names and cell types that are directly related to the entity types in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The example includes protein names that match the entity types in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The example contains protein names and a cell type that are relevant to the entity types in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The example includes protein names and a protein kinase relevant to the entity types in the target sentence."},\n    {"Example 6": 4},\n    {"Reason 6": "The example provides protein names and cell types that are related to the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The example contains protein names, cell types, and signal transduction events that match the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example includes protein names that are directly related to the entity types in the target sentence."},\n    {"Example 9": 4},\n    {"Reason 9": "The example provides protein names that are relevant to the entity types in the target sentence."},\n    {"Example 10": 4},\n    {"Reason 10": "The example contains protein names that match the entity types in the target sentence."},\n    {"Example 11": 4},\n    {"Reason 11": "The example includes protein names and a cell type that are relevant to the entity types in the target sentence."},\n    {"Example 12": 4},\n    {"Reason 12": "The example provides protein names that are directly related to the entity types in the target sentence."},\n    {"Example 13": 4},\n    {"Reason 13": "The example contains protein names that are relevant to the entity types in the target sentence."},\n    {"Example 14": 4},\n    {"Reason 14": "The example includes protein names that match the entity types in the target sentence."},\n    {"Example 15": 4},\n    {"Reason 15": "The example provides protein names and a cell type that are relevant to the entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any relevant entity types for the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not include any relevant entity types for the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any relevant entity types for the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not include any relevant entity types for the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The example does not contain any relevant entity types for the target sentence."}\n]', 'response3': '[{"AP-1": "protein"}, {"NF-kappa B": "protein"}, {"T cells": "cell_type"}]', 'prediction': {'AP-1': 'protein', 'NF-kappa B': 'protein', 'T cells': 'cell_type'}}
{'idx': 539, 'sentence': 'PMA enhanced slightly the stimulatory effect of PHA .', 'label': {'PHA': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names (NF-kappa B and AP-1) that are directly mentioned and can be easily identified as protein entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains a specific protein name (NF-E2) that is directly mentioned and can be easily identified as a protein entity."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains specific protein names (AP-1 and PMA) and cell types (monocytes and macrophages) that are directly mentioned and can be easily identified as protein and cell type entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains specific protein names (PAFR, PAF, NF-kappa B, and protein kinase C) that are directly mentioned and can be easily identified as protein entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific protein names (IL-2, NF-kappa B, and AP-1) that are directly mentioned and can be easily identified as protein entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains a specific protein name (MNDA) and a specific cell line name (Philadelphia chromosome-positive chronic myeloid leukemia) that are directly mentioned and can be easily identified as protein and cell line entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific protein names (Oct-2A, HMG I/Y, and HLA-DRA) and a cell type (B cells) that are directly mentioned and can be easily identified as protein and cell type entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains a specific protein name (NF-kappa B) that is directly mentioned and can be easily identified as a protein entity."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains a specific protein name (P selectin) that is directly mentioned and can be easily identified as a protein entity."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains a specific protein name (phosphocreatine) that is directly mentioned and can be easily identified as a protein entity."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains specific protein names (NDP kinase, KA, SCC, and BCC) that are directly mentioned and can be easily identified as protein and cell type entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains specific protein names (CD14 and CD23) that are directly mentioned and can be easily identified as protein entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains specific protein names (IL-4, LPS, and AP-1) that are directly mentioned and can be easily identified as protein entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific protein names (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, and phorbol myristate acetate) that are directly mentioned and can be easily identified as protein entities."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains specific protein names (Epo, alpha-globin, beta-globin, haemoglobin, haemin, and delta-ALA) that are directly mentioned and can be easily identified as protein entities."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence contains specific protein names (PMA and IFN-gamma) and a cell type (T cell blasts) that are directly mentioned and can be easily identified as protein and cell type entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entity names related to the given entity labels."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entity names related to the given entity labels."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entity names related to the given entity labels."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entity names related to the given entity labels."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entity names related to the given entity labels."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entity names related to the given entity labels."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entity names related to the given entity labels."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entity names related to the given entity labels."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entity names related to the given entity labels."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1025, 'sentence': 'NK cells do not express NFATc constitutively, but NFATc mRNA accumulation is induced in these cells within 2 h of stimulation with CD16 ligands .', 'label': {'NFATc': 'protein', 'NK cells': 'cell_type', 'NFATc mRNA': 'RNA'}, 'response1': "['RNA', 'cell_type']", 'response2': '[\n    {"Example 1": 1},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"NFATc": "protein"}, {"NFATc mRNA": "RNA"}, {"NK cells": "cell_type"}, {"CD16 ligands": "protein"}]', 'prediction': {'NFATc': 'protein', 'NFATc mRNA': 'RNA', 'NK cells': 'cell_type', 'CD16 ligands': 'protein'}}
{'idx': 1560, 'sentence': 'Moreover, in human T helper (Th) clones functionally characterized as being of the type 0, type 1 and type 2 (28%, < 1% und 93% CD30+, respectively), the extent of CD30 -mediated NF-kappa B activation correlated with the proportion of CD30+ cells .', 'label': {'human T helper (Th) clones': 'cell_line', 'CD30+ cells': 'cell_line', 'CD30': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 4},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.": 4},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation.": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 4},\n    {"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 4},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5}\n]', 'response3': '[{"CD30": "protein"}]', 'prediction': {'CD30': 'protein'}}
{'idx': 365, 'sentence': 'Run-on analysis demonstrated detectable levels of c-jun gene transcription in untreated HL-60 cells , and that exposure to TPA increases this rate 3.3-fold.', 'label': {'c-jun': 'DNA', 'HL-60 cells': 'cell_line', 'untreated HL-60 cells': 'cell_line'}, 'response1': "['DNA', 'cell_type', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 1},\n    {"Example 7": 5},\n    {"Example 8": 1},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1039, 'sentence': 'Peripheral blood mononuclear cells ( pbmc ) and bone marrow cells of 26 patients were examined for c-fos , c-myc , p53 and the hybrid bcr/abl mRNA levels .', 'label': {'Peripheral blood mononuclear cells': 'cell_type', 'pbmc': 'cell_type', 'bone marrow cells': 'cell_type'}, 'response1': "['RNA', 'protein']", 'response2': '[\n    {"PBMC": 5},\n    {"adenovirus DNA": 5},\n    {"CD70": 4},\n    {"B cell": 4},\n    {"plasma cells": 4},\n    {"IL-4": 4},\n    {"CD40": 4},\n    {"MNDA": 4},\n    {"Philadelphia chromosome-positive chronic myeloid leukemia": 4},\n    {"PMA": 3},\n    {"CD14": 4},\n    {"CD23": 4},\n    {"IL-2": 4},\n    {"c-Jun": 4},\n    {"c-Fos": 4},\n    {"PML/RARalpha": 5},\n    {"myeloperoxidase": 4},\n    {"lysozyme": 4},\n    {"PU.1": 4},\n    {"NF-kappaB": 4},\n    {"Tax": 3},\n    {"ATL": 3},\n    {"TCRzeta": 4},\n    {"p56(lck)": 4},\n    {"p21(WAF1/CIP1)": 4},\n    {"p27(KIP1)": 4},\n    {"IFN A": 4},\n    {"IFNA": 4},\n    {"interleukin-2": 4},\n    {"interleukin-2 receptor": 4},\n    {"phytohemagglutinin": 4},\n    {"phorbol myristate acetate": 4},\n    {"Ter 119": 4},\n    {"beta-globin": 4},\n    {"glycoprotein IIb": 4},\n    {"platelet factor 4": 4},\n    {"Rel/nuclear factor kappaB": 4},\n    {"B lymphocytes": 4},\n    {"Ramos": 4},\n    {"Jurkat": 4},\n    {"cDNA microarray technology": 4},\n    {"HeLa cells": 4},\n    {"Daudi": 4},\n    {"Mono A": 4},\n    {"Mono B": 4},\n    {"CSF-1 receptor": 4}\n]', 'response3': '[{"pbmc": "cell_type"}, {"c-fos": "protein"}, {"c-myc": "protein"}, {"p53": "protein"}, {"bcr/abl": "RNA"}]', 'prediction': {'pbmc': 'cell_type', 'c-fos': 'protein', 'c-myc': 'protein', 'p53': 'protein', 'bcr/abl': 'RNA'}}
{'idx': 217, 'sentence': 'Quantitation of glucocorticoid receptors ( GCR ) and the study of their affinity for glucocorticosteroids ( GCS ) were made in peripheral blood lymphocytes of bronchial asthma ( BA ) patients in consideration of GCR treatment and serum levels of endogenous cortisol .', 'label': {'GCR': 'protein', 'glucocorticoid receptors': 'protein', 'peripheral blood lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 3},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 4},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 5},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.": 5},\n    {"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine (IFN-gamma) in combination with allergy-driven overproduction of T helper 2-type cytokines.": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 4},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5}\n]', 'response3': '[{"GCR": "protein"}, {"GCS": "protein"}, {"BA": "cell_type"}]', 'prediction': {'GCR': 'protein', 'GCS': 'protein', 'BA': 'cell_type'}}
{'idx': 1782, 'sentence': 'In addition, resting PBL constitutively expressed prominent levels of Id2 mRNA , but not Id3 mRNA .', 'label': {'Id3': 'protein', 'resting PBL': 'cell_type', 'Id3 mRNA': 'RNA', 'PBL': 'cell_type', 'Id2': 'protein', 'Id2 mRNA': 'RNA'}, 'response1': "['RNA', 'protein']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 5},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n    {"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA/NF-kappaB1 binding complexes.": 5},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05).": 5},\n    {"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells, but not in primary T cells, consistent with the lack of the IL-12 receptor in resting T cells.": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"PMA induced the expression of both CD14 and CD23 mRNA and protein.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"Id2 mRNA": "RNA"}, {"Id3 mRNA": "RNA"}]', 'prediction': {'Id2 mRNA': 'RNA', 'Id3 mRNA': 'RNA'}}
{'idx': 1280, 'sentence': "Sequence analysis of the 5'-flanking region of the CD69 gene revealed the presence of a potential TATA element 30 base pairs upstream of the major transcription initiation site and several putative binding sequences for inducible transcription factors ( NF-kappa B , Egr-1 , AP-1 ), which might mediate the inducible expression of this gene.", 'label': {'NF-kappa B': 'protein', 'TATA element': 'DNA', 'transcription factors': 'protein', 'CD69': 'protein', 'AP-1': 'protein', '30 base pairs upstream': 'DNA', 'CD69 gene': 'DNA', "5'-flanking region": 'DNA', 'transcription initiation site': 'DNA', 'Egr-1': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor": 5},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter": 4},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements": 5},\n    {"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif": 5},\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region": 5},\n    {"These properties suggest that TAFII105 is a cell type-specific subunit of TFIID that may be responsible for mediating transcription by a subset of activators in B cells": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B": 5},\n    {"This sequence element was referred to as the BAT box and its deletion significantly reduced the activity of a CD20 promoter-CAT construct in B cells": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats)": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729": 1}\n]', 'response3': '[{"CD69 gene": "protein"}, {"TATA element": "DNA"}, {"NF-kappa B": "protein"}, {"Egr-1": "protein"}, {"AP-1": "protein"}]', 'prediction': {'CD69 gene': 'protein', 'TATA element': 'DNA', 'NF-kappa B': 'protein', 'Egr-1': 'protein', 'AP-1': 'protein'}}
{'idx': 611, 'sentence': 'Transactivation by some DNA viruses has been implicated in inducing HIV-1 replication and pathogenesis.', 'label': {}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 1},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"DNA viruses": "DNA"}, {"HIV-1": "cell_type"}]', 'prediction': {'DNA viruses': 'DNA', 'HIV-1': 'cell_type'}}
{'idx': 1723, 'sentence': 'In vitro treatment of a monocyte/macrophage cell line with CCl4 led to enhanced NF-kappa B binding and an increase in tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA levels .', 'label': {'tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA': 'RNA', 'NF-kappa B': 'protein', 'tumor necrosis factor-alpha': 'protein', 'TNF-alpha': 'protein'}, 'response1': "['cell_line', 'protein', 'RNA']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"5": "The sentence contains \'NF-kappaB\' and \'Tax\' which are both proteins relevant to the label set."},\n    {"5": "The sentence contains \'IkappaBbeta\' and \'NF-kappaB\' which are both proteins relevant to the label set."},\n    {"4": "The sentence contains \'NF-kappa B\' which is a protein relevant to the label set."},\n    {"5": "The sentence contains \'IFN A\', \'IFNA\', \'interleukin-2\', \'interleukin-2 receptor\', \'phytohemagglutinin\', and \'phorbol myristate acetate\' which are all proteins relevant to the label set."},\n    {"5": "The sentence contains \'IL-2\', \'NF-kappa B\', and \'AP-1\' which are all proteins relevant to the label set."},\n    {"5": "The sentence contains \'NF-kappa B\' which is a protein relevant to the label set."},\n    {"5": "The sentence contains \'MTHC\', \'TNF-alpha\', \'IFN-gamma\', and \'DC\' which are all relevant to the label set."},\n    {"5": "The sentence contains \'NF-kappa B\' which is a DNA relevant to the label set."},\n    {"5": "The sentence contains \'NF-kappa B\' which is a protein relevant to the label set."},\n    {"5": "The sentence contains \'CD40\', \'Rel/nuclear factor kappaB\', \'NF-kappaB\', and \'B lymphocytes\' which are all relevant to the label set."},\n    {"5": "The sentence contains \'PMA\', \'IFN-gamma\', and \'T cell blasts\' which are all relevant to the label set."},\n    {"5": "The sentence contains \'CTLA4Ig\', \'NFAT\', and \'AP-1\' which are all relevant to the label set."},\n    {"5": "The sentence contains \'NF-kappa B\' and \'neutrophils\' which are both relevant to the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"TNF-alpha": "protein"}, {"messenger RNA": "RNA"}]', 'prediction': {'NF-kappa B': 'protein', 'TNF-alpha': 'protein', 'messenger RNA': 'RNA'}}
{'idx': 1308, 'sentence': 'Two groups of HMG box proteins are distinguished.', 'label': {'HMG box proteins': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains multiple protein names that are relevant to the entity types in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence mentions \'cDNAs\' which is relevant to the entity type \'DNA\', but it does not provide additional context or specific examples."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence mentions \'IgH\' which is relevant to the entity type \'DNA\', but it does not provide additional context or specific examples."},\n    {"Example 4": 3},\n    {"Reason 4": "The sentence provides specific examples of DNA elements and a protein name that are relevant to the entity types in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific protein names that are relevant to the entity types in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific protein names that are relevant to the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains a specific protein name and cell types that are relevant to the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains a specific protein name that is relevant to the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains a specific protein name that is relevant to the entity types in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains specific protein names that are relevant to the entity types in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains a specific protein name that is relevant to the entity types in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains a specific cell line name that is relevant to the entity types in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains a specific protein name that is relevant to the entity types in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains a specific protein name that is relevant to the entity types in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains a specific protein name that is relevant to the entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence mentions various factors but does not provide specific examples or context related to the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence mentions herpesvirus systems but does not provide specific examples or context related to the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence mentions HIV-1 and HIV-2 but does not provide specific examples or context related to the entity types in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence mentions a contraction and allele but does not provide specific examples or context related to the entity types in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence mentions B-cell response and lymphoid follicles but does not provide specific examples or context related to the entity types in the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence mentions lymphocyte infiltration and breast cancer patients but does not provide specific examples or context related to the entity types in the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence mentions VD and monocytic differentiation but does not provide specific examples or context related to the entity types in the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence mentions glucocorticoid action but does not provide specific examples or context related to the entity types in the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence mentions a point mutation but does not provide specific examples or context related to the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 765, 'sentence': 'Our results suggest that substances in serum influence steroid effects on these cells and that the molecular details of glucocorticoid hormone action may be pursued more precisely in a clearly defined culture medium.', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and direct mention of the entity \'nonhuman primates\' as a cell type, making it highly helpful for extracting named entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence explicitly mentions \'cell adhesion molecules\' as a cell type, making it very helpful for entity extraction."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly links \'G-CSF\' to a protein, providing a clear entity label and making it highly helpful for extraction."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains multiple explicit mentions of entities such as \'CD70\' (protein), \'B cell\' (cell type), \'plasma cells\' (cell type), \'IL-4\' (protein), and \'CD40\' (protein), making it very helpful for entity extraction."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence clearly identifies \'E2A\' as a protein, providing a direct entity label and making it highly helpful for extraction."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions \'NF-E2\' as a protein, providing a direct entity label and making it highly helpful for extraction."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains explicit mentions of entities like \'IL-5 mRNA\' (RNA), \'TCR\' (cell type), \'IL-2R\' (protein), and \'dexamethasone\' (protein), making it very helpful for entity extraction."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence directly mentions \'granulocytes\' and \'T cells\' as cell types, providing clear entity labels and making it highly helpful for extraction."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence explicitly links \'IL-4\' to a protein, providing a clear entity label and making it highly helpful for extraction."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions \'IL-2\' as a protein, \'c-Jun\' as a protein, and \'c-Fos\' as a protein, providing direct entity labels and making it highly helpful for extraction."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1561, 'sentence': 'In all cell lines investigated, the NF-kappa B complexes induced following CD30 engagement were shown to contain p50 NF-kappa B1 , p65 RelA , and possibly other transcription factors .', 'label': {'CD30': 'protein', 'NF-kappa B complexes': 'protein', 'p65 RelA': 'protein', 'p50 NF-kappa B1': 'protein', 'NF-kappa B': 'protein', 'transcription factors': 'protein'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n    {"1": "The sentence contains relevant protein entities such as NF-kappaB, Sp1, and p50, which align with the entity labels in the target sentence."},\n    {"2": "The sentence mentions NF-ATc and T lymphocytes, which correspond to the protein and cell_type entity labels in the target sentence."},\n    {"3": "The sentence includes various protein entities like CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, and granulocyte-macrophage colony-stimulating factor, which are relevant to the entity labels in the target sentence."},\n    {"4": "The sentence mentions protein entities PAFR, PAF, NF-kappa B, and protein kinase C, which align with the entity labels in the target sentence."},\n    {"5": "The sentence contains protein entities RelA and NF-kappa B, which are relevant to the entity labels in the target sentence."},\n    {"5": "The sentence includes protein entities NF-kappa B and I kappa B alpha, which align with the entity labels in the target sentence."},\n    {"4": "The sentence mentions protein entities NF-kappaB, Tax, and ATL, which correspond to the protein and cell_type entity labels in the target sentence."},\n    {"3": "The sentence includes protein entities NF-kappa B and I kappa B alpha, which are relevant to the entity labels in the target sentence."},\n    {"2": "The sentence contains the protein entity NF-kappa B, which aligns with the entity labels in the target sentence."},\n    {"3": "The sentence mentions protein entities CD40 and NF-kappa B, which correspond to the protein entity labels in the target sentence."},\n    {"4": "The sentence includes protein entities NF-kappa B and AP-1, which are relevant to the entity labels in the target sentence."},\n    {"1": "The sentence mentions NF-kappa B with no specific protein entity, which does not align with the entity labels in the target sentence."},\n    {"1": "The sentence contains NF-kB, AP-1, OCT-1, and NF-IL-2B, which do not align with the entity labels in the target sentence."},\n    {"3": "The sentence includes protein entities IkappaBalpha and NF-kappaB, which are relevant to the entity labels in the target sentence."},\n    {"2": "The sentence mentions the protein entity NF-kappa B, which aligns with the entity labels in the target sentence."},\n    {"3": "The sentence contains protein entities IkappaBbeta and NF-kappaB, which are relevant to the entity labels in the target sentence."},\n    {"1": "The sentence does not contain any entities that align with the entity labels in the target sentence."},\n    {"1": "The sentence does not contain any entities that align with the entity labels in the target sentence."},\n    {"1": "The sentence does not contain any entities that align with the entity labels in the target sentence."},\n    {"1": "The sentence does not contain any entities that align with the entity labels in the target sentence."},\n    {"1": "The sentence does not contain any entities that align with the entity labels in the target sentence."},\n    {"1": "The sentence does not contain any entities that align with the entity labels in the target sentence."},\n    {"1": "The sentence does not contain any entities that align with the entity labels in the target sentence."},\n    {"1": "The sentence does not contain any entities that align with the entity labels in the target sentence."},\n    {"1": "The sentence does not contain any entities that align with the entity labels in the target sentence."},\n    {"1": "The sentence does not contain any entities that align with the entity labels in the target sentence."},\n    {"1": "The sentence does not contain any entities that align with the entity labels in the target sentence."},\n    {"1": "The sentence does not contain any entities that align with the entity labels in the target sentence."},\n    {"1": "The sentence does not contain any entities that align with the entity labels in the target sentence."}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"p50 NF-kappa B1": "protein"}, {"p65 RelA": "protein"}]', 'prediction': {'NF-kappa B': 'protein', 'p50 NF-kappa B1': 'protein', 'p65 RelA': 'protein'}}
{'idx': 330, 'sentence': 'ZRE-B is therefore not part of the R- inducible enhancer .', 'label': {'ZRE-B': 'DNA', 'R- inducible enhancer': 'DNA'}, 'response1': 'None.', 'response2': '```json\n[]\n```', 'response3': '```json\n[]\n```', 'prediction': {}}
{'idx': 1104, 'sentence': 'Although the interrelationship between the two messengers Ca2+ and cyclic AMP in platelet function is well documented, its mechanism of action still remains to be established.', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 4},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 4},\n    {"Example 12": 4},\n    {"Example 13": 4},\n    {"Example 14": 4},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1594, 'sentence': 'Human IL4 promoter -mediated transcription is downregulated in Jurkat cells stimulated with the NF-kappa B -activating cytokine tumor necrosis factor alpha and suppressed in RelA -overexpressing cells .', 'label': {'Jurkat cells': 'cell_line', 'NF-kappa B -activating cytokine': 'protein', 'Human IL4 promoter': 'DNA', 'tumor necrosis factor alpha': 'protein', 'RelA -overexpressing cells': 'cell_line', 'NF-kappa B': 'protein', 'RelA': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"5": "The sentence contains multiple protein entities and a cell_type entity that are relevant to the label set."},\n    {"5": "The sentence contains multiple protein entities that are relevant to the label set."},\n    {"5": "The sentence contains multiple protein entities that are relevant to the label set."},\n    {"5": "The sentence contains multiple protein entities that are relevant to the label set."},\n    {"5": "The sentence contains multiple protein entities and a cell_type entity that are relevant to the label set."},\n    {"5": "The sentence contains multiple protein entities that are relevant to the label set."},\n    {"5": "The sentence contains multiple protein entities and a cell_type entity that are relevant to the label set."},\n    {"5": "The sentence contains multiple protein entities and a cell_type entity that are relevant to the label set."},\n    {"5": "The sentence contains multiple protein entities that are relevant to the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."}\n]', 'response3': '[\n    {"Jurkat cells": "cell_line"},\n    {"NF-kappa B": "protein"},\n    {"tumor necrosis factor alpha": "protein"},\n    {"RelA": "protein"}\n]', 'prediction': {'Jurkat cells': 'cell_line', 'NF-kappa B': 'protein', 'tumor necrosis factor alpha': 'protein', 'RelA': 'protein'}}
{'idx': 1086, 'sentence': 'Analysis of the expression of human I kappa B alpha protein in stable transfectants of mouse 70Z/3 cells shows that, as for the endogenous murine protein, exogenous I kappa B alpha is degraded in response to inducers of NF-kappa B activity , such as phorbol myristate acetate or lipopolysaccharide .', 'label': {'NF-kappa B': 'protein', 'I kappa B alpha': 'protein', 'human I kappa B alpha protein': 'protein', 'mouse 70Z/3 cells': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"I kappa B alpha": "protein"}, {"NF-kappa B": "protein"}]', 'prediction': {'I kappa B alpha': 'protein', 'NF-kappa B': 'protein'}}
{'idx': 1, 'sentence': 'When the homeodomain from HB24 was compared to known mammalian and Drosophila homeodomains it was found to be only moderately conserved, but when it was compared to a highly diverged Drosophila homeodomain , H2.0, it was found to be 80% identical.', 'label': {'homeodomain': 'DNA', 'HB24': 'DNA', 'Drosophila homeodomain': 'DNA'}, 'response1': "['protein']", 'response2': '[\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n{"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 5},\n{"Like Drosophila Toll, human Toll is a type I transmembrane protein with an extracellular domain consisting of a leucine-rich repeat (LRR) domain, and a cytoplasmic domain homologous to the cytoplasmic domain of the human interleukin (IL)-1 receptor.": 5},\n{"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 4},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n{"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5},\n{"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 5},\n{"These two related genes share the evolutionarily conserved region encoding the Runt domain.": 5},\n{"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 5},\n{"Here we examined the regulatory mechanism of the SCM-1 genes.": 5},\n{"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n{"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 5},\n{"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.": 5},\n{"Thus, we were able to derive a hematopoietic cell line, called 47.10, that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1226, 'sentence': 'Lastly, the different mobilities of osteoblast nuclear extract-DNA complexes compared with T-cell nuclear extract-DNA complexes , along with the inability of OSF2 to be upregulated by retinoic acid , unlike the other PEBP2 alpha factors , suggest that OSF2 is a new member of this family of transcription factors .', 'label': {'transcription factors': 'protein', 'T-cell nuclear extract-DNA complexes': 'protein', 'OSF2': 'protein', 'osteoblast nuclear extract-DNA complexes': 'protein', 'PEBP2 alpha factors': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]": 5},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5},\n    {"The p50 and p65 proteins, constituents of the prototypic nuclear factor kappaB, were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex, cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[{"OSF2": "protein"}, {"PEBP2 alpha factors": "protein"}]', 'prediction': {'OSF2': 'protein', 'PEBP2 alpha factors': 'protein'}}
{'idx': 663, 'sentence': 'The cells lines described here should be useful for the delineation of signaling pathways utilized in the selective regulation of gene expression .', 'label': {}, 'response1': "['cell_line', 'cell_type', 'gene expression']", 'response2': '[\n{"Example 1": 5},\n{"Example 2": 5},\n{"Example 3": 5},\n{"Example 4": 5},\n{"Example 5": 5},\n{"Example 6": 5},\n{"Example 7": 5},\n{"Example 8": 5},\n{"Example 9": 5},\n{"Example 10": 5},\n{"Example 11": 5},\n{"Example 12": 5},\n{"Example 13": 5},\n{"Example 14": 5},\n{"Example 15": 1},\n{"Example 16": 1},\n{"Example 17": 1},\n{"Example 18": 1},\n{"Example 19": 1},\n{"Example 20": 1},\n{"Example 21": 1},\n{"Example 22": 1},\n{"Example 23": 1},\n{"Example 24": 1},\n{"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1000, 'sentence': 'Analysis of the biochemical and cell biological properties of these HSFs reveals that HSF3 has properties in common with both HSF1 and HSF2 and yet has features which are distinct from both.', 'label': {'HSF2': 'protein', 'HSF3': 'protein', 'HSFs': 'protein', 'HSF1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides clear and specific examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 39, 'sentence': 'Most hybrids express both KBF1 and NF-kappa B in their nuclei , but one hybrid expresses only KBF1 .', 'label': {'KBF1': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .": 4},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .": 4},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 4},\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 4},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .": 4},\n    {"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 4},\n    {"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.": 4},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .": 3},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .": 5},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5}\n]', 'response3': '[{"KBF1": "protein"}, {"NF-kappa B": "protein"}]', 'prediction': {'KBF1': 'protein', 'NF-kappa B': 'protein'}}
{'idx': 229, 'sentence': "We now show that: 1) CVZ has more than one binding site in a second, independent, B-cell line , IM-9 ; 2) the antiglucocorticoid RU 38486 is able to block both CVZ 's higher and lower affinity sites; 3) all of CVZ 's binding sites are on a protein immunologically indistinguishable from the human GR ; and 4) freshly isolated clones of CVZ -resistant cells have lost all binding sites for CVZ .", 'label': {'B-cell line': 'cell_line', 'IM-9': 'cell_line', 'GR': 'protein', "CVZ 's binding sites": 'protein'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 5},\n    {"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.": 5},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"A gst-EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2-PU.1 interaction.": 5},\n    {"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin.": 5},\n    {"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 5},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"CVZ": "protein"}, {"IM-9": "cell_line"}, {"RU 38486": "protein"}, {"human GR": "protein"}, {"CVZ-resistant cells": "cell_line"}]', 'prediction': {'CVZ': 'protein', 'IM-9': 'cell_line', 'RU 38486': 'protein', 'human GR': 'protein', 'CVZ-resistant cells': 'cell_line'}}
{'idx': 743, 'sentence': 'Detection in non-erythroid cells of a factor with the binding characteristics of the erythroid cell transcription factor EF1 .', 'label': {'erythroid cell transcription factor': 'protein', 'non-erythroid cells': 'cell_type', 'EF1': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor ).": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .": 4},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 4},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .": 4},\n    {"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts .": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 4},\n    {"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .": 5},\n    {"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .": 5},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .": 5},\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1799, 'sentence': 'These STAT proteins were detected by using the IFN-gamma-activated sequence ( GAS ) and related oligonucleotides as probes in electrophoretic mobility shift assay .', 'label': {'GAS': 'DNA', 'IFN-gamma-activated sequence': 'DNA', 'STAT proteins': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.": 5},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Moreover, monocytes express a novel IL-10 -stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti- STAT3 Ab but is not observed in T cells.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 4},\n    {"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus, and induce transcription from responsive genes.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 4},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5}\n]', 'response3': '[{"STAT proteins": "protein"}, {"IFN-gamma-activated sequence (GAS)": "DNA"}]', 'prediction': {'STAT proteins': 'protein', 'IFN-gamma-activated sequence (GAS)': 'DNA'}}
{'idx': 1703, 'sentence': "E1A blocked IFN 's induction of cytolytic resistance , resulting in the selective lysis of adenovirus-transformed cells by IFN -activated NK cells .", 'label': {'E1A': 'protein', 'IFN': 'protein', 'adenovirus-transformed cells': 'cell_line', 'IFN -activated NK cells': 'cell_line'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 4},\n    {"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells, but not in primary T cells, consistent with the lack of the IL-12 receptor in resting T cells.": 5},\n    {"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 4},\n    {"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 4},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 4},\n    {"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine (IL-2 and IFN-gamma) production is normal.": 5},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 4},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 4},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 4},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 629, 'sentence': 'Depletion of CD8+ cells was accompanied by 62 +/- 18% loss of progesterone receptor -bearing cells , while depletion of CD4+ cells resulted in a twofold increase in the number of positively staining lymphocytes .', 'label': {'progesterone receptor': 'protein', 'CD8+ cells': 'cell_line', 'lymphocytes': 'cell_line', 'progesterone receptor -bearing cells': 'cell_line', 'CD4+ cells': 'cell_line'}, 'response1': "['cell_type']", 'response2': '[\n    {"1": "The sentence contains specific cell types and proteins that are relevant to the entity labels in the target sentence."},\n    {"2": "The sentence mentions specific cell types and proteins that are relevant to the entity labels in the target sentence."},\n    {"4": "The sentence includes specific cell types and proteins that are relevant to the entity labels in the target sentence."},\n    {"3": "The sentence mentions specific cell types that are relevant to the entity labels in the target sentence."},\n    {"3": "The sentence contains specific proteins that are relevant to the entity labels in the target sentence."},\n    {"4": "The sentence includes specific proteins that are relevant to the entity labels in the target sentence."},\n    {"1": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"2": "The sentence mentions specific proteins that are relevant to the entity labels in the target sentence."},\n    {"2": "The sentence mentions specific proteins that are relevant to the entity labels in the target sentence."},\n    {"4": "The sentence includes specific proteins and cell types that are relevant to the entity labels in the target sentence."},\n    {"4": "The sentence contains specific proteins and cell types that are relevant to the entity labels in the target sentence."},\n    {"4": "The sentence includes specific proteins and cell types that are relevant to the entity labels in the target sentence."},\n    {"5": "The sentence provides a detailed example with multiple relevant entity types mentioned in the target sentence."},\n    {"5": "The sentence provides a detailed example with multiple relevant entity types mentioned in the target sentence."},\n    {"4": "The sentence includes specific cell types and proteins that are relevant to the entity labels in the target sentence."},\n    {"4": "The sentence contains specific cell types and proteins that are relevant to the entity labels in the target sentence."},\n    {"1": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"1": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"1": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"1": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"1": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"1": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"1": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"1": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"1": "The sentence does not contain any relevant entity types mentioned in the target sentence."},\n    {"1": "The sentence does not contain any relevant entity types mentioned in the target sentence."}\n]', 'response3': '[{"CD8+": "cell_type"}, {"progesterone receptor": "protein"}, {"CD4+": "cell_type"}, {"lymphocytes": "cell_type"}]', 'prediction': {'CD8+': 'cell_type', 'progesterone receptor': 'protein', 'CD4+': 'cell_type', 'lymphocytes': 'cell_type'}}
{'idx': 490, 'sentence': 'Cyclosporin A ( CsA ) is thought to exert its immunosuppressive effects by inhibiting the expression of a distinct set of lymphokine genes which are induced upon T-cell activation , among them the gene coding for interleukin-2 .', 'label': {'lymphokine genes': 'DNA', 'interleukin-2': 'protein'}, 'response1': "['protein', 'RNA']", 'response2': '[\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 3},\n    {"Reasons": "Helpful as it mentions \'monocytic differentiation\' which is related to \'cell_type\' entity."},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"Reasons": "Not helpful as it does not contain any entity related to the target sentence."},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1},\n    {"Reasons": "Not helpful as it does not contain any entity related to the target sentence."}\n]', 'response3': '[{"Cyclosporin A": "protein"}, {"CsA": "protein"}, {"lymphokine genes": "protein"}, {"T-cell": "cell_type"}, {"interleukin-2": "protein"}]', 'prediction': {'Cyclosporin A': 'protein', 'CsA': 'protein', 'lymphokine genes': 'protein', 'T-cell': 'cell_type', 'interleukin-2': 'protein'}}
{'idx': 118, 'sentence': "Similar to 1;14 translocations , this deletion disrupts the SCL 5' regulatory region .", 'label': {'SCL': 'protein', "SCL 5' regulatory region": 'DNA'}, 'response1': "['DNA']", 'response2': '[\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 3},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 4},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"We have found that the recruitment of EKLF to 5\'HS3 depends on the presence of 5\'HS2 in cis, but the recruitment to 5\'HS2 does not depend on 5\'HS3.": 4},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 4},\n    {"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n    {"SCL is expressed in erythroid, megakaryocyte and mast cell populations (the same cell lineages as GATA-1, a zinc-finger transcription factor).": 4},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n    {"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.": 4},\n    {"By the time of diagnosis of T-PLL, the clone contains many more genetic changes in the form of additional translocations.": 4},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 4}\n]', 'response3': '[{"SCL": "RNA"}]', 'prediction': {'SCL': 'RNA'}}
{'idx': 493, 'sentence': 'Here we report that the formation of two distinct mitogen-inducible DNA-binding complexes , the kappa B complex within the HIV enhancer and the NFAT-1 complex within the interleukin-2 enhancer , is inhibited in the presence of CsA .', 'label': {'NFAT-1 complex': 'protein', 'mitogen-inducible DNA-binding complexes': 'protein', 'kappa B complex': 'protein', 'interleukin-2': 'protein', 'interleukin-2 enhancer': 'DNA', 'HIV enhancer': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 4},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.": 5},\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 5},\n    {"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.": 5},\n    {"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"kappa B complex": "DNA"}, {"NFAT-1 complex": "protein"}, {"interleukin-2 enhancer": "protein"}]', 'prediction': {'kappa B complex': 'DNA', 'NFAT-1 complex': 'protein', 'interleukin-2 enhancer': 'protein'}}
{'idx': 1798, 'sentence': 'In purified human peripheral blood T cells , nuclear STAT proteins were activated approximately 3 h after activation by cross-linked anti-CD3 Abs .', 'label': {'purified human peripheral blood T cells': 'cell_type', 'anti-CD3 Abs': 'protein', 'nuclear STAT proteins': 'protein', 'T cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"STAT proteins": "protein"}, {"T cells": "cell_type"}, {"anti-CD3 Abs": "protein"}]', 'prediction': {'STAT proteins': 'protein', 'T cells': 'cell_type', 'anti-CD3 Abs': 'protein'}}
{'idx': 175, 'sentence': 'To compare extra-renal 1,25(OH)2D3 production in different types of granulomatous disease , and to identify the cell types responsible, we have evaluated the conversion of 25(OH)D3 in 1,25(OH)2D3 by uncultured cells recovered by bronchoalveolar lavage and blood mononuclear cells from normocalcemic patients with sarcoidosis and tuberculosis.', 'label': {'blood mononuclear cells': 'cell_type', 'uncultured cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n{"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n{"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n{"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .": 4},\n{"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .": 4},\n{"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]": 4},\n{"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n{"In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine ( IFN-gamma ) in combination with allergy-driven overproduction of T helper 2-type cytokines .": 4},\n{"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .": 5},\n{"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .": 4},\n{"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 4},\n{"Changes in PKC isoforms in human alveolar macrophages compared with blood monocytes .": 5},\n{"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .": 4},\n{"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .": 5},\n{"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .": 4},\n{"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .": 4},\n{"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5}\n]', 'response3': '[{"bronchoalveolar lavage": "cell_type"}, {"blood mononuclear cells": "cell_type"}, {"sarcoidosis": "cell_type"}, {"tuberculosis": "cell_type"}]', 'prediction': {'bronchoalveolar lavage': 'cell_type', 'blood mononuclear cells': 'cell_type', 'sarcoidosis': 'cell_type', 'tuberculosis': 'cell_type'}}
{'idx': 1498, 'sentence': 'Steroid mediated lysis of lymphoblasts requires the DNA binding region of the steroid hormone receptor.', 'label': {'lymphoblasts': 'cell_type'}, 'response1': "['DNA', 'cell_type']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of proteins and their corresponding labels, which directly match the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides a clear example of a protein (NF-E2) matching the entity type in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence directly mentions the DNA-binding protein AP-1, which aligns with the entity type in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence includes various proteins (CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, granulocyte-macrophage colony-stimulating factor) that match the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of proteins (IL-2, Aiolos, Ras) that correspond to the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions the protein IL-2 receptor alpha subunit, p21ras, and B cell, all aligning with the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence directly mentions lymphoid neoplasms, which matches the cell_type entity type in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence includes examples of proteins (RXR) that correspond to the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of proteins (CD40, NF-kappa B) that align with the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions the protein G-CSF, which matches the entity type in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence includes proteins (interleukin 10, IL-10R, STAT3, IL-6) that correspond to the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of proteins (IL-2, c-Jun, c-Fos) that align with the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions the protein GATA-1, which matches the entity type in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence includes examples of RNA (IL-5 mRNA), cell_type (TCR, B cell), and proteins (IL-2R, dexamethasone) that correspond to the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of proteins (CD70, IL-4, CD40) and cell types (B cell, plasma cells) that align with the entity types in the target sentence."},\n    {"Sentence": 5},\n    {"Reason": "The sentence directly mentions the DNA-binding protein NF-kappa B, which aligns with the entity type in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entities matching the entity types in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entities matching the entity types in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entities matching the entity types in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entities matching the entity types in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entities matching the entity types in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entities matching the entity types in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entities matching the entity types in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entities matching the entity types in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entities matching the entity types in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entities matching the entity types in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any entities matching the entity types in the target sentence."}\n]', 'response3': '[{"DNA binding region": "DNA"}]', 'prediction': {'DNA binding region': 'DNA'}}
{'idx': 995, 'sentence': 'The hierarchy of transcriptional control in B-cell development has recently been analyzed by targeted gene inactivation in the mouse .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific gene names and their corresponding entity labels, making it highly relevant for extracting named entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence provides specific gene names and their corresponding entity labels, aiding in the extraction of named entities."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence includes a specific gene name and its corresponding entity label, contributing to the extraction of named entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence mentions a specific gene name and its corresponding entity label, which is crucial for extracting named entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains a specific gene name and its corresponding entity label, which is essential for extracting named entities."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence provides specific gene names and their corresponding entity labels, aiding in the extraction of named entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence includes specific gene names and their corresponding entity labels, which are crucial for extracting named entities."},\n    {"Example 8": 4},\n    {"Reason 8": "The sentence mentions a specific gene name and its corresponding entity label, contributing to the extraction of named entities."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence provides a specific gene name and its corresponding entity label, aiding in the extraction of named entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains a specific gene name and its corresponding entity label, which is essential for extracting named entities."},\n    {"Example 11": 4},\n    {"Reason 11": "The sentence includes specific gene names and their corresponding entity labels, aiding in the extraction of named entities."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence provides specific gene names and their corresponding entity labels, aiding in the extraction of named entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions specific gene names and their corresponding entity labels, which are crucial for extracting named entities."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence includes a specific gene name and its corresponding entity label, contributing to the extraction of named entities."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains specific gene names and their corresponding entity labels, making it highly relevant for extracting named entities."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific gene names or entity labels, making it irrelevant for extracting named entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not provide any specific gene names or entity labels, making it irrelevant for extracting named entities."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific gene names or entity labels, making it irrelevant for extracting named entities."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not provide any specific gene names or entity labels, making it irrelevant for extracting named entities."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any specific gene names or entity labels, making it irrelevant for extracting named entities."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not provide any specific gene names or entity labels, making it irrelevant for extracting named entities."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any specific gene names or entity labels, making it irrelevant for extracting named entities."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not provide any specific gene names or entity labels, making it irrelevant for extracting named entities."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any specific gene names or entity labels, making it irrelevant for extracting named entities."}\n]', 'response3': '[{"B-cell": "cell_type"}, {"mouse": "cell_type"}]', 'prediction': {'B-cell': 'cell_type', 'mouse': 'cell_type'}}
{'idx': 1671, 'sentence': 'Both phosphorylation and proliferation were inhibited by IL-6 neutralizing antibodies .', 'label': {'IL-6 neutralizing antibodies': 'protein', 'IL-6': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."}\n]', 'response3': '[{"IL-6": "protein"}]', 'prediction': {'IL-6': 'protein'}}
{'idx': 141, 'sentence': 'TNF-alpha was able to increase expression of the HIV LTR in T cells , but in monocytic cells , TNF-alpha did not induce the HIV LTR above a constitutive level of activity .', 'label': {'monocytic cells': 'cell_type', 'TNF-alpha': 'protein', 'HIV LTR': 'DNA', 'T cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"TNF-alpha": "protein"}, {"HIV LTR": "DNA"}, {"T cells": "cell_type"}, {"monocytic cells": "cell_type"}]', 'prediction': {'TNF-alpha': 'protein', 'HIV LTR': 'DNA', 'T cells': 'cell_type', 'monocytic cells': 'cell_type'}}
{'idx': 1557, 'sentence': "In this report, we show that following incubation of L540 cells ( Hodgkin's disease -derived, T cell-like, CD30 + cells ) with the agonistic anti- CD30 monoclonal antibodies ( mAb ) M44 and M67 , two nuclear factor (NF)-kappa B DNA binding activities were induced in nuclear extracts , as determined in gel retardation assays .", 'label': {"Hodgkin's disease -derived, T cell-like, CD30 + cells": 'cell_line', 'nuclear factor (NF)-kappa B': 'protein', 'M44': 'protein', 'L540 cells': 'cell_line', 'M67': 'protein', 'mAb': 'protein', 'agonistic anti- CD30 monoclonal antibodies': 'protein', 'CD30': 'protein'}, 'response1': "['cell_line', 'protein', 'DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of NF-kappa B DNA binding activity, which directly matches the entity label \'DNA\' in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions RelA and Rel homology family, which are related to the NF-kappa B complex, matching the entity label \'protein\' in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence provides multiple examples of proteins such as CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, and granulocyte-macrophage colony-stimulating factor, all of which match the entity label \'protein\' in the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence mentions NF-kappa B binding activity, which matches the entity label \'protein\' in the target sentence."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence mentions CD40, IFN-gamma, tumor necrosis factor-alpha, and interleukin (IL)-1beta, all of which are related to proteins, matching the entity label \'protein\' in the target sentence."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence mentions IL-2 receptor alpha subunit, p21ras, and B cell activation, all of which match the entity labels \'protein\' and \'cell_type\' in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides examples of IL-2, NF-kappa B, and AP-1, all of which match the entity labels \'protein\' in the target sentence."},\n    {"Example 8": 4},\n    {"Reason 8": "The sentence mentions NF-kappa B activation, which matches the entity label \'protein\' in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides examples of CD70, B cell, plasma cells, IL-4, and CD40 signaling, all of which match the entity labels \'protein\' and \'cell_type\' in the target sentence."},\n    {"Example 10": 4},\n    {"Reason 10": "The sentence mentions NF-kappaB, Tax, and ATL, all of which match the entity labels \'protein\' and \'cell_type\' in the target sentence."},\n    {"Example 11": 4},\n    {"Reason 11": "The sentence mentions IkappaBbeta and NF-kappaB, which match the entity labels \'protein\' in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides examples of IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, and phorbol myristate acetate, all of which match the entity labels \'protein\' in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides examples of CD40 and NF-kappa B, which match the entity labels \'protein\' in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides examples of p50, p65, DNA, and protein, all of which match the entity labels \'protein\' and \'DNA\' in the target sentence."}\n]', 'response3': '[{"L540 cells": "cell_line"}, {"Hodgkin\'s disease": "cell_type"}, {"T cell-like": "cell_type"}, {"CD30": "protein"}, {"NF-kappa B": "DNA"}, {"mAb": "protein"}, {"M44": "protein"}, {"M67": "protein"}]', 'prediction': {'L540 cells': 'cell_line', "Hodgkin's disease": 'cell_type', 'T cell-like': 'cell_type', 'CD30': 'protein', 'NF-kappa B': 'DNA', 'mAb': 'protein', 'M44': 'protein', 'M67': 'protein'}}
{'idx': 1090, 'sentence': 'Further analysis reveals that the inducible phosphorylation of I kappa B alpha maps to two serines in the N terminus of the protein (residues 32 and 36) and that the mutation of either residue is sufficient to abolish ligand-induced degradation, whereas both residues must be mutated to abolish inducible phosphorylation of the protein.', 'label': {'N terminus': 'protein', 'I kappa B alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n{"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.": 4},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.": 4},\n{"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras.": 5},\n{"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 4},\n{"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n{"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF.": 5},\n{"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events.": 5},\n{"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n{"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 3},\n{"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation.": 4},\n{"Control of NF-kappa B activity by the I kappa B beta inhibitor.": 4},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n{"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.": 4},\n{"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations.": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[{"I kappa B alpha": "protein"}]', 'prediction': {'I kappa B alpha': 'protein'}}
{'idx': 1568, 'sentence': 'The inverse relation between high density lipoprotein ( HDL ) and atherosclerotic events may in part be due to enzymes associated with HDL that destroy the biologically active lipids generated in LDL .', 'label': {'enzymes': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"NF-kappa B": 5},\n{"retinoic acid receptor alpha": 5},\n{"myeloperoxidase": 5},\n{"lysozyme": 5},\n{"PU.1": 5},\n{"IL-4": 5},\n{"LPS": 5},\n{"AP-1": 5},\n{"alpha-tocopherol": 4},\n{"monocyte": 4},\n{"endothelial cells": 4},\n{"phosphocreatine": 4},\n{"AP-1": 4},\n{"P selectin": 4},\n{"cAMP-dependent protein kinase": 5},\n{"Rap1": 5},\n{"Stat3": 5},\n{"Stat5": 5},\n{"c-Mpl": 5},\n{"NF-kappa B": 5},\n{"cell adhesion molecules": 4},\n{"interleukin-2": 5},\n{"alpha chain": 5},\n{"CD25": 5},\n{"IL-2 receptor": 5},\n{"Protein kinase B": 5},\n{"phosphatidylinositol 3-kinase": 5},\n{"STAT5": 5},\n{"erythropoietin": 5},\n{"HCD57": 4},\n{"EPO": 5},\n{"HCD57-SREI": 4},\n{"c-Akt": 5},\n{"T lymphocytes": 5},\n{"adenovirus vectors": 5},\n{"sickle red blood cells": 5},\n{"leukocytes": 5},\n{"vascular endothelium": 5},\n{"blood vessel": 5}\n]', 'response3': "[{'HDL': 'protein'}, {'LDL': 'protein'}]", 'prediction': {'HDL': 'protein', 'LDL': 'protein'}}
{'idx': 257, 'sentence': 'Because of the presence of a functional receptor-effector system for VD3 and multiple biological responses to the hormone, these cells provide a unique model system with which to probe the specific effects of VD3 on cell growth and differentiation in chronic myelogenous leukemia .', 'label': {}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"5": "The example contains the entity \'G-CSF\' which is a protein, matching one of the entity types in the target sentence."},\n    {"5": "The example contains the entity \'retinoic acid receptor alpha\' which is a protein, matching one of the entity types in the target sentence."},\n    {"5": "The example contains the entity \'NF-E2\' which is a protein, matching one of the entity types in the target sentence."},\n    {"5": "The example contains the entities \'c-kit\' and \'IL-4R alpha chain\' which are proteins, matching two of the entity types in the target sentence."},\n    {"5": "The example contains the entities \'CD70\', \'IL-4\', and \'CD40\' which are proteins, and \'B cell\' and \'plasma cells\' which are cell types, matching multiple entity types in the target sentence."},\n    {"5": "The example contains the entity \'CD14\' which is a protein, matching one of the entity types in the target sentence."},\n    {"5": "The example contains the entities \'IFN A\', \'IFNA\', \'interleukin-2\', \'interleukin-2 receptor\', \'phytohemagglutinin\', and \'phorbol myristate acetate\' which are proteins, matching multiple entity types in the target sentence."},\n    {"5": "The example contains the entities \'MNDA\' which is a protein, and \'Philadelphia chromosome-positive chronic myeloid leukemia\' which is a cell line, matching two of the entity types in the target sentence."},\n    {"5": "The example contains the entities \'WT1\' which is a protein, and \'myeloid cell lines\' which is a cell line, matching two of the entity types in the target sentence."},\n    {"5": "The example contains the entities \'IL-7R\' and \'gamma(c)\' which are proteins, matching two of the entity types in the target sentence."},\n    {"5": "The example contains the entities \'interleukin 10\', \'IL-10R\', \'STAT3\', and \'IL-6\' which are proteins, matching multiple entity types in the target sentence."},\n    {"5": "The example contains the entities \'IL4\', \'IL13\', \'STAT6\', \'STAT3\', \'STAT5\', and \'B cells\' which are proteins and a cell type, matching multiple entity types in the target sentence."},\n    {"5": "The example contains the entities \'Stat3\', \'Stat5\', and \'c-Mpl\' which are proteins, matching multiple entity types in the target sentence."},\n    {"5": "The example contains the entities \'interleukin-2\', \'alpha chain\', \'CD25\', and \'IL-2 receptor\' which are proteins, matching multiple entity types in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 262, 'sentence': 'This complementary DNA encoded a protein with structural similarities to the c-jun proto-oncogene product , and its target sequence was closely related to the palindromic target sequence of c-jun .', 'label': {'complementary DNA': 'DNA', 'c-jun proto-oncogene product': 'protein', 'palindromic target sequence': 'DNA', 'c-jun': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 3},\n{"Here we examined the regulatory mechanism of the SCM-1 genes.": 2},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"These two related genes share the evolutionarily conserved region encoding the Runt domain.": 4},\n{"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 4},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 3},\n{"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n{"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 4},\n{"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 3},\n{"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 4},\n{"This protein has now been purified and its encoding gene cloned.": 4},\n{"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 4},\n{"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 5},\n{"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n{"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n{"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1351, 'sentence': 'Western blotting yielded a set of bands ranging from 25 kD to 55 kD, resulting from extensive alternative splicing .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 5},\n    {"Example 17": 5},\n    {"Example 18": 5},\n    {"Example 19": 5},\n    {"Example 20": 5}\n]', 'response3': '[{"25 kD": "protein"}, {"55 kD": "protein"}]', 'prediction': {'25 kD': 'protein', '55 kD': 'protein'}}
{'idx': 973, 'sentence': 'To assess the transcription regulatory function of MZF-1 , the full-length MZF-1 coding region was fused to the DNA binding domain of the yeast transactivator GAL4 .', 'label': {'MZF-1': 'DNA', 'DNA binding domain': 'protein', 'yeast transactivator GAL4': 'protein', 'GAL4': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"Here we examined the regulatory mechanism of the SCM-1 genes.": 1},\n{"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n{"To evaluate the PML/RARalpha role in myelopoiesis, transgenic mice expressing PML/RARalpha were engineered.": 4},\n{"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.": 5},\n{"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n{"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.": 4},\n{"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 4},\n{"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 4},\n{"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n{"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 4},\n{"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system.": 4},\n{"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 4},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.": 4},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 4},\n{"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n{"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"MZF-1": "protein"}, {"MZF-1": "protein"}, {"DNA": "DNA"}, {"GAL4": "protein"}]', 'prediction': {'MZF-1': 'protein', 'DNA': 'DNA', 'GAL4': 'protein'}}
{'idx': 1125, 'sentence': 'This indicates that the CR of GR may be of functional significance.', 'label': {'GR': 'protein'}, 'response1': "['protein']", 'response2': '[{"Example 1": 5},{"Reason 1": "The example contains a specific entity with the label \'DNA\' that directly matches an entity type in the target sentence."}]\n[{"Example 2": 4},{"Reason 2": "The example contains specific entities with labels \'protein\' and \'cell_line\' that match entity types in the target sentence."}]\n[{"Example 3": 4},{"Reason 3": "The example contains specific entities with labels \'protein\' that match entity types in the target sentence."}]\n[{"Example 4": 5},{"Reason 4": "The example contains specific entities with labels \'cell_type\' that match entity types in the target sentence."}]\n[{"Example 5": 4},{"Reason 5": "The example contains a specific entity with the label \'protein\' that matches an entity type in the target sentence."}]\n[{"Example 6": 4},{"Reason 6": "The example contains a specific entity with the label \'protein\' that matches an entity type in the target sentence."}]\n[{"Example 7": 4},{"Reason 7": "The example contains a specific entity with the label \'protein\' that matches an entity type in the target sentence."}]\n[{"Example 8": 5},{"Reason 8": "The example contains a specific entity with the label \'cell_line\' that matches an entity type in the target sentence."}]\n[{"Example 9": 4},{"Reason 9": "The example contains specific entities with labels \'protein\' that match entity types in the target sentence."}]\n[{"Example 10": 5},{"Reason 10": "The example contains specific entities with labels \'protein\' that match entity types in the target sentence."}]\n[{"Example 11": 5},{"Reason 11": "The example contains a specific entity with the label \'cell_type\' that matches an entity type in the target sentence."}]\n[{"Example 12": 5},{"Reason 12": "The example contains a specific entity with the label \'cell_line\' that matches an entity type in the target sentence."}]\n[{"Example 13": 5},{"Reason 13": "The example contains a specific entity with the label \'RNA\' that matches an entity type in the target sentence."}]\n[{"Example 14": 4},{"Reason 14": "The example contains a specific entity with the label \'protein\' that matches an entity type in the target sentence."}]\n[{"Example 15": 4},{"Reason 15": "The example contains specific entities with labels \'protein\' that match entity types in the target sentence."}]', 'response3': '[]', 'prediction': {}}
{'idx': 338, 'sentence': 'Nuclear T3R in lymphocytes was determined by radio-ligand binding analysis .', 'label': {'T3R': 'protein', 'lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"T3R": "protein"}]', 'prediction': {'T3R': 'protein'}}
{'idx': 1080, 'sentence': 'However, the concurrent addition of iron (in the form of ferrous or ferric chloride and other iron salts ) reversed the inhibition of proliferation caused by tepoxalin .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains a specific entity with a clear entity label that matches the entity type in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains a specific entity with a clear entity label that matches the entity type in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains a specific entity with a clear entity label that matches the entity type in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entities with entity labels matching the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities with entity labels matching the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities with entity labels matching the entity types in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities with entity labels matching the entity types in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities with entity labels matching the entity types in the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities with entity labels matching the entity types in the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities with entity labels matching the entity types in the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities with entity labels matching the entity types in the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities with entity labels matching the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1786, 'sentence': 'Binding of plasma Factor VII/VIIa to the tissue factor (TF) receptor initiates the coagulation protease cascades .', 'label': {'coagulation protease': 'protein', 'tissue factor (TF) receptor': 'protein', 'plasma Factor VII/VIIa': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains multiple instances of protein names and cell types, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains multiple instances of protein names and cell types, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains multiple instances of protein names, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains multiple instances of protein names, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains multiple instances of protein names, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains multiple instances of protein names and cell types, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains multiple instances of protein names, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains protein names and cell types, which are directly relevant to the entity labels in the target sentence."},\n    {"Example 9": 1},\n    {"Reason 9": "The sentence does not contain any entity names that are relevant to the entity labels in the target sentence."},\n    {"Example 10": 1},\n    {"Reason 10": "The sentence does not contain any entity names that are relevant to the entity labels in the target sentence."},\n    {"Example 11": 1},\n    {"Reason 11": "The sentence does not contain any entity names that are relevant to the entity labels in the target sentence."},\n    {"Example 12": 1},\n    {"Reason 12": "The sentence does not contain any entity names that are relevant to the entity labels in the target sentence."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not contain any entity names that are relevant to the entity labels in the target sentence."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not contain any entity names that are relevant to the entity labels in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any entity names that are relevant to the entity labels in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entity names that are relevant to the entity labels in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entity names that are relevant to the entity labels in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entity names that are relevant to the entity labels in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entity names that are relevant to the entity labels in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entity names that are relevant to the entity labels in the target sentence."}\n]', 'response3': "[{'Factor VII/VIIa': 'protein'}, {'TF': 'protein'}]", 'prediction': {'Factor VII/VIIa': 'protein', 'TF': 'protein'}}
{'idx': 1242, 'sentence': 'LPS signaling was found to involve NF kappa B activation by the p50/p65 heterodimers .', 'label': {'NF kappa B': 'protein', 'p50/p65 heterodimers': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n    {"Control of NF-kappa B activity by the I kappa B beta inhibitor.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 5},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 4},\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.": 5},\n    {"Recently, activation of NF-kappa B has been linked to ARDS and has been shown to be a critical proximal step in the initiation of neutrophilic inflammation in animal models.": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 5},\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"NF kappa B": "protein"}, {"p50": "protein"}, {"p65": "protein"}]', 'prediction': {'NF kappa B': 'protein', 'p50': 'protein', 'p65': 'protein'}}
{'idx': 866, 'sentence': 'T cell activation results in high levels of HIV replication and is thought to be one mechanism leading to the conversion from latent to active viral infection .', 'label': {'T cell': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein and cell type names that are directly mentioned."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains specific protein and cell type names that are directly mentioned."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence contains specific protein and DNA names that are directly mentioned."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence contains specific protein names that are directly mentioned."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific protein and cell type names that are directly mentioned."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific protein and DNA names that are directly mentioned."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence contains specific protein name that is directly mentioned."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific protein and cell type names that are directly mentioned."},\n    {"Example 9": 3},\n    {"Reason 9": "The sentence contains specific protein names but no entity types from the label set."},\n    {"Example 10": 3},\n    {"Reason 10": "The sentence contains specific protein names but no entity types from the label set."},\n    {"Example 11": 3},\n    {"Reason 11": "The sentence contains specific protein names but no entity types from the label set."},\n    {"Example 12": 3},\n    {"Reason 12": "The sentence contains specific protein names but no entity types from the label set."},\n    {"Example 13": 3},\n    {"Reason 13": "The sentence contains specific protein names but no entity types from the label set."},\n    {"Example 14": 3},\n    {"Reason 14": "The sentence contains specific protein names but no entity types from the label set."},\n    {"Example 15": 3},\n    {"Reason 15": "The sentence contains specific protein names but no entity types from the label set."},\n    {"Example 16": 3},\n    {"Reason 16": "The sentence contains specific protein names but no entity types from the label set."},\n    {"Example 17": 3},\n    {"Reason 17": "The sentence contains specific protein names but no entity types from the label set."},\n    {"Example 18": 3},\n    {"Reason 18": "The sentence contains specific protein names but no entity types from the label set."},\n    {"Example 19": 3},\n    {"Reason 19": "The sentence contains specific protein names but no entity types from the label set."},\n    {"Example 20": 3},\n    {"Reason 20": "The sentence contains specific protein names but no entity types from the label set."}\n]', 'response3': "[{'T cell': 'cell_type'}, {'HIV': 'cell_type'}]", 'prediction': {'T cell': 'cell_type', 'HIV': 'cell_type'}}
{'idx': 433, 'sentence': 'Competition experiments did not reveal any high-affinity binding site for BSAP in known regulatory regions of immunoglobulin and class II major histocompatibility (MHC) genes , suggesting that BSAP is a regulator of a different set of B-lymphoid-specific genes .', 'label': {'regulatory regions': 'DNA', 'BSAP': 'protein', 'high-affinity binding site': 'DNA', 'B-lymphoid-specific genes': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"BSAP": "protein"}, {"immunoglobulin": "protein"}, {"class II major histocompatibility (MHC) genes": "protein"}, {"B-lymphoid-specific genes": "cell_type"}]', 'prediction': {'BSAP': 'protein', 'immunoglobulin': 'protein', 'class II major histocompatibility (MHC) genes': 'protein', 'B-lymphoid-specific genes': 'cell_type'}}
{'idx': 1546, 'sentence': 'Identification of essential GATA and Ets binding motifs within the promoter of the platelet glycoprotein Ib alpha gene .', 'label': {'platelet glycoprotein Ib alpha gene': 'DNA', 'GATA': 'DNA', 'Ets binding motifs': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 4},\n    {"Example 3": 4},\n    {"Example 4": 4},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1},\n    {"Example 26": 1},\n    {"Example 27": 1}\n]', 'response3': '[{"GATA": "protein"}, {"Ets": "protein"}]', 'prediction': {'GATA': 'protein', 'Ets': 'protein'}}
{'idx': 1412, 'sentence': 'We found that these parameters were indistinguishable for one of the PRL- and IL-2- induced factors .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a clear entity with a specific entity label that directly matches one of the entity types in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The example provides multiple entities with specific entity labels that directly match the entity types in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides multiple entities with specific entity labels that directly match the entity types in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The example provides multiple entities with specific entity labels that directly match the entity types in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides multiple entities with specific entity labels that directly match the entity types in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The example provides multiple entities with specific entity labels that directly match the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides multiple entities with specific entity labels that directly match the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides multiple entities with specific entity labels that directly match the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides multiple entities with specific entity labels that directly match the entity types in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides multiple entities with specific entity labels that directly match the entity types in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides a clear entity with a specific entity label that directly matches one of the entity types in the target sentence."},\n    {"Example 12": 1},\n    {"Reason 12": "The example does not contain any entities that match the entity types in the target sentence."},\n    {"Example 13": 1},\n    {"Reason 13": "The example does not contain any entities that match the entity types in the target sentence."},\n    {"Example 14": 1},\n    {"Reason 14": "The example does not contain any entities that match the entity types in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The example does not contain any entities that match the entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any entities that match the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any entities that match the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any entities that match the entity types in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain any entities that match the entity types in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The example does not contain any entities that match the entity types in the target sentence."}\n]', 'response3': "[{'PRL-': 'protein'}, {'IL-2-': 'protein'}]", 'prediction': {'PRL-': 'protein', 'IL-2-': 'protein'}}
{'idx': 411, 'sentence': 'There was a significant positive correlation between VDR concentration and serum phosphate (P less than 0.05).', 'label': {'VDR': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 5},\n{"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n{"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 4},\n{"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 4},\n{"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n{"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n{"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n{"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05).": 4},\n{"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n{"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.": 5},\n{"Both haemin and delta-ALA caused a de novo increase in alpha-globin expression as well as enhancing Epo-induced beta-globin expression, leading to a marked increase in haemoglobin production.": 5},\n{"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 4},\n{"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.": 4},\n{"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.": 4},\n{"The affinity of the BAT box binding proteins for the BAT box was approximately 25-fold less than for the octamer sequence and the BAT box binding proteins dissociated from the BAT box 10-fold more rapidly than from the octamer sequence.": 5}\n]', 'response3': '[{"VDR concentration": "protein"}, {"serum phosphate": "protein"}]', 'prediction': {'VDR concentration': 'protein', 'serum phosphate': 'protein'}}
{'idx': 1460, 'sentence': 'In contrast, in a number of multiple myeloma cell lines , representing differentiated, plasma cell-like B cells , PU.1 DNA binding activity , mRNA expression , and Pu box -dependent transactivation were absent or detectable at a very low level.', 'label': {'multiple myeloma cell lines': 'cell_line', 'PU.1': 'protein', 'Pu box': 'DNA', 'differentiated, plasma cell-like B cells': 'cell_type'}, 'response1': "['cell_line', 'DNA', 'RNA', 'protein']", 'response2': '[\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.": 3},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.": 4},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.": 3},\n    {"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.": 4},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 4},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 4},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 3},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.": 4},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 5},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 4}\n]', 'response3': '[{"multiple myeloma cell lines": "cell_line"}, {"B cells": "cell_type"}, {"PU.1": "protein"}, {"DNA": "DNA"}, {"mRNA": "RNA"}]', 'prediction': {'multiple myeloma cell lines': 'cell_line', 'B cells': 'cell_type', 'PU.1': 'protein', 'DNA': 'DNA', 'mRNA': 'RNA'}}
{'idx': 638, 'sentence': 'Thus the VLA-5 fibronectin receptor on CD4 cells can play a complementary role in CD3 - TCR -mediated signal transduction through its interaction with fibronectin .', 'label': {'CD3': 'protein', 'TCR': 'protein', 'VLA-5 fibronectin receptor': 'protein', 'fibronectin': 'protein', 'CD4 cells': 'cell_line'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names and their functions, which directly relate to the entity labels in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence provides examples of chimeric receptors containing specific protein names, which are relevant to the entity labels in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence mentions protein names and cell types in the context of signal transduction, directly related to the entity labels in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence discusses specific protein names involved in signal transduction, which align with the entity labels in the target sentence."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence provides examples of protein names and their role in signaling pathways, which are relevant to the entity labels in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions protein names, cell types, and specific signaling proteins, directly related to the entity labels in the target sentence."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence discusses protein names and cell types in the context of transcriptional properties, which are relevant to the entity labels in the target sentence."},\n    {"Example 8": 4},\n    {"Reason 8": "The sentence provides an example of cell adhesion molecules, which are relevant to the entity labels in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence mentions protein names, cell types, and signaling molecules, directly related to the entity labels in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence discusses specific protein names involved in receptor function, which align with the entity labels in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides examples of protein names and their role in signal transduction, directly related to the entity labels in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions protein names, cell types, and specific signaling proteins, directly related to the entity labels in the target sentence."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence discusses protein names and their role in receptor function, which are relevant to the entity labels in the target sentence."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence provides examples of protein names up-regulated by specific factors, which are relevant to the entity labels in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any entity names or types relevant to the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entity names or types relevant to the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entity names or types relevant to the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entity names or types relevant to the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entity names or types relevant to the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entity names or types relevant to the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entity names or types relevant to the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entity names or types relevant to the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entity names or types relevant to the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entity names or types relevant to the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1375, 'sentence': 'We have analyzed the expression of TCL1 mRNA and protein in peripheral blood lymphocytes ( PBLs ) from four AT cases and from healthy controls .', 'label': {'PBLs': 'cell_type', 'peripheral blood lymphocytes': 'cell_type', 'TCL1 mRNA': 'RNA', 'protein': 'protein'}, 'response1': "['RNA', 'protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence directly mentions the entity \'TCL1\' and specifies that it is expressed, indicating it is a protein."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence mentions entities like \'IL-2\', \'c-Jun\', and \'c-Fos\' in the context of binding to nuclear factors, indicating they are proteins."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly mentions the entity \'SCM-1\' in the context of genes, indicating it is a cell line."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence directly mentions the entity \'AP-1\' in the context of DNA binding activity, indicating it is DNA."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence mentions entities like \'NF-kappaB\', \'Tax\', and \'ATL\' in the context of activation and leukemic cells, indicating they are proteins or cell types."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions entities like \'TAL1\' and \'T-ALL\' in the context of promoting development, indicating they are proteins or cell types."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence mentions entities like \'SCL\' and \'GATA-1\' in the context of cell lineages and zinc-finger transcription factors, indicating they are proteins."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence directly mentions the entity \'SLAP-130\' in the context of T cell antigen receptor-stimulated protein tyrosine kinases, indicating it is a protein."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence directly mentions the entity \'E2A\' in the context of gene expression at the protein level, indicating it is a protein."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions entities like \'MNDA\' and \'Philadelphia chromosome-positive chronic myeloid leukemia\' in the context of expression and specificity, indicating they are proteins or cell lines."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions entities like \'TCRzeta\' and \'p56(lck)\' in the context of detection and reduced levels, indicating they are proteins."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions entities like \'granulocytes\' and \'T cells\' in the context of methylation, indicating they are cell types."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence directly mentions the entity \'WT1\' in the context of paternal expression, indicating it is a protein."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions entities like \'CD70\', \'B cell\', \'plasma cells\', \'IL-4\', and \'CD40\' in the context of differentiation, signaling, and promotion, indicating they are proteins or cell types."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions entities like \'B and T cell activation\', \'Ramos\', \'Jurkat\', and \'cDNA microarray technology\' in the context of gene expression and technology, indicating they are cell types, cell lines, or DNA."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence mentions entities like \'CD40\', \'Rel/nuclear factor kappaB\', \'NF-kappaB\', and \'B lymphocytes\' in the context of stimulation, activity, and nuclear appearance, indicating they are proteins or cell types."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities from the given label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities from the given label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities from the given label set."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities from the given label set."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities from the given label set."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities from the given label set."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities from the given label set."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities from the given label set."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities from the given label set."}\n]', 'response3': '[{"TCL1 mRNA": "RNA"}, {"protein": "protein"}, {"PBLs": "cell_type"}, {"AT cases": "cell_type"}]', 'prediction': {'TCL1 mRNA': 'RNA', 'protein': 'protein', 'PBLs': 'cell_type', 'AT cases': 'cell_type'}}
{'idx': 764, 'sentence': 'The increased sensitivity of CEM-C7 cells and its subclones to dexamethasone in serum-free medium returned to previous levels when these cells were recultured in serum-containing medium .', 'label': {'CEM-C7': 'cell_line', 'CEM-C7 cells': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .": 4},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 4},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .": 4},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .": 4},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 4},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .": 4},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .": 4},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice .": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5}\n]', 'response3': '[{"CEM-C7 cells": "cell_line"}]', 'prediction': {'CEM-C7 cells': 'cell_line'}}
{'idx': 897, 'sentence': 'The system is based on the use of an oligomerized NFAT-1 binding motif that directs transcription of SV40 T-antigen in transgenic mice .', 'label': {'transcription of SV40 T-antigen': 'protein', 'NFAT-1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 5},\n    {"Example 17": 5},\n    {"Example 18": 5},\n    {"Example 19": 5},\n    {"Example 20": 5},\n    {"Example 21": 5},\n    {"Example 22": 5},\n    {"Example 23": 5},\n    {"Example 24": 5},\n    {"Example 25": 5}\n]', 'response3': '[{"NFAT-1": "protein"}, {"SV40 T-antigen": "protein"}]', 'prediction': {'NFAT-1': 'protein', 'SV40 T-antigen': 'protein'}}
{'idx': 1842, 'sentence': 'Individually or collectively, none of the three enhancer-binding proteins ( LEF-1 , Ets-1 , and TFE-3 ) could activate transcription in the absence of Sp1 .', 'label': {'Ets-1': 'protein', 'TFE-3': 'protein', 'LEF-1': 'protein', 'enhancer-binding proteins': 'protein', 'Sp1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."}\n]', 'response3': '[{"LEF-1": "protein"}, {"Ets-1": "protein"}, {"TFE-3": "protein"}, {"Sp1": "protein"}]', 'prediction': {'LEF-1': 'protein', 'Ets-1': 'protein', 'TFE-3': 'protein', 'Sp1': 'protein'}}
{'idx': 1059, 'sentence': 'Transcription factors belonging to the NF-kappa B family are controlled by inhibitory I kappa B proteins , mainly I kappa B alpha and I kappa B beta .', 'label': {'NF-kappa B family': 'protein', 'Transcription factors': 'protein', 'I kappa B beta': 'protein', 'inhibitory I kappa B proteins': 'protein', 'I kappa B alpha': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains multiple entities that are relevant to the entity labels in the target sentence, such as \'NF-kappaB\', \'Tax\', and \'ATL\', which are correctly identified as \'protein\', \'cell_type\', and \'cell_type\' respectively."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains entities \'NF-ATc\' and \'T lymphocytes\' which are relevant to the entity labels in the target sentence, identified as \'protein\' and \'cell_type\' respectively."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains entities \'NF-kappa B\' and \'I kappa B alpha\' which are relevant to the entity labels in the target sentence, identified as \'protein\'."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains entities \'NF-kappa B\' and \'I kappa B beta\' which are relevant to the entity labels in the target sentence, identified as \'protein\'."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains entities \'IkappaBalpha\' and \'NF-kappaB\' which are relevant to the entity labels in the target sentence, identified as \'protein\'."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains entities \'IkappaBbeta\' and \'NF-kappaB\' which are relevant to the entity labels in the target sentence, identified as \'protein\'."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains entities \'NF-ATc\', \'T lymphocytes\', and \'embryonic cardiac cells\' which are relevant to the entity labels in the target sentence, identified as \'protein\' and \'cell_type\'."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains entities \'NF-kappa B\' and \'AP-1\' which are relevant to the entity labels in the target sentence, identified as \'protein\'."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains entities \'NF-kappaB\' and \'rheumatoid arthritis\' which are relevant to the entity labels in the target sentence, identified as \'protein\' and \'cell_type\'."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains entities \'NF-kappaB\', \'Sp1\', and \'p50\' which are relevant to the entity labels in the target sentence, identified as \'protein\'."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains entities \'RelA\' and \'NF-kappa B\' which are relevant to the entity labels in the target sentence, identified as \'protein\'."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains entities \'PAFR\', \'PAF\', \'NF-kappa B\', and \'protein kinase C\' which are relevant to the entity labels in the target sentence, identified as \'protein\'."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains entities \'NF-kappa B\' and \'I kappa B alpha\' which are relevant to the entity labels in the target sentence, identified as \'protein\'."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains entity \'NF-kappa B\' which is relevant to the entity labels in the target sentence, identified as \'protein\'."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any entities relevant to the entity labels in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entities relevant to the entity labels in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities relevant to the entity labels in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities relevant to the entity labels in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities relevant to the entity labels in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities relevant to the entity labels in the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities relevant to the entity labels in the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities relevant to the entity labels in the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities relevant to the entity labels in the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities relevant to the entity labels in the target sentence."}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"I kappa B": "protein"}, {"I kappa B alpha": "protein"}, {"I kappa B beta": "protein"}]', 'prediction': {'NF-kappa B': 'protein', 'I kappa B': 'protein', 'I kappa B alpha': 'protein', 'I kappa B beta': 'protein'}}
{'idx': 924, 'sentence': 'We conclude that p56 exists in cytosol in a higher order complex containing hsp70 and hsp90 , both of which in turn have been found to be associated with untransformed steroid receptors .', 'label': {'hsp70': 'protein', 'untransformed steroid receptors': 'protein', 'hsp90': 'protein', 'p56': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 4},\n    {"Example 3": 4},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1},\n    {"Example 26": 1},\n    {"Example 27": 1},\n    {"Example 28": 1},\n    {"Example 29": 1},\n    {"Example 30": 1}\n]', 'response3': '[{"p56": "protein"}, {"hsp70": "protein"}, {"hsp90": "protein"}, {"untransformed steroid receptors": "protein"}]', 'prediction': {'p56': 'protein', 'hsp70': 'protein', 'hsp90': 'protein', 'untransformed steroid receptors': 'protein'}}
{'idx': 247, 'sentence': 'Antigen B27 seems to be a cause of lower levels of glucocorticoid receptors in blood lymphocytes .', 'label': {'Antigen B27': 'protein', 'glucocorticoid receptors': 'protein', 'blood lymphocytes': 'cell_type', 'lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.": 4},\n    {"Benzene toxicity towards lymphocytes is thought to be mediated by metabolites of benzene including benzoquinone ( BQ ).": 3},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 4},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes.": 3},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 4},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 4},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 3},\n    {"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.": 4},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.": 4},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 3},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 4},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.": 4},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5}\n]', 'response3': '[{"Antigen B27": "protein"}, {"glucocorticoid receptors": "protein"}, {"blood lymphocytes": "cell_type"}]', 'prediction': {'Antigen B27': 'protein', 'glucocorticoid receptors': 'protein', 'blood lymphocytes': 'cell_type'}}
{'idx': 507, 'sentence': 'Thus, the transcriptional activity of TCF-1 alpha appears to depend on the TCF-2 alpha and T alpha 1 ( CREB ) transcription factors and the context of its binding site within the TCR alpha enhancer .', 'label': {'TCF-2 alpha': 'protein', 'TCR alpha enhancer': 'DNA', 'CREB': 'protein', 'transcription factors': 'protein', 'T alpha 1': 'protein', 'TCR': 'protein', 'TCF-1 alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"TCF-1 alpha": "protein"}, {"TCF-2 alpha": "protein"}, {"T alpha 1": "protein"}, {"CREB": "protein"}, {"TCR alpha": "protein"}]', 'prediction': {'TCF-1 alpha': 'protein', 'TCF-2 alpha': 'protein', 'T alpha 1': 'protein', 'CREB': 'protein', 'TCR alpha': 'protein'}}
{'idx': 460, 'sentence': "To characterize these regulatory elements further, mutations in these regions were inserted into both the 5' and 3' HIV LTRs and infectious proviral constructs were assembled.", 'label': {'HIV LTRs': 'DNA', 'regulatory elements': 'DNA'}, 'response1': "['DNA', 'RNA']", 'response2': '[\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 5},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 5},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 5},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes.": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 5},\n    {"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems ( herpes simplex, cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[{"HIV LTRs": "DNA"}]', 'prediction': {'HIV LTRs': 'DNA'}}
{'idx': 131, 'sentence': 'Truncation of TR alpha 1 at amino acid 210 prevented additional complex formation in the presence of NE without affecting DNA binding , suggesting that the carboxyl-terminus of the TRs is essential for interaction with nuclear proteins .', 'label': {'TRs': 'protein', 'carboxyl-terminus': 'protein', 'TR alpha 1': 'protein', 'nuclear proteins': 'protein', 'amino acid 210': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[\n    {"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes.": 5},\n    {"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system.": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n    {"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events.": 5},\n    {"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex.": 5},\n    {"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.": 5},\n    {"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 4},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[{"TR alpha 1": "protein"}, {"NE": "cell_line"}, {"DNA": "DNA"}, {"TRs": "protein"}]', 'prediction': {'TR alpha 1': 'protein', 'NE': 'cell_line', 'DNA': 'DNA', 'TRs': 'protein'}}
{'idx': 692, 'sentence': 'The human T-cell leukemia virus type I ( HTLV-I ) promoter contains three copies of imperfect repeats of a 21-base pair sequence designated here as TRE ( Tax -response element ) that is responsive to the virally encoded transactivator protein Tax .', 'label': {'virally encoded transactivator protein': 'protein', 'Tax -response element': 'DNA', 'TRE': 'DNA', 'human T-cell leukemia virus type I ( HTLV-I ) promoter': 'DNA', 'Tax': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n{"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.": 5},\n{"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 5},\n{"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n{"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n{"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n{"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 5},\n{"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n{"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n{"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5},\n{"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB- induced trans-activation of the H4 promoter.": 5},\n{"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n{"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.": 5}\n]', 'response3': '[{"HTLV-I": "cell_type"}, {"TRE": "DNA"}, {"Tax": "protein"}]', 'prediction': {'HTLV-I': 'cell_type', 'TRE': 'DNA', 'Tax': 'protein'}}
{'idx': 43, 'sentence': 'T-helper-cell determinants in protein antigens are preferentially located in cysteine-rich antigen segments resistant to proteolytic cleavage by cathepsin B , L , and D .', 'label': {'cysteine-rich antigen segments': 'protein', 'T-helper-cell determinants': 'protein', 'protein antigens': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 4},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 4},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Tat-binding protein 7 is a subunit of the 26S protease.": 4},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.": 4},\n    {"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.": 4},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 4},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 4}\n]', 'response3': '[{"T-helper-cell": "cell_type"}, {"protein": "protein"}, {"cysteine-rich antigen segments": "protein"}, {"cathepsin B": "protein"}, {"cathepsin L": "protein"}, {"cathepsin D": "protein"}]', 'prediction': {'T-helper-cell': 'cell_type', 'protein': 'protein', 'cysteine-rich antigen segments': 'protein', 'cathepsin B': 'protein', 'cathepsin L': 'protein', 'cathepsin D': 'protein'}}
{'idx': 1204, 'sentence': 'Hirsutism , graded by the modified Ferriman-Gallwey score , and hormonal parameters were evaluated basally and at 4-month intervals during treatment.', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence provides a clear example of a cell line (SCM-1) being examined in a study, making it highly relevant for identifying cell line entities."},\n{"Example 2": 5},\n{"Reason 2": "The sentence explicitly mentions a protein (NF-E2) and its role in a cellular differentiation program, making it highly relevant for identifying protein entities."},\n{"Example 3": 5},\n{"Reason 3": "The sentence contains multiple instances of proteins (dexamethasone, cortisol, lysozyme) and a cell line (HML) being evaluated, making it very helpful for identifying protein and cell line entities."},\n{"Example 4": 4},\n{"Reason 4": "The sentence mentions phosphocreatine, which is relevant for identifying protein entities, but the context could be clearer."},\n{"Example 5": 5},\n{"Reason 5": "The sentence explicitly mentions lymphoid neoplasms, indicating a specific cell type, making it highly relevant for identifying cell type entities."},\n{"Example 6": 5},\n{"Reason 6": "The sentence describes the examination of a gene at the protein level, specifically mentioning the E2A gene and its protein expression, making it highly relevant for identifying protein entities."},\n{"Example 7": 5},\n{"Reason 7": "The sentence clearly identifies granulocytes and T cells, indicating specific cell types, making it highly relevant for identifying cell type entities."},\n{"Example 8": 5},\n{"Reason 8": "The sentence mentions AP-1 DNA binding activity in lymphocytes, providing a clear example of DNA entity, making it highly relevant for identifying DNA entities."},\n{"Example 9": 5},\n{"Reason 9": "The sentence describes the mRNA expression of a transcription factor (GATA-1) during eosinophil differentiation, making it highly relevant for identifying protein entities."},\n{"Example 10": 5},\n{"Reason 10": "The sentence mentions Egr-1 mRNA expression and protein tyrosine phosphorylation, providing clear examples of RNA and protein entities, making it highly relevant for identifying these entities."},\n{"Example 11": 5},\n{"Reason 11": "The sentence mentions transcription factors (ATF1, CREB) and the H4 promoter, providing clear examples of protein and DNA entities, making it highly relevant for identifying these entities."},\n{"Example 12": 5},\n{"Reason 12": "The sentence describes the generation of conditional EBV mutants and the expression of EBNA2 and estrogen receptor, providing clear examples of DNA and protein entities, making it highly relevant for identifying these entities."},\n{"Example 13": 5},\n{"Reason 13": "The sentence mentions MR, aldosterone, and progesterone, providing clear examples of protein entities, making it highly relevant for identifying these entities."},\n{"Example 14": 5},\n{"Reason 14": "The sentence describes ras-transformed lymphocytes and their functional IL-2r, c-fos induction, and growth stimulation, providing clear examples of protein entities, making it highly relevant for identifying these entities."},\n{"Example 15": 5},\n{"Reason 15": "The sentence mentions Type I and Type II receptors, indicating specific cell types, making it highly relevant for identifying cell type entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1134, 'sentence': 'Reverse transcriptase (RT) assays were positive in purified viral material from both LCLs .', 'label': {'LCLs': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 4},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05).": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 5},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 4},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 4},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 4},\n    {"In addition, assay of PBMC by the adenovirus-specific PCR may help detect early invasive disease and warrants further evaluation.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 4},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 4},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 471, 'sentence': 'The lymphocyte nuclear T3 receptor was found with an affinity close to that of normal volunteers (Ka: 1.42 x 10(10) M-1 vs 1.95 +/- 0.35 x 10(10) M-1) and a binding capacity markedly increased (9.9 vs 3.7 +/- 0.4 fmol T3 /100 micrograms DNA).', 'label': {'lymphocyte nuclear T3 receptor': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 3},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 3},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 3},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 3},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 5},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[{"T3 receptor": "protein"}, {"DNA": "DNA"}]', 'prediction': {'T3 receptor': 'protein', 'DNA': 'DNA'}}
{'idx': 1205, 'sentence': 'Gonadotropin-releasing hormone and ACTH stimulation tests were performed before and after 3 to 4 months of therapy .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides multiple examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence provides an example of a named entity with its corresponding entity label, which is helpful for extracting named entities from the target sentence."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence provides multiple examples of named entities with their corresponding entity labels, making it helpful for extracting named entities from the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence provides an example of a named entity with its corresponding entity label, which is helpful for extracting named entities from the target sentence."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence provides an example of a named entity with its corresponding entity label, which is helpful for extracting named entities from the target sentence."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence provides multiple examples of named entities with their corresponding entity labels, making it helpful for extracting named entities from the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides multiple examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 8": 4},\n    {"Reason 8": "The sentence provides an example of a named entity with its corresponding entity label, which is helpful for extracting named entities from the target sentence."},\n    {"Example 9": 1},\n    {"Reason 9": "The sentence does not contain any named entities from the given entity label set, hence not helpful for extracting named entities from the target sentence."},\n    {"Example 10": 1},\n    {"Reason 10": "The sentence does not contain any named entities from the given entity label set, hence not helpful for extracting named entities from the target sentence."},\n    {"Example 11": 1},\n    {"Reason 11": "The sentence does not contain any named entities from the given entity label set, hence not helpful for extracting named entities from the target sentence."},\n    {"Example 12": 1},\n    {"Reason 12": "The sentence does not contain any named entities from the given entity label set, hence not helpful for extracting named entities from the target sentence."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not contain any named entities from the given entity label set, hence not helpful for extracting named entities from the target sentence."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not contain any named entities from the given entity label set, hence not helpful for extracting named entities from the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any named entities from the given entity label set, hence not helpful for extracting named entities from the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any named entities from the given entity label set, hence not helpful for extracting named entities from the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities from the given entity label set, hence not helpful for extracting named entities from the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities from the given entity label set, hence not helpful for extracting named entities from the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any named entities from the given entity label set, hence not helpful for extracting named entities from the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any named entities from the given entity label set, hence not helpful for extracting named entities from the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 14, 'sentence': 'Moreover, platelet-activating factor was capable of inducing transcription of the nuclear proto-oncogenes c-fos and c-jun .', 'label': {'c-fos': 'DNA', 'nuclear proto-oncogenes': 'DNA', 'c-jun': 'DNA', 'platelet-activating factor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"c-fos": "protein"}, {"c-jun": "protein"}]', 'prediction': {'c-fos': 'protein', 'c-jun': 'protein'}}
{'idx': 145, 'sentence': 'Two consensus sequences, called X and Y boxes , capable of binding nuclear proteins and regulating expression in B cells have been defined within the immediate upstream region of major histocompatibility complex (MHC) class II promoters .', 'label': {'nuclear proteins': 'protein', 'major histocompatibility complex (MHC) class II promoters': 'DNA', 'B cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 4},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 3},\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 4},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 4},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 4},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5},\n    {"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif.": 5}\n]', 'response3': '[{"X boxes": "protein"}, {"Y boxes": "protein"}, {"B cells": "cell_type"}, {"major histocompatibility complex (MHC) class II promoters": "DNA"}]', 'prediction': {'X boxes': 'protein', 'Y boxes': 'protein', 'B cells': 'cell_type', 'major histocompatibility complex (MHC) class II promoters': 'DNA'}}
{'idx': 1449, 'sentence': 'DNA binding specificity of complex 3 overlaps with that of upstream stimulatory factor but is clearly distinct.', 'label': {'upstream stimulatory factor': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 5},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n    {"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF.": 5},\n    {"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 5},\n    {"In fact, mAb L243 but not the staphylococcal superantigens , staphylococcal exotoxin toxic shock syndrome toxin-I or staphylococcal enterotoxin B , regulate the NF-kappa B binding activity.": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 5}\n]', 'response3': '[{"DNA": "DNA"}, {"upstream stimulatory factor": "protein"}]', 'prediction': {'DNA': 'DNA', 'upstream stimulatory factor': 'protein'}}
{'idx': 1292, 'sentence': "Promoter function of the 5' flanking region of the thromboxane receptor gene was evaluated by transfection of thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids into platelet-like K562 cells .", 'label': {'thromboxane receptor': 'protein', 'thromboxane receptor gene': 'DNA', 'CAT': 'protein', 'chloramphenicol acetyltransferase': 'protein', "5' flanking region": 'DNA', 'thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids': 'DNA', 'K562 cells': 'cell_line'}, 'response1': "['DNA', 'protein', 'cell_line']", 'response2': '[\n{"1": "The sentence does not contain any named entities from the given entity label set."},\n{"1": "The sentence does not contain any named entities from the given entity label set."},\n{"1": "The sentence does not contain any named entities from the given entity label set."},\n{"5": "The sentence contains multiple protein entities (Stat3, Stat5, c-Mpl) which are directly related to the entity labels provided."},\n{"1": "The sentence does not contain any named entities from the given entity label set."},\n{"5": "The sentence contains multiple protein entities (PAFR, PAF, NF-kappa B, protein kinase C) which are directly related to the entity labels provided."},\n{"5": "The sentence contains multiple protein entities (Sp1, CD14) which are directly related to the entity labels provided."},\n{"5": "The sentence contains a protein entity (E2A) which is directly related to the entity labels provided."},\n{"5": "The sentence contains multiple protein entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) which are directly related to the entity labels provided."},\n{"5": "The sentence contains a protein entity (CD95 ligand) which is directly related to the entity labels provided."},\n{"5": "The sentence contains a cell line entity (SCM-1) which is directly related to the entity labels provided."},\n{"5": "The sentence contains multiple protein entities (Ter 119, beta-globin, glycoprotein IIb, platelet factor 4) which are directly related to the entity labels provided."},\n{"5": "The sentence contains multiple protein entities (ATF1, CREB, H4) which are directly related to the entity labels provided."},\n{"5": "The sentence contains a DNA entity (BAT box), a protein entity (CD20), and a cell type entity (B cells) which are directly related to the entity labels provided."},\n{"5": "The sentence contains multiple DNA entities (IL-2, NFAT), protein entities (NFAT delta418, calcineurin, Tpl-2, cyclosporin A) which are directly related to the entity labels provided."},\n{"1": "The sentence does not contain any named entities from the given entity label set."},\n{"1": "The sentence does not contain any named entities from the given entity label set."},\n{"1": "The sentence does not contain any named entities from the given entity label set."},\n{"1": "The sentence does not contain any named entities from the given entity label set."},\n{"1": "The sentence does not contain any named entities from the given entity label set."},\n{"1": "The sentence does not contain any named entities from the given entity label set."},\n{"1": "The sentence does not contain any named entities from the given entity label set."},\n{"1": "The sentence does not contain any named entities from the given entity label set."},\n{"1": "The sentence does not contain any named entities from the given entity label set."},\n{"1": "The sentence does not contain any named entities from the given entity label set."},\n{"1": "The sentence does not contain any named entities from the given entity label set."},\n{"1": "The sentence does not contain any named entities from the given entity label set."},\n{"1": "The sentence does not contain any named entities from the given entity label set."},\n{"1": "The sentence does not contain any named entities from the given entity label set."},\n{"1": "The sentence does not contain any named entities from the given entity label set."}\n]', 'response3': '[{"thromboxane receptor gene": "protein"}, {"thromboxane receptor gene promoter": "protein"}, {"chloramphenicol acetyltransferase (CAT)": "protein"}, {"K562 cells": "cell_line"}]', 'prediction': {'thromboxane receptor gene': 'protein', 'thromboxane receptor gene promoter': 'protein', 'chloramphenicol acetyltransferase (CAT)': 'protein', 'K562 cells': 'cell_line'}}
{'idx': 120, 'sentence': 'Two other T cell lines , CEM and RPMI 8402 , have essentially identical deletions.', 'label': {'RPMI 8402': 'cell_line', 'T cell lines': 'cell_line', 'CEM': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 1},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 3},\n    {"These two related genes share the evolutionarily conserved region encoding the Runt domain.": 1},\n    {"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 4},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 1},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 5},\n    {"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.": 4},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 1},\n    {"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 4},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 4},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5}\n]', 'response3': '[{"CEM": "cell_line"}, {"RPMI 8402": "cell_line"}]', 'prediction': {'CEM': 'cell_line', 'RPMI 8402': 'cell_line'}}
{'idx': 468, 'sentence': 'A 52-year-old male presented himself with tachycardia crises which appeared first during childhood, increased in frequency without goiter or exophthalmos .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 5},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 5},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 4},\n    {"By the time of diagnosis of T-PLL, the clone contains many more genetic changes in the form of additional translocations.": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n    {"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 4},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 4},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.": 5},\n    {"Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients.": 5},\n    {"Initiation of proliferation but not of differentiation was followed by a 20- to 25-fold increase in the nuclear level of the DNA polymerase-associated processivity factor PCNA and of the proliferation-specific transcription factor E2F1.": 5},\n    {"A total of 37 chronic, severe, nonsmoking asthmatic patients with documented reversible airways obstruction were classified as glucocorticoid-sensitive or -resistant on the basis of changes in FEV1, FVC, and peak expiratory flow (PEF) after oral prednisolone.": 4}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 138, 'sentence': 'The effects of TNF-alpha on gene expression were examined by transient expression assays using reporter chloramphenicol acetyltransferase plasmids linked to regulatory elements from the HIV long terminal repeat ( LTR ) and the beta interferon promoter .', 'label': {'beta interferon promoter': 'DNA', 'regulatory elements': 'DNA', 'HIV long terminal repeat': 'DNA', 'TNF-alpha': 'protein', 'LTR': 'DNA', 'reporter chloramphenicol acetyltransferase plasmids': 'DNA'}, 'response1': "['protein', 'DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 4},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 4},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 1},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"TNF-alpha": "protein"}, {"HIV long terminal repeat (LTR)": "DNA"}, {"beta interferon promoter": "DNA"}]', 'prediction': {'TNF-alpha': 'protein', 'HIV long terminal repeat (LTR)': 'DNA', 'beta interferon promoter': 'DNA'}}
{'idx': 64, 'sentence': 'Uninduced or Sendai virus induced HeLa extracts were used to examine transcription in vitro using a series of IFN beta promoter deletions .', 'label': {'IFN beta promoter deletions': 'DNA'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 4},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 4},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner.": 5},\n    {"We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of degradation of inhibitor-kappaB alpha.": 4},\n    {"NF-E1 is encoded by the same gene as the YY-1 protein, which binds to the adeno-associated virus P5 promoter.": 4},\n    {"We conclude, rather, that alpha 4 beta 1 in freshly isolated T cells delivers a distinct signal that synergizes early with signals initiated by TCR/CD3 ligation to induce DNA binding of multiple transcription factors required for cytokine gene induction.": 5},\n    {"Extracts prepared from XP-B and XP-D lymphoblastoid cells exhibited similar transcription activity from the adenovirus major late promoter when compared to that in extracts from normal cells.": 4}\n]', 'response3': '[{"HeLa": "cell_line"}, {"IFN beta": "protein"}]', 'prediction': {'HeLa': 'cell_line', 'IFN beta': 'protein'}}
{'idx': 1760, 'sentence': 'This inhibitory effect was limited to the first 2 h after mitogenic activation , localizing the time-frame of action of cysteamine to within the commitment period .', 'label': {}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n{"Example 2": 4},\n{"Reason 2": "The sentence contains a specific protein name that matches one of the entity types in the target sentence."},\n{"Example 3": 5},\n{"Reason 3": "The sentence contains multiple specific entity names (RNA, cell_type, protein) that directly match the entity types in the target sentence."},\n{"Example 4": 4},\n{"Reason 4": "The sentence contains specific protein and DNA names that match the entity types in the target sentence."},\n{"Example 5": 5},\n{"Reason 5": "The sentence contains specific cell_type and protein names that match the entity types in the target sentence."},\n{"Example 6": 4},\n{"Reason 6": "The sentence contains a specific protein name that matches one of the entity types in the target sentence."},\n{"Example 7": 5},\n{"Reason 7": "The sentence contains specific protein names that match the entity types in the target sentence."},\n{"Example 8": 5},\n{"Reason 8": "The sentence contains specific protein names that match the entity types in the target sentence."},\n{"Example 9": 4},\n{"Reason 9": "The sentence contains a specific cell_type name that matches one of the entity types in the target sentence."},\n{"Example 10": 5},\n{"Reason 10": "The sentence contains specific protein names that match the entity types in the target sentence."},\n{"Example 11": 4},\n{"Reason 11": "The sentence contains a specific RNA name that matches one of the entity types in the target sentence."},\n{"Example 12": 4},\n{"Reason 12": "The sentence contains specific DNA and cell_line names that match the entity types in the target sentence."},\n{"Example 13": 5},\n{"Reason 13": "The sentence contains specific protein names that match the entity types in the target sentence."},\n{"Example 14": 5},\n{"Reason 14": "The sentence contains specific protein and cell_type names that match the entity types in the target sentence."},\n{"Example 15": 1},\n{"Reason 15": "The sentence does not contain any specific entity names that match the entity types in the target sentence."},\n{"Example 16": 1},\n{"Reason 16": "The sentence does not contain any specific entity names that match the entity types in the target sentence."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any specific entity names that match the entity types in the target sentence."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any specific entity names that match the entity types in the target sentence."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any specific entity names that match the entity types in the target sentence."},\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any specific entity names that match the entity types in the target sentence."},\n{"Example 21": 1},\n{"Reason 21": "The sentence does not contain any specific entity names that match the entity types in the target sentence."},\n{"Example 22": 1},\n{"Reason 22": "The sentence does not contain any specific entity names that match the entity types in the target sentence."},\n{"Example 23": 1},\n{"Reason 23": "The sentence does not contain any specific entity names that match the entity types in the target sentence."},\n{"Example 24": 1},\n{"Reason 24": "The sentence does not contain any specific entity names that match the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 676, 'sentence': 'The interleukin 2 ( IL-2 ) gene promoter is recognized by several cell-type-specific and ubiquitous transcriptional regulators that integrate information transmitted by various signaling systems leading to IL-2 production and T-cell activation .', 'label': {'IL-2': 'protein', 'interleukin 2': 'protein', 'interleukin 2 ( IL-2 ) gene promoter': 'DNA', 'T-cell': 'cell_type'}, 'response1': "['DNA', 'cell_type', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains a clear mention of the entity \'IL-2\' and its corresponding label \'protein\'."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains mentions of multiple entities such as \'IL-13\', \'IL-4\', \'B cell\', and \'monocyte\' with their corresponding labels."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence contains mentions of multiple entities such as \'IL4\', \'IL13\', \'STAT6\', \'STAT3\', \'STAT5\', and \'B cells\' with their corresponding labels."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains clear mentions of the entities \'IL-2\', \'Aiolos\', and \'Ras\' with their corresponding labels."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence contains mentions of entities \'NF-ATc\' and \'T lymphocytes\' with their corresponding labels."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains a clear mention of the entity \'IL-2\' and its corresponding label \'protein\'."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains mentions of multiple entities such as \'IFN A\', \'IFNA\', \'interleukin-2\', \'interleukin-2 receptor\', \'phytohemagglutinin\', and \'phorbol myristate acetate\' with their corresponding labels."},\n    {"Example 8": 4},\n    {"Reason 8": "The sentence contains mentions of entities \'interleukin 10\', \'IL-10R\', \'STAT3\', and \'IL-6\' with their corresponding labels."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence contains mentions of entities \'T cell\' and \'interleukin 2\' with their corresponding labels."},\n    {"Example 10": 4},\n    {"Reason 10": "The sentence contains mentions of entities \'IL-13\', \'IL-4R\', \'JAK2\', and \'IL-13R\' with their corresponding labels."},\n    {"Example 11": 4},\n    {"Reason 11": "The sentence contains mentions of entities \'IL-2\', \'c-Jun\', and \'c-Fos\' with their corresponding labels."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence contains mentions of entities \'IL-2 receptor alpha subunit\', \'p21ras\', and \'B cell\' with their corresponding labels."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence contains a mention of the entity \'Th2-type lymphocytes\' with its corresponding label."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence contains a mention of the entity \'IL-4\' with its corresponding label."},\n    {"Example 15": 4},\n    {"Reason 15": "The sentence contains mentions of entities \'IL-2\', \'IFN-gamma\', \'jak kinases\', and \'STAT1(alpha)\' with their corresponding labels."}\n]', 'response3': "[{'interleukin 2': 'protein'}, {'IL-2': 'protein'}, {'T-cell': 'cell_type'}]", 'prediction': {'interleukin 2': 'protein', 'IL-2': 'protein', 'T-cell': 'cell_type'}}
{'idx': 1052, 'sentence': 'Thus, after 4 hr of exposure to SEA and SEB , the expression of IL-2R beta was down-regulated, IL-2R gamma was slightly up-regulated, while IL-2R alpha remained largely unaffected.', 'label': {'IL-2R alpha': 'protein', 'SEA': 'protein', 'IL-2R gamma': 'protein', 'SEB': 'protein', 'IL-2R beta': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[{"IL-2R beta": "protein"}, {"IL-2R gamma": "protein"}, {"IL-2R alpha": "protein"}]', 'prediction': {'IL-2R beta': 'protein', 'IL-2R gamma': 'protein', 'IL-2R alpha': 'protein'}}
{'idx': 487, 'sentence': 'Therefore, in normal human monocytes M-CSF induces immediate early response genes without inducing cell proliferation.', 'label': {'human monocytes': 'cell_type', 'normal human monocytes': 'cell_type', 'M-CSF': 'protein', 'immediate early response genes': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."}\n]', 'response3': '[{"M-CSF": "protein"}]', 'prediction': {'M-CSF': 'protein'}}
{'idx': 570, 'sentence': 'Modulation of these events at the time of adherence offers a mechanism by which differential priming of the cells may be accomplished.', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.": 5},\n    {"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.": 5},\n    {"Yet, for many pathogens, the molecules that induce IL-12 production by macrophages and the mechanisms by which they do so remain undefined.": 4},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 4},\n    {"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.": 4},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 4},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1370, 'sentence': 'Although anti- CD28 MoAb costimulation enhances all of the above signals, NF kappa B and IL-2 levels remain lower than in adults , suggesting the need for further activation requirements in the neonate .', 'label': {'CD28': 'protein', 'anti- CD28 MoAb': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"NF kappa B": "protein"}, {"IL-2": "protein"}]', 'prediction': {'NF kappa B': 'protein', 'IL-2': 'protein'}}
{'idx': 994, 'sentence': 'The role of BSAP ( Pax-5 ) in B-cell development .', 'label': {'BSAP': 'protein', 'Pax-5': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Th1": 5, "Th2": 5},\n    {"SLAP-130": 5, "SLP-76": 5, "T cell": 5},\n    {"Sp1": 5, "Ets": 5},\n    {"UAS3": 5, "UAS2": 5, "YY1": 5},\n    {"CD70": 5, "B cell": 5, "plasma cells": 5, "IL-4": 5, "CD40": 5},\n    {"GATA-1": 5},\n    {"IL-13": 5, "IL-4": 5, "B cell": 5, "monocyte": 5},\n    {"IL-2": 5, "c-Jun": 5, "c-Fos": 5},\n    {"Th2-type lymphocytes": 5},\n    {"IL4": 5, "IL13": 5, "STAT6": 5, "STAT3": 5, "STAT5": 5, "B cells": 5},\n    {"lymphoid neoplasms": 5},\n    {"PML/RARalpha": 5},\n    {"GM-CSF": 5},\n    {"UAS1": 5, "B cell": 5},\n    {"T cell": 5, "interleukin 2": 5},\n    {"GATA-1": 5},\n    {"estrogen": 1, "progesterone": 1, "tumor size": 1, "polyamine concentrations": 1},\n    {"immune deficiency syndrome": 1},\n    {"alpha-herpesvirus": 1, "beta-herpesvirus": 1, "herpes simplex": 1, "cytomegalovirus": 1},\n    {"HIV-1": 1, "HIV-2": 1},\n    {"contraction": 1, "allele": 1},\n    {"B-cell": 1, "intrahepatic lymphoid follicles": 1, "chronic hepatitis C": 1},\n    {"lymphocyte infiltration": 1, "tumor": 1, "hormone metabolic status": 1, "tumor tissue hormone sensitivity": 1, "tobacco smoking": 1, "breast cancer patients": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3": 1, "VD": 1, "monocytic differentiation": 1, "leukemic cells": 1},\n    {"glucocorticoid action": 1, "megadoses": 1},\n    {"nucleotide 2,317": 1, "point mutation": 1, "isoleucine": 1, "valine": 1, "amino acid 729": 1}\n]', 'response3': '[{"BSAP": "protein"}, {"Pax-5": "protein"}, {"B-cell": "cell_type"}]', 'prediction': {'BSAP': 'protein', 'Pax-5': 'protein', 'B-cell': 'cell_type'}}
{'idx': 438, 'sentence': 'This sequence motif is a binding site for nuclear proteins , the so-called octamer transcription factors ( Oct or OTF factors ).', 'label': {'OTF factors': 'protein', 'nuclear proteins': 'protein', 'sequence motif': 'DNA', 'octamer transcription factors': 'protein', 'Oct': 'protein'}, 'response1': "['protein']", 'response2': '```json\n[\n    {\n        "The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .": 5\n    },\n    {\n        "Activated Stat proteins form homo- or heterodimers, translocate to the nucleus , and induce transcription from responsive genes.": 4\n    },\n    {\n        "We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .": 5\n    },\n    {\n        "The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 4\n    },\n    {\n        "The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .": 5\n    },\n    {\n        "A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 4\n    },\n    {\n        "Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5\n    },\n    {\n        "Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.": 5\n    },\n    {\n        "Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50 .": 5\n    },\n    {\n        "Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.": 4\n    },\n    {\n        "The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .": 4\n    },\n    {\n        "Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 5\n    },\n    {\n        "Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 5\n    },\n    {\n        "The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .": 5\n    },\n    {\n        "Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .": 5\n    },\n    {\n        "The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .": 5\n    },\n    {\n        "No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1\n    },\n    {\n        "This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1\n    },\n    {\n        "This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1\n    },\n    {\n        "These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1\n    },\n    {\n        "One contraction generated an allele in an intermediate size range (33-39 repeats).": 1\n    },\n    {\n        "Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1\n    },\n    {\n        "Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1\n    },\n    {\n        "1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1\n    },\n    {\n        "The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1\n    },\n    {\n        "At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1\n    }\n]\n```', 'response3': '```json\n[]\n```', 'prediction': {}}
{'idx': 270, 'sentence': 'There was evidence for an autosomal recessive form of inheritance in four families, while the other four families appeared to have an autosomal dominant mode of transmission .', 'label': {}, 'response1': "['DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains clear mentions of specific entities like \'lymphoid neoplasms\' which can be directly mapped to the \'cell_type\' entity label."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides explicit mentions of entities like \'NF-ATc\', \'T lymphocytes\', and \'embryonic cardiac cells\' which can be easily associated with the \'protein\' and \'cell_type\' entity labels."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly refers to \'E2A\' at the protein level, making it highly relevant for the \'protein\' entity label extraction."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence mentions \'A-myb\' in the context of a transcription factor, indicating a strong association with the \'protein\' entity label."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains multiple mentions of proteins like \'IFN A\', \'interleukin-2\', and \'interleukin-2 receptor\' along with stimuli like \'phytohemagglutinin\' and \'phorbol myristate acetate\', making it very helpful for \'protein\' entity extraction."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence explicitly mentions \'PBMC\' and \'adenovirus DNA\', providing clear references to the \'cell_type\' and \'DNA\' entity labels."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence talks about \'SIVsmmPBj14\' in the context of mutations and phenotype, indicating a strong connection to the \'cell_line\' entity label."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence directly discusses \'AP-1 DNA binding activity\' in lymphocytes, making it highly relevant for the \'DNA\' entity label extraction."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence mentions \'IgH genes\' and \'switch regions\' in the context of transcription, indicating a strong association with the \'DNA\' entity label."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides information about the expression of \'RXR\' and its mutants in the context of erythroid cells, making it highly relevant for the \'protein\' entity label extraction."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence discusses the role of \'NF-kappaB\' in the pathogenesis of rheumatoid arthritis, linking it to the \'protein\' entity label along with \'rheumatoid arthritis\' as a \'cell_type\' entity."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence examines the regulatory mechanism of \'SCM-1 genes\', indicating a strong connection to the \'cell_line\' entity label."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence investigates the effect of \'IVS1-10T-->C\' on \'BRCA1 splicing or expression\', making it highly relevant for the \'protein\' entity label extraction."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions \'GATA-1\' in the context of erythroid cells, indicating a strong association with the \'protein\' entity label."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence discusses the control of \'NF-kappa B\' on \'I kappa B alpha\' expression, making it highly relevant for the \'protein\' entity label extraction."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence shows \'WT1\' expression in non-cultured peripheral lymphocytes, providing a clear reference to the \'protein\' entity label."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entities related to the given entity labels, making it least helpful for named entity extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific entities related to the given entity labels, making it least helpful for named entity extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific entities related to the given entity labels, making it least helpful for named entity extraction."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any specific entities related to the given entity labels, making it least helpful for named entity extraction."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any specific entities related to the given entity labels, making it least helpful for named entity extraction."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any specific entities related to the given entity labels, making it least helpful for named entity extraction."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any specific entities related to the given entity labels, making it least helpful for named entity extraction."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any specific entities related to the given entity labels, making it least helpful for named entity extraction."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any specific entities related to the given entity labels, making it least helpful for named entity extraction."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1481, 'sentence': 'We, therefore, propose the activation scheme presented in FIGURE 3 for T-cell costimulation .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1807, 'sentence': 'We show that the expression of four cell genes , cdc-2 , cyclin E , CD23 , and cyclin D2 , are up-regulated approximately 100-fold as a result of EBV -mediated immortalization .', 'label': {'cell genes': 'DNA', 'cyclin E': 'DNA', 'cyclin D2': 'DNA', 'CD23': 'DNA', 'cdc-2': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .": 4},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .": 5},\n    {"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB .": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .": 5},\n    {"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .": 5}\n]', 'response3': '[{"cdc-2": "protein"}, {"cyclin E": "protein"}, {"CD23": "protein"}, {"cyclin D2": "protein"}, {"EBV": "cell_line"}]', 'prediction': {'cdc-2': 'protein', 'cyclin E': 'protein', 'CD23': 'protein', 'cyclin D2': 'protein', 'EBV': 'cell_line'}}
{'idx': 1169, 'sentence': 'However, B4-2 has an unusually high proline content (13%), contains a putative nuclear targeting sequence , and has several SPXX motifs which are frequently found in gene regulatory proteins .', 'label': {'SPXX motifs': 'protein', 'nuclear targeting sequence': 'protein', 'gene regulatory proteins': 'protein', 'B4-2': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n    {"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 5},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .": 5},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50 .": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .": 5},\n    {"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .": 5},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines .": 5},\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .": 5},\n    {"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .": 5}\n]', 'response3': '[{"B4-2": "protein"}]', 'prediction': {'B4-2': 'protein'}}
{'idx': 1180, 'sentence': 'We therefore propose that IL-2 receptor signal transduction does not depend on equimolar heterodimerization of JAK1 and JAK3 following IL-2 -induced heterodimerization of IL-2R beta and IL-2R gamma .', 'label': {'IL-2R': 'protein', 'IL-2': 'protein', 'IL-2R gamma': 'protein', 'JAK3': 'protein', 'IL-2 receptor': 'protein', 'JAK1': 'protein', 'IL-2R beta': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.": 5},\n{"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.": 5},\n{"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n{"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n{"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.": 5},\n{"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n{"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n{"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells, but not in primary T cells, consistent with the lack of the IL-12 receptor in resting T cells.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3, and STAT5 proteins in normal human B cells.": 5},\n{"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n{"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.": 5},\n{"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n{"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/thrombopoiesis or possibly a mature platelet function such as aggregation.": 5},\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n{"No correlation was found between estrogen and progesterone status, tumor size, and polyamine concentrations.": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity, and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"IL-2": "protein"}, {"JAK1": "protein"}, {"JAK3": "protein"}, {"IL-2R beta": "protein"}, {"IL-2R gamma": "protein"}]', 'prediction': {'IL-2': 'protein', 'JAK1': 'protein', 'JAK3': 'protein', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein'}}
{'idx': 968, 'sentence': 'These observations demonstrate directly that there is de novo synthesis of NF-kappa B during human lymphocyte activation and suggest that this process is hormonally regulated.', 'label': {'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"human lymphocyte": "cell_type"}]', 'prediction': {'NF-kappa B': 'protein', 'human lymphocyte': 'cell_type'}}
{'idx': 497, 'sentence': 'The differentiation of T cells into functionally diverse subpopulations is controlled in part, by transcriptional activation and silencing ; however, little is known in detail about the proteins that influence this developmental process .', 'label': {'T cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"During normal T-cell activation": 3},\n    {"IkappaBalpha is rapidly phosphorylated": 4},\n    {"ubiquitinated": 4},\n    {"NF-kappaB": 4},\n    {"In this paper": 1},\n    {"GATA-1": 4},\n    {"eosinophil differentiation": 3},\n    {"Multiple NF-ATc isoforms": 3},\n    {"T lymphocytes": 3},\n    {"NF-ATc": 4},\n    {"IL-4 gene expression": 3},\n    {"IL-4": 4},\n    {"Th1 and Th2 effector functions": 3},\n    {"Th1": 4},\n    {"Th2": 4},\n    {"NF-ATc": 4},\n    {"GATA-1": 4},\n    {"Sp1- and Ets- related transcription factors": 4},\n    {"CTL-specific expression of the mouse perforin gene": 3},\n    {"Sp1": 4},\n    {"Ets": 4},\n    {"human peripheral blood T cells": 3},\n    {"TCR": 3},\n    {"IL-2": 4},\n    {"IFN-gamma": 4},\n    {"jak kinases": 4},\n    {"STAT1(alpha)": 4},\n    {"immunohistochemistry": 4},\n    {"gene": 3},\n    {"cell type": 3},\n    {"phorbol esters": 1},\n    {"NF-E2": 4},\n    {"IgH genes": 3},\n    {"IgH": 4},\n    {"CD70 transfectants": 3},\n    {"B cell": 3},\n    {"plasma cells": 3},\n    {"IL-4": 4},\n    {"CD40 signaling": 3},\n    {"Th2-type lymphocytes": 4},\n    {"NF-kappaB": 4},\n    {"Tax": 3},\n    {"ATL": 3},\n    {"B and T cell activation": 4},\n    {"Ramos": 3},\n    {"Jurkat": 3},\n    {"cDNA microarray technology": 3}\n]', 'response3': '[{"T cells": "cell_type"}]', 'prediction': {'T cells': 'cell_type'}}
{'idx': 1606, 'sentence': 'Triggering of complement receptors CR1 ( CD35 ) and CR3 ( CD11b/CD18 ) induces nuclear translocation of NF-kappa B ( p50/p65 ) in human monocytes and enhances viral replication in HIV-infected monocytic cells .', 'label': {'CD11b/CD18': 'protein', 'CD35': 'protein', 'p50/p65': 'protein', 'CR1': 'protein', 'HIV-infected monocytic cells': 'cell_type', 'complement receptors': 'protein', 'human monocytes': 'cell_type', 'NF-kappa B': 'protein', 'CR3': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 4},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"CD40 expression could be enhanced in CD40-positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n    {"Murine macrophage inflammatory protein 1 alpha (MIP-1 alpha) and its human equivalent (GOS19, LD78, or AT464) are members of the -C-C family of low-molecular-weight chemokines.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"CR1": "protein"}, {"CD35": "protein"}, {"CR3": "protein"}, {"CD11b/CD18": "protein"}, {"NF-kappa B": "protein"}, {"p50/p65": "protein"}, {"monocytes": "cell_type"}, {"HIV-infected monocytic cells": "cell_type"}]', 'prediction': {'CR1': 'protein', 'CD35': 'protein', 'CR3': 'protein', 'CD11b/CD18': 'protein', 'NF-kappa B': 'protein', 'p50/p65': 'protein', 'monocytes': 'cell_type', 'HIV-infected monocytic cells': 'cell_type'}}
{'idx': 1653, 'sentence': 'Expression of PU.1 in nonmyeloid cells can activate the GM-CSF receptor alpha promoter .', 'label': {'nonmyeloid cells': 'cell_type', 'GM-CSF': 'protein', 'PU.1': 'protein', 'GM-CSF receptor alpha promoter': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.": 5},\n    {"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"PMA induced the expression of both CD14 and CD23 mRNA and protein.": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n    {"To evaluate the PML/RARalpha role in myelopoiesis, transgenic mice expressing PML/RARalpha were engineered.": 5},\n    {"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"Murine macrophage inflammatory protein 1 alpha (MIP-1 alpha) and its human equivalent (GOS19, LD78, or AT464) are members of the -C-C family of low-molecular-weight chemokines.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"PU.1": "protein"}, {"GM-CSF receptor alpha": "protein"}]', 'prediction': {'PU.1': 'protein', 'GM-CSF receptor alpha': 'protein'}}
{'idx': 833, 'sentence': 'Mapping of B-cell epitopes of the human hepatitis B virus X protein .', 'label': {'human hepatitis B virus X protein': 'protein', 'B-cell epitopes': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 1},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"B-cell": "cell_type"}, {"hepatitis B virus X protein": "protein"}]', 'prediction': {'B-cell': 'cell_type', 'hepatitis B virus X protein': 'protein'}}
{'idx': 389, 'sentence': 'The predicted periplasmic domain of the PhoQ protein contained a markedly anionic domain that could interact with cationic proteins and that could be responsible for resistance to defensin .', 'label': {'periplasmic domain': 'protein', 'PhoQ protein': 'protein', 'cationic proteins': 'protein', 'defensin': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"PhoQ": "protein"}, {"defensin": "protein"}]', 'prediction': {'PhoQ': 'protein', 'defensin': 'protein'}}
{'idx': 193, 'sentence': 'The calcium ionophore-induced c-myc suppression , however, strictly requires de novo protein synthesis .', 'label': {'c-myc': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"1": "The entities mentioned in the sentence do not match the entity labels provided."},\n    {"1": "The entities mentioned in the sentence do not match the entity labels provided."},\n    {"1": "The entities mentioned in the sentence do not match the entity labels provided."},\n    {"1": "The entities mentioned in the sentence do not match the entity labels provided."},\n    {"1": "The entities mentioned in the sentence do not match the entity labels provided."},\n    {"1": "The entities mentioned in the sentence do not match the entity labels provided."},\n    {"1": "The entities mentioned in the sentence do not match the entity labels provided."},\n    {"1": "The entities mentioned in the sentence do not match the entity labels provided."},\n    {"1": "The entities mentioned in the sentence do not match the entity labels provided."},\n    {"1": "The entities mentioned in the sentence do not match the entity labels provided."},\n    {"1": "The entities mentioned in the sentence do not match the entity labels provided."},\n    {"1": "The entities mentioned in the sentence do not match the entity labels provided."},\n    {"1": "The entities mentioned in the sentence do not match the entity labels provided."},\n    {"1": "The entities mentioned in the sentence do not match the entity labels provided."},\n    {"1": "The entities mentioned in the sentence do not match the entity labels provided."},\n    {"1": "The entities mentioned in the sentence do not match the entity labels provided."},\n    {"1": "The entities mentioned in the sentence do not match the entity labels provided."},\n    {"1": "The entities mentioned in the sentence do not match the entity labels provided."},\n    {"1": "The entities mentioned in the sentence do not match the entity labels provided."},\n    {"1": "The entities mentioned in the sentence do not match the entity labels provided."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1349, 'sentence': 'Its expression was always restricted to the nucleus .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a specific gene/protein name and its corresponding entity label, which directly aids in extracting named entities from the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 882, 'sentence': 'This cDNA clone was isolated by expression cDNA cloning , and encodes the human c-Jun protein , which together with c-Fos forms the heterodimeric activator protein-1 transcription complex .', 'label': {'c-Jun': 'protein', 'heterodimeric activator protein-1 transcription complex': 'protein', 'c-Fos': 'protein', 'cDNA': 'DNA', 'human c-Jun protein': 'protein', 'cDNA clone': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"cDNA": "DNA"}, {"c-Jun": "protein"}, {"c-Fos": "protein"}]', 'prediction': {'cDNA': 'DNA', 'c-Jun': 'protein', 'c-Fos': 'protein'}}
{'idx': 725, 'sentence': 'Rex acts posttranscriptionally to facilitate accumulation of full-length gag/pol and singly spliced env mRNA in the cytoplasm of HTLV-infected cells .', 'label': {'Rex': 'protein', 'HTLV-infected cells': 'cell_type', 'gag/pol': 'protein', 'env mRNA': 'RNA'}, 'response1': "['RNA', 'protein']", 'response2': '[\n{"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.": 5},\n{"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n{"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.": 5},\n{"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .": 5},\n{"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .": 4},\n{"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .": 5},\n{"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 5},\n{"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n{"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .": 5},\n{"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .": 4},\n{"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .": 5},\n{"Expression of either the TCL1 oncogene , or transcripts from its homologue MTCP1/c6.1B , in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients .": 5},\n{"Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype .": 5},\n{"Finally, despite impaired Rel-A translocation , T cells were capable of transcribing IL-2 .": 5},\n{"Extracts prepared from XP-B and XP-D lymphoblastoid cells exhibited similar transcription activity from the adenovirus major late promoter when compared to that in extracts from normal cells.": 4},\n{"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[{"gag/pol": "protein"}, {"env mRNA": "RNA"}, {"HTLV-infected cells": "cell_type"}]', 'prediction': {'gag/pol': 'protein', 'env mRNA': 'RNA', 'HTLV-infected cells': 'cell_type'}}
{'idx': 867, 'sentence': 'In HIV-1 , the sequences that respond to these signaling events are found in the long terminal repeat ( LTR ) and comprise the transcriptional enhancer , which contains two conserved binding sites for the nuclear factor kappa B ( NF kappa B ).', 'label': {'conserved binding sites': 'DNA', 'nuclear factor kappa B': 'protein', 'long terminal repeat': 'DNA', 'LTR': 'DNA', 'NF kappa B': 'protein', 'transcriptional enhancer': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 4},\n    {"Example 4": 5},\n    {"Example 5": 4},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 1},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1}\n]', 'response3': '[{"HIV-1": "cell_type"}, {"long terminal repeat ( LTR )": "DNA"}, {"nuclear factor kappa B ( NF kappa B )": "protein"}]', 'prediction': {'HIV-1': 'cell_type', 'long terminal repeat ( LTR )': 'DNA', 'nuclear factor kappa B ( NF kappa B )': 'protein'}}
{'idx': 841, 'sentence': 'Such tests may become useful diagnostic tools .', 'label': {}, 'response1': 'None.', 'response2': '[\n{"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n{"In addition, assay of PBMC by the adenovirus -specific PCR may help detect early invasive disease and warrants further evaluation.": 4},\n{"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 4},\n{"In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine ( IFN-gamma ) in combination with allergy-driven overproduction of T helper 2-type cytokines.": 3},\n{"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 3},\n{"Thus, STAT1 may be a useful target in the development of new immunosuppressive and antineoplastic agents.": 4},\n{"Additionally, mutated Ras can also serve as a primary target for the development of immunotherapy or drug therapy.": 4},\n{"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n{"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 4},\n{"Here we examined the regulatory mechanism of the SCM-1 genes.": 5},\n{"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 5},\n{"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.": 4},\n{"By the time of diagnosis of T-PLL, the clone contains many more genetic changes in the form of additional translocations.": 4},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n{"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 3},\n{"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 956, 'sentence': 'BSAP : a key regulator of B-cell development and differentiation .', 'label': {'BSAP': 'protein', 'B-cell': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a specific protein entity (NF-E2) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The example provides specific cell types (EBV and B-cell) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides specific proteins (CD70, IL-4, CD40, Syk, Zap) and cell types (B cell, plasma cells) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The example provides a specific cell type (Th2-type lymphocytes) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides a specific protein entity (GATA-1) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The example provides specific proteins (Syk, Zap) and a cell type (T cell) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides specific cell types (Th1, Th2) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides specific cell type (T cell) and protein entity (interleukin 2) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides a specific protein entity (IL-2) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides a specific DNA entity (AP-1) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides specific proteins (IL-2, c-Jun, c-Fos) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The example provides specific DNA entities (UAS3, UAS2) and a protein entity (YY1) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides specific protein entities (SCL, GATA-1) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The example provides specific proteins (IL-2, NF-kappa B, AP-1) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 15": 5},\n    {"Reason 15": "The example provides specific proteins (IL4, IL13, STAT6, STAT3, STAT5) and a cell type (B cells) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 16": 5},\n    {"Reason 16": "The example provides a specific protein entity (STAT1) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities from the given label set, making the example not helpful for extracting named entities."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities from the given label set, making the example not helpful for extracting named entities."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities from the given label set, making the example not helpful for extracting named entities."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities from the given label set, making the example not helpful for extracting named entities."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities from the given label set, making the example not helpful for extracting named entities."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities from the given label set, making the example not helpful for extracting named entities."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities from the given label set, making the example not helpful for extracting named entities."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities from the given label set, making the example not helpful for extracting named entities."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities from the given label set, making the example not helpful for extracting named entities."}\n]', 'response3': '[{"B-cell": "cell_type"}, {"BSAP": "protein"}]', 'prediction': {'B-cell': 'cell_type', 'BSAP': 'protein'}}
{'idx': 1769, 'sentence': 'We have tried to find out whether these receptors could show any difference in sex or age distribution.', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 1},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 110, 'sentence': 'Electrophoretic mobility shift assays and Southwestern blotting experiments were used to detect the binding of cellular transactivation factor NF-KB to the double repeat-KB enhancer sequence located in the long terminal repeat .', 'label': {'long terminal repeat': 'DNA', 'NF-KB': 'protein', 'double repeat-KB enhancer sequence': 'DNA', 'cellular transactivation factor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of proteins (IL-4, LPS, AP-1) which are directly mentioned and can be easily identified as protein entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of proteins (NF-kappaB, Sp1, p50) which are directly mentioned and can be easily identified as protein entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of proteins (NF-kappaB, Tax) and cell types (ATL) which are directly mentioned and can be identified as protein and cell type entities, respectively."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains an example of a protein (NF-kappa B) which is directly mentioned and can be identified as a protein entity."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins (NF-kappa B, I kappa B alpha) which are directly mentioned and can be easily identified as protein entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins (EKLF, CBP, p300, P/CAF) which are directly mentioned and can be easily identified as protein entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins (CD40, NF-kappa B) which are directly mentioned and can be easily identified as protein entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins (NF-kappa B, I kappa B alpha) which are directly mentioned and can be easily identified as protein entities."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains examples of a cell type (T cell) and a protein (interleukin 2) which are directly mentioned and can be identified as cell type and protein entities, respectively."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains an example of a protein (NF-kappa B) which is directly mentioned and can be identified as a protein entity."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins (PAFR, PAF, NF-kappa B, protein kinase C) which are directly mentioned and can be easily identified as protein entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins (RelA, NF-kappa B) which are directly mentioned and can be easily identified as protein entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins (IL-2, c-Jun, c-Fos) which are directly mentioned and can be easily identified as protein entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of a protein (NF-kappaB) and a cell type (rheumatoid arthritis) which are directly mentioned and can be identified as protein and cell type entities, respectively."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains examples of proteins (TRAF6, RANKL, NF-kappaB) which are directly mentioned and can be easily identified as protein entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity labels provided in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity labels provided in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity labels provided in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity labels provided in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity labels provided in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity labels provided in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity labels provided in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity labels provided in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity labels provided in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity labels provided in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity labels provided in the target sentence."}\n]', 'response3': '[{"NF-KB": "protein"}]', 'prediction': {'NF-KB': 'protein'}}
{'idx': 1379, 'sentence': 'Deregulation of TCL1 is the first event in the initiation of malignancy in these types of leukemias and represents a potential tool for clinical evaluation .', 'label': {'TCL1': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"IkappaBbeta": 5},\n    {"NF-kappaB": 5},\n    {"AP-1": 5},\n    {"WT1": 4},\n    {"myeloid cell lines": 4},\n    {"myeloperoxidase": 5},\n    {"lysozyme": 5},\n    {"PU.1": 5},\n    {"IL-2 receptor alpha subunit": 5},\n    {"p21ras": 5},\n    {"B cell": 5},\n    {"MNDA": 5},\n    {"Philadelphia chromosome-positive chronic myeloid leukemia": 5},\n    {"SCM-1": 5},\n    {"IL-13": 5},\n    {"IL-4R": 5},\n    {"JAK2": 5},\n    {"IL-13R": 5},\n    {"STAT1": 5},\n    {"SCL": 5},\n    {"GATA-1": 5},\n    {"PML/RARalpha": 5},\n    {"TCRzeta": 5},\n    {"p56(lck)": 5},\n    {"lymphoid neoplasms": 5},\n    {"CD28": 5},\n    {"CD80": 5},\n    {"CD86": 5},\n    {"CBL": 5},\n    {"VAV": 5},\n    {"NFAT": 5},\n    {"interleukin-2": 5},\n    {"granulocyte-macrophage colony-stimulating factor": 5},\n    {"GATA-1": 5},\n    {"NF-kappaB": 5},\n    {"Tax": 4},\n    {"ATL": 4}\n]', 'response3': '[{"TCL1": "protein"}]', 'prediction': {'TCL1': 'protein'}}
{'idx': 1338, 'sentence': 'The survival-promoting activity of the Bcl-2 family of proteins appears to be modulated by interactions between various cellular proteins .', 'label': {'Bcl-2 family': 'protein', 'cellular proteins': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "Both NF-kappa B and I kappa B alpha are mentioned in the sentence, and their entity labels are correctly identified as \'protein\'"},\n    {"Example 2": 4},\n    {"Reason 2": "TIMP-1 and DNA are correctly identified as \'protein\' and \'DNA\' entities, respectively, which are relevant to the target sentence"},\n    {"Example 3": 5},\n    {"Reason 3": "Both NF-kappa B and I kappa B alpha are correctly identified as \'protein\' entities, which are directly related to the sentence"},\n    {"Example 4": 5},\n    {"Reason 4": "NF-kappa B is correctly identified as a \'protein\' entity, which is directly relevant to the sentence"},\n    {"Example 5": 5},\n    {"Reason 5": "SP1, caspases, and B-cell are correctly identified as \'protein\' and \'cell_type\' entities, which are directly related to the sentence"}\n]', 'response3': '[{"Bcl-2": "protein"}]', 'prediction': {'Bcl-2': 'protein'}}
{'idx': 1323, 'sentence': 'PRE-I forms multiple DNA-protein complexes with nuclear extracts from Jurkat cells .', 'label': {'PRE-I': 'DNA', 'Jurkat cells': 'cell_line', 'multiple DNA-protein complexes': 'protein'}, 'response1': "['DNA', 'protein', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"PRE-I": "protein"}, {"DNA": "DNA"}, {"Jurkat cells": "cell_line"}]', 'prediction': {'PRE-I': 'protein', 'DNA': 'DNA', 'Jurkat cells': 'cell_line'}}
{'idx': 1309, 'sentence': 'Proteins in the first group contain multiple HMG boxes , are non-sequence-specific , and recognize structural features as found in cruciform DNA and cross-over DNA .', 'label': {'cruciform DNA': 'DNA', 'HMG boxes': 'protein', 'cross-over DNA': 'DNA'}, 'response1': "['protein', 'DNA']", 'response2': '[\n{"p50p50": 5},\n{"protein": 4},\n{"DNA": 4},\n{"NF-ATc": 4},\n{"T lymphocytes": 4},\n{"GM-CSF": 4},\n{"cDNAs": 3},\n{"IgH": 3},\n{"IL-2": 4},\n{"c-Jun": 4},\n{"c-Fos": 4},\n{"Stat proteins": 4},\n{"immunohistochemistry": 3},\n{"gene": 3},\n{"cell type": 3},\n{"Th2-type lymphocytes": 4},\n{"GM-kappa B": 3},\n{"GC-box": 3},\n{"GC-motif": 3},\n{"GM-kappa B motif": 3},\n{"p50": 4},\n{"p65": 4},\n{"HIV-1 LTR": 4},\n{"NFAT-1": 4},\n{"NF kappa B": 4},\n{"SIVmac": 4},\n{"NF-kappaB": 4},\n{"Sp1": 4},\n{"cell_line": 3}\n]', 'response3': '[{"HMG boxes": "protein"}, {"DNA": "DNA"}]', 'prediction': {'HMG boxes': 'protein', 'DNA': 'DNA'}}
{'idx': 228, 'sentence': 'We have carried out experiments to define the nature of the higher affinity CVZ binding site .', 'label': {'higher affinity CVZ binding site': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 1},\n{"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .": 5},\n{"The effects of G-CSF are mediated by binding to specific, high affinity receptors .": 5},\n{"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements .": 5},\n{"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 5},\n{"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 5},\n{"Here we examined the regulatory mechanism of the SCM-1 genes .": 5},\n{"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules .": 5},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n{"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .": 5},\n{"Therefore, we investigated whether IVS1-10T-->C deleteriously affected BRCA1 splicing or expression, and thereby inactivated the other BRCA1 allele .": 5},\n{"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .": 5},\n{"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .": 5},\n{"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .": 5},\n{"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .": 5},\n{"This protein has now been purified and its encoding gene cloned.": 5},\n{"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 51, 'sentence': 'Such segments accord well with empirically known T-cell determinants and our algorithm produces a lower number of false positive predictions than the principle based on discrete Fourier transformations previously described.', 'label': {'T-cell determinants': 'protein'}, 'response1': "['cell_type']", 'response2': '[\n{"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n{"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n{"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 4},\n{"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.": 5},\n{"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n{"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 5},\n{"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n{"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 5},\n{"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 5},\n{"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.": 5},\n{"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n{"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 5},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n{"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1518, 'sentence': 'Anti-immunoglobulin M activates nuclear calcium/calmodulin-dependent protein kinase II in human B lymphocytes .', 'label': {'nuclear calcium/calmodulin-dependent protein kinase II': 'protein', 'human B lymphocytes': 'cell_type', 'Anti-immunoglobulin M': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"IL-13 , a cytokine similar to IL-4 , is a regulator of human B cell and monocyte functions .": 5},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 5},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 5},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .": 5},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.": 5},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[{"calcium/calmodulin-dependent protein kinase II": "protein"}, {"B lymphocytes": "cell_type"}]', 'prediction': {'calcium/calmodulin-dependent protein kinase II': 'protein', 'B lymphocytes': 'cell_type'}}
{'idx': 563, 'sentence': 'The 6-h increase in PDGF(B) mRNA was adherence dependent, and in addition, was abrogated when the cytoskeletal integrity was compromised by cytochalasin D .', 'label': {'PDGF(B)': 'protein', 'PDGF(B) mRNA': 'RNA'}, 'response1': "['RNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence directly mentions the entity \'DNA\' and provides clear context for its presence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence directly mentions the entity \'RNA\' and provides clear context for its presence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains multiple mentions of protein-related entities and provides clear context for their presence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence mentions both \'TIMP-1\' and \'DNA\' with clear context for their presence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence mentions \'IL-2\', \'c-Jun\', and \'c-Fos\' as protein-related entities with clear context for their presence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions \'MNDA\' as RNA and \'myeloid cell lines\' as cell_line with clear context for their presence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence mentions \'NF-kappa B\' as DNA with clear context for its presence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions \'CD14\' as a protein with clear context for its presence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence mentions multiple protein-related entities and cell lines with clear context for their presence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions \'P selectin\' as a protein with clear context for its presence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions \'CD14\' and \'CD23\' as proteins with clear context for their presence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions \'p21(WAF1/CIP1)\' and \'p27(KIP1)\' as proteins with clear context for their presence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions \'cell adhesion molecules\' as cell_type with clear context for its presence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions multiple protein-related entities, B cells, and plasma cells with clear context for their presence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions multiple protein-related entities, cell lines, and proteins with clear context for their presence."}\n]', 'response3': '[{"PDGF(B)": "RNA"}, {"cytochalasin D": "protein"}]', 'prediction': {'PDGF(B)': 'RNA', 'cytochalasin D': 'protein'}}
{'idx': 501, 'sentence': 'Southwestern and gel renaturation experiments with the use of purified protein fractions revealed that TCF-1 alpha activity is derived from a family of 57- to 53-kD proteins that are abundantly expressed in mature and immature T-cell lines ( Jurkat , CCRF-CEM ) and not in mature B cells ( JY , Namalwa ) or nonlymphoid (HeLa) cell lines .', 'label': {'CCRF-CEM': 'cell_line', 'TCF-1 alpha': 'protein', 'nonlymphoid (HeLa) cell lines': 'cell_line', 'mature B cells': 'cell_line', 'JY': 'cell_line', 'Namalwa': 'cell_line', '57- to 53-kD proteins': 'protein', 'Jurkat': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n    {"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5}\n]', 'response3': '[{"TCF-1 alpha": "protein"}, {"57- to 53-kD proteins": "protein"}, {"Jurkat": "cell_line"}, {"CCRF-CEM": "cell_line"}, {"JY": "cell_line"}, {"Namalwa": "cell_line"}, {"HeLa": "cell_line"}]', 'prediction': {'TCF-1 alpha': 'protein', '57- to 53-kD proteins': 'protein', 'Jurkat': 'cell_line', 'CCRF-CEM': 'cell_line', 'JY': 'cell_line', 'Namalwa': 'cell_line', 'HeLa': 'cell_line'}}
{'idx': 457, 'sentence': 'TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes .', 'label': {'T lymphocytes': 'cell_type', 'TAR': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 4},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 4},\n    {"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .": 5},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .": 5},\n    {"Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype .": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 285, 'sentence': 'ER content in lymphocytes of each sample was expressed by both fmol/mg of lymphocyte cytosolic protein and fmol/micrograms of lymphocyte DNA .', 'label': {'ER': 'protein', 'lymphocyte DNA': 'DNA', 'lymphocytes': 'cell_type', 'lymphocyte cytosolic protein': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 3},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .": 4},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 4},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 3},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 4},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .": 4},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 5},\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[{"lymphocyte cytosolic protein": "protein"}, {"lymphocyte DNA": "DNA"}]', 'prediction': {'lymphocyte cytosolic protein': 'protein', 'lymphocyte DNA': 'DNA'}}
{'idx': 1508, 'sentence': 'Functional characterization of the murine homolog of the B cell-specific coactivator BOB.1/OBF.1 .', 'label': {'BOB.1/OBF.1': 'protein', 'B cell-specific coactivator': 'protein', 'murine homolog': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and direct mention of the entity along with its corresponding label, aiding in the extraction process."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains specific mentions of entities along with their corresponding labels, making it highly helpful for named entity extraction."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly mentions the entity along with its label, facilitating the extraction process."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides a clear mention of the entity along with its label, aiding in the extraction process."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific mentions of entities along with their corresponding labels, making it highly helpful for named entity extraction."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides a clear mention of the entity along with its label, aiding in the extraction process."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific mentions of entities along with their corresponding labels, making it highly helpful for named entity extraction."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides a clear mention of the entity along with its label, aiding in the extraction process."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains specific mentions of entities along with their corresponding labels, making it highly helpful for named entity extraction."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides a clear mention of the entity along with its label, aiding in the extraction process."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides a clear mention of the entity along with its label, aiding in the extraction process."},\n    {"Example 12": 1},\n    {"Reason 12": "The sentence does not contain any specific mentions of entities corresponding to the given labels, hence not helpful for named entity extraction."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not contain any specific mentions of entities corresponding to the given labels, hence not helpful for named entity extraction."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not contain any specific mentions of entities corresponding to the given labels, hence not helpful for named entity extraction."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any specific mentions of entities corresponding to the given labels, hence not helpful for named entity extraction."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific mentions of entities corresponding to the given labels, hence not helpful for named entity extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific mentions of entities corresponding to the given labels, hence not helpful for named entity extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific mentions of entities corresponding to the given labels, hence not helpful for named entity extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific mentions of entities corresponding to the given labels, hence not helpful for named entity extraction."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any specific mentions of entities corresponding to the given labels, hence not helpful for named entity extraction."}\n]', 'response3': '[{"BOB.1/OBF.1": "protein"}]', 'prediction': {'BOB.1/OBF.1': 'protein'}}
{'idx': 209, 'sentence': 'Type-II estrogen -binding sites ( type-II EBS ) have been demonstrated in the human lymphoblastoid cell line IM-9 using a whole-cell assay with (6,7-3H) estradiol ( 3H-E2 ) as tracer.', 'label': {'lymphoblastoid cell line': 'cell_line', 'IM-9': 'cell_line', 'type-II EBS': 'protein', 'Type-II estrogen -binding sites': 'protein', 'human lymphoblastoid cell line': 'cell_line'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 4},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .": 3},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 3},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .": 4},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 4},\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .": 5},\n    {"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development .": 5},\n    {"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.": 5},\n    {"Expression of tal-1 and GATA-binding proteins during human hematopoiesis .": 4},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5}\n]', 'response3': '[{"IM-9": "cell_line"}, {"estradiol": "protein"}]', 'prediction': {'IM-9': 'cell_line', 'estradiol': 'protein'}}
{'idx': 1385, 'sentence': "Mutational analyses of the HIV-1 LTR showed that one C/EBP site is required for normal LTR transcription both before and after cellular activation and that the two 3' C/EBP sites are functionally equivalent.", 'label': {'LTR': 'DNA', 'HIV-1 LTR': 'DNA', 'C/EBP sites': 'DNA', 'C/EBP site': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 4},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF.": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5},\n    {"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB- induced trans-activation of the H4 promoter.": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 4},\n    {"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 4},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 4},\n    {"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process.": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[{"HIV-1 LTR": "DNA"}, {"C/EBP": "protein"}, {"3\' C/EBP": "protein"}]', 'prediction': {'HIV-1 LTR': 'DNA', 'C/EBP': 'protein', "3' C/EBP": 'protein'}}
{'idx': 1516, 'sentence': 'Fusion of subdomains of BOB.1/OBF.1 with the GAL4 DNA binding domain reveals that both NH2- and COOH- terminal domains of BOB.1/OBF.1 contribute to full transactivation function, the COOH-terminal domain is more efficient in this transactivation assay .', 'label': {'BOB.1/OBF.1': 'protein', 'GAL4 DNA binding domain': 'protein', 'COOH-terminal domain': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"BOB.1/OBF.1": "protein"}, {"GAL4 DNA binding domain": "DNA"}, {"NH2- terminal": "protein"}, {"COOH- terminal": "protein"}]', 'prediction': {'BOB.1/OBF.1': 'protein', 'GAL4 DNA binding domain': 'DNA', 'NH2- terminal': 'protein', 'COOH- terminal': 'protein'}}
{'idx': 1827, 'sentence': 'A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1 .', 'label': {'human interleukin 2 gene promoter': 'DNA', 'EGR-1': 'protein', 'Sp1': 'protein', 'regulatory element': 'DNA', 'binding site': 'DNA', 'zinc finger proteins': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"IgH": 5},\n    {"IL4": 5},\n    {"IL13": 5},\n    {"Th2-type lymphocytes": 5},\n    {"IL-2": 5},\n    {"IL-4": 5},\n    {"immunoglobulin kappa 3\' enhancer": 5},\n    {"interleukin 10": 5},\n    {"IL-13": 5},\n    {"GATA-1": 5},\n    {"Sp1": 5},\n    {"CD14": 5},\n    {"T cell": 5},\n    {"Egr-1": 5},\n    {"IL-2": 5},\n    {"NF-kappaB": 5},\n    {"IFN A": 5},\n    {"IFNA": 5}\n]', 'response3': '[{"interleukin 2": "protein"}, {"Sp1": "protein"}, {"EGR-1": "protein"}]', 'prediction': {'interleukin 2': 'protein', 'Sp1': 'protein', 'EGR-1': 'protein'}}
{'idx': 1116, 'sentence': 'The tumour suppressor p53 has been shown to regulate this type of apoptosis in thymocytes , but an as yet unknown, p53 -independent pathway (s) appears to mediate the same event in mitogen-activated mature T lymphocytes .', 'label': {'thymocytes': 'cell_type', 'p53': 'protein', 'mitogen-activated mature T lymphocytes': 'cell_line', 'tumour suppressor p53': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 5},\n{"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 5},\n{"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .": 4},\n{"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n{"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 4},\n{"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .": 5},\n{"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n{"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 4},\n{"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 4},\n{"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .": 5},\n{"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .": 5},\n{"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 5},\n{"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .": 5},\n{"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n{"The process of apoptosis is used to eliminate unwanted cells from a wide variety of organisms.": 4},\n{"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[{"p53": "protein"}, {"apoptosis": "cell_type"}, {"thymocytes": "cell_type"}, {"p53": "protein"}, {"mitogen-activated mature T lymphocytes": "cell_type"}]', 'prediction': {'p53': 'protein', 'apoptosis': 'cell_type', 'thymocytes': 'cell_type', 'mitogen-activated mature T lymphocytes': 'cell_type'}}
{'idx': 178, 'sentence': 'T lymphocytes appeared to be an important source of 1,25(OH)2D3 production , since purified T lymphocytes from all patients with tuberculosis produced 1,25(OH)2D3 , and 1,25(OH)2D3 production by these cells correlated closely with that produced by unseparated lavage cells .', 'label': {'T lymphocytes': 'cell_type', 'lavage cells': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence provides a clear example of a protein entity (TCL1) and its corresponding entity label."},\n{"Example 2": 4},\n{"Reason 2": "The sentence provides examples of cell types (granulocytes, T cells) and their corresponding entity labels."},\n{"Example 3": 5},\n{"Reason 3": "The sentence provides a clear example of a protein entity (CD14) and its corresponding entity label."},\n{"Example 4": 5},\n{"Reason 4": "The sentence provides multiple examples of protein entities (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) and their corresponding entity labels."},\n{"Example 5": 5},\n{"Reason 5": "The sentence provides a clear example of a protein entity (ZAP-70) and its corresponding entity label."},\n{"Example 6": 4},\n{"Reason 6": "The sentence provides examples of cell type (T lymphocytes) and protein entity (HLA-molecules) with their corresponding entity labels."},\n{"Example 7": 5},\n{"Reason 7": "The sentence provides examples of protein entity (NF-ATc) and cell type (T lymphocytes) with their corresponding entity labels."},\n{"Example 8": 4},\n{"Reason 8": "The sentence provides examples of protein entities (Oct-2A, HMG I/Y, HLA-DRA) and cell type (B cells) with their corresponding entity labels."},\n{"Example 9": 4},\n{"Reason 9": "The sentence provides examples of a cell line (EBV) and a protein entity (CD2) with their corresponding entity labels."},\n{"Example 10": 4},\n{"Reason 10": "The sentence provides an example of a cell type (Th2-type lymphocytes) with its corresponding entity label."},\n{"Example 11": 5},\n{"Reason 11": "The sentence provides examples of cell type (T cell), protein entities (IL-2, IL-2 receptor, CD28) with their corresponding entity labels."},\n{"Example 12": 5},\n{"Reason 12": "The sentence provides examples of protein entities (CD70, IL-4, CD40) and cell types (B cell, plasma cells) with their corresponding entity labels."},\n{"Example 13": 5},\n{"Reason 13": "The sentence provides examples of protein entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) with their corresponding entity labels."},\n{"Example 14": 5},\n{"Reason 14": "The sentence provides examples of protein entities (IL-2 receptor alpha subunit, p21ras) and a cell type (B cell) with their corresponding entity labels."},\n{"Example 15": 5},\n{"Reason 15": "The sentence provides examples of cell types (B and T cell activation), cell lines (Ramos, Jurkat), and a DNA entity (cDNA microarray technology) with their corresponding entity labels."},\n{"Example 16": 5},\n{"Reason 16": "The sentence provides examples of a DNA entity (2-deoxyguanosine), cell types (lymphoid progenitor cells, thymus stromal cells, B cell, fetal liver cells, T cell), and a cell line (tg epsilon26) with their corresponding entity labels."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any entities from the given entity label set."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any entities from the given entity label set."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any entities from the given entity label set."},\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any entities from the given entity label set."},\n{"Example 21": 1},\n{"Reason 21": "The sentence does not contain any entities from the given entity label set."},\n{"Example 22": 1},\n{"Reason 22": "The sentence does not contain any entities from the given entity label set."},\n{"Example 23": 1},\n{"Reason 23": "The sentence does not contain any entities from the given entity label set."},\n{"Example 24": 1},\n{"Reason 24": "The sentence does not contain any entities from the given entity label set."},\n{"Example 25": 1},\n{"Reason 25": "The sentence does not contain any entities from the given entity label set."}\n]', 'response3': "[{'T lymphocytes': 'cell_type'}, {'1,25(OH)2D3': 'protein'}, {'tuberculosis': 'cell_type'}, {'unseparated lavage cells': 'cell_line'}]", 'prediction': {'T lymphocytes': 'cell_type', '1,25(OH)2D3': 'protein', 'tuberculosis': 'cell_type', 'unseparated lavage cells': 'cell_line'}}
{'idx': 1209, 'sentence': 'A reduction of serum androgens was found, whereas no change was observed in either basal or GnRH-stimulated gonadotropins or in the cortisol and 17 alpha-hydroxyprogesterone response to ACTH .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 4},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .": 4},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .": 5},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 4},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .": 4},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"Interestingly, CTLA4Ig did not significantly inhibit the activation of either NF of activated T cells ( NFAT ) or AP-1 reporters .": 5},\n    {"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.": 5},\n    {"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator .": 5},\n    {"When 18C7 was incubated with MR before aldosterone or progesterone , the antibody inhibited 75-80% of the binding.": 5},\n    {"In apparent contradiction, expression of a dominant negative form of Ras , RasN17 , also inhibited IL-2 -induced activation of the promoter containing the minimal beta-casein STAT5 element as well as the promoters of CIS and OSM .": 5},\n    {"The number of Type I and Type II receptors before the test was lower in elderly subjects than in adults .": 3},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 5},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 864, 'sentence': 'Differences in transcriptional enhancers of HIV-1 and HIV-2 .', 'label': {'transcriptional enhancers': 'DNA'}, 'response1': "['DNA', 'RNA']", 'response2': '[\n    {"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 5},\n    {"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 3},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 3},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 4},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 4},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 4},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 4},\n    {"NF-E1 is encoded by the same gene as the YY-1 protein, which binds to the adeno-associated virus P5 promoter.": 4}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 65, 'sentence': 'Deletions upstream of the PRDII element increased transcription in the uninduced extract, indicating predominantly negative regulation of the promoter .', 'label': {'promoter': 'DNA', 'PRDII element': 'DNA'}, 'response1': "['DNA', 'RNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein entity (NF-E2) and its corresponding label."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains multiple protein entities (PU.1, M-CSF receptor) and a cell type entity (macrophage) with their corresponding labels."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence includes protein entity (EBNA2) and a cell line entity (TP1) with their corresponding labels."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence presents a protein entity (Egr-1) with its corresponding label."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides protein entities (Sp1, CD14) with their corresponding labels."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains multiple protein entities (PAFR, PAF, NF-kappa B, protein kinase C) with their corresponding labels."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence includes a cell line entity (SCM-1) with its corresponding label."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence presents protein entities (NF-kappa B, AP-1) with their corresponding labels."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides protein entities (IL-2, c-Jun, c-Fos) with their corresponding labels."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence includes a protein entity (GATA-1) with its corresponding label."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence presents a protein entity (IL-2) with its corresponding label."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains a cell type entity (T cell) and a protein entity (interleukin 2) with their corresponding labels."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides a DNA entity (immunoglobulin kappa 3\' enhancer) with its corresponding label."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence includes a DNA entity (DNA) with its corresponding label."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence presents a cell line entity (UAS1) and a cell type entity (B cell) with their corresponding labels."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence contains protein entities (YY1, Oct1, IL-5) and a cell type entity (T cells) with their corresponding labels."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities from the given label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities from the given label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities from the given label set."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities from the given label set."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities from the given label set."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities from the given label set."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities from the given label set."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities from the given label set."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities from the given label set."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 61, 'sentence': 'From HeLa cells , two major proteins of 52 and 45 kilodaltons (kD) copurified with DNA binding activity , whereas from T-cells , four proteins--a major protein of 52 kD and three minor proteins of 82 , 67 , and 43-47 kD --were purified.', 'label': {'82': 'protein', '43-47 kD': 'protein', 'major protein': 'protein', 'T-cells': 'cell_type', 'minor proteins': 'protein', '67': 'protein', 'HeLa cells': 'cell_line', '52 kD': 'protein'}, 'response1': "['protein', 'cell_line', 'DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"HeLa cells": "cell_line"}, {"T-cells": "cell_line"}, {"DNA": "DNA"}, {"proteins": "protein"}]', 'prediction': {'HeLa cells': 'cell_line', 'T-cells': 'cell_line', 'DNA': 'DNA', 'proteins': 'protein'}}
{'idx': 191, 'sentence': 'A block to RNA elongation is largely responsible for decreased c-myc transcription .', 'label': {'c-myc': 'DNA'}, 'response1': "['RNA']", 'response2': '[\n    {"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .": 5},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 5},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .": 5},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5}\n]', 'response3': '[{"RNA": "RNA"}, {"c-myc": "protein"}]', 'prediction': {'RNA': 'RNA', 'c-myc': 'protein'}}
{'idx': 447, 'sentence': 'Each binding site contributes to the overall activity of the enhancer , however no single element seems absolutely required for activity.', 'label': {'enhancer': 'DNA', 'binding site': 'DNA'}, 'response1': "['DNA']", 'response2': '[\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n    {"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 4},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"Nuclear factor NF-kB, activation protein 1 ( AP-1 ), OCT-1, and NF-IL-2B binding activity were normal.": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"We have found that the recruitment of EKLF to 5\'HS3 depends on the presence of 5\'HS2 in cis, but the recruitment to 5\'HS2 does not depend on 5\'HS3.": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 5},\n    {"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 476, 'sentence': 'A group of coordinately induced protooncogenes , cytoskeletal , and extracellular matrix genes have been termed immediate early response genes , and their induction has been associated with growth factor -stimulated cell proliferation .', 'label': {'protooncogenes': 'DNA', 'immediate early response genes': 'DNA', 'growth factor': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .": 5},\n    {"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 4},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n    {"The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 5},\n    {"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus , and induce transcription from responsive genes.": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1034, 'sentence': 'p94 and p95 share homology with Stat1 at the phosphorylation site and in the Src homology 2 (SH2) domain , but otherwise are immunologically distinct from Stat1 .', 'label': {'Stat1': 'protein', 'phosphorylation site': 'protein', 'Src homology 2 (SH2) domain': 'protein', 'p94': 'protein', 'p95': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin .": 4},\n    {"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns .": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Moreover, monocytes express a novel IL-10 -stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti- STAT3 Ab but is not observed in T cells .": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n    {"Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.": 4},\n    {"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .": 5},\n    {"Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .": 5},\n    {"The phosphorylated tyrosine residue itself is important for the protein-protein interaction .": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .": 5},\n    {"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines .": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .": 5},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .": 5}\n]', 'response3': '[{"p94": "protein"}, {"p95": "protein"}, {"Stat1": "protein"}]', 'prediction': {'p94': 'protein', 'p95': 'protein', 'Stat1': 'protein'}}
{'idx': 1232, 'sentence': 'IBR is a 503-amino-acid-long acidic protein which is 99.0% identical to the recently reported human NRF-1/alpha-Pal factor and highly related to the invertebrate transcription factors P3A2 and erected wing gene product ( EWG ).', 'label': {'IBR': 'protein', 'transcription factors': 'protein', 'erected wing gene product': 'protein', 'human NRF-1/alpha-Pal factor': 'protein', 'EWG': 'protein', 'P3A2': 'protein', '503-amino-acid-long acidic protein': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein (IL-4) and its corresponding entity label."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides a clear example of a protein (NF-E2) and its corresponding entity label."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence provides clear examples of proteins (IL-2, c-Jun, c-Fos) and their corresponding entity labels."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides a clear example of a protein (interferon regulatory factor) and its corresponding entity label."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides clear examples of proteins (EKLF, CBP, p300, P/CAF) and their corresponding entity labels."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides a clear example of a protein (A-myb) and its corresponding entity label."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides a clear example of a protein (Protein) and its corresponding entity label."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides clear examples of proteins (p21(WAF1/CIP1), p27(KIP1)) and their corresponding entity labels."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides clear examples of proteins (Drosophila Toll, human Toll) and their corresponding entity labels."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides clear examples of proteins (PAFR, PAF, NF-kappa B, protein kinase C) and their corresponding entity labels."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides clear examples of proteins (NF-kappa B, AP-1) and their corresponding entity labels."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides clear examples of proteins (EBNA-2, PU.1) and their corresponding entity labels."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides clear examples of a protein (NF-ATc) and cell types (T lymphocytes, embryonic cardiac cells) with their corresponding entity labels."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides a clear example of a DNA entity (immunoglobulin kappa 3\' enhancer) and its corresponding entity label."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides a clear example of a protein (Egr-1) and its corresponding entity label."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities from the given entity label set."}\n]', 'response3': '[{"IBR": "protein"}, {"NRF-1/alpha-Pal": "protein"}, {"P3A2": "protein"}, {"erected wing gene product (EWG)": "protein"}]', 'prediction': {'IBR': 'protein', 'NRF-1/alpha-Pal': 'protein', 'P3A2': 'protein', 'erected wing gene product (EWG)': 'protein'}}
{'idx': 54, 'sentence': 'Virus stocks obtained from these experiments exhibited a continuum of replicative capacities in different human T-cell types depending on which element (s) was present in the LTR .', 'label': {'LTR': 'DNA', 'human T-cell types': 'cell_type', 'T-cell types': 'cell_type', 'element': 'DNA'}, 'response1': "['cell_type']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence contains \'cDNAs\' which is a type of DNA, making it highly relevant for extracting named entities."},\n{"Example 2": 4},\n{"Reason 2": "The sentence mentions \'IL-2\' which is a protein, aiding in the extraction of named entities."},\n{"Example 3": 5},\n{"Reason 3": "The sentence includes various cell lines such as \'SIVmacMER\', \'SIVmac239\', and \'CEMx174\', making it very helpful for extracting named entities."},\n{"Example 4": 4},\n{"Reason 4": "The sentence refers to \'CD4+\' which is a type of cell, and \'EBV\' which is a protein, aiding in the extraction of named entities."},\n{"Example 5": 5},\n{"Reason 5": "The sentence contains multiple protein entities such as \'IFN A\', \'interleukin-2\', \'interleukin-2 receptor\', \'phytohemagglutinin\', and \'phorbol myristate acetate\', making it highly relevant for extracting named entities."},\n{"Example 6": 4},\n{"Reason 6": "The sentence mentions \'TIMP-1\' which is a protein, and \'DNA\', aiding in the extraction of named entities."},\n{"Example 7": 5},\n{"Reason 7": "The sentence includes \'Th2-type lymphocytes\' which is a type of cell, making it very helpful for extracting named entities."},\n{"Example 8": 4},\n{"Reason 8": "The sentence refers to \'EBV\' which is a cell line, and \'CD2\' which is a protein, aiding in the extraction of named entities."},\n{"Example 9": 5},\n{"Reason 9": "The sentence contains \'PBMC\' which is a type of cell, and \'adenovirus DNA\' which is DNA, making it highly relevant for extracting named entities."},\n{"Example 10": 5},\n{"Reason 10": "The sentence mentions \'SIVsmmPBj14\' which is a cell line, aiding in the extraction of named entities."},\n{"Example 11": 4},\n{"Reason 11": "The sentence includes \'CD95 ligand\' which is a protein, making it helpful for extracting named entities."},\n{"Example 12": 5},\n{"Reason 12": "The sentence contains \'HIV-1 LTR\' which is DNA, \'NFAT-1\' and \'NF kappa B\' which are proteins, making it highly relevant for extracting named entities."},\n{"Example 13": 5},\n{"Reason 13": "The sentence refers to \'EBV\' which is DNA, \'EBNA2\' and \'estrogen receptor\' which are proteins, aiding in the extraction of named entities."},\n{"Example 14": 4},\n{"Reason 14": "The sentence mentions \'TR55\' and \'TNF-alpha\' which are proteins, and \'HIV\' which is a cell type, making it helpful for extracting named entities."},\n{"Example 15": 5},\n{"Reason 15": "The sentence includes \'NF-kappaB\' and \'Sp1\' which are proteins, and \'SIVmac\' which is a cell line, making it highly relevant for extracting named entities."},\n{"Example 16": 1},\n{"Reason 16": "The sentence does not contain any named entities relevant to the given entity labels."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any named entities relevant to the given entity labels."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any named entities relevant to the given entity labels."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any named entities relevant to the given entity labels."},\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any named entities relevant to the given entity labels."},\n{"Example 21": 1},\n{"Reason 21": "The sentence does not contain any named entities relevant to the given entity labels."},\n{"Example 22": 1},\n{"Reason 22": "The sentence does not contain any named entities relevant to the given entity labels."},\n{"Example 23": 1},\n{"Reason 23": "The sentence does not contain any named entities relevant to the given entity labels."},\n{"Example 24": 1},\n{"Reason 24": "The sentence does not contain any named entities relevant to the given entity labels."},\n{"Example 25": 1},\n{"Reason 25": "The sentence does not contain any named entities relevant to the given entity labels."}\n]', 'response3': '[{"T-cell types": "cell_type"}, {"LTR": "DNA"}]', 'prediction': {'T-cell types': 'cell_type', 'LTR': 'DNA'}}
{'idx': 1149, 'sentence': 'The expression and activity of NF-kappa B and Sp1 were, therefore, analyzed in isolated T cells and DCs from humans and mice .', 'label': {'Sp1': 'protein', 'DCs': 'cell_type', 'NF-kappa B': 'protein', 'T cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 5},\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .": 4},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .": 4},\n    {"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .": 5},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .": 5},\n    {"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.": 4},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .": 5},\n    {"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .": 5},\n    {"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .": 4},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .": 5},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .": 5}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"Sp1": "protein"}, {"T cells": "cell_type"}, {"DCs": "cell_type"}]', 'prediction': {'NF-kappa B': 'protein', 'Sp1': 'protein', 'T cells': 'cell_type', 'DCs': 'cell_type'}}
{'idx': 407, 'sentence': 'Since most of the actions of vitamin D are mediated by its receptors ( VDR ), abnormalities of VDR have been postulated in XLH .', 'label': {'VDR': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 5},\n    {"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.": 5},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage.": 5},\n    {"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.": 5},\n    {"Benzene toxicity towards lymphocytes is thought to be mediated by metabolites of benzene including benzoquinone (BQ).": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 5},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 5},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 5},\n    {"Furthermore, the two VDR 3\'-UTR haplotypes conferred an identical half-life on a heterologous beta-globin reporter gene, in an in vitro assay.": 5}\n]', 'response3': '[{"VDR": "protein"}]', 'prediction': {'VDR': 'protein'}}
{'idx': 1466, 'sentence': 'As we observed that activated endothelial cells also expressed NFAT , we tested the antiinflammatory properties of CsA in endothelial cells .', 'label': {'endothelial cells': 'cell_type', 'NFAT': 'protein', 'activated endothelial cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a DNA binding activity, which directly corresponds to the \'DNA\' entity label in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains examples of proteins such as NF-kappa B and I kappa B alpha, which are directly related to the \'protein\' entity label in the target sentence."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence mentions proteins like AP-1 and PMA, as well as cell types like monocytes and macrophages, which align with the \'protein\' and \'cell_type\' entity labels in the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence refers to cell types like granulocytes and T cells, which are relevant to the \'cell_type\' entity label in the target sentence."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence discusses the activation of NF-kappa B, which is associated with the \'protein\' entity label in the target sentence."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence mentions NF-kappaB, Tax, and ATL, which correspond to the \'protein\' and \'cell_type\' entity labels in the target sentence."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence talks about alpha-tocopherol, monocytes, and endothelial cells, which relate to the \'protein\' and \'cell_type\' entity labels in the target sentence."},\n    {"Example 8": 4},\n    {"Reason 8": "The sentence discusses the inhibition of NF-kappa B activation, which is relevant to the \'protein\' entity label in the target sentence."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence mentions P selectin, which is associated with the \'protein\' entity label in the target sentence."},\n    {"Example 10": 4},\n    {"Reason 10": "The sentence refers to NF-kappa B and ARDS, which align with the \'protein\' and \'cell_type\' entity labels in the target sentence."},\n    {"Example 11": 4},\n    {"Reason 11": "The sentence discusses NF-kappa B activation in neutrophils, which is relevant to the \'protein\' entity label in the target sentence."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence mentions persistent activation of NF-kappa B, which corresponds to the \'protein\' entity label in the target sentence."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence talks about MNDA and cell lines, which relate to the \'protein\' and \'cell_line\' entity labels in the target sentence."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence discusses the expression of the E2A gene at the protein level, which is associated with the \'protein\' entity label in the target sentence."},\n    {"Example 15": 4},\n    {"Reason 15": "The sentence mentions the inhibition of NF-kappa B and AP-1, which align with the \'protein\' entity label in the target sentence."},\n    {"Example 16": 4},\n    {"Reason 16": "The sentence provides examples of proteins like IFN A, interleukin-2, and interleukin-2 receptor, as well as stimuli like phytohemagglutinin and phorbol myristate acetate, which are directly related to the \'protein\' entity label in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities that match the entity labels in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities that match the entity labels in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities that match the entity labels in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities that match the entity labels in the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities that match the entity labels in the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities that match the entity labels in the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities that match the entity labels in the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities that match the entity labels in the target sentence."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities that match the entity labels in the target sentence."}\n]', 'response3': '[{"NFAT": "protein"}, {"CsA": "protein"}, {"endothelial cells": "cell_type"}]', 'prediction': {'NFAT': 'protein', 'CsA': 'protein', 'endothelial cells': 'cell_type'}}
{'idx': 1330, 'sentence': 'Stimulation of cells leads to a rapid phosphorylation of I kappa B alpha , which is presumed to be important for the subsequent degradation .', 'label': {'I kappa B alpha': 'protein', 'I kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"I kappa B alpha": "protein"}]', 'prediction': {'I kappa B alpha': 'protein'}}
{'idx': 1436, 'sentence': 'Similar levels of hTR beta 1 mRNA levels were detected in thyroid gland from euthyroid patients .', 'label': {'hTR beta 1 mRNA': 'RNA', 'hTR beta 1': 'protein'}, 'response1': "['RNA']", 'response2': '[\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.": 5},\n    {"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus, and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 5}\n]', 'response3': '[{"hTR beta 1 mRNA": "RNA"}]', 'prediction': {'hTR beta 1 mRNA': 'RNA'}}
{'idx': 859, 'sentence': 'We show that at least one inducible , C1 , and one constitutive, C2 , protein can bind to the HIV enhancer in Jurkat cells .', 'label': {'inducible': 'protein', 'Jurkat cells': 'cell_line', 'C1': 'protein', 'HIV enhancer': 'DNA', 'C2': 'protein', 'constitutive, C2 , protein': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n{"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n{"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n{"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 4},\n{"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n{"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 4},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n{"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n{"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n{"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n{"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 5},\n{"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n{"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5},\n{"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 5},\n{"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells (Daudi) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner.": 5}\n]', 'response3': '[{"C1": "protein"}, {"C2": "protein"}, {"HIV enhancer": "DNA"}, {"Jurkat": "cell_line"}]', 'prediction': {'C1': 'protein', 'C2': 'protein', 'HIV enhancer': 'DNA', 'Jurkat': 'cell_line'}}
{'idx': 451, 'sentence': 'However, despite its ability to activate transcription of a transfected reporter gene , the factor is apparently unable to bind to the endogenous Ig heavy chain enhancer in non- lymphoid cells : In previous experiments by others, the characteristic in vivo footprint of this factor, designated NF-muE3 , was detected in B cells but not in non-B cells .', 'label': {'NF-muE3': 'protein', 'B cells': 'cell_type', 'lymphoid cells': 'cell_type', 'transfected reporter gene': 'DNA', 'Ig heavy chain enhancer': 'DNA', 'non- lymphoid cells': 'cell_type', 'non-B cells': 'cell_type', 'endogenous Ig heavy chain enhancer': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein entity (p50p50) and its corresponding label."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides a clear example of a protein entity (Egr-1) and its corresponding label."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence provides multiple examples of protein entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor) and their corresponding labels, as well as other protein-related terms (phytohemagglutinin, phorbol myristate acetate)."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides a clear example of a protein entity (TCF-1) and its corresponding label."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides examples of protein entities (IL-2 receptor alpha subunit, p21ras) and a cell type entity (B cell) with their corresponding labels."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides examples of a protein entity (NF-ATc) and cell type entities (T lymphocytes, embryonic cardiac cells) with their corresponding labels."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides a clear example of a protein entity (IL-2) and its corresponding label."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides examples of protein entities (NF-kappaB, Sp1, p50) with their corresponding labels."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides examples of protein entities (c-kit, IL-4R alpha chain) with their corresponding labels."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides examples of protein entities (IL-2, c-Jun, c-Fos) with their corresponding labels."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides an example of a DNA entity (immunoglobulin kappa 3\' enhancer) and its corresponding label."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides examples of protein entities (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) with their corresponding labels."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides examples of a protein entity (NF-kappaB) and a cell type entity (rheumatoid arthritis) with their corresponding labels."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides examples of protein entities (CD40, Rel/nuclear factor kappaB, NF-kappaB) and a cell type entity (B lymphocytes) with their corresponding labels."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides examples of protein entities (NF-kappaB, Sp1) and a cell line entity (SIVmac) with their corresponding labels."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence provides examples of protein entities (CTLA4Ig, NFAT, AP-1) with their corresponding labels."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities from the given label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities from the given label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities from the given label set."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities from the given label set."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities from the given label set."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities from the given label set."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities from the given label set."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities from the given label set."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities from the given label set."}\n]', 'response3': '[{"Ig heavy chain enhancer": "DNA"}, {"NF-muE3": "protein"}, {"B cells": "cell_type"}]', 'prediction': {'Ig heavy chain enhancer': 'DNA', 'NF-muE3': 'protein', 'B cells': 'cell_type'}}
{'idx': 919, 'sentence': 'The human protein recognized by the EC1 antibody is a 56-kDa protein ( p56 ) of moderate abundance located predominantly in the cytoplasm by indirect immunofluorescence .', 'label': {'56-kDa protein': 'protein', 'p56': 'protein', 'EC1 antibody': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 5},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"EC1 antibody": "protein"}, {"p56": "protein"}]', 'prediction': {'EC1 antibody': 'protein', 'p56': 'protein'}}
{'idx': 1206, 'sentence': 'In addition, the concentration of androgen receptors in mononuclear leukocytes was measured, in both the follicular and luteal phases of the menstrual cycle , basally and after 4 months of flutamide treatment.', 'label': {'androgen receptors': 'protein', 'mononuclear leukocytes': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and direct mention of the entity \'RXR\' with the corresponding label \'protein\', making it highly helpful for extracting named entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions \'granulocytes\' and \'T cells\' as entities with the labels \'cell_type\', which is helpful for identifying cell types in the text."},\n    {"Example 3": 3},\n    {"Reason 3": "The sentence mentions \'lymphoid neoplasms\' as an entity with the label \'cell_type\', providing some context for cell types involved."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence directly mentions \'CD14\' as an entity with the label \'protein\', aiding in the extraction of named entities."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence mentions \'phosphocreatine\' as an entity with the label \'protein\', which can help in identifying proteins involved in the text."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions \'HML\', \'dexamethasone\', \'cortisol\', and \'lysozyme\' as entities with the labels \'cell_line\' and \'protein\', aiding in the extraction of named entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence mentions \'NF-E2\' as an entity with the label \'protein\', providing a clear example for extracting named entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions \'E2A\' as an entity with the label \'protein\', aiding in the extraction of named entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence mentions \'CD70\', \'B cell\', \'plasma cells\', \'IL-4\', and \'CD40\' as entities with the labels \'protein\' and \'cell_type\', providing valuable information for named entity extraction."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions \'protein kinase A\' and \'Rap1\' as entities with the label \'protein\', aiding in the extraction of named entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions \'CD40\', \'Rel/nuclear factor kappaB\', \'NF-kappaB\', and \'B lymphocytes\' as entities with the labels \'protein\' and \'cell_type\', providing clear examples for named entity extraction."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions \'PU.1\', \'CSF-1 receptor\', \'Mono A\', and \'Mono B\' as entities with the label \'protein\', aiding in the extraction of named entities."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence mentions \'nuclear factor-kappa B\' and \'NF-kappa B\' as entities with the label \'DNA\', providing context for DNA-related entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions \'NF-kappa B\' and \'fibrinogen\' as entities with the label \'protein\', aiding in the extraction of named entities."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions \'MNDA\', \'monocytes\', \'macrophages\', and \'leukemia/B lymphoma cell lines\' as entities with the labels \'protein\' and \'cell_type\', providing valuable examples for named entity extraction."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence mentions \'PMA\' and \'U1 cells\' as entities with the label \'cell_line\', aiding in the extraction of named entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities from the given label set, making it not helpful for named entity extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities from the given label set, making it not helpful for named entity extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities from the given label set, making it not helpful for named entity extraction."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities from the given label set, making it not helpful for named entity extraction."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities from the given label set, making it not helpful for named entity extraction."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities from the given label set, making it not helpful for named entity extraction."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities from the given label set, making it not helpful for named entity extraction."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities from the given label set, making it not helpful for named entity extraction."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities from the given label set, making it not helpful for named entity extraction."},\n    {"Example 26": 1},\n    {"Reason 26": "The sentence does not contain any entities from the given label set, making it not helpful for named entity extraction."},\n    {"Example 27": 1},\n    {"Reason 27": "The sentence does not contain any entities from the given label set, making it not helpful for named entity extraction."},\n    {"Example 28": 1},\n    {"Reason 28": "The sentence does not contain any entities from the given label set, making it not helpful for named entity extraction."},\n    {"Example 29": 1},\n    {"Reason 29": "The sentence does not contain any entities from the given label set, making it not helpful for named entity extraction."},\n    {"Example 30": 1},\n    {"Reason 30": "The sentence does not contain any entities from the given label set, making it not helpful for named entity extraction."}\n]', 'response3': "[{'androgen receptors': 'protein'}, {'mononuclear leukocytes': 'cell_type'}, {'follicular': 'cell_type'}, {'luteal': 'cell_type'}, {'menstrual cycle': 'cell_type'}, {'flutamide': 'protein'}]", 'prediction': {'androgen receptors': 'protein', 'mononuclear leukocytes': 'cell_type', 'follicular': 'cell_type', 'luteal': 'cell_type', 'menstrual cycle': 'cell_type', 'flutamide': 'protein'}}
{'idx': 569, 'sentence': 'In addition, the increases in c-jun , EGR2 , and PDGF(B) may depend on cytoskeletal rearrangement .', 'label': {'PDGF(B)': 'protein', 'EGR2': 'DNA', 'c-jun': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.": 5},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 5},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 5},\n    {"The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.": 5},\n    {"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n    {"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1657, 'sentence': 'HMG-I binds to GATA motifs : implications for an HPFH syndrome .', 'label': {'HMG-I': 'protein', 'GATA motifs': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides clear examples of named entities with their corresponding entity labels, aiding in understanding the relationship between the entities and their types."}\n]', 'response3': '[{"HMG-I": "protein"}, {"GATA motifs": "DNA"}, {"HPFH syndrome": "cell_type"}]', 'prediction': {'HMG-I': 'protein', 'GATA motifs': 'DNA', 'HPFH syndrome': 'cell_type'}}
{'idx': 1780, 'sentence': 'Interestingly, Id2 , but not Id3 , mRNA was strongly expressed in 4/5 T-cell lines infected with human T-cell leukemia virus type I ( HTLV-I ) ( ATL-1k , MT-2 , S-LB1 ) and type II ( Mo ) .', 'label': {'Id3': 'protein', 'Mo': 'cell_line', 'Id2': 'protein', '4/5 T-cell lines': 'cell_line', 'S-LB1': 'cell_line', 'MT-2': 'cell_line', 'ATL-1k': 'cell_line'}, 'response1': "['RNA', 'cell_line']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"4": "The sentence contains \'STAT\' and \'T cells\' which are both relevant entity types present in the target sentence."},\n    {"4": "The sentence contains \'NF-ATc\' and \'T lymphocytes\' which are both relevant entity types present in the target sentence."},\n    {"5": "The sentence contains multiple relevant entity types such as \'IL-2\', \'IFN-gamma\', \'jak kinases\', and \'STAT1(alpha)\' present in the target sentence."},\n    {"5": "The sentence contains \'SIVmacMER\', \'SIVmac239\', and \'CEMx174\' which are all relevant entity types present in the target sentence."},\n    {"4": "The sentence contains \'NF-ATc\', \'T lymphocytes\', and \'embryonic cardiac cells\' which are relevant entity types present in the target sentence."},\n    {"3": "The sentence contains \'Th2-type lymphocytes\' which is a relevant entity type present in the target sentence."},\n    {"5": "The sentence contains multiple relevant entity types such as \'IFN A\', \'IFNA\', \'interleukin-2\', \'interleukin-2 receptor\', \'phytohemagglutinin\', and \'phorbol myristate acetate\' present in the target sentence."},\n    {"4": "The sentence contains \'PBMC\' and \'adenovirus DNA\' which are both relevant entity types present in the target sentence."},\n    {"4": "The sentence contains \'TCL1\' which is a relevant entity type present in the target sentence."},\n    {"4": "The sentence contains \'HIV-1\', \'IFN\', \'PKR\', and \'IkappaBalpha\' which are relevant entity types present in the target sentence."},\n    {"5": "The sentence contains multiple relevant entity types such as \'B and T cell activation\', \'Ramos\', \'Jurkat\', and \'cDNA microarray technology\' present in the target sentence."},\n    {"4": "The sentence contains \'tal-1\', \'GATA-binding proteins\', and \'hematopoiesis\' which are relevant entity types present in the target sentence."},\n    {"4": "The sentence contains \'HIV-1 LTR\', \'NFAT-1\', and \'NF kappa B\' which are relevant entity types present in the target sentence."},\n    {"4": "The sentence contains \'TCL1\' and \'MTCP1/c6.1B\' which are relevant entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"Id2": "RNA"}, {"Id3": "RNA"}, {"T-cell lines": "cell_line"}, {"human T-cell leukemia virus type I (HTLV-I)": "cell_type"}, {"ATL-1k": "cell_line"}, {"MT-2": "cell_line"}, {"S-LB1": "cell_line"}, {"type II (Mo)": "cell_type"}]', 'prediction': {'Id2': 'RNA', 'Id3': 'RNA', 'T-cell lines': 'cell_line', 'human T-cell leukemia virus type I (HTLV-I)': 'cell_type', 'ATL-1k': 'cell_line', 'MT-2': 'cell_line', 'S-LB1': 'cell_line', 'type II (Mo)': 'cell_type'}}
{'idx': 13, 'sentence': 'We further demonstrate the impact of platelet-activating factor binding to B cells by measuring platelet-activating factor induced arachidonic acid release and 5-hydroxyeicosatetraenoic acid production.', 'label': {'platelet-activating factor': 'protein', 'B cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 4},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 4},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 3},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"We have examined the effect of alpha-tocopherol ( alpha-tcp ) on one cellular event in atherosclerotic plaque development , monocyte adhesion to stimulated endothelial cells ( ECs ).": 4},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 4},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects.": 5},\n    {"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.": 4},\n    {"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation.": 5},\n    {"PMA induced the expression of both CD14 and CD23 mRNA and protein.": 5},\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation.": 4},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 4},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1554, 'sentence': 'The results define essential cis-acting elements responsible for the expression of GP Ib alpha and provide insights into molecular events coinciding with the release of normal platelets into the bloodstream .', 'label': {'GP': 'protein', 'normal platelets': 'cell_type', 'cis-acting elements': 'DNA', 'GP Ib alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.": 4},\n    {"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 3},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .": 4},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements .": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .": 4},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .": 4},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .": 5},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .": 4},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .": 5},\n    {"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts .": 4},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 4},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[{"GP Ib alpha": "protein"}]', 'prediction': {'GP Ib alpha': 'protein'}}
{'idx': 1650, 'sentence': 'This is the first demonstration of a specific interaction with PU.1 on a myeloid PU.1 binding site .', 'label': {'PU.1': 'protein', 'myeloid PU.1 binding site': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1},\n    {"Example 26": 1},\n    {"Example 27": 1},\n    {"Example 28": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 326, 'sentence': 'We show here that domain B is an R-responsive element in HeLa cells and is therefore not an EB1 -responsive B-cell-specific element .', 'label': {'EB1': 'protein', 'R-responsive element': 'DNA', 'HeLa cells': 'cell_line', 'domain B': 'DNA', 'EB1 -responsive B-cell-specific element': 'DNA'}, 'response1': "['cell_line', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 1},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"HeLa cells": "cell_line"}, {"EB1": "protein"}, {"B-cell-specific": "cell_type"}]', 'prediction': {'HeLa cells': 'cell_line', 'EB1': 'protein', 'B-cell-specific': 'cell_type'}}
{'idx': 1429, 'sentence': 'Data from cell culture and animal studies indicate that TR expression may be regulated to modulate target organ responsiveness to thyroid hormone .', 'label': {'TR': 'protein'}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific entities and their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains specific entities and their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains specific entities and their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains specific entities and their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific entities and their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific entities and their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific entities and their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific entities and their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains specific entities and their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains specific entities and their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains specific entities and their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains specific entities and their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains specific entities and their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific entities and their corresponding labels that directly match the entity types in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any entities or labels that match the entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entities or labels that match the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities or labels that match the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities or labels that match the entity types in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities or labels that match the entity types in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities or labels that match the entity types in the target sentence."}\n]', 'response3': '[{"TR": "protein"}]', 'prediction': {'TR': 'protein'}}
{'idx': 865, 'sentence': 'Response to T cell activation signals .', 'label': {'T cell': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n{"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n{"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n{"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.": 4},\n{"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n{"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 4},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n{"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n{"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.": 5},\n{"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.": 5},\n{"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n{"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n{"Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency.": 5},\n{"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n{"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 4},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n{"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5}\n]', 'response3': '[{"T cell": "cell_type"}]', 'prediction': {'T cell': 'cell_type'}}
{'idx': 696, 'sentence': 'First, from different cell lines three or all four of the nuclear proteins were specifically cross-linked by UV irradiation to the radioactively labeled TRE -DNA fragment .', 'label': {'TRE -DNA fragment': 'DNA', 'nuclear proteins': 'protein', 'TRE': 'DNA'}, 'response1': "['protein', 'cell_line', 'DNA']", 'response2': '[\n{"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n{"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .": 5},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n{"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n{"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50 .": 5},\n{"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n{"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .": 5},\n{"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n{"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .": 5},\n{"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .": 5},\n{"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .": 5},\n{"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .": 5},\n{"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .": 5}\n]', 'response3': '[{"UV irradiation": "None"}, {"radioactively labeled TRE -DNA fragment": "DNA"}]', 'prediction': {'UV irradiation': 'None', 'radioactively labeled TRE -DNA fragment': 'DNA'}}
{'idx': 318, 'sentence': 'Furthermore, the existence of estrogen receptor (estrogen binding activity) was examined histochemically in 39 cases and it was detected in 8.', 'label': {'estrogen receptor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein entity (RXR) and its corresponding label."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides a clear example of a protein entity (retinoic acid receptor alpha) and its corresponding label."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence provides a clear example of a protein entity (NF-E2) and its corresponding label."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides clear examples of protein entities (IL-2, c-Jun, c-Fos) and their corresponding labels."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides a clear example of a protein entity (E2A) and its corresponding label."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides clear examples of protein entities (NF-kB, AP-1, OCT-1, NF-IL-2B) and their corresponding labels."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides clear examples of protein entities (TCRzeta, p56(lck)) and their corresponding labels."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides clear examples of protein entities (Ter 119, beta-globin, glycoprotein IIb, platelet factor 4) and their corresponding labels."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides clear examples of protein entities (Erbstatin, genistein, Egr-1) and their corresponding labels."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides clear examples of protein entities (EBV, EBNA2, estrogen receptor) and their corresponding labels."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides clear examples of cell line entities (PMA, U1 cells) and their corresponding labels."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides clear examples of DNA entities (nuclear factor-kappa B, NF-kappa B) and their corresponding labels."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides clear examples of protein entities (CD3.TcR, CD18, CD29) and their corresponding labels."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides clear examples of DNA and protein entities (DNA, PCNA, E2F1) and their corresponding labels."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides clear examples of protein entities (MR, aldosterone, progesterone) and their corresponding labels."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence provides clear examples of protein entities (E2F, E2F-4, DP-1, p130) and a cell type entity (AML) and their corresponding labels."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities from the given label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities from the given label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities from the given label set."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities from the given label set."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities from the given label set."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities from the given label set."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities from the given label set."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities from the given label set."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities from the given label set."},\n    {"Example 26": 1},\n    {"Reason 26": "The sentence does not contain any entities from the given label set."},\n    {"Example 27": 1},\n    {"Reason 27": "The sentence does not contain any entities from the given label set."},\n    {"Example 28": 1},\n    {"Reason 28": "The sentence does not contain any entities from the given label set."},\n    {"Example 29": 1},\n    {"Reason 29": "The sentence does not contain any entities from the given label set."}\n]', 'response3': '[{"estrogen receptor": "protein"}]', 'prediction': {'estrogen receptor': 'protein'}}
{'idx': 440, 'sentence': 'All three proteins show the same sequence specificity and binding affinity .', 'label': {}, 'response1': "['protein']", 'response2': '[\n{"These two related genes share the evolutionarily conserved region encoding the Runt domain.": 5},\n{"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.": 5},\n{"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 5},\n{"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 5},\n{"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 5},\n{"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.": 5},\n{"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.": 5},\n{"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 5},\n{"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 5},\n{"Tat-binding protein 7 is a subunit of the 26S protease.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n{"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n{"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n{"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n{"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 5},\n{"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1563, 'sentence': 'Pathogenesis of atherosclerosis .', 'label': {}, 'response1': 'None.', 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides specific examples with corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 689, 'sentence': 'High-risk patients can be recognized morphologically.', 'label': {}, 'response1': 'None.', 'response2': '[\n    {"PBMC": 5},\n    {"adenovirus": 5},\n    {"WT1": 5},\n    {"CD70": 5},\n    {"B cell": 5},\n    {"plasma cells": 5},\n    {"IL-4": 5},\n    {"CD40": 5},\n    {"TCL1": 5},\n    {"myeloperoxidase": 5},\n    {"lysozyme": 5},\n    {"PU.1": 5},\n    {"Ras": 5},\n    {"T-PLL": 5},\n    {"T lymphocytes": 5},\n    {"HLA-molecules": 5},\n    {"MNDA": 5},\n    {"Philadelphia chromosome-positive chronic myeloid leukemia": 5},\n    {"granulocytes": 5},\n    {"T cells": 5},\n    {"TCRzeta": 5},\n    {"p56(lck)": 5},\n    {"PML/RARalpha": 5},\n    {"SIVmacMER": 5},\n    {"SIVmac239": 5},\n    {"CEMx174": 5},\n    {"lymphoid neoplasms": 5},\n    {"SIVsmmPBj14": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 189, 'sentence': 'Transcriptional down-regulation of c-myc expression by protein synthesis -dependent and -independent pathways in a human T lymphoblastic tumor cell line .', 'label': {'human T lymphoblastic tumor cell line': 'cell_line', 'c-myc': 'DNA'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"2": "The sentence does not contain any of the entity types in the label set."},\n    {"3": "The sentence contains relevant protein entities (Sp1, CD14) which are helpful for entity extraction."},\n    {"4": "The sentence contains relevant protein entities (IkappaBbeta, tax protein, NF-kappaB) which are helpful for entity extraction."},\n    {"5": "The sentence contains relevant protein entities (Sp1, Ets) which are helpful for entity extraction."},\n    {"6": "The sentence contains relevant cell type entity (Th2-type lymphocytes) which is helpful for entity extraction."},\n    {"7": "The sentence contains relevant protein entity (WT1) and cell line entity (myeloid cell lines) which are helpful for entity extraction."},\n    {"8": "The sentence contains relevant protein entity (NF-ATc) and cell type entities (T lymphocytes, embryonic cardiac cells) which are helpful for entity extraction."},\n    {"9": "The sentence contains relevant protein entities (SP1, caspases) and cell type entity (B-cell) which are helpful for entity extraction."},\n    {"10": "The sentence contains relevant protein entity (GATA-1) which is helpful for entity extraction."},\n    {"11": "The sentence contains relevant protein entities (ZEB, c-Myb, Ets) and cell type entity (hematopoietic cells) which are helpful for entity extraction."},\n    {"12": "The sentence contains relevant protein entities (YY1, Oct1, IL-5) and cell type entity (T cells) which are helpful for entity extraction."},\n    {"13": "The sentence contains relevant cell type entities (B and T cell activation, Ramos, Jurkat) and DNA entity (cDNA microarray technology) which are helpful for entity extraction."},\n    {"14": "The sentence contains relevant protein entities (tal-1, GATA-binding proteins) and cell type entity (hematopoiesis) which are helpful for entity extraction."},\n    {"15": "The sentence contains relevant DNA entity (cDNA), cell line entity (Jurkat), and cell type entity (DRE 1) which are helpful for entity extraction."},\n    {"16": "The sentence contains relevant protein entities (AP-1, c-jun, IL-2, NF-AT) and cell type entity (T cell) which are helpful for entity extraction."},\n    {"17": "The sentence does not contain any of the entity types in the label set."},\n    {"18": "The sentence does not contain any of the entity types in the label set."},\n    {"19": "The sentence does not contain any of the entity types in the label set."},\n    {"20": "The sentence does not contain any of the entity types in the label set."},\n    {"21": "The sentence does not contain any of the entity types in the label set."},\n    {"22": "The sentence does not contain any of the entity types in the label set."},\n    {"23": "The sentence does not contain any of the entity types in the label set."},\n    {"24": "The sentence does not contain any of the entity types in the label set."},\n    {"25": "The sentence does not contain any of the entity types in the label set."},\n    {"26": "The sentence does not contain any of the entity types in the label set."},\n    {"27": "The sentence does not contain any of the entity types in the label set."},\n    {"28": "The sentence does not contain any of the entity types in the label set."},\n    {"29": "The sentence does not contain any of the entity types in the label set."},\n    {"30": "The sentence does not contain any of the entity types in the label set."}\n]', 'response3': '[{"c-myc": "protein"}, {"T lymphoblastic tumor cell line": "cell_line"}]', 'prediction': {'c-myc': 'protein', 'T lymphoblastic tumor cell line': 'cell_line'}}
{'idx': 778, 'sentence': 'Addition of a highly enriched preparation of OTF-1 made from one of these pre-B cells or from HeLa cells specifically stimulated in vitro transcription of an immunoglobulin gene .', 'label': {'OTF-1': 'protein', 'pre-B cells': 'cell_line', 'immunoglobulin gene': 'DNA', 'HeLa cells': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 4},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 5},\n    {"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 4},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 4},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .": 4},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"T cell blasts treated with PMA are now responsive to IFN-gamma .": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .": 5},\n    {"Fibroblast growth factor-1 ( FGF-1 ) enhances IL-2 production and nuclear translocation of NF-kappaB in FGF receptor -bearing Jurkat T cells .": 5}\n]', 'response3': '[{"OTF-1": "protein"}, {"pre-B cells": "cell_type"}, {"HeLa cells": "cell_line"}, {"immunoglobulin gene": "protein"}]', 'prediction': {'OTF-1': 'protein', 'pre-B cells': 'cell_type', 'HeLa cells': 'cell_line', 'immunoglobulin gene': 'protein'}}
{'idx': 198, 'sentence': "Tamoxifen , an oestrogen antagonist , has been given in some patients with CLL and Hodgkin's disease , with dramatic response in single cases.", 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 735, 'sentence': 'This prompted us to analyze the octamer-binding proteins in the latter cells.', 'label': {'octamer-binding proteins': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example directly mentions the entity type \'DNA\' which is present in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The example provides a clear link between the entity \'CD95 ligand\' and the entity type \'protein\' present in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The example mentions the entities \'EBNA-2\' and \'PU.1\' which are both of type \'protein\' present in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The example directly mentions the entity type \'DNA\' which is present in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides multiple instances of protein entities (\'IL-2\', \'c-Jun\', \'c-Fos\') present in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The example directly mentions the entity \'NF-kappa B\' which is of type \'protein\' present in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The example links the entities \'c-kit\' and \'IL-4R alpha chain\' to the entity type \'protein\' present in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides a clear link between the entities \'Oct-2A\', \'HMG I/Y\', \'HLA-DRA\', and \'B cells\' to the entity types present in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example mentions the entities \'EKLF\', \'CBP\', \'p300\', and \'P/CAF\' which are all of type \'protein\' present in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides a direct link between the entities \'IL-4\', \'LPS\', and \'AP-1\' to the entity type \'protein\' present in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The example directly mentions the entity types \'granulocytes\' and \'T cells\' present in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The example mentions the entity \'SCM-1\' which is of type \'cell_line\' present in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides a clear link between the entities \'CD40\' and \'NF-kappa B\' to the entity types present in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The example mentions the entities \'p21(WAF1/CIP1)\' and \'p27(KIP1)\' which are both of type \'protein\' present in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The example directly mentions the entity \'E2A\' which is of type \'protein\' present in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any entity types present in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any entity types present in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any entity types present in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain any entity types present in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The example does not contain any entity types present in the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The example does not contain any entity types present in the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The example does not contain any entity types present in the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The example does not contain any entity types present in the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The example does not contain any entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1735, 'sentence': 'We therefore examined vitamin D3 -mediated repression of activated IL-2 expression by cotransfecting Jurkat cells with IL-2 promoter/reporter constructs and a VDR overexpression vector and by DNA binding .', 'label': {'VDR': 'protein', 'IL-2 promoter/reporter constructs': 'DNA', 'Jurkat cells': 'cell_line', 'VDR overexpression vector': 'DNA', 'IL-2': 'protein'}, 'response1': "['DNA', 'protein', 'cell_line']", 'response2': '[\n{"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 4},\n{"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 4},\n{"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n{"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .": 5},\n{"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .": 4},\n{"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex .": 5},\n{"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n{"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .": 5},\n{"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .": 5},\n{"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n{"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .": 5},\n{"While the activation of the IL-2 promoter and an NFAT -driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418 , it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2 -mediated NFAT activation is under the control of a combination of calcineurin- dependent and independent pathways .": 5},\n{"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .": 5}\n]', 'response3': '[{"IL-2": "protein"}, {"Jurkat": "cell_line"}, {"IL-2": "DNA"}, {"VDR": "protein"}, {"DNA": "DNA"}]', 'prediction': {'IL-2': 'DNA', 'Jurkat': 'cell_line', 'VDR': 'protein', 'DNA': 'DNA'}}
{'idx': 704, 'sentence': 'Activity of the immunoglobulin heavy and kappa light chain gene enhancers depends on a complex interplay of ubiquitous and developmentally regulated proteins .', 'label': {'ubiquitous and developmentally regulated proteins': 'protein', 'ubiquitous': 'protein', 'developmentally regulated proteins': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"immunoglobulin heavy and kappa light chain gene enhancers": "DNA"}]', 'prediction': {'immunoglobulin heavy and kappa light chain gene enhancers': 'DNA'}}
{'idx': 1236, 'sentence': 'Binding site selection revealed that the alternating RCGCRYGCGY consensus constitutes high-affinity IBR/F binding sites and that the direct-repeat palindrome TGCGCATGCGCA is the optimal site .', 'label': {'direct-repeat palindrome': 'DNA', 'IBR/F': 'protein', 'IBR/F binding sites': 'DNA', 'optimal site': 'DNA', 'alternating RCGCRYGCGY consensus': 'protein'}, 'response1': "['DNA']", 'response2': '[\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements": 4},\n    {"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 4},\n    {"Therefore, we investigated whether IVS1-10T-->C deleteriously affected BRCA1 splicing or expression, and thereby inactivated the other BRCA1 allele": 4},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50": 4},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes": 4},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes": 4},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions": 4},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex": 5},\n    {"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 541, 'sentence': 'To be or not to be a responder in T-cell responses : ubiquitous oligopeptides in all proteins.', 'label': {}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n    {"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.": 4},\n    {"Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n    {"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"Yet, for many pathogens, the molecules that induce IL-12 production by macrophages and the mechanisms by which they do so remain undefined.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1652, 'sentence': 'Furthermore, we demonstrate that the PU-SF complex binds to PU.1 sites found on a number of myeloid promoters , and its formation requires an intact PU.1 site adjacent to a single-stranded region.', 'label': {'PU.1': 'protein', 'PU-SF complex': 'protein', 'myeloid promoters': 'DNA', 'PU.1 site': 'DNA', 'PU-SF': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 3},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 4},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 4},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 3},\n    {"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.": 4},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 4},\n    {"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 3},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 4},\n    {"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 4},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 4},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes.": 3},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 4},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 4},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex, cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[{"PU-SF complex": "protein"}, {"PU.1": "protein"}, {"myeloid": "cell_type"}]', 'prediction': {'PU-SF complex': 'protein', 'PU.1': 'protein', 'myeloid': 'cell_type'}}
{'idx': 88, 'sentence': 'TNF alpha did not activate cAMP production and its signal was not modulated by cAMP activators .', 'label': {'TNF alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1494, 'sentence': 'Increased intracellular stores of latent NF-kappa B may also result in rapid inducibility of NF-kappa B -dependent cytokine gene expression .', 'label': {'latent NF-kappa B': 'protein', 'cytokine': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 4},\n    {"Example 6": 4},\n    {"Example 7": 4},\n    {"Example 8": 4},\n    {"Example 9": 4},\n    {"Example 10": 4},\n    {"Example 11": 4},\n    {"Example 12": 1},\n    {"Example 13": 4},\n    {"Example 14": 4},\n    {"Example 15": 3},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"NF-kappa B": "protein"}]', 'prediction': {'NF-kappa B': 'protein'}}
{'idx': 940, 'sentence': 'Tamoxifen was also found to compete with 17 beta-estradiol for type II EBS in PBMC , although to a lesser extent than diethylstilbestrol .', 'label': {'PBMC': 'cell_type', 'type II EBS': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a specific protein entity (NF-E2) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The example provides multiple entities (protein, cell_type) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 3": 4},\n    {"Reason 3": "The example provides multiple protein entities (NF-kappa B, AP-1) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 4": 4},\n    {"Reason 4": "The example provides multiple protein entities (IL-2, NF-kappa B, AP-1) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 5": 4},\n    {"Reason 5": "The example provides multiple entities (RNA, cell_type, protein) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 6": 4},\n    {"Reason 6": "The example provides a specific protein entity (retinoic acid receptor alpha) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 7": 4},\n    {"Reason 7": "The example provides multiple entities (protein, cell_line) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 8": 4},\n    {"Reason 8": "The example provides multiple protein entities (NF-kappa B, I kappa B beta) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 9": 3},\n    {"Reason 9": "The example provides entities (cell_type, chemical compound) mentioned in the sentence, but they are not directly related to the entity types in the target sentence."},\n    {"Example 10": 3},\n    {"Reason 10": "The example provides a protein entity (NF-kappa B) mentioned in the sentence, but it is not directly related to the entity types in the target sentence."},\n    {"Example 11": 3},\n    {"Reason 11": "The example provides entities (cell_line, protein) mentioned in the sentence, but they are not directly related to the entity types in the target sentence."},\n    {"Example 12": 4},\n    {"Reason 12": "The example provides multiple entities (protein, protein, RNA) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 13": 4},\n    {"Reason 13": "The example provides multiple entities (cell_type, protein) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 14": 4},\n    {"Reason 14": "The example provides multiple entities (DNA, protein) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 15": 4},\n    {"Reason 15": "The example provides multiple entities (cell_line, cell_line) mentioned in the sentence, aiding in the extraction of named entities."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not provide any entities mentioned in the sentence, hence not aiding in the extraction of named entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not provide any entities mentioned in the sentence, hence not aiding in the extraction of named entities."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not provide any entities mentioned in the sentence, hence not aiding in the extraction of named entities."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not provide any entities mentioned in the sentence, hence not aiding in the extraction of named entities."},\n    {"Example 20": 1},\n    {"Reason 20": "The example does not provide any entities mentioned in the sentence, hence not aiding in the extraction of named entities."},\n    {"Example 21": 1},\n    {"Reason 21": "The example does not provide any entities mentioned in the sentence, hence not aiding in the extraction of named entities."},\n    {"Example 22": 1},\n    {"Reason 22": "The example does not provide any entities mentioned in the sentence, hence not aiding in the extraction of named entities."},\n    {"Example 23": 1},\n    {"Reason 23": "The example does not provide any entities mentioned in the sentence, hence not aiding in the extraction of named entities."},\n    {"Example 24": 1},\n    {"Reason 24": "The example does not provide any entities mentioned in the sentence, hence not aiding in the extraction of named entities."}\n]', 'response3': "[{'17 beta-estradiol': 'protein'}, {'diethylstilbestrol': 'protein'}]", 'prediction': {'17 beta-estradiol': 'protein', 'diethylstilbestrol': 'protein'}}
{'idx': 1098, 'sentence': 'Thus, intact microtubules are essential for 1,25(OH)2D3 -dependent modulation of gene transcription .', 'label': {'microtubules': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.": 5},\n{"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.": 5},\n{"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 5},\n{"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis.": 5},\n{"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n{"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras.": 5},\n{"Here we examined the regulatory mechanism of the SCM-1 genes.": 5},\n{"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n{"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription.": 5},\n{"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation.": 5},\n{"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n{"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.": 5},\n{"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 5},\n{"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n{"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 5},\n{"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5}\n]', 'response3': '[{"microtubules": "protein"}]', 'prediction': {'microtubules': 'protein'}}
{'idx': 255, 'sentence': 'c-myc RNA , which is constitutively expressed in RWLeu-4 cells , increased after 0.5 h of treatment with 50 nM VD3 and then rapidly decreased to barely detectable levels after 4 h of treatment.', 'label': {'c-myc RNA': 'RNA', 'RWLeu-4 cells': 'cell_line'}, 'response1': "['RNA', 'cell_line']", 'response2': '[\n    {"CD40 expression could be enhanced in CD40-positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n    {"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 4},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 4},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 4},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 5},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]": 4},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 4},\n    {"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.": 4},\n    {"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.": 5}\n]', 'response3': '[{"c-myc RNA": "RNA"}, {"RWLeu-4 cells": "cell_line"}, {"VD3": "protein"}]', 'prediction': {'c-myc RNA': 'RNA', 'RWLeu-4 cells': 'cell_line', 'VD3': 'protein'}}
{'idx': 775, 'sentence': 'Some of these proteins (referred to as OTF-2 ) are lymphoid specific, whereas at least one other, and possibly more (referred to as OTF-1 ), is found ubiquitously in all cell types.', 'label': {'OTF-1': 'protein', 'OTF-2': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"NF-ATc isoforms": 5},\n    {"T lymphocytes": 5},\n    {"IL-4": 5},\n    {"Protein": 5},\n    {"WT1": 5},\n    {"IFN A": 5},\n    {"IFNA": 5},\n    {"interleukin-2": 5},\n    {"interleukin-2 receptor": 5},\n    {"phytohemagglutinin": 5},\n    {"phorbol myristate acetate": 5},\n    {"GATA-1": 5},\n    {"Syk": 5},\n    {"Zap": 5},\n    {"T cell": 5},\n    {"RXR": 5},\n    {"E2A": 5},\n    {"Th2-type lymphocytes": 5},\n    {"TCF-1": 5},\n    {"immunohistochemistry": 5},\n    {"gene": 1},\n    {"DNA": 1},\n    {"cell type": 5},\n    {"myeloperoxidase": 5},\n    {"lysozyme": 5},\n    {"PU.1": 5},\n    {"Th1": 5},\n    {"Th2": 5},\n    {"Egr-1": 5},\n    {"CD70": 5},\n    {"B cell": 5},\n    {"plasma cells": 5},\n    {"IL-4": 5},\n    {"CD40": 5}\n]', 'response3': '[{"OTF-2": "protein"}, {"OTF-1": "protein"}]', 'prediction': {'OTF-2': 'protein', 'OTF-1': 'protein'}}
{'idx': 161, 'sentence': 'Steroid dose sparing : pharmacodynamic responses to single versus divided doses of methylprednisolone in man.', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"2": "The sentence contains multiple protein entities and their corresponding labels, which can aid in extracting named entities related to proteins."},\n    {"3": "The sentence contains a protein entity and its corresponding label, which can aid in extracting named entities related to proteins."},\n    {"4": "The sentence contains multiple named entities from the given entity label set, aiding in extracting named entities related to cell lines and proteins."},\n    {"5": "The sentence contains a cell type entity and its corresponding label, aiding in extracting named entities related to cell types."},\n    {"6": "The sentence contains multiple named entities from the given entity label set, aiding in extracting named entities related to RNA, cell types, and proteins."},\n    {"7": "The sentence contains named entities related to proteins, caspases, and cell types, aiding in extracting named entities from the target sentence."},\n    {"8": "The sentence contains named entities related to proteins and their corresponding labels, aiding in extracting named entities related to proteins."},\n    {"9": "The sentence contains a protein entity and its corresponding label, aiding in extracting named entities related to proteins."},\n    {"10": "The sentence contains a protein entity and its corresponding label, aiding in extracting named entities related to proteins."},\n    {"11": "The sentence contains named entities related to proteins and a cell line, aiding in extracting named entities from the target sentence."},\n    {"12": "The sentence contains named entities related to a cell line and its corresponding label, aiding in extracting named entities related to cell lines."},\n    {"13": "The sentence contains named entities related to cell types, proteins, and a protein kinase, aiding in extracting named entities from the target sentence."},\n    {"14": "The sentence contains named entities related to proteins, a cell type, and a protein kinase, aiding in extracting named entities from the target sentence."},\n    {"15": "The sentence contains named entities related to proteins, a cell type, and a protein kinase, aiding in extracting named entities from the target sentence."},\n    {"16": "The sentence does not contain any named entities from the given entity label set."},\n    {"17": "The sentence does not contain any named entities from the given entity label set."},\n    {"18": "The sentence does not contain any named entities from the given entity label set."},\n    {"19": "The sentence does not contain any named entities from the given entity label set."},\n    {"20": "The sentence does not contain any named entities from the given entity label set."},\n    {"21": "The sentence does not contain any named entities from the given entity label set."},\n    {"22": "The sentence does not contain any named entities from the given entity label set."},\n    {"23": "The sentence does not contain any named entities from the given entity label set."},\n    {"24": "The sentence does not contain any named entities from the given entity label set."},\n    {"25": "The sentence does not contain any named entities from the given entity label set."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1130, 'sentence': 'B-lymphoblastoid cell lines from multiple sclerosis patients and a healthy control producing a putative new human retrovirus and Epstein-Barr virus .', 'label': {'B-lymphoblastoid cell lines': 'cell_line'}, 'response1': "['cell_line', 'virus']", 'response2': '[\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 1},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .": 4},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n    {"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.": 3},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 3},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .": 5},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .": 4},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 3},\n    {"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .": 5},\n    {"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice .": 5},\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[{"B-lymphoblastoid cell lines": "cell_line"}, {"multiple sclerosis patients": "cell_type"}, {"a healthy control": "cell_type"}, {"putative new human retrovirus": "protein"}, {"Epstein-Barr virus": "protein"}]', 'prediction': {'B-lymphoblastoid cell lines': 'cell_line', 'multiple sclerosis patients': 'cell_type', 'a healthy control': 'cell_type', 'putative new human retrovirus': 'protein', 'Epstein-Barr virus': 'protein'}}
{'idx': 600, 'sentence': 'Involvement of a second lymphoid-specific enhancer element in the regulation of immunoglobulin heavy-chain gene expression .', 'label': {'immunoglobulin heavy-chain gene': 'DNA', 'lymphoid-specific enhancer element': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"lymphoid-specific enhancer element": "DNA"}, {"immunoglobulin heavy-chain gene": "protein"}]', 'prediction': {'lymphoid-specific enhancer element': 'DNA', 'immunoglobulin heavy-chain gene': 'protein'}}
{'idx': 1698, 'sentence': 'Oncogenicity of human papillomavirus- or adenovirus- transformed cells correlates with resistance to lysis by natural killer cells .', 'label': {'natural killer cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"2": "The sentence does not contain any of the entity types in the target sentence."},\n    {"3": "The sentence contains \'NF-kappaB\' which is a protein, \'Tax\' and \'ATL\' which are cell types."},\n    {"4": "The sentence contains \'WT1\' which is a protein and \'myeloid cell lines\' which is a cell line."},\n    {"5": "The sentence contains \'IFN A\' and \'IFNA\' which are proteins, \'interleukin-2\' and \'interleukin-2 receptor\' which are proteins, \'phytohemagglutinin\' and \'phorbol myristate acetate\' which are proteins."},\n    {"6": "The sentence contains \'NF-kappa B\' which is a protein."},\n    {"7": "The sentence contains \'IkappaBbeta\' and \'NF-kappaB\' which are proteins."},\n    {"8": "The sentence contains \'TIMP-1\' which is a protein and \'DNA\' which is DNA."},\n    {"9": "The sentence contains \'PBMC\' which is a cell type and \'adenovirus DNA\' which is DNA."},\n    {"10": "The sentence contains \'HIV-1\' which is a cell type, \'IFN\' and \'PKR\' which are proteins, \'IkappaBalpha\' which is a protein."},\n    {"11": "The sentence contains \'NF-kappaB\' and \'Sp1\' which are proteins, \'SIVmac\' which is a cell line."},\n    {"12": "The sentence contains \'pRB\' and \'p53\' which are proteins, \'U937\' which is a cell line, \'apoptosis\' which is a cell type, \'calphostin C\' and \'ceramide\' which are proteins, \'serum withdrawal\' which is a cell type."},\n    {"13": "The sentence contains \'T lymphocytes\' which is a cell type, \'adenovirus vectors\' which is DNA."},\n    {"14": "The sentence contains \'NF-kappa B\' which is a protein, \'neutrophils\' which is a cell type."},\n    {"15": "The sentence contains \'HIV\' which is a protein, \'NF-kappa B\', \'p105\', \'p50\', and \'MAD3\' which are proteins."},\n    {"16": "The sentence does not contain any of the entity types in the target sentence."},\n    {"17": "The sentence does not contain any of the entity types in the target sentence."},\n    {"18": "The sentence does not contain any of the entity types in the target sentence."},\n    {"19": "The sentence does not contain any of the entity types in the target sentence."},\n    {"20": "The sentence does not contain any of the entity types in the target sentence."},\n    {"21": "The sentence does not contain any of the entity types in the target sentence."},\n    {"22": "The sentence does not contain any of the entity types in the target sentence."},\n    {"23": "The sentence does not contain any of the entity types in the target sentence."},\n    {"24": "The sentence does not contain any of the entity types in the target sentence."},\n    {"25": "The sentence does not contain any of the entity types in the target sentence."}\n]', 'response3': "[{'human papillomavirus-': 'cell_type'}, {'adenovirus-': 'cell_type'}, {'natural killer cells': 'cell_type'}]", 'prediction': {'human papillomavirus-': 'cell_type', 'adenovirus-': 'cell_type', 'natural killer cells': 'cell_type'}}
{'idx': 1287, 'sentence': 'Platelet thromboxane receptors are acutely and reversibly upregulated after acute myocardial infarction .', 'label': {'Platelet thromboxane receptors': 'protein', 'Platelet': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides clear and specific examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."}\n]', 'response3': '[{"Platelet thromboxane receptors": "protein"}]', 'prediction': {'Platelet thromboxane receptors': 'protein'}}
{'idx': 1266, 'sentence': 'Human herpesvirus 6 , a predominantly T lymphotropic virus , has been recently shown to infect some EBV -positive B cell lines , and to induce in them the activation of the EBV lytic cycle .', 'label': {'EBV -positive B cell lines': 'cell_line'}, 'response1': "['cell_line', 'cell_line', 'cell_line', 'cell_line', 'cell_line', 'cell_line', 'cell_line', 'cell_line']", 'response2': '[\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 3},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 4},\n    {"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .": 3},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .": 4},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 3},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 4},\n    {"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development .": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .": 4},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 4},\n    {"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .": 5},\n    {"Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype .": 4}\n]', 'response3': '[{"EBV": "cell_type"}, {"B cell lines": "cell_line"}, {"EBV": "cell_type"}]', 'prediction': {'EBV': 'cell_type', 'B cell lines': 'cell_line'}}
{'idx': 1813, 'sentence': 'Northern blot analysis revealed that BLR2 mRNA could be highly stimulated in mitogen- and anti-CD3- treated peripheral blood lymphocytes .', 'label': {'BLR2 mRNA': 'RNA', 'BLR2': 'protein'}, 'response1': "['RNA', 'cell_type']", 'response2': '[\n    {"Example 1": 1},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 1},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"BLR2 mRNA": "RNA"}, {"mitogen": "protein"}, {"anti-CD3": "protein"}, {"peripheral blood lymphocytes": "cell_type"}]', 'prediction': {'BLR2 mRNA': 'RNA', 'mitogen': 'protein', 'anti-CD3': 'protein', 'peripheral blood lymphocytes': 'cell_type'}}
{'idx': 1764, 'sentence': 'The inhibitory effect of cysteamine may be mediated at least in part by an effect on transcription factor function , as the DNA binding activities of AP-1 and NF-kappa B extracted from mitogen-stimulated cells were significantly inhibited by cysteamine treatment .', 'label': {'AP-1': 'protein', 'NF-kappa B': 'protein', 'transcription factor': 'protein', 'mitogen-stimulated cells': 'cell_type'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"5": "The sentence contains multiple named entities (IL-2, NF-kappa B, AP-1) that are directly related to the entity labels provided."},\n    {"5": "The sentence contains named entities (NF-kappa B, I kappa B alpha) that are directly related to the entity labels provided."},\n    {"3": "The sentence contains a named entity (AP-1) that is directly related to the entity labels provided."},\n    {"5": "The sentence contains a named entity (NF-kappa B) that is directly related to the entity labels provided."},\n    {"5": "The sentence contains named entities (NF-kappa B, I kappa B beta) that are directly related to the entity labels provided."},\n    {"5": "The sentence contains named entities (IL-4, LPS, AP-1) that are directly related to the entity labels provided."},\n    {"3": "The sentence contains a named entity (NF-E2) that is directly related to the entity labels provided."},\n    {"5": "The sentence contains named entities (RelA, NF-kappaB1) that are directly related to the entity labels provided."},\n    {"5": "The sentence contains named entities (IL-2, c-Jun, c-Fos) that are directly related to the entity labels provided."},\n    {"5": "The sentence contains named entities (NF-kappa B, AP-1) that are directly related to the entity labels provided."},\n    {"5": "The sentence contains named entities (PAFR, PAF, NF-kappa B, protein kinase C) that are directly related to the entity labels provided."},\n    {"3": "The sentence contains a named entity (P selectin) that is directly related to the entity labels provided."},\n    {"5": "The sentence contains named entities (IL-2, NFAT, NFAT delta418, calcineurin, Tpl-2, cyclosporin A) that are directly related to the entity labels provided."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."}\n]', 'response3': '[{"DNA": "DNA"}, {"AP-1": "protein"}, {"NF-kappa B": "protein"}]', 'prediction': {'DNA': 'DNA', 'AP-1': 'protein', 'NF-kappa B': 'protein'}}
{'idx': 740, 'sentence': 'On the basis of these assays, all N-Oct-factors were found to be distinct from the ubiquitous Oct-1 and the lymphoid-specific Oct-2A proteins.', 'label': {'ubiquitous Oct-1': 'protein', 'Oct-1': 'protein', 'Oct-2A': 'protein', 'lymphoid-specific Oct-2A': 'protein', 'N-Oct-factors': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and direct mention of the entity \'protein\' and its specific names, which can aid in the extraction of named entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence directly mentions the entity \'DNA\' and provides a clear context for its extraction as a named entity."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence explicitly mentions the entity \'protein\' and its specific name, aiding in the extraction of named entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains multiple mentions of the entity \'protein\' and its specific names, providing clear context for named entity extraction."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence mentions multiple proteins by their specific names, aiding in the extraction of named entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides direct mentions of the entities \'protein\' and their specific names, aiding in named entity extraction."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence mentions the entity \'protein\' by its specific name, providing clear context for named entity extraction."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions the entity \'protein\' by its specific name, aiding in the extraction of named entities."},\n    {"Example 9": 1},\n    {"Reason 9": "The sentence does not contain any entity types present in the target sentence, making it least helpful for named entity extraction."},\n    {"Example 10": 1},\n    {"Reason 10": "The sentence does not contain any entity types present in the target sentence, making it least helpful for named entity extraction."},\n    {"Example 11": 1},\n    {"Reason 11": "The sentence does not contain any entity types present in the target sentence, making it least helpful for named entity extraction."},\n    {"Example 12": 1},\n    {"Reason 12": "The sentence does not contain any entity types present in the target sentence, making it least helpful for named entity extraction."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not contain any entity types present in the target sentence, making it least helpful for named entity extraction."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not contain any entity types present in the target sentence, making it least helpful for named entity extraction."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any entity types present in the target sentence, making it least helpful for named entity extraction."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entity types present in the target sentence, making it least helpful for named entity extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entity types present in the target sentence, making it least helpful for named entity extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entity types present in the target sentence, making it least helpful for named entity extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entity types present in the target sentence, making it least helpful for named entity extraction."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entity types present in the target sentence, making it least helpful for named entity extraction."}\n]', 'response3': '[{"Oct-1": "protein"}, {"Oct-2A": "protein"}]', 'prediction': {'Oct-1': 'protein', 'Oct-2A': 'protein'}}
{'idx': 1182, 'sentence': 'Moreover, STAT5 was found to be the predominant STAT transcription factor used by IL-2 in human T cells , and specifically required a COOH-terminal region of IL-2R beta ( Ser386-Val525 ), while STAT5 recruitment was not correlated to activation of IL-2R gamma or JAK3 .', 'label': {'IL-2': 'protein', 'T cells': 'cell_type', 'COOH-terminal region': 'protein', 'human T cells': 'cell_type', 'Ser386-Val525': 'protein', 'JAK3': 'protein', 'STAT transcription factor': 'protein', 'STAT5': 'protein', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .": 5},\n{"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 1},\n{"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n{"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 5},\n{"Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.": 5},\n{"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .": 5},\n{"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n{"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells .": 5},\n{"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function .": 5},\n{"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines .": 5},\n{"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .": 5},\n{"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5}\n]', 'response3': '[{"STAT5": "protein"}, {"IL-2": "protein"}, {"IL-2R beta": "protein"}, {"IL-2R gamma": "protein"}, {"JAK3": "protein"}, {"T cells": "cell_type"}]', 'prediction': {'STAT5': 'protein', 'IL-2': 'protein', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein', 'JAK3': 'protein', 'T cells': 'cell_type'}}
{'idx': 393, 'sentence': 'We also tested for the ability of defensins NP-1 , NP-5 , and HNP-1 to activate pag expression and found that these peptides have no effect.', 'label': {'HNP-1': 'protein', 'pag': 'DNA', 'NP-1': 'protein', 'defensins': 'protein', 'NP-5': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 1},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 5},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1442, 'sentence': 'T cell expression of interleukin 3 ( IL-3 ) is directed by positive and negative cis-acting DNA elements clustered within 300 base pairs of the transcriptional start site .', 'label': {'interleukin 3': 'protein', 'transcriptional start site': 'DNA', 'IL-3': 'protein'}, 'response1': "['DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 1},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"IL-3": "protein"}]', 'prediction': {'IL-3': 'protein'}}
{'idx': 142, 'sentence': 'This level of NF-kappa B -independent activity appears to be sufficient for virus multiplication , since TNF-alpha treatment had no effect on the kinetics of de novo HIV type 1 ( HIV-1 ) infection and viral RNA production in U937 cells .', 'label': {'U937 cells': 'cell_line', 'NF-kappa B': 'protein', 'viral RNA': 'RNA', 'TNF-alpha': 'protein'}, 'response1': "['RNA', 'protein', 'cell_line']", 'response2': '[\n{"TIMP-1": 5, "DNA": 4},\n{"NF-kB": 5, "AP-1": 5, "OCT-1": 5, "NF-IL-2B": 5},\n{"RelA": 5, "NF-kappa B": 5},\n{"NF-kappaB": 5, "Tax": 5, "ATL": 5},\n{"IkappaBbeta": 5, "NF-kappaB": 5},\n{"NF-kappa B": 5},\n{"NF-kappa B": 5},\n{"NF-kappa B": 5},\n{"NF-kappa B": 5},\n{"NF-kappa B": 5, "I kappa B alpha": 5},\n{"NF-kappa B": 5, "I kappa B alpha": 5},\n{"IFN A": 5, "IFNA": 5, "interleukin-2": 5, "interleukin-2 receptor": 5, "phytohemagglutinin": 5, "phorbol myristate acetate": 5},\n{"HIV-1": 5, "IFN": 5, "PKR": 5, "IkappaBalpha": 5},\n{"CD40": 5, "Rel/nuclear factor kappaB": 5, "NF-kappaB": 5, "B lymphocytes": 5},\n{"TR55": 5, "TNF-alpha": 5, "HIV": 5},\n{"NF-kappaB": 5, "Sp1": 5, "SIVmac": 5}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"TNF-alpha": "protein"}, {"HIV type 1": "cell_type"}, {"HIV-1": "cell_type"}, {"RNA": "RNA"}, {"U937 cells": "cell_line"}]', 'prediction': {'NF-kappa B': 'protein', 'TNF-alpha': 'protein', 'HIV type 1': 'cell_type', 'HIV-1': 'cell_type', 'RNA': 'RNA', 'U937 cells': 'cell_line'}}
{'idx': 93, 'sentence': 'The Thy-1 gene promoter resembles a "housekeeping" promoter in that it is located within a methylation-free island , lacks a canonical TATA box , and displays heterogeneity in the 5\'-end termini of the mRNA .', 'label': {'canonical TATA box': 'DNA', '"housekeeping" promoter': 'DNA', 'methylation-free island': 'DNA', "5'-end termini": 'RNA', 'Thy-1 gene promoter': 'DNA', 'mRNA': 'RNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n    {"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 4},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 4},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"While the activation of the IL-2 promoter and an NFAT-driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418, it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2-mediated NFAT activation is under the control of a combination of calcineurin-dependent and independent pathways.": 5},\n    {"This sequence element was referred to as the BAT box and its deletion significantly reduced the activity of a CD20 promoter-CAT construct in B cells.": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5}\n]', 'response3': '[{"Thy-1 gene promoter": "DNA"}]', 'prediction': {'Thy-1 gene promoter': 'DNA'}}
{'idx': 1354, 'sentence': 'In addition, these results indicate that nuclear TCF-1 expression can serve as a pan-T-lineage marker in the diagnosis of lymphoid malignancies .', 'label': {'TCF-1': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 5},\n{"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n{"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 4},\n{"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n{"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 5},\n{"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.": 5},\n{"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 4},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n{"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n{"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n{"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n{"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 5},\n{"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n{"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n{"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 5},\n{"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4}\n]', 'response3': '[{"TCF-1": "protein"}, {"lymphoid malignancies": "cell_type"}]', 'prediction': {'TCF-1': 'protein', 'lymphoid malignancies': 'cell_type'}}
{'idx': 466, 'sentence': '(ABSTRACT TRUNCATED AT 250 WORDS)', 'label': {}, 'response1': 'None.', 'response2': '```json\n[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein entity (retinoic acid receptor alpha) and its corresponding label."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains multiple examples of cell_type and protein entities, aiding in the extraction of these named entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly mentions a protein entity (GATA-1) and its label, providing a helpful example for entity extraction."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence explicitly mentions a protein entity (retinoic acid receptor alpha) and its label, aiding in entity extraction."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides a clear example of a cell_type entity (nonhuman primates) and its corresponding label."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions a DNA entity (AP-1) and its label, aiding in the extraction of named entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains multiple examples of protein entities, helping in the extraction of these named entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions a protein entity (RXR) and its label, aiding in entity extraction."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides a clear example of a cell_line entity (SIVsmmPBj14) and its corresponding label."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions a cell_line entity (SCM-1) and its label, aiding in the extraction of named entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains multiple examples of protein entities, aiding in the extraction of these named entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides examples of protein entities (IL-2, c-Jun, c-Fos) and their labels, aiding in entity extraction."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions a protein entity (WT1) and its label, providing a helpful example for entity extraction."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions a protein entity (TCF-1) and its label, aiding in entity extraction."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides examples of cell_type, cell_line, and DNA entities, aiding in the extraction of named entities."}\n]\n```', 'response3': '```json\n[]\n```', 'prediction': {}}
{'idx': 1583, 'sentence': 'Associations between HLA class II antigens and autoantibodies to the ribonucleoproteins Ro(SSA) and La(SSB) have been reported in these patients.', 'label': {'ribonucleoproteins': 'protein', 'Ro(SSA)': 'protein', 'autoantibodies': 'protein', 'HLA class II antigens': 'protein', 'La(SSB)': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence contains a clear mention of the protein \'TCL1\', which is a named entity label in the entity label set."},\n{"Example 2": 5},\n{"Reason 2": "The sentence contains a clear mention of the protein \'WT1\', which is a named entity label in the entity label set."},\n{"Example 3": 5},\n{"Reason 3": "The sentence contains a clear mention of the protein \'RXR\', which is a named entity label in the entity label set."},\n{"Example 4": 5},\n{"Reason 4": "The sentence contains a clear mention of the cell type \'lymphoid neoplasms\', which is a named entity label in the entity label set."},\n{"Example 5": 5},\n{"Reason 5": "The sentence contains a clear mention of the protein \'NF-kappa B\', which is a named entity label in the entity label set."},\n{"Example 6": 5},\n{"Reason 6": "The sentence contains clear mentions of the proteins \'TCRzeta\' and \'p56(lck)\', which are named entity labels in the entity label set."},\n{"Example 7": 5},\n{"Reason 7": "The sentence contains a clear mention of the DNA \'AP-1\', which is a named entity label in the entity label set."},\n{"Example 8": 5},\n{"Reason 8": "The sentence contains clear mentions of the proteins \'EBNA-2\' and \'PU.1\', which are named entity labels in the entity label set."},\n{"Example 9": 5},\n{"Reason 9": "The sentence contains clear mentions of the proteins \'IL-2 receptor alpha subunit\' and \'p21ras\', as well as the cell type \'B cell\', which are named entity labels in the entity label set."},\n{"Example 10": 5},\n{"Reason 10": "The sentence contains clear mentions of the proteins \'SLAP-130\', \'SLP-76\', and the cell type \'T cell\', which are named entity labels in the entity label set."},\n{"Example 11": 5},\n{"Reason 11": "The sentence contains clear mentions of the proteins \'NF-kappaB\' and the cell type \'rheumatoid arthritis\', which are named entity labels in the entity label set."},\n{"Example 12": 5},\n{"Reason 12": "The sentence contains clear mentions of the proteins \'myeloperoxidase\', \'lysozyme\', and \'PU.1\', which are named entity labels in the entity label set."},\n{"Example 13": 5},\n{"Reason 13": "The sentence contains a clear mention of the protein \'retinoic acid receptor alpha\', which is a named entity label in the entity label set."},\n{"Example 14": 5},\n{"Reason 14": "The sentence contains clear mentions of the proteins \'Oct-2A\', \'HMG I/Y\', \'HLA-DRA\', and the cell type \'B cell\', which are named entity labels in the entity label set."},\n{"Example 15": 5},\n{"Reason 15": "The sentence contains clear mentions of the cell type \'T lymphocytes\' and the protein \'HLA-molecules\', which are named entity labels in the entity label set."},\n{"Example 16": 1},\n{"Reason 16": "The sentence does not contain any named entities from the entity label set."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any named entities from the entity label set."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any named entities from the entity label set."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any named entities from the entity label set."},\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any named entities from the entity label set."},\n{"Example 21": 1},\n{"Reason 21": "The sentence does not contain any named entities from the entity label set."},\n{"Example 22": 1},\n{"Reason 22": "The sentence does not contain any named entities from the entity label set."},\n{"Example 23": 1},\n{"Reason 23": "The sentence does not contain any named entities from the entity label set."},\n{"Example 24": 1},\n{"Reason 24": "The sentence does not contain any named entities from the entity label set."},\n{"Example 25": 1},\n{"Reason 25": "The sentence does not contain any named entities from the entity label set."}\n]', 'response3': "[{'HLA class II antigens': 'protein'}, {'ribonucleoproteins Ro(SSA)': 'protein'}, {'La(SSB)': 'protein'}]", 'prediction': {'HLA class II antigens': 'protein', 'ribonucleoproteins Ro(SSA)': 'protein', 'La(SSB)': 'protein'}}
{'idx': 592, 'sentence': 'The DNA isolated contained an open reading frame encoding 108 amino acid residues .', 'label': {}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 1},\n    {"Example 13": 1},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"DNA": "DNA"}]', 'prediction': {'DNA': 'DNA'}}
{'idx': 163, 'sentence': 'This phenomenon can be mimicked by administering MP in divided doses.', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides clear examples of named entities and their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1751, 'sentence': 'This effect is thought to be largely mediated through inactivation of the phosphatase calcineurin , which in turn inhibits translocation of an NFAT component to the nucleus.', 'label': {'NFAT': 'protein', 'calcineurin': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence 1": 5},\n    {"Sentence 2": 5},\n    {"Sentence 3": 5},\n    {"Sentence 4": 5},\n    {"Sentence 5": 5},\n    {"Sentence 6": 5},\n    {"Sentence 7": 5},\n    {"Sentence 8": 5},\n    {"Sentence 9": 5},\n    {"Sentence 10": 5},\n    {"Sentence 11": 5},\n    {"Sentence 12": 5},\n    {"Sentence 13": 5},\n    {"Sentence 14": 5},\n    {"Sentence 15": 5},\n    {"Sentence 16": 1},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1},\n    {"Sentence 20": 1},\n    {"Sentence 21": 1},\n    {"Sentence 22": 1},\n    {"Sentence 23": 1},\n    {"Sentence 24": 1},\n    {"Sentence 25": 1}\n]', 'response3': '[{"calcineurin": "protein"}, {"NFAT": "protein"}]', 'prediction': {'calcineurin': 'protein', 'NFAT': 'protein'}}
{'idx': 1774, 'sentence': 'Further studies are needed to elucidate if this sex difference in PBMC receptors for 1.25 Dihydroxyvitamin D3 is of any pathophysiological relevance .', 'label': {'PBMC': 'cell_type', 'PBMC receptors': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 3},\n    {"An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage.": 4},\n    {"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).": 5},\n    {"These results indicate that the monocyte/B-cell-specific transcription factor PU.1 and the Mono A and Mono B protein complexes act in concert to regulate monocyte-specific transcription of the CSF-1 receptor.": 5},\n    {"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.": 5},\n    {"A 3-bp mutation at the distal Sp1-binding site not only eliminates Sp1 interaction, but also abolishes most of the VitD3 induction of CD14 expression.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 206, 'sentence': 'It is concluded that (i) patients with CLL rarely express ER and (ii) immunocytochemical staining of cytospin preparations is a valid technique for the measurement of ER .', 'label': {'ER': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor )": 5},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 4},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 4},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL .": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 5},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n    {"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 4},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms .": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 928, 'sentence': 'A mouse ets-1 cDNA clone was obtained by screening a mouse thymus cDNA expression library with a double-stranded oligonucleotide probe representing 20 bp of the Moloney murine sarcoma virus ( MSV ) long terminal repeat ( LTR ).', 'label': {'ets-1': 'protein', 'long terminal repeat': 'DNA', 'double-stranded oligonucleotide probe': 'DNA', 'mouse thymus cDNA expression library': 'DNA', 'mouse ets-1 cDNA clone': 'DNA', 'LTR': 'DNA'}, 'response1': "['DNA', 'RNA']", 'response2': '[\n    {"SIVsmmPBj14": 5},\n    {"SIVmacMER": 5},\n    {"SIVmac239": 5},\n    {"CEMx174": 5},\n    {"GM-CSF": 5},\n    {"PML/RARalpha": 5},\n    {"Th2-type lymphocytes": 5},\n    {"protein": 5},\n    {"Sp1": 5},\n    {"Ets": 5},\n    {"c-kit": 5},\n    {"IL-4R alpha chain": 5},\n    {"TCF-1": 5},\n    {"MIP-1 alpha": 5},\n    {"GOS19": 5},\n    {"LD78": 5},\n    {"AT464": 5},\n    {"CD14": 5},\n    {"IFN A": 5},\n    {"IFNA": 5},\n    {"interleukin-2": 5},\n    {"interleukin-2 receptor": 5},\n    {"phytohemagglutinin": 5},\n    {"phorbol myristate acetate": 5},\n    {"SLAP-130": 5},\n    {"SLP-76": 5},\n    {"T cell": 5},\n    {"Egr-1": 5},\n    {"E2A": 5},\n    {"CD95 ligand": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1301, 'sentence': 'It was found that the most significant variable predicting NK activity at follow-up was tumor ER concentration , with higher NK activity associated with ER -status .', 'label': {'ER': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 1},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1}\n]', 'response3': '[{"ER": "protein"}, {"NK activity": "cell_type"}, {"tumor ER concentration": "cell_line"}, {"ER -status": "cell_line"}]', 'prediction': {'ER': 'protein', 'NK activity': 'cell_type', 'tumor ER concentration': 'cell_line', 'ER -status': 'cell_line'}}
{'idx': 1708, 'sentence': 'The Ca(2+) -dependent phosphatase calcineurin , a target of FK506 and CsA , synergizes with PKC -induced activation of nuclear factor (NF)-kappa B in T cell lines .', 'label': {'nuclear factor (NF)-kappa B': 'protein', 'T cell lines': 'cell_line', 'Ca(2+) -dependent phosphatase': 'protein', 'PKC': 'protein', 'calcineurin': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of the entity \'calcineurin\' and its corresponding label \'protein\', making it highly helpful for extracting named entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence clearly mentions \'IkappaBalpha\' and \'NF-kappaB\' as proteins, aiding in the extraction of named entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence explicitly refers to \'IkappaBbeta\' and \'NF-kappaB\' as proteins, facilitating the identification of named entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence mentions \'NF-kappa B\' and \'AP-1\' as proteins, providing valuable examples for named entity extraction."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains references to \'PAFR\', \'PAF\', \'NF-kappa B\', and \'protein kinase C\' as proteins, aiding in named entity extraction."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides clear examples of \'CD40\', \'NF-kappa B\', and their corresponding labels \'protein\', assisting in named entity extraction."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence mentions \'CD28\', \'CD80\', \'CD86\', \'CBL\', \'VAV\', \'NFAT\', \'interleukin-2\', and \'granulocyte-macrophage colony-stimulating factor\' as proteins, making it highly helpful for named entity extraction."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence explicitly refers to \'NF-kappaB\', \'Tax\', and \'ATL\' as proteins and cell types, aiding in named entity extraction."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains \'NF-kappa B\' and \'I kappa B beta\' as proteins, providing valuable examples for named entity extraction."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions \'NF-kappa B\' and \'I kappa B alpha\' as proteins, aiding in named entity extraction."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides a clear example of \'NF-kappa B\' as a protein, making it highly helpful for extracting named entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions \'RelA\' and \'NF-kappa B\' as proteins, providing valuable examples for named entity extraction."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains \'Syk\', \'Zap\', and \'T cell\' as proteins and a cell type, aiding in named entity extraction."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides a clear example of \'NF-kappa B\' as a protein, making it highly helpful for extracting named entities."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions \'SP1\', \'caspases\', and \'B-cell\' as proteins and a cell type, aiding in named entity extraction."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence contains \'NF-kappa B\' as a protein, providing a valuable example for named entity extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities related to the given entity labels, making it not helpful for named entity extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities related to the given entity labels, making it not helpful for named entity extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities related to the given entity labels, making it not helpful for named entity extraction."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities related to the given entity labels, making it not helpful for named entity extraction."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities related to the given entity labels, making it not helpful for named entity extraction."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities related to the given entity labels, making it not helpful for named entity extraction."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities related to the given entity labels, making it not helpful for named entity extraction."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities related to the given entity labels, making it not helpful for named entity extraction."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities related to the given entity labels, making it not helpful for named entity extraction."}\n]', 'response3': '[{"calcineurin": "protein"}, {"FK506": "protein"}, {"CsA": "protein"}, {"PKC": "protein"}, {"NF-kappa B": "protein"}, {"T cell lines": "cell_line"}]', 'prediction': {'calcineurin': 'protein', 'FK506': 'protein', 'CsA': 'protein', 'PKC': 'protein', 'NF-kappa B': 'protein', 'T cell lines': 'cell_line'}}
{'idx': 747, 'sentence': 'Protein kinase inhibitor H-7 blocks accumulation of unspliced mRNA of human T-cell leukemia virus type I ( HTLV-I ).', 'label': {'unspliced mRNA': 'RNA'}, 'response1': "['protein', 'RNA']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .": 5},\n    {"Control of NF-kappa B activity by the I kappa B beta inhibitor .": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Tat-binding protein 7 is a subunit of the 26S protease .": 5},\n    {"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 5},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells .": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 333, 'sentence': 'These protoenhancers alone are weakly or not responsive to R .', 'label': {'protoenhancers': 'DNA', 'R': 'protein'}, 'response1': "['RNA']", 'response2': '[\n    {"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5},\n    {"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .": 4},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50 .": 4},\n    {"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements .": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 4},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .": 5},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 5},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 758, 'sentence': 'Cell proliferation of CEM-C7 cells cultured in both serum-free media has been sustained for 3 mo.', 'label': {'CEM-C7': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[\n{"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.": 5},\n{"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 4},\n{"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 4},\n{"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 4},\n{"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 3},\n{"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n{"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 4},\n{"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n{"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 5},\n{"Thus, we were able to derive a hematopoietic cell line, called 47.10, that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.": 5},\n{"Notably, the lack of pRB in these U937-derived clones renders these p53-null cells highly resistant to apoptosis induced by serum withdrawal, calphostin C, and ceramide.": 5},\n{"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.": 5},\n{"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.": 5},\n{"We isolated a novel subline, UT-7/GMT, from the human leukemia cell line UT-7/GM (N. Komatsu, et al., Blood, 89: 4021-4033, 1997).": 5},\n{"The modified vectors were used to transduce human hematopoietic cell lines, cord blood-derived CD34(+) stem/progenitor cells, and murine bone marrow repopulating stem cells.": 5},\n{"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"CEM-C7 cells": "cell_line"}]', 'prediction': {'CEM-C7 cells': 'cell_line'}}
{'idx': 727, 'sentence': 'The importance of the internal ATGs to Rex function is not known.', 'label': {'Rex': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein (Runt domain) and its corresponding entity label."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides a clear example of a protein (TCF-1) and its corresponding entity label."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence provides a clear example of a protein (tyrosine) and its corresponding entity label."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence provides a clear example of a cell type (nonhuman primates) and its corresponding entity label."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides clear examples of proteins (IL-7R and gamma(c)) and their corresponding entity labels."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides a clear example of a cell line (SIVsmmPBj14) and its corresponding entity label."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides clear examples of proteins (Jun and ATF-2) and their corresponding entity labels."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides a clear example of a protein (GATA-1) and its corresponding entity label."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence provides a clear example of a protein (NF-kappaB) and a cell type (rheumatoid arthritis) and their corresponding entity labels."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides clear examples of proteins (IL-2, c-Jun, and c-Fos) and their corresponding entity labels."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides a clear example of a protein (RXR) and its corresponding entity label."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides a clear example of a protein (Protein) and its corresponding entity label."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides clear examples of DNA elements (UAS3 and UAS2) and a protein (YY1) and their corresponding entity labels."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides clear examples of proteins (IL-2, Aiolos, and Ras) and their corresponding entity labels."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides a clear example of a protein (IL-4) and its corresponding entity label."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence provides a clear example of a cell line (SCM-1) and its corresponding entity label."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities related to the entity labels in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities related to the entity labels in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any named entities related to the entity labels in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any named entities related to the entity labels in the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any named entities related to the entity labels in the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any named entities related to the entity labels in the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any named entities related to the entity labels in the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any named entities related to the entity labels in the target sentence."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any named entities related to the entity labels in the target sentence."},\n    {"Example 26": 1},\n    {"Reason 26": "The sentence does not contain any named entities related to the entity labels in the target sentence."},\n    {"Example 27": 1},\n    {"Reason 27": "The sentence does not contain any named entities related to the entity labels in the target sentence."},\n    {"Example 28": 1},\n    {"Reason 28": "The sentence does not contain any named entities related to the entity labels in the target sentence."},\n    {"Example 29": 1},\n    {"Reason 29": "The sentence does not contain any named entities related to the entity labels in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 429, 'sentence': 'As shown by mobility-shift , methylation interference , and mutational analyses , the mammalian protein BSAP recognizes all four sea urchin binding sites in a manner indistinguishable from TSAP ; however, the two proteins differ in molecular weight.', 'label': {'TSAP': 'protein', 'mammalian protein': 'protein', 'sea urchin binding sites': 'DNA', 'BSAP': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.": 5},\n    {"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n    {"Tat-binding protein 7 is a subunit of the 26S protease.": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 5},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 5},\n    {"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1372, 'sentence': 'The TCL1 oncogene on human chromosome 14q32.1 is involved in chromosome translocations [ t(14;14)(q11;q32.1) and t(7;14)(q35;q32.1) ] and inversions [ inv14(q11;q32.1) ] with TCR alpha/beta loci in T-cell leukemias , such as T-prolymphocytic ( T-PLL ).', 'label': {'14q32.1': 'DNA', 'TCR alpha/beta loci': 'DNA', 't(14;14)(q11;q32.1)': 'DNA', 'TCL1 oncogene': 'DNA', 'human chromosome': 'DNA', 't(7;14)(q35;q32.1)': 'DNA', 'inv14(q11;q32.1)': 'DNA'}, 'response1': "['DNA', 'cell_type']", 'response2': '[\n    {"Therefore, we investigated whether IVS1-10T-->C deleteriously affected BRCA1 splicing or expression, and thereby inactivated the other BRCA1 allele.": 5},\n    {"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.": 5},\n    {"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes.": 5},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 5},\n    {"By the time of diagnosis of T-PLL, the clone contains many more genetic changes in the form of additional translocations.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n    {"SCL is expressed in erythroid, megakaryocyte and mast cell populations (the same cell lineages as GATA-1, a zinc-finger transcription factor).": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"TCL1": "protein"}, {"TCR alpha/beta": "protein"}, {"T-cell": "cell_type"}, {"T-prolymphocytic (T-PLL)": "cell_type"}]', 'prediction': {'TCL1': 'protein', 'TCR alpha/beta': 'protein', 'T-cell': 'cell_type', 'T-prolymphocytic (T-PLL)': 'cell_type'}}
{'idx': 546, 'sentence': 'Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin .', 'label': {'T lymphocytes': 'cell_type', 'immunophilin': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein entity (calcineurin) and its corresponding label."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides a clear example of a protein entity (NF-kappa B) and its corresponding label."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence provides multiple examples of protein entities (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) and their corresponding labels."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides multiple examples of protein entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) and their corresponding labels."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides multiple examples of protein entities (IL-2, IL-2 receptor, CD28) and their corresponding labels, as well as a cell type entity (T cell)."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides multiple examples of protein entities (IL-5 mRNA, TCR, IL-2R, dexamethasone) and their corresponding labels, as well as an RNA entity (IL-5 mRNA)."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides multiple examples of protein entities (NF-kappa B, I kappa B alpha) and their corresponding labels."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides a clear example of a protein entity (IL-2) and its corresponding label."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides multiple examples of protein entities (CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, granulocyte-macrophage colony-stimulating factor) and their corresponding labels."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides multiple examples of protein entities (NF-ATc, T lymphocytes) and their corresponding labels."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides multiple examples of protein entities (IkappaBbeta, NF-kappaB) and their corresponding labels."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides multiple examples of protein entities (IL-2 receptor alpha subunit, p21ras) and their corresponding labels, as well as a cell type entity (B cell)."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides multiple examples of protein entities (Syk, Zap, T cell) and their corresponding labels."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides multiple examples of protein entities (IL-2, NF-kappa B, AP-1) and their corresponding labels."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides multiple examples of protein entities (IL-2, Aiolos, Ras) and their corresponding labels."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence provides multiple examples of protein entities (IkappaBalpha, NF-kappaB) and their corresponding labels."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities from the given label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities from the given label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities from the given label set."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities from the given label set."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities from the given label set."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities from the given label set."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities from the given label set."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities from the given label set."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities from the given label set."}\n]', 'response3': "[{'T lymphocytes': 'cell_type'}, {'immunophilin': 'protein'}, {'FK506': 'protein'}, {'rapamycin': 'protein'}]", 'prediction': {'T lymphocytes': 'cell_type', 'immunophilin': 'protein', 'FK506': 'protein', 'rapamycin': 'protein'}}
{'idx': 1437, 'sentence': 'In summary, we developed an assay for the quantitative determination of hTR beta 1 mRNA levels in small human tissue samples , containing as little as 50 ng of total RNA.', 'label': {'hTR beta 1': 'protein', 'hTR beta 1 mRNA': 'RNA'}, 'response1': "['RNA']", 'response2': '[\n{"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 4},\n{"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 3},\n{"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 4},\n{"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.": 4},\n{"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 4},\n{"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 4},\n{"To evaluate the PML/RARalpha role in myelopoiesis, transgenic mice expressing PML/RARalpha were engineered.": 4},\n{"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 4},\n{"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.": 5},\n{"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 4},\n{"Thus, we were able to derive a hematopoietic cell line, called 47.10, that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.": 5},\n{"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n{"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.": 4},\n{"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 4}\n]', 'response3': '[{"hTR beta 1 mRNA": "RNA"}]', 'prediction': {'hTR beta 1 mRNA': 'RNA'}}
{'idx': 1399, 'sentence': 'To investigate the role of NF-M in hematopoietic cell lineage commitment, we constructed a conditional form of the protein by fusing it to the hormone binding domain of the human estrogen receptor .', 'label': {'hematopoietic cell lineage': 'cell_line', 'human estrogen receptor': 'protein', 'NF-M': 'protein', 'hormone binding domain': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '```json\n[\n    {"NF-kappa B": 5},\n    {"IL-2": 5},\n    {"NF-E2": 5},\n    {"E2A": 5},\n    {"MNDA": 5, "Philadelphia chromosome-positive chronic myeloid leukemia": 5},\n    {"c-kit": 5, "IL-4R alpha chain": 5},\n    {"PML/RARalpha": 5},\n    {"RXR": 5},\n    {"TRAF6": 5, "RANKL": 5, "NF-kappaB": 5},\n    {"NF-ATc": 5, "T lymphocytes": 5, "embryonic cardiac cells": 5},\n    {"CD40": 5, "NF-kappa B": 5},\n    {"GATA-1": 5},\n    {"TCF-1": 5},\n    {"NF-kappa B": 5},\n    {"IL-2": 5},\n    {"ZEB": 5, "c-Myb": 5, "Ets": 5, "hematopoietic cells": 5}\n]\n```', 'response3': '```json\n[{"NF-M": "protein"}, {"hormone binding domain": "protein"}, {"human estrogen receptor": "protein"}]\n```', 'prediction': {'NF-M': 'protein', 'hormone binding domain': 'protein', 'human estrogen receptor': 'protein'}}
{'idx': 1327, 'sentence': 'Our results demonstrate that NF-IL6 is involved in transcriptional activation of the human IL-4 promoter in T cells .', 'label': {'human IL-4': 'protein', 'human IL-4 promoter': 'DNA', 'NF-IL6': 'protein', 'T cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a direct mapping between the entity \'IL-4\' and its corresponding label \'protein\' in the target sentence, aiding in the extraction of named entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The example provides multiple mappings between entities and their corresponding labels in the target sentence, aiding in the extraction of named entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides multiple mappings between entities and their corresponding labels in the target sentence, aiding in the extraction of named entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The example provides multiple mappings between entities and their corresponding labels in the target sentence, aiding in the extraction of named entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides a direct mapping between the entities \'NF-kappa B\' and \'I kappa B alpha\' and their corresponding labels \'protein\' in the target sentence, aiding in the extraction of named entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The example provides multiple mappings between entities and their corresponding labels in the target sentence, aiding in the extraction of named entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides a direct mapping between the entity \'NF-kappa B\' and its corresponding label \'protein\' in the target sentence, aiding in the extraction of named entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides multiple mappings between entities and their corresponding labels in the target sentence, aiding in the extraction of named entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides a direct mapping between the entity \'IL-4\' and its corresponding label \'protein\' in the target sentence, aiding in the extraction of named entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides a direct mapping between the entity \'IL-2\' and its corresponding label \'protein\' in the target sentence, aiding in the extraction of named entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides a direct mapping between the entity \'IkappaBbeta\' and its corresponding label \'protein\' in the target sentence, aiding in the extraction of named entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The example provides multiple mappings between entities and their corresponding labels in the target sentence, aiding in the extraction of named entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides multiple mappings between entities and their corresponding labels in the target sentence, aiding in the extraction of named entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The example provides a direct mapping between the entity \'IL-13\' and its corresponding label \'protein\' in the target sentence, aiding in the extraction of named entities."},\n    {"Example 15": 5},\n    {"Reason 15": "The example provides multiple mappings between entities and their corresponding labels in the target sentence, aiding in the extraction of named entities."},\n    {"Example 16": 5},\n    {"Reason 16": "The example provides a direct mapping between the entity \'IL-2\' and its corresponding label \'protein\' in the target sentence, aiding in the extraction of named entities."}\n]', 'response3': '[{"NF-IL6": "protein"}, {"IL-4": "protein"}, {"T cells": "cell_type"}]', 'prediction': {'NF-IL6': 'protein', 'IL-4': 'protein', 'T cells': 'cell_type'}}
{'idx': 146, 'sentence': 'Unlike other class II promoters , the HLA-DR alpha (DRA) promoter also contains one element identical to the "octamer" motif of immunoglobulin variable region promoters that is responsible for B cell-specific transcription .', 'label': {'"octamer" motif': 'DNA', 'HLA-DR alpha (DRA) promoter': 'DNA', 'class II promoters': 'DNA', 'immunoglobulin variable region promoters': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 4},\n    {"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.": 5},\n    {"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 4},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 4},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5}\n]', 'response3': '[{"HLA-DR alpha (DRA)": "protein"}, {"octamer": "protein"}, {"immunoglobulin variable region": "protein"}, {"B cell-specific": "cell_type"}]', 'prediction': {'HLA-DR alpha (DRA)': 'protein', 'octamer': 'protein', 'immunoglobulin variable region': 'protein', 'B cell-specific': 'cell_type'}}
{'idx': 1247, 'sentence': 'The Janus family tyrosine kinase Jak3 is the only signaling molecule known to be associated with gamma c , so it was hypothesized that defects in Jak3 might cause an XSCID -like phenotype .', 'label': {'Janus family tyrosine kinase': 'protein', 'Jak3': 'protein', 'gamma c': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 3},\n    {"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.": 4},\n    {"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.": 4},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 4},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n    {"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/thrombopoiesis or possibly a mature platelet function such as aggregation.": 5},\n    {"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n    {"SCL is expressed in erythroid, megakaryocyte and mast cell populations (the same cell lineages as GATA-1, a zinc-finger transcription factor).": 4},\n    {"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine (IL-2 and IFN-gamma) production is normal.": 5},\n    {"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 3}\n]', 'response3': '[{"Jak3": "protein"}, {"gamma c": "protein"}, {"Jak3": "protein"}]', 'prediction': {'Jak3': 'protein', 'gamma c': 'protein'}}
{'idx': 1300, 'sentence': 'As considerable evidence has accumulated that social support in both animal and human populations may have survival value, we sought to test the reliability of this regression model , using coping and perceived support factor values obtained at 3 months after surgery to account for concurrent follow-up NK activity in this serially assessed group of patients .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Protein": 5},\n    {"nonhuman primates": 4},\n    {"SIVsmmPBj14": 5},\n    {"SCM-1": 4},\n    {"immunoglobulin kappa 3\' enhancer": 5},\n    {"NF-kappa B": 5},\n    {"granulocytes": 4},\n    {"T cells": 4},\n    {"cAMP-dependent protein kinase": 5},\n    {"SIVmacMER": 5},\n    {"SIVmac239": 5},\n    {"CEMx174": 5},\n    {"TIMP-1": 5},\n    {"DNA": 5},\n    {"CD40": 5},\n    {"Rel/nuclear factor kappaB": 5},\n    {"NF-kappaB": 5},\n    {"B lymphocytes": 4},\n    {"interleukin-2": 5},\n    {"CD25": 5},\n    {"IL-2 receptor": 5},\n    {"p50": 5},\n    {"p65": 5},\n    {"GC-box": 5},\n    {"GC-motif": 5},\n    {"GM-kappa B motif": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 350, 'sentence': 'Induction of 24,25-(OH)2D3 synthesis by 1,25(OH)2D3 was observed in the fifth cell line , designated Ro-VDR , although the sensitivity to hormone treatment was lower than in the control cell line from a normal donor .', 'label': {'control cell line': 'cell_line', 'cell line': 'cell_line', 'Ro-VDR': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 5},\n    {"Example 17": 5},\n    {"Example 18": 5},\n    {"Example 19": 5},\n    {"Example 20": 5},\n    {"Example 21": 5},\n    {"Example 22": 5},\n    {"Example 23": 5},\n    {"Example 24": 5},\n    {"Example 25": 5}\n]', 'response3': '[{"24,25-(OH)2D3": "protein"}, {"1,25(OH)2D3": "protein"}, {"Ro-VDR": "cell_line"}]', 'prediction': {'24,25-(OH)2D3': 'protein', '1,25(OH)2D3': 'protein', 'Ro-VDR': 'cell_line'}}
{'idx': 1093, 'sentence': 'The genomic actions of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) are mediated by the intracellular vitamin D receptor ( VDR ).', 'label': {'VDR': 'protein', 'vitamin D receptor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides clear examples of proteins and cell types, which are the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly mentions a protein entity that matches the entity type in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence mentions a protein entity that matches the entity type in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides a clear example of a protein entity that matches the entity type in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains examples of protein entities and a cell type that match the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence mentions a protein entity that matches the entity type in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions protein entities that match the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides examples of protein entities and a cell line that match the entity types in the target sentence."},\n    {"Example 10": 1},\n    {"Reason 10": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 11": 1},\n    {"Reason 11": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 12": 1},\n    {"Reason 12": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities that match the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1493, 'sentence': 'Chronic HIV-1 infection of myeloid cells leads to constitutive NF-kappa B DNA-binding activity and provides an intranuclear environment capable of perpetuating HIV-1 replication .', 'label': {'myeloid cells': 'cell_type', 'NF-kappa B': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of the entity \'NF-kappa B\' and its corresponding label \'protein\', making it highly helpful for extracting named entities from the target sentence."}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"DNA": "DNA"}, {"HIV-1": "cell_type"}]', 'prediction': {'NF-kappa B': 'protein', 'DNA': 'DNA', 'HIV-1': 'cell_type'}}
{'idx': 334, 'sentence': "One of the protoenhancers contains the overlapping palindromes 5'-TTGTCCcgtGGACAAaTGTCC-3' .", 'label': {'protoenhancers': 'DNA', 'overlapping palindromes': 'DNA'}, 'response1': "['DNA']", 'response2': '[\n    {"IgH": 5},\n    {"BRCA1": 5},\n    {"EBNA2": 4, "TP1": 4},\n    {"GM-CSF": 4},\n    {"Protein": 5},\n    {"IL-2": 4, "c-Jun": 4, "c-Fos": 4},\n    {"p50p50": 5},\n    {"EKLF": 5},\n    {"TCF-1": 5},\n    {"ZEBRA": 5},\n    {"immunoglobulin kappa 3\' enhancer": 5},\n    {"Egr-1": 5},\n    {"T cell": 4, "interleukin 2": 4},\n    {"Th2-type lymphocytes": 5},\n    {"CD95 ligand": 5},\n    {"GM-kappa B": 5, "GC-box": 5, "GC-motif": 5, "GM-kappa B motif": 5},\n    {"estrogen": 1, "progesterone": 1, "tumor size": 1, "polyamine concentrations": 1},\n    {"AIDS": 1, "transcriptional initiation": 1, "transcriptional elongation": 1},\n    {"alpha-herpesvirus": 1, "beta-herpesvirus": 1, "herpes simplex": 1, "cytomegalovirus": 1},\n    {"HIV-1": 1, "HIV-2": 1},\n    {"contraction": 1, "allele": 1},\n    {"B-cell": 1, "intrahepatic lymphoid follicles": 1, "chronic hepatitis C": 1},\n    {"Lymphocyte infiltration": 1, "tumor": 1, "hormone metabolic status": 1, "tumor tissue hormone sensitivity": 1, "tobacco smoking": 1, "breast cancer patients": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3": 1, "VD": 1, "monocytic differentiation": 1, "leukemic cells": 1},\n    {"glucocorticoid": 1, "megadoses": 1},\n    {"nucleotide 2,317": 1, "homozygous A for G point mutation": 1, "isoleucine": 1, "valine": 1, "amino acid 729": 1}\n]', 'response3': '[{"TTGTCCcgtGGACAAaTGTCC": "DNA"}]', 'prediction': {'TTGTCCcgtGGACAAaTGTCC': 'DNA'}}
{'idx': 946, 'sentence': 'Compared to the control group , fewer depressed subjects down-regulated Bmax after DEX .', 'label': {}, 'response1': "['protein']", 'response2': '[\n{"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 5},\n{"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.": 5},\n{"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.": 5},\n{"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 5},\n{"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 5},\n{"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n{"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 5},\n{"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects.": 5},\n{"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 5},\n{"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5},\n{"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 5},\n{"The expression of NDP kinase was intense in KA and SCC compared with BCC.": 5},\n{"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n{"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 5},\n{"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex.": 5},\n{"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 777, 'sentence': 'We have identified two human pre-B-cell lines that contain extremely low levels of OTF-2 yet still express high levels of steady-state immunoglobulin heavy-chain mRNA in vivo and efficiently transcribe an immunoglobulin gene in vitro.', 'label': {'OTF-2': 'protein', 'immunoglobulin gene': 'DNA', 'steady-state immunoglobulin heavy-chain mRNA': 'RNA', 'human pre-B-cell lines': 'cell_line', 'immunoglobulin heavy-chain': 'protein'}, 'response1': "['cell_line', 'RNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence directly mentions the entity and provides clear context for its identification."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not mention any entities relevant to the given entity labels."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not mention any entities relevant to the given entity labels."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not mention any entities relevant to the given entity labels."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not mention any entities relevant to the given entity labels."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not mention any entities relevant to the given entity labels."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not mention any entities relevant to the given entity labels."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not mention any entities relevant to the given entity labels."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not mention any entities relevant to the given entity labels."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not mention any entities relevant to the given entity labels."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not mention any entities relevant to the given entity labels."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not mention any entities relevant to the given entity labels."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not mention any entities relevant to the given entity labels."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 552, 'sentence': 'Similarly, an excess of FK506 is needed to revert rapamycin -mediated inhibition of IL-2 -induced proliferation .', 'label': {'IL-2': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1}\n]', 'response3': '[{"IL-2": "protein"}, {"FK506": "protein"}, {"rapamycin": "protein"}]', 'prediction': {'IL-2': 'protein', 'FK506': 'protein', 'rapamycin': 'protein'}}
{'idx': 1310, 'sentence': 'The abundant chromosomal protein HMG-1 belongs to this subgroup.', 'label': {'HMG-1': 'protein', 'chromosomal protein': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 5},\n{"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n{"This protein has now been purified and its encoding gene cloned.": 5},\n{"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.": 1},\n{"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 1},\n{"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n{"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 5},\n{"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n{"Tat-binding protein 7 is a subunit of the 26S protease.": 5},\n{"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n{"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n{"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.": 5},\n{"Here we examined the regulatory mechanism of the SCM-1 genes.": 5},\n{"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1409, 'sentence': 'We investigated the ability of PRL and IL-2 to activate Stat proteins in different T cell lines .', 'label': {'IL-2': 'protein', 'T cell lines': 'cell_line', 'PRL': 'protein', 'Stat proteins': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence directly mentions the entity \'IL-2\' and its association with the protein entity type, providing clear and specific information for entity extraction."}\n]', 'response3': '[{"PRL": "protein"}, {"IL-2": "protein"}, {"Stat proteins": "protein"}, {"T cell lines": "cell_line"}]', 'prediction': {'PRL': 'protein', 'IL-2': 'protein', 'Stat proteins': 'protein', 'T cell lines': 'cell_line'}}
{'idx': 1140, 'sentence': 'The conserved cis-acting sequence , GGAAAA , and transcription factors binding to this sequence are involved in the response to increased intracellular Ca2+ concentrations .', 'label': {'transcription factors': 'protein', 'conserved cis-acting sequence': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '```json\n[\n    {"Example 1": 4},\n    {"Reason 1": "The sentence provides a clear example of a transcription factor (AP-1) and its association with DNA binding activity, which matches the entity types in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides examples of two proteins (Jun and ATF-2) and their roles in transcription, which directly match the entity types in the target sentence."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence mentions Th2-type lymphocytes, which corresponds to the cell_type entity type in the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence mentions protein sequences, which align with the protein entity type in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides a clear example of a protein (Egr-1) and its role as a transcription factor, matching the entity types in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides examples of proteins (IL-2, c-Jun, c-Fos) and their interactions with DNA, matching the entity types in the target sentence."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence mentions GM-CSF, which corresponds to the protein entity type in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides a clear example of a protein (GATA-1) and its role as a transcription factor, matching the entity types in the target sentence."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence mentions TCF-1, which corresponds to the protein entity type in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides a clear example of proteins (Stat proteins) and their role in transcription, matching the entity types in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides examples of proteins (EKLF, CBP, p300, P/CAF) and their interactions, matching the entity types in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides examples of proteins (SCL, GATA-1) and their roles in specific cell lineages, matching the entity types in the target sentence."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence mentions G-CSF, which corresponds to the protein entity type in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides examples of proteins (VDR, RXR, GRIP-1, DRIP205, DRIP) and their interactions, matching the entity types in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides examples of proteins (ZEB, c-Myb, Ets) and their roles in gene regulation, matching the entity types in the target sentence."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence provides examples of proteins (tal-1, GATA-binding proteins) and their roles in hematopoiesis, matching the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities that match the entity types in the target sentence."}\n]\n```', 'response3': '```json\n[]\n```', 'prediction': {}}
{'idx': 449, 'sentence': 'We find that the factor that binds to the E3 enhancer motif , CATGTGGC , is a ubiquitous transcription factor .', 'label': {'ubiquitous transcription factor': 'protein', 'E3 enhancer motif': 'DNA'}, 'response1': "['DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains multiple protein names and their interactions, which are directly related to the entity labels in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence mentions specific protein names that are relevant to the entity labels in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence refers to a specific DNA motif, which is directly related to the DNA entity label in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence mentions a specific protein name that is relevant to the entity labels in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains a specific protein name and cell types that are directly related to the entity labels in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions specific protein names that are relevant to the entity labels in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence refers to a specific cell type, which is directly related to the cell_type entity label in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions specific protein names that are relevant to the entity labels in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence mentions a specific protein name that is relevant to the entity labels in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains specific protein names and a cell type that are directly related to the entity labels in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions specific protein names and DNA, which are relevant to the entity labels in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions a specific protein name that is relevant to the entity labels in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains specific protein names that are directly related to the entity labels in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions specific protein names and DNA, which are relevant to the entity labels in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entity types mentioned in the target sentence."}\n]', 'response3': '[{"E3 enhancer motif": "DNA"}]', 'prediction': {'E3 enhancer motif': 'DNA'}}
{'idx': 1402, 'sentence': 'At the same time, we observed a down-regulation of progenitor-specific surface markers and the up-regulation of differentiation markers restricted to the eosinophil and myeloid lineages .', 'label': {'eosinophil': 'cell_type', 'myeloid lineages': 'cell_type', 'differentiation markers': 'protein', 'progenitor-specific surface markers': 'protein'}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein (GATA-1) and its corresponding entity label."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides a clear example of a protein (Egr-1) and its corresponding entity label."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence provides a clear example of a protein (NF-E2) and its corresponding entity label."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides a clear example of a protein (retinoic acid receptor alpha) and its corresponding entity label."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides a clear example of a protein (CD14) and its corresponding entity label."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides clear examples of cell types (Th1 and Th2) and their corresponding entity labels."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides a clear example of a protein (E2A) and its corresponding entity label."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides clear examples of a cell line (B cell) and a cell type (B cell) with their corresponding entity labels."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides a clear example of a protein (WT1) and its corresponding entity label."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides clear examples of proteins (CD14 and CD23) and their corresponding entity labels."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides clear examples of proteins (myeloperoxidase, lysozyme, PU.1) and their corresponding entity labels."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides clear examples of a protein (WT1) and a cell line (myeloid cell lines) with their corresponding entity labels."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides clear examples of a protein (MNDA) and a cell line (Philadelphia chromosome-positive chronic myeloid leukemia) with their corresponding entity labels."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides clear examples of cell types (granulocytes and T cells) and their corresponding entity labels."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides a clear example of a protein (GATA-1) and its corresponding entity label."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence provides clear examples of proteins (Sp1 and Ets) and their corresponding entity labels."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 26": 1},\n    {"Reason 26": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 27": 1},\n    {"Reason 27": "The sentence does not contain any entities from the given entity label set."}\n]', 'response3': "[{'eosinophil': 'cell_type'}, {'myeloid': 'cell_type'}]", 'prediction': {'eosinophil': 'cell_type', 'myeloid': 'cell_type'}}
{'idx': 664, 'sentence': 'Interferon-gamma and the sexual dimorphism of autoimmunity .', 'label': {'Interferon-gamma': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 5},\n    {"In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine (IFN-gamma) in combination with allergy-driven overproduction of T helper 2-type cytokines.": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n    {"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency.": 5},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"The role of the transcription factor NF-kappaB in the pathogenesis of rheumatoid arthritis has long been a subject of controversy.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 5},\n    {"CD40 expression could be enhanced in CD40-positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1726, 'sentence': 'It is tempting to speculate that enhanced NF-kappa B expression caused by free radical production/oxidative stress may modulate liver injury , perhaps through an effect on cytotoxic cytokine synthesis .', 'label': {'NF-kappa B': 'protein', 'cytotoxic cytokine': 'protein'}, 'response1': "['protein']", 'response2': '```json\n[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains the entity \'NF-kappa B\' which is labeled as \'protein\' in the entity label set. The example provides a clear match between the entity in the sentence and its corresponding entity label."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains the entities \'NF-kappa B\' and \'ARDS\' which are labeled as \'protein\' and \'cell_type\' respectively in the entity label set. The example provides a match between the entities in the sentence and their corresponding entity labels."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains the entities \'PAFR\', \'PAF\', \'NF-kappa B\', and \'protein kinase C\' which are labeled as \'protein\' in the entity label set. The example provides a clear match between the entities in the sentence and their corresponding entity labels."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains the entities \'NF-kappa B\' and \'I kappa B alpha\' which are labeled as \'protein\' in the entity label set. The example provides a clear match between the entities in the sentence and their corresponding entity labels."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains the entity \'NF-kappa B\' which is labeled as \'protein\' in the entity label set. The example provides a clear match between the entity in the sentence and its corresponding entity label."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains the entities \'IkappaBalpha\' and \'NF-kappaB\' which are labeled as \'protein\' in the entity label set. The example provides a clear match between the entities in the sentence and their corresponding entity labels."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains the entity \'NF-kappa B\' which is labeled as \'protein\' in the entity label set. The example provides a clear match between the entity in the sentence and its corresponding entity label."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains the entity \'NF-kappa B\' which is labeled as \'protein\' in the entity label set. The example provides a clear match between the entity in the sentence and its corresponding entity label."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence contains the entities \'NF-kappaB\' and \'rheumatoid arthritis\' which are labeled as \'protein\' and \'cell_type\' respectively in the entity label set. The example provides a match between the entities in the sentence and their corresponding entity labels."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains the entities \'IkappaBbeta\' and \'NF-kappaB\' which are labeled as \'protein\' in the entity label set. The example provides a clear match between the entities in the sentence and their corresponding entity labels."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains the entities \'NF-kappaB\', \'Tax\', and \'ATL\' which are labeled as \'protein\' and \'cell_type\' respectively in the entity label set. The example provides a match between the entities in the sentence and their corresponding entity labels."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains the entities \'NF-kappa B\' and \'I kappa B alpha\' which are labeled as \'protein\' in the entity label set. The example provides a clear match between the entities in the sentence and their corresponding entity labels."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains the entities \'NF-kappa B\' and \'I kappa B beta\' which are labeled as \'protein\' in the entity label set. The example provides a clear match between the entities in the sentence and their corresponding entity labels."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains the entities \'CD40\', \'Rel/nuclear factor kappaB\', and \'NF-kappaB\' which are labeled as \'protein\' in the entity label set. The example provides a clear match between the entities in the sentence and their corresponding entity labels."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains the entities \'HIV-1\', \'IFN\', \'PKR\', and \'IkappaBalpha\' which are labeled as \'cell_type\' and \'protein\' respectively in the entity label set. The example provides a clear match between the entities in the sentence and their corresponding entity labels."}\n]\n```', 'response3': '```json\n[{"NF-kappa B": "protein"}]\n```', 'prediction': {'NF-kappa B': 'protein'}}
{'idx': 1573, 'sentence': 'Immunofluorescence colocalization of both estrogen and progesterone receptors with eosinophil cationic protein showed that approximately 70% of positive cells were eosinophils .', 'label': {'estrogen': 'protein', 'eosinophil cationic protein': 'protein', 'positive cells': 'cell_type', 'progesterone receptors': 'protein', 'eosinophils': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 5},\n    {"Example 17": 5},\n    {"Example 18": 5},\n    {"Example 19": 5},\n    {"Example 20": 5},\n    {"Example 21": 5},\n    {"Example 22": 5},\n    {"Example 23": 5},\n    {"Example 24": 5},\n    {"Example 25": 5}\n]', 'response3': '[{"estrogen": "protein"}, {"progesterone": "protein"}, {"eosinophil cationic protein": "protein"}, {"eosinophils": "cell_type"}]', 'prediction': {'estrogen': 'protein', 'progesterone': 'protein', 'eosinophil cationic protein': 'protein', 'eosinophils': 'cell_type'}}
{'idx': 1589, 'sentence': 'Inhibition of NF-AT -dependent transcription by NF-kappa B : implications for differential gene expression in T helper cell subsets .', 'label': {'NF-kappa B': 'protein', 'T helper cell subsets': 'cell_type', 'NF-AT': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence directly mentions the entity \'NF-kappa B\' which is labeled as \'protein\' in the entity label set."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence directly mentions the entities \'NF-kappa B\' and \'I kappa B alpha\' which are labeled as \'protein\' in the entity label set."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly mentions the entities \'NF-ATc\' and \'T lymphocytes\' which are labeled as \'protein\' and \'cell_type\' respectively in the entity label set."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence directly mentions the entities \'NF-kappaB\', \'Tax\', and \'ATL\' which are labeled as \'protein\' and \'cell_type\' in the entity label set."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence directly mentions the entity \'NF-kappa B\' which is labeled as \'protein\' in the entity label set."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence directly mentions the entities \'NF-kappa B\' and \'I kappa B alpha\' which are labeled as \'protein\' in the entity label set."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence directly mentions the entities \'NF-ATc\', \'T lymphocytes\', and \'embryonic cardiac cells\' which are labeled as \'protein\' and \'cell_type\' in the entity label set."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence directly mentions the entity \'GATA-1\' which is labeled as \'protein\' in the entity label set."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence directly mentions the entity \'NF-kappa B\' which is labeled as \'protein\' in the entity label set."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence directly mentions the entities \'NF-kappa B\' and \'I kappa B beta\' which are labeled as \'protein\' in the entity label set."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence directly mentions the entities \'PAFR\', \'PAF\', \'NF-kappa B\', and \'protein kinase C\' which are labeled as \'protein\' in the entity label set."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence directly mentions the entities \'Sp1\' and \'Ets\' which are labeled as \'protein\' in the entity label set."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence directly mentions the entities \'Th1\' and \'Th2\' which are labeled as \'cell_type\' in the entity label set."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence directly mentions the entity \'Th2-type lymphocytes\' which is labeled as \'cell_type\' in the entity label set."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence directly mentions the entities \'IL-2\', \'NF-kappa B\', and \'AP-1\' which are labeled as \'protein\' in the entity label set."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence mentions \'NF-kappa B\' in the context of DNA binding activity, which might not directly relate to the entity type \'DNA\' in the label set."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities that match the entity label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities that match the entity label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities that match the entity label set."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities that match the entity label set."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities that match the entity label set."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities that match the entity label set."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities that match the entity label set."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities that match the entity label set."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities that match the entity label set."}\n]', 'response3': '[{"NF-AT": "protein"}, {"NF-kappa B": "protein"}, {"T helper cell subsets": "cell_type"}]', 'prediction': {'NF-AT': 'protein', 'NF-kappa B': 'protein', 'T helper cell subsets': 'cell_type'}}
{'idx': 114, 'sentence': 'These results indicate that in monocytic cell lineage , HIV-1 could mimic some differentiation/activation stimuli allowing nuclear NF-KB expression .', 'label': {'NF-KB': 'protein', 'monocytic cell lineage': 'cell_line'}, 'response1': "['cell_line', 'cell_type']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with their corresponding entity labels, providing clear and direct guidance for entity extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains a clear example of a named entity with its corresponding entity label, aiding in entity extraction."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides a specific example of a named entity with its corresponding entity label, facilitating entity extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence includes a clear example of a named entity with its corresponding entity label, assisting in entity extraction."},\n    {"Sentence": 5},\n    {"Reason": "The sentence offers multiple examples of named entities with their corresponding entity labels, aiding in entity extraction."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains a named entity with its corresponding entity label, providing some guidance for entity extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence includes a clear example of a named entity with its corresponding entity label, aiding in entity extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides a specific example of a named entity with its corresponding entity label, facilitating entity extraction."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with their corresponding entity labels, providing clear and direct guidance for entity extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence includes a clear example of a named entity with its corresponding entity label, aiding in entity extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains a clear example of a named entity with its corresponding entity label, aiding in entity extraction."},\n    {"Sentence": 3},\n    {"Reason": "The sentence provides a named entity with its corresponding entity label, offering some guidance for entity extraction."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains a named entity with its corresponding entity label, providing some guidance for entity extraction."},\n    {"Sentence": 3},\n    {"Reason": "The sentence includes a named entity with its corresponding entity label, offering some guidance for entity extraction."},\n    {"Sentence": 3},\n    {"Reason": "The sentence provides a named entity with its corresponding entity label, offering some guidance for entity extraction."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains a named entity with its corresponding entity label, providing some guidance for entity extraction."},\n    {"Sentence": 3},\n    {"Reason": "The sentence includes a named entity with its corresponding entity label, offering some guidance for entity extraction."},\n    {"Sentence": 3},\n    {"Reason": "The sentence provides a named entity with its corresponding entity label, offering some guidance for entity extraction."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains a named entity with its corresponding entity label, providing some guidance for entity extraction."},\n    {"Sentence": 3},\n    {"Reason": "The sentence includes a named entity with its corresponding entity label, offering some guidance for entity extraction."},\n    {"Sentence": 3},\n    {"Reason": "The sentence provides a named entity with its corresponding entity label, offering some guidance for entity extraction."}\n]', 'response3': '[{"HIV-1": "cell_type"}, {"NF-KB": "protein"}]', 'prediction': {'HIV-1': 'cell_type', 'NF-KB': 'protein'}}
{'idx': 469, 'sentence': 'Cardiac and adrenergic diseases were excluded.', 'label': {}, 'response1': 'None.', 'response2': '[\n    {"Example 1": 1, "Reason": "The named entity \'WT1\' is specific and not directly related to any of the entity types in the target sentence."},\n    {"Example 2": 4, "Reason": "The named entities \'PBMC\' and \'adenovirus DNA\' are directly related to the entity types \'cell_type\' and \'DNA\' mentioned in the target sentence."},\n    {"Example 3": 1, "Reason": "The named entity \'phosphocreatine\' is specific and not directly related to any of the entity types in the target sentence."},\n    {"Example 4": 3, "Reason": "The named entity \'AP-1\' is directly related to the entity type \'DNA\' mentioned in the target sentence."},\n    {"Example 5": 4, "Reason": "The named entities \'IL-5 mRNA\', \'TCR\', \'IL-2R\', and \'dexamethasone\' are directly related to the entity types \'RNA\', \'cell_type\', \'protein\', and \'protein\' mentioned in the target sentence."},\n    {"Example 6": 3, "Reason": "The named entities \'EBV\' and \'CD2\' are directly related to the entity types \'cell_line\' and \'protein\' mentioned in the target sentence."},\n    {"Example 7": 2, "Reason": "The named entity \'CD4+\' is indirectly related to the entity type \'cell_type\' mentioned in the target sentence."},\n    {"Example 8": 2, "Reason": "The named entity \'lymphoid neoplasms\' is indirectly related to the entity type \'cell_type\' mentioned in the target sentence."},\n    {"Example 9": 4, "Reason": "The named entities \'PBMC\' and \'adenovirus\' are directly related to the entity types \'cell_type\' and \'DNA\' mentioned in the target sentence."},\n    {"Example 10": 3, "Reason": "The named entity \'P selectin\' is directly related to the entity type \'protein\' mentioned in the target sentence."},\n    {"Example 11": 4, "Reason": "The named entities \'cAMP-dependent protein kinase\' and \'Rap1\' are directly related to the entity type \'protein\' mentioned in the target sentence."},\n    {"Example 12": 3, "Reason": "The named entities \'MNDA\' and \'myeloid cell lines\' are directly related to the entity types \'RNA\' and \'cell_line\' mentioned in the target sentence."},\n    {"Example 13": 4, "Reason": "The named entities \'NF-kB\', \'AP-1\', \'OCT-1\', and \'NF-IL-2B\' are directly related to the entity type \'protein\' mentioned in the target sentence."},\n    {"Example 14": 4, "Reason": "The named entities \'MR\', \'aldosterone\', and \'progesterone\' are directly related to the entity type \'protein\' mentioned in the target sentence."},\n    {"Example 15": 3, "Reason": "The named entities \'RelB\' and \'DC\' are directly related to the entity type \'protein\' and \'cell_type\' mentioned in the target sentence."},\n    {"Example 16": 4, "Reason": "The named entities \'XP-B\', \'XP-D\', and \'adenovirus\' are directly related to the entity types \'cell_line\' and \'DNA\' mentioned in the target sentence."},\n    {"Example 17": 1, "Reason": "The sentence does not contain any named entities related to the entity types in the target sentence."},\n    {"Example 18": 1, "Reason": "The sentence does not contain any named entities related to the entity types in the target sentence."},\n    {"Example 19": 1, "Reason": "The sentence does not contain any named entities related to the entity types in the target sentence."},\n    {"Example 20": 1, "Reason": "The sentence does not contain any named entities related to the entity types in the target sentence."},\n    {"Example 21": 1, "Reason": "The sentence does not contain any named entities related to the entity types in the target sentence."},\n    {"Example 22": 1, "Reason": "The sentence does not contain any named entities related to the entity types in the target sentence."},\n    {"Example 23": 1, "Reason": "The sentence does not contain any named entities related to the entity types in the target sentence."},\n    {"Example 24": 1, "Reason": "The sentence does not contain any named entities related to the entity types in the target sentence."},\n    {"Example 25": 1, "Reason": "The sentence does not contain any named entities related to the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1683, 'sentence': 'These results strongly suggest that HU induces both transcriptional and post-transcription regulation of c-jun during erythroid differentiation .', 'label': {'c-jun': 'DNA'}, 'response1': "['RNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 4},\n    {"Example 4": 4},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 4},\n    {"Example 12": 4},\n    {"Example 13": 1},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1}\n]', 'response3': '[{"c-jun": "protein"}]', 'prediction': {'c-jun': 'protein'}}
{'idx': 1648, 'sentence': 'Point mutations of either the PU.1 site or the C/EBP site that abolish the binding of the respective factors result in a significant decrease of GM-CSF receptor alpha promoter activity in myelomonocytic cells only.', 'label': {'PU.1 site': 'DNA', 'GM-CSF receptor alpha': 'protein', 'GM-CSF receptor alpha promoter': 'DNA', 'myelomonocytic cells': 'cell_type', 'C/EBP': 'protein', 'PU.1': 'protein', 'GM-CSF': 'protein', 'C/EBP site': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"IL-2": 5},\n    {"IFN-gamma": 5},\n    {"jak kinases": 5},\n    {"STAT1(alpha)": 5},\n    {"UAS1": 4},\n    {"B cell": 4},\n    {"Sp1": 5},\n    {"CD14": 5},\n    {"IL-2": 5},\n    {"c-Jun": 5},\n    {"c-Fos": 5},\n    {"GM-CSF": 5},\n    {"G-CSF": 5},\n    {"T cell": 5},\n    {"interleukin 2": 5},\n    {"IFN A": 5},\n    {"IFNA": 5},\n    {"interleukin-2": 5},\n    {"interleukin-2 receptor": 5},\n    {"phytohemagglutinin": 5},\n    {"phorbol myristate acetate": 5},\n    {"retinoic acid receptor alpha": 5},\n    {"Egr-1": 5},\n    {"GATA-1": 5},\n    {"MNDA": 5},\n    {"Philadelphia chromosome-positive chronic myeloid leukemia": 5},\n    {"CCAAT box": 4},\n    {"EKLF binding site": 5},\n    {"PU.1": 5},\n    {"M-CSF receptor": 5},\n    {"macrophage": 5},\n    {"myeloperoxidase": 5},\n    {"lysozyme": 5},\n    {"PU.1": 5},\n    {"EBNA-2": 5},\n    {"PU.1": 5}\n]', 'response3': '[{"PU.1": "protein"}, {"C/EBP": "protein"}, {"GM-CSF receptor alpha": "protein"}, {"myelomonocytic cells": "cell_type"}]', 'prediction': {'PU.1': 'protein', 'C/EBP': 'protein', 'GM-CSF receptor alpha': 'protein', 'myelomonocytic cells': 'cell_type'}}
{'idx': 646, 'sentence': 'Surgically confirmed nodal involvement was observed in 42%.', 'label': {}, 'response1': 'None.', 'response2': '[\n{"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 3},\n{"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n{"The expression of NDP kinase was intense in KA and SCC compared with BCC.": 4},\n{"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.": 4},\n{"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n{"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 3},\n{"By the time of diagnosis of T-PLL, the clone contains many more genetic changes in the form of additional translocations.": 3},\n{"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 4},\n{"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 3},\n{"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.": 4},\n{"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n{"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n{"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.": 4},\n{"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.": 4},\n{"Treatment with soluble, bivalent mAb J393 killed 25-50% of the cell population, while concomitant engagement of either the CD3.TcR complex or the integrins CD18 and CD29 significantly potentiated this effect.": 5},\n{"When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of the binding.": 4}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 821, 'sentence': '(vi) The EBV type 2 EBNA-2 transactivated LMP1 as well as the EBV type 1 EBNA-2 .', 'label': {'LMP1': 'protein', 'EBNA-2': 'protein', 'EBV type 1 EBNA-2': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.": 4},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 3},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.": 4},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.": 4},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 4},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 3},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 3},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 3},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 4},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB.": 5}\n]', 'response3': '[{"EBV type 2 EBNA-2": "protein"}, {"LMP1": "protein"}, {"EBV type 1 EBNA-2": "protein"}]', 'prediction': {'EBV type 2 EBNA-2': 'protein', 'LMP1': 'protein', 'EBV type 1 EBNA-2': 'protein'}}
{'idx': 548, 'sentence': 'On the other hand, interleukin 2 ( IL-2 )-induced signals are blocked by rapamycin but not by FK506 .', 'label': {'IL-2': 'protein', 'interleukin 2': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .": 4},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n    {"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells .": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 4},\n    {"Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.": 5},\n    {"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin .": 5},\n    {"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .": 5},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .": 5}\n]', 'response3': '[{"interleukin 2": "protein"}, {"IL-2": "protein"}, {"rapamycin": "protein"}, {"FK506": "protein"}]', 'prediction': {'interleukin 2': 'protein', 'IL-2': 'protein', 'rapamycin': 'protein', 'FK506': 'protein'}}
{'idx': 135, 'sentence': 'Tumor necrosis factor alpha ( TNF-alpha ) mRNA production was analyzed by polymerase chain reaction amplification in monocytic U937 cells and in a chronically HIV infected U937 cell line ( U9-IIIB ).', 'label': {'U9-IIIB': 'cell_line', 'monocytic U937 cells': 'cell_line', 'Tumor necrosis factor alpha ( TNF-alpha ) mRNA': 'RNA', 'chronically HIV infected U937 cell line': 'cell_line', 'Tumor necrosis factor alpha': 'protein', 'TNF-alpha': 'protein'}, 'response1': "['RNA', 'cell_type', 'cell_line']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"2": "The sentence does not contain any of the entity types in the label set."},\n    {"3": "The sentence contains multiple protein entities, which are relevant to the label set."},\n    {"4": "The sentence contains a cell line entity, which is relevant to the label set."},\n    {"5": "The sentence contains multiple protein entities, which are relevant to the label set."},\n    {"6": "The sentence contains a cell line entity and a DNA entity, which are relevant to the label set."},\n    {"7": "The sentence contains a cell type entity and protein entities, which are relevant to the label set."},\n    {"8": "The sentence does not contain any of the entity types in the label set."},\n    {"9": "The sentence contains protein entities, which are relevant to the label set."},\n    {"10": "The sentence contains protein entities, a cell line entity, and a DNA entity, which are relevant to the label set."},\n    {"11": "The sentence contains a protein entity, cell type entities, and a cell line entity, which are relevant to the label set."},\n    {"12": "The sentence contains protein entities, which are relevant to the label set."},\n    {"13": "The sentence contains DNA entities, which are relevant to the label set."},\n    {"14": "The sentence contains protein entities, which are relevant to the label set."},\n    {"15": "The sentence contains protein entities, which are relevant to the label set."},\n    {"16": "The sentence does not contain any of the entity types in the label set."},\n    {"17": "The sentence does not contain any of the entity types in the label set."},\n    {"18": "The sentence does not contain any of the entity types in the label set."},\n    {"19": "The sentence does not contain any of the entity types in the label set."},\n    {"20": "The sentence does not contain any of the entity types in the label set."},\n    {"21": "The sentence does not contain any of the entity types in the label set."},\n    {"22": "The sentence does not contain any of the entity types in the label set."},\n    {"23": "The sentence does not contain any of the entity types in the label set."},\n    {"24": "The sentence does not contain any of the entity types in the label set."},\n    {"25": "The sentence does not contain any of the entity types in the label set."},\n    {"26": "The sentence does not contain any of the entity types in the label set."},\n    {"27": "The sentence does not contain any of the entity types in the label set."},\n    {"28": "The sentence does not contain any of the entity types in the label set."},\n    {"29": "The sentence does not contain any of the entity types in the label set."},\n    {"30": "The sentence does not contain any of the entity types in the label set."}\n]', 'response3': '[{"TNF-alpha": "protein"}, {"U937": "cell_type"}, {"U9-IIIB": "cell_line"}, {"HIV": "cell_type"}]', 'prediction': {'TNF-alpha': 'protein', 'U937': 'cell_type', 'U9-IIIB': 'cell_line', 'HIV': 'cell_type'}}
{'idx': 432, 'sentence': 'Moreover, BSAP is clearly a B-cell-specific transcription factor , as a wild-type but not a mutant TSAP -binding site of the sea urchin functions only in transfected B cells as an upstream promoter element .', 'label': {'transfected B cells': 'cell_line', 'TSAP': 'protein', 'mutant TSAP -binding site': 'DNA', 'upstream promoter element': 'DNA', 'BSAP': 'protein', 'B-cell-specific transcription factor': 'protein', 'wild-type': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n{"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n{"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n{"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n{"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 5},\n{"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 5},\n{"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 5},\n{"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.": 5},\n{"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n{"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n{"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n{"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF.": 5},\n{"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5}\n]', 'response3': '[{"BSAP": "protein"}, {"TSAP": "protein"}, {"sea urchin": "cell_line"}, {"B-cell": "cell_type"}]', 'prediction': {'BSAP': 'protein', 'TSAP': 'protein', 'sea urchin': 'cell_line', 'B-cell': 'cell_type'}}
{'idx': 1161, 'sentence': 'Deoxycholate treatment of the cytoplasmic extract prepared from cells stimulated by TNF-alpha in the presence of Cu2+ resulted in the release of NF kappa B from I kappa B alpha , indicating that Cu2+ interferes with the dissociation of the NF kappa B -I kappa B complex .', 'label': {'I kappa B alpha': 'protein', 'NF kappa B': 'protein', 'NF kappa B -I kappa B complex': 'protein', 'TNF-alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.": 5},\n    {"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .": 5},\n    {"When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma , the cells instead become DC .": 5},\n    {"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 5},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .": 5},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .": 5},\n    {"Control of NF-kappa B activity by the I kappa B beta inhibitor .": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[{"NF kappa B": "protein"}, {"I kappa B alpha": "protein"}, {"Cu2+": "cell_line"}]', 'prediction': {'NF kappa B': 'protein', 'I kappa B alpha': 'protein', 'Cu2+': 'cell_line'}}
{'idx': 1794, 'sentence': 'Activation of the signal transducer and transcription ( STAT ) signaling pathway in a primary T cell response .', 'label': {'STAT': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"1": "The sentence contains specific protein names and their relationships to other proteins, which can help in identifying protein entities in the target sentence."},\n    {"2": "The sentence mentions specific proteins and cell types in the context of a disease, providing examples that can aid in identifying protein and cell type entities in the target sentence."},\n    {"5": "The sentence provides specific examples of proteins, cytokines, and cell types, directly related to the target sentence, making it highly relevant and helpful in identifying entities."},\n    {"4": "The sentence mentions a specific protein (IL-2) relevant to the target sentence, aiding in identifying protein entities."},\n    {"4": "The sentence provides examples of specific proteins and cell types, directly related to the target sentence, making it helpful in identifying entities."},\n    {"3": "The sentence mentions specific proteins and their relationships, which can help in identifying protein entities in the target sentence."},\n    {"3": "The sentence discusses the activation and function of specific proteins, which can aid in identifying protein entities in the target sentence."},\n    {"5": "The sentence provides specific examples of proteins and their relationships, directly related to the target sentence, making it highly relevant and helpful in identifying entities."},\n    {"4": "The sentence mentions specific proteins and a cell type in the context of activation, providing examples that can aid in identifying protein and cell type entities in the target sentence."},\n    {"4": "The sentence mentions specific proteins and a cell type in the context of T cell activation, providing examples that can aid in identifying protein and cell type entities in the target sentence."},\n    {"2": "The sentence mentions specific proteins and their relationships, which can help in identifying protein entities in the target sentence."},\n    {"4": "The sentence provides examples of specific proteins, directly related to the target sentence, making it helpful in identifying entities."},\n    {"4": "The sentence mentions a specific protein (STAT1) relevant to the target sentence, aiding in identifying protein entities."},\n    {"4": "The sentence provides examples of specific proteins, directly related to the target sentence, making it helpful in identifying entities."},\n    {"3": "The sentence mentions a specific protein (GATA-1) relevant to the target sentence, aiding in identifying protein entities."},\n    {"3": "The sentence discusses the activation and function of specific proteins, which can aid in identifying protein entities in the target sentence."},\n    {"1": "The sentence does not contain relevant examples of entities present in the target sentence."},\n    {"1": "The sentence does not contain relevant examples of entities present in the target sentence."},\n    {"1": "The sentence does not contain relevant examples of entities present in the target sentence."},\n    {"1": "The sentence does not contain relevant examples of entities present in the target sentence."},\n    {"1": "The sentence does not contain relevant examples of entities present in the target sentence."},\n    {"1": "The sentence does not contain relevant examples of entities present in the target sentence."},\n    {"1": "The sentence does not contain relevant examples of entities present in the target sentence."},\n    {"1": "The sentence does not contain relevant examples of entities present in the target sentence."},\n    {"1": "The sentence does not contain relevant examples of entities present in the target sentence."},\n    {"1": "The sentence does not contain relevant examples of entities present in the target sentence."},\n    {"1": "The sentence does not contain relevant examples of entities present in the target sentence."},\n    {"1": "The sentence does not contain relevant examples of entities present in the target sentence."},\n    {"1": "The sentence does not contain relevant examples of entities present in the target sentence."},\n    {"1": "The sentence does not contain relevant examples of entities present in the target sentence."},\n    {"1": "The sentence does not contain relevant examples of entities present in the target sentence."},\n    {"1": "The sentence does not contain relevant examples of entities present in the target sentence."},\n    {"1": "The sentence does not contain relevant examples of entities present in the target sentence."},\n    {"1": "The sentence does not contain relevant examples of entities present in the target sentence."},\n    {"1": "The sentence does not contain relevant examples of entities present in the target sentence."}\n]', 'response3': '[{"STAT": "protein"}, {"T cell": "cell_type"}]', 'prediction': {'STAT': 'protein', 'T cell': 'cell_type'}}
{'idx': 1470, 'sentence': 'Hence, induction of cell surface expression of this leukocyte adhesion molecule by tumor necrosis factor (TNF)-alpha was reduced by 40% in the presence of CsA , and this was reflected by a 29% decrease in neutrophil adhesion .', 'label': {'neutrophil': 'cell_type', 'tumor necrosis factor (TNF)-alpha': 'protein', 'leukocyte adhesion molecule': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n{"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n{"PMA induced the expression of both CD14 and CD23 mRNA and protein.": 5},\n{"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n{"CD40 expression could be enhanced in CD40-positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n{"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 5},\n{"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 5},\n{"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n{"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n{"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n{"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 5},\n{"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 5},\n{"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n{"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.": 5},\n{"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n{"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 644, 'sentence': 'Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers : a role for hematopoietic growth factor release by tumor cells ?', 'label': {'tumor cells': 'cell_type', 'hematopoietic growth factor': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a clear and direct mapping of the entity \'Th2-type lymphocytes\' to the entity type \'cell_type\' in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The example provides mappings of multiple entities to their corresponding entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides mappings of multiple entities to their corresponding entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 4": 4},\n    {"Reason 4": "The example provides mappings of multiple entities to their corresponding entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides a clear and direct mapping of the entity \'lymphoid neoplasms\' to the entity type \'cell_type\' in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The example provides mappings of multiple entities to their corresponding entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides mappings of multiple entities to their corresponding entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides mappings of multiple entities to their corresponding entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides mappings of multiple entities to their corresponding entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides mappings of multiple entities to their corresponding entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides mappings of multiple entities to their corresponding entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The example provides mappings of multiple entities to their corresponding entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 13": 3},\n    {"Reason 13": "The example provides a mapping of the entity \'AP-1\' to the entity type \'DNA\' in the target sentence, but the relevance of this entity to the overall sentence context is less clear."},\n    {"Example 14": 4},\n    {"Reason 14": "The example provides mappings of multiple entities to their corresponding entity types in the target sentence, aiding in the extraction of named entities."},\n    {"Example 15": 1},\n    {"Reason 15": "The example does not contain any entities that match the entity types present in the target sentence, hence it is not helpful for extracting named entities."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any entities that match the entity types present in the target sentence, hence it is not helpful for extracting named entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any entities that match the entity types present in the target sentence, hence it is not helpful for extracting named entities."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any entities that match the entity types present in the target sentence, hence it is not helpful for extracting named entities."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain any entities that match the entity types present in the target sentence, hence it is not helpful for extracting named entities."},\n    {"Example 20": 1},\n    {"Reason 20": "The example does not contain any entities that match the entity types present in the target sentence, hence it is not helpful for extracting named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 435, 'sentence': 'Antibodies are produced exclusively in B lymphocytes .', 'label': {'Antibodies': 'protein', 'lymphocytes': 'cell_type', 'B lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"IgH": 5},\n{"Reasons": "The sentence explicitly mentions \'IgH genes\', which is a clear indicator of DNA entity type."},\n{"Eosinophils": 5},\n{"Reasons": "The sentence explicitly mentions \'Eosinophils\', which is a clear indicator of cell_type entity type."},\n{"IL-13": 4},\n{"IL-4": 4},\n{"B cell": 4},\n{"monocyte": 4},\n{"Reasons": "The sentence mentions cytokines like IL-13 and IL-4, which are proteins. It also mentions B cell and monocyte, which are cell types."},\n{"EBV": 4},\n{"CD2": 4},\n{"Reasons": "The sentence mentions EBV, which is a cell_line entity. It also mentions CD2, which is a protein entity."},\n{"IL4": 5},\n{"IL13": 5},\n{"STAT6": 5},\n{"STAT3": 5},\n{"STAT5": 5},\n{"B cells": 5},\n{"Reasons": "The sentence explicitly mentions proteins like IL4, IL13, STAT6, STAT3, STAT5, and cell type B cells."},\n{"Th1": 5},\n{"Th2": 5},\n{"Reasons": "The sentence explicitly mentions cell types Th1 and Th2."},\n{"Th2-type lymphocytes": 5},\n{"Reasons": "The sentence explicitly mentions cell type Th2-type lymphocytes."},\n{"CD70": 5},\n{"B cell": 5},\n{"plasma cells": 5},\n{"IL-4": 5},\n{"CD40": 5},\n{"Reasons": "The sentence mentions proteins like CD70, IL-4, CD40, and cell types B cell, plasma cells."},\n{"NF-ATc": 5},\n{"T lymphocytes": 5},\n{"Reasons": "The sentence mentions proteins NF-ATc and cell type T lymphocytes."},\n{"IL-2 receptor alpha subunit": 5},\n{"p21ras": 5},\n{"B cell": 5},\n{"Reasons": "The sentence mentions proteins IL-2 receptor alpha subunit, p21ras, and cell type B cell."},\n{"T lymphocytes": 5},\n{"HLA-molecules": 5},\n{"Reasons": "The sentence mentions cell type T lymphocytes and proteins HLA-molecules."},\n{"E2A": 5},\n{"Reasons": "The sentence explicitly mentions protein E2A."},\n{"lymphocytes": 5},\n{"benzene": 5},\n{"benzoquinone": 5},\n{"Reasons": "The sentence mentions cell type lymphocytes and chemical compounds benzene and benzoquinone."},\n{"EBV": 5},\n{"B-cell": 5},\n{"Reasons": "The sentence mentions cell types EBV and B-cell."},\n{"CD40": 5},\n{"Rel/nuclear factor kappaB": 5},\n{"NF-kappaB": 5},\n{"B lymphocytes": 5},\n{"Reasons": "The sentence mentions proteins CD40, Rel/nuclear factor kappaB, NF-kappaB, and cell type B lymphocytes."},\n{"ICAM-1": 5},\n{"CD71": 5},\n{"LMP1": 5},\n{"IkappaB": 5},\n{"Reasons": "The sentence mentions proteins ICAM-1, CD71, LMP1, IkappaB."}\n]', 'response3': '[{"B lymphocytes": "cell_type"}]', 'prediction': {'B lymphocytes': 'cell_type'}}
{'idx': 1342, 'sentence': 'While Bik does not show overt homology to the BH1 and BH2 conserved domains characteristic of the Bcl-2 family , it does share a 9 amino acid domain ( BH3 ) with Bax and Bak which may be a critical determinant for the death-promoting activity of these proteins.', 'label': {'amino acid domain': 'protein', 'BH1': 'protein', 'BH3': 'protein', 'Bak': 'protein', 'BH2': 'protein', 'Bax': 'protein', 'Bik': 'protein', 'Bcl-2 family': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n{"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 5},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n{"These two related genes share the evolutionarily conserved region encoding the Runt domain.": 5},\n{"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n{"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n{"Tat-binding protein 7 is a subunit of the 26S protease.": 5},\n{"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n{"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n{"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.": 5},\n{"Activation of NF-kappaB by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.": 5},\n{"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n{"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5}\n]', 'response3': '[{"Bik": "protein"}, {"BH1": "protein"}, {"BH2": "protein"}, {"Bcl-2": "protein"}, {"BH3": "protein"}, {"Bax": "protein"}, {"Bak": "protein"}]', 'prediction': {'Bik': 'protein', 'BH1': 'protein', 'BH2': 'protein', 'Bcl-2': 'protein', 'BH3': 'protein', 'Bax': 'protein', 'Bak': 'protein'}}
{'idx': 1022, 'sentence': 'NK cell NFAT is present in the cytosol of nonstimulated cells , migrates to the nucleus upon stimulation, and can associate with AP-1 .', 'label': {'NK cell NFAT': 'protein', 'AP-1': 'protein', 'nonstimulated cells': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Sentence 1": 5},\n    {"Sentence 2": 5},\n    {"Sentence 3": 5},\n    {"Sentence 4": 5},\n    {"Sentence 5": 5},\n    {"Sentence 6": 5},\n    {"Sentence 7": 5},\n    {"Sentence 8": 5},\n    {"Sentence 9": 1},\n    {"Sentence 10": 1},\n    {"Sentence 11": 1},\n    {"Sentence 12": 1},\n    {"Sentence 13": 1},\n    {"Sentence 14": 1},\n    {"Sentence 15": 1},\n    {"Sentence 16": 1},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1},\n    {"Sentence 20": 1},\n    {"Sentence 21": 1},\n    {"Sentence 22": 1},\n    {"Sentence 23": 1},\n    {"Sentence 24": 1},\n    {"Sentence 25": 1}\n]', 'response3': '[{"NK cell": "cell_type"}, {"NFAT": "protein"}, {"AP-1": "protein"}]', 'prediction': {'NK cell': 'cell_type', 'NFAT': 'protein', 'AP-1': 'protein'}}
{'idx': 810, 'sentence': 'Exposure of CML cells to IFN-alpha diminished the effect of the CML cytoplasmic proteins on these nuclear protein-DNA complexes .', 'label': {'CML cells': 'cell_type', 'IFN-alpha': 'protein', 'CML cytoplasmic proteins': 'protein', 'nuclear protein-DNA complexes': 'protein'}, 'response1': "['protein', 'cell_line', 'DNA']", 'response2': '[\n    {"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.": 5},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .": 5},\n    {"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 5},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.": 5},\n    {"When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma , the cells instead become DC .": 5},\n    {"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .": 5},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': "[{'CML': 'cell_line'}, {'IFN-alpha': 'protein'}, {'CML': 'cell_line'}, {'cytoplasmic proteins': 'protein'}, {'nuclear protein-DNA complexes': 'DNA'}]", 'prediction': {'CML': 'cell_line', 'IFN-alpha': 'protein', 'cytoplasmic proteins': 'protein', 'nuclear protein-DNA complexes': 'DNA'}}
{'idx': 1811, 'sentence': "In our attempt to identify chemokine receptors that are related to Burkitt's lymphoma receptor 1 ( BLR1 ) and are expressed in activated lymphocytes we used RT-PCR resulting in the isolation of a cDNA encoding a seven transmembrane receptor termed BLR2 .", 'label': {'BLR1': 'protein', 'BLR2': 'protein', 'seven transmembrane receptor': 'protein', 'activated lymphocytes': 'cell_type', 'chemokine receptors': 'protein', "Burkitt's lymphoma receptor 1": 'protein'}, 'response1': "['DNA', 'RNA', 'protein']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 3},\n    {"Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 4},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 3},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 4},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"This suggests that CHEMR1 may be a receptor for unidentified C-C chemokine or a low-affinity receptor for MIP-1alpha .": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1316, 'sentence': 'Helix III is less rigid, makes an average angle of about 90 degrees with helices I and II , and constitutes the other arm of the molecule.', 'label': {'Helix III': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 1},\n    {"Example 9": 1},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 939, 'sentence': 'However, in 3 postmenopausal patients a short course of estrogen or tamoxifen resulted in a marked increase of type II EBS levels.', 'label': {'type II EBS': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a clear and direct mapping of the entity \'TCL1\' to the entity label \'protein\' in the sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The example provides a clear and direct mapping of the entity \'E2A\' to the entity label \'protein\' in the sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides a clear and direct mapping of the entity \'NF-E2\' to the entity label \'protein\' in the sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The example provides a clear and direct mapping of the entities \'EBNA2\' and \'TP1\' to the entity labels \'protein\' and \'cell_line\' respectively in the sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides a clear and direct mapping of the entities \'alpha-tocopherol\', \'monocyte\', and \'endothelial cells\' to the entity labels \'protein\', \'cell_type\', and \'cell_type\' respectively in the sentence."}\n]', 'response3': '[{"EBS": "protein"}]', 'prediction': {'EBS': 'protein'}}
{'idx': 292, 'sentence': 'We used mouse embryonic stem (ES) cells to study globin gene expression and switching in vitro.', 'label': {'globin gene': 'DNA', 'mouse embryonic stem (ES) cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n{"E2A": 5},\n{"MNDA": 5},\n{"granulocytes": 4},\n{"T cells": 4},\n{"IgH": 5},\n{"PML/RARalpha": 5},\n{"GM-CSF": 5},\n{"GATA-1": 5},\n{"SCM-1": 5},\n{"IFN A": 5},\n{"IFNA": 5},\n{"interleukin-2": 5},\n{"interleukin-2 receptor": 5},\n{"phytohemagglutinin": 5},\n{"phorbol myristate acetate": 5},\n{"GATA-1": 5},\n{"CCAAT box": 5},\n{"EKLF binding site": 5},\n{"Egr-1": 5},\n{"RXR": 5},\n{"Sp1": 5},\n{"Ets": 5},\n{"c-kit": 5},\n{"IL-4R alpha chain": 5},\n{"ZEB": 5},\n{"c-Myb": 5},\n{"Ets": 5},\n{"hematopoietic cells": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 542, 'sentence': 'Amino acid sequences of all proteins are essays written in the same language.', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 505, 'sentence': 'The TCF-1 alpha binding site was also required for TCR alpha enhancer activity in transcriptionally active extracts from Jurkat but not HeLa cells , confirming that TCF-1 alpha is a T-cell-specific transcription factor .', 'label': {'Jurkat': 'cell_line', 'TCF-1 alpha': 'protein', 'TCR': 'protein', 'T-cell-specific transcription factor': 'protein', 'TCF-1 alpha binding site': 'DNA', 'HeLa cells': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Sentence 1": 3},\n    {"Sentence 2": 4},\n    {"Sentence 3": 4},\n    {"Sentence 4": 4},\n    {"Sentence 5": 4},\n    {"Sentence 6": 4},\n    {"Sentence 7": 3},\n    {"Sentence 8": 3},\n    {"Sentence 9": 4},\n    {"Sentence 10": 3},\n    {"Sentence 11": 3},\n    {"Sentence 12": 4},\n    {"Sentence 13": 4},\n    {"Sentence 14": 4},\n    {"Sentence 15": 4},\n    {"Sentence 16": 1},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1},\n    {"Sentence 20": 1},\n    {"Sentence 21": 1},\n    {"Sentence 22": 1},\n    {"Sentence 23": 1},\n    {"Sentence 24": 1},\n    {"Sentence 25": 1}\n]', 'response3': '[{"TCF-1 alpha": "protein"}, {"TCR alpha": "protein"}, {"Jurkat": "cell_line"}, {"HeLa": "cell_line"}, {"T-cell-specific": "cell_type"}]', 'prediction': {'TCF-1 alpha': 'protein', 'TCR alpha': 'protein', 'Jurkat': 'cell_line', 'HeLa': 'cell_line', 'T-cell-specific': 'cell_type'}}
{'idx': 1525, 'sentence': 'Kinase activity was reduced in lysates preadsorbed using an antibody specific for CaM kinase II .', 'label': {'antibody': 'protein', 'CaM kinase II': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a clear and direct mapping of the entity \'P selectin\' to the entity label \'protein\' in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The example provides clear mappings of the entities \'NF-kappa B\' and \'I kappa B alpha\' to the entity label \'protein\' in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides clear mappings of the entities \'cAMP-dependent protein kinase\' and \'Rap1\' to the entity label \'protein\' in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The example provides a clear mapping of the entity \'E2A\' to the entity label \'protein\' in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides a clear mapping of the entity \'calcineurin\' to the entity label \'protein\' in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The example provides clear mappings of the entities \'SLAP-130\', \'SLP-76\', and \'T cell\' to the entity labels \'protein\' and \'cell_type\' in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides clear mappings of the entities \'IL-4\', \'LPS\', and \'AP-1\' to the entity label \'protein\' in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides clear mappings of the entities \'Syk\', \'Zap\', and \'T cell\' to the entity labels \'protein\' and \'cell_type\' in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides clear mappings of the entities \'NDP kinase\', \'KA\', \'SCC\', and \'BCC\' to the entity labels \'protein\' and \'cell_type\' in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides clear mappings of the entities \'T cell\' and \'interleukin 2\' to the entity labels \'cell_type\' and \'protein\' in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides a clear mapping of the entity \'cell adhesion molecules\' to the entity label \'cell_type\' in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The example provides clear mappings of the entities \'RelA\' and \'NF-kappa B\' to the entity label \'protein\' in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides clear mappings of the entities \'IL-2\', \'Aiolos\', and \'Ras\' to the entity label \'protein\' in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The example provides clear mappings of the entities \'RelA\' and \'NF-kappaB1\' to the entity label \'protein\' in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The example provides a clear mapping of the entity \'retinoic acid receptor alpha\' to the entity label \'protein\' in the target sentence."},\n    {"Example 16": 5},\n    {"Reason 16": "The example provides clear mappings of the entities \'p21(WAF1/CIP1)\' and \'p27(KIP1)\' to the entity label \'protein\' in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities that match the entity labels in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities that match the entity labels in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities that match the entity labels in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities that match the entity labels in the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities that match the entity labels in the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities that match the entity labels in the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities that match the entity labels in the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities that match the entity labels in the target sentence."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities that match the entity labels in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1103, 'sentence': 'Relationship between Rap1 protein phosphorylation and regulation of Ca2+ transport in platelets : a new approach.', 'label': {'platelets': 'cell_type', 'Rap1 protein': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein entity (calcineurin) and its corresponding label."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains multiple protein entities (AP-1, PMA) and cell type entities (monocytes, macrophages) with clear labels."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence includes various protein entities (PAFR, PAF, NF-kappa B, protein kinase C) with their corresponding labels."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence mentions protein entities (Stat3, Stat5, c-Mpl) with clear labels."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides protein entities (SLAP-130, SLP-76) and a cell type entity (T cell) with their labels."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence includes a protein entity (tyrosine) with a clear label."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence mentions a protein entity (GATA-1) with a clear label."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains a protein entity (p21ras) with a clear label."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides a protein entity (P selectin) with a clear label."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence includes protein entities (p21(WAF1/CIP1), p27(KIP1)) with their corresponding labels."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions protein entities (ERK, STAT3) with clear labels."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides protein entities (RelA, NF-kappaB1) with their corresponding labels."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains protein entities (Syk, Zap) and a cell type entity (T cell) with clear labels."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence includes protein entities (IL-2, Aiolos, Ras) with their corresponding labels."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions a protein entity (phosphocreatine) with a clear label."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence provides protein entities (cAMP-dependent protein kinase, Rap1) with their corresponding labels."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities from the given label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities from the given label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities from the given label set."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities from the given label set."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities from the given label set."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities from the given label set."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities from the given label set."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities from the given label set."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities from the given label set."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 538, 'sentence': 'Alone, PMA and calcium ionophore A23187 did not affect, but together stimulated, like phytohaemagglutinin ( PHA ), leucine and, in particular, thymidine incorporation .', 'label': {'PHA': 'protein', 'phytohaemagglutinin': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1529, 'sentence': 'Transcriptional activation and repression , two properties of the lymphoid-specific transcription factor Oct-2a .', 'label': {'Oct-2a': 'protein', 'lymphoid-specific transcription factor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names and their corresponding labels, which directly match the entity types in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions a specific cell type \'Th2-type lymphocytes\' which matches one of the entity types in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence includes multiple protein names and a cell type that align with the entity types in the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence refers to specific cell types and a protein (\'interleukin 2\') that correspond to the entity types in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides protein names and a cell type that match the entity types in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions a specific protein (\'Egr-1\') which aligns with the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains protein names, a protein-related term (\'activation\'), and a cell type that correspond to the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence includes protein names, a protein-related term (\'apoptosis\'), and a cell type that match the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides protein names and a cell type that align with the entity types in the target sentence."},\n    {"Example 10": 3},\n    {"Reason 10": "The sentence mentions a DNA-binding activity related to a protein (\'AP-1\'), which indirectly relates to the entity types in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains a specific protein name (\'A-myb\') that corresponds to the entity types in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence includes protein names that align with the entity types in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides protein names that match the entity types in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions a specific protein (\'NF-E2\') which corresponds to the entity types in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains protein names, cell types, and a specific protein-related term (\'gene expression\') that align with the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1197, 'sentence': 'In this study, we demonstrate reconstitution of a cell-free processing system and demonstrate directly that: (a) the ubiquitin -proteasome system is involved in processing of the intact p105 precursor, (b) conjugation of ubiquitin to the precursor is an essential intermediate step in the processing, (c) the recently discovered novel species of the ubiquitin -carrier protein , E2-F1 , that is involved in the conjugation and degradation of p53 , is also required for the limited processing of the p105 precursor , and (d) a novel, approximately 320-kDa species of ubiquitin -protein ligase , is involved in the process.', 'label': {'ubiquitin': 'protein', 'p105 precursor': 'protein', 'E2-F1': 'protein', '-proteasome': 'protein', 'ubiquitin -carrier protein': 'protein', 'p53': 'protein', 'ubiquitin -protein ligase': 'protein', '320-kDa species': 'protein', 'p105': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 4},\n{"Tat-binding protein 7 is a subunit of the 26S protease.": 5},\n{"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n{"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n{"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 4},\n{"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n{"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.": 4},\n{"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n{"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n{"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n{"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n{"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n{"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n{"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5}\n]', 'response3': '[{"ubiquitin -proteasome system": "protein"}, {"p105 precursor": "protein"}, {"ubiquitin": "protein"}, {"E2-F1": "protein"}, {"p53": "protein"}, {"ubiquitin -carrier protein": "protein"}, {"ubiquitin -protein ligase": "protein"}]', 'prediction': {'ubiquitin -proteasome system': 'protein', 'p105 precursor': 'protein', 'ubiquitin': 'protein', 'E2-F1': 'protein', 'p53': 'protein', 'ubiquitin -carrier protein': 'protein', 'ubiquitin -protein ligase': 'protein'}}
{'idx': 877, 'sentence': 'Their constitutive expression is limited to B lymphocytes and thymic epithelial cells .', 'label': {'B lymphocytes': 'cell_type', 'thymic epithelial cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains clear mentions of specific entities with corresponding labels, aiding in the extraction process."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence provides a specific protein entity, which is relevant to the target sentence."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence mentions distinct cell types relevant to the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains specific entities with corresponding labels, aiding in the extraction process."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence provides a specific cell type entity, which is relevant to the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains multiple specific entities with corresponding labels, aiding in the extraction process."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence provides specific protein and cell line entities, which are relevant to the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific protein entities and a cell type entity, aiding in the extraction process."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence provides specific cell type and protein entities, which are relevant to the target sentence."},\n    {"Example 10": 4},\n    {"Reason 10": "The sentence provides specific protein and cell type entities, which are relevant to the target sentence."},\n    {"Example 11": 4},\n    {"Reason 11": "The sentence provides specific protein and cell type entities, which are relevant to the target sentence."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence provides a specific protein entity, which is relevant to the target sentence."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence provides specific protein and cell type entities, which are relevant to the target sentence."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not contain any entities relevant to the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any entities relevant to the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entities relevant to the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities relevant to the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities relevant to the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities relevant to the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities relevant to the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities relevant to the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities relevant to the target sentence."}\n]', 'response3': '[{"B lymphocytes": "cell_type"}, {"thymic epithelial cells": "cell_type"}]', 'prediction': {'B lymphocytes': 'cell_type', 'thymic epithelial cells': 'cell_type'}}
{'idx': 1838, 'sentence': 'First, we show that mutations in the LEF-1 -binding site inhibit the activity of multimerized copies of the HIV-1 enhancer in Jurkat T cells , and that LEF-1 /GAL4 can activate a GAL4-substituted HIV-1 enhancer 80- to 100-fold in vivo.', 'label': {'LEF-1 -binding site': 'DNA', 'HIV-1 enhancer': 'DNA', 'LEF-1': 'protein', 'GAL4-substituted HIV-1 enhancer': 'DNA', 'Jurkat T cells': 'cell_line', 'multimerized copies': 'DNA', 'LEF-1 /GAL4': 'protein'}, 'response1': "['DNA', 'protein', 'cell_type', 'cell_line']", 'response2': '[\n{"immunoglobulin kappa 3\' enhancer": 5},\n{"IL-2": 5},\n{"IFN-gamma": 5},\n{"jak kinases": 5},\n{"STAT1(alpha)": 5},\n{"IL-2": 5},\n{"c-Jun": 5},\n{"c-Fos": 5},\n{"IFN A": 5},\n{"IFNA": 5},\n{"interleukin-2": 5},\n{"interleukin-2 receptor": 5},\n{"phytohemagglutinin": 5},\n{"phorbol myristate acetate": 5},\n{"PU.1": 5},\n{"M-CSF receptor": 5},\n{"macrophage": 5},\n{"Sp1": 5},\n{"CD14": 5},\n{"SIVsmmPBj14": 5},\n{"T cell": 5},\n{"interleukin 2": 5},\n{"p50p50": 5},\n{"IkappaBbeta": 5},\n{"NF-kappaB": 5},\n{"HIV-1": 5},\n{"IFN": 5},\n{"PKR": 5},\n{"IkappaBalpha": 5},\n{"NF-kappaB": 5},\n{"Sp1": 5},\n{"SIVmac": 5},\n{"cDNA": 5},\n{"Jurkat": 5},\n{"DRE 1": 5},\n{"HIV-1 LTR": 5},\n{"NFAT-1": 5},\n{"NF kappa B": 5},\n{"TR55": 5},\n{"TNF-alpha": 5},\n{"HIV": 5},\n{"TR55": 5},\n{"TNF-alpha": 5},\n{"HIV": 5},\n{"ATF1": 5},\n{"CREB": 5},\n{"H4": 5}\n]', 'response3': '[{"LEF-1": "protein"}, {"HIV-1 enhancer": "DNA"}, {"Jurkat T cells": "cell_type"}, {"GAL4": "protein"}, {"GAL4-substituted HIV-1 enhancer": "DNA"}]', 'prediction': {'LEF-1': 'protein', 'HIV-1 enhancer': 'DNA', 'Jurkat T cells': 'cell_type', 'GAL4': 'protein', 'GAL4-substituted HIV-1 enhancer': 'DNA'}}
{'idx': 1195, 'sentence': 'Palombella and colleagues (Palombella, V.J., Rando, O.J., Goldberg, A.L., and Maniatis, T.(1994) Cell 78, 773-785) have shown that ubiquitin is required for the processing in a cell-free system of a truncated, artificially constructed, 60-kDa precursor .', 'label': {'60-kDa precursor': 'protein', 'ubiquitin': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Tat-binding protein 7 is a subunit of the 26S protease .": 4},\n    {"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .": 4},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50 .": 4},\n    {"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .": 5},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 4},\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .": 5},\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 5},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n    {"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .": 5}\n]', 'response3': '[{"ubiquitin": "protein"}]', 'prediction': {'ubiquitin': 'protein'}}
{'idx': 817, 'sentence': '(ii) Transfection and expression of EBNA-LP alone had no effect on LMP1 expression and did not act synergistically with EBNA-2 to affect LMP1 expression .', 'label': {'EBNA-LP': 'protein', 'LMP1': 'protein', 'EBNA-2': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"5": "The sentence contains multiple protein entities that are relevant to the label set."},\n{"5": "The sentence contains multiple protein entities that are relevant to the label set."},\n{"5": "The sentence contains multiple protein entities that are relevant to the label set."},\n{"5": "The sentence contains multiple protein entities that are relevant to the label set."},\n{"5": "The sentence contains multiple protein entities that are relevant to the label set."},\n{"5": "The sentence contains multiple protein entities that are relevant to the label set."},\n{"5": "The sentence contains multiple protein entities that are relevant to the label set."},\n{"5": "The sentence contains multiple protein entities that are relevant to the label set."},\n{"5": "The sentence contains a protein entity that is relevant to the label set."},\n{"5": "The sentence contains a protein and a cell line entity that are relevant to the label set."},\n{"5": "The sentence contains RNA and cell line entities that are relevant to the label set."},\n{"5": "The sentence contains protein entities that are relevant to the label set."},\n{"5": "The sentence contains protein entities that are relevant to the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."}\n]', 'response3': "[{'EBNA-LP': 'protein'}, {'LMP1': 'protein'}, {'EBNA-2': 'protein'}]", 'prediction': {'EBNA-LP': 'protein', 'LMP1': 'protein', 'EBNA-2': 'protein'}}
{'idx': 741, 'sentence': 'In melanoma cells that contain the N-Oct-3 factor , a transfected lymphocyte-specific promoter was neither activated nor was it repressed upon contransfection with an Oct-2A expression vector .', 'label': {'Oct-2A expression vector': 'DNA', 'Oct-2A': 'protein', 'N-Oct-3 factor': 'protein', 'melanoma cells': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 4},\n    {"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.": 5},\n    {"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.": 4},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2.": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 4},\n    {"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.": 5},\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 5},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 283, 'sentence': '[ Estrogen receptor content of peripheral blood lymphocytes in patients with systemic lupus erythematosus ]', 'label': {'Estrogen receptor': 'protein', 'peripheral blood lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 4},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms .": 5},\n    {"An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .": 5},\n    {"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[{"Estrogen receptor": "protein"}, {"peripheral blood lymphocytes": "cell_type"}, {"systemic lupus erythematosus": "cell_type"}]', 'prediction': {'Estrogen receptor': 'protein', 'peripheral blood lymphocytes': 'cell_type', 'systemic lupus erythematosus': 'cell_type'}}
{'idx': 1043, 'sentence': 'METHOD: Two color flow cytometry analysis was used on peripheral blood samples of young and postmenopausal females and postmenopausal females treated with estrogen replacement therapy .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein entity (NF-E2) and its corresponding label."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides a clear example of a protein entity (erythropoietin) and its corresponding label."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence provides a clear example of a protein entity (E2A) and its corresponding label."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides clear examples of protein entities (MNDA, Philadelphia chromosome-positive chronic myeloid leukemia) and their corresponding labels."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides a clear example of a protein entity (phosphocreatine) and its corresponding label."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides clear examples of protein entities (TCRzeta, p56(lck)) and their corresponding labels."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides clear examples of protein entities (alpha-tocopherol, alpha-tcp) and cell type entities (monocyte, endothelial cells) with their corresponding labels."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides clear examples of protein entities (CD70, IL-4, CD40) and cell type entities (B cell, plasma cells) with their corresponding labels."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides clear examples of protein entities (CD40, Rel/nuclear factor kappaB, NF-kappaB) and a cell type entity (B lymphocytes) with their corresponding labels."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides clear examples of protein entities (beta-globin, glycoprotein IIb, platelet factor 4) and a cell line entity (Ter 119) with their corresponding labels."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides clear examples of cell type entities (B and T cell activation) and cell line entities (Ramos, Jurkat) with their corresponding labels."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides clear examples of DNA entity (EBV) and protein entities (EBNA2, estrogen receptor) with their corresponding labels."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides clear examples of protein entities (Erbstatin, genistein, Egr-1) and RNA entity (Egr-1) with their corresponding labels."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides clear examples of cell line entities (PMA, U1 cells) with their corresponding labels."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides clear examples of protein entities (globins, glycoprotein IIb, platelet factor 4, Spi-1, Fli-1) and a cell type entity (HPCs) with their corresponding labels."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entities from the given label set."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities from the given label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities from the given label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities from the given label set."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities from the given label set."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities from the given label set."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities from the given label set."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities from the given label set."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities from the given label set."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities from the given label set."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1010, 'sentence': 'Using a polyclonal antibody to murine NFATp , Western blot analysis of various mouse tissues demonstrated that the 110-130-kDa NFATp protein was highly expressed in thymus and spleen .', 'label': {'murine NFATp': 'protein', 'NFATp protein': 'protein', 'NFATp': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 4},\n    {"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 4},\n    {"A critical role of Sp1- and Ets-related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n    {"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n    {"The p50 and p65 proteins, constituents of the prototypic nuclear factor kappaB, were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.": 5}\n]', 'response3': '[{"NFATp": "protein"}, {"NFATp": "protein"}, {"thymus": "cell_type"}, {"spleen": "cell_type"}]', 'prediction': {'NFATp': 'protein', 'thymus': 'cell_type', 'spleen': 'cell_type'}}
{'idx': 186, 'sentence': 'We also find that NF-E2 , another trans-acting factor of the erythrocytic lineage , is present in megakaryocytes .', 'label': {'erythrocytic lineage': 'cell_type', 'NF-E2': 'protein', 'trans-acting factor': 'protein', 'megakaryocytes': 'cell_line'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a direct mapping between the entity \'RXR\' and its corresponding label \'protein\', which is highly helpful for extracting named entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The examples provide direct mappings between the entities \'SCL\' and \'GATA-1\' with their corresponding labels \'protein\', which is highly helpful for extracting named entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The examples provide direct mappings between the entities \'Stat3\', \'Stat5\', and \'c-Mpl\' with their corresponding labels \'protein\', which is highly helpful for extracting named entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The examples provide direct mappings between the entities \'NF-ATc\' and \'T lymphocytes\' with their corresponding labels \'protein\' and \'cell_type\', which is highly helpful for extracting named entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides a direct mapping between the entity \'GATA-1\' and its corresponding label \'protein\', which is highly helpful for extracting named entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The examples provide direct mappings between the entities \'granulocytes\' and \'T cells\' with their corresponding labels \'cell_type\', which is highly helpful for extracting named entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The examples provide direct mappings between the entities \'EKLF\', \'CBP\', \'p300\', and \'P/CAF\' with their corresponding labels \'protein\', which is highly helpful for extracting named entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides a direct mapping between the entity \'Egr-1\' and its corresponding label \'protein\', which is highly helpful for extracting named entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The examples provide direct mappings between the entities \'NF-ATc\', \'T lymphocytes\', and \'embryonic cardiac cells\' with their corresponding labels \'protein\' and \'cell_type\', which is highly helpful for extracting named entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides a direct mapping between the entity \'erythropoietin\' and its corresponding label \'protein\', which is highly helpful for extracting named entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides a direct mapping between the entity \'NF-E2\' and its corresponding label \'protein\', which is highly helpful for extracting named entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The example provides a direct mapping between the entity \'E2A\' and its corresponding label \'protein\', which is highly helpful for extracting named entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides a direct mapping between the entity \'GATA-1\' and its corresponding label \'protein\', which is highly helpful for extracting named entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The examples provide direct mappings between the entities \'CD40\', \'Rel/nuclear factor kappaB\', \'NF-kappaB\', and \'B lymphocytes\' with their corresponding labels \'protein\' and \'cell_type\', which is highly helpful for extracting named entities."},\n    {"Example 15": 5},\n    {"Reason 15": "The examples provide direct mappings between the entities \'ZEB\', \'c-Myb\', \'Ets\', and \'hematopoietic cells\' with their corresponding labels \'protein\' and \'cell_type\', which is highly helpful for extracting named entities."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entities with the provided entity labels, hence not helpful for extracting named entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities with the provided entity labels, hence not helpful for extracting named entities."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities with the provided entity labels, hence not helpful for extracting named entities."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities with the provided entity labels, hence not helpful for extracting named entities."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities with the provided entity labels, hence not helpful for extracting named entities."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities with the provided entity labels, hence not helpful for extracting named entities."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities with the provided entity labels, hence not helpful for extracting named entities."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities with the provided entity labels, hence not helpful for extracting named entities."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities with the provided entity labels, hence not helpful for extracting named entities."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities with the provided entity labels, hence not helpful for extracting named entities."}\n]', 'response3': '[{"NF-E2": "protein"}, {"megakaryocytes": "cell_type"}]', 'prediction': {'NF-E2': 'protein', 'megakaryocytes': 'cell_type'}}
{'idx': 1547, 'sentence': 'Platelet glycoprotein ( GP ) Ib-IX-V is a multisubunit adhesion receptor that supports platelet attachment to thrombogenic surfaces at sites of vascular injury .', 'label': {'multisubunit adhesion receptor': 'protein', 'Ib-IX-V': 'protein', 'Platelet glycoprotein': 'protein', 'GP': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Example 2": 5},\n    {"Example 3": 1},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 1},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 96, 'sentence': 'We have analyzed the functional domains of the minimal Thy-1 promoter and show that the dominant promoter elements consist of multiple binding sites for the transcription factor Sp1 , an inverted CCAAT box , and sequences proximal to the transcription start site .', 'label': {'Sp1': 'protein', 'dominant promoter elements': 'DNA', 'minimal Thy-1 promoter': 'DNA', 'transcription factor': 'protein', 'multiple binding sites': 'DNA', 'CCAAT box': 'DNA', 'transcription start site': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes.": 3},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 5},\n    {"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 4},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 5},\n    {"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif.": 5}\n]', 'response3': '[{"Thy-1": "protein"}, {"Sp1": "protein"}]', 'prediction': {'Thy-1': 'protein', 'Sp1': 'protein'}}
{'idx': 1763, 'sentence': 'Cysteamine treatment inhibited both expression of the IL-2 mRNA and secretion of IL-2 into the culture medium .', 'label': {'IL-2': 'protein', 'IL-2 mRNA': 'RNA'}, 'response1': "['RNA', 'protein']", 'response2': '[\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 5},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .": 4},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .": 4},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .": 5},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .": 4},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells .": 5}\n]', 'response3': '[{"IL-2 mRNA": "RNA"}, {"IL-2": "protein"}]', 'prediction': {'IL-2 mRNA': 'RNA', 'IL-2': 'protein'}}
{'idx': 224, 'sentence': 'Cortivazol ( CVZ ) is a unique, high potency synthetic glucocorticoid , which has a phenylpyrazol fused to the A-ring of the steroid nucleus and displays binding consistent with two or more sites in the cytosol from CEM C7 cells (a human acute lymphoblastic T-cell line ).', 'label': {'CEM C7 cells': 'cell_line', 'human acute lymphoblastic T-cell line': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 5},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"CEM C7 cells": "cell_line"}]', 'prediction': {'CEM C7 cells': 'cell_line'}}
{'idx': 313, 'sentence': 'Immunohistochemical study of steroid hormones and an estrogen binding assay in malignant soft tissue tumors .', 'label': {'malignant soft tissue tumors': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein (E2A) being mentioned in relation to a gene expression study."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence clearly mentions a protein (GATA-1) in the context of gene expression during eosinophil differentiation."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence mentions lymphoid neoplasms, which is related to the cell_type entity."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence mentions phosphocreatine, which is related to the protein entity."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides multiple examples of proteins (SLAP-130, SLP-76, NF-E2) and mentions T cell as a cell_type entity."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions NF-E2 in the context of a cell-specific transcription factor, which is related to the protein entity."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides examples of immunohistochemistry, gene, and cell type entities being mentioned together."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions retinoic acid receptor alpha, which is related to the protein entity."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence mentions CD14, which is related to the protein entity."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides examples of cell_line and protein entities being mentioned together."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides examples of proteins (CD40, Rel/nuclear factor kappaB, NF-kappaB) and B lymphocytes as a cell_type entity."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides examples of cell_type, cell_line, and DNA entities being mentioned together."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions tal-1 and GATA-binding proteins, which are related to the protein entity, and hematopoiesis, which is related to the cell_type entity."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides examples of proteins (Erbstatin, genistein, Egr-1) and RNA entity being mentioned together."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides examples of DNA and protein entities being mentioned together."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence provides examples of protein entities (MR, aldosterone, progesterone) being mentioned together."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entity types mentioned in the target sentence."}\n]', 'response3': '[{"steroid hormones": "protein"}, {"estrogen": "protein"}]', 'prediction': {'steroid hormones': 'protein', 'estrogen': 'protein'}}
{'idx': 1285, 'sentence': "Characterization of 5' end of human thromboxane receptor gene .", 'label': {"5' end of human thromboxane receptor gene": 'DNA', 'human thromboxane receptor gene': 'DNA'}, 'response1': "['DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and specific example of a protein entity (p50p50) and its function, aiding in the extraction of named entities from the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 327, 'sentence': 'However, there is an EB1 -binding site ( ZRE-B ) located within the R-responsive enhancer region .', 'label': {'R-responsive enhancer region': 'DNA', 'EB1 -binding site': 'DNA', 'EB1': 'protein', 'ZRE-B': 'DNA'}, 'response1': "['protein']", 'response2': '[\n{"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n{"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF.": 5},\n{"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 4},\n{"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n{"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n{"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n{"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 5},\n{"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 4},\n{"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 5},\n{"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n{"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n{"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n{"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5},\n{"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n{"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations.": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[{"EB1": "protein"}, {"ZRE-B": "DNA"}]', 'prediction': {'EB1': 'protein', 'ZRE-B': 'DNA'}}
{'idx': 1622, 'sentence': 'Analysis of whole-cell lysates by antiphosphotyrosine immunoblotting showed that incubation with gamma interferon brought about specific increases in phosphotyrosine labeling of several proteins.', 'label': {'gamma interferon': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"gamma interferon": "protein"}]', 'prediction': {'gamma interferon': 'protein'}}
{'idx': 1393, 'sentence': 'This enhancer in HIV-1 is the T-cell activation response element ; in HIV-2 , however, it is the second enhancer that is mainly responsible for activation in response to T-cell activators .', 'label': {'second enhancer': 'DNA', 'T-cell activation response element': 'DNA', 'enhancer': 'DNA'}, 'response1': "['cell_type']", 'response2': '[\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 4},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5},\n    {"These properties suggest that TAFII105 is a cell type-specific subunit of TFIID that may be responsible for mediating transcription by a subset of activators in B cells.": 5},\n    {"Interleukin 2 and T cell antigen receptor signals converge upon serine 727.": 5},\n    {"The response element for NF-AT is a sequence localized between -285/-254 in the IL-2 regulatory region.": 5}\n]', 'response3': '[{"HIV-1": "cell_type"}, {"T-cell": "cell_type"}, {"HIV-2": "cell_type"}, {"T-cell": "cell_type"}]', 'prediction': {'HIV-1': 'cell_type', 'T-cell': 'cell_type', 'HIV-2': 'cell_type'}}
{'idx': 1221, 'sentence': 'To identify osteoblast-specific cis-acting elements and trans-acting factors , we initiated an analysis of the promoter of a mouse osteocalcin gene , an osteoblast-specific gene .', 'label': {'mouse osteocalcin gene': 'DNA', 'promoter': 'DNA', 'osteoblast-specific cis-acting elements': 'DNA', 'trans-acting factors': 'protein', 'osteoblast-specific gene': 'DNA'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes.": 3},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 4},\n    {"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 4},\n    {"A critical role of Sp1- and Ets-related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"To evaluate the PML/RARalpha role in myelopoiesis, transgenic mice expressing PML/RARalpha were engineered.": 4},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 4},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 4},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 4},\n    {"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"osteoblast": "cell_type"}, {"cis-acting elements": "None"}, {"trans-acting factors": "None"}, {"promoter": "None"}, {"mouse osteocalcin gene": "protein"}, {"osteoblast-specific gene": "cell_type"}]', 'prediction': {'osteoblast': 'cell_type', 'cis-acting elements': 'None', 'trans-acting factors': 'None', 'promoter': 'None', 'mouse osteocalcin gene': 'protein', 'osteoblast-specific gene': 'cell_type'}}
{'idx': 130, 'sentence': 'At high concentration of NE , all of the TR bound to TREp was more greatly retarded than in the absence of NE .', 'label': {'TREp': 'DNA', 'TR': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 788, 'sentence': 'The number of mineralocorticoid receptors /cell were within or close to the normal range (n = 9).', 'label': {'mineralocorticoid receptors': 'protein'}, 'response1': "['cell_type']", 'response2': '[\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 1},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA/NF-kappaB1 binding complexes.": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 4},\n    {"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.": 5},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.": 5},\n    {"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.": 5},\n    {"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.": 5},\n    {"When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of the binding.": 5},\n    {"A total of 37 chronic, severe, nonsmoking asthmatic patients with documented reversible airways obstruction were classified as glucocorticoid-sensitive or -resistant on the basis of changes in FEV1, FVC, and peak expiratory flow (PEF) after oral prednisolone.": 5},\n    {"The number of Type I and Type II receptors before the test was lower in elderly subjects than in adults.": 5},\n    {"Membrane receptors for aldosterone: a novel pathway for mineralocorticoid action.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 5},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 5},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 5},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 781, 'sentence': 'Effects of aldosterone on intralymphocytic sodium and potassium in patients with essential hypertension .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a clear and direct mapping of the entity \'GATA-1\' to the entity label \'protein\' in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The example provides a direct mapping of the entity \'phosphocreatine\' to the entity label \'protein\' in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides clear mappings of the entities \'IL-2\', \'NF-kappa B\', and \'AP-1\' to the entity label \'protein\' in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The example provides a direct mapping of the entity \'T lymphocytes\' to the entity label \'cell_type\' in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides a direct mapping of the entity \'lymphoid neoplasms\' to the entity label \'cell_type\' in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The example provides clear mappings of the entities \'alpha-tocopherol\', \'monocyte\', and \'endothelial cells\' to the entity labels \'protein\', \'cell_type\', and \'cell_type\' respectively in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides clear mappings of the entities \'IL-5 mRNA\', \'TCR\', \'IL-2R\', and \'dexamethasone\' to the entity labels \'RNA\', \'cell_type\', \'protein\', and \'protein\' respectively in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides a direct mapping of the entity \'NF-E2\' to the entity label \'protein\' in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides a direct mapping of the entity \'NF-kappa B\' to the entity label \'protein\' in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides a direct mapping of the entity \'P selectin\' to the entity label \'protein\' in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides a direct mapping of the entity \'AP-1\' to the entity label \'DNA\' in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The example provides a direct mapping of the entity \'Eosinophils\' to the entity label \'cell_type\' in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides a direct mapping of the entity \'NF-kappa B\' to the entity label \'protein\' in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The example provides a direct mapping of the entity \'G-CSF\' to the entity label \'protein\' in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The example provides clear mappings of the entities \'cAMP-dependent protein kinase\' and \'Rap1\' to the entity labels \'protein\' in the target sentence."},\n    {"Example 16": 5},\n    {"Reason 16": "The example provides clear mappings of the entities \'CD40\', \'Rel/nuclear factor kappaB\', \'NF-kappaB\', and \'B lymphocytes\' to the entity labels \'protein\' and \'cell_type\' in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1220, 'sentence': 'A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element .', 'label': {'PEBP2 alpha/AML-1-related factor': 'protein', 'osteocalcin promoter': 'DNA', 'osteoblast-specific cis-acting element': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"5": "The sentence contains multiple protein entities which are present in the label set."},\n    {"5": "The sentence contains multiple protein entities which are present in the label set."},\n    {"5": "The sentence contains multiple protein entities which are present in the label set."},\n    {"5": "The sentence contains a protein entity which is present in the label set."},\n    {"5": "The sentence contains a protein entity which is present in the label set."},\n    {"5": "The sentence contains protein and cell_line entities which are present in the label set."},\n    {"5": "The sentence contains protein and cell_type entities which are present in the label set."},\n    {"5": "The sentence contains protein and cell_type entities which are present in the label set."},\n    {"5": "The sentence contains protein and cell_type entities which are present in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."}\n]', 'response3': '[{"PEBP2 alpha/AML-1-related factor": "protein"}, {"osteocalcin": "protein"}, {"osteoblast-specific": "cell_type"}]', 'prediction': {'PEBP2 alpha/AML-1-related factor': 'protein', 'osteocalcin': 'protein', 'osteoblast-specific': 'cell_type'}}
{'idx': 958, 'sentence': 'Here, Markus Neurath, Eckhard Stuber and Warren Strober describe the molecular structure of BSAP and focus on the ability of this protein to regulate the expression of B-cell-specific genes .', 'label': {'B-cell-specific genes': 'DNA', 'BSAP': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of proteins and their corresponding labels, which can aid in the extraction of named entities from the target sentence."}\n]', 'response3': '[{"Markus Neurath": "None"}, {"Eckhard Stuber": "None"}, {"Warren Strober": "None"}, {"BSAP": "protein"}, {"B-cell-specific genes": "None"}]', 'prediction': {'Markus Neurath': 'None', 'Eckhard Stuber': 'None', 'Warren Strober': 'None', 'BSAP': 'protein', 'B-cell-specific genes': 'None'}}
{'idx': 1083, 'sentence': 'These data suggest that the action of tepoxalin to inhibit proliferation in PBMC may be at least in part due to its ability to reduce the amount of available iron resulting in decreased activation of NF kappa B and subsequent inhibition of cytokine production .', 'label': {'cytokine': 'protein', 'NF kappa B': 'protein', 'PBMC': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 514, 'sentence': 'Induction of the enhancer may have a role in the increase in globin gene transcription that characterizes erythroid maturation .', 'label': {'globin gene': 'DNA', 'enhancer': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence provides a clear and direct mention of the entity \'GATA-1\' and its entity label \'protein\', making it highly helpful for extracting named entities from the target sentence."},\n\n{"Example 2": 5},\n{"Reason 2": "The sentence directly mentions the entity \'NF-E2\' and its entity label \'protein\', providing valuable information for extracting named entities from the target sentence."},\n\n{"Example 3": 5},\n{"Reason 3": "The sentence explicitly mentions \'Th2-type lymphocytes\' as a cell type, making it highly relevant and helpful for identifying named entities in the target sentence."},\n\n{"Example 4": 5},\n{"Reason 4": "The sentence mentions \'Egr-1\' as a zinc finger transcription factor, providing a clear entity label \'protein\' that aids in extracting named entities from the target sentence."},\n\n{"Example 5": 5},\n{"Reason 5": "The sentence directly mentions \'erythropoietin\' as essential for red blood cell production, providing a clear entity label \'protein\' that is highly relevant for extracting named entities from the target sentence."},\n\n{"Example 6": 5},\n{"Reason 6": "The sentence mentions \'CCAAT box\' as DNA and \'EKLF binding site\' as protein, providing specific entity labels that are valuable for extracting named entities from the target sentence."},\n\n{"Example 7": 5},\n{"Reason 7": "The sentence mentions \'AP-1\' in the context of DNA binding activity, providing a clear entity label \'DNA\' that is helpful for extracting named entities from the target sentence."},\n\n{"Example 8": 5},\n{"Reason 8": "The sentence mentions \'IL-4\' in relation to gene expression and identifies it as a protein, which is valuable for extracting named entities from the target sentence."},\n\n{"Example 9": 5},\n{"Reason 9": "The sentence mentions \'retinoic acid receptor alpha\' as a protein, providing a specific entity label that aids in extracting named entities from the target sentence."},\n\n{"Example 10": 5},\n{"Reason 10": "The sentence mentions \'RXR\' as a protein and its mutants in the context of erythroid cells, providing valuable information for extracting named entities from the target sentence."},\n\n{"Example 11": 5},\n{"Reason 11": "The sentence mentions \'WT1\' as a protein and \'myeloid cell lines\' as a cell line, providing specific entity labels that are helpful for extracting named entities from the target sentence."},\n\n{"Example 12": 5},\n{"Reason 12": "The sentence mentions \'IL-2 receptor alpha subunit\' as a protein, \'p21ras\' as a protein, and \'B cell\' as a cell type, providing multiple specific entity labels that aid in extracting named entities from the target sentence."},\n\n{"Example 13": 5},\n{"Reason 13": "The sentence mentions \'IgH\' in the context of DNA gene control, providing a specific entity label \'DNA\' that is valuable for extracting named entities from the target sentence."},\n\n{"Example 14": 5},\n{"Reason 14": "The sentence mentions \'GATA-1\' as a protein in erythroid cells, providing a specific entity label that aids in extracting named entities from the target sentence."},\n\n{"Example 15": 5},\n{"Reason 15": "The sentence mentions \'immunoglobulin kappa 3\' enhancer\' as DNA, providing a specific entity label that is highly relevant for extracting named entities from the target sentence."},\n\n{"Example 16": 5},\n{"Reason 16": "The sentence mentions \'SCL\' and \'GATA-1\' as proteins in the context of cell lineages, providing specific entity labels that are valuable for extracting named entities from the target sentence."},\n\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any relevant entities or entity labels that can aid in extracting named entities from the target sentence."},\n\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any relevant entities or entity labels that can aid in extracting named entities from the target sentence."},\n\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any relevant entities or entity labels that can aid in extracting named entities from the target sentence."},\n\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any relevant entities or entity labels that can aid in extracting named entities from the target sentence."},\n\n{"Example 21": 1},\n{"Reason 21": "The sentence does not contain any relevant entities or entity labels that can aid in extracting named entities from the target sentence."},\n\n{"Example 22": 1},\n{"Reason 22": "The sentence does not contain any relevant entities or entity labels that can aid in extracting named entities from the target sentence."},\n\n{"Example 23": 1},\n{"Reason 23": "The sentence does not contain any relevant entities or entity labels that can aid in extracting named entities from the target sentence."},\n\n{"Example 24": 1},\n{"Reason 24": "The sentence does not contain any relevant entities or entity labels that can aid in extracting named entities from the target sentence."},\n\n{"Example 25": 1},\n{"Reason 25": "The sentence does not contain any relevant entities or entity labels that can aid in extracting named entities from the target sentence."}\n]', 'response3': "[{'globin gene': 'protein'}, {'enhancer': 'DNA'}, {'erythroid': 'cell_type'}]", 'prediction': {'globin gene': 'protein', 'enhancer': 'DNA', 'erythroid': 'cell_type'}}
{'idx': 1133, 'sentence': 'Both LCLs were found by EM to produce RVLP and EBV particles .', 'label': {'LCLs': 'cell_line'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.": 4},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .": 4},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 4},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .": 4},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 4},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 5},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms .": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .": 5},\n    {"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB .": 5}\n]', 'response3': '[{"LCLs": "cell_line"}, {"RVLP": "protein"}, {"EBV": "cell_line"}]', 'prediction': {'LCLs': 'cell_line', 'RVLP': 'protein', 'EBV': 'cell_line'}}
{'idx': 1762, 'sentence': 'Taking the IL-2 gene as a candidate, we examined the effect of cysteamine treatment on early gene expression during lymphocyte activation , and on the activity of transcription factors AP-1 , NF-kappa B , NF-AT and Oct1 , whose functions are required for expression of the IL-2 mRNA.', 'label': {'IL-2': 'protein', 'early gene': 'DNA', 'NF-kappa B': 'protein', 'Oct1': 'protein', 'transcription factors': 'protein', 'NF-AT': 'protein', 'AP-1': 'protein', 'IL-2 gene': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 4},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes.": 5},\n    {"While the activation of the IL-2 promoter and an NFAT-driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418, it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2-mediated NFAT activation is under the control of a combination of calcineurin-dependent and independent pathways.": 5},\n    {"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.": 5},\n    {"These results suggest that oxidative signals can positively and negatively regulate T cell transcriptional events and that changes in cellular redox can uncouple AP-1 regulation of c-jun from transcriptional up-regulation of IL-2 via NF-AT.": 5},\n    {"Together, these findings suggest that LITAF plays an important role in the activation of the human TNF-alpha gene and proposes a new mechanism to control TNF-alpha gene expression.": 5}\n]', 'response3': '[{"IL-2": "protein"}, {"cysteamine": "protein"}, {"AP-1": "protein"}, {"NF-kappa B": "protein"}, {"NF-AT": "protein"}, {"Oct1": "protein"}]', 'prediction': {'IL-2': 'protein', 'cysteamine': 'protein', 'AP-1': 'protein', 'NF-kappa B': 'protein', 'NF-AT': 'protein', 'Oct1': 'protein'}}
{'idx': 23, 'sentence': 'Furthermore, a mutant E6 motif lost both in vitro binding activity and in vivo enhancer activity .', 'label': {'mutant E6 motif': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Example 2": 1},\n    {"Example 3": 1},\n    {"Example 4": 5},\n    {"Example 5": 4},\n    {"Example 6": 4},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 4},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"E6 motif": "protein"}]', 'prediction': {'E6 motif': 'protein'}}
{'idx': 1476, 'sentence': 'Protein phosphorylation has an important role in the regulation of these two factors: (1) it induces the transactivating capacity of the AP-1 protein c-Jun ; and (2) it is involved in the release of the cytoplasmic inhibitor , I kappa B , from NF-kappa B , allowing translocation of the latter into the nucleus .', 'label': {'AP-1 protein': 'protein', 'c-Jun': 'protein', 'I kappa B': 'protein', 'NF-kappa B': 'protein', 'cytoplasmic inhibitor': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n{"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 5},\n{"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.": 5},\n{"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n{"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.": 5},\n{"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.": 5},\n{"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n{"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.": 5},\n{"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus, and induce transcription from responsive genes.": 5},\n{"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n{"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.": 5},\n{"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.": 5},\n{"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.": 5},\n{"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"AP-1": "protein"}, {"c-Jun": "protein"}, {"I kappa B": "protein"}, {"NF-kappa B": "protein"}]', 'prediction': {'AP-1': 'protein', 'c-Jun': 'protein', 'I kappa B': 'protein', 'NF-kappa B': 'protein'}}
{'idx': 234, 'sentence': 'A similar infection with a recombinant retrovirus containing the beta-galactosidase gene with an adenovirus E2 promoter , results in beta-galactosidase activity in a limited number of cultured and primary cells .', 'label': {'cultured': 'cell_line', 'primary cells': 'cell_type', 'adenovirus E2 promoter': 'DNA', 'beta-galactosidase gene': 'DNA', 'beta-galactosidase': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 4},\n    {"In addition, assay of PBMC by the adenovirus-specific PCR may help detect early invasive disease and warrants further evaluation.": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 3},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"This protein has now been purified and its encoding gene cloned.": 5},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 4},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 4},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 5},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 4},\n    {"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n    {"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.": 4},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 4},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 4}\n]', 'response3': '[{"beta-galactosidase gene": "protein"}, {"adenovirus E2 promoter": "DNA"}]', 'prediction': {'beta-galactosidase gene': 'protein', 'adenovirus E2 promoter': 'DNA'}}
{'idx': 1396, 'sentence': 'NF-M ( chicken C/EBP beta ) induces eosinophilic differentiation and apoptosis in a hematopoietic progenitor cell line .', 'label': {'hematopoietic progenitor cell line': 'cell_line', 'NF-M': 'protein', 'chicken C/EBP beta': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '```json\n[\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 4},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 4},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"Control of NF-kappa B activity by the I kappa B beta inhibitor.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 4},\n    {"Recently, activation of NF-kappa B has been linked to ARDS and has been shown to be a critical proximal step in the initiation of neutrophilic inflammation in animal models.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 4},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 4},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 5},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 5}\n]\n```', 'response3': '```json\n[{"NF-M": "protein"}, {"C/EBP beta": "protein"}, {"hematopoietic progenitor cell line": "cell_line"}]\n```', 'prediction': {'NF-M': 'protein', 'C/EBP beta': 'protein', 'hematopoietic progenitor cell line': 'cell_line'}}
{'idx': 1812, 'sentence': 'The protein shows significant sequence similarities to the family of G-protein coupled chemokine receptors and turned out to be identical to the recently described receptor EBI1 .', 'label': {'G-protein coupled chemokine receptors': 'protein', 'chemokine receptors': 'protein', 'G-protein': 'protein', 'receptor EBI1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"EBV": 1},\n    {"B-cell": 1},\n    {"retinoic acid receptor alpha": 1},\n    {"Protein": 1},\n    {"MIP-1 alpha": 1},\n    {"GOS19": 1},\n    {"LD78": 1},\n    {"AT464": 1},\n    {"EBNA-2": 1},\n    {"PU.1": 1},\n    {"CREB": 1},\n    {"AR-CRE": 1},\n    {"Egr-1": 1},\n    {"E2A": 1},\n    {"GM-CSF": 1},\n    {"protein": 1},\n    {"EKLF": 1},\n    {"CBP": 1},\n    {"p300": 1},\n    {"P/CAF": 1},\n    {"EBNA2": 1},\n    {"TP1": 1},\n    {"c-kit": 1},\n    {"IL-4R alpha chain": 1},\n    {"interleukin 10": 1},\n    {"IL-10R": 1},\n    {"STAT3": 1},\n    {"IL-6": 1},\n    {"GATA-1": 1},\n    {"IL4": 1},\n    {"IL13": 1},\n    {"STAT6": 1},\n    {"STAT5": 1},\n    {"B cells": 1}\n]', 'response3': '[{"G-protein coupled chemokine receptors": "protein"}, {"EBI1": "protein"}]', 'prediction': {'G-protein coupled chemokine receptors': 'protein', 'EBI1': 'protein'}}
{'idx': 1099, 'sentence': 'Interestingly, microtubule disruption also decreased monocyte 1,25(OH)2D3 synthesis , not by decreasing the Vmax of monocyte mitochondrial 1 alpha-hydroxylase but through an increase in the Km for 25(OH)2D3 .', 'label': {'monocyte mitochondrial 1 alpha-hydroxylase': 'protein', 'monocyte': 'cell_type', 'microtubule': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 1},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 3},\n    {"Changes in PKC isoforms in human alveolar macrophages compared with blood monocytes.": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"We have examined the effect of alpha-tocopherol (alpha-tcp) on one cellular event in atherosclerotic plaque development, monocyte adhesion to stimulated endothelial cells (ECs).": 4},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 4},\n    {"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.": 4},\n    {"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.": 4},\n    {"When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma, the cells instead become DC.": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 4},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 4},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]": 4},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 4}\n]', 'response3': '[{"monocyte": "cell_type"}, {"1,25(OH)2D3": "protein"}, {"Vmax": "protein"}, {"monocyte mitochondrial 1 alpha-hydroxylase": "protein"}, {"Km": "protein"}, {"25(OH)2D3": "protein"}]', 'prediction': {'monocyte': 'cell_type', '1,25(OH)2D3': 'protein', 'Vmax': 'protein', 'monocyte mitochondrial 1 alpha-hydroxylase': 'protein', 'Km': 'protein', '25(OH)2D3': 'protein'}}
{'idx': 1537, 'sentence': 'Furthermore, we identified a repression domain at the N-terminus of Oct-2a .', 'label': {'Oct-2a': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 1},\n{"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n{"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.": 4},\n{"Here we examined the regulatory mechanism of the SCM-1 genes.": 3},\n{"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n{"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.": 5},\n{"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n{"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 4},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 4},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n{"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system.": 5},\n{"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n{"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n{"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations.": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[{"Oct-2a": "protein"}]', 'prediction': {'Oct-2a': 'protein'}}
{'idx': 1574, 'sentence': 'CONCLUSIONS: Sexual hormones , through their receptors , may influence the activity of eosinophils in patients with VKC .', 'label': {'receptors': 'protein', 'eosinophils': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Eosinophils play an important role in the effector phase of allergic inflammation.": 5},\n{"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n{"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.": 5},\n{"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 4},\n{"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 5},\n{"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 5},\n{"In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine (IFN-gamma) in combination with allergy-driven overproduction of T helper 2-type cytokines.": 5},\n{"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n{"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 5},\n{"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n{"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n{"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n{"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n{"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.": 5},\n{"To study the regulatory mechanism of gp91phox gene expression in eosinophils, we transiently transfected eosinophil-committed HL-60-C15 cells with gp91phox promoter constructs, and identified a negative element from bp -267 to -246 of the gp91phox gene, the deletion of which caused an 83% increase in promoter activity.": 5},\n{"This phenomenon is mediated, in part, through inducible expression of the CXC chemokine, interleukin-8 (IL-8).": 5}\n]', 'response3': '[{"eosinophils": "cell_type"}]', 'prediction': {'eosinophils': 'cell_type'}}
{'idx': 1312, 'sentence': 'A solution structure for the non-sequence-specific C-terminal HMG box of HMG-1 has recently been proposed.', 'label': {'HMG-1': 'protein', 'C-terminal HMG box': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1},\n    {"Example 26": 1},\n    {"Example 27": 1},\n    {"Example 28": 1},\n    {"Example 29": 1},\n    {"Example 30": 1}\n]', 'response3': '[{"HMG-1": "protein"}]', 'prediction': {'HMG-1': 'protein'}}
{'idx': 601, 'sentence': 'To determine whether enhancer elements in addition to the highly conserved octamer (OCTA)-nucleotide motif are important for lymphoid-specific expression of the immunoglobulin heavy-chain (IgH) gene , we have investigated the effect of mutating the binding site for a putative additional lymphoid-specific transcription factor , designated NF-microB , in the murine IgH enhancer .', 'label': {'murine IgH enhancer': 'DNA', 'putative additional lymphoid-specific transcription factor': 'protein', 'octamer (OCTA)-nucleotide motif': 'DNA', 'NF-microB': 'protein', 'enhancer elements': 'DNA', 'immunoglobulin heavy-chain (IgH) gene': 'DNA', 'binding site': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n{"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells .": 5},\n{"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .": 5},\n{"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n{"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 5},\n{"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 5},\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 5},\n{"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 5},\n{"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements .": 5},\n{"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n{"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 5},\n{"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .": 5},\n{"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .": 5}\n]', 'response3': '[{"NF-microB": "protein"}, {"IgH": "DNA"}]', 'prediction': {'NF-microB': 'protein', 'IgH': 'DNA'}}
{'idx': 890, 'sentence': 'Treatment of 10 with warm HCl furnished 19-chloro-4,21-dihydroxypregna-4,9(11)-diene-3,20-dione (13).', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.": 4},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 3},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 4},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of degradation of inhibitor-kappaB alpha.": 4},\n    {"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.": 4},\n    {"This hybrid clone, designated NR2, was characterized by several methods, including PCR, with eight pairs of oligonucleotides mapped to Chr 20: D20S5, D20S41, D20S42, D20S56, D20S57, D20S58, adenosine deaminase (ADA), and Prion protein (PRIP); Restriction Fragment Length Polymorphism (RFLP) analyses with four genomic anonymous probes (D20S5, cD3H12, D20S17, D20S18); and fluorescent in situ hybridization (FISH) with total human DNA and D20Z1, a sequence specific to the human Chr 20 centromere, as probes.": 5},\n    {"Treatment with soluble, bivalent mAb J393 killed 25-50% of the cell population, while concomitant engagement of either the CD3.TcR complex or the integrins CD18 and CD29 significantly potentiated this effect.": 5},\n    {"Combined treatment of HPCs with alpha-PML and alpha-Rb oligomers inhibited both PML and Rb protein expression and completely blocked erythroid colony development.": 5},\n    {"When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of the binding.": 5},\n    {"A 3-bp mutation at the distal Sp1-binding site not only eliminates Sp1 interaction, but also abolishes most of the VitD3 induction of CD14 expression.": 5},\n    {"CONCLUSION: Our results show that the tested agents (except indomethacin) are inhibitors of the T cell-mediated immune response, as expected, that aspirin is an effective suppressor of adhesion molecule expression, and that all three agents can induce Hsp60 in HUVECs.": 4}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 323, 'sentence': 'The Epstein-Barr virus ( EBV ) ORI1yt enhancer is not B-cell specific and does not respond synergistically to the EBV transcription factors R and Z .', 'label': {'Epstein-Barr virus ( EBV ) ORI1yt enhancer': 'DNA'}, 'response1': "['DNA', 'cell_type', 'protein']", 'response2': '[\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"5": "The sentence contains multiple instances of protein entities (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) which are relevant to the label set."},\n{"5": "The sentence contains multiple instances of protein entities (NF-kappaB, Sp1, p50) which are relevant to the label set."},\n{"3": "The sentence contains the protein entity EBNA2 which is relevant to the label set, but the cell_line entity TP1 is less common."},\n{"3": "The sentence contains the cell_type entity T cell and the protein entity interleukin 2 which are relevant to the label set."},\n{"4": "The sentence contains the protein entity IL-2 which is relevant to the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"5": "The sentence contains multiple instances of protein entities (NF-kB, AP-1, OCT-1, NF-IL-2B) which are relevant to the label set."},\n{"3": "The sentence contains the cell_line entity EBV and the protein entity CD2 which are relevant to the label set."},\n{"3": "The sentence contains the cell_type entity CD4+ and the protein entity EBV which are relevant to the label set."},\n{"5": "The sentence contains the protein entities EBNA-2 and PU.1 which are relevant to the label set."},\n{"3": "The sentence contains the cell_line entity UAS1 and the cell_type entity B cell which are relevant to the label set."},\n{"3": "The sentence contains the cell_type entities EBV and B-cell which are relevant to the label set."},\n{"5": "The sentence contains the protein entity GATA-1 which is relevant to the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."}\n]', 'response3': "[{'Epstein-Barr virus': 'cell_line'}, {'EBV': 'cell_line'}, {'R': 'protein'}, {'Z': 'protein'}]", 'prediction': {'Epstein-Barr virus': 'cell_line', 'EBV': 'cell_line', 'R': 'protein', 'Z': 'protein'}}
{'idx': 929, 'sentence': 'The cDNA sequence has an 813-bp open reading frame ( ORF ) whose predicted amino acid sequence is 97.6% identical to the 272 carboxy-terminal amino acids of the human ets-1 protein .', 'label': {'ORF': 'DNA', '272 carboxy-terminal amino acids': 'protein', 'ets-1': 'protein', 'human ets-1 protein': 'protein', '813-bp open reading frame': 'DNA', 'cDNA sequence': 'DNA', 'amino acid sequence': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n{"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 4},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n{"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n{"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 4},\n{"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n{"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n{"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 5},\n{"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n{"This protein has now been purified and its encoding gene cloned.": 5},\n{"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n{"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 5},\n{"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB-induced trans-activation of the H4 promoter.": 5},\n{"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5},\n{"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n{"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"cDNA": "DNA"}, {"ets-1 protein": "protein"}]', 'prediction': {'cDNA': 'DNA', 'ets-1 protein': 'protein'}}
{'idx': 6, 'sentence': 'Platelet-activating factor induces phospholipid turnover , calcium flux , arachidonic acid liberation , eicosanoid generation , and oncogene expression in a human B cell line .', 'label': {'Platelet-activating factor': 'protein', 'oncogene': 'DNA', 'human B cell line': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 4},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 4},\n    {"Example 7": 3},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 4},\n    {"Example 11": 4},\n    {"Example 12": 3},\n    {"Example 13": 3},\n    {"Example 14": 3},\n    {"Example 15": 3},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"phospholipid turnover": "protein"}, {"calcium flux": "protein"}, {"arachidonic acid liberation": "protein"}, {"eicosanoid generation": "protein"}, {"oncogene expression": "protein"}, {"human B cell line": "cell_line"}]', 'prediction': {'phospholipid turnover': 'protein', 'calcium flux': 'protein', 'arachidonic acid liberation': 'protein', 'eicosanoid generation': 'protein', 'oncogene expression': 'protein', 'human B cell line': 'cell_line'}}
{'idx': 1478, 'sentence': 'Furthermore, in activated T cells , the kinetics of the two phosphorylation events are essentially similar.', 'label': {'activated T cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 4},\n    {"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"The phosphorylated tyrosine residue itself is important for the protein-protein interaction .": 4},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .": 4},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .": 5},\n    {"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .": 5},\n    {"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .": 5},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1793, 'sentence': 'The clinical benefits of salicylates in the treatment of several diseases, including atherosclerosis and rheumatoid arthritis , may be related to their ability to reduce monocyte gene expression .', 'label': {}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Sentence": 5, "Reason": "The sentence contains multiple examples of named entities with their corresponding labels, making it highly helpful for extracting named entities from the target sentence."},\n    {"Sentence": 4, "Reason": "The sentence provides an example of a named entity with its corresponding label, which is helpful for extracting named entities from the target sentence."},\n    {"Sentence": 4, "Reason": "The sentence provides an example of a named entity with its corresponding label, which is helpful for extracting named entities from the target sentence."},\n    {"Sentence": 4, "Reason": "The sentence provides an example of a named entity with its corresponding label, which is helpful for extracting named entities from the target sentence."},\n    {"Sentence": 4, "Reason": "The sentence provides an example of a named entity with its corresponding label, which is helpful for extracting named entities from the target sentence."},\n    {"Sentence": 4, "Reason": "The sentence provides an example of a named entity with its corresponding label, which is helpful for extracting named entities from the target sentence."},\n    {"Sentence": 5, "Reason": "The sentence contains multiple examples of named entities with their corresponding labels, making it highly helpful for extracting named entities from the target sentence."},\n    {"Sentence": 4, "Reason": "The sentence provides an example of a named entity with its corresponding label, which is helpful for extracting named entities from the target sentence."},\n    {"Sentence": 3, "Reason": "The sentence provides an example of a named entity with its corresponding label, but it may not be directly relevant to the target sentence."},\n    {"Sentence": 3, "Reason": "The sentence provides an example of a named entity with its corresponding label, but it may not be directly relevant to the target sentence."},\n    {"Sentence": 4, "Reason": "The sentence provides an example of a named entity with its corresponding label, which is helpful for extracting named entities from the target sentence."},\n    {"Sentence": 4, "Reason": "The sentence provides an example of a named entity with its corresponding label, which is helpful for extracting named entities from the target sentence."},\n    {"Sentence": 4, "Reason": "The sentence provides an example of a named entity with its corresponding label, which is helpful for extracting named entities from the target sentence."},\n    {"Sentence": 3, "Reason": "The sentence provides an example of a named entity with its corresponding label, but it may not be directly relevant to the target sentence."},\n    {"Sentence": 1, "Reason": "The sentence does not provide any relevant examples of named entities with their corresponding labels for extracting named entities from the target sentence."},\n    {"Sentence": 1, "Reason": "The sentence does not provide any relevant examples of named entities with their corresponding labels for extracting named entities from the target sentence."},\n    {"Sentence": 1, "Reason": "The sentence does not provide any relevant examples of named entities with their corresponding labels for extracting named entities from the target sentence."},\n    {"Sentence": 1, "Reason": "The sentence does not provide any relevant examples of named entities with their corresponding labels for extracting named entities from the target sentence."},\n    {"Sentence": 1, "Reason": "The sentence does not provide any relevant examples of named entities with their corresponding labels for extracting named entities from the target sentence."},\n    {"Sentence": 1, "Reason": "The sentence does not provide any relevant examples of named entities with their corresponding labels for extracting named entities from the target sentence."},\n    {"Sentence": 1, "Reason": "The sentence does not provide any relevant examples of named entities with their corresponding labels for extracting named entities from the target sentence."},\n    {"Sentence": 1, "Reason": "The sentence does not provide any relevant examples of named entities with their corresponding labels for extracting named entities from the target sentence."},\n    {"Sentence": 1, "Reason": "The sentence does not provide any relevant examples of named entities with their corresponding labels for extracting named entities from the target sentence."},\n    {"Sentence": 1, "Reason": "The sentence does not provide any relevant examples of named entities with their corresponding labels for extracting named entities from the target sentence."},\n    {"Sentence": 1, "Reason": "The sentence does not provide any relevant examples of named entities with their corresponding labels for extracting named entities from the target sentence."},\n    {"Sentence": 1, "Reason": "The sentence does not provide any relevant examples of named entities with their corresponding labels for extracting named entities from the target sentence."},\n    {"Sentence": 1, "Reason": "The sentence does not provide any relevant examples of named entities with their corresponding labels for extracting named entities from the target sentence."},\n    {"Sentence": 1, "Reason": "The sentence does not provide any relevant examples of named entities with their corresponding labels for extracting named entities from the target sentence."},\n    {"Sentence": 1, "Reason": "The sentence does not provide any relevant examples of named entities with their corresponding labels for extracting named entities from the target sentence."}\n]', 'response3': '[{"salicylates": "protein"}, {"atherosclerosis": "cell_type"}, {"rheumatoid arthritis": "cell_type"}, {"monocyte": "cell_type"}]', 'prediction': {'salicylates': 'protein', 'atherosclerosis': 'cell_type', 'rheumatoid arthritis': 'cell_type', 'monocyte': 'cell_type'}}
{'idx': 1473, 'sentence': 'Costimulation requirement for AP-1 and NF-kappa B transcription factor activation in T cells .', 'label': {'NF-kappa B': 'protein', 'T cells': 'cell_type', 'AP-1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example contains specific protein names that are relevant to the target sentence, aiding in the extraction of protein entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The example contains protein names and cell types that are relevant to the target sentence, aiding in the extraction of protein and cell type entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The example contains specific protein names that are relevant to the target sentence, aiding in the extraction of protein entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The example contains specific protein names that are relevant to the target sentence, aiding in the extraction of protein entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The example contains specific protein names that are relevant to the target sentence, aiding in the extraction of protein entities."},\n    {"Example 6": 4},\n    {"Reason 6": "The example contains protein names and cell types that are relevant to the target sentence, aiding in the extraction of protein and cell type entities."},\n    {"Example 7": 4},\n    {"Reason 7": "The example contains protein names and cell types that are relevant to the target sentence, aiding in the extraction of protein and cell type entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The example contains specific protein names that are relevant to the target sentence, aiding in the extraction of protein entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The example contains specific protein names that are relevant to the target sentence, aiding in the extraction of protein entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The example contains specific protein names that are relevant to the target sentence, aiding in the extraction of protein entities."},\n    {"Example 11": 4},\n    {"Reason 11": "The example contains protein names and cell types that are relevant to the target sentence, aiding in the extraction of protein and cell type entities."},\n    {"Example 12": 1},\n    {"Reason 12": "The example does not contain any relevant entity types to the target sentence, hence not helpful in entity extraction."},\n    {"Example 13": 1},\n    {"Reason 13": "The example does not contain any relevant entity types to the target sentence, hence not helpful in entity extraction."},\n    {"Example 14": 1},\n    {"Reason 14": "The example does not contain any relevant entity types to the target sentence, hence not helpful in entity extraction."},\n    {"Example 15": 1},\n    {"Reason 15": "The example does not contain any relevant entity types to the target sentence, hence not helpful in entity extraction."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any relevant entity types to the target sentence, hence not helpful in entity extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any relevant entity types to the target sentence, hence not helpful in entity extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any relevant entity types to the target sentence, hence not helpful in entity extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain any relevant entity types to the target sentence, hence not helpful in entity extraction."},\n    {"Example 20": 1},\n    {"Reason 20": "The example does not contain any relevant entity types to the target sentence, hence not helpful in entity extraction."}\n]', 'response3': '[{"AP-1": "protein"}, {"NF-kappa B": "protein"}, {"T cells": "cell_type"}]', 'prediction': {'AP-1': 'protein', 'NF-kappa B': 'protein', 'T cells': 'cell_type'}}
{'idx': 539, 'sentence': 'PMA enhanced slightly the stimulatory effect of PHA .', 'label': {'PHA': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names (NF-kappa B, AP-1) that match the entity labels in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains a specific protein name (NF-E2) that matches the entity label in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains specific protein names (AP-1, PMA) and cell types (monocytes, macrophages) that match the entity labels in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains specific protein names (PAFR, PAF, NF-kappa B, protein kinase C) that match the entity labels in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific protein names (IL-2, NF-kappa B, AP-1) that match the entity labels in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains a specific protein name (MNDA) and a specific cell line (Philadelphia chromosome-positive chronic myeloid leukemia) that match the entity labels in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific protein names (Oct-2A, HMG I/Y, HLA-DRA) and a cell type (B cells) that match the entity labels in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains a specific protein name (NF-kappa B) that matches the entity label in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains a specific protein name (P selectin) that matches the entity label in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains a specific protein name (phosphocreatine) that matches the entity label in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains specific protein names (NDP kinase, KA, SCC, BCC) that match the entity labels in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains specific protein names (CD14, CD23) that match the entity labels in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains specific protein names (IL-4, LPS, AP-1) that match the entity labels in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific protein names (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) that match the entity labels in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains specific protein names (Epo, alpha-globin, beta-globin, haemoglobin, haemin, delta-ALA) that match the entity labels in the target sentence."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence contains specific protein names (PMA, IFN-gamma) and a cell type (T cell blasts) that match the entity labels in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entity names that match the entity labels in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entity names that match the entity labels in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entity names that match the entity labels in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entity names that match the entity labels in the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entity names that match the entity labels in the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entity names that match the entity labels in the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entity names that match the entity labels in the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entity names that match the entity labels in the target sentence."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entity names that match the entity labels in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1025, 'sentence': 'NK cells do not express NFATc constitutively, but NFATc mRNA accumulation is induced in these cells within 2 h of stimulation with CD16 ligands .', 'label': {'NFATc': 'protein', 'NK cells': 'cell_type', 'NFATc mRNA': 'RNA'}, 'response1': "['RNA', 'cell_type', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein entity (NF-kappa B) which is directly mentioned in the sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides multiple examples of protein entities (NF-ATc, RelA) and cell type entities (T lymphocytes, embryonic cardiac cells) which are directly mentioned in the sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence provides multiple examples of protein entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) which are directly mentioned in the sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides multiple examples of protein entities (CD40, IFN-gamma, tumor necrosis factor-alpha, interleukin (IL)-1beta) which are directly mentioned in the sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides a clear example of a DNA entity (NF-kappa B) which is directly mentioned in the sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides multiple examples of protein entities (NF-kappa B, I kappa B alpha) which are directly mentioned in the sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides multiple examples of protein entities (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) which are directly mentioned in the sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides multiple examples of protein entities (RelA, NF-kappa B) which are directly mentioned in the sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides multiple examples of protein entities (FasL, IL-2, IFN-gamma) which are directly mentioned in the sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides multiple examples of protein entities (NF-ATc) and cell type entities (T lymphocytes) which are directly mentioned in the sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides multiple examples of protein entities (NF-kappa B, I kappa B alpha) which are directly mentioned in the sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides multiple examples of protein entities (CD40, NF-kappa B) which are directly mentioned in the sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides multiple examples of protein entities (NF-kappaB, Tax) and cell type entities (ATL) which are directly mentioned in the sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides multiple examples of protein entities (STAT, STAT3) and cell type entities (T cells) which are directly mentioned in the sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides multiple examples of protein entities (IkappaBbeta, NF-kappaB) which are directly mentioned in the sentence."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence provides multiple examples of protein entities (CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, granulocyte-macrophage colony-stimulating factor) which are directly mentioned in the sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities from the given entity label set."}\n]', 'response3': '[{"NFATc": "protein"}, {"NFATc mRNA": "RNA"}, {"NK cells": "cell_type"}, {"CD16 ligands": "protein"}]', 'prediction': {'NFATc': 'protein', 'NFATc mRNA': 'RNA', 'NK cells': 'cell_type', 'CD16 ligands': 'protein'}}
{'idx': 1560, 'sentence': 'Moreover, in human T helper (Th) clones functionally characterized as being of the type 0, type 1 and type 2 (28%, < 1% und 93% CD30+, respectively), the extent of CD30 -mediated NF-kappa B activation correlated with the proportion of CD30+ cells .', 'label': {'human T helper (Th) clones': 'cell_line', 'CD30+ cells': 'cell_line', 'CD30': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"Th": "cell_type"}, {"CD30": "protein"}, {"NF-kappa B": "protein"}]', 'prediction': {'Th': 'cell_type', 'CD30': 'protein', 'NF-kappa B': 'protein'}}
{'idx': 365, 'sentence': 'Run-on analysis demonstrated detectable levels of c-jun gene transcription in untreated HL-60 cells , and that exposure to TPA increases this rate 3.3-fold.', 'label': {'c-jun': 'DNA', 'HL-60 cells': 'cell_line', 'untreated HL-60 cells': 'cell_line'}, 'response1': "['DNA', 'cell_type', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 1},\n    {"Example 7": 1},\n    {"Example 8": 1},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1039, 'sentence': 'Peripheral blood mononuclear cells ( pbmc ) and bone marrow cells of 26 patients were examined for c-fos , c-myc , p53 and the hybrid bcr/abl mRNA levels .', 'label': {'Peripheral blood mononuclear cells': 'cell_type', 'pbmc': 'cell_type', 'bone marrow cells': 'cell_type'}, 'response1': "['RNA', 'protein']", 'response2': '[\n    {"PBMC": 5},\n    {"adenovirus DNA": 5},\n    {"CD70": 5},\n    {"B cell": 5},\n    {"plasma cells": 5},\n    {"IL-4": 5},\n    {"CD40": 5},\n    {"MNDA": 5},\n    {"Philadelphia chromosome-positive chronic myeloid leukemia": 5},\n    {"PMA": 4},\n    {"CD14": 5},\n    {"CD23": 5},\n    {"IL-2": 5},\n    {"c-Jun": 5},\n    {"c-Fos": 5},\n    {"PML/RARalpha": 5},\n    {"myeloperoxidase": 5},\n    {"lysozyme": 5},\n    {"PU.1": 5},\n    {"NF-kappaB": 5},\n    {"Tax": 4},\n    {"ATL": 4},\n    {"TCRzeta": 5},\n    {"p56(lck)": 5},\n    {"p21(WAF1/CIP1)": 5},\n    {"p27(KIP1)": 5},\n    {"IFN A": 5},\n    {"IFNA": 5},\n    {"interleukin-2": 5},\n    {"interleukin-2 receptor": 5},\n    {"phytohemagglutinin": 5},\n    {"phorbol myristate acetate": 5},\n    {"Ter 119": 5},\n    {"beta-globin": 5},\n    {"glycoprotein IIb": 5},\n    {"platelet factor 4": 5},\n    {"Rel/nuclear factor kappaB": 5},\n    {"B lymphocytes": 5},\n    {"Ramos": 5},\n    {"Jurkat": 5},\n    {"cDNA microarray technology": 5},\n    {"HeLa cells": 5},\n    {"Daudi": 5},\n    {"Mono A": 5},\n    {"Mono B": 5},\n    {"CSF-1 receptor": 5}\n]', 'response3': '[{"pbmc": "cell_type"}, {"c-fos": "protein"}, {"c-myc": "protein"}, {"p53": "protein"}, {"bcr/abl": "RNA"}]', 'prediction': {'pbmc': 'cell_type', 'c-fos': 'protein', 'c-myc': 'protein', 'p53': 'protein', 'bcr/abl': 'RNA'}}
{'idx': 217, 'sentence': 'Quantitation of glucocorticoid receptors ( GCR ) and the study of their affinity for glucocorticosteroids ( GCS ) were made in peripheral blood lymphocytes of bronchial asthma ( BA ) patients in consideration of GCR treatment and serum levels of endogenous cortisol .', 'label': {'GCR': 'protein', 'glucocorticoid receptors': 'protein', 'peripheral blood lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 3},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 4},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 5},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.": 5},\n    {"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine (IFN-gamma) in combination with allergy-driven overproduction of T helper 2-type cytokines.": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 4},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5}\n]', 'response3': '[{"GCR": "protein"}, {"GCS": "protein"}, {"bronchial asthma": "cell_type"}, {"cortisol": "protein"}]', 'prediction': {'GCR': 'protein', 'GCS': 'protein', 'bronchial asthma': 'cell_type', 'cortisol': 'protein'}}
{'idx': 1782, 'sentence': 'In addition, resting PBL constitutively expressed prominent levels of Id2 mRNA , but not Id3 mRNA .', 'label': {'Id3': 'protein', 'resting PBL': 'cell_type', 'Id3 mRNA': 'RNA', 'PBL': 'cell_type', 'Id2': 'protein', 'Id2 mRNA': 'RNA'}, 'response1': "['RNA', 'protein']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 5},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n    {"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA/NF-kappaB1 binding complexes.": 5},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05).": 5},\n    {"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells, but not in primary T cells, consistent with the lack of the IL-12 receptor in resting T cells.": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"PMA induced the expression of both CD14 and CD23 mRNA and protein.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"Id2 mRNA": "RNA"}, {"Id3 mRNA": "RNA"}]', 'prediction': {'Id2 mRNA': 'RNA', 'Id3 mRNA': 'RNA'}}
{'idx': 1280, 'sentence': "Sequence analysis of the 5'-flanking region of the CD69 gene revealed the presence of a potential TATA element 30 base pairs upstream of the major transcription initiation site and several putative binding sequences for inducible transcription factors ( NF-kappa B , Egr-1 , AP-1 ), which might mediate the inducible expression of this gene.", 'label': {'NF-kappa B': 'protein', 'TATA element': 'DNA', 'transcription factors': 'protein', 'CD69': 'protein', 'AP-1': 'protein', '30 base pairs upstream': 'DNA', 'CD69 gene': 'DNA', "5'-flanking region": 'DNA', 'transcription initiation site': 'DNA', 'Egr-1': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms": 4},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor": 5},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter": 4},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements": 5},\n    {"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif": 5},\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region": 5},\n    {"These properties suggest that TAFII105 is a cell type-specific subunit of TFIID that may be responsible for mediating transcription by a subset of activators in B cells": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B": 5},\n    {"This sequence element was referred to as the BAT box and its deletion significantly reduced the activity of a CD20 promoter-CAT construct in B cells": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats)": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729": 1}\n]', 'response3': '[{"CD69 gene": "protein"}, {"TATA element": "DNA"}, {"NF-kappa B": "protein"}, {"Egr-1": "protein"}, {"AP-1": "protein"}]', 'prediction': {'CD69 gene': 'protein', 'TATA element': 'DNA', 'NF-kappa B': 'protein', 'Egr-1': 'protein', 'AP-1': 'protein'}}
{'idx': 611, 'sentence': 'Transactivation by some DNA viruses has been implicated in inducing HIV-1 replication and pathogenesis.', 'label': {}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 1},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"DNA viruses": "DNA"}, {"HIV-1": "cell_type"}]', 'prediction': {'DNA viruses': 'DNA', 'HIV-1': 'cell_type'}}
{'idx': 1723, 'sentence': 'In vitro treatment of a monocyte/macrophage cell line with CCl4 led to enhanced NF-kappa B binding and an increase in tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA levels .', 'label': {'tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA': 'RNA', 'NF-kappa B': 'protein', 'tumor necrosis factor-alpha': 'protein', 'TNF-alpha': 'protein'}, 'response1': "['cell_line', 'protein', 'RNA']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"5": "The sentence contains \'NF-kappaB\' and \'Tax\' which are both protein entities similar to the entities in the target sentence."},\n    {"5": "The sentence contains \'IkappaBbeta\' and \'NF-kappaB\' which are both protein entities similar to the entities in the target sentence."},\n    {"4": "The sentence contains \'NF-kappa B\' which is a protein entity similar to the entities in the target sentence."},\n    {"5": "The sentence contains \'IFN A\', \'IFNA\', \'interleukin-2\', \'interleukin-2 receptor\', \'phytohemagglutinin\', and \'phorbol myristate acetate\' which are all protein entities similar to the entities in the target sentence."},\n    {"5": "The sentence contains \'IL-2\', \'NF-kappa B\', and \'AP-1\' which are all protein entities similar to the entities in the target sentence."},\n    {"5": "The sentence contains \'NF-kappa B\' which is a protein entity similar to the entities in the target sentence."},\n    {"5": "The sentence contains \'MTHC\', \'TNF-alpha\', \'IFN-gamma\', and \'DC\' which are all entities similar to the entities in the target sentence."},\n    {"5": "The sentence contains \'NF-kappa B\' which is a DNA entity similar to the entities in the target sentence."},\n    {"5": "The sentence contains \'NF-kappa B\' which is a protein entity similar to the entities in the target sentence."},\n    {"5": "The sentence contains \'CD40\', \'Rel/nuclear factor kappaB\', \'NF-kappaB\', and \'B lymphocytes\' which are all entities similar to the entities in the target sentence."},\n    {"5": "The sentence contains \'PMA\', \'IFN-gamma\', and \'T cell blasts\' which are all entities similar to the entities in the target sentence."},\n    {"5": "The sentence contains \'CTLA4Ig\', \'NFAT\', and \'AP-1\' which are all entities similar to the entities in the target sentence."},\n    {"5": "The sentence contains \'NF-kappa B\' and \'neutrophils\' which are both entities similar to the entities in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1308, 'sentence': 'Two groups of HMG box proteins are distinguished.', 'label': {'HMG box proteins': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 4},\n    {"Example 3": 4},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 5},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1},\n    {"Example 26": 1},\n    {"Example 27": 1},\n    {"Example 28": 1},\n    {"Example 29": 1},\n    {"Example 30": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 765, 'sentence': 'Our results suggest that substances in serum influence steroid effects on these cells and that the molecular details of glucocorticoid hormone action may be pursued more precisely in a clearly defined culture medium.', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and direct mention of the entity \'nonhuman primates\' as a cell type, making it highly helpful for extracting named entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence directly mentions \'cell adhesion molecules\' as a cell type, providing a clear indication for entity extraction."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence explicitly states \'G-CSF\' as a protein, making it very helpful for named entity extraction."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains multiple entities explicitly labeled, such as \'CD70\' (protein), \'B cell\' (cell type), \'plasma cells\' (cell type), \'IL-4\' (protein), and \'CD40\' (protein), making it highly informative for entity extraction."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence directly mentions \'E2A\' as a protein, providing a clear indication for named entity extraction."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence explicitly mentions \'NF-E2\' as a protein, making it very helpful for named entity extraction."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains multiple entities explicitly labeled, such as \'IL-5 mRNA\' (RNA), \'TCR\' (cell type), \'IL-2R\' (protein), and \'dexamethasone\' (protein), making it highly informative for entity extraction."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides clear mentions of \'granulocytes\' and \'T cells\' as cell types, making it highly helpful for named entity extraction."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence explicitly mentions \'IL-4\' as a protein, providing a clear indication for named entity extraction."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains multiple entities explicitly labeled, such as \'IL-2\' (protein), \'c-Jun\' (protein), and \'c-Fos\' (protein), making it highly informative for entity extraction."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence directly mentions \'phosphocreatine\' as a protein, providing a clear indication for named entity extraction."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains multiple entities explicitly labeled, such as \'HML\' (cell line), \'dexamethasone\' (protein), \'cortisol\' (protein), and \'lysozyme\' (protein), making it highly informative for entity extraction."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence explicitly mentions \'IFN-gamma\' as a protein, making it very helpful for named entity extraction."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence explicitly mentions \'NF-kappa B\' as a protein, making it very helpful for named entity extraction."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains multiple entities explicitly labeled, such as \'VDR\' (protein), \'RXR\' (protein), \'GRIP-1\' (protein), \'DRIP205\' (protein), and \'DRIP\' (protein), making it highly informative for entity extraction."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence contains multiple entities explicitly labeled, such as \'CD40\' (protein), \'Rel/nuclear factor kappaB\' (protein), \'NF-kappaB\' (protein), and \'B lymphocytes\' (cell type), making it highly informative for entity extraction."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1561, 'sentence': 'In all cell lines investigated, the NF-kappa B complexes induced following CD30 engagement were shown to contain p50 NF-kappa B1 , p65 RelA , and possibly other transcription factors .', 'label': {'CD30': 'protein', 'NF-kappa B complexes': 'protein', 'p65 RelA': 'protein', 'p50 NF-kappa B1': 'protein', 'NF-kappa B': 'protein', 'transcription factors': 'protein'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of the entity types present in the target sentence, such as NF-kappaB, Sp1, and p50, making it highly relevant for extracting named entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of the entity types present in the target sentence, such as NF-ATc and T lymphocytes, which can aid in extracting named entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of the entity types present in the target sentence, such as CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, and granulocyte-macrophage colony-stimulating factor, making it highly relevant for extracting named entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of the entity types present in the target sentence, such as PAFR, PAF, NF-kappa B, and protein kinase C, which can aid in extracting named entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of the entity types present in the target sentence, such as RelA and NF-kappa B, which can aid in extracting named entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of the entity types present in the target sentence, such as NF-kappa B and I kappa B alpha, which can aid in extracting named entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of the entity types present in the target sentence, such as NF-kappaB, Tax, and ATL, which can aid in extracting named entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of the entity types present in the target sentence, such as NF-kappa B and I kappa B alpha, which can aid in extracting named entities."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains an example of the entity type present in the target sentence, NF-kappa B, which can aid in extracting named entities."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains examples of the entity types present in the target sentence, such as NF-kB, AP-1, OCT-1, and NF-IL-2B, which can aid in extracting named entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of the entity types present in the target sentence, such as IkappaBalpha and NF-kappaB, which can aid in extracting named entities."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains an example of the entity type present in the target sentence, NF-kappa B, which can aid in extracting named entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of the entity types present in the target sentence, such as IkappaBbeta and NF-kappaB, which can aid in extracting named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity types present in the target sentence, making it not helpful for extracting named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity types present in the target sentence, making it not helpful for extracting named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity types present in the target sentence, making it not helpful for extracting named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity types present in the target sentence, making it not helpful for extracting named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity types present in the target sentence, making it not helpful for extracting named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity types present in the target sentence, making it not helpful for extracting named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity types present in the target sentence, making it not helpful for extracting named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity types present in the target sentence, making it not helpful for extracting named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity types present in the target sentence, making it not helpful for extracting named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity types present in the target sentence, making it not helpful for extracting named entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any examples of the entity types present in the target sentence, making it not helpful for extracting named entities."}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"p50 NF-kappa B1": "protein"}, {"p65 RelA": "protein"}]', 'prediction': {'NF-kappa B': 'protein', 'p50 NF-kappa B1': 'protein', 'p65 RelA': 'protein'}}
{'idx': 330, 'sentence': 'ZRE-B is therefore not part of the R- inducible enhancer .', 'label': {'ZRE-B': 'DNA', 'R- inducible enhancer': 'DNA'}, 'response1': 'None.', 'response2': '[\n{"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 5},\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n{"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 4},\n{"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 5},\n{"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 4},\n{"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n{"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 4},\n{"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n{"RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes.": 5},\n{"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 5},\n{"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n{"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 5},\n{"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 5},\n{"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription.": 5},\n{"We have found that the recruitment of EKLF to 5\'HS3 depends on the presence of 5\'HS2 in cis, but the recruitment to 5\'HS2 does not depend on 5\'HS3.": 5},\n{"The protein from E. coli specifically converted dUTP to dUMP and did not react with other dNTPs or NTPs.": 5},\n{"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex, cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1104, 'sentence': 'Although the interrelationship between the two messengers Ca2+ and cyclic AMP in platelet function is well documented, its mechanism of action still remains to be established.', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 4},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1594, 'sentence': 'Human IL4 promoter -mediated transcription is downregulated in Jurkat cells stimulated with the NF-kappa B -activating cytokine tumor necrosis factor alpha and suppressed in RelA -overexpressing cells .', 'label': {'Jurkat cells': 'cell_line', 'NF-kappa B -activating cytokine': 'protein', 'Human IL4 promoter': 'DNA', 'tumor necrosis factor alpha': 'protein', 'RelA -overexpressing cells': 'cell_line', 'NF-kappa B': 'protein', 'RelA': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"5": "The sentence contains multiple protein entities and a cell type entity that are relevant to the label set."},\n    {"5": "The sentence contains multiple protein entities that are relevant to the label set."},\n    {"5": "The sentence contains multiple protein entities that are relevant to the label set."},\n    {"5": "The sentence contains multiple protein entities that are relevant to the label set."},\n    {"5": "The sentence contains multiple protein entities and a cell type entity that are relevant to the label set."},\n    {"5": "The sentence contains multiple protein entities that are relevant to the label set."},\n    {"5": "The sentence contains multiple protein entities and a cell type entity that are relevant to the label set."},\n    {"5": "The sentence contains multiple protein entities and a cell type entity that are relevant to the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."}\n]', 'response3': '[{"Jurkat cells": "cell_line"}, {"NF-kappa B": "protein"}, {"tumor necrosis factor alpha": "protein"}, {"RelA": "protein"}]', 'prediction': {'Jurkat cells': 'cell_line', 'NF-kappa B': 'protein', 'tumor necrosis factor alpha': 'protein', 'RelA': 'protein'}}
{'idx': 1086, 'sentence': 'Analysis of the expression of human I kappa B alpha protein in stable transfectants of mouse 70Z/3 cells shows that, as for the endogenous murine protein, exogenous I kappa B alpha is degraded in response to inducers of NF-kappa B activity , such as phorbol myristate acetate or lipopolysaccharide .', 'label': {'NF-kappa B': 'protein', 'I kappa B alpha': 'protein', 'human I kappa B alpha protein': 'protein', 'mouse 70Z/3 cells': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"1": 5},\n    {"2": 5},\n    {"3": 5},\n    {"4": 5},\n    {"5": 5},\n    {"6": 5},\n    {"7": 5},\n    {"8": 5},\n    {"9": 5},\n    {"10": 5},\n    {"11": 5},\n    {"12": 5},\n    {"13": 5},\n    {"14": 5},\n    {"15": 5},\n    {"16": 1},\n    {"17": 1},\n    {"18": 1},\n    {"19": 1},\n    {"20": 1},\n    {"21": 1},\n    {"22": 1},\n    {"23": 1},\n    {"24": 1},\n    {"25": 1}\n]', 'response3': '[{"I kappa B alpha": "protein"}, {"NF-kappa B": "protein"}]', 'prediction': {'I kappa B alpha': 'protein', 'NF-kappa B': 'protein'}}
{'idx': 1, 'sentence': 'When the homeodomain from HB24 was compared to known mammalian and Drosophila homeodomains it was found to be only moderately conserved, but when it was compared to a highly diverged Drosophila homeodomain , H2.0, it was found to be 80% identical.', 'label': {'homeodomain': 'DNA', 'HB24': 'DNA', 'Drosophila homeodomain': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n    {"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 5},\n    {"Like Drosophila Toll, human Toll is a type I transmembrane protein with an extracellular domain consisting of a leucine-rich repeat (LRR) domain, and a cytoplasmic domain homologous to the cytoplasmic domain of the human interleukin (IL)-1 receptor.": 5},\n    {"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5},\n    {"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 5},\n    {"These two related genes share the evolutionarily conserved region encoding the Runt domain.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 5},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes.": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 5},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.": 5},\n    {"Thus, we were able to derive a hematopoietic cell line, called 47.10, that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1226, 'sentence': 'Lastly, the different mobilities of osteoblast nuclear extract-DNA complexes compared with T-cell nuclear extract-DNA complexes , along with the inability of OSF2 to be upregulated by retinoic acid , unlike the other PEBP2 alpha factors , suggest that OSF2 is a new member of this family of transcription factors .', 'label': {'transcription factors': 'protein', 'T-cell nuclear extract-DNA complexes': 'protein', 'OSF2': 'protein', 'osteoblast nuclear extract-DNA complexes': 'protein', 'PEBP2 alpha factors': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]": 5},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5},\n    {"The p50 and p65 proteins, constituents of the prototypic nuclear factor kappaB, were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex, cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[{"OSF2": "protein"}, {"PEBP2 alpha factors": "protein"}]', 'prediction': {'OSF2': 'protein', 'PEBP2 alpha factors': 'protein'}}
{'idx': 663, 'sentence': 'The cells lines described here should be useful for the delineation of signaling pathways utilized in the selective regulation of gene expression .', 'label': {}, 'response1': "['cell_line', 'cell_type', 'gene expression']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and direct example of the entity label \'RNA\' with the mention of \'SCL mRNA.\'"},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains multiple clear examples of entity labels such as \'protein\' with \'NF-ATc\', \'cell_type\' with \'T lymphocytes\' and \'embryonic cardiac cells.\'"},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly mentions \'GATA-1\' as a \'protein,\' providing a clear example of the entity label."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence explicitly mentions \'SCM-1 genes\' as a \'cell_line,\' providing a direct example of the entity label."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence clearly mentions \'nonhuman primates\' as a \'cell_type,\' providing a direct example of the entity label."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides a direct example of the entity label \'protein\' with the mention of \'E2A gene.\'"},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence directly mentions \'GATA-1\' as a \'protein,\' providing a clear example of the entity label."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains multiple clear examples of entity labels such as \'protein\' with \'immunohistochemistry\' and \'I kappa B alpha,\' \'DNA\' with \'gene,\' and \'cell_type\' with \'cell type.\'"},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides clear examples of entity labels with \'NF-kappa B\' as a \'protein\' and \'I kappa B alpha\' as a \'protein.\'"},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence directly mentions \'IL-4\' as a \'protein,\' providing a clear example of the entity label."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides clear examples of entity labels with \'MNDA\' as a \'protein\' and \'Philadelphia chromosome-positive chronic myeloid leukemia\' as a \'cell_line.\'"},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains multiple clear examples of entity labels such as \'protein\' with \'Sp1\' and \'Ets,\' and \'cell_type\' with \'mouse perforin gene.\'"},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides clear examples of entity labels with \'p21(WAF1/CIP1)\' as a \'protein\' and \'p27(KIP1)\' as a \'protein.\'"},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence directly mentions \'cell adhesion molecules\' as a \'cell_type,\' providing a clear example of the entity label."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides clear examples of entity labels with \'IL-13\' as a \'protein,\' \'IL-4R\' as a \'protein,\' \'JAK2\' as a \'protein,\' and \'IL-13R\' as a \'protein.\'"},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence contains multiple clear examples of entity labels such as \'protein\' with \'ZEB,\' \'c-Myb,\' and \'Ets,\' and \'cell_type\' with \'hematopoietic cells.\'"}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1000, 'sentence': 'Analysis of the biochemical and cell biological properties of these HSFs reveals that HSF3 has properties in common with both HSF1 and HSF2 and yet has features which are distinct from both.', 'label': {'HSF2': 'protein', 'HSF3': 'protein', 'HSFs': 'protein', 'HSF1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides clear and specific examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 39, 'sentence': 'Most hybrids express both KBF1 and NF-kappa B in their nuclei , but one hybrid expresses only KBF1 .', 'label': {'KBF1': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of proteins (PAFR, PAF, NF-kappa B, protein kinase C) that are directly mentioned and can be easily identified."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions NF-kappa B, which is a protein, and its inhibition, providing a clear example of a protein entity."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of proteins (NF-kappaB, Sp1, p50) that are involved in transcription factor binding, aiding in the identification of protein entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence directly mentions NF-kappa B, a protein, and its activation, providing a clear example of a protein entity."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions NF-kappa B and I kappa B alpha, both proteins involved in the activation process, aiding in the identification of protein entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of proteins (RelA, NF-kappa B) involved in abnormal kappa B-binding activity, aiding in the identification of protein entities."},\n    {"Sentence": 4},\n    {"Reason": "The sentence mentions NF-kappaB, a protein, and its activation, providing a clear example of a protein entity."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of proteins (NF-ATc, NF-ATc isoforms) synthesized in T lymphocytes, aiding in the identification of protein and cell_type entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions NF-kB, AP-1, OCT-1, and NF-IL-2B, all proteins involved in binding activity, aiding in the identification of protein entities."},\n    {"Sentence": 3},\n    {"Reason": "The sentence mentions NF-kappa B, which is a protein, and its DNA binding activity, providing an example of a protein entity but not directly related to the sentence context."},\n    {"Sentence": 4},\n    {"Reason": "The sentence provides examples of proteins (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) involved in the expression process, aiding in the identification of protein entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence mentions NF-kappa B and I kappa B alpha, both proteins involved in the expression control, aiding in the identification of protein entities."},\n    {"Sentence": 5},\n    {"Reason": "The sentence provides examples of proteins (NF-kappa B, AP-1) involved in the inhibition process, aiding in the identification of protein entities."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant examples of the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant examples of the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant examples of the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant examples of the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant examples of the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant examples of the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant examples of the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant examples of the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant examples of the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant examples of the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant examples of the entity labels in the target sentence."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any relevant examples of the entity labels in the target sentence."}\n]', 'response3': '[{"KBF1": "protein"}, {"NF-kappa B": "protein"}]', 'prediction': {'KBF1': 'protein', 'NF-kappa B': 'protein'}}
{'idx': 229, 'sentence': "We now show that: 1) CVZ has more than one binding site in a second, independent, B-cell line , IM-9 ; 2) the antiglucocorticoid RU 38486 is able to block both CVZ 's higher and lower affinity sites; 3) all of CVZ 's binding sites are on a protein immunologically indistinguishable from the human GR ; and 4) freshly isolated clones of CVZ -resistant cells have lost all binding sites for CVZ .", 'label': {'B-cell line': 'cell_line', 'IM-9': 'cell_line', 'GR': 'protein', "CVZ 's binding sites": 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 5},\n    {"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.": 5},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"A gst-EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2-PU.1 interaction.": 5},\n    {"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin.": 5},\n    {"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5}\n]', 'response3': '[{"CVZ": "protein"}, {"IM-9": "cell_line"}, {"RU 38486": "protein"}, {"human GR": "protein"}, {"CVZ": "protein"}, {"CVZ": "protein"}]', 'prediction': {'CVZ': 'protein', 'IM-9': 'cell_line', 'RU 38486': 'protein', 'human GR': 'protein'}}
{'idx': 743, 'sentence': 'Detection in non-erythroid cells of a factor with the binding characteristics of the erythroid cell transcription factor EF1 .', 'label': {'erythroid cell transcription factor': 'protein', 'non-erythroid cells': 'cell_type', 'EF1': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor ).": 4},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .": 4},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 4},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .": 4},\n    {"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts .": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 4},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 4},\n    {"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .": 4},\n    {"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .": 5},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .": 4},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 4},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 4},\n    {"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .": 5},\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .": 4},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 4},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1799, 'sentence': 'These STAT proteins were detected by using the IFN-gamma-activated sequence ( GAS ) and related oligonucleotides as probes in electrophoretic mobility shift assay .', 'label': {'GAS': 'DNA', 'IFN-gamma-activated sequence': 'DNA', 'STAT proteins': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.": 5},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Moreover, monocytes express a novel IL-10 -stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti- STAT3 Ab but is not observed in T cells.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus, and induce transcription from responsive genes.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"STAT proteins": "protein"}, {"IFN-gamma-activated sequence (GAS)": "DNA"}]', 'prediction': {'STAT proteins': 'protein', 'IFN-gamma-activated sequence (GAS)': 'DNA'}}
{'idx': 1703, 'sentence': "E1A blocked IFN 's induction of cytolytic resistance , resulting in the selective lysis of adenovirus-transformed cells by IFN -activated NK cells .", 'label': {'E1A': 'protein', 'IFN': 'protein', 'adenovirus-transformed cells': 'cell_line', 'IFN -activated NK cells': 'cell_line'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.": 4},\n    {"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells.": 5},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 4},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 4},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 4},\n    {"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.": 5},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 4},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis.": 4},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 4},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5}\n]', 'response3': '[{"E1A": "protein"}, {"IFN": "protein"}, {"adenovirus-transformed cells": "cell_line"}, {"NK cells": "cell_type"}]', 'prediction': {'E1A': 'protein', 'IFN': 'protein', 'adenovirus-transformed cells': 'cell_line', 'NK cells': 'cell_type'}}
{'idx': 629, 'sentence': 'Depletion of CD8+ cells was accompanied by 62 +/- 18% loss of progesterone receptor -bearing cells , while depletion of CD4+ cells resulted in a twofold increase in the number of positively staining lymphocytes .', 'label': {'progesterone receptor': 'protein', 'CD8+ cells': 'cell_line', 'lymphocytes': 'cell_line', 'progesterone receptor -bearing cells': 'cell_line', 'CD4+ cells': 'cell_line'}, 'response1': "['cell_type']", 'response2': '[\n    {"1": "The sentence contains specific cell types and proteins that are relevant to the entity labels in the target sentence."},\n    {"2": "The sentence mentions specific cell types and proteins that are relevant to the entity labels in the target sentence."},\n    {"3": "The sentence includes specific cell types and proteins that are relevant to the entity labels in the target sentence."},\n    {"4": "The sentence provides examples of specific cell types and proteins that are relevant to the entity labels in the target sentence."},\n    {"5": "The sentence contains multiple examples of specific cell types and proteins that are relevant to the entity labels in the target sentence."}\n]', 'response3': '[{"CD8+": "cell_type"}, {"progesterone receptor": "protein"}, {"CD4+": "cell_type"}, {"lymphocytes": "cell_type"}]', 'prediction': {'CD8+': 'cell_type', 'progesterone receptor': 'protein', 'CD4+': 'cell_type', 'lymphocytes': 'cell_type'}}
{'idx': 490, 'sentence': 'Cyclosporin A ( CsA ) is thought to exert its immunosuppressive effects by inhibiting the expression of a distinct set of lymphokine genes which are induced upon T-cell activation , among them the gene coding for interleukin-2 .', 'label': {'lymphokine genes': 'DNA', 'interleukin-2': 'protein'}, 'response1': "['protein', 'RNA']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"5": "The sentence contains multiple instances of the entity type \'protein\' which are relevant to the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"3": "The sentence contains \'IL-2R\' which is relevant to the target sentence as it refers to a protein involved in T-cell activation."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"5": "The sentence contains multiple instances of the entity type \'protein\' which are relevant to the target sentence."},\n    {"5": "The sentence contains multiple instances of the entity type \'protein\' which are relevant to the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."}\n]', 'response3': "[{'Cyclosporin A': 'protein'}, {'CsA': 'protein'}, {'lymphokine genes': 'protein'}, {'T-cell': 'cell_type'}, {'interleukin-2': 'protein'}]", 'prediction': {'Cyclosporin A': 'protein', 'CsA': 'protein', 'lymphokine genes': 'protein', 'T-cell': 'cell_type', 'interleukin-2': 'protein'}}
{'idx': 118, 'sentence': "Similar to 1;14 translocations , this deletion disrupts the SCL 5' regulatory region .", 'label': {'SCL': 'protein', "SCL 5' regulatory region": 'DNA'}, 'response1': "['DNA']", 'response2': '[\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 3},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 4},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"We have found that the recruitment of EKLF to 5\'HS3 depends on the presence of 5\'HS2 in cis, but the recruitment to 5\'HS2 does not depend on 5\'HS3.": 3},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 4},\n    {"Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n    {"SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor ).": 4},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n    {"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.": 3},\n    {"By the time of diagnosis of T-PLL , the clone contains many more genetic changes in the form of additional translocations.": 4},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 4}\n]', 'response3': '[{"SCL": "protein"}]', 'prediction': {'SCL': 'protein'}}
{'idx': 493, 'sentence': 'Here we report that the formation of two distinct mitogen-inducible DNA-binding complexes , the kappa B complex within the HIV enhancer and the NFAT-1 complex within the interleukin-2 enhancer , is inhibited in the presence of CsA .', 'label': {'NFAT-1 complex': 'protein', 'mitogen-inducible DNA-binding complexes': 'protein', 'kappa B complex': 'protein', 'interleukin-2': 'protein', 'interleukin-2 enhancer': 'DNA', 'HIV enhancer': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 4},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 4},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.": 5},\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 5},\n    {"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.": 5},\n    {"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"kappa B complex": "DNA"}, {"NFAT-1 complex": "protein"}, {"interleukin-2 enhancer": "protein"}]', 'prediction': {'kappa B complex': 'DNA', 'NFAT-1 complex': 'protein', 'interleukin-2 enhancer': 'protein'}}
{'idx': 1798, 'sentence': 'In purified human peripheral blood T cells , nuclear STAT proteins were activated approximately 3 h after activation by cross-linked anti-CD3 Abs .', 'label': {'purified human peripheral blood T cells': 'cell_type', 'anti-CD3 Abs': 'protein', 'nuclear STAT proteins': 'protein', 'T cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"STAT proteins": "protein"}, {"T cells": "cell_type"}, {"anti-CD3 Abs": "protein"}]', 'prediction': {'STAT proteins': 'protein', 'T cells': 'cell_type', 'anti-CD3 Abs': 'protein'}}
{'idx': 175, 'sentence': 'To compare extra-renal 1,25(OH)2D3 production in different types of granulomatous disease , and to identify the cell types responsible, we have evaluated the conversion of 25(OH)D3 in 1,25(OH)2D3 by uncultured cells recovered by bronchoalveolar lavage and blood mononuclear cells from normocalcemic patients with sarcoidosis and tuberculosis.', 'label': {'blood mononuclear cells': 'cell_type', 'uncultured cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n{"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n{"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n{"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .": 4},\n{"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .": 4},\n{"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]": 4},\n{"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n{"In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine ( IFN-gamma ) in combination with allergy-driven overproduction of T helper 2-type cytokines .": 4},\n{"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .": 5},\n{"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .": 4},\n{"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 4},\n{"Changes in PKC isoforms in human alveolar macrophages compared with blood monocytes .": 5},\n{"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .": 4},\n{"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .": 5},\n{"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .": 4},\n{"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .": 4},\n{"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5}\n]', 'response3': '[{"bronchoalveolar lavage": "cell_type"}, {"blood mononuclear cells": "cell_type"}, {"sarcoidosis": "cell_type"}, {"tuberculosis": "cell_type"}]', 'prediction': {'bronchoalveolar lavage': 'cell_type', 'blood mononuclear cells': 'cell_type', 'sarcoidosis': 'cell_type', 'tuberculosis': 'cell_type'}}
{'idx': 1498, 'sentence': 'Steroid mediated lysis of lymphoblasts requires the DNA binding region of the steroid hormone receptor.', 'label': {'lymphoblasts': 'cell_type'}, 'response1': "['DNA', 'cell_type']", 'response2': '[\n    {"Sentence: IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Reason: The sentence provides multiple examples of proteins (IL4, IL13, STAT6, STAT3, STAT5) and a cell type (B cells) that are relevant to the target sentence.": 5},\n    {"Sentence: Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.": 4},\n    {"Reason: The sentence provides an example of a protein (NF-E2) that is relevant to the target sentence.": 4},\n    {"Sentence: The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"Reason: The sentence provides an example of a DNA-binding protein (AP-1) that is relevant to the target sentence.": 4},\n    {"Sentence: Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras.": 5},\n    {"Reason: The sentence provides examples of proteins (IL-2, Aiolos, Ras) that are relevant to the target sentence.": 5},\n    {"Sentence: Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"Reason: The sentence provides examples of proteins (IL-2 receptor alpha subunit, p21ras) and a cell type (B cell) that are relevant to the target sentence.": 5},\n    {"Sentence: This review suggests roles for these alterations in the development of lymphoid neoplasms.": 4},\n    {"Reason: The sentence provides an example of a cell type (lymphoid neoplasms) that is relevant to the target sentence.": 4},\n    {"Sentence: It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"Reason: The sentence provides an example of a protein (RXR) that is relevant to the target sentence.": 4},\n    {"Sentence: Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"Reason: The sentence provides examples of proteins (CD40, NF-kappa B) that are relevant to the target sentence.": 5},\n    {"Sentence: The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 5},\n    {"Reason: The sentence provides an example of a protein (G-CSF) that is relevant to the target sentence.": 5},\n    {"Sentence: The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"Reason: The sentence provides examples of proteins (interleukin 10, IL-10R, STAT3, IL-6) that are relevant to the target sentence.": 5},\n    {"Sentence: Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Reason: The sentence provides examples of proteins (IL-2, AP-1, c-Jun, c-Fos) that are relevant to the target sentence.": 5},\n    {"Sentence: The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.": 4},\n    {"Reason: The sentence provides an example of a protein (GATA-1) that is relevant to the target sentence.": 4},\n    {"Sentence: Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 5},\n    {"Reason: The sentence provides examples of RNA (IL-5 mRNA), a cell type (TCR), and proteins (IL-2R, dexamethasone) that are relevant to the target sentence.": 5},\n    {"Sentence: Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"Reason: The sentence provides examples of proteins (CD70, IL-4, CD40) and cell types (B cell, plasma cells) that are relevant to the target sentence.": 5},\n    {"Sentence: Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 5},\n    {"Reason: The sentence provides an example of a DNA-binding protein (NF-kappa B) that is relevant to the target sentence.": 5},\n    {"Sentence: No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations.": 1},\n    {"Reason: The sentence does not provide any examples of entities relevant to the target sentence.": 1},\n    {"Sentence: This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"Reason: The sentence does not provide any examples of entities relevant to the target sentence.": 1},\n    {"Sentence: This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"Reason: The sentence does not provide any examples of entities relevant to the target sentence.": 1},\n    {"Sentence: These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"Reason: The sentence does not provide any examples of entities relevant to the target sentence.": 1},\n    {"Sentence: One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Reason: The sentence does not provide any examples of entities relevant to the target sentence.": 1},\n    {"Sentence: Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Reason: The sentence does not provide any examples of entities relevant to the target sentence.": 1},\n    {"Sentence: Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"Reason: The sentence does not provide any examples of entities relevant to the target sentence.": 1},\n    {"Sentence: 1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"Reason: The sentence does not provide any examples of entities relevant to the target sentence.": 1},\n    {"Sentence: The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"Reason: The sentence does not provide any examples of entities relevant to the target sentence.": 1},\n    {"Sentence: At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1},\n    {"Reason: The sentence does not provide any examples of entities relevant to the target sentence.": 1}\n]', 'response3': '[{"DNA binding region": "DNA"}]', 'prediction': {'DNA binding region': 'DNA'}}
{'idx': 995, 'sentence': 'The hierarchy of transcriptional control in B-cell development has recently been analyzed by targeted gene inactivation in the mouse .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific gene names and their corresponding entity labels, making it highly relevant for extracting named entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence provides specific gene names and their corresponding entity labels, which are helpful for extracting named entities, but not as diverse as Example 1."},\n    {"Example 3": 3},\n    {"Reason 3": "The sentence mentions a specific gene name and its corresponding entity label, which is somewhat helpful for extracting named entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains a specific gene name and its corresponding entity label, making it highly relevant for extracting named entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence mentions a specific gene name and its corresponding entity label, making it highly relevant for extracting named entities."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence provides specific gene names and their corresponding entity labels, which are helpful for extracting named entities, but not as diverse as Example 1."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific gene names and their corresponding entity labels, making it highly relevant for extracting named entities."},\n    {"Example 8": 4},\n    {"Reason 8": "The sentence provides specific gene names and their corresponding entity labels, which are helpful for extracting named entities, but not as diverse as Example 1."},\n    {"Example 9": 3},\n    {"Reason 9": "The sentence mentions a specific gene name and its corresponding entity label, which is somewhat helpful for extracting named entities."},\n    {"Example 10": 3},\n    {"Reason 10": "The sentence mentions a specific gene name and its corresponding entity label, which is somewhat helpful for extracting named entities."},\n    {"Example 11": 4},\n    {"Reason 11": "The sentence provides specific gene names and their corresponding entity labels, which are helpful for extracting named entities, but not as diverse as Example 1."},\n    {"Example 12": 3},\n    {"Reason 12": "The sentence mentions a specific gene name and its corresponding entity label, which is somewhat helpful for extracting named entities."},\n    {"Example 13": 3},\n    {"Reason 13": "The sentence mentions a specific gene name and its corresponding entity label, which is somewhat helpful for extracting named entities."},\n    {"Example 14": 3},\n    {"Reason 14": "The sentence mentions a specific gene name and its corresponding entity label, which is somewhat helpful for extracting named entities."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any specific gene names or entity labels relevant to the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific gene names or entity labels relevant to the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific gene names or entity labels relevant to the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific gene names or entity labels relevant to the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific gene names or entity labels relevant to the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any specific gene names or entity labels relevant to the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any specific gene names or entity labels relevant to the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any specific gene names or entity labels relevant to the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any specific gene names or entity labels relevant to the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any specific gene names or entity labels relevant to the target sentence."}\n]', 'response3': '[{"B-cell": "cell_type"}, {"mouse": "cell_type"}]', 'prediction': {'B-cell': 'cell_type', 'mouse': 'cell_type'}}
{'idx': 1671, 'sentence': 'Both phosphorylation and proliferation were inhibited by IL-6 neutralizing antibodies .', 'label': {'IL-6 neutralizing antibodies': 'protein', 'IL-6': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."}\n]', 'response3': '[{"IL-6": "protein"}]', 'prediction': {'IL-6': 'protein'}}
{'idx': 141, 'sentence': 'TNF-alpha was able to increase expression of the HIV LTR in T cells , but in monocytic cells , TNF-alpha did not induce the HIV LTR above a constitutive level of activity .', 'label': {'monocytic cells': 'cell_type', 'TNF-alpha': 'protein', 'HIV LTR': 'DNA', 'T cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a DNA binding activity, which directly corresponds to the \'DNA\' entity label in the target sentence."}\n]', 'response3': '[{"TNF-alpha": "protein"}, {"HIV LTR": "DNA"}, {"T cells": "cell_type"}, {"monocytic cells": "cell_type"}]', 'prediction': {'TNF-alpha': 'protein', 'HIV LTR': 'DNA', 'T cells': 'cell_type', 'monocytic cells': 'cell_type'}}
{'idx': 1557, 'sentence': "In this report, we show that following incubation of L540 cells ( Hodgkin's disease -derived, T cell-like, CD30 + cells ) with the agonistic anti- CD30 monoclonal antibodies ( mAb ) M44 and M67 , two nuclear factor (NF)-kappa B DNA binding activities were induced in nuclear extracts , as determined in gel retardation assays .", 'label': {"Hodgkin's disease -derived, T cell-like, CD30 + cells": 'cell_line', 'nuclear factor (NF)-kappa B': 'protein', 'M44': 'protein', 'L540 cells': 'cell_line', 'M67': 'protein', 'mAb': 'protein', 'agonistic anti- CD30 monoclonal antibodies': 'protein', 'CD30': 'protein'}, 'response1': "['cell_line', 'protein', 'DNA']", 'response2': '[\n    {"1": "The entity labels in the sentence do not match any of the entity types in the target sentence."},\n    {"1": "The entity labels in the sentence do not match any of the entity types in the target sentence."},\n    {"1": "The entity labels in the sentence do not match any of the entity types in the target sentence."},\n    {"1": "The entity labels in the sentence do not match any of the entity types in the target sentence."},\n    {"1": "The entity labels in the sentence do not match any of the entity types in the target sentence."},\n    {"1": "The entity labels in the sentence do not match any of the entity types in the target sentence."},\n    {"1": "The entity labels in the sentence do not match any of the entity types in the target sentence."},\n    {"1": "The entity labels in the sentence do not match any of the entity types in the target sentence."},\n    {"1": "The entity labels in the sentence do not match any of the entity types in the target sentence."},\n    {"1": "The entity labels in the sentence do not match any of the entity types in the target sentence."},\n    {"1": "The entity labels in the sentence do not match any of the entity types in the target sentence."},\n    {"1": "The entity labels in the sentence do not match any of the entity types in the target sentence."},\n    {"5": "The sentence provides examples of proteins (p50, p65) and DNA, which are relevant entity types in the target sentence."},\n    {"5": "The sentence provides examples of proteins (CD40, Rel/nuclear factor kappaB, NF-kappaB) and a cell type (B lymphocytes), which are relevant entity types in the target sentence."},\n    {"5": "The sentence provides examples of a cell type (HIV-1) and proteins (IFN, PKR, IkappaBalpha), which are relevant entity types in the target sentence."},\n    {"1": "The entity labels in the sentence do not match any of the entity types in the target sentence."},\n    {"1": "The entity labels in the sentence do not match any of the entity types in the target sentence."},\n    {"1": "The entity labels in the sentence do not match any of the entity types in the target sentence."},\n    {"1": "The entity labels in the sentence do not match any of the entity types in the target sentence."},\n    {"1": "The entity labels in the sentence do not match any of the entity types in the target sentence."},\n    {"1": "The entity labels in the sentence do not match any of the entity types in the target sentence."},\n    {"1": "The entity labels in the sentence do not match any of the entity types in the target sentence."},\n    {"1": "The entity labels in the sentence do not match any of the entity types in the target sentence."},\n    {"1": "The entity labels in the sentence do not match any of the entity types in the target sentence."},\n    {"1": "The entity labels in the sentence do not match any of the entity types in the target sentence."}\n]', 'response3': '[{"NF-kappa B": "DNA"}, {"CD30": "protein"}, {"mAb": "protein"}, {"M44": "protein"}, {"M67": "protein"}]', 'prediction': {'NF-kappa B': 'DNA', 'CD30': 'protein', 'mAb': 'protein', 'M44': 'protein', 'M67': 'protein'}}
{'idx': 1090, 'sentence': 'Further analysis reveals that the inducible phosphorylation of I kappa B alpha maps to two serines in the N terminus of the protein (residues 32 and 36) and that the mutation of either residue is sufficient to abolish ligand-induced degradation, whereas both residues must be mutated to abolish inducible phosphorylation of the protein.', 'label': {'N terminus': 'protein', 'I kappa B alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n{"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.": 4},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 4},\n{"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.": 4},\n{"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras.": 5},\n{"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 4},\n{"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 4},\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n{"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF.": 5},\n{"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events.": 5},\n{"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n{"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 3},\n{"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation.": 4},\n{"Control of NF-kappa B activity by the I kappa B beta inhibitor.": 4},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n{"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.": 4},\n{"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations.": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[{"I kappa B alpha": "protein"}]', 'prediction': {'I kappa B alpha': 'protein'}}
{'idx': 1568, 'sentence': 'The inverse relation between high density lipoprotein ( HDL ) and atherosclerotic events may in part be due to enzymes associated with HDL that destroy the biologically active lipids generated in LDL .', 'label': {'enzymes': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 4},\n    {"Example 6": 4},\n    {"Example 7": 1},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 1},\n    {"Example 13": 1},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"HDL": "protein"}, {"LDL": "protein"}]', 'prediction': {'HDL': 'protein', 'LDL': 'protein'}}
{'idx': 257, 'sentence': 'Because of the presence of a functional receptor-effector system for VD3 and multiple biological responses to the hormone, these cells provide a unique model system with which to probe the specific effects of VD3 on cell growth and differentiation in chronic myelogenous leukemia .', 'label': {}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"5": "The example contains the entity \'G-CSF\' which is a protein, matching one of the entity types in the target sentence."},\n    {"5": "The example contains the entity \'retinoic acid receptor alpha\' which is a protein, matching one of the entity types in the target sentence."},\n    {"5": "The example contains the entity \'NF-E2\' which is a protein, matching one of the entity types in the target sentence."},\n    {"5": "The example contains the entities \'c-kit\' and \'IL-4R alpha chain\' which are proteins, matching two of the entity types in the target sentence."},\n    {"5": "The example contains the entities \'CD70\', \'IL-4\', and \'CD40\' which are proteins, and \'B cell\' and \'plasma cells\' which are cell types, matching multiple entity types in the target sentence."},\n    {"5": "The example contains the entity \'CD14\' which is a protein, matching one of the entity types in the target sentence."},\n    {"5": "The example contains the entities \'IFN A\', \'IFNA\', \'interleukin-2\', \'interleukin-2 receptor\', \'phytohemagglutinin\', and \'phorbol myristate acetate\' which are proteins, matching multiple entity types in the target sentence."},\n    {"5": "The example contains the entities \'MNDA\' which is a protein, and \'Philadelphia chromosome-positive chronic myeloid leukemia\' which is a cell line, matching two of the entity types in the target sentence."},\n    {"5": "The example contains the entities \'WT1\' which is a protein, and \'myeloid cell lines\' which is a cell line, matching two of the entity types in the target sentence."},\n    {"5": "The example contains the entities \'IL-7R\' and \'gamma(c)\' which are proteins, matching two of the entity types in the target sentence."},\n    {"5": "The example contains the entities \'interleukin 10\', \'IL-10R\', \'STAT3\', and \'IL-6\' which are proteins, matching multiple entity types in the target sentence."},\n    {"5": "The example contains the entities \'IL4\', \'IL13\', \'STAT6\', \'STAT3\', \'STAT5\', and \'B cells\' which are proteins and a cell type, matching multiple entity types in the target sentence."},\n    {"5": "The example contains the entities \'Stat3\', \'Stat5\', and \'c-Mpl\' which are proteins, matching multiple entity types in the target sentence."},\n    {"5": "The example contains the entities \'interleukin-2\', \'alpha chain\', \'CD25\', and \'IL-2 receptor\' which are proteins, matching multiple entity types in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."},\n    {"1": "The example does not contain any entities present in the target sentence."}\n]', 'response3': "[{'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'},", 'prediction': {}}
{'idx': 262, 'sentence': 'This complementary DNA encoded a protein with structural similarities to the c-jun proto-oncogene product , and its target sequence was closely related to the palindromic target sequence of c-jun .', 'label': {'complementary DNA': 'DNA', 'c-jun proto-oncogene product': 'protein', 'palindromic target sequence': 'DNA', 'c-jun': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 3},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes.": 2},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"These two related genes share the evolutionarily conserved region encoding the Runt domain.": 4},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 3},\n    {"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 4},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 3},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 4},\n    {"This protein has now been purified and its encoding gene cloned.": 5},\n    {"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 4},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 4},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1351, 'sentence': 'Western blotting yielded a set of bands ranging from 25 kD to 55 kD, resulting from extensive alternative splicing .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 5},\n    {"Example 17": 5},\n    {"Example 18": 5},\n    {"Example 19": 5},\n    {"Example 20": 5}\n]', 'response3': '[{"25 kD": "protein"}, {"55 kD": "protein"}]', 'prediction': {'25 kD': 'protein', '55 kD': 'protein'}}
{'idx': 973, 'sentence': 'To assess the transcription regulatory function of MZF-1 , the full-length MZF-1 coding region was fused to the DNA binding domain of the yeast transactivator GAL4 .', 'label': {'MZF-1': 'DNA', 'DNA binding domain': 'protein', 'yeast transactivator GAL4': 'protein', 'GAL4': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein (SCM-1) and its corresponding entity label (cell_line), making it highly helpful for extracting named entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence clearly mentions the protein \'p50p50\' and its binding activity, providing a direct example for the entity label \'protein\', making it very helpful for entity extraction."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence explicitly mentions the protein \'PML/RARalpha\' and its role, making it a highly relevant example for the entity label \'protein\', thus very helpful for entity extraction."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides multiple examples of proteins (EKLF, CBP, p300, P/CAF) and their interactions, making it very helpful for extracting named entities with the label \'protein\'."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence clearly mentions the protein \'GATA-1\' and its role, providing a direct example for the entity label \'protein\', making it very helpful for entity extraction."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence explicitly mentions the protein \'TCF-1\' and its transactivation activity, making it a highly relevant example for the entity label \'protein\', thus very helpful for entity extraction."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides a clear example of the protein \'ZEBRA\' and its transactivation ability, making it highly helpful for extracting named entities with the label \'protein\'."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence explicitly mentions the protein \'A-myb\' and its expression pattern, making it a highly relevant example for the entity label \'protein\', thus very helpful for entity extraction."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence mentions \'Protein\' in the context of genomic sequences and transcription, indicating a clear example for the entity label \'protein\', making it very helpful for entity extraction."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides a direct example of the protein \'CD95 ligand\' and its promoter elements, making it highly helpful for extracting named entities with the label \'protein\'."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence clearly mentions the proteins \'Tax\' and \'TFIIA\' and their interaction, providing direct examples for the entity label \'protein\', making it very helpful for entity extraction."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence explicitly mentions the protein \'Egr-1\' and its role as a transcription factor, making it a highly relevant example for the entity label \'protein\', thus very helpful for entity extraction."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides a clear example of the protein \'GATA-1\' and its role in erythroid development, making it highly helpful for extracting named entities with the label \'protein\'."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence explicitly mentions the protein \'E2A\' and its expression level, making it a highly relevant example for the entity label \'protein\', thus very helpful for entity extraction."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides examples of the proteins \'Sp1\' and \'Ets\' and their role in gene regulation, making it very helpful for extracting named entities with the label \'protein\'."}\n]', 'response3': '[{"MZF-1": "protein"}, {"MZF-1": "protein"}, {"DNA": "DNA"}, {"GAL4": "protein"}]', 'prediction': {'MZF-1': 'protein', 'DNA': 'DNA', 'GAL4': 'protein'}}
{'idx': 1125, 'sentence': 'This indicates that the CR of GR may be of functional significance.', 'label': {'GR': 'protein'}, 'response1': "['protein']", 'response2': '[{"Example 1": 5},{"Example 2": 5},{"Example 3": 5},{"Example 4": 5},{"Example 5": 5},{"Example 6": 5},{"Example 7": 5},{"Example 8": 5},{"Example 9": 5},{"Example 10": 5},{"Example 11": 5},{"Example 12": 5},{"Example 13": 5},{"Example 14": 5},{"Example 15": 5},{"Example 16": 5},{"Example 17": 5},{"Example 18": 5},{"Example 19": 5},{"Example 20": 5},{"Example 21": 5},{"Example 22": 5},{"Example 23": 5},{"Example 24": 5},{"Example 25": 5}]', 'response3': '[]', 'prediction': {}}
{'idx': 338, 'sentence': 'Nuclear T3R in lymphocytes was determined by radio-ligand binding analysis .', 'label': {'T3R': 'protein', 'lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1080, 'sentence': 'However, the concurrent addition of iron (in the form of ferrous or ferric chloride and other iron salts ) reversed the inhibition of proliferation caused by tepoxalin .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 5},\n    {"Example 17": 5},\n    {"Example 18": 5},\n    {"Example 19": 5},\n    {"Example 20": 5},\n    {"Example 21": 5},\n    {"Example 22": 5},\n    {"Example 23": 5},\n    {"Example 24": 5},\n    {"Example 25": 5}\n]', 'response3': '[{"iron": "protein"}, {"ferrous": "protein"}, {"ferric chloride": "protein"}, {"iron salts": "protein"}, {"tepoxalin": "protein"}]', 'prediction': {'iron': 'protein', 'ferrous': 'protein', 'ferric chloride': 'protein', 'iron salts': 'protein', 'tepoxalin': 'protein'}}
{'idx': 1786, 'sentence': 'Binding of plasma Factor VII/VIIa to the tissue factor (TF) receptor initiates the coagulation protease cascades .', 'label': {'coagulation protease': 'protein', 'tissue factor (TF) receptor': 'protein', 'plasma Factor VII/VIIa': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 1},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"Factor VII/VIIa": "protein"}, {"TF": "protein"}]', 'prediction': {'Factor VII/VIIa': 'protein', 'TF': 'protein'}}
{'idx': 1242, 'sentence': 'LPS signaling was found to involve NF kappa B activation by the p50/p65 heterodimers .', 'label': {'NF kappa B': 'protein', 'p50/p65 heterodimers': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n    {"Control of NF-kappa B activity by the I kappa B beta inhibitor.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 5},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 4},\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.": 5},\n    {"Recently, activation of NF-kappa B has been linked to ARDS and has been shown to be a critical proximal step in the initiation of neutrophilic inflammation in animal models.": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 5},\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5}\n]', 'response3': '[{"NF kappa B": "protein"}, {"p50": "protein"}, {"p65": "protein"}]', 'prediction': {'NF kappa B': 'protein', 'p50': 'protein', 'p65': 'protein'}}
{'idx': 866, 'sentence': 'T cell activation results in high levels of HIV replication and is thought to be one mechanism leading to the conversion from latent to active viral infection .', 'label': {'T cell': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides specific protein names and a cell type related to T cell, matching the entity types in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence mentions a protein and DNA synthesis, which align with the entity types in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence includes protein names and a transcription factor, matching the entity types in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains protein names, a cell type related to B cells, and a process related to cell activation, all aligning with the entity types in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides protein names, a cell type related to T cells, and a process related to cell activation, all matching the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence mentions a protein name that is a transcriptional activator, which aligns with the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence includes a protein name related to T cell tyrosine kinase, matching the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides protein names, a cell type related to myeloid cells, and processes related to viral activation, all aligning with the entity types in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions cell types related to B and T cell activation, specific cell line names, and a technology related to DNA study, all matching the entity types in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains DNA and protein names that align with the entity types in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides protein names, a cell type related to T cells, and a process related to viral activation, all matching the entity types in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence includes cell type names and a DNA-related term, aligning with the entity types in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions protein names, a cell type related to T cells, and a mitogenic coactivator, all matching the entity types in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides protein names, a transcription factor, and a cell type related to monocytes and macrophages, all aligning with the entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entity types present in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entity types present in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entity types present in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entity types present in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entity types present in the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entity types present in the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entity types present in the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entity types present in the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entity types present in the target sentence."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 433, 'sentence': 'Competition experiments did not reveal any high-affinity binding site for BSAP in known regulatory regions of immunoglobulin and class II major histocompatibility (MHC) genes , suggesting that BSAP is a regulator of a different set of B-lymphoid-specific genes .', 'label': {'regulatory regions': 'DNA', 'BSAP': 'protein', 'high-affinity binding site': 'DNA', 'B-lymphoid-specific genes': 'DNA'}, 'response1': "['protein']", 'response2': '[\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n{"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n{"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n{"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.": 5},\n{"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n{"Here we examined the regulatory mechanism of the SCM-1 genes.": 4},\n{"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 5},\n{"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n{"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n{"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 5},\n{"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 5},\n{"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 5},\n{"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n{"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n{"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex, cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[{"BSAP": "protein"}, {"immunoglobulin": "protein"}, {"class II major histocompatibility (MHC) genes": "protein"}, {"B-lymphoid-specific genes": "cell_type"}]', 'prediction': {'BSAP': 'protein', 'immunoglobulin': 'protein', 'class II major histocompatibility (MHC) genes': 'protein', 'B-lymphoid-specific genes': 'cell_type'}}
{'idx': 1546, 'sentence': 'Identification of essential GATA and Ets binding motifs within the promoter of the platelet glycoprotein Ib alpha gene .', 'label': {'platelet glycoprotein Ib alpha gene': 'DNA', 'GATA': 'DNA', 'Ets binding motifs': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 4},\n    {"Example 3": 4},\n    {"Example 4": 4},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"GATA": "protein"}, {"Ets": "protein"}]', 'prediction': {'GATA': 'protein', 'Ets': 'protein'}}
{'idx': 1412, 'sentence': 'We found that these parameters were indistinguishable for one of the PRL- and IL-2- induced factors .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a clear entity-label mapping for the term \'SCM-1\', aiding in the extraction of the cell line entity from the target sentence."},\n\n    {"Example 2": 5},\n    {"Reason 2": "The example provides clear entity-label mappings for the terms \'CREB\' and \'AR-CRE\', aiding in the extraction of protein entities from the target sentence."},\n\n    {"Example 3": 5},\n    {"Reason 3": "The example provides clear entity-label mappings for the terms \'IL-2\', \'c-Jun\', and \'c-Fos\', aiding in the extraction of protein entities from the target sentence."},\n\n    {"Example 4": 5},\n    {"Reason 4": "The example provides clear entity-label mappings for the terms \'granulocytes\' and \'T cells\', aiding in the extraction of cell type entities from the target sentence."},\n\n    {"Example 5": 5},\n    {"Reason 5": "The example provides clear entity-label mappings for the terms \'IL-2 receptor alpha subunit\', \'p21ras\', and \'B cell\', aiding in the extraction of protein and cell type entities from the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 411, 'sentence': 'There was a significant positive correlation between VDR concentration and serum phosphate (P less than 0.05).', 'label': {'VDR': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 5},\n{"Reasons": "The sentence directly mentions \'DNA binding activity\', which is a clear indicator of the entity type \'DNA\'."},\n\n{"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n{"Reasons": "The sentence explicitly mentions \'granulocytes\' and \'T cells\', which are indicative of the entity type \'cell_type\'."},\n\n{"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n{"Reasons": "The sentence mentions \'phosphocreatine\', which is likely a \'protein\' entity based on context."},\n\n{"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 4},\n{"Reasons": "The sentence mentions \'CD14\', which is likely a \'protein\' entity based on context."},\n\n{"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 4},\n{"Reasons": "The sentence mentions \'PBMC\', which is indicative of the entity type \'cell_type\'. It also mentions \'adenovirus DNA\', which is a clear indicator of the entity type \'DNA\'."},\n\n{"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 4},\n{"Reasons": "The sentence mentions \'TCRzeta\' and \'p56(lck)\', which are likely \'protein\' entities based on context."},\n\n{"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n{"Reasons": "The sentence mentions \'retinoic acid receptor alpha\', which is likely a \'protein\' entity based on context."},\n\n{"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n{"Reasons": "The sentence mentions \'RXR\', which is likely a \'protein\' entity based on context."},\n\n{"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05).": 3},\n{"Reasons": "The sentence mentions \'CD4+\', which is indicative of the entity type \'cell_type\'. It also mentions \'EBV\', which is likely a \'protein\' entity based on context."},\n\n{"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n{"Reasons": "The sentence mentions \'Protein\', which is likely a \'protein\' entity based on context."},\n\n{"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.": 5},\n{"Reasons": "The sentence mentions \'VDR\', \'RXR\', \'GRIP-1\', and \'DRIP205\', all of which are likely \'protein\' entities based on context."},\n\n{"Both haemin and delta-ALA caused a de novo increase in alpha-globin expression as well as enhancing Epo-induced beta-globin expression, leading to a marked increase in haemoglobin production.": 5},\n{"Reasons": "The sentence mentions \'Epo\', \'alpha-globin\', \'beta-globin\', \'haemoglobin\', \'haemin\', and \'delta-ALA\', all of which are likely \'protein\' entities based on context."},\n\n{"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 4},\n{"Reasons": "The sentence mentions \'cDNA\', which is indicative of the entity type \'DNA\'. It also mentions \'Jurkat\', which is likely a \'cell_line\' entity based on context."},\n\n{"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.": 4},\n{"Reasons": "The sentence mentions \'PMA\', which is likely a \'cell_line\' entity based on context. It also mentions \'U1 cells\', which is indicative of the entity type \'cell_line\'."},\n\n{"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.": 4},\n{"Reasons": "The sentence mentions \'nuclear factor-kappa B\' and \'NF-kappa B\', which are likely \'DNA\' entities based on context."},\n\n{"The affinity of the BAT box binding proteins for the BAT box was approximately 25-fold less than for the octamer sequence and the BAT box binding proteins dissociated from the BAT box 10-fold more rapidly than from the octamer sequence.": 5},\n{"Reasons": "The sentence mentions \'BAT box\' and \'octamer sequence\', both of which are clear indicators of the entity type \'DNA\'."}\n]', 'response3': '[{"VDR concentration": "protein"}, {"serum phosphate": "protein"}]', 'prediction': {'VDR concentration': 'protein', 'serum phosphate': 'protein'}}
{'idx': 1460, 'sentence': 'In contrast, in a number of multiple myeloma cell lines , representing differentiated, plasma cell-like B cells , PU.1 DNA binding activity , mRNA expression , and Pu box -dependent transactivation were absent or detectable at a very low level.', 'label': {'multiple myeloma cell lines': 'cell_line', 'PU.1': 'protein', 'Pu box': 'DNA', 'differentiated, plasma cell-like B cells': 'cell_type'}, 'response1': "['cell_line', 'DNA', 'mRNA']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"2": "The sentence does not contain any of the entity types in the target sentence."},\n    {"3": "The sentence does not contain any of the entity types in the target sentence."},\n    {"4": "The sentence contains relevant entity types (DNA, protein) but the examples are not directly related to the target sentence."},\n    {"5": "The sentence contains a relevant entity type (protein) but the example is not directly related to the target sentence."},\n    {"6": "The sentence contains relevant entity types (protein, cell_line) but the examples are not directly related to the target sentence."},\n    {"7": "The sentence contains relevant entity types (protein) but the examples are not directly related to the target sentence."},\n    {"8": "The sentence contains relevant entity types (protein) but the examples are not directly related to the target sentence."},\n    {"9": "The sentence does not contain any of the entity types in the target sentence."},\n    {"10": "The sentence does not contain any of the entity types in the target sentence."},\n    {"11": "The sentence does not contain any of the entity types in the target sentence."},\n    {"12": "The sentence contains relevant entity types (protein) but the examples are not directly related to the target sentence."},\n    {"13": "The sentence contains relevant entity types (protein) but the examples are not directly related to the target sentence."},\n    {"14": "The sentence contains relevant entity types (protein, cell_line) but the examples are not directly related to the target sentence."},\n    {"15": "The sentence contains relevant entity types (DNA, cell_type) but the examples are not directly related to the target sentence."},\n    {"16": "The sentence does not contain any of the entity types in the target sentence."},\n    {"17": "The sentence does not contain any of the entity types in the target sentence."},\n    {"18": "The sentence does not contain any of the entity types in the target sentence."},\n    {"19": "The sentence does not contain any of the entity types in the target sentence."},\n    {"20": "The sentence does not contain any of the entity types in the target sentence."},\n    {"21": "The sentence does not contain any of the entity types in the target sentence."},\n    {"22": "The sentence does not contain any of the entity types in the target sentence."},\n    {"23": "The sentence does not contain any of the entity types in the target sentence."},\n    {"24": "The sentence does not contain any of the entity types in the target sentence."},\n    {"25": "The sentence does not contain any of the entity types in the target sentence."}\n]', 'response3': "[{'PU.1': 'protein'}, {'mRNA': 'RNA'}]", 'prediction': {'PU.1': 'protein', 'mRNA': 'RNA'}}
{'idx': 638, 'sentence': 'Thus the VLA-5 fibronectin receptor on CD4 cells can play a complementary role in CD3 - TCR -mediated signal transduction through its interaction with fibronectin .', 'label': {'CD3': 'protein', 'TCR': 'protein', 'VLA-5 fibronectin receptor': 'protein', 'fibronectin': 'protein', 'CD4 cells': 'cell_line'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names that match the entity labels in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains specific protein names that match the entity labels in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains specific protein and cell type names that match the entity labels in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains specific protein names that match the entity labels in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific protein names that match the entity labels in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific protein and cell type names that match the entity labels in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific protein and cell type names that match the entity labels in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific protein names that match the entity labels in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains specific protein names that match the entity labels in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains specific protein names that match the entity labels in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains specific protein names that match the entity labels in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains specific protein names that match the entity labels in the target sentence."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not contain any entity names that match the entity labels in the target sentence."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not contain any entity names that match the entity labels in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any entity names that match the entity labels in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entity names that match the entity labels in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entity names that match the entity labels in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entity names that match the entity labels in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entity names that match the entity labels in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entity names that match the entity labels in the target sentence."}\n]', 'response3': '[{"VLA-5": "protein"}, {"CD4 cells": "cell_type"}, {"CD3": "protein"}, {"TCR": "protein"}, {"fibronectin": "protein"}]', 'prediction': {'VLA-5': 'protein', 'CD4 cells': 'cell_type', 'CD3': 'protein', 'TCR': 'protein', 'fibronectin': 'protein'}}
{'idx': 1375, 'sentence': 'We have analyzed the expression of TCL1 mRNA and protein in peripheral blood lymphocytes ( PBLs ) from four AT cases and from healthy controls .', 'label': {'PBLs': 'cell_type', 'peripheral blood lymphocytes': 'cell_type', 'TCL1 mRNA': 'RNA', 'protein': 'protein'}, 'response1': "['RNA', 'protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence directly mentions the entity and its corresponding label."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence directly mentions the entities and their corresponding labels."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly mentions the entity and its corresponding label."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence directly mentions the entity and its corresponding label."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence directly mentions the entities and their corresponding labels."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence directly mentions the entities and their corresponding labels."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence directly mentions the entity and its corresponding label."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence directly mentions the entities and their corresponding labels."},\n    {"Example 9": 1},\n    {"Reason 9": "The sentence does not mention any entities from the given label set."},\n    {"Example 10": 1},\n    {"Reason 10": "The sentence does not mention any entities from the given label set."},\n    {"Example 11": 1},\n    {"Reason 11": "The sentence does not mention any entities from the given label set."},\n    {"Example 12": 1},\n    {"Reason 12": "The sentence does not mention any entities from the given label set."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not mention any entities from the given label set."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not mention any entities from the given label set."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not mention any entities from the given label set."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not mention any entities from the given label set."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not mention any entities from the given label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not mention any entities from the given label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not mention any entities from the given label set."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not mention any entities from the given label set."}\n]', 'response3': '[{"TCL1 mRNA": "RNA"}, {"protein": "protein"}, {"PBLs": "cell_type"}, {"AT": "cell_type"}]', 'prediction': {'TCL1 mRNA': 'RNA', 'protein': 'protein', 'PBLs': 'cell_type', 'AT': 'cell_type'}}
{'idx': 764, 'sentence': 'The increased sensitivity of CEM-C7 cells and its subclones to dexamethasone in serum-free medium returned to previous levels when these cells were recultured in serum-containing medium .', 'label': {'CEM-C7': 'cell_line', 'CEM-C7 cells': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .": 4},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 4},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .": 4},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .": 4},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 4},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .": 4},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .": 4},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice .": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5}\n]', 'response3': '[{"CEM-C7 cells": "cell_line"}]', 'prediction': {'CEM-C7 cells': 'cell_line'}}
{'idx': 897, 'sentence': 'The system is based on the use of an oligomerized NFAT-1 binding motif that directs transcription of SV40 T-antigen in transgenic mice .', 'label': {'transcription of SV40 T-antigen': 'protein', 'NFAT-1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"NFAT-1": "protein"}, {"SV40 T-antigen": "protein"}]', 'prediction': {'NFAT-1': 'protein', 'SV40 T-antigen': 'protein'}}
{'idx': 1842, 'sentence': 'Individually or collectively, none of the three enhancer-binding proteins ( LEF-1 , Ets-1 , and TFE-3 ) could activate transcription in the absence of Sp1 .', 'label': {'Ets-1': 'protein', 'TFE-3': 'protein', 'LEF-1': 'protein', 'enhancer-binding proteins': 'protein', 'Sp1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."}\n]', 'response3': '[{"LEF-1": "protein"}, {"Ets-1": "protein"}, {"TFE-3": "protein"}, {"Sp1": "protein"}]', 'prediction': {'LEF-1': 'protein', 'Ets-1': 'protein', 'TFE-3': 'protein', 'Sp1': 'protein'}}
{'idx': 1059, 'sentence': 'Transcription factors belonging to the NF-kappa B family are controlled by inhibitory I kappa B proteins , mainly I kappa B alpha and I kappa B beta .', 'label': {'NF-kappa B family': 'protein', 'Transcription factors': 'protein', 'I kappa B beta': 'protein', 'inhibitory I kappa B proteins': 'protein', 'I kappa B alpha': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains multiple named entities relevant to the entity labels in the target sentence, such as \'NF-kappaB\', \'Tax\', and \'ATL\', making it highly helpful for extracting named entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains named entities \'NF-ATc\' and \'T lymphocytes\' which are relevant to the entity labels in the target sentence, making it quite helpful for extracting named entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly mentions \'NF-kappa B\' and \'I kappa B alpha\', which are entities present in the target sentence, making it very helpful for extracting named entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence mentions \'NF-kappa B\' and \'I kappa B beta\', which are entities present in the target sentence, making it very helpful for extracting named entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains \'IkappaBalpha\' and \'NF-kappaB\', which are entities present in the target sentence, making it very helpful for extracting named entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions \'IkappaBbeta\' and \'NF-kappaB\', which are entities present in the target sentence, making it very helpful for extracting named entities."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence contains \'NF-ATc\', \'T lymphocytes\', and \'embryonic cardiac cells\', which are relevant to the entity labels in the target sentence, making it quite helpful for extracting named entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions \'NF-kappa B\' and \'AP-1\', which are entities present in the target sentence, making it very helpful for extracting named entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains \'NF-kappaB\' and \'rheumatoid arthritis\', which are entities present in the target sentence, making it very helpful for extracting named entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions \'NF-kappaB\', \'Sp1\', and \'p50\', which are entities present in the target sentence, making it very helpful for extracting named entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains \'RelA\' and \'NF-kappa B\', which are entities present in the target sentence, making it very helpful for extracting named entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions \'PAFR\', \'PAF\', \'NF-kappa B\', and \'protein kinase C\', which are entities present in the target sentence, making it very helpful for extracting named entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains \'NF-kappa B\' and \'I kappa B alpha\', which are entities present in the target sentence, making it very helpful for extracting named entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions \'NF-kappa B\', which is an entity present in the target sentence, making it very helpful for extracting named entities."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, making it not helpful for extracting named entities."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, making it not helpful for extracting named entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, making it not helpful for extracting named entities."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, making it not helpful for extracting named entities."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, making it not helpful for extracting named entities."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, making it not helpful for extracting named entities."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, making it not helpful for extracting named entities."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, making it not helpful for extracting named entities."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, making it not helpful for extracting named entities."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, making it not helpful for extracting named entities."}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"I kappa B": "protein"}, {"I kappa B alpha": "protein"}, {"I kappa B beta": "protein"}]', 'prediction': {'NF-kappa B': 'protein', 'I kappa B': 'protein', 'I kappa B alpha': 'protein', 'I kappa B beta': 'protein'}}
{'idx': 924, 'sentence': 'We conclude that p56 exists in cytosol in a higher order complex containing hsp70 and hsp90 , both of which in turn have been found to be associated with untransformed steroid receptors .', 'label': {'hsp70': 'protein', 'untransformed steroid receptors': 'protein', 'hsp90': 'protein', 'p56': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"p56": "protein"}, {"hsp70": "protein"}, {"hsp90": "protein"}, {"untransformed steroid receptors": "protein"}]', 'prediction': {'p56': 'protein', 'hsp70': 'protein', 'hsp90': 'protein', 'untransformed steroid receptors': 'protein'}}
{'idx': 247, 'sentence': 'Antigen B27 seems to be a cause of lower levels of glucocorticoid receptors in blood lymphocytes .', 'label': {'Antigen B27': 'protein', 'glucocorticoid receptors': 'protein', 'blood lymphocytes': 'cell_type', 'lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"Benzene toxicity towards lymphocytes is thought to be mediated by metabolites of benzene including benzoquinone ( BQ ).": 4},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 4},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes.": 3},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 4},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 4},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 3},\n    {"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.": 4},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.": 4},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 3},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 4},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.": 4},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 507, 'sentence': 'Thus, the transcriptional activity of TCF-1 alpha appears to depend on the TCF-2 alpha and T alpha 1 ( CREB ) transcription factors and the context of its binding site within the TCR alpha enhancer .', 'label': {'TCF-2 alpha': 'protein', 'TCR alpha enhancer': 'DNA', 'CREB': 'protein', 'transcription factors': 'protein', 'T alpha 1': 'protein', 'TCR': 'protein', 'TCF-1 alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 3},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 4},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 3},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 4},\n    {"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n    {"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system.": 4},\n    {"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 3},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 4},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 3},\n    {"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.": 4},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes.": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5},\n    {"While the activation of the IL-2 promoter and an NFAT -driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418, it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2 -mediated NFAT activation is under the control of a combination of calcineurin- dependent and independent pathways.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex, cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[{"TCF-1 alpha": "protein"}, {"TCF-2 alpha": "protein"}, {"T alpha 1": "protein"}, {"CREB": "protein"}, {"TCR alpha enhancer": "DNA"}]', 'prediction': {'TCF-1 alpha': 'protein', 'TCF-2 alpha': 'protein', 'T alpha 1': 'protein', 'CREB': 'protein', 'TCR alpha enhancer': 'DNA'}}
{'idx': 460, 'sentence': "To characterize these regulatory elements further, mutations in these regions were inserted into both the 5' and 3' HIV LTRs and infectious proviral constructs were assembled.", 'label': {'HIV LTRs': 'DNA', 'regulatory elements': 'DNA'}, 'response1': "['DNA']", 'response2': '[\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 5},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 5},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 5},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes.": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 5},\n    {"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 131, 'sentence': 'Truncation of TR alpha 1 at amino acid 210 prevented additional complex formation in the presence of NE without affecting DNA binding , suggesting that the carboxyl-terminus of the TRs is essential for interaction with nuclear proteins .', 'label': {'TRs': 'protein', 'carboxyl-terminus': 'protein', 'TR alpha 1': 'protein', 'nuclear proteins': 'protein', 'amino acid 210': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[\n    {"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes.": 5},\n    {"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system.": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n    {"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events.": 5},\n    {"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex.": 5},\n    {"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.": 5},\n    {"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 4},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[{"TR alpha 1": "protein"}, {"NE": "cell_line"}, {"DNA": "DNA"}, {"TRs": "protein"}]', 'prediction': {'TR alpha 1': 'protein', 'NE': 'cell_line', 'DNA': 'DNA', 'TRs': 'protein'}}
{'idx': 692, 'sentence': 'The human T-cell leukemia virus type I ( HTLV-I ) promoter contains three copies of imperfect repeats of a 21-base pair sequence designated here as TRE ( Tax -response element ) that is responsive to the virally encoded transactivator protein Tax .', 'label': {'virally encoded transactivator protein': 'protein', 'Tax -response element': 'DNA', 'TRE': 'DNA', 'human T-cell leukemia virus type I ( HTLV-I ) promoter': 'DNA', 'Tax': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n{"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.": 5},\n{"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 5},\n{"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n{"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n{"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n{"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 5},\n{"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n{"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n{"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5},\n{"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB- induced trans-activation of the H4 promoter.": 5},\n{"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n{"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.": 5}\n]', 'response3': '[{"HTLV-I": "cell_type"}, {"TRE": "DNA"}, {"Tax": "protein"}]', 'prediction': {'HTLV-I': 'cell_type', 'TRE': 'DNA', 'Tax': 'protein'}}
{'idx': 43, 'sentence': 'T-helper-cell determinants in protein antigens are preferentially located in cysteine-rich antigen segments resistant to proteolytic cleavage by cathepsin B , L , and D .', 'label': {'cysteine-rich antigen segments': 'protein', 'T-helper-cell determinants': 'protein', 'protein antigens': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 4},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Tat-binding protein 7 is a subunit of the 26S protease.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.": 4},\n    {"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 4},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 4},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"T-helper-cell": "cell_type"}, {"protein": "protein"}, {"cathepsin B": "protein"}, {"cathepsin L": "protein"}, {"cathepsin D": "protein"}]', 'prediction': {'T-helper-cell': 'cell_type', 'protein': 'protein', 'cathepsin B': 'protein', 'cathepsin L': 'protein', 'cathepsin D': 'protein'}}
{'idx': 1204, 'sentence': 'Hirsutism , graded by the modified Ferriman-Gallwey score , and hormonal parameters were evaluated basally and at 4-month intervals during treatment.', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence provides a clear example of a cell line (SCM-1) being examined in a regulatory mechanism context."},\n{"Example 2": 5},\n{"Reason 2": "The sentence clearly mentions a protein (NF-E2) in the context of a cellular differentiation program and transcription factor binding."},\n{"Example 3": 5},\n{"Reason 3": "The sentence contains multiple instances of proteins (dexamethasone, cortisol, lysozyme) and a cell line (HML) being evaluated for glucocorticoid responsiveness."},\n{"Example 4": 4},\n{"Reason 4": "The sentence mentions phosphocreatine in the context of energy substrates and hormone responses, which could be related to proteins."},\n{"Example 5": 5},\n{"Reason 5": "The sentence directly refers to lymphoid neoplasms, indicating a specific cell type."},\n{"Example 6": 5},\n{"Reason 6": "The sentence describes the examination of the E2A gene at the protein level, providing a clear example of a protein (E2A)."},\n{"Example 7": 5},\n{"Reason 7": "The sentence clearly mentions granulocytes and T cells, indicating specific cell types."},\n{"Example 8": 5},\n{"Reason 8": "The sentence discusses the impaired DNA binding activity of the transcription factor AP-1 in lymphocytes."},\n{"Example 9": 5},\n{"Reason 9": "The sentence describes the mRNA expression of the GATA-1 binding transcription factor, providing a clear example of a protein (GATA-1)."},\n{"Example 10": 5},\n{"Reason 10": "The sentence mentions Erbstatin, genistein, and Egr-1 mRNA expression, indicating proteins and RNA."},\n{"Example 11": 5},\n{"Reason 11": "The sentence provides examples of proteins (ATF1, CREB) and a protein promoter (H4) in the context of transcription factor-induced trans-activation."},\n{"Example 12": 5},\n{"Reason 12": "The sentence mentions EBV, EBNA2, and the estrogen receptor, indicating DNA, protein, and protein interactions."},\n{"Example 13": 5},\n{"Reason 13": "The sentence mentions MR, aldosterone, and progesterone, indicating proteins and hormones."},\n{"Example 14": 5},\n{"Reason 14": "The sentence describes the classification of asthmatic patients based on changes in FEV1, FVC, and PEF, indicating proteins."},\n{"Example 15": 5},\n{"Reason 15": "The sentence mentions IL-2r, c-fos, IL-2, and a lymphokine, indicating proteins and RNA."},\n{"Example 16": 5},\n{"Reason 16": "The sentence refers to Type I and Type II receptors, indicating specific cell types."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any specific entities related to the provided entity labels."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any specific entities related to the provided entity labels."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any specific entities related to the provided entity labels."},\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any specific entities related to the provided entity labels."},\n{"Example 21": 1},\n{"Reason 21": "The sentence does not contain any specific entities related to the provided entity labels."},\n{"Example 22": 1},\n{"Reason 22": "The sentence does not contain any specific entities related to the provided entity labels."},\n{"Example 23": 1},\n{"Reason 23": "The sentence does not contain any specific entities related to the provided entity labels."},\n{"Example 24": 1},\n{"Reason 24": "The sentence does not contain any specific entities related to the provided entity labels."},\n{"Example 25": 1},\n{"Reason 25": "The sentence does not contain any specific entities related to the provided entity labels."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1134, 'sentence': 'Reverse transcriptase (RT) assays were positive in purified viral material from both LCLs .', 'label': {'LCLs': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 4},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05).": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 5},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 4},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 4},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 4},\n    {"In addition, assay of PBMC by the adenovirus-specific PCR may help detect early invasive disease and warrants further evaluation.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 4},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 4}\n]', 'response3': '[{"RT": "protein"}, {"LCLs": "cell_line"}]', 'prediction': {'RT': 'protein', 'LCLs': 'cell_line'}}
{'idx': 471, 'sentence': 'The lymphocyte nuclear T3 receptor was found with an affinity close to that of normal volunteers (Ka: 1.42 x 10(10) M-1 vs 1.95 +/- 0.35 x 10(10) M-1) and a binding capacity markedly increased (9.9 vs 3.7 +/- 0.4 fmol T3 /100 micrograms DNA).', 'label': {'lymphocyte nuclear T3 receptor': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 3},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 4},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 3},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 4},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[{"T3 receptor": "protein"}, {"T3": "protein"}, {"DNA": "DNA"}]', 'prediction': {'T3 receptor': 'protein', 'T3': 'protein', 'DNA': 'DNA'}}
{'idx': 1205, 'sentence': 'Gonadotropin-releasing hormone and ACTH stimulation tests were performed before and after 3 to 4 months of therapy .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides multiple examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence only provides one example of a named entity with its corresponding entity label, which may not cover all entity types present in the target sentence."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence provides multiple examples of named entities with their corresponding entity labels, covering a variety of entity types present in the target sentence."},\n    {"Example 4": 1},\n    {"Reason 4": "The sentence only provides one example of a named entity with its corresponding entity label, which may not cover all entity types present in the target sentence."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence provides multiple examples of named entities with their corresponding entity labels, covering a variety of entity types present in the target sentence."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence provides multiple examples of named entities with their corresponding entity labels, covering a variety of entity types present in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides multiple examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 8": 1},\n    {"Reason 8": "The sentence only provides one example of a named entity with its corresponding entity label, which may not cover all entity types present in the target sentence."},\n    {"Example 9": 1},\n    {"Reason 9": "The sentence does not provide any examples of named entities with their corresponding entity labels, making it less helpful for extracting named entities from the target sentence."},\n    {"Example 10": 1},\n    {"Reason 10": "The sentence does not provide any examples of named entities with their corresponding entity labels, making it less helpful for extracting named entities from the target sentence."},\n    {"Example 11": 1},\n    {"Reason 11": "The sentence does not provide any examples of named entities with their corresponding entity labels, making it less helpful for extracting named entities from the target sentence."},\n    {"Example 12": 1},\n    {"Reason 12": "The sentence does not provide any examples of named entities with their corresponding entity labels, making it less helpful for extracting named entities from the target sentence."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not provide any examples of named entities with their corresponding entity labels, making it less helpful for extracting named entities from the target sentence."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not provide any examples of named entities with their corresponding entity labels, making it less helpful for extracting named entities from the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not provide any examples of named entities with their corresponding entity labels, making it less helpful for extracting named entities from the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not provide any examples of named entities with their corresponding entity labels, making it less helpful for extracting named entities from the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not provide any examples of named entities with their corresponding entity labels, making it less helpful for extracting named entities from the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not provide any examples of named entities with their corresponding entity labels, making it less helpful for extracting named entities from the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not provide any examples of named entities with their corresponding entity labels, making it less helpful for extracting named entities from the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not provide any examples of named entities with their corresponding entity labels, making it less helpful for extracting named entities from the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 14, 'sentence': 'Moreover, platelet-activating factor was capable of inducing transcription of the nuclear proto-oncogenes c-fos and c-jun .', 'label': {'c-fos': 'DNA', 'nuclear proto-oncogenes': 'DNA', 'c-jun': 'DNA', 'platelet-activating factor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1},\n    {"Example 26": 1},\n    {"Example 27": 1},\n    {"Example 28": 1},\n    {"Example 29": 1},\n    {"Example 30": 1}\n]', 'response3': '[{"c-fos": "protein"}, {"c-jun": "protein"}]', 'prediction': {'c-fos': 'protein', 'c-jun': 'protein'}}
{'idx': 145, 'sentence': 'Two consensus sequences, called X and Y boxes , capable of binding nuclear proteins and regulating expression in B cells have been defined within the immediate upstream region of major histocompatibility complex (MHC) class II promoters .', 'label': {'nuclear proteins': 'protein', 'major histocompatibility complex (MHC) class II promoters': 'DNA', 'B cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 4},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 3},\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 4},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 4},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 4},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5},\n    {"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif.": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 4},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 4}\n]', 'response3': '[{"X boxes": "protein"}, {"Y boxes": "protein"}, {"B cells": "cell_type"}, {"major histocompatibility complex (MHC) class II promoters": "DNA"}]', 'prediction': {'X boxes': 'protein', 'Y boxes': 'protein', 'B cells': 'cell_type', 'major histocompatibility complex (MHC) class II promoters': 'DNA'}}
{'idx': 1449, 'sentence': 'DNA binding specificity of complex 3 overlaps with that of upstream stimulatory factor but is clearly distinct.', 'label': {'upstream stimulatory factor': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 5},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n    {"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF.": 5},\n    {"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 5},\n    {"In fact, mAb L243 but not the staphylococcal superantigens , staphylococcal exotoxin toxic shock syndrome toxin-I or staphylococcal enterotoxin B , regulate the NF-kappa B binding activity.": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 5}\n]', 'response3': '[{"DNA": "DNA"}, {"upstream stimulatory factor": "protein"}]', 'prediction': {'DNA': 'DNA', 'upstream stimulatory factor': 'protein'}}
{'idx': 1292, 'sentence': "Promoter function of the 5' flanking region of the thromboxane receptor gene was evaluated by transfection of thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids into platelet-like K562 cells .", 'label': {'thromboxane receptor': 'protein', 'thromboxane receptor gene': 'DNA', 'CAT': 'protein', 'chloramphenicol acetyltransferase': 'protein', "5' flanking region": 'DNA', 'thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids': 'DNA', 'K562 cells': 'cell_line'}, 'response1': "['DNA', 'protein', 'cell_line']", 'response2': '[\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"5": "The sentence contains multiple protein entities (Stat3, Stat5, c-Mpl) which are directly related to the entity labels provided."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"5": "The sentence contains multiple protein entities (PAFR, PAF, NF-kappa B, protein kinase C) which are directly related to the entity labels provided."},\n    {"5": "The sentence contains multiple protein entities (Sp1, CD14) which are directly related to the entity labels provided."},\n    {"5": "The sentence contains a protein entity (E2A) which is directly related to the entity labels provided."},\n    {"5": "The sentence contains multiple protein entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) which are directly related to the entity labels provided."},\n    {"5": "The sentence contains a protein entity (CD95 ligand) which is directly related to the entity labels provided."},\n    {"5": "The sentence contains a cell line entity (SCM-1) which is directly related to the entity labels provided."},\n    {"5": "The sentence contains multiple protein entities (Ter 119, beta-globin, glycoprotein IIb, platelet factor 4) which are directly related to the entity labels provided."},\n    {"5": "The sentence contains multiple protein entities (ATF1, CREB, H4) which are directly related to the entity labels provided."},\n    {"5": "The sentence contains a DNA entity (BAT box), a protein entity (CD20), and a cell type entity (B cells) which are directly related to the entity labels provided."},\n    {"5": "The sentence contains multiple DNA entities (IL-2, NFAT), protein entities (NFAT delta418, calcineurin, Tpl-2, cyclosporin A) which are directly related to the entity labels provided."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."}\n]', 'response3': '[{"thromboxane receptor gene": "protein"}, {"thromboxane receptor gene promoter": "protein"}, {"chloramphenicol acetyltransferase": "protein"}, {"K562 cells": "cell_line"}]', 'prediction': {'thromboxane receptor gene': 'protein', 'thromboxane receptor gene promoter': 'protein', 'chloramphenicol acetyltransferase': 'protein', 'K562 cells': 'cell_line'}}
{'idx': 120, 'sentence': 'Two other T cell lines , CEM and RPMI 8402 , have essentially identical deletions.', 'label': {'RPMI 8402': 'cell_line', 'T cell lines': 'cell_line', 'CEM': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 1},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 3},\n    {"These two related genes share the evolutionarily conserved region encoding the Runt domain.": 1},\n    {"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 4},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 1},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 5},\n    {"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.": 4},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 1},\n    {"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 4},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 4},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 468, 'sentence': 'A 52-year-old male presented himself with tachycardia crises which appeared first during childhood, increased in frequency without goiter or exophthalmos .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 5},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 5},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 4},\n    {"By the time of diagnosis of T-PLL, the clone contains many more genetic changes in the form of additional translocations.": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n    {"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.": 5},\n    {"Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients.": 5},\n    {"Initiation of proliferation but not of differentiation was followed by a 20- to 25-fold increase in the nuclear level of the DNA polymerase-associated processivity factor PCNA and of the proliferation-specific transcription factor E2F1.": 5},\n    {"A total of 37 chronic, severe, nonsmoking asthmatic patients with documented reversible airways obstruction were classified as glucocorticoid-sensitive or -resistant on the basis of changes in FEV1, FVC, and peak expiratory flow (PEF) after oral prednisolone.": 4}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 138, 'sentence': 'The effects of TNF-alpha on gene expression were examined by transient expression assays using reporter chloramphenicol acetyltransferase plasmids linked to regulatory elements from the HIV long terminal repeat ( LTR ) and the beta interferon promoter .', 'label': {'beta interferon promoter': 'DNA', 'regulatory elements': 'DNA', 'HIV long terminal repeat': 'DNA', 'TNF-alpha': 'protein', 'LTR': 'DNA', 'reporter chloramphenicol acetyltransferase plasmids': 'DNA'}, 'response1': "['protein', 'DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 4},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 4},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1}\n]', 'response3': '[{"TNF-alpha": "protein"}, {"HIV long terminal repeat (LTR)": "DNA"}, {"beta interferon promoter": "DNA"}]', 'prediction': {'TNF-alpha': 'protein', 'HIV long terminal repeat (LTR)': 'DNA', 'beta interferon promoter': 'DNA'}}
{'idx': 64, 'sentence': 'Uninduced or Sendai virus induced HeLa extracts were used to examine transcription in vitro using a series of IFN beta promoter deletions .', 'label': {'IFN beta promoter deletions': 'DNA'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 3},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 3},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 4},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 4},\n    {"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 4},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner.": 5},\n    {"We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of degradation of inhibitor-kappaB alpha.": 4},\n    {"NF-E1 is encoded by the same gene as the YY-1 protein, which binds to the adeno-associated virus P5 promoter.": 4},\n    {"We conclude, rather, that alpha 4 beta 1 in freshly isolated T cells delivers a distinct signal that synergizes early with signals initiated by TCR/CD3 ligation to induce DNA binding of multiple transcription factors required for cytokine gene induction.": 5},\n    {"Extracts prepared from XP-B and XP-D lymphoblastoid cells exhibited similar transcription activity from the adenovirus major late promoter when compared to that in extracts from normal cells.": 4}\n]', 'response3': '[{"HeLa": "cell_line"}, {"IFN beta": "protein"}]', 'prediction': {'HeLa': 'cell_line', 'IFN beta': 'protein'}}
{'idx': 1760, 'sentence': 'This inhibitory effect was limited to the first 2 h after mitogenic activation , localizing the time-frame of action of cysteamine to within the commitment period .', 'label': {}, 'response1': "['protein']", 'response2': '[\n{"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n{"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 4},\n{"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 5},\n{"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 4},\n{"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.": 4},\n{"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 4},\n{"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n{"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.": 5},\n{"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.": 3},\n{"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 4},\n{"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n{"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.": 4},\n{"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 4},\n{"While the activation of the IL-2 promoter and an NFAT-driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418, it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2-mediated NFAT activation is under the control of a combination of calcineurin-dependent and independent pathways.": 5},\n{"To our knowledge, this represents the first demonstration that phagocytic stimuli can induce NF-kappa B activation in human neutrophils.": 4}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 676, 'sentence': 'The interleukin 2 ( IL-2 ) gene promoter is recognized by several cell-type-specific and ubiquitous transcriptional regulators that integrate information transmitted by various signaling systems leading to IL-2 production and T-cell activation .', 'label': {'IL-2': 'protein', 'interleukin 2': 'protein', 'interleukin 2 ( IL-2 ) gene promoter': 'DNA', 'T-cell': 'cell_type'}, 'response1': "['DNA', 'cell_type', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains a clear mention of the entity \'IL-2\' and its corresponding label \'protein\'."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains mentions of entities \'IL-13\', \'IL-4\', \'B cell\', and \'monocyte\' with their corresponding labels \'protein\' and \'cell_type\'."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains mentions of entities \'IL4\', \'IL13\', \'STAT6\', \'STAT3\', \'STAT5\', and \'B cells\' with their corresponding labels \'protein\' and \'cell_type\'."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains mentions of entities \'IL-2\', \'Aiolos\', and \'Ras\' with their corresponding labels \'protein\'."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains mentions of entities \'NF-ATc\' and \'T lymphocytes\' with their corresponding labels \'protein\' and \'cell_type\'."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains a clear mention of the entity \'IL-2\' and its corresponding label \'protein\'."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains mentions of entities \'IFN A\', \'IFNA\', \'interleukin-2\', \'interleukin-2 receptor\', \'phytohemagglutinin\', and \'phorbol myristate acetate\' with their corresponding labels \'protein\'."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains mentions of entities \'CD28\', \'CD80\', \'CD86\', \'CBL\', \'VAV\', \'NFAT\', \'interleukin-2\', and \'granulocyte-macrophage colony-stimulating factor\' with their corresponding labels \'protein\'."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains mentions of entities \'interleukin 10\', \'IL-10R\', \'STAT3\', and \'IL-6\' with their corresponding labels \'protein\'."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains mentions of entities \'T cell\' and \'interleukin 2\' with their corresponding labels \'cell_type\' and \'protein\'."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains mentions of entities \'IL-13\', \'IL-4R\', \'JAK2\', and \'IL-13R\' with their corresponding labels \'protein\'."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains mentions of entities \'IL-2\', \'c-Jun\', and \'c-Fos\' with their corresponding labels \'protein\'."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains mentions of entities \'IL-2 receptor alpha subunit\', \'p21ras\', and \'B cell\' with their corresponding labels \'protein\' and \'cell_type\'."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains a mention of the entity \'Th2-type lymphocytes\' with its corresponding label \'cell_type\'."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains a mention of the entity \'IL-4\' with its corresponding label \'protein\'."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence contains mentions of entities \'IL-2\', \'IFN-gamma\', \'jak kinases\', and \'STAT1(alpha)\' with their corresponding labels \'protein\'."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities related to the given entity labels."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities related to the given entity labels."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities related to the given entity labels."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities related to the given entity labels."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities related to the given entity labels."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities related to the given entity labels."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities related to the given entity labels."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities related to the given entity labels."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities related to the given entity labels."}\n]', 'response3': "[{'interleukin 2': 'protein'}, {'T-cell': 'cell_type'}]", 'prediction': {'interleukin 2': 'protein', 'T-cell': 'cell_type'}}
{'idx': 1052, 'sentence': 'Thus, after 4 hr of exposure to SEA and SEB , the expression of IL-2R beta was down-regulated, IL-2R gamma was slightly up-regulated, while IL-2R alpha remained largely unaffected.', 'label': {'IL-2R alpha': 'protein', 'SEA': 'protein', 'IL-2R gamma': 'protein', 'SEB': 'protein', 'IL-2R beta': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[{"IL-2R beta": "protein"}, {"IL-2R gamma": "protein"}, {"IL-2R alpha": "protein"}]', 'prediction': {'IL-2R beta': 'protein', 'IL-2R gamma': 'protein', 'IL-2R alpha': 'protein'}}
{'idx': 487, 'sentence': 'Therefore, in normal human monocytes M-CSF induces immediate early response genes without inducing cell proliferation.', 'label': {'human monocytes': 'cell_type', 'normal human monocytes': 'cell_type', 'M-CSF': 'protein', 'immediate early response genes': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."}\n]', 'response3': '[{"M-CSF": "protein"}]', 'prediction': {'M-CSF': 'protein'}}
{'idx': 570, 'sentence': 'Modulation of these events at the time of adherence offers a mechanism by which differential priming of the cells may be accomplished.', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.": 5},\n    {"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.": 5},\n    {"Yet, for many pathogens, the molecules that induce IL-12 production by macrophages and the mechanisms by which they do so remain undefined.": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 4},\n    {"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.": 5},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1370, 'sentence': 'Although anti- CD28 MoAb costimulation enhances all of the above signals, NF kappa B and IL-2 levels remain lower than in adults , suggesting the need for further activation requirements in the neonate .', 'label': {'CD28': 'protein', 'anti- CD28 MoAb': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"NF kappa B": "protein"}, {"IL-2": "protein"}]', 'prediction': {'NF kappa B': 'protein', 'IL-2': 'protein'}}
{'idx': 994, 'sentence': 'The role of BSAP ( Pax-5 ) in B-cell development .', 'label': {'BSAP': 'protein', 'Pax-5': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Th1": 5, "Th2": 5},\n    {"SLAP-130": 5, "SLP-76": 5, "T cell": 5},\n    {"Sp1": 5, "Ets": 5},\n    {"UAS3": 5, "UAS2": 5, "YY1": 5},\n    {"CD70": 5, "B cell": 5, "plasma cells": 5, "IL-4": 5, "CD40": 5},\n    {"GATA-1": 5},\n    {"IL-13": 5, "IL-4": 5, "B cell": 5, "monocyte": 5},\n    {"IL-2": 5, "c-Jun": 5, "c-Fos": 5},\n    {"Th2-type lymphocytes": 5},\n    {"IL4": 5, "IL13": 5, "STAT6": 5, "STAT3": 5, "STAT5": 5, "B cells": 5},\n    {"lymphoid neoplasms": 5},\n    {"PML/RARalpha": 5},\n    {"GM-CSF": 5},\n    {"UAS1": 5, "B cell": 5},\n    {"T cell": 5, "interleukin 2": 5},\n    {"GATA-1": 5},\n    {"estrogen": 1, "progesterone": 1, "tumor size": 1, "polyamine concentrations": 1},\n    {"AIDS": 1, "transcriptional initiation": 1, "transcriptional elongation": 1},\n    {"alpha-herpesvirus": 1, "beta-herpesvirus": 1, "herpes simplex": 1, "cytomegalovirus": 1},\n    {"HIV-1": 1, "HIV-2": 1},\n    {"allele": 1},\n    {"B-cell": 1, "intrahepatic lymphoid follicles": 1, "chronic hepatitis C": 1},\n    {"lymphocyte infiltration": 1, "hormone metabolic status": 1, "tumor tissue hormone sensitivity": 1, "tobacco smoking": 1, "breast cancer patients": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3": 1, "VD": 1, "monocytic differentiation": 1, "leukemic cells": 1},\n    {"glucocorticoid action": 1, "megadoses": 1},\n    {"nucleotide 2,317": 1, "point mutation": 1, "isoleucine": 1, "valine": 1},\n]', 'response3': '[{"BSAP": "protein"}, {"Pax-5": "protein"}, {"B-cell": "cell_type"}]', 'prediction': {'BSAP': 'protein', 'Pax-5': 'protein', 'B-cell': 'cell_type'}}
{'idx': 438, 'sentence': 'This sequence motif is a binding site for nuclear proteins , the so-called octamer transcription factors ( Oct or OTF factors ).', 'label': {'OTF factors': 'protein', 'nuclear proteins': 'protein', 'sequence motif': 'DNA', 'octamer transcription factors': 'protein', 'Oct': 'protein'}, 'response1': "['protein']", 'response2': '```json\n[\n    {\n        "The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .": 5\n    },\n    {\n        "Activated Stat proteins form homo- or heterodimers, translocate to the nucleus , and induce transcription from responsive genes.": 4\n    },\n    {\n        "We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .": 5\n    },\n    {\n        "The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 4\n    },\n    {\n        "The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .": 5\n    },\n    {\n        "A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 4\n    },\n    {\n        "Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5\n    },\n    {\n        "Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.": 5\n    },\n    {\n        "Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50 .": 5\n    },\n    {\n        "Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.": 5\n    },\n    {\n        "The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .": 4\n    },\n    {\n        "Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 4\n    },\n    {\n        "Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4\n    },\n    {\n        "The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .": 5\n    },\n    {\n        "Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .": 5\n    },\n    {\n        "The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .": 5\n    },\n    {\n        "No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1\n    },\n    {\n        "This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1\n    },\n    {\n        "This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1\n    },\n    {\n        "These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1\n    },\n    {\n        "One contraction generated an allele in an intermediate size range (33-39 repeats).": 1\n    },\n    {\n        "Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1\n    },\n    {\n        "Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1\n    },\n    {\n        "1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1\n    },\n    {\n        "The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1\n    },\n    {\n        "At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1\n    }\n]\n```', 'response3': '```json\n[]\n```', 'prediction': {}}
{'idx': 270, 'sentence': 'There was evidence for an autosomal recessive form of inheritance in four families, while the other four families appeared to have an autosomal dominant mode of transmission .', 'label': {}, 'response1': "['DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains clear mentions of specific entities such as \'lymphoid neoplasms\' which can be directly mapped to the \'cell_type\' entity label."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides explicit mentions of entities like \'NF-ATc\', \'T lymphocytes\', and \'embryonic cardiac cells\' which can be accurately classified as \'protein\' and \'cell_type\' entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly mentions \'E2A\' as a protein, making it highly helpful for entity extraction."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence mentions \'A-myb\' as a transcription factor, providing a clear example of a \'protein\' entity."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains multiple mentions of proteins like \'IFN A\', \'interleukin-2\', and \'interleukin-2 receptor\', making it very helpful for identifying \'protein\' entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions \'PBMC\' as a cell type and \'adenovirus DNA\' as DNA, providing clear examples for entity extraction."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence mentions \'SIVsmmPBj14\' as a cell line, which is a specific example aiding in entity extraction."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions \'AP-1 DNA binding activity\' as DNA, providing a direct example for entity extraction."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence mentions \'IgH genes\' as DNA, aiding in the identification of DNA entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions \'RXR\' as a protein, providing a clear example for entity extraction."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions \'NF-kappaB\' as a protein and \'rheumatoid arthritis\' as a cell type, aiding in entity extraction."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions \'SCM-1 genes\' as a cell line, providing a specific example for entity extraction."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions \'BRCA1\' as a protein, aiding in the identification of protein entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions \'GATA-1\' as a protein, providing a clear example for entity extraction."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions \'NF-kappa B\' and \'I kappa B alpha\' as proteins, aiding in entity extraction."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence mentions \'WT1\' as a protein, providing a specific example for entity extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entities related to the given entity labels, hence not helpful for extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific entities related to the given entity labels, hence not helpful for extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific entities related to the given entity labels, hence not helpful for extraction."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any specific entities related to the given entity labels, hence not helpful for extraction."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any specific entities related to the given entity labels, hence not helpful for extraction."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any specific entities related to the given entity labels, hence not helpful for extraction."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any specific entities related to the given entity labels, hence not helpful for extraction."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any specific entities related to the given entity labels, hence not helpful for extraction."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any specific entities related to the given entity labels, hence not helpful for extraction."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1481, 'sentence': 'We, therefore, propose the activation scheme presented in FIGURE 3 for T-cell costimulation .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1807, 'sentence': 'We show that the expression of four cell genes , cdc-2 , cyclin E , CD23 , and cyclin D2 , are up-regulated approximately 100-fold as a result of EBV -mediated immortalization .', 'label': {'cell genes': 'DNA', 'cyclin E': 'DNA', 'cyclin D2': 'DNA', 'CD23': 'DNA', 'cdc-2': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .": 4},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .": 5},\n    {"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB .": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .": 5},\n    {"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .": 5}\n]', 'response3': '[{"cdc-2": "protein"}, {"cyclin E": "protein"}, {"CD23": "protein"}, {"cyclin D2": "protein"}, {"EBV": "cell_line"}]', 'prediction': {'cdc-2': 'protein', 'cyclin E': 'protein', 'CD23': 'protein', 'cyclin D2': 'protein', 'EBV': 'cell_line'}}
{'idx': 1169, 'sentence': 'However, B4-2 has an unusually high proline content (13%), contains a putative nuclear targeting sequence , and has several SPXX motifs which are frequently found in gene regulatory proteins .', 'label': {'SPXX motifs': 'protein', 'nuclear targeting sequence': 'protein', 'gene regulatory proteins': 'protein', 'B4-2': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n    {"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 5},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .": 5},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50 .": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .": 5},\n    {"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .": 5},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines .": 5},\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .": 5},\n    {"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .": 5}\n]', 'response3': '[{"B4-2": "protein"}]', 'prediction': {'B4-2': 'protein'}}
{'idx': 1180, 'sentence': 'We therefore propose that IL-2 receptor signal transduction does not depend on equimolar heterodimerization of JAK1 and JAK3 following IL-2 -induced heterodimerization of IL-2R beta and IL-2R gamma .', 'label': {'IL-2R': 'protein', 'IL-2': 'protein', 'IL-2R gamma': 'protein', 'JAK3': 'protein', 'IL-2 receptor': 'protein', 'JAK1': 'protein', 'IL-2R beta': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 4},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 4},\n    {"Example 10": 4},\n    {"Example 11": 4},\n    {"Example 12": 4},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 4},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"IL-2": "protein"}, {"JAK1": "protein"}, {"JAK3": "protein"}, {"IL-2R beta": "protein"}, {"IL-2R gamma": "protein"}]', 'prediction': {'IL-2': 'protein', 'JAK1': 'protein', 'JAK3': 'protein', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein'}}
{'idx': 968, 'sentence': 'These observations demonstrate directly that there is de novo synthesis of NF-kappa B during human lymphocyte activation and suggest that this process is hormonally regulated.', 'label': {'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example sentences contain specific entities that match the entity types in the target sentence, making them highly relevant for named entity extraction."}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"human lymphocyte": "cell_type"}]', 'prediction': {'NF-kappa B': 'protein', 'human lymphocyte': 'cell_type'}}
{'idx': 497, 'sentence': 'The differentiation of T cells into functionally diverse subpopulations is controlled in part, by transcriptional activation and silencing ; however, little is known in detail about the proteins that influence this developmental process .', 'label': {'T cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 4},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 4},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 4},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 4},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 4},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 4},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 4},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 4},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5}\n]', 'response3': '[{"T cells": "cell_type"}]', 'prediction': {'T cells': 'cell_type'}}
{'idx': 1606, 'sentence': 'Triggering of complement receptors CR1 ( CD35 ) and CR3 ( CD11b/CD18 ) induces nuclear translocation of NF-kappa B ( p50/p65 ) in human monocytes and enhances viral replication in HIV-infected monocytic cells .', 'label': {'CD11b/CD18': 'protein', 'CD35': 'protein', 'p50/p65': 'protein', 'CR1': 'protein', 'HIV-infected monocytic cells': 'cell_type', 'complement receptors': 'protein', 'human monocytes': 'cell_type', 'NF-kappa B': 'protein', 'CR3': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 4},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"CD40 expression could be enhanced in CD40-positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n    {"Murine macrophage inflammatory protein 1 alpha (MIP-1 alpha) and its human equivalent (GOS19, LD78, or AT464) are members of the -C-C family of low-molecular-weight chemokines.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"CR1": "protein"}, {"CD35": "protein"}, {"CR3": "protein"}, {"CD11b/CD18": "protein"}, {"NF-kappa B": "protein"}, {"p50/p65": "protein"}, {"monocytes": "cell_type"}, {"HIV-infected monocytic cells": "cell_type"}]', 'prediction': {'CR1': 'protein', 'CD35': 'protein', 'CR3': 'protein', 'CD11b/CD18': 'protein', 'NF-kappa B': 'protein', 'p50/p65': 'protein', 'monocytes': 'cell_type', 'HIV-infected monocytic cells': 'cell_type'}}
{'idx': 1653, 'sentence': 'Expression of PU.1 in nonmyeloid cells can activate the GM-CSF receptor alpha promoter .', 'label': {'nonmyeloid cells': 'cell_type', 'GM-CSF': 'protein', 'PU.1': 'protein', 'GM-CSF receptor alpha promoter': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.": 5},\n    {"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"PMA induced the expression of both CD14 and CD23 mRNA and protein.": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n    {"To evaluate the PML/RARalpha role in myelopoiesis, transgenic mice expressing PML/RARalpha were engineered.": 5},\n    {"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"Murine macrophage inflammatory protein 1 alpha (MIP-1 alpha) and its human equivalent (GOS19, LD78, or AT464) are members of the -C-C family of low-molecular-weight chemokines.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"PU.1": "protein"}, {"GM-CSF receptor alpha": "protein"}]', 'prediction': {'PU.1': 'protein', 'GM-CSF receptor alpha': 'protein'}}
{'idx': 833, 'sentence': 'Mapping of B-cell epitopes of the human hepatitis B virus X protein .', 'label': {'human hepatitis B virus X protein': 'protein', 'B-cell epitopes': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains multiple entities from the given entity label set, and each entity is clearly identified."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence contains an entity from the given entity label set, which is related to the context of the sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains multiple entities from the given entity label set, and each entity is clearly identified."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains multiple entities from the given entity label set, and each entity is clearly identified."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains multiple entities from the given entity label set, and each entity is clearly identified."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains multiple entities from the given entity label set, and each entity is clearly identified."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains multiple entities from the given entity label set, and each entity is clearly identified."},\n    {"Example 9": 1},\n    {"Reason 9": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 10": 1},\n    {"Reason 10": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 11": 1},\n    {"Reason 11": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 12": 1},\n    {"Reason 12": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities from the given entity label set."}\n]', 'response3': '[{"B-cell": "cell_type"}, {"hepatitis B virus X protein": "protein"}]', 'prediction': {'B-cell': 'cell_type', 'hepatitis B virus X protein': 'protein'}}
{'idx': 389, 'sentence': 'The predicted periplasmic domain of the PhoQ protein contained a markedly anionic domain that could interact with cationic proteins and that could be responsible for resistance to defensin .', 'label': {'periplasmic domain': 'protein', 'PhoQ protein': 'protein', 'cationic proteins': 'protein', 'defensin': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"PhoQ": "protein"}, {"defensin": "protein"}]', 'prediction': {'PhoQ': 'protein', 'defensin': 'protein'}}
{'idx': 193, 'sentence': 'The calcium ionophore-induced c-myc suppression , however, strictly requires de novo protein synthesis .', 'label': {'c-myc': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"c-myc": "protein"}]', 'prediction': {'c-myc': 'protein'}}
{'idx': 1349, 'sentence': 'Its expression was always restricted to the nucleus .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a specific gene or protein name along with its corresponding entity label, which directly aids in extracting named entities from the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 882, 'sentence': 'This cDNA clone was isolated by expression cDNA cloning , and encodes the human c-Jun protein , which together with c-Fos forms the heterodimeric activator protein-1 transcription complex .', 'label': {'c-Jun': 'protein', 'heterodimeric activator protein-1 transcription complex': 'protein', 'c-Fos': 'protein', 'cDNA': 'DNA', 'human c-Jun protein': 'protein', 'cDNA clone': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.": 5},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 5},\n    {"This protein has now been purified and its encoding gene cloned.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 4},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines.": 5},\n    {"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.": 5}\n]', 'response3': '[{"cDNA clone": "DNA"}, {"human c-Jun protein": "protein"}, {"c-Fos": "protein"}, {"activator protein-1": "protein"}]', 'prediction': {'cDNA clone': 'DNA', 'human c-Jun protein': 'protein', 'c-Fos': 'protein', 'activator protein-1': 'protein'}}
{'idx': 725, 'sentence': 'Rex acts posttranscriptionally to facilitate accumulation of full-length gag/pol and singly spliced env mRNA in the cytoplasm of HTLV-infected cells .', 'label': {'Rex': 'protein', 'HTLV-infected cells': 'cell_type', 'gag/pol': 'protein', 'env mRNA': 'RNA'}, 'response1': "['RNA', 'protein']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence contains the entity \'TCF-1\' which is labeled as \'protein\', providing a clear example for the model to learn from."},\n{"Example 2": 5},\n{"Reason 2": "The sentence contains the entity \'TCL1\' which is labeled as \'protein\', providing a clear example for the model to learn from."},\n{"Example 3": 5},\n{"Reason 3": "The sentence contains the entity \'PML/RARalpha\' which is labeled as \'protein\', providing a clear example for the model to learn from."},\n{"Example 4": 5},\n{"Reason 4": "The sentence contains the entities \'hepatitis B virus\' labeled as \'DNA\' and \'HBxAg\' labeled as \'protein\', providing clear examples for the model to learn from."},\n{"Example 5": 5},\n{"Reason 5": "The sentence contains the entity \'SIVsmmPBj14\' which is labeled as \'cell_line\', providing a clear example for the model to learn from."},\n{"Example 6": 5},\n{"Reason 6": "The sentence contains multiple entities such as \'IFN A\', \'IFNA\', \'interleukin-2\', \'interleukin-2 receptor\', \'phytohemagglutinin\', and \'phorbol myristate acetate\' all labeled as \'protein\', providing multiple clear examples for the model to learn from."},\n{"Example 7": 5},\n{"Reason 7": "The sentence contains the entities \'TIMP-1\' labeled as \'protein\' and \'DNA\' labeled as \'DNA\', providing clear examples for the model to learn from."},\n{"Example 8": 5},\n{"Reason 8": "The sentence contains the entity \'Egr-1\' which is labeled as \'protein\', providing a clear example for the model to learn from."},\n{"Example 9": 5},\n{"Reason 9": "The sentence contains the entities \'HIV-1\' labeled as \'cell_type\', \'IFN\' labeled as \'protein\', \'PKR\' labeled as \'protein\', and \'IkappaBalpha\' labeled as \'protein\', providing clear examples for the model to learn from."},\n{"Example 10": 5},\n{"Reason 10": "The sentence contains the entities \'HIV-1 LTR\' labeled as \'DNA\', \'NFAT-1\' labeled as \'protein\', and \'NF kappa B\' labeled as \'protein\', providing clear examples for the model to learn from."},\n{"Example 11": 5},\n{"Reason 11": "The sentence contains the entities \'cDNA\' labeled as \'DNA\', \'Jurkat\' labeled as \'cell_line\', and \'DRE 1\' labeled as \'cell_type\', providing clear examples for the model to learn from."},\n{"Example 12": 5},\n{"Reason 12": "The sentence contains the entities \'TR55\' labeled as \'protein\', \'TNF-alpha\' labeled as \'protein\', and \'HIV\' labeled as \'cell_type\', providing clear examples for the model to learn from."},\n{"Example 13": 5},\n{"Reason 13": "The sentence contains the entities \'TCL1\' labeled as \'protein\' and \'MTCP1/c6.1B\' labeled as \'protein\', providing clear examples for the model to learn from."},\n{"Example 14": 5},\n{"Reason 14": "The sentence contains the entities \'T lymphocytes\' labeled as \'cell_type\' and \'adenovirus vectors\' labeled as \'DNA\', providing clear examples for the model to learn from."},\n{"Example 15": 5},\n{"Reason 15": "The sentence contains the entities \'Rel-A\' labeled as \'protein\', \'T cells\' labeled as \'cell_type\', and \'IL-2\' labeled as \'protein\', providing clear examples for the model to learn from."},\n{"Example 16": 5},\n{"Reason 16": "The sentence contains the entities \'XP-B\' labeled as \'cell_line\', \'XP-D\' labeled as \'cell_line\', and \'adenovirus\' labeled as \'DNA\', providing clear examples for the model to learn from."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any entities from the given entity label set, hence it does not provide any examples for the model to learn from."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any entities from the given entity label set, hence it does not provide any examples for the model to learn from."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any entities from the given entity label set, hence it does not provide any examples for the model to learn from."},\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any entities from the given entity label set, hence it does not provide any examples for the model to learn from."},\n{"Example 21": 1},\n{"Reason 21": "The sentence does not contain any entities from the given entity label set, hence it does not provide any examples for the model to learn from."},\n{"Example 22": 1},\n{"Reason 22": "The sentence does not contain any entities from the given entity label set, hence it does not provide any examples for the model to learn from."},\n{"Example 23": 1},\n{"Reason 23": "The sentence does not contain any entities from the given entity label set, hence it does not provide any examples for the model to learn from."},\n{"Example 24": 1},\n{"Reason 24": "The sentence does not contain any entities from the given entity label set, hence it does not provide any examples for the model to learn from."},\n{"Example 25": 1},\n{"Reason 25": "The sentence does not contain any entities from the given entity label set, hence it does not provide any examples for the model to learn from."}\n]', 'response3': "[{'gag/pol': 'protein'}, {'env mRNA': 'RNA'}, {'HTLV-infected cells': 'cell_type'}]", 'prediction': {'gag/pol': 'protein', 'env mRNA': 'RNA', 'HTLV-infected cells': 'cell_type'}}
{'idx': 867, 'sentence': 'In HIV-1 , the sequences that respond to these signaling events are found in the long terminal repeat ( LTR ) and comprise the transcriptional enhancer , which contains two conserved binding sites for the nuclear factor kappa B ( NF kappa B ).', 'label': {'conserved binding sites': 'DNA', 'nuclear factor kappa B': 'protein', 'long terminal repeat': 'DNA', 'LTR': 'DNA', 'NF kappa B': 'protein', 'transcriptional enhancer': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 4},\n    {"Example 4": 5},\n    {"Example 5": 4},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"HIV-1": "cell_type"}, {"long terminal repeat ( LTR )": "DNA"}, {"transcriptional enhancer": "DNA"}, {"nuclear factor kappa B ( NF kappa B )": "protein"}]', 'prediction': {'HIV-1': 'cell_type', 'long terminal repeat ( LTR )': 'DNA', 'transcriptional enhancer': 'DNA', 'nuclear factor kappa B ( NF kappa B )': 'protein'}}
{'idx': 841, 'sentence': 'Such tests may become useful diagnostic tools .', 'label': {}, 'response1': 'None.', 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence contains specific protein names that are directly related to the entity label \'protein\'."},\n{"Example 2": 4},\n{"Reason 2": "The sentence mentions PBMC, which is related to the entity label \'cell_type\', and adenovirus, which is related to the entity label \'DNA\'."},\n{"Example 3": 3},\n{"Reason 3": "The sentence mentions IFN-gamma, which is related to the entity label \'protein\'."},\n{"Example 4": 2},\n{"Reason 4": "The sentence mentions lymphoid neoplasms, which is related to the entity label \'cell_type\'."},\n{"Example 5": 2},\n{"Reason 5": "The sentence mentions STAT1, which is related to the entity label \'protein\'."},\n{"Example 6": 2},\n{"Reason 6": "The sentence mentions Ras, which is related to the entity label \'protein\'."},\n{"Example 7": 3},\n{"Reason 7": "The sentence mentions immunohistochemistry, gene, and cell type, which are related to the entity labels \'protein\', \'DNA\', and \'cell_type\' respectively."},\n{"Example 8": 3},\n{"Reason 8": "The sentence mentions NF-kappa B, which is related to the entity label \'protein\'."},\n{"Example 9": 1},\n{"Reason 9": "The sentence mentions SCM-1, which is related to the entity label \'cell_line\'."},\n{"Example 10": 1},\n{"Reason 10": "The sentence mentions SIVsmmPBj14, which is related to the entity label \'cell_line\'."},\n{"Example 11": 4},\n{"Reason 11": "The sentence mentions nonhuman primates, which is related to the entity label \'cell_type\'."},\n{"Example 12": 2},\n{"Reason 12": "The sentence mentions T-PLL, which is related to the entity label \'cell_type\'."},\n{"Example 13": 5},\n{"Reason 13": "The sentence mentions E2A, which is related to the entity label \'protein\'."},\n{"Example 14": 4},\n{"Reason 14": "The sentence mentions AP-1, which is related to the entity label \'DNA\'."},\n{"Example 15": 3},\n{"Reason 15": "The sentence mentions B and T cell activation, Ramos, Jurkat, and cDNA microarray technology, which are related to the entity labels \'cell_type\', \'cell_line\', and \'DNA\'."},\n{"Example 16": 1},\n{"Reason 16": "The sentence does not contain any entity types mentioned in the target sentence."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any entity types mentioned in the target sentence."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any entity types mentioned in the target sentence."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any entity types mentioned in the target sentence."},\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any entity types mentioned in the target sentence."},\n{"Example 21": 1},\n{"Reason 21": "The sentence does not contain any entity types mentioned in the target sentence."},\n{"Example 22": 1},\n{"Reason 22": "The sentence does not contain any entity types mentioned in the target sentence."},\n{"Example 23": 1},\n{"Reason 23": "The sentence does not contain any entity types mentioned in the target sentence."},\n{"Example 24": 1},\n{"Reason 24": "The sentence does not contain any entity types mentioned in the target sentence."},\n{"Example 25": 1},\n{"Reason 25": "The sentence does not contain any entity types mentioned in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 956, 'sentence': 'BSAP : a key regulator of B-cell development and differentiation .', 'label': {'BSAP': 'protein', 'B-cell': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein and cell type names that match the entity labels in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains specific cell type names that match the entity labels in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains specific protein and cell type names that match the entity labels in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains a specific cell type name that matches the entity label in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains a specific protein name that matches the entity label in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific protein and cell type names that match the entity labels in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific cell type names that match the entity labels in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific protein names that match the entity labels in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains a specific protein name that matches the entity label in the target sentence."},\n    {"Example 10": 1},\n    {"Reason 10": "The sentence does not contain any entity names that match the entity labels in the target sentence."},\n    {"Example 11": 1},\n    {"Reason 11": "The sentence does not contain any entity names that match the entity labels in the target sentence."},\n    {"Example 12": 1},\n    {"Reason 12": "The sentence does not contain any entity names that match the entity labels in the target sentence."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not contain any entity names that match the entity labels in the target sentence."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not contain any entity names that match the entity labels in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any entity names that match the entity labels in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entity names that match the entity labels in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entity names that match the entity labels in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entity names that match the entity labels in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entity names that match the entity labels in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entity names that match the entity labels in the target sentence."}\n]', 'response3': '[{"B-cell": "cell_type"}]', 'prediction': {'B-cell': 'cell_type'}}
{'idx': 1769, 'sentence': 'We have tried to find out whether these receptors could show any difference in sex or age distribution.', 'label': {}, 'response1': 'None.', 'response2': '[\n    {"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.": 5},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 4},\n    {"We have found that the recruitment of EKLF to 5\'HS3 depends on the presence of 5\'HS2 in cis, but the recruitment to 5\'HS2 does not depend on 5\'HS3.": 3},\n    {"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 4},\n    {"Therefore, we investigated whether IVS1-10T-->C deleteriously affected BRCA1 splicing or expression, and thereby inactivated the other BRCA1 allele.": 4},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.": 4},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes.": 3},\n    {"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.": 4},\n    {"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 110, 'sentence': 'Electrophoretic mobility shift assays and Southwestern blotting experiments were used to detect the binding of cellular transactivation factor NF-KB to the double repeat-KB enhancer sequence located in the long terminal repeat .', 'label': {'long terminal repeat': 'DNA', 'NF-KB': 'protein', 'double repeat-KB enhancer sequence': 'DNA', 'cellular transactivation factor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of proteins (IL-4, LPS, AP-1) which are relevant to the entity labels in the target sentence."}\n]', 'response3': '[{"NF-KB": "protein"}]', 'prediction': {'NF-KB': 'protein'}}
{'idx': 1379, 'sentence': 'Deregulation of TCL1 is the first event in the initiation of malignancy in these types of leukemias and represents a potential tool for clinical evaluation .', 'label': {'TCL1': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"IkappaBbeta": 5},\n    {"NF-kappaB": 5},\n    {"AP-1": 5},\n    {"WT1": 4},\n    {"myeloid cell lines": 4},\n    {"myeloperoxidase": 5},\n    {"lysozyme": 5},\n    {"PU.1": 5},\n    {"IL-2 receptor alpha subunit": 5},\n    {"p21ras": 5},\n    {"B cell": 5},\n    {"MNDA": 5},\n    {"Philadelphia chromosome-positive chronic myeloid leukemia": 5},\n    {"SCM-1": 5},\n    {"IL-13": 5},\n    {"IL-4R": 5},\n    {"JAK2": 5},\n    {"IL-13R": 5},\n    {"STAT1": 5},\n    {"SCL": 5},\n    {"GATA-1": 5},\n    {"PML/RARalpha": 5},\n    {"TCRzeta": 5},\n    {"p56(lck)": 5},\n    {"lymphoid neoplasms": 5},\n    {"CD28": 5},\n    {"CD80": 5},\n    {"CD86": 5},\n    {"CBL": 5},\n    {"VAV": 5},\n    {"NFAT": 5},\n    {"interleukin-2": 5},\n    {"granulocyte-macrophage colony-stimulating factor": 5},\n    {"GATA-1": 5},\n    {"NF-kappaB": 5},\n    {"Tax": 4},\n    {"ATL": 4}\n]', 'response3': '[{"TCL1": "protein"}]', 'prediction': {'TCL1': 'protein'}}
{'idx': 1338, 'sentence': 'The survival-promoting activity of the Bcl-2 family of proteins appears to be modulated by interactions between various cellular proteins .', 'label': {'Bcl-2 family': 'protein', 'cellular proteins': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names that are directly mentioned in the sentence, making it highly relevant for extracting named entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions specific proteins and DNA, which are relevant entities in the context of the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly mentions specific protein names that are crucial for extracting named entities in the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence mentions a specific protein name that is directly related to the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific protein names and a cell type that are directly relevant to the entities in the target sentence."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence mentions cell adhesion molecules, which are relevant entities in the context of the target sentence."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence mentions NF-kappa B, which is a crucial protein entity in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific protein names that are directly mentioned in the sentence, making it highly relevant for extracting named entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains specific protein names and a cell type that are directly relevant to the entities in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions specific protein names that are crucial for extracting named entities in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions specific protein names that are directly mentioned in the sentence, making it highly relevant for extracting named entities."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence mentions specific protein names and cell lines, which are relevant entities in the context of the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains specific protein names and a cell type that are directly relevant to the entities in the target sentence."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence mentions a specific protein name that is directly related to the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any relevant entities mentioned in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any relevant entities mentioned in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any relevant entities mentioned in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any relevant entities mentioned in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any relevant entities mentioned in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any relevant entities mentioned in the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any relevant entities mentioned in the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any relevant entities mentioned in the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any relevant entities mentioned in the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any relevant entities mentioned in the target sentence."}\n]', 'response3': "[{'Bcl-2': 'protein'}]", 'prediction': {'Bcl-2': 'protein'}}
{'idx': 1323, 'sentence': 'PRE-I forms multiple DNA-protein complexes with nuclear extracts from Jurkat cells .', 'label': {'PRE-I': 'DNA', 'Jurkat cells': 'cell_line', 'multiple DNA-protein complexes': 'protein'}, 'response1': "['DNA', 'protein', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains multiple instances of named entities that match the entity types in the target sentence, providing direct and relevant examples for extraction."}\n]', 'response3': '[{"PRE-I": "protein"}, {"DNA": "DNA"}, {"Jurkat cells": "cell_line"}]', 'prediction': {'PRE-I': 'protein', 'DNA': 'DNA', 'Jurkat cells': 'cell_line'}}
{'idx': 1309, 'sentence': 'Proteins in the first group contain multiple HMG boxes , are non-sequence-specific , and recognize structural features as found in cruciform DNA and cross-over DNA .', 'label': {'cruciform DNA': 'DNA', 'HMG boxes': 'protein', 'cross-over DNA': 'DNA'}, 'response1': "['protein', 'DNA']", 'response2': '[\n{"p50p50": 5},\n{"protein": 4},\n{"DNA": 4},\n{"NF-ATc": 4},\n{"T lymphocytes": 4},\n{"GM-CSF": 4},\n{"cDNAs": 3},\n{"IgH": 3},\n{"IL-2": 4},\n{"c-Jun": 4},\n{"c-Fos": 4},\n{"Stat proteins": 4},\n{"immunohistochemistry": 3},\n{"gene": 3},\n{"cell type": 3},\n{"Th2-type lymphocytes": 4},\n{"GM-kappa B": 3},\n{"GC-box": 3},\n{"GC-motif": 3},\n{"GM-kappa B motif": 3},\n{"p50": 4},\n{"p65": 4},\n{"HIV-1 LTR": 4},\n{"NFAT-1": 4},\n{"NF kappa B": 4},\n{"SIVmac": 4},\n{"NF-kappaB": 4},\n{"Sp1": 4},\n{"AIDS": 1},\n{"estrogen": 1},\n{"progesterone": 1},\n{"polyamine concentrations": 1},\n{"herpesvirus": 1},\n{"herpes simplex": 1},\n{"cytomegalovirus": 1},\n{"clinical spectra": 1},\n{"HIV-1": 1},\n{"HIV-2": 1},\n{"therapeutic approaches": 1},\n{"allele": 1},\n{"B-cell response": 1},\n{"intrahepatic lymphoid follicles": 1},\n{"chronic hepatitis C": 1},\n{"Lymphocyte infiltration": 1},\n{"hormone metabolic status": 1},\n{"tumor tissue hormone sensitivity": 1},\n{"tobacco smoking": 1},\n{"breast cancer patients": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3": 1},\n{"VD": 1},\n{"monocytic differentiation": 1},\n{"glucocorticoid action": 1},\n{"megadoses": 1},\n{"nucleotide 2,317": 1},\n{"point mutation": 1},\n{"isoleucine": 1},\n{"valine": 1},\n{"amino acid 729": 1}\n]', 'response3': '[{"HMG boxes": "protein"}, {"DNA": "DNA"}, {"DNA": "DNA"}]', 'prediction': {'HMG boxes': 'protein', 'DNA': 'DNA'}}
{'idx': 228, 'sentence': 'We have carried out experiments to define the nature of the higher affinity CVZ binding site .', 'label': {'higher affinity CVZ binding site': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 1},\n{"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .": 5},\n{"The effects of G-CSF are mediated by binding to specific, high affinity receptors .": 5},\n{"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements .": 5},\n{"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 5},\n{"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 5},\n{"Here we examined the regulatory mechanism of the SCM-1 genes .": 5},\n{"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules .": 5},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n{"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .": 5},\n{"Therefore, we investigated whether IVS1-10T-->C deleteriously affected BRCA1 splicing or expression, and thereby inactivated the other BRCA1 allele .": 5},\n{"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .": 5},\n{"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .": 5},\n{"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .": 5},\n{"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .": 5},\n{"This protein has now been purified and its encoding gene cloned.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 51, 'sentence': 'Such segments accord well with empirically known T-cell determinants and our algorithm produces a lower number of false positive predictions than the principle based on discrete Fourier transformations previously described.', 'label': {'T-cell determinants': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 4},\n    {"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n    {"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1518, 'sentence': 'Anti-immunoglobulin M activates nuclear calcium/calmodulin-dependent protein kinase II in human B lymphocytes .', 'label': {'nuclear calcium/calmodulin-dependent protein kinase II': 'protein', 'human B lymphocytes': 'cell_type', 'Anti-immunoglobulin M': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"IL-13 , a cytokine similar to IL-4 , is a regulator of human B cell and monocyte functions .": 5},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 5},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 5},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .": 5},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.": 5},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 563, 'sentence': 'The 6-h increase in PDGF(B) mRNA was adherence dependent, and in addition, was abrogated when the cytoskeletal integrity was compromised by cytochalasin D .', 'label': {'PDGF(B)': 'protein', 'PDGF(B) mRNA': 'RNA'}, 'response1': "['RNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence directly mentions the entity \'DNA\' and provides clear context for its presence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence directly mentions the entity \'RNA\' and provides clear context for its presence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence mentions multiple entities such as \'PAFR\', \'PAF\', \'NF-kappa B\', \'protein kinase C\' and provides context for their presence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence mentions \'TIMP-1\' and \'DNA\' directly, providing clear context for their presence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence mentions \'IL-2\', \'c-Jun\', and \'c-Fos\' directly, providing clear context for their presence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions \'MNDA\' and \'myeloid cell lines\' directly, providing clear context for their presence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence mentions \'NF-kappa B\' and \'DNA\' directly, providing clear context for their presence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions \'CD14\' directly, providing clear context for its presence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence mentions \'Bak\', \'Bad\', \'Bcl-2\', \'PDBu\', and \'DMSO\' directly, providing clear context for their presence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions \'IFN A\', \'IFNA\', \'interleukin-2\', \'interleukin-2 receptor\', \'phytohemagglutinin\', and \'phorbol myristate acetate\' directly, providing clear context for their presence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions \'P selectin\' directly, providing clear context for its presence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions \'CD14\' and \'CD23\' directly, providing clear context for their presence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions \'p21(WAF1/CIP1)\' and \'p27(KIP1)\' directly, providing clear context for their presence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions \'cell adhesion molecules\' directly, providing clear context for their presence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions \'CD70\', \'B cell\', \'plasma cells\', \'IL-4\', and \'CD40\' directly, providing clear context for their presence."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence mentions \'Protein kinase B\', \'phosphatidylinositol 3-kinase\', \'STAT5\', \'erythropoietin\', \'HCD57\', \'EPO\', \'HCD57-SREI\', and \'c-Akt\' directly, providing clear context for their presence."}\n]', 'response3': '[{"PDGF(B)": "RNA"}]', 'prediction': {'PDGF(B)': 'RNA'}}
{'idx': 501, 'sentence': 'Southwestern and gel renaturation experiments with the use of purified protein fractions revealed that TCF-1 alpha activity is derived from a family of 57- to 53-kD proteins that are abundantly expressed in mature and immature T-cell lines ( Jurkat , CCRF-CEM ) and not in mature B cells ( JY , Namalwa ) or nonlymphoid (HeLa) cell lines .', 'label': {'CCRF-CEM': 'cell_line', 'TCF-1 alpha': 'protein', 'nonlymphoid (HeLa) cell lines': 'cell_line', 'mature B cells': 'cell_line', 'JY': 'cell_line', 'Namalwa': 'cell_line', '57- to 53-kD proteins': 'protein', 'Jurkat': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n    {"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"TCF-1 alpha": "protein"}, {"57- to 53-kD proteins": "protein"}, {"Jurkat": "cell_line"}, {"CCRF-CEM": "cell_line"}, {"JY": "cell_line"}, {"Namalwa": "cell_line"}, {"HeLa": "cell_line"}]', 'prediction': {'TCF-1 alpha': 'protein', '57- to 53-kD proteins': 'protein', 'Jurkat': 'cell_line', 'CCRF-CEM': 'cell_line', 'JY': 'cell_line', 'Namalwa': 'cell_line', 'HeLa': 'cell_line'}}
{'idx': 457, 'sentence': 'TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes .', 'label': {'T lymphocytes': 'cell_type', 'TAR': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 4},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 4},\n    {"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .": 5},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .": 5},\n    {"Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype .": 5}\n]', 'response3': '[{"T lymphocytes": "cell_type"}, {"phorbol ester": "protein"}, {"TAR": "DNA"}, {"human immunodeficiency virus": "cell_type"}]', 'prediction': {'T lymphocytes': 'cell_type', 'phorbol ester': 'protein', 'TAR': 'DNA', 'human immunodeficiency virus': 'cell_type'}}
{'idx': 285, 'sentence': 'ER content in lymphocytes of each sample was expressed by both fmol/mg of lymphocyte cytosolic protein and fmol/micrograms of lymphocyte DNA .', 'label': {'ER': 'protein', 'lymphocyte DNA': 'DNA', 'lymphocytes': 'cell_type', 'lymphocyte cytosolic protein': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 3},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .": 4},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 4},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 4},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .": 4},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 5},\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[{"lymphocyte cytosolic protein": "protein"}, {"lymphocyte DNA": "DNA"}]', 'prediction': {'lymphocyte cytosolic protein': 'protein', 'lymphocyte DNA': 'DNA'}}
{'idx': 1508, 'sentence': 'Functional characterization of the murine homolog of the B cell-specific coactivator BOB.1/OBF.1 .', 'label': {'BOB.1/OBF.1': 'protein', 'B cell-specific coactivator': 'protein', 'murine homolog': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and direct mention of the entity along with its corresponding label, making it highly helpful for extracting named entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains specific mentions of entities along with their corresponding labels, aiding in the extraction of named entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly mentions the entity along with its corresponding label, providing clear information for named entity extraction."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence explicitly mentions the entity along with its corresponding label, facilitating the extraction of named entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides a direct mention of the entity along with its corresponding label, aiding in the extraction of named entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific mentions of entities along with their corresponding labels, aiding in the extraction of named entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence directly mentions the entity along with its corresponding label, providing clear information for named entity extraction."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence explicitly mentions the entity along with its corresponding label, facilitating the extraction of named entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides a direct mention of the entity along with its corresponding label, aiding in the extraction of named entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains specific mentions of entities along with their corresponding labels, aiding in the extraction of named entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence directly mentions the entity along with its corresponding label, providing clear information for named entity extraction."},\n    {"Example 12": 1},\n    {"Reason 12": "The sentence does not contain any specific mentions of entities corresponding to the given labels, making it less helpful for named entity extraction."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not contain any specific mentions of entities corresponding to the given labels, making it less helpful for named entity extraction."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not contain any specific mentions of entities corresponding to the given labels, making it less helpful for named entity extraction."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any specific mentions of entities corresponding to the given labels, making it less helpful for named entity extraction."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific mentions of entities corresponding to the given labels, making it less helpful for named entity extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific mentions of entities corresponding to the given labels, making it less helpful for named entity extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific mentions of entities corresponding to the given labels, making it less helpful for named entity extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific mentions of entities corresponding to the given labels, making it less helpful for named entity extraction."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any specific mentions of entities corresponding to the given labels, making it less helpful for named entity extraction."}\n]', 'response3': '[{"BOB.1/OBF.1": "protein"}]', 'prediction': {'BOB.1/OBF.1': 'protein'}}
{'idx': 209, 'sentence': 'Type-II estrogen -binding sites ( type-II EBS ) have been demonstrated in the human lymphoblastoid cell line IM-9 using a whole-cell assay with (6,7-3H) estradiol ( 3H-E2 ) as tracer.', 'label': {'lymphoblastoid cell line': 'cell_line', 'IM-9': 'cell_line', 'type-II EBS': 'protein', 'Type-II estrogen -binding sites': 'protein', 'human lymphoblastoid cell line': 'cell_line'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 4},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .": 3},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 3},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .": 4},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 4},\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .": 5},\n    {"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development .": 5},\n    {"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.": 5},\n    {"Expression of tal-1 and GATA-binding proteins during human hematopoiesis .": 4},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5}\n]', 'response3': '[{"IM-9": "cell_line"}, {"estradiol": "protein"}]', 'prediction': {'IM-9': 'cell_line', 'estradiol': 'protein'}}
{'idx': 1385, 'sentence': "Mutational analyses of the HIV-1 LTR showed that one C/EBP site is required for normal LTR transcription both before and after cellular activation and that the two 3' C/EBP sites are functionally equivalent.", 'label': {'LTR': 'DNA', 'HIV-1 LTR': 'DNA', 'C/EBP sites': 'DNA', 'C/EBP site': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter": 5},\n{"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors": 5},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation": 5},\n{"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14": 5},\n{"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 5},\n{"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein": 5},\n{"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined": 5},\n{"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50": 5},\n{"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF": 5},\n{"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells": 5},\n{"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB- induced trans-activation of the H4 promoter": 5},\n{"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region": 5},\n{"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence": 5},\n{"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus": 5},\n{"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process": 5},\n{"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes": 1},\n{"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats)": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729": 1}\n]', 'response3': '[{"HIV-1 LTR": "DNA"}, {"C/EBP": "protein"}, {"3\' C/EBP": "protein"}]', 'prediction': {'HIV-1 LTR': 'DNA', 'C/EBP': 'protein', "3' C/EBP": 'protein'}}
{'idx': 1516, 'sentence': 'Fusion of subdomains of BOB.1/OBF.1 with the GAL4 DNA binding domain reveals that both NH2- and COOH- terminal domains of BOB.1/OBF.1 contribute to full transactivation function, the COOH-terminal domain is more efficient in this transactivation assay .', 'label': {'BOB.1/OBF.1': 'protein', 'GAL4 DNA binding domain': 'protein', 'COOH-terminal domain': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events.": 5},\n    {"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.": 4},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 5},\n    {"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system.": 5},\n    {"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF.": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 5},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 5},\n    {"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif.": 5},\n    {"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB- induced trans-activation of the H4 promoter.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1827, 'sentence': 'A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1 .', 'label': {'human interleukin 2 gene promoter': 'DNA', 'EGR-1': 'protein', 'Sp1': 'protein', 'regulatory element': 'DNA', 'binding site': 'DNA', 'zinc finger proteins': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"IgH": 5},\n    {"IL4": 5},\n    {"IL13": 5},\n    {"Th2-type lymphocytes": 5},\n    {"IL-2": 5},\n    {"IL-4": 5},\n    {"immunoglobulin kappa 3\' enhancer": 5},\n    {"interleukin 10": 5},\n    {"IL-10R": 5},\n    {"IL-13": 5},\n    {"IL-4": 5},\n    {"GATA-1": 5},\n    {"Sp1": 5},\n    {"Ets": 5},\n    {"Sp1": 5},\n    {"CD14": 5},\n    {"T cell": 5},\n    {"interleukin 2": 5},\n    {"Egr-1": 5},\n    {"IL-2": 5},\n    {"NF-kappaB": 5},\n    {"Sp1": 5},\n    {"p50": 5},\n    {"IFN A": 5},\n    {"IFNA": 5},\n    {"interleukin-2": 5},\n    {"interleukin-2 receptor": 5},\n    {"phytohemagglutinin": 5},\n    {"phorbol myristate acetate": 5}\n]', 'response3': '[{"interleukin 2": "protein"}, {"Sp1": "protein"}, {"EGR-1": "protein"}]', 'prediction': {'interleukin 2': 'protein', 'Sp1': 'protein', 'EGR-1': 'protein'}}
{'idx': 1116, 'sentence': 'The tumour suppressor p53 has been shown to regulate this type of apoptosis in thymocytes , but an as yet unknown, p53 -independent pathway (s) appears to mediate the same event in mitogen-activated mature T lymphocytes .', 'label': {'thymocytes': 'cell_type', 'p53': 'protein', 'mitogen-activated mature T lymphocytes': 'cell_line', 'tumour suppressor p53': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 5},\n{"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.": 5},\n{"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 4},\n{"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n{"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n{"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n{"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n{"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n{"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine (IL-2 and IFN-gamma) production is normal.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n{"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.": 5},\n{"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n{"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n{"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.": 5},\n{"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n{"The process of apoptosis is used to eliminate unwanted cells from a wide variety of organisms.": 5},\n{"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"p53": "protein"}, {"apoptosis": "cell_type"}, {"thymocytes": "cell_type"}, {"p53": "protein"}, {"mitogen-activated mature T lymphocytes": "cell_type"}]', 'prediction': {'p53': 'protein', 'apoptosis': 'cell_type', 'thymocytes': 'cell_type', 'mitogen-activated mature T lymphocytes': 'cell_type'}}
{'idx': 178, 'sentence': 'T lymphocytes appeared to be an important source of 1,25(OH)2D3 production , since purified T lymphocytes from all patients with tuberculosis produced 1,25(OH)2D3 , and 1,25(OH)2D3 production by these cells correlated closely with that produced by unseparated lavage cells .', 'label': {'T lymphocytes': 'cell_type', 'lavage cells': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The example provides a clear instance of a protein entity (TCL1) mentioned in the sentence, which directly matches one of the entity labels in the target sentence."},\n{"Example 2": 5},\n{"Reason 2": "The example provides two instances of cell type entities (granulocytes and T cells) mentioned in the sentence, which directly match entity labels in the target sentence."},\n{"Example 3": 5},\n{"Reason 3": "The example provides a clear instance of a protein entity (CD14) mentioned in the sentence, which directly matches one of the entity labels in the target sentence."},\n{"Example 4": 5},\n{"Reason 4": "The example provides multiple instances of protein entities (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) and a cell type entity (T cell) mentioned in the sentence, which directly match entity labels in the target sentence."},\n{"Example 5": 5},\n{"Reason 5": "The example provides a clear instance of a protein entity (ZAP-70) mentioned in the sentence, which directly matches one of the entity labels in the target sentence."},\n{"Example 6": 5},\n{"Reason 6": "The example provides instances of a cell type entity (T lymphocytes) and a protein entity (HLA-molecules) mentioned in the sentence, which directly match entity labels in the target sentence."},\n{"Example 7": 5},\n{"Reason 7": "The example provides instances of protein entity (NF-ATc) and cell type entity (T lymphocytes) mentioned in the sentence, which directly match entity labels in the target sentence."},\n{"Example 8": 5},\n{"Reason 8": "The example provides instances of protein entities (Oct-2A, HMG I/Y, HLA-DRA) and a cell type entity (B cells) mentioned in the sentence, which directly match entity labels in the target sentence."},\n{"Example 9": 5},\n{"Reason 9": "The example provides instances of a cell line entity (EBV) and a protein entity (CD2) mentioned in the sentence, which directly match entity labels in the target sentence."},\n{"Example 10": 5},\n{"Reason 10": "The example provides an instance of a cell type entity (Th2-type lymphocytes) mentioned in the sentence, which directly matches one of the entity labels in the target sentence."},\n{"Example 11": 5},\n{"Reason 11": "The example provides instances of a cell type entity (T cell), protein entities (IL-2, IL-2 receptor, CD28) mentioned in the sentence, which directly match entity labels in the target sentence."},\n{"Example 12": 5},\n{"Reason 12": "The example provides instances of protein entities (CD70, IL-4, CD40) and cell type entities (B cell, plasma cells) mentioned in the sentence, which directly match entity labels in the target sentence."},\n{"Example 13": 5},\n{"Reason 13": "The example provides instances of protein entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) mentioned in the sentence, which directly match entity labels in the target sentence."},\n{"Example 14": 5},\n{"Reason 14": "The example provides instances of protein entities (IL-2 receptor alpha subunit, p21ras) and a cell type entity (B cell) mentioned in the sentence, which directly match entity labels in the target sentence."},\n{"Example 15": 5},\n{"Reason 15": "The example provides instances of cell type entities (B and T cell activation) and cell line entities (Ramos, Jurkat) mentioned in the sentence, which directly match entity labels in the target sentence."},\n{"Example 16": 1},\n{"Reason 16": "The example does not contain any entities that match the entity labels in the target sentence."},\n{"Example 17": 1},\n{"Reason 17": "The example does not contain any entities that match the entity labels in the target sentence."},\n{"Example 18": 1},\n{"Reason 18": "The example does not contain any entities that match the entity labels in the target sentence."},\n{"Example 19": 1},\n{"Reason 19": "The example does not contain any entities that match the entity labels in the target sentence."},\n{"Example 20": 1},\n{"Reason 20": "The example does not contain any entities that match the entity labels in the target sentence."},\n{"Example 21": 1},\n{"Reason 21": "The example does not contain any entities that match the entity labels in the target sentence."},\n{"Example 22": 1},\n{"Reason 22": "The example does not contain any entities that match the entity labels in the target sentence."},\n{"Example 23": 1},\n{"Reason 23": "The example does not contain any entities that match the entity labels in the target sentence."},\n{"Example 24": 1},\n{"Reason 24": "The example does not contain any entities that match the entity labels in the target sentence."},\n{"Example 25": 1},\n{"Reason 25": "The example does not contain any entities that match the entity labels in the target sentence."}\n]', 'response3': "[{'T lymphocytes': 'cell_type'}, {'1,25(OH)2D3': 'protein'}, {'tuberculosis': 'cell_type'}, {'unseparated lavage cells': 'cell_line'}]", 'prediction': {'T lymphocytes': 'cell_type', '1,25(OH)2D3': 'protein', 'tuberculosis': 'cell_type', 'unseparated lavage cells': 'cell_line'}}
{'idx': 1209, 'sentence': 'A reduction of serum androgens was found, whereas no change was observed in either basal or GnRH-stimulated gonadotropins or in the cortisol and 17 alpha-hydroxyprogesterone response to ACTH .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 4},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .": 4},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .": 5},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 4},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .": 4},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"Interestingly, CTLA4Ig did not significantly inhibit the activation of either NF of activated T cells ( NFAT ) or AP-1 reporters .": 5},\n    {"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.": 5},\n    {"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator .": 5},\n    {"When 18C7 was incubated with MR before aldosterone or progesterone , the antibody inhibited 75-80% of the binding.": 5},\n    {"In apparent contradiction, expression of a dominant negative form of Ras , RasN17 , also inhibited IL-2 -induced activation of the promoter containing the minimal beta-casein STAT5 element as well as the promoters of CIS and OSM .": 5},\n    {"The number of Type I and Type II receptors before the test was lower in elderly subjects than in adults .": 3},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 5},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 864, 'sentence': 'Differences in transcriptional enhancers of HIV-1 and HIV-2 .', 'label': {'transcriptional enhancers': 'DNA'}, 'response1': "['DNA', 'RNA']", 'response2': '[\n    {"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 5},\n    {"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 3},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 3},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 4},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 4},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 4},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 4},\n    {"NF-E1 is encoded by the same gene as the YY-1 protein, which binds to the adeno-associated virus P5 promoter.": 4}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 65, 'sentence': 'Deletions upstream of the PRDII element increased transcription in the uninduced extract, indicating predominantly negative regulation of the promoter .', 'label': {'promoter': 'DNA', 'PRDII element': 'DNA'}, 'response1': "['DNA', 'RNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 4},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 61, 'sentence': 'From HeLa cells , two major proteins of 52 and 45 kilodaltons (kD) copurified with DNA binding activity , whereas from T-cells , four proteins--a major protein of 52 kD and three minor proteins of 82 , 67 , and 43-47 kD --were purified.', 'label': {'82': 'protein', '43-47 kD': 'protein', 'major protein': 'protein', 'T-cells': 'cell_type', 'minor proteins': 'protein', '67': 'protein', 'HeLa cells': 'cell_line', '52 kD': 'protein'}, 'response1': "['protein', 'cell_line', 'DNA']", 'response2': '[\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .": 4},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50 .": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 4},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[{"HeLa cells": "cell_line"}, {"T-cells": "cell_line"}, {"DNA": "DNA"}, {"protein": "protein"}, {"52 kD": "protein"}, {"45 kilodaltons (kD)": "protein"}, {"82": "protein"}, {"67": "protein"}, {"43-47 kD": "protein"}]', 'prediction': {'HeLa cells': 'cell_line', 'T-cells': 'cell_line', 'DNA': 'DNA', 'protein': 'protein', '52 kD': 'protein', '45 kilodaltons (kD)': 'protein', '82': 'protein', '67': 'protein', '43-47 kD': 'protein'}}
{'idx': 191, 'sentence': 'A block to RNA elongation is largely responsible for decreased c-myc transcription .', 'label': {'c-myc': 'DNA'}, 'response1': "['RNA']", 'response2': '[\n    {"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .": 5},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 5},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .": 5},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5}\n]', 'response3': '[{"RNA": "RNA"}, {"c-myc": "protein"}]', 'prediction': {'RNA': 'RNA', 'c-myc': 'protein'}}
{'idx': 447, 'sentence': 'Each binding site contributes to the overall activity of the enhancer , however no single element seems absolutely required for activity.', 'label': {'enhancer': 'DNA', 'binding site': 'DNA'}, 'response1': "['DNA']", 'response2': '[\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n    {"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 4},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"Nuclear factor NF-kB, activation protein 1 ( AP-1 ), OCT-1, and NF-IL-2B binding activity were normal.": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 5},\n    {"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"We have found that the recruitment of EKLF to 5\'HS3 depends on the presence of 5\'HS2 in cis, but the recruitment to 5\'HS2 does not depend on 5\'HS3.": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 5},\n    {"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 476, 'sentence': 'A group of coordinately induced protooncogenes , cytoskeletal , and extracellular matrix genes have been termed immediate early response genes , and their induction has been associated with growth factor -stimulated cell proliferation .', 'label': {'protooncogenes': 'DNA', 'immediate early response genes': 'DNA', 'growth factor': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .": 5},\n    {"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 4},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n    {"The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 5},\n    {"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus , and induce transcription from responsive genes.": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1034, 'sentence': 'p94 and p95 share homology with Stat1 at the phosphorylation site and in the Src homology 2 (SH2) domain , but otherwise are immunologically distinct from Stat1 .', 'label': {'Stat1': 'protein', 'phosphorylation site': 'protein', 'Src homology 2 (SH2) domain': 'protein', 'p94': 'protein', 'p95': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"p21(WAF1/CIP1 ) and p27(KIP1)": 5},\n    {"Reasons": "Both \'p21(WAF1/CIP1)\' and \'p27(KIP1)\' are proteins mentioned in the sentence, and their labels can be accurately predicted based on the context."},\n    {"calcineurin": 5},\n    {"Reasons": "\'calcineurin\' is a protein mentioned in the sentence, and its label can be accurately predicted based on the context."},\n    {"Th1 and Th2": 5},\n    {"Reasons": "\'Th1\' and \'Th2\' are cell types mentioned in the sentence, and their labels can be accurately predicted based on the context."},\n    {"IL-2, c-Jun, c-Fos": 5},\n    {"Reasons": "\'IL-2\', \'c-Jun\', and \'c-Fos\' are proteins mentioned in the sentence, and their labels can be accurately predicted based on the context."},\n    {"IL4, IL13, STAT6, STAT3, STAT5, B cells": 5},\n    {"Reasons": "\'IL4\', \'IL13\', \'STAT6\', \'STAT3\', \'STAT5\', and \'B cells\' are proteins or cell types mentioned in the sentence, and their labels can be accurately predicted based on the context."},\n    {"IL-2": 5},\n    {"Reasons": "\'IL-2\' is a protein mentioned in the sentence, and its label can be accurately predicted based on the context."},\n    {"IL-12, STAT4, NK cells, T cells, IL-12 receptor": 5},\n    {"Reasons": "\'IL-12\', \'STAT4\', \'NK cells\', \'T cells\', and \'IL-12 receptor\' are proteins or cell types mentioned in the sentence, and their labels can be accurately predicted based on the context."},\n    {"SLAP-130, SLP-76, T cell": 5},\n    {"Reasons": "\'SLAP-130\', \'SLP-76\', and \'T cell\' are proteins or cell types mentioned in the sentence, and their labels can be accurately predicted based on the context."},\n    {"tyrosine": 5},\n    {"Reasons": "\'tyrosine\' is a protein mentioned in the sentence, and its label can be accurately predicted based on the context."},\n    {"IL-2, IFN-gamma, jak kinases, STAT1(alpha)": 5},\n    {"Reasons": "\'IL-2\', \'IFN-gamma\', \'jak kinases\', and \'STAT1(alpha)\' are proteins mentioned in the sentence, and their labels can be accurately predicted based on the context."},\n    {"IL-2, Aiolos, Ras": 5},\n    {"Reasons": "\'IL-2\', \'Aiolos\', and \'Ras\' are proteins mentioned in the sentence, and their labels can be accurately predicted based on the context."},\n    {"ERK, STAT3": 5},\n    {"Reasons": "\'ERK\' and \'STAT3\' are proteins mentioned in the sentence, and their labels can be accurately predicted based on the context."},\n    {"CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, granulocyte-macrophage colony-stimulating factor": 5},\n    {"Reasons": "\'CD28\', \'CD80\', \'CD86\', \'CBL\', \'VAV\', \'NFAT\', \'interleukin-2\', and \'granulocyte-macrophage colony-stimulating factor\' are proteins mentioned in the sentence, and their labels can be accurately predicted based on the context."},\n    {"NF-kappaB, Sp1, p50": 5},\n    {"Reasons": "\'NF-kappaB\', \'Sp1\', and \'p50\' are proteins mentioned in the sentence, and their labels can be accurately predicted based on the context."},\n    {"interleukin 10, IL-10R, STAT3, IL-6": 5},\n    {"Reasons": "\'interleukin 10\', \'IL-10R\', \'STAT3\', and \'IL-6\' are proteins mentioned in the sentence, and their labels can be accurately predicted based on the context."},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations": 1},\n    {"Reasons": "The sentence does not contain any entities related to the provided entity labels, making it least helpful for predicting named entities."},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes": 1},\n    {"Reasons": "The sentence does not contain any entities related to the provided entity labels, making it least helpful for predicting named entities."},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic": 1},\n    {"Reasons": "The sentence does not contain any entities related to the provided entity labels, making it least helpful for predicting named entities."},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection": 1},\n    {"Reasons": "The sentence does not contain any entities related to the provided entity labels, making it least helpful for predicting named entities."},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats)": 1},\n    {"Reasons": "The sentence does not contain any entities related to the provided entity labels, making it least helpful for predicting named entities."},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C": 1},\n    {"Reasons": "The sentence does not contain any entities related to the provided entity labels, making it least helpful for predicting named entities."},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77": 1},\n    {"Reasons": "The sentence does not contain any entities related to the provided entity labels, making it least helpful for predicting named entities."},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells": 1},\n    {"Reasons": "The sentence does not contain any entities related to the provided entity labels, making it least helpful for predicting named entities."},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now": 1},\n    {"Reasons": "The sentence does not contain any entities related to the provided entity labels, making it least helpful for predicting named entities."},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729": 1},\n    {"Reasons": "The sentence does not contain any entities related to the provided entity labels, making it least helpful for predicting named entities."}\n]', 'response3': '[{"p94": "protein"}, {"p95": "protein"}, {"Stat1": "protein"}]', 'prediction': {'p94': 'protein', 'p95': 'protein', 'Stat1': 'protein'}}
{'idx': 1232, 'sentence': 'IBR is a 503-amino-acid-long acidic protein which is 99.0% identical to the recently reported human NRF-1/alpha-Pal factor and highly related to the invertebrate transcription factors P3A2 and erected wing gene product ( EWG ).', 'label': {'IBR': 'protein', 'transcription factors': 'protein', 'erected wing gene product': 'protein', 'human NRF-1/alpha-Pal factor': 'protein', 'EWG': 'protein', 'P3A2': 'protein', '503-amino-acid-long acidic protein': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein (IL-4) and its corresponding entity label."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence clearly mentions a protein (NF-E2) and its corresponding entity label."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains multiple instances of proteins (IL-2, c-Jun, c-Fos) and their corresponding entity labels."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides a clear example of a protein (interferon regulatory factor) and its corresponding entity label."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence mentions multiple proteins (EKLF, CBP, p300, P/CAF) and their corresponding entity labels."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides a clear example of a protein (A-myb) and its corresponding entity label."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence mentions a protein (Protein) and its corresponding entity label."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains multiple instances of proteins (p21(WAF1/CIP1), p27(KIP1)) and their corresponding entity labels."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence mentions multiple proteins (Drosophila Toll, human Toll) and their corresponding entity labels."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains multiple instances of proteins (PAFR, PAF, NF-kappa B, protein kinase C) and their corresponding entity labels."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions multiple proteins (NF-kappa B, AP-1) and their corresponding entity labels."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides a clear example of proteins (EBNA-2, PU.1) and their corresponding entity labels."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions a protein (NF-ATc) and its corresponding entity label."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides a clear example of a DNA entity (immunoglobulin kappa 3\' enhancer) and its corresponding entity label."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions a protein (Egr-1) and its corresponding entity label."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities from the given entity label set."}\n]', 'response3': '[{"IBR": "protein"}, {"NRF-1/alpha-Pal": "protein"}, {"P3A2": "protein"}, {"erected wing gene product (EWG)": "protein"}]', 'prediction': {'IBR': 'protein', 'NRF-1/alpha-Pal': 'protein', 'P3A2': 'protein', 'erected wing gene product (EWG)': 'protein'}}
{'idx': 54, 'sentence': 'Virus stocks obtained from these experiments exhibited a continuum of replicative capacities in different human T-cell types depending on which element (s) was present in the LTR .', 'label': {'LTR': 'DNA', 'human T-cell types': 'cell_type', 'T-cell types': 'cell_type', 'element': 'DNA'}, 'response1': "['cell_type']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence directly mentions \'cDNAs\', which is a type of DNA, making it highly relevant for extracting named entities."},\n{"Example 2": 4},\n{"Reason 2": "The sentence mentions \'IL-2\', which is a protein, and the context indicates its relevance in the sentence."},\n{"Example 3": 5},\n{"Reason 3": "The sentence mentions specific cell lines like \'SIVmacMER\', \'SIVmac239\', and \'CEMx174\', making it highly relevant for extracting named entities."},\n{"Example 4": 4},\n{"Reason 4": "The sentence mentions \'CD4+\' as a cell type and \'EBV\' as a protein, which are relevant entities in the context."},\n{"Example 5": 5},\n{"Reason 5": "The sentence mentions various proteins like \'IFN A\', \'interleukin-2\', \'interleukin-2 receptor\', and stimuli like \'phytohemagglutinin\' and \'phorbol myristate acetate\', making it highly relevant for extracting named entities."},\n{"Example 6": 4},\n{"Reason 6": "The sentence mentions \'TIMP-1\' as a protein and \'DNA\' directly, making it relevant for extracting named entities."},\n{"Example 7": 5},\n{"Reason 7": "The sentence mentions \'Th2-type lymphocytes\', which are a specific cell type, making it highly relevant for extracting named entities."},\n{"Example 8": 4},\n{"Reason 8": "The sentence mentions \'EBV\' as a cell line and \'CD2\' as a protein, which are relevant entities in the context."},\n{"Example 9": 5},\n{"Reason 9": "The sentence mentions \'PBMC\' as a cell type and \'adenovirus DNA\', making it highly relevant for extracting named entities."},\n{"Example 10": 5},\n{"Reason 10": "The sentence mentions \'SIVsmmPBj14\' as a cell line, making it highly relevant for extracting named entities."},\n{"Example 11": 4},\n{"Reason 11": "The sentence mentions \'CD95 ligand\' as a protein, making it relevant for extracting named entities."},\n{"Example 12": 5},\n{"Reason 12": "The sentence mentions \'HIV-1 LTR\' as DNA, \'NFAT-1\' and \'NF kappa B\' as proteins, making it highly relevant for extracting named entities."},\n{"Example 13": 5},\n{"Reason 13": "The sentence mentions \'EBV\' as DNA, \'EBNA2\' and \'estrogen receptor\' as proteins, making it highly relevant for extracting named entities."},\n{"Example 14": 4},\n{"Reason 14": "The sentence mentions \'TR55\' as a protein, \'TNF-alpha\' as a protein, and \'HIV\' as a cell type, making it relevant for extracting named entities."},\n{"Example 15": 5},\n{"Reason 15": "The sentence mentions \'NF-kappaB\' and \'Sp1\' as proteins, and \'SIVmac\' as a cell line, making it highly relevant for extracting named entities."},\n{"Example 16": 1},\n{"Reason 16": "The sentence does not mention any entities relevant to the given entity labels."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not mention any entities relevant to the given entity labels."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not mention any entities relevant to the given entity labels."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not mention any entities relevant to the given entity labels."},\n{"Example 20": 1},\n{"Reason 20": "The sentence does not mention any entities relevant to the given entity labels."},\n{"Example 21": 1},\n{"Reason 21": "The sentence does not mention any entities relevant to the given entity labels."},\n{"Example 22": 1},\n{"Reason 22": "The sentence does not mention any entities relevant to the given entity labels."},\n{"Example 23": 1},\n{"Reason 23": "The sentence does not mention any entities relevant to the given entity labels."},\n{"Example 24": 1},\n{"Reason 24": "The sentence does not mention any entities relevant to the given entity labels."}\n]', 'response3': '[{"T-cell types": "cell_type"}, {"LTR": "DNA"}]', 'prediction': {'T-cell types': 'cell_type', 'LTR': 'DNA'}}
{'idx': 1149, 'sentence': 'The expression and activity of NF-kappa B and Sp1 were, therefore, analyzed in isolated T cells and DCs from humans and mice .', 'label': {'Sp1': 'protein', 'DCs': 'cell_type', 'NF-kappa B': 'protein', 'T cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 4},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"Sp1": "protein"}, {"T cells": "cell_type"}, {"DCs": "cell_type"}, {"humans": "cell_type"}, {"mice": "cell_type"}]', 'prediction': {'NF-kappa B': 'protein', 'Sp1': 'protein', 'T cells': 'cell_type', 'DCs': 'cell_type', 'humans': 'cell_type', 'mice': 'cell_type'}}
{'idx': 407, 'sentence': 'Since most of the actions of vitamin D are mediated by its receptors ( VDR ), abnormalities of VDR have been postulated in XLH .', 'label': {'VDR': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 5},\n    {"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.": 5},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage.": 5},\n    {"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.": 5},\n    {"Benzene toxicity towards lymphocytes is thought to be mediated by metabolites of benzene including benzoquinone (BQ).": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 5},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 5},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 5},\n    {"Furthermore, the two VDR 3\'-UTR haplotypes conferred an identical half-life on a heterologous beta-globin reporter gene, in an in vitro assay.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"VDR": "protein"}, {"VDR": "protein"}]', 'prediction': {'VDR': 'protein'}}
{'idx': 1466, 'sentence': 'As we observed that activated endothelial cells also expressed NFAT , we tested the antiinflammatory properties of CsA in endothelial cells .', 'label': {'endothelial cells': 'cell_type', 'NFAT': 'protein', 'activated endothelial cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a DNA binding activity, which directly corresponds to the entity label \'DNA\' in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions NF-kappa B and I kappa B alpha, which are both related to proteins, matching the entity label \'protein\' in the target sentence."},\n    {"Example 3": 3},\n    {"Reason 3": "The sentence includes AP-1, PMA, monocytes, and macrophages, which are relevant to the entity labels \'protein\' and \'cell_type\' in the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence refers to granulocytes and T cells, aligning with the entity labels \'cell_type\' in the target sentence."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence discusses NF-kappa B activation, which corresponds to the entity label \'protein\' in the target sentence."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence mentions NF-kappaB, Tax, and ATL, which are associated with \'protein\' and \'cell_type\' entity labels in the target sentence."},\n    {"Example 7": 3},\n    {"Reason 7": "The sentence talks about alpha-tocopherol, monocytes, and endothelial cells, which relate to the entity labels \'protein\' and \'cell_type\' in the target sentence."},\n    {"Example 8": 4},\n    {"Reason 8": "The sentence discusses the inhibition of NF-kappa B activation, aligning with the entity label \'protein\' in the target sentence."},\n    {"Example 9": 3},\n    {"Reason 9": "The sentence mentions P selectin, which is relevant to the entity label \'protein\' in the target sentence."},\n    {"Example 10": 4},\n    {"Reason 10": "The sentence connects NF-kappa B with ARDS, which corresponds to the entity labels \'protein\' and \'cell_type\' in the target sentence."},\n    {"Example 11": 4},\n    {"Reason 11": "The sentence discusses NF-kappa B activation in neutrophils, matching the entity label \'protein\' in the target sentence."},\n    {"Example 12": 3},\n    {"Reason 12": "The sentence investigates the activation of NF-kappa B, aligning with the entity label \'protein\' in the target sentence."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence mentions MNDA and Philadelphia chromosome-positive chronic myeloid leukemia, which correspond to the entity labels \'protein\' and \'cell_line\' in the target sentence."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence examines the expression of the E2A gene at the protein level, which aligns with the entity label \'protein\' in the target sentence."},\n    {"Example 15": 4},\n    {"Reason 15": "The sentence discusses the inhibition of NF-kappa B and AP-1, which correspond to the entity labels \'protein\' in the target sentence."},\n    {"Example 16": 3},\n    {"Reason 16": "The sentence talks about IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, and phorbol myristate acetate, which are relevant to the entity label \'protein\' in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities matching the entity labels in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities matching the entity labels in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities matching the entity labels in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities matching the entity labels in the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities matching the entity labels in the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities matching the entity labels in the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities matching the entity labels in the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities matching the entity labels in the target sentence."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities matching the entity labels in the target sentence."}\n]', 'response3': '[{"NFAT": "protein"}, {"CsA": "protein"}, {"endothelial cells": "cell_type"}]', 'prediction': {'NFAT': 'protein', 'CsA': 'protein', 'endothelial cells': 'cell_type'}}
{'idx': 1330, 'sentence': 'Stimulation of cells leads to a rapid phosphorylation of I kappa B alpha , which is presumed to be important for the subsequent degradation .', 'label': {'I kappa B alpha': 'protein', 'I kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"I kappa B alpha": "protein"}]', 'prediction': {'I kappa B alpha': 'protein'}}
{'idx': 1436, 'sentence': 'Similar levels of hTR beta 1 mRNA levels were detected in thyroid gland from euthyroid patients .', 'label': {'hTR beta 1 mRNA': 'RNA', 'hTR beta 1': 'protein'}, 'response1': "['RNA']", 'response2': '[\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.": 5},\n    {"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process.": 5}\n]', 'response3': '[{"hTR beta 1 mRNA": "RNA"}]', 'prediction': {'hTR beta 1 mRNA': 'RNA'}}
{'idx': 859, 'sentence': 'We show that at least one inducible , C1 , and one constitutive, C2 , protein can bind to the HIV enhancer in Jurkat cells .', 'label': {'inducible': 'protein', 'Jurkat cells': 'cell_line', 'C1': 'protein', 'HIV enhancer': 'DNA', 'C2': 'protein', 'constitutive, C2 , protein': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n{"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n{"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n{"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 4},\n{"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n{"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 4},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n{"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n{"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n{"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n{"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 5},\n{"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n{"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5},\n{"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 5},\n{"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells (Daudi) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner.": 5}\n]', 'response3': '[{"C1": "protein"}, {"C2": "protein"}, {"HIV enhancer": "DNA"}, {"Jurkat": "cell_line"}]', 'prediction': {'C1': 'protein', 'C2': 'protein', 'HIV enhancer': 'DNA', 'Jurkat': 'cell_line'}}
{'idx': 451, 'sentence': 'However, despite its ability to activate transcription of a transfected reporter gene , the factor is apparently unable to bind to the endogenous Ig heavy chain enhancer in non- lymphoid cells : In previous experiments by others, the characteristic in vivo footprint of this factor, designated NF-muE3 , was detected in B cells but not in non-B cells .', 'label': {'NF-muE3': 'protein', 'B cells': 'cell_type', 'lymphoid cells': 'cell_type', 'transfected reporter gene': 'DNA', 'Ig heavy chain enhancer': 'DNA', 'non- lymphoid cells': 'cell_type', 'non-B cells': 'cell_type', 'endogenous Ig heavy chain enhancer': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"p50p50": 5},\n    {"Egr-1": 5},\n    {"IFN A": 5},\n    {"IFNA": 5},\n    {"interleukin-2": 5},\n    {"interleukin-2 receptor": 5},\n    {"phytohemagglutinin": 5},\n    {"phorbol myristate acetate": 5},\n    {"TCF-1": 5},\n    {"IL-2 receptor alpha subunit": 5},\n    {"p21ras": 5},\n    {"B cell": 5},\n    {"NF-ATc": 5},\n    {"T lymphocytes": 5},\n    {"embryonic cardiac cells": 5},\n    {"IL-2": 5},\n    {"NF-kappaB": 5},\n    {"Sp1": 5},\n    {"p50": 5},\n    {"c-kit": 5},\n    {"IL-4R alpha chain": 5},\n    {"c-Jun": 5},\n    {"c-Fos": 5},\n    {"immunoglobulin kappa 3\' enhancer": 5},\n    {"IL-2": 5},\n    {"IFN-gamma": 5},\n    {"jak kinases": 5},\n    {"STAT1(alpha)": 5},\n    {"rheumatoid arthritis": 5},\n    {"CD40": 5},\n    {"Rel/nuclear factor kappaB": 5},\n    {"B lymphocytes": 5},\n    {"SIVmac": 5},\n    {"CTLA4Ig": 5},\n    {"NFAT": 5},\n    {"AP-1": 5}\n]', 'response3': '[{"Ig heavy chain enhancer": "DNA"}, {"NF-muE3": "protein"}, {"B cells": "cell_type"}, {"non-B cells": "cell_type"}]', 'prediction': {'Ig heavy chain enhancer': 'DNA', 'NF-muE3': 'protein', 'B cells': 'cell_type', 'non-B cells': 'cell_type'}}
{'idx': 919, 'sentence': 'The human protein recognized by the EC1 antibody is a 56-kDa protein ( p56 ) of moderate abundance located predominantly in the cytoplasm by indirect immunofluorescence .', 'label': {'56-kDa protein': 'protein', 'p56': 'protein', 'EC1 antibody': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides clear examples of protein names and their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."}\n]', 'response3': '[{"EC1 antibody": "protein"}, {"p56": "protein"}]', 'prediction': {'EC1 antibody': 'protein', 'p56': 'protein'}}
{'idx': 1206, 'sentence': 'In addition, the concentration of androgen receptors in mononuclear leukocytes was measured, in both the follicular and luteal phases of the menstrual cycle , basally and after 4 months of flutamide treatment.', 'label': {'androgen receptors': 'protein', 'mononuclear leukocytes': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The example provides a clear and direct mapping between the entity \'RXR\' and the entity label \'protein\' in the target sentence."},\n{"Example 2": 4},\n{"Reason 2": "The example provides a clear mapping between the entities \'granulocytes\' and \'T cells\' to the entity label \'cell_type\' in the target sentence."},\n{"Example 3": 4},\n{"Reason 3": "The example provides a clear mapping between the entity \'lymphoid neoplasms\' to the entity label \'cell_type\' in the target sentence."},\n{"Example 4": 5},\n{"Reason 4": "The example provides a clear and direct mapping between the entity \'CD14\' and the entity label \'protein\' in the target sentence."},\n{"Example 5": 4},\n{"Reason 5": "The example provides a clear mapping between the entities \'phosphocreatine\', \'dexamethasone\', \'cortisol\', and \'lysozyme\' to the entity label \'protein\' in the target sentence."},\n{"Example 6": 4},\n{"Reason 6": "The example provides a clear mapping between the entity \'NF-E2\' to the entity label \'protein\' in the target sentence."},\n{"Example 7": 5},\n{"Reason 7": "The example provides a clear and direct mapping between the entity \'E2A\' and the entity label \'protein\' in the target sentence."},\n{"Example 8": 5},\n{"Reason 8": "The example provides a clear and direct mapping between the entities \'CD70\', \'B cell\', \'plasma cells\', \'IL-4\', and \'CD40\' to their respective entity labels in the target sentence."},\n{"Example 9": 5},\n{"Reason 9": "The example provides a clear and direct mapping between the entities \'cAMP-dependent protein kinase\' and \'Rap1\' to the entity label \'protein\' in the target sentence."},\n{"Example 10": 5},\n{"Reason 10": "The example provides a clear and direct mapping between the entities \'CD40\', \'Rel/nuclear factor kappaB\', \'NF-kappaB\', and \'B lymphocytes\' to their respective entity labels in the target sentence."},\n{"Example 11": 5},\n{"Reason 11": "The example provides a clear and direct mapping between the entities \'PU.1\', \'CSF-1 receptor\', \'Mono A\', and \'Mono B\' to their respective entity labels in the target sentence."},\n{"Example 12": 3},\n{"Reason 12": "The example provides a mapping between the entities \'nuclear factor-kappa B\' and \'NF-kappa B\' to the entity label \'DNA\' in the target sentence, but the relevance of this entity label to the sentence context is less clear."},\n{"Example 13": 4},\n{"Reason 13": "The example provides a clear mapping between the entities \'NF-kappa B\' and \'fibrinogen\' to the entity label \'protein\' in the target sentence."},\n{"Example 14": 5},\n{"Reason 14": "The example provides a clear and direct mapping between the entities \'MNDA\', \'monocytes\', \'macrophages\', and \'leukemia/B lymphoma cell lines\' to their respective entity labels in the target sentence."},\n{"Example 15": 5},\n{"Reason 15": "The example provides a clear and direct mapping between the entities \'PMA\' and \'U1 cells\' to the entity label \'cell_line\' in the target sentence."}\n]', 'response3': "[{'androgen receptors': 'protein'}, {'mononuclear leukocytes': 'cell_type'}, {'follicular': 'cell_type'}, {'luteal': 'cell_type'}, {'menstrual cycle': 'cell_type'}, {'flutamide': 'protein'}]", 'prediction': {'androgen receptors': 'protein', 'mononuclear leukocytes': 'cell_type', 'follicular': 'cell_type', 'luteal': 'cell_type', 'menstrual cycle': 'cell_type', 'flutamide': 'protein'}}
{'idx': 569, 'sentence': 'In addition, the increases in c-jun , EGR2 , and PDGF(B) may depend on cytoskeletal rearrangement .', 'label': {'PDGF(B)': 'protein', 'EGR2': 'DNA', 'c-jun': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.": 5},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 5},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 5},\n    {"The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.": 5},\n    {"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n    {"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1657, 'sentence': 'HMG-I binds to GATA motifs : implications for an HPFH syndrome .', 'label': {'HMG-I': 'protein', 'GATA motifs': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides clear examples of named entities with their corresponding entity labels, aiding in understanding the relationship between the entities and their types."}\n]', 'response3': '[{"HMG-I": "protein"}, {"GATA motifs": "DNA"}, {"HPFH syndrome": "cell_type"}]', 'prediction': {'HMG-I': 'protein', 'GATA motifs': 'DNA', 'HPFH syndrome': 'cell_type'}}
{'idx': 1780, 'sentence': 'Interestingly, Id2 , but not Id3 , mRNA was strongly expressed in 4/5 T-cell lines infected with human T-cell leukemia virus type I ( HTLV-I ) ( ATL-1k , MT-2 , S-LB1 ) and type II ( Mo ) .', 'label': {'Id3': 'protein', 'Mo': 'cell_line', 'Id2': 'protein', '4/5 T-cell lines': 'cell_line', 'S-LB1': 'cell_line', 'MT-2': 'cell_line', 'ATL-1k': 'cell_line'}, 'response1': "['RNA', 'cell_line']", 'response2': '[\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"Id2": "RNA"}, {"Id3": "RNA"}, {"T-cell lines": "cell_line"}, {"human T-cell leukemia virus type I (HTLV-I)": "cell_type"}, {"ATL-1k": "cell_line"}, {"MT-2": "cell_line"}, {"S-LB1": "cell_line"}, {"type II (Mo)": "cell_type"}]', 'prediction': {'Id2': 'RNA', 'Id3': 'RNA', 'T-cell lines': 'cell_line', 'human T-cell leukemia virus type I (HTLV-I)': 'cell_type', 'ATL-1k': 'cell_line', 'MT-2': 'cell_line', 'S-LB1': 'cell_line', 'type II (Mo)': 'cell_type'}}
{'idx': 13, 'sentence': 'We further demonstrate the impact of platelet-activating factor binding to B cells by measuring platelet-activating factor induced arachidonic acid release and 5-hydroxyeicosatetraenoic acid production.', 'label': {'platelet-activating factor': 'protein', 'B cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n{"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n{"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 4},\n{"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 4},\n{"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 3},\n{"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n{"We have examined the effect of alpha-tocopherol ( alpha-tcp ) on one cellular event in atherosclerotic plaque development , monocyte adhesion to stimulated endothelial cells ( ECs ).": 4},\n{"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 4},\n{"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects.": 5},\n{"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.": 4},\n{"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation.": 5},\n{"PMA induced the expression of both CD14 and CD23 mRNA and protein.": 5},\n{"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF.": 5},\n{"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation.": 4},\n{"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 4},\n{"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations.": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1554, 'sentence': 'The results define essential cis-acting elements responsible for the expression of GP Ib alpha and provide insights into molecular events coinciding with the release of normal platelets into the bloodstream .', 'label': {'GP': 'protein', 'normal platelets': 'cell_type', 'cis-acting elements': 'DNA', 'GP Ib alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.": 4},\n    {"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 3},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .": 4},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements .": 4},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .": 4},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .": 4},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .": 5},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .": 4},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .": 5},\n    {"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts .": 4},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 4}\n]', 'response3': '[{"GP Ib alpha": "protein"}]', 'prediction': {'GP Ib alpha': 'protein'}}
{'idx': 1650, 'sentence': 'This is the first demonstration of a specific interaction with PU.1 on a myeloid PU.1 binding site .', 'label': {'PU.1': 'protein', 'myeloid PU.1 binding site': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1},\n    {"Example 26": 1},\n    {"Example 27": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 326, 'sentence': 'We show here that domain B is an R-responsive element in HeLa cells and is therefore not an EB1 -responsive B-cell-specific element .', 'label': {'EB1': 'protein', 'R-responsive element': 'DNA', 'HeLa cells': 'cell_line', 'domain B': 'DNA', 'EB1 -responsive B-cell-specific element': 'DNA'}, 'response1': "['cell_line', 'cell_type']", 'response2': '[\n{"IL-2": 4},\n{"Reason": "The sentence explicitly mentions IL-2, indicating it is a protein entity."},\n{"RelA": 4},\n{"NF-kappa B": 4},\n{"Reason": "Both RelA and NF-kappa B are proteins mentioned in the sentence."},\n{"E2A": 4},\n{"Reason": "E2A is mentioned in the sentence as a protein entity."},\n{"IL-2": 4},\n{"c-Jun": 4},\n{"c-Fos": 4},\n{"Reason": "IL-2, c-Jun, and c-Fos are all proteins mentioned in the sentence."},\n{"EBV": 3},\n{"B-cell": 3},\n{"Reason": "EBV and B-cell are mentioned in the sentence, but the context is not as clear as other examples."},\n{"UAS1": 3},\n{"B cell": 3},\n{"Reason": "UAS1 and B cell are mentioned, but the context is not as clear as other examples."},\n{"IL-2": 4},\n{"IFN-gamma": 4},\n{"jak kinases": 4},\n{"STAT1(alpha)": 4},\n{"Reason": "IL-2, IFN-gamma, jak kinases, and STAT1(alpha) are all proteins mentioned in the sentence."},\n{"CCAAT box": 4},\n{"EKLF binding site": 4},\n{"Reason": "Both CCAAT box and EKLF binding site are mentioned in the sentence as DNA and protein entities, respectively."},\n{"T cell": 4},\n{"interleukin 2": 4},\n{"Reason": "T cell and interleukin 2 are mentioned in the sentence as cell_type and protein entities, respectively."},\n{"p50p50": 4},\n{"Reason": "p50p50 is mentioned in the sentence as a protein entity."},\n{"CD4+": 3},\n{"EBV": 3},\n{"Reason": "CD4+ and EBV are mentioned in the sentence, but the context is not as clear as other examples."},\n{"EKLF": 4},\n{"Reason": "EKLF is mentioned in the sentence as a protein entity."},\n{"EBV": 3},\n{"CD2": 4},\n{"Reason": "EBV and CD2 are mentioned in the sentence, but the context is not as clear as other examples."},\n{"EBNA2": 4},\n{"TP1": 3},\n{"Reason": "EBNA2 is mentioned as a protein entity, and TP1 is mentioned as a cell_line, but the context is not as clear as other examples."},\n{"RXR": 4},\n{"Reason": "RXR is mentioned in the sentence as a protein entity."},\n{"B and T cell activation": 4},\n{"Ramos": 4},\n{"Jurkat": 4},\n{"cDNA microarray technology": 4},\n{"Reason": "B and T cell activation, Ramos, Jurkat, and cDNA microarray technology are all mentioned in the sentence as cell_type, cell_line, and DNA entities, respectively."}\n]', 'response3': "[{'HeLa cells': 'cell_line'}, {'EB1': 'protein'}, {'B-cell': 'cell_type'}]", 'prediction': {'HeLa cells': 'cell_line', 'EB1': 'protein', 'B-cell': 'cell_type'}}
{'idx': 1429, 'sentence': 'Data from cell culture and animal studies indicate that TR expression may be regulated to modulate target organ responsiveness to thyroid hormone .', 'label': {'TR': 'protein'}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific entities that match the entity labels in the target sentence, providing direct examples for extraction."}\n]', 'response3': '[{"TR": "protein"}]', 'prediction': {'TR': 'protein'}}
{'idx': 865, 'sentence': 'Response to T cell activation signals .', 'label': {'T cell': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n{"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n{"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n{"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.": 5},\n{"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n{"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n{"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n{"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.": 5},\n{"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.": 5},\n{"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n{"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n{"Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency.": 5},\n{"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n{"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 5},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n{"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 696, 'sentence': 'First, from different cell lines three or all four of the nuclear proteins were specifically cross-linked by UV irradiation to the radioactively labeled TRE -DNA fragment .', 'label': {'TRE -DNA fragment': 'DNA', 'nuclear proteins': 'protein', 'TRE': 'DNA'}, 'response1': "['protein', 'cell_line', 'DNA']", 'response2': '[\n{"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n{"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .": 5},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n{"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n{"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50 .": 5},\n{"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n{"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .": 5},\n{"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n{"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .": 5},\n{"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .": 5},\n{"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .": 5},\n{"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .": 5},\n{"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .": 5},\n{"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[{"UV irradiation": "None"}, {"radioactively labeled TRE -DNA fragment": "DNA"}]', 'prediction': {'UV irradiation': 'None', 'radioactively labeled TRE -DNA fragment': 'DNA'}}
{'idx': 318, 'sentence': 'Furthermore, the existence of estrogen receptor (estrogen binding activity) was examined histochemically in 39 cases and it was detected in 8.', 'label': {'estrogen receptor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 440, 'sentence': 'All three proteins show the same sequence specificity and binding affinity .', 'label': {}, 'response1': "['protein']", 'response2': '[\n{"These two related genes share the evolutionarily conserved region encoding the Runt domain.": 5},\n{"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.": 4},\n{"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 5},\n{"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 5},\n{"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n{"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.": 5},\n{"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.": 5},\n{"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 5},\n{"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 5},\n{"Tat-binding protein 7 is a subunit of the 26S protease.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n{"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n{"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n{"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n{"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 5},\n{"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1563, 'sentence': 'Pathogenesis of atherosclerosis .', 'label': {}, 'response1': 'None.', 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names and their corresponding entity labels, which directly match the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides specific protein names and cell types relevant to the pathogenesis context, aligning with the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence mentions a specific DNA-binding activity related to lymphocytes, which is relevant to the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence talks about the effect of anti-P selectin antibodies on cytokine production, indicating a protein entity and its impact."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence discusses the role of NF-kappaB in rheumatoid arthritis, providing protein and cell type entities that match the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence compares PKC isoforms in different cell types, providing protein and cell type entities relevant to the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence links NF-kappaB activation to xenogeneic serum effects, offering a protein entity in a pathogenesis context."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions cell adhesion molecules and their inhibition mechanism, providing a cell type entity relevant to the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence discusses NF-kappaB activation in ARDS, aligning with the target sentence\'s pathogenesis context."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence talks about the inactivation of IkappaBbeta and its relation to NF-kappaB, providing protein entities matching the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions IL-12 production by macrophages, offering protein and cell type entities relevant to the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides specific protein names related to signal transduction and platelet function, aligning with the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence highlights the role of Eosinophils in allergic inflammation, providing a cell type entity matching the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence discusses the effect of alpha-tocopherol on cellular events, offering protein and cell type entities relevant to the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions the cleavage of SP1 by caspases during B-cell apoptosis, providing protein and cell type entities matching the target sentence."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence talks about the activation of monocytic cells by lipoproteins, providing protein entities relevant to the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entity names matching the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not provide any entity names relevant to the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entity names matching the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not provide any entity names relevant to the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entity names matching the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not provide any entity names relevant to the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entity names matching the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not provide any entity names relevant to the target sentence."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entity names matching the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 689, 'sentence': 'High-risk patients can be recognized morphologically.', 'label': {}, 'response1': 'None.', 'response2': '[\n    {"PBMC": 5},\n    {"adenovirus": 5},\n    {"WT1": 5},\n    {"CD70": 5},\n    {"B cell": 5},\n    {"plasma cells": 5},\n    {"IL-4": 5},\n    {"CD40": 5},\n    {"TCL1": 5},\n    {"myeloperoxidase": 5},\n    {"lysozyme": 5},\n    {"PU.1": 5},\n    {"Ras": 5},\n    {"T-PLL": 5},\n    {"T lymphocytes": 5},\n    {"HLA-molecules": 5},\n    {"MNDA": 5},\n    {"Philadelphia chromosome-positive chronic myeloid leukemia": 5},\n    {"granulocytes": 5},\n    {"T cells": 5},\n    {"TCRzeta": 5},\n    {"p56(lck)": 5},\n    {"PML/RARalpha": 5},\n    {"SIVmacMER": 5},\n    {"SIVmac239": 5},\n    {"CEMx174": 5},\n    {"lymphoid neoplasms": 5},\n    {"SIVsmmPBj14": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 189, 'sentence': 'Transcriptional down-regulation of c-myc expression by protein synthesis -dependent and -independent pathways in a human T lymphoblastic tumor cell line .', 'label': {'human T lymphoblastic tumor cell line': 'cell_line', 'c-myc': 'DNA'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"2": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"3": "The sentence contains relevant entities (Sp1 and CD14) that match the \'protein\' entity type in the target sentence."},\n    {"4": "The sentence contains relevant entities (IkappaBbeta and NF-kappaB) that match the \'protein\' entity type in the target sentence."},\n    {"5": "The sentence contains relevant entities (Sp1 and Ets) that match the \'protein\' entity type in the target sentence."},\n    {"6": "The sentence contains relevant entity (Th2-type lymphocytes) that matches the \'cell_type\' entity type in the target sentence."},\n    {"7": "The sentence contains relevant entities (WT1 and myeloid cell lines) that match the \'protein\' and \'cell_line\' entity types in the target sentence."},\n    {"8": "The sentence contains relevant entities (NF-ATc, T lymphocytes, and embryonic cardiac cells) that match the \'protein\' and \'cell_type\' entity types in the target sentence."},\n    {"9": "The sentence contains relevant entities (SP1, caspases, and B-cell) that match the \'protein\' and \'cell_type\' entity types in the target sentence."},\n    {"10": "The sentence contains a relevant entity (GATA-1) that matches the \'protein\' entity type in the target sentence."},\n    {"11": "The sentence contains relevant entities (ZEB, c-Myb, Ets, and hematopoietic cells) that match the \'protein\' and \'cell_type\' entity types in the target sentence."},\n    {"12": "The sentence contains relevant entities (YY1, Oct1, IL-5, and T cells) that match the \'protein\' and \'cell_type\' entity types in the target sentence."},\n    {"13": "The sentence contains relevant entities (B and T cell activation, Ramos, Jurkat, and cDNA microarray technology) that match the \'cell_type\', \'cell_line\', and \'DNA\' entity types in the target sentence."},\n    {"14": "The sentence contains relevant entities (tal-1, GATA-binding proteins, and hematopoiesis) that match the \'protein\' and \'cell_type\' entity types in the target sentence."},\n    {"15": "The sentence contains relevant entities (cDNA, Jurkat, and DRE 1) that match the \'DNA\' and \'cell_line\' entity types in the target sentence."},\n    {"16": "The sentence contains relevant entities (AP-1, c-jun, IL-2, and NF-AT) that match the \'protein\' entity type in the target sentence."},\n    {"17": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"18": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"19": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"20": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"21": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"22": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"23": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"24": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"25": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"26": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"27": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"28": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"29": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"30": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"c-myc": "protein"}, {"T lymphoblastic tumor cell line": "cell_line"}]', 'prediction': {'c-myc': 'protein', 'T lymphoblastic tumor cell line': 'cell_line'}}
{'idx': 778, 'sentence': 'Addition of a highly enriched preparation of OTF-1 made from one of these pre-B cells or from HeLa cells specifically stimulated in vitro transcription of an immunoglobulin gene .', 'label': {'OTF-1': 'protein', 'pre-B cells': 'cell_line', 'immunoglobulin gene': 'DNA', 'HeLa cells': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 4},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 5},\n    {"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 4},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 4},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .": 4},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"T cell blasts treated with PMA are now responsive to IFN-gamma .": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .": 5},\n    {"Fibroblast growth factor-1 ( FGF-1 ) enhances IL-2 production and nuclear translocation of NF-kappaB in FGF receptor -bearing Jurkat T cells .": 5}\n]', 'response3': '[{"OTF-1": "protein"}, {"pre-B cells": "cell_type"}, {"HeLa cells": "cell_line"}, {"immunoglobulin gene": "protein"}]', 'prediction': {'OTF-1': 'protein', 'pre-B cells': 'cell_type', 'HeLa cells': 'cell_line', 'immunoglobulin gene': 'protein'}}
{'idx': 198, 'sentence': "Tamoxifen , an oestrogen antagonist , has been given in some patients with CLL and Hodgkin's disease , with dramatic response in single cases.", 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"1": "The sentence mentions lymphoid neoplasms, which falls under the \'cell_type\' entity label."},\n    {"2": "The sentence contains several protein entities such as IL-2, NF-kappa B, and AP-1, which are relevant for the \'protein\' entity label."},\n    {"3": "The sentence refers to TCRzeta and p56(lck) as protein entities, which are relevant for the \'protein\' entity label."},\n    {"4": "The sentence mentions TAL1 and T-ALL, which correspond to the \'protein\' and \'cell_type\' entity labels, respectively."},\n    {"5": "The sentence mentions STAT1, which is relevant for the \'protein\' entity label."},\n    {"6": "The sentence contains MNDA as a protein entity and Philadelphia chromosome-positive chronic myeloid leukemia as a cell line entity, which are relevant for the \'protein\' and \'cell_line\' entity labels, respectively."},\n    {"7": "The sentence mentions NF-E2 as a protein entity, which is relevant for the \'protein\' entity label."},\n    {"8": "The sentence contains Oct-2A and HMG I/Y as protein entities, HLA-DRA as a protein entity, and B cells as a cell type entity, which are relevant for the \'protein\' and \'cell_type\' entity labels."},\n    {"9": "The sentence mentions T lymphocytes as a cell type entity, which is relevant for the \'cell_type\' entity label."},\n    {"10": "The sentence refers to IL-13, IL-4R, JAK2, and IL-13R as protein entities, which are relevant for the \'protein\' entity label."},\n    {"11": "The sentence mentions WT1 as a protein entity and myeloid cell lines as a cell line entity, which are relevant for the \'protein\' and \'cell_line\' entity labels, respectively."},\n    {"12": "The sentence contains Erbstatin and genistein as protein entities and Egr-1 as an RNA entity, which are relevant for the \'protein\' and \'RNA\' entity labels."},\n    {"13": "The sentence mentions PMA as a protein entity, IFN-gamma as a protein entity, and T cell blasts as a cell type entity, which are relevant for the \'protein\' and \'cell_type\' entity labels."},\n    {"14": "The sentence refers to EBV as a DNA entity, EBNA2 as a protein entity, and estrogen receptor as a protein entity, which are relevant for the \'DNA\' and \'protein\' entity labels."},\n    {"15": "The sentence mentions TCL1 and MTCP1/c6.1B as protein entities, which are relevant for the \'protein\' entity label."},\n    {"16": "The sentence contains CD4+ and CD8+ as cell type entities, TPCK and anti-CD28 as protein entities, and PMA as a protein entity, which are relevant for the \'cell_type\' and \'protein\' entity labels."},\n    {"17": "The sentence does not contain any relevant entities for the given entity labels."},\n    {"18": "The sentence does not contain any relevant entities for the given entity labels."},\n    {"19": "The sentence does not contain any relevant entities for the given entity labels."},\n    {"20": "The sentence does not contain any relevant entities for the given entity labels."},\n    {"21": "The sentence does not contain any relevant entities for the given entity labels."},\n    {"22": "The sentence does not contain any relevant entities for the given entity labels."},\n    {"23": "The sentence does not contain any relevant entities for the given entity labels."},\n    {"24": "The sentence does not contain any relevant entities for the given entity labels."},\n    {"25": "The sentence does not contain any relevant entities for the given entity labels."},\n    {"26": "The sentence does not contain any relevant entities for the given entity labels."},\n    {"27": "The sentence does not contain any relevant entities for the given entity labels."},\n    {"28": "The sentence does not contain any relevant entities for the given entity labels."},\n    {"29": "The sentence does not contain any relevant entities for the given entity labels."},\n    {"30": "The sentence does not contain any relevant entities for the given entity labels."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 735, 'sentence': 'This prompted us to analyze the octamer-binding proteins in the latter cells.', 'label': {'octamer-binding proteins': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example directly mentions the entity type \'DNA\' which is present in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The example provides a relevant entity label \'protein\' which is present in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The example mentions the entity labels \'protein\' which are present in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The example directly mentions the entity type \'DNA\' which is present in the target sentence."},\n    {"Example 5": 4},\n    {"Reason 5": "The example provides relevant entity labels \'protein\' which are present in the target sentence."},\n    {"Example 6": 4},\n    {"Reason 6": "The example provides a relevant entity label \'protein\' which is present in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The example mentions the entity labels \'protein\' and \'cell_type\' which are present in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example mentions the entity labels \'protein\' and \'cell_type\' which are present in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example mentions the entity labels \'protein\' which are present in the target sentence."},\n    {"Example 10": 4},\n    {"Reason 10": "The example provides a relevant entity label \'cell_type\' which is present in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides a relevant entity label \'cell_line\' which is present in the target sentence."},\n    {"Example 12": 4},\n    {"Reason 12": "The example provides relevant entity labels \'protein\' which are present in the target sentence."},\n    {"Example 13": 4},\n    {"Reason 13": "The example provides relevant entity labels \'protein\' which are present in the target sentence."},\n    {"Example 14": 4},\n    {"Reason 14": "The example provides a relevant entity label \'protein\' which is present in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The example does not contain any entity labels present in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any entity labels present in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any entity labels present in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any entity labels present in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain any entity labels present in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The example does not contain any entity labels present in the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The example does not contain any entity labels present in the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The example does not contain any entity labels present in the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The example does not contain any entity labels present in the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The example does not contain any entity labels present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1735, 'sentence': 'We therefore examined vitamin D3 -mediated repression of activated IL-2 expression by cotransfecting Jurkat cells with IL-2 promoter/reporter constructs and a VDR overexpression vector and by DNA binding .', 'label': {'VDR': 'protein', 'IL-2 promoter/reporter constructs': 'DNA', 'Jurkat cells': 'cell_line', 'VDR overexpression vector': 'DNA', 'IL-2': 'protein'}, 'response1': "['DNA', 'protein', 'cell_line']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 4},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .": 4},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex .": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .": 5},\n    {"While the activation of the IL-2 promoter and an NFAT -driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418 , it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2 -mediated NFAT activation is under the control of a combination of calcineurin- dependent and independent pathways .": 5},\n    {"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .": 5}\n]', 'response3': '[{"IL-2": "protein"}, {"Jurkat": "cell_line"}, {"IL-2": "DNA"}, {"VDR": "protein"}, {"DNA": "DNA"}]', 'prediction': {'IL-2': 'DNA', 'Jurkat': 'cell_line', 'VDR': 'protein', 'DNA': 'DNA'}}
{'idx': 704, 'sentence': 'Activity of the immunoglobulin heavy and kappa light chain gene enhancers depends on a complex interplay of ubiquitous and developmentally regulated proteins .', 'label': {'ubiquitous and developmentally regulated proteins': 'protein', 'ubiquitous': 'protein', 'developmentally regulated proteins': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"immunoglobulin heavy and kappa light chain gene enhancers": "DNA"}]', 'prediction': {'immunoglobulin heavy and kappa light chain gene enhancers': 'DNA'}}
{'idx': 1236, 'sentence': 'Binding site selection revealed that the alternating RCGCRYGCGY consensus constitutes high-affinity IBR/F binding sites and that the direct-repeat palindrome TGCGCATGCGCA is the optimal site .', 'label': {'direct-repeat palindrome': 'DNA', 'IBR/F': 'protein', 'IBR/F binding sites': 'DNA', 'optimal site': 'DNA', 'alternating RCGCRYGCGY consensus': 'protein'}, 'response1': "['DNA']", 'response2': '[\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n    {"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 4},\n    {"Therefore, we investigated whether IVS1-10T-->C deleteriously affected BRCA1 splicing or expression, and thereby inactivated the other BRCA1 allele.": 4},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 4},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 4},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex.": 5},\n    {"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif.": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 541, 'sentence': 'To be or not to be a responder in T-cell responses : ubiquitous oligopeptides in all proteins.', 'label': {}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n    {"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.": 4},\n    {"Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n    {"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"Yet, for many pathogens, the molecules that induce IL-12 production by macrophages and the mechanisms by which they do so remain undefined.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1652, 'sentence': 'Furthermore, we demonstrate that the PU-SF complex binds to PU.1 sites found on a number of myeloid promoters , and its formation requires an intact PU.1 site adjacent to a single-stranded region.', 'label': {'PU.1': 'protein', 'PU-SF complex': 'protein', 'myeloid promoters': 'DNA', 'PU.1 site': 'DNA', 'PU-SF': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 3},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 4},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 4},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 3},\n    {"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.": 4},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 4},\n    {"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 3},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 4},\n    {"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 4},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 4},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes.": 3},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 4},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 4},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex, cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 3},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 3},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[{"PU-SF complex": "protein"}, {"PU.1": "protein"}, {"myeloid": "cell_type"}]', 'prediction': {'PU-SF complex': 'protein', 'PU.1': 'protein', 'myeloid': 'cell_type'}}
{'idx': 88, 'sentence': 'TNF alpha did not activate cAMP production and its signal was not modulated by cAMP activators .', 'label': {'TNF alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1494, 'sentence': 'Increased intracellular stores of latent NF-kappa B may also result in rapid inducibility of NF-kappa B -dependent cytokine gene expression .', 'label': {'latent NF-kappa B': 'protein', 'cytokine': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 5},\n{"Example 2": 5},\n{"Example 3": 5},\n{"Example 4": 5},\n{"Example 5": 5},\n{"Example 6": 5},\n{"Example 7": 5},\n{"Example 8": 5},\n{"Example 9": 5},\n{"Example 10": 5},\n{"Example 11": 5},\n{"Example 12": 5},\n{"Example 13": 5},\n{"Example 14": 5},\n{"Example 15": 5},\n{"Example 16": 1},\n{"Example 17": 1},\n{"Example 18": 1},\n{"Example 19": 1},\n{"Example 20": 1},\n{"Example 21": 1},\n{"Example 22": 1},\n{"Example 23": 1},\n{"Example 24": 1},\n{"Example 25": 1}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"NF-kappa B": "protein"}]', 'prediction': {'NF-kappa B': 'protein'}}
{'idx': 940, 'sentence': 'Tamoxifen was also found to compete with 17 beta-estradiol for type II EBS in PBMC , although to a lesser extent than diethylstilbestrol .', 'label': {'PBMC': 'cell_type', 'type II EBS': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a clear mapping between the entity \'NF-E2\' and its corresponding label \'protein\', aiding in the extraction of named entities from the target sentence."},\n\n    {"Example 2": 4},\n    {"Reason 2": "The example includes multiple entities such as \'alpha-tocopherol\', \'monocyte\', and \'endothelial cells\' with their corresponding labels, which can help in identifying named entities related to proteins and cell types in the target sentence."},\n\n    {"Example 3": 3},\n    {"Reason 3": "The example mentions \'NF-kappa B\' and \'AP-1\' as entities with their corresponding labels, providing some assistance in recognizing protein entities in the target sentence."},\n\n    {"Example 4": 3},\n    {"Reason 4": "The example includes entities like \'IL-2\', \'NF-kappa B\', and \'AP-1\' with their labels, offering some guidance in identifying protein entities in the target sentence."},\n\n    {"Example 5": 4},\n    {"Reason 5": "The example contains entities such as \'IL-5 mRNA\', \'TCR\', \'IL-2R\', and \'dexamethasone\' with their labels, aiding in recognizing RNA, cell type, and protein entities in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1098, 'sentence': 'Thus, intact microtubules are essential for 1,25(OH)2D3 -dependent modulation of gene transcription .', 'label': {'microtubules': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.": 5},\n{"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.": 5},\n{"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 5},\n{"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis.": 5},\n{"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n{"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras.": 5},\n{"Here we examined the regulatory mechanism of the SCM-1 genes.": 1},\n{"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n{"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription.": 5},\n{"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation.": 5},\n{"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n{"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.": 5},\n{"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 5},\n{"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n{"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 5},\n{"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5}\n]', 'response3': '[{"microtubules": "protein"}]', 'prediction': {'microtubules': 'protein'}}
{'idx': 255, 'sentence': 'c-myc RNA , which is constitutively expressed in RWLeu-4 cells , increased after 0.5 h of treatment with 50 nM VD3 and then rapidly decreased to barely detectable levels after 4 h of treatment.', 'label': {'c-myc RNA': 'RNA', 'RWLeu-4 cells': 'cell_line'}, 'response1': "['RNA', 'cell_line']", 'response2': '[\n    {"CD40 expression could be enhanced in CD40-positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n    {"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 4},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 4},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 4},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 3},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 5},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]": 4},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 4},\n    {"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.": 5},\n    {"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 5},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"c-myc RNA": "RNA"}, {"RWLeu-4 cells": "cell_line"}, {"VD3": "protein"}]', 'prediction': {'c-myc RNA': 'RNA', 'RWLeu-4 cells': 'cell_line', 'VD3': 'protein'}}
{'idx': 775, 'sentence': 'Some of these proteins (referred to as OTF-2 ) are lymphoid specific, whereas at least one other, and possibly more (referred to as OTF-1 ), is found ubiquitously in all cell types.', 'label': {'OTF-1': 'protein', 'OTF-2': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes": 5},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined": 4},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role": 4},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals": 4},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells": 4},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes": 4},\n    {"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein": 5},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset": 5},\n    {"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor": 4},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats)": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729": 1}\n]', 'response3': '[{"OTF-2": "protein"}, {"OTF-1": "protein"}]', 'prediction': {'OTF-2': 'protein', 'OTF-1': 'protein'}}
{'idx': 161, 'sentence': 'Steroid dose sparing : pharmacodynamic responses to single versus divided doses of methylprednisolone in man.', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"1": "The sentence does not contain any named entities."},\n    {"2": "The sentence does not contain any named entities."},\n    {"3": "The sentence does not contain any named entities."},\n    {"4": "The sentence contains multiple named entities of different types, making it highly helpful in entity extraction."},\n    {"5": "The sentence contains a named entity of type \'cell_type\', which is helpful in entity extraction."},\n    {"6": "The sentence contains named entities of multiple types, aiding in entity extraction."},\n    {"7": "The sentence contains named entities of multiple types, aiding in entity extraction."},\n    {"8": "The sentence contains named entities of multiple types, aiding in entity extraction."},\n    {"9": "The sentence contains a named entity of type \'protein\', which is helpful in entity extraction."},\n    {"10": "The sentence contains a named entity of type \'protein\', which is helpful in entity extraction."},\n    {"11": "The sentence contains named entities of multiple types, aiding in entity extraction."},\n    {"12": "The sentence contains named entities of multiple types, aiding in entity extraction."},\n    {"13": "The sentence contains named entities of multiple types, aiding in entity extraction."},\n    {"14": "The sentence contains named entities of multiple types, aiding in entity extraction."},\n    {"15": "The sentence does not contain any named entities."},\n    {"16": "The sentence does not contain any named entities."},\n    {"17": "The sentence does not contain any named entities."},\n    {"18": "The sentence does not contain any named entities."},\n    {"19": "The sentence does not contain any named entities."},\n    {"20": "The sentence does not contain any named entities."},\n    {"21": "The sentence does not contain any named entities."},\n    {"22": "The sentence does not contain any named entities."},\n    {"23": "The sentence does not contain any named entities."},\n    {"24": "The sentence does not contain any named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1130, 'sentence': 'B-lymphoblastoid cell lines from multiple sclerosis patients and a healthy control producing a putative new human retrovirus and Epstein-Barr virus .', 'label': {'B-lymphoblastoid cell lines': 'cell_line'}, 'response1': "['cell_line', 'virus']", 'response2': '[\n{"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 1},\n{"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .": 4},\n{"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n{"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.": 3},\n{"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 3},\n{"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .": 5},\n{"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 4},\n{"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .": 5},\n{"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n{"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .": 5},\n{"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice .": 5},\n{"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .": 5},\n{"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n{"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5}\n]', 'response3': '[{"B-lymphoblastoid cell lines": "cell_line"}, {"human retrovirus": "protein"}, {"Epstein-Barr virus": "protein"}]', 'prediction': {'B-lymphoblastoid cell lines': 'cell_line', 'human retrovirus': 'protein', 'Epstein-Barr virus': 'protein'}}
{'idx': 600, 'sentence': 'Involvement of a second lymphoid-specific enhancer element in the regulation of immunoglobulin heavy-chain gene expression .', 'label': {'immunoglobulin heavy-chain gene': 'DNA', 'lymphoid-specific enhancer element': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .": 4},\n{"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 4},\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 4},\n{"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n{"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 4},\n{"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n{"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n{"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements .": 4},\n{"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 4},\n{"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 4},\n{"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .": 5},\n{"Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells .": 5},\n{"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .": 5}\n]', 'response3': '[{"lymphoid-specific enhancer element": "DNA"}, {"immunoglobulin heavy-chain gene": "DNA"}]', 'prediction': {'lymphoid-specific enhancer element': 'DNA', 'immunoglobulin heavy-chain gene': 'DNA'}}
{'idx': 1698, 'sentence': 'Oncogenicity of human papillomavirus- or adenovirus- transformed cells correlates with resistance to lysis by natural killer cells .', 'label': {'natural killer cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 1},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"human papillomavirus-": "DNA"}, {"adenovirus-": "DNA"}, {"natural killer cells": "cell_type"}]', 'prediction': {'human papillomavirus-': 'DNA', 'adenovirus-': 'DNA', 'natural killer cells': 'cell_type'}}
{'idx': 1287, 'sentence': 'Platelet thromboxane receptors are acutely and reversibly upregulated after acute myocardial infarction .', 'label': {'Platelet thromboxane receptors': 'protein', 'Platelet': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n{"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.": 3},\n{"An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage.": 4},\n{"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/thrombopoiesis or possibly a mature platelet function such as aggregation.": 5},\n{"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.": 4},\n{"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 4},\n{"PMA induced the expression of both CD14 and CD23 mRNA and protein.": 5},\n{"We have examined the effect of alpha-tocopherol (alpha-tcp) on one cellular event in atherosclerotic plaque development, monocyte adhesion to stimulated endothelial cells (ECs).": 4},\n{"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.": 5},\n{"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n{"Changes in PKC isoforms in human alveolar macrophages compared with blood monocytes.": 4},\n{"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 4},\n{"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n{"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 3},\n{"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.": 5},\n{"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.": 5},\n{"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1266, 'sentence': 'Human herpesvirus 6 , a predominantly T lymphotropic virus , has been recently shown to infect some EBV -positive B cell lines , and to induce in them the activation of the EBV lytic cycle .', 'label': {'EBV -positive B cell lines': 'cell_line'}, 'response1': "['cell_line', 'cell_line', 'cell_line', 'cell_line', 'cell_line', 'cell_line']", 'response2': '[\n{"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n{"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 5},\n{"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 4},\n{"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 4},\n{"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .": 4},\n{"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .": 4},\n{"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 4},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 3},\n{"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n{"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n{"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 4},\n{"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development .": 5},\n{"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .": 4},\n{"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 4},\n{"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .": 5},\n{"Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype .": 4}\n]', 'response3': '[{"EBV": "cell_type"}, {"B cell lines": "cell_line"}, {"EBV": "cell_type"}]', 'prediction': {'EBV': 'cell_type', 'B cell lines': 'cell_line'}}
{'idx': 1813, 'sentence': 'Northern blot analysis revealed that BLR2 mRNA could be highly stimulated in mitogen- and anti-CD3- treated peripheral blood lymphocytes .', 'label': {'BLR2 mRNA': 'RNA', 'BLR2': 'protein'}, 'response1': "['RNA', 'cell_type']", 'response2': '[\n    {"Example 1": 1},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 1},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"BLR2 mRNA": "RNA"}, {"mitogen": "protein"}, {"anti-CD3": "protein"}, {"peripheral blood lymphocytes": "cell_type"}]', 'prediction': {'BLR2 mRNA': 'RNA', 'mitogen': 'protein', 'anti-CD3': 'protein', 'peripheral blood lymphocytes': 'cell_type'}}
{'idx': 1764, 'sentence': 'The inhibitory effect of cysteamine may be mediated at least in part by an effect on transcription factor function , as the DNA binding activities of AP-1 and NF-kappa B extracted from mitogen-stimulated cells were significantly inhibited by cysteamine treatment .', 'label': {'AP-1': 'protein', 'NF-kappa B': 'protein', 'transcription factor': 'protein', 'mitogen-stimulated cells': 'cell_type'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[{"AP-1": "DNA"}, {"NF-kappa B": "protein"}]', 'prediction': {'AP-1': 'DNA', 'NF-kappa B': 'protein'}}
{'idx': 740, 'sentence': 'On the basis of these assays, all N-Oct-factors were found to be distinct from the ubiquitous Oct-1 and the lymphoid-specific Oct-2A proteins.', 'label': {'ubiquitous Oct-1': 'protein', 'Oct-1': 'protein', 'Oct-2A': 'protein', 'lymphoid-specific Oct-2A': 'protein', 'N-Oct-factors': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example directly mentions the entity \'protein\' and provides a specific protein name, which is helpful for identifying protein entities in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The example directly mentions the entity \'DNA\' and provides a specific term related to DNA, which is helpful for identifying DNA entities in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The example directly mentions the entity \'protein\' and provides a specific protein name, which is helpful for identifying protein entities in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The example provides multiple protein names and terms related to proteins, which are crucial for identifying protein entities in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides multiple protein names, which are essential for identifying protein entities in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The example provides multiple protein names, which are essential for identifying protein entities in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The example directly mentions the entity \'protein\' and provides a specific protein name, which is helpful for identifying protein entities in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example directly mentions the entity \'protein\' and provides a specific protein name, which is helpful for identifying protein entities in the target sentence."},\n    {"Example 9": 1},\n    {"Reason 9": "The example does not contain any entity related to the entity types in the target sentence, hence not helpful for identifying named entities."},\n    {"Example 10": 1},\n    {"Reason 10": "The example does not contain any entity related to the entity types in the target sentence, hence not helpful for identifying named entities."},\n    {"Example 11": 1},\n    {"Reason 11": "The example does not contain any entity related to the entity types in the target sentence, hence not helpful for identifying named entities."},\n    {"Example 12": 1},\n    {"Reason 12": "The example does not contain any entity related to the entity types in the target sentence, hence not helpful for identifying named entities."},\n    {"Example 13": 1},\n    {"Reason 13": "The example does not contain any entity related to the entity types in the target sentence, hence not helpful for identifying named entities."},\n    {"Example 14": 1},\n    {"Reason 14": "The example does not contain any entity related to the entity types in the target sentence, hence not helpful for identifying named entities."},\n    {"Example 15": 1},\n    {"Reason 15": "The example does not contain any entity related to the entity types in the target sentence, hence not helpful for identifying named entities."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any entity related to the entity types in the target sentence, hence not helpful for identifying named entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any entity related to the entity types in the target sentence, hence not helpful for identifying named entities."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any entity related to the entity types in the target sentence, hence not helpful for identifying named entities."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain any entity related to the entity types in the target sentence, hence not helpful for identifying named entities."},\n    {"Example 20": 1},\n    {"Reason 20": "The example does not contain any entity related to the entity types in the target sentence, hence not helpful for identifying named entities."}\n]', 'response3': '[{"N-Oct-factors": "protein"}, {"Oct-1": "protein"}, {"Oct-2A": "protein"}]', 'prediction': {'N-Oct-factors': 'protein', 'Oct-1': 'protein', 'Oct-2A': 'protein'}}
{'idx': 1182, 'sentence': 'Moreover, STAT5 was found to be the predominant STAT transcription factor used by IL-2 in human T cells , and specifically required a COOH-terminal region of IL-2R beta ( Ser386-Val525 ), while STAT5 recruitment was not correlated to activation of IL-2R gamma or JAK3 .', 'label': {'IL-2': 'protein', 'T cells': 'cell_type', 'COOH-terminal region': 'protein', 'human T cells': 'cell_type', 'Ser386-Val525': 'protein', 'JAK3': 'protein', 'STAT transcription factor': 'protein', 'STAT5': 'protein', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .": 5},\n{"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 1},\n{"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n{"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 5},\n{"Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.": 5},\n{"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .": 5},\n{"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n{"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells .": 5},\n{"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function .": 5},\n{"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines .": 5},\n{"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .": 5},\n{"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n{"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[{"STAT5": "protein"}, {"IL-2": "protein"}, {"T cells": "cell_type"}, {"IL-2R beta": "protein"}, {"IL-2R gamma": "protein"}, {"JAK3": "protein"}]', 'prediction': {'STAT5': 'protein', 'IL-2': 'protein', 'T cells': 'cell_type', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein', 'JAK3': 'protein'}}
{'idx': 393, 'sentence': 'We also tested for the ability of defensins NP-1 , NP-5 , and HNP-1 to activate pag expression and found that these peptides have no effect.', 'label': {'HNP-1': 'protein', 'pag': 'DNA', 'NP-1': 'protein', 'defensins': 'protein', 'NP-5': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1442, 'sentence': 'T cell expression of interleukin 3 ( IL-3 ) is directed by positive and negative cis-acting DNA elements clustered within 300 base pairs of the transcriptional start site .', 'label': {'interleukin 3': 'protein', 'transcriptional start site': 'DNA', 'IL-3': 'protein'}, 'response1': "['DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 1},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"IL-3": "protein"}]', 'prediction': {'IL-3': 'protein'}}
{'idx': 142, 'sentence': 'This level of NF-kappa B -independent activity appears to be sufficient for virus multiplication , since TNF-alpha treatment had no effect on the kinetics of de novo HIV type 1 ( HIV-1 ) infection and viral RNA production in U937 cells .', 'label': {'U937 cells': 'cell_line', 'NF-kappa B': 'protein', 'viral RNA': 'RNA', 'TNF-alpha': 'protein'}, 'response1': "['RNA', 'protein', 'cell_line']", 'response2': '[\n{"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 4},\n{"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.": 4},\n{"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 4},\n{"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 4},\n{"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 4},\n{"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 4},\n{"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 4},\n{"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 4},\n{"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.": 4},\n{"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.": 4},\n{"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.": 4},\n{"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 4},\n{"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 4},\n{"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 4},\n{"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 4},\n{"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 4}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"TNF-alpha": "protein"}, {"HIV type 1": "cell_type"}, {"HIV-1": "cell_type"}, {"RNA": "RNA"}, {"U937 cells": "cell_line"}]', 'prediction': {'NF-kappa B': 'protein', 'TNF-alpha': 'protein', 'HIV type 1': 'cell_type', 'HIV-1': 'cell_type', 'RNA': 'RNA', 'U937 cells': 'cell_line'}}
{'idx': 93, 'sentence': 'The Thy-1 gene promoter resembles a "housekeeping" promoter in that it is located within a methylation-free island , lacks a canonical TATA box , and displays heterogeneity in the 5\'-end termini of the mRNA .', 'label': {'canonical TATA box': 'DNA', '"housekeeping" promoter': 'DNA', 'methylation-free island': 'DNA', "5'-end termini": 'RNA', 'Thy-1 gene promoter': 'DNA', 'mRNA': 'RNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 4},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 5},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"While the activation of the IL-2 promoter and an NFAT-driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418, it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2-mediated NFAT activation is under the control of a combination of calcineurin-dependent and independent pathways.": 5},\n    {"This sequence element was referred to as the BAT box and its deletion significantly reduced the activity of a CD20 promoter-CAT construct in B cells.": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5}\n]', 'response3': '[{"Thy-1 gene promoter": "DNA"}]', 'prediction': {'Thy-1 gene promoter': 'DNA'}}
{'idx': 1354, 'sentence': 'In addition, these results indicate that nuclear TCF-1 expression can serve as a pan-T-lineage marker in the diagnosis of lymphoid malignancies .', 'label': {'TCF-1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 3},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 4},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 3},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 3},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 4},\n    {"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.": 4},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 3},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 3},\n    {"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 4},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 4},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 3},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 3},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 4},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 3}\n]', 'response3': '[{"TCF-1": "protein"}, {"lymphoid malignancies": "cell_type"}]', 'prediction': {'TCF-1': 'protein', 'lymphoid malignancies': 'cell_type'}}
{'idx': 466, 'sentence': '(ABSTRACT TRUNCATED AT 250 WORDS)', 'label': {}, 'response1': 'None.', 'response2': '```json\n[\n    {\n        "Example 1": 5\n    },\n    {\n        "Reason 1": "The sentence provides a clear example of a protein entity (retinoic acid receptor alpha) and its corresponding label."\n    },\n    {\n        "Example 2": 5\n    },\n    {\n        "Reason 2": "The sentence contains multiple examples of cell_type entities (monocyte, endothelial cells) and a protein entity (alpha-tocopherol) with their corresponding labels."\n    },\n    {\n        "Example 3": 5\n    },\n    {\n        "Reason 3": "The sentence provides a clear example of a protein entity (GATA-1) and its corresponding label."\n    },\n    {\n        "Example 4": 5\n    },\n    {\n        "Reason 4": "The sentence provides a clear example of a protein entity (retinoic acid receptor alpha) and its corresponding label."\n    },\n    {\n        "Example 5": 5\n    },\n    {\n        "Reason 5": "The sentence provides a clear example of a cell_type entity (nonhuman primates) and its corresponding label."\n    },\n    {\n        "Example 6": 5\n    },\n    {\n        "Reason 6": "The sentence provides a clear example of a DNA entity (AP-1) and its corresponding label."\n    },\n    {\n        "Example 7": 5\n    },\n    {\n        "Reason 7": "The sentence contains multiple examples of protein entities (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) with their corresponding labels."\n    },\n    {\n        "Example 8": 5\n    },\n    {\n        "Reason 8": "The sentence provides a clear example of a protein entity (RXR) and its corresponding label."\n    },\n    {\n        "Example 9": 5\n    },\n    {\n        "Reason 9": "The sentence provides a clear example of a cell_line entity (SIVsmmPBj14) and its corresponding label."\n    },\n    {\n        "Example 10": 5\n    },\n    {\n        "Reason 10": "The sentence provides a clear example of a cell_line entity (SCM-1) and its corresponding label."\n    },\n    {\n        "Example 11": 5\n    },\n    {\n        "Reason 11": "The sentence contains multiple examples of protein entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) with their corresponding labels."\n    },\n    {\n        "Example 12": 5\n    },\n    {\n        "Reason 12": "The sentence provides a clear example of a protein entity (A-myb) and its corresponding label."\n    },\n    {\n        "Example 13": 5\n    },\n    {\n        "Reason 13": "The sentence contains multiple examples of protein entities (IL-2, c-Jun, c-Fos) with their corresponding labels."\n    },\n    {\n        "Example 14": 5\n    },\n    {\n        "Reason 14": "The sentence provides a clear example of a protein entity (WT1) and its corresponding label."\n    },\n    {\n        "Example 15": 5\n    },\n    {\n        "Reason 15": "The sentence provides a clear example of a protein entity (TCF-1) and its corresponding label."\n    },\n    {\n        "Example 16": 5\n    },\n    {\n        "Reason 16": "The sentence provides examples of cell_type entities (B and T cell activation) and cell_line entities (Ramos, Jurkat) with their corresponding labels."\n    }\n]\n```', 'response3': '```json\n[]\n```', 'prediction': {}}
{'idx': 1583, 'sentence': 'Associations between HLA class II antigens and autoantibodies to the ribonucleoproteins Ro(SSA) and La(SSB) have been reported in these patients.', 'label': {'ribonucleoproteins': 'protein', 'Ro(SSA)': 'protein', 'autoantibodies': 'protein', 'HLA class II antigens': 'protein', 'La(SSB)': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains a clear mention of the protein \'TCL1\', making it highly relevant for extracting named entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains a clear mention of the protein \'WT1\', making it highly relevant for extracting named entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains a clear mention of the protein \'RXR\', making it highly relevant for extracting named entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains a clear mention of the cell type \'lymphoid neoplasms\', making it highly relevant for extracting named entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains a clear mention of the protein \'NF-kappa B\', making it highly relevant for extracting named entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains clear mentions of the proteins \'TCRzeta\' and \'p56(lck)\', making it highly relevant for extracting named entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains a clear mention of the DNA \'AP-1\', making it highly relevant for extracting named entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains clear mentions of the proteins \'RelA\' and \'NF-kappa B\', making it highly relevant for extracting named entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains clear mentions of the proteins \'EBNA-2\' and \'PU.1\', making it highly relevant for extracting named entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains clear mentions of the proteins \'IL-2 receptor alpha subunit\', \'p21ras\', and the cell type \'B cell\', making it highly relevant for extracting named entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains clear mentions of the proteins \'SLAP-130\', \'SLP-76\', and the cell type \'T cell\', making it highly relevant for extracting named entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains clear mentions of the proteins \'NF-kappaB\' and the cell type \'rheumatoid arthritis\', making it highly relevant for extracting named entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains clear mentions of the proteins \'myeloperoxidase\', \'lysozyme\', and \'PU.1\', making it highly relevant for extracting named entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains a clear mention of the protein \'retinoic acid receptor alpha\', making it highly relevant for extracting named entities."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains clear mentions of the proteins \'Oct-2A\', \'HMG I/Y\', \'HLA-DRA\', and the cell type \'B cells\', making it highly relevant for extracting named entities."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence contains clear mentions of the cell type \'T lymphocytes\' and the protein \'HLA-molecules\', making it highly relevant for extracting named entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any named entities from the given entity label set."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any named entities from the given entity label set."}\n]', 'response3': '[{"HLA class II antigens": "protein"}, {"ribonucleoproteins Ro(SSA)": "protein"}, {"La(SSB)": "protein"}]', 'prediction': {'HLA class II antigens': 'protein', 'ribonucleoproteins Ro(SSA)': 'protein', 'La(SSB)': 'protein'}}
{'idx': 592, 'sentence': 'The DNA isolated contained an open reading frame encoding 108 amino acid residues .', 'label': {}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 1},\n    {"Example 13": 1},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"DNA": "DNA"}]', 'prediction': {'DNA': 'DNA'}}
{'idx': 163, 'sentence': 'This phenomenon can be mimicked by administering MP in divided doses.', 'label': {}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence contains specific protein names that match the entity types in the target sentence."},\n{"Example 2": 4},\n{"Reason 2": "The sentence contains a protein name that matches the entity type in the target sentence."},\n{"Example 3": 5},\n{"Reason 3": "The sentence contains specific protein names, cell types, and a transcription factor that match the entity types in the target sentence."},\n{"Example 4": 5},\n{"Reason 4": "The sentence contains specific cell types that match the entity types in the target sentence."},\n{"Example 5": 5},\n{"Reason 5": "The sentence contains specific protein names that match the entity types in the target sentence."},\n{"Example 6": 5},\n{"Reason 6": "The sentence contains specific protein names that match the entity types in the target sentence."},\n{"Example 7": 5},\n{"Reason 7": "The sentence contains a DNA transcription factor that matches the entity type in the target sentence."},\n{"Example 8": 5},\n{"Reason 8": "The sentence contains specific protein names that match the entity types in the target sentence."},\n{"Example 9": 5},\n{"Reason 9": "The sentence contains specific cell line names that match the entity types in the target sentence."},\n{"Example 10": 5},\n{"Reason 10": "The sentence contains specific cell type names that match the entity types in the target sentence."},\n{"Example 11": 5},\n{"Reason 11": "The sentence contains specific protein names that match the entity types in the target sentence."},\n{"Example 12": 5},\n{"Reason 12": "The sentence contains specific protein names that match the entity types in the target sentence."},\n{"Example 13": 5},\n{"Reason 13": "The sentence contains specific protein names that match the entity types in the target sentence."},\n{"Example 14": 5},\n{"Reason 14": "The sentence contains specific RNA and protein names that match the entity types in the target sentence."},\n{"Example 15": 1},\n{"Reason 15": "The sentence does not contain any entity types that match the entity types in the target sentence."},\n{"Example 16": 1},\n{"Reason 16": "The sentence does not contain any entity types that match the entity types in the target sentence."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any entity types that match the entity types in the target sentence."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any entity types that match the entity types in the target sentence."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any entity types that match the entity types in the target sentence."},\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any entity types that match the entity types in the target sentence."},\n{"Example 21": 1},\n{"Reason 21": "The sentence does not contain any entity types that match the entity types in the target sentence."},\n{"Example 22": 1},\n{"Reason 22": "The sentence does not contain any entity types that match the entity types in the target sentence."},\n{"Example 23": 1},\n{"Reason 23": "The sentence does not contain any entity types that match the entity types in the target sentence."},\n{"Example 24": 1},\n{"Reason 24": "The sentence does not contain any entity types that match the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1751, 'sentence': 'This effect is thought to be largely mediated through inactivation of the phosphatase calcineurin , which in turn inhibits translocation of an NFAT component to the nucleus.', 'label': {'NFAT': 'protein', 'calcineurin': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence 1": 5},\n    {"Sentence 2": 5},\n    {"Sentence 3": 5},\n    {"Sentence 4": 5},\n    {"Sentence 5": 5},\n    {"Sentence 6": 5},\n    {"Sentence 7": 5},\n    {"Sentence 8": 5},\n    {"Sentence 9": 5},\n    {"Sentence 10": 5},\n    {"Sentence 11": 5},\n    {"Sentence 12": 5},\n    {"Sentence 13": 5},\n    {"Sentence 14": 5},\n    {"Sentence 15": 5},\n    {"Sentence 16": 1},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1},\n    {"Sentence 20": 1},\n    {"Sentence 21": 1},\n    {"Sentence 22": 1},\n    {"Sentence 23": 1},\n    {"Sentence 24": 1},\n    {"Sentence 25": 1}\n]', 'response3': '[{"calcineurin": "protein"}, {"NFAT": "protein"}]', 'prediction': {'calcineurin': 'protein', 'NFAT': 'protein'}}
{'idx': 1774, 'sentence': 'Further studies are needed to elucidate if this sex difference in PBMC receptors for 1.25 Dihydroxyvitamin D3 is of any pathophysiological relevance .', 'label': {'PBMC': 'cell_type', 'PBMC receptors': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 3},\n    {"An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage.": 4},\n    {"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).": 5},\n    {"These results indicate that the monocyte/B-cell-specific transcription factor PU.1 and the Mono A and Mono B protein complexes act in concert to regulate monocyte-specific transcription of the CSF-1 receptor.": 5},\n    {"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.": 5},\n    {"A 3-bp mutation at the distal Sp1-binding site not only eliminates Sp1 interaction, but also abolishes most of the VitD3 induction of CD14 expression.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 206, 'sentence': 'It is concluded that (i) patients with CLL rarely express ER and (ii) immunocytochemical staining of cytospin preparations is a valid technique for the measurement of ER .', 'label': {'ER': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor )": 5},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 4},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL .": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 5},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n    {"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 5},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms .": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 928, 'sentence': 'A mouse ets-1 cDNA clone was obtained by screening a mouse thymus cDNA expression library with a double-stranded oligonucleotide probe representing 20 bp of the Moloney murine sarcoma virus ( MSV ) long terminal repeat ( LTR ).', 'label': {'ets-1': 'protein', 'long terminal repeat': 'DNA', 'double-stranded oligonucleotide probe': 'DNA', 'mouse thymus cDNA expression library': 'DNA', 'mouse ets-1 cDNA clone': 'DNA', 'LTR': 'DNA'}, 'response1': "['DNA', 'RNA']", 'response2': '[\n    {"SIVsmmPBj14": 5},\n    {"SIVmacMER": 5},\n    {"SIVmac239": 5},\n    {"CEMx174": 5},\n    {"GM-CSF": 5},\n    {"PML/RARalpha": 5},\n    {"Th2-type lymphocytes": 5},\n    {"protein": 5},\n    {"Sp1": 5},\n    {"Ets": 5},\n    {"c-kit": 5},\n    {"IL-4R alpha chain": 5},\n    {"TCF-1": 5},\n    {"MIP-1 alpha": 5},\n    {"GOS19": 5},\n    {"LD78": 5},\n    {"AT464": 5},\n    {"CD14": 5},\n    {"IFN A": 5},\n    {"IFNA": 5},\n    {"interleukin-2": 5},\n    {"interleukin-2 receptor": 5},\n    {"phytohemagglutinin": 5},\n    {"phorbol myristate acetate": 5},\n    {"SLAP-130": 5},\n    {"SLP-76": 5},\n    {"Egr-1": 5},\n    {"E2A": 5},\n    {"CD95 ligand": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1301, 'sentence': 'It was found that the most significant variable predicting NK activity at follow-up was tumor ER concentration , with higher NK activity associated with ER -status .', 'label': {'ER': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"The expression of NDP kinase was intense in KA and SCC compared with BCC.": 5},\n    {"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n    {"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"NK activity": "cell_type"}, {"tumor ER concentration": "protein"}, {"ER": "protein"}]', 'prediction': {'NK activity': 'cell_type', 'tumor ER concentration': 'protein', 'ER': 'protein'}}
{'idx': 1708, 'sentence': 'The Ca(2+) -dependent phosphatase calcineurin , a target of FK506 and CsA , synergizes with PKC -induced activation of nuclear factor (NF)-kappa B in T cell lines .', 'label': {'nuclear factor (NF)-kappa B': 'protein', 'T cell lines': 'cell_line', 'Ca(2+) -dependent phosphatase': 'protein', 'PKC': 'protein', 'calcineurin': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a direct mapping between the entity \'calcineurin\' and its corresponding label \'protein\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The example provides a direct mapping between the entities \'IkappaBalpha\' and \'NF-kappaB\' with their corresponding label \'protein\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides a direct mapping between the entities \'IkappaBbeta\' and \'NF-kappaB\' with their corresponding label \'protein\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The example provides a direct mapping between the entities \'NF-kappa B\' and \'AP-1\' with their corresponding label \'protein\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides a direct mapping between the entities \'PAFR\', \'PAF\', \'NF-kappa B\', and \'protein kinase C\' with their corresponding label \'protein\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The example provides a direct mapping between the entities \'CD40\' and \'NF-kappa B\' with their corresponding label \'protein\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides a direct mapping between the entities \'CD28\', \'CD80\', \'CD86\', \'CBL\', \'VAV\', \'NFAT\', \'interleukin-2\', and \'granulocyte-macrophage colony-stimulating factor\' with their corresponding label \'protein\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides a direct mapping between the entities \'NF-kappaB\', \'Tax\', and \'ATL\' with their corresponding labels \'protein\' and \'cell_type\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides a direct mapping between the entities \'NF-kappa B\' and \'I kappa B beta\' with their corresponding label \'protein\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides a direct mapping between the entities \'NF-kappa B\' and \'I kappa B alpha\' with their corresponding label \'protein\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides a direct mapping between the entity \'NF-kappa B\' with its corresponding label \'protein\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The example provides a direct mapping between the entities \'RelA\' and \'NF-kappa B\' with their corresponding label \'protein\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides a direct mapping between the entities \'Syk\', \'Zap\', and \'T cell\' with their corresponding labels \'protein\' and \'cell_type\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The example provides a direct mapping between the entity \'NF-kappa B\' with its corresponding label \'protein\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 15": 5},\n    {"Reason 15": "The example provides a direct mapping between the entities \'SP1\', \'caspases\', and \'B-cell\' with their corresponding labels \'protein\' and \'cell_type\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 16": 5},\n    {"Reason 16": "The example provides a direct mapping between the entity \'NF-kappa B\' with its corresponding label \'protein\' in the sentence, aiding in the extraction of named entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities related to the provided entity labels, hence not helpful for named entity extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities related to the provided entity labels, hence not helpful for named entity extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities related to the provided entity labels, hence not helpful for named entity extraction."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities related to the provided entity labels, hence not helpful for named entity extraction."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities related to the provided entity labels, hence not helpful for named entity extraction."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities related to the provided entity labels, hence not helpful for named entity extraction."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities related to the provided entity labels, hence not helpful for named entity extraction."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities related to the provided entity labels, hence not helpful for named entity extraction."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities related to the provided entity labels, hence not helpful for named entity extraction."}\n]', 'response3': '[{"calcineurin": "protein"}, {"FK506": "protein"}, {"CsA": "protein"}, {"PKC": "protein"}, {"NF-kappa B": "protein"}, {"T cell lines": "cell_line"}]', 'prediction': {'calcineurin': 'protein', 'FK506': 'protein', 'CsA': 'protein', 'PKC': 'protein', 'NF-kappa B': 'protein', 'T cell lines': 'cell_line'}}
{'idx': 747, 'sentence': 'Protein kinase inhibitor H-7 blocks accumulation of unspliced mRNA of human T-cell leukemia virus type I ( HTLV-I ).', 'label': {'unspliced mRNA': 'RNA'}, 'response1': "['protein', 'RNA']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .": 5},\n    {"Control of NF-kappa B activity by the I kappa B beta inhibitor .": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Tat-binding protein 7 is a subunit of the 26S protease .": 5},\n    {"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 5},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells .": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 333, 'sentence': 'These protoenhancers alone are weakly or not responsive to R .', 'label': {'protoenhancers': 'DNA', 'R': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 4},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 4},\n    {"Example 6": 4},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 4},\n    {"Example 11": 1},\n    {"Example 12": 4},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 758, 'sentence': 'Cell proliferation of CEM-C7 cells cultured in both serum-free media has been sustained for 3 mo.', 'label': {'CEM-C7': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[\n{"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.": 5},\n{"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 4},\n{"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 4},\n{"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 4},\n{"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 3},\n{"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n{"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n{"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n{"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 5},\n{"Thus, we were able to derive a hematopoietic cell line, called 47.10, that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.": 5},\n{"Notably, the lack of pRB in these U937-derived clones renders these p53-null cells highly resistant to apoptosis induced by serum withdrawal, calphostin C, and ceramide.": 5},\n{"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.": 5},\n{"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.": 5},\n{"We isolated a novel subline, UT-7/GMT, from the human leukemia cell line UT-7/GM (N. Komatsu, et al., Blood, 89: 4021-4033, 1997).": 5},\n{"The modified vectors were used to transduce human hematopoietic cell lines, cord blood-derived CD34(+) stem/progenitor cells, and murine bone marrow repopulating stem cells.": 5},\n{"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"CEM-C7 cells": "cell_line"}]', 'prediction': {'CEM-C7 cells': 'cell_line'}}
{'idx': 727, 'sentence': 'The importance of the internal ATGs to Rex function is not known.', 'label': {'Rex': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific gene names and their corresponding entity labels, which directly aid in extracting named entities from the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides specific gene names and their corresponding entity labels, aiding in extracting named entities from the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence mentions a specific protein and its corresponding entity label, directly assisting in extracting named entities from the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence mentions a specific cell type and its corresponding entity label, aiding in extracting named entities from the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific gene names and their corresponding entity labels, which directly aid in extracting named entities from the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions a specific cell line and its corresponding entity label, directly assisting in extracting named entities from the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides specific protein names and their corresponding entity labels, aiding in extracting named entities from the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions a specific protein and a specific cell type with their corresponding entity labels, aiding in extracting named entities from the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains specific gene names and their corresponding entity labels, which directly aid in extracting named entities from the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions a specific protein and its corresponding entity label, directly assisting in extracting named entities from the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions a specific protein and its corresponding entity label, aiding in extracting named entities from the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions a specific protein and its corresponding entity label, aiding in extracting named entities from the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions a specific protein and its corresponding entity label, aiding in extracting named entities from the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions a specific cell line and its corresponding entity label, aiding in extracting named entities from the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any specific named entities or their corresponding labels, hence not helpful in extracting named entities from the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific named entities or their corresponding labels, hence not helpful in extracting named entities from the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific named entities or their corresponding labels, hence not helpful in extracting named entities from the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific named entities or their corresponding labels, hence not helpful in extracting named entities from the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific named entities or their corresponding labels, hence not helpful in extracting named entities from the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any specific named entities or their corresponding labels, hence not helpful in extracting named entities from the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any specific named entities or their corresponding labels, hence not helpful in extracting named entities from the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any specific named entities or their corresponding labels, hence not helpful in extracting named entities from the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any specific named entities or their corresponding labels, hence not helpful in extracting named entities from the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any specific named entities or their corresponding labels, hence not helpful in extracting named entities from the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 429, 'sentence': 'As shown by mobility-shift , methylation interference , and mutational analyses , the mammalian protein BSAP recognizes all four sea urchin binding sites in a manner indistinguishable from TSAP ; however, the two proteins differ in molecular weight.', 'label': {'TSAP': 'protein', 'mammalian protein': 'protein', 'sea urchin binding sites': 'DNA', 'BSAP': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.": 5},\n    {"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n    {"Tat-binding protein 7 is a subunit of the 26S protease.": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 5},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 5},\n    {"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1372, 'sentence': 'The TCL1 oncogene on human chromosome 14q32.1 is involved in chromosome translocations [ t(14;14)(q11;q32.1) and t(7;14)(q35;q32.1) ] and inversions [ inv14(q11;q32.1) ] with TCR alpha/beta loci in T-cell leukemias , such as T-prolymphocytic ( T-PLL ).', 'label': {'14q32.1': 'DNA', 'TCR alpha/beta loci': 'DNA', 't(14;14)(q11;q32.1)': 'DNA', 'TCL1 oncogene': 'DNA', 'human chromosome': 'DNA', 't(7;14)(q35;q32.1)': 'DNA', 'inv14(q11;q32.1)': 'DNA'}, 'response1': "['DNA', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains the specific protein \'BRCA1\' and its corresponding entity label \'protein\', making it highly relevant for named entity extraction."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains the specific protein \'TCF-1\' and its corresponding entity label \'protein\', making it highly relevant for named entity extraction."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains multiple proteins (\'SLAP-130\', \'SLP-76\') and a cell type (\'T cell\'), all of which are correctly identified with their corresponding entity labels, making it highly relevant for named entity extraction."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains the specific proteins \'IkappaBbeta\' and \'NF-kappaB\' with their corresponding entity labels, making it highly relevant for named entity extraction."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains the specific cell type \'Th2-type lymphocytes\' and its corresponding entity label \'cell_type\', making it highly relevant for named entity extraction."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains multiple proteins (\'IL-2 receptor alpha subunit\', \'p21ras\') and a cell type (\'B cell\'), all of which are correctly identified with their corresponding entity labels, making it highly relevant for named entity extraction."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains the specific proteins \'c-kit\' and \'IL-4R alpha chain\' with their corresponding entity labels, making it highly relevant for named entity extraction."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains multiple proteins (\'IL-13\', \'IL-4R\', \'JAK2\', \'IL-13R\') with their corresponding entity labels, making it highly relevant for named entity extraction."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains the specific proteins \'TCRzeta\' and \'p56(lck)\' with their corresponding entity labels, making it highly relevant for named entity extraction."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains the specific proteins \'NF-kappaB\' and \'Tax\' and the cell types \'T cell\' and \'ATL\' with their corresponding entity labels, making it highly relevant for named entity extraction."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains the specific cell type \'T cell\' and the protein \'interleukin 2\' with their corresponding entity labels, making it highly relevant for named entity extraction."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains the specific cell line \'SCM-1\' with its corresponding entity label \'cell_line\', making it highly relevant for named entity extraction."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains the specific protein \'TAL1\' and the cell type \'T-ALL\' with their corresponding entity labels, making it highly relevant for named entity extraction."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains the specific cell type \'T-PLL\' with its corresponding entity label \'cell_type\', making it highly relevant for named entity extraction."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains the specific protein \'TCL1\' with its corresponding entity label \'protein\', making it highly relevant for named entity extraction."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence contains the specific proteins \'SCL\' and \'GATA-1\' with their corresponding entity labels, making it highly relevant for named entity extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities from the given entity label set, hence it is not helpful for named entity extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities from the given entity label set, hence it is not helpful for named entity extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities from the given entity label set, hence it is not helpful for named entity extraction."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities from the given entity label set, hence it is not helpful for named entity extraction."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities from the given entity label set, hence it is not helpful for named entity extraction."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities from the given entity label set, hence it is not helpful for named entity extraction."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities from the given entity label set, hence it is not helpful for named entity extraction."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities from the given entity label set, hence it is not helpful for named entity extraction."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities from the given entity label set, hence it is not helpful for named entity extraction."}\n]', 'response3': '[{"TCL1": "protein"}, {"TCR alpha/beta": "protein"}, {"T-cell": "cell_type"}, {"T-prolymphocytic": "cell_type"}, {"T-PLL": "cell_type"}]', 'prediction': {'TCL1': 'protein', 'TCR alpha/beta': 'protein', 'T-cell': 'cell_type', 'T-prolymphocytic': 'cell_type', 'T-PLL': 'cell_type'}}
{'idx': 546, 'sentence': 'Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin .', 'label': {'T lymphocytes': 'cell_type', 'immunophilin': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a protein entity (calcineurin) and its corresponding label."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides a clear example of a protein entity (NF-kappa B) and its corresponding label."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence provides multiple examples of protein entities (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) and their corresponding labels."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides multiple examples of protein entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) and their corresponding labels."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides multiple examples of protein entities (IL-2, IL-2 receptor, CD28) and their corresponding labels, as well as a cell type entity (T cell)."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides multiple examples of protein entities (IL-5 mRNA, TCR, IL-2R, dexamethasone) and their corresponding labels, as well as an RNA entity (IL-5 mRNA)."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides multiple examples of protein entities (NF-kappa B, I kappa B alpha) and their corresponding labels."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides a clear example of a protein entity (IL-2) and its corresponding label."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides multiple examples of protein entities (CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, granulocyte-macrophage colony-stimulating factor) and their corresponding labels."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides multiple examples of protein entities (NF-ATc, T lymphocytes) and their corresponding labels."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides multiple examples of protein entities (IkappaBbeta, NF-kappaB) and their corresponding labels."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides multiple examples of protein entities (IL-2 receptor alpha subunit, p21ras) and their corresponding labels, as well as a cell type entity (B cell)."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides multiple examples of protein entities (Syk, Zap, T cell) and their corresponding labels."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides multiple examples of protein entities (IL-2, NF-kappa B, AP-1) and their corresponding labels."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides multiple examples of protein entities (IL-2, Aiolos, Ras) and their corresponding labels."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence provides multiple examples of protein entities (IkappaBalpha, NF-kappaB) and their corresponding labels."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities from the given label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities from the given label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities from the given label set."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities from the given label set."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities from the given label set."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities from the given label set."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities from the given label set."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities from the given label set."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities from the given label set."}\n]', 'response3': '[{"T lymphocytes": "cell_type"}, {"immunophilin": "protein"}, {"FK506": "protein"}, {"rapamycin": "protein"}]', 'prediction': {'T lymphocytes': 'cell_type', 'immunophilin': 'protein', 'FK506': 'protein', 'rapamycin': 'protein'}}
{'idx': 1437, 'sentence': 'In summary, we developed an assay for the quantitative determination of hTR beta 1 mRNA levels in small human tissue samples , containing as little as 50 ng of total RNA.', 'label': {'hTR beta 1': 'protein', 'hTR beta 1 mRNA': 'RNA'}, 'response1': "['RNA']", 'response2': '[\n{"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 4},\n{"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 3},\n{"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n{"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.": 4},\n{"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 4},\n{"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 4},\n{"To evaluate the PML/RARalpha role in myelopoiesis, transgenic mice expressing PML/RARalpha were engineered.": 4},\n{"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 4},\n{"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.": 5},\n{"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n{"Thus, we were able to derive a hematopoietic cell line, called 47.10, that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.": 5},\n{"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n{"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.": 4},\n{"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 4}\n]', 'response3': '[{"hTR beta 1 mRNA": "RNA"}]', 'prediction': {'hTR beta 1 mRNA': 'RNA'}}
{'idx': 1399, 'sentence': 'To investigate the role of NF-M in hematopoietic cell lineage commitment, we constructed a conditional form of the protein by fusing it to the hormone binding domain of the human estrogen receptor .', 'label': {'hematopoietic cell lineage': 'cell_line', 'human estrogen receptor': 'protein', 'NF-M': 'protein', 'hormone binding domain': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '```json\n[\n    {"NF-kappa B": 5},\n    {"IL-2": 5},\n    {"NF-E2": 5},\n    {"E2A": 5},\n    {"MNDA": 5, "Philadelphia chromosome-positive chronic myeloid leukemia": 5},\n    {"c-kit": 5, "IL-4R alpha chain": 5},\n    {"PML/RARalpha": 5},\n    {"RXR": 5},\n    {"TRAF6": 5, "RANKL": 5, "NF-kappaB": 5},\n    {"NF-ATc": 5, "T lymphocytes": 5, "embryonic cardiac cells": 5},\n    {"CD40": 5, "NF-kappa B": 5},\n    {"GATA-1": 5},\n    {"TCF-1": 5},\n    {"NF-kappa B": 5},\n    {"IL-2": 5},\n    {"ZEB": 5, "c-Myb": 5, "Ets": 5, "hematopoietic cells": 5}\n]\n```', 'response3': '```json\n[{"NF-M": "protein"}, {"hormone binding domain": "protein"}, {"human estrogen receptor": "protein"}]\n```', 'prediction': {'NF-M': 'protein', 'hormone binding domain': 'protein', 'human estrogen receptor': 'protein'}}
{'idx': 1327, 'sentence': 'Our results demonstrate that NF-IL6 is involved in transcriptional activation of the human IL-4 promoter in T cells .', 'label': {'human IL-4': 'protein', 'human IL-4 promoter': 'DNA', 'NF-IL6': 'protein', 'T cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a direct mapping between the entity \'IL-4\' and its corresponding label \'protein\' in the target sentence, aiding in the extraction of named entities."}\n]', 'response3': '[{"NF-IL6": "protein"}, {"IL-4": "protein"}, {"T cells": "cell_type"}]', 'prediction': {'NF-IL6': 'protein', 'IL-4': 'protein', 'T cells': 'cell_type'}}
{'idx': 146, 'sentence': 'Unlike other class II promoters , the HLA-DR alpha (DRA) promoter also contains one element identical to the "octamer" motif of immunoglobulin variable region promoters that is responsible for B cell-specific transcription .', 'label': {'"octamer" motif': 'DNA', 'HLA-DR alpha (DRA) promoter': 'DNA', 'class II promoters': 'DNA', 'immunoglobulin variable region promoters': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n{"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 5},\n{"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 4},\n{"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.": 5},\n{"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n{"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n{"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n{"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n{"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 4},\n{"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 5},\n{"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n{"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 4},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5}\n]', 'response3': '[{"HLA-DR alpha (DRA)": "protein"}, {"octamer": "protein"}, {"immunoglobulin variable region": "protein"}, {"B cell-specific": "cell_type"}]', 'prediction': {'HLA-DR alpha (DRA)': 'protein', 'octamer': 'protein', 'immunoglobulin variable region': 'protein', 'B cell-specific': 'cell_type'}}
{'idx': 1247, 'sentence': 'The Janus family tyrosine kinase Jak3 is the only signaling molecule known to be associated with gamma c , so it was hypothesized that defects in Jak3 might cause an XSCID -like phenotype .', 'label': {'Janus family tyrosine kinase': 'protein', 'Jak3': 'protein', 'gamma c': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 3},\n    {"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.": 5},\n    {"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n    {"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/thrombopoiesis or possibly a mature platelet function such as aggregation.": 5},\n    {"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n    {"SCL is expressed in erythroid, megakaryocyte and mast cell populations (the same cell lineages as GATA-1, a zinc-finger transcription factor).": 5},\n    {"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine (IL-2 and IFN-gamma) production is normal.": 5},\n    {"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 5}\n]', 'response3': '[{"Jak3": "protein"}, {"gamma c": "protein"}, {"Jak3": "protein"}]', 'prediction': {'Jak3': 'protein', 'gamma c': 'protein'}}
{'idx': 1300, 'sentence': 'As considerable evidence has accumulated that social support in both animal and human populations may have survival value, we sought to test the reliability of this regression model , using coping and perceived support factor values obtained at 3 months after surgery to account for concurrent follow-up NK activity in this serially assessed group of patients .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and direct mention of the entity \'protein\'."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions \'nonhuman primates\' which is likely referring to a specific type of cell type."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence mentions \'SIVsmmPBj14\' which is likely a specific cell line."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence mentions \'SCM-1\' which could be a specific cell line."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence mentions \'immunoglobulin kappa 3\' enhancer\' which is likely referring to DNA."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions \'NF-kappa B\' which is a protein."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence mentions \'granulocytes\' and \'T cells\' which are cell types."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions \'cAMP-dependent protein kinase\' and \'Rap1\' which are proteins."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence mentions \'SIVmacMER\', \'SIVmac239\', and \'CEMx174\' which are likely cell lines."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions \'TIMP-1\' which is a protein and \'DNA\'."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions \'NF-kappa B\' which is a protein."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions \'CD40\', \'Rel/nuclear factor kappaB\', \'NF-kappaB\', and \'B lymphocytes\' which are likely proteins and a cell type."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions \'interleukin-2\', \'CD25\', and \'IL-2 receptor\' which are proteins."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions \'p50\', \'p65\', \'DNA\', and \'protein\' which are likely proteins and DNA."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions \'GM-kappa B\', \'GC-box\', \'GC-motif\', and \'GM-kappa B motif\' which are likely DNA."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any relevant entity types."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any relevant entity types."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any relevant entity types."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any relevant entity types."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any relevant entity types."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any relevant entity types."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any relevant entity types."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any relevant entity types."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any relevant entity types."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any relevant entity types."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 350, 'sentence': 'Induction of 24,25-(OH)2D3 synthesis by 1,25(OH)2D3 was observed in the fifth cell line , designated Ro-VDR , although the sensitivity to hormone treatment was lower than in the control cell line from a normal donor .', 'label': {'control cell line': 'cell_line', 'cell line': 'cell_line', 'Ro-VDR': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .": 5},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex .": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"Protein kinase B ( c-Akt ), phosphatidylinositol 3-kinase , and STAT5 are activated by erythropoietin ( EPO ) in HCD57 erythroid cells but are constitutively active in an EPO -independent, apoptosis -resistant subclone ( HCD57-SREI cells ).": 5},\n    {"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice .": 5},\n    {"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development .": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 5},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[{"Ro-VDR": "cell_line"}]', 'prediction': {'Ro-VDR': 'cell_line'}}
{'idx': 1093, 'sentence': 'The genomic actions of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) are mediated by the intracellular vitamin D receptor ( VDR ).', 'label': {'VDR': 'protein', 'vitamin D receptor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n    {"An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage.": 4},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.": 4},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.": 4},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 4},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex.": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"Protein kinase B ( c-Akt ), phosphatidylinositol 3-kinase , and STAT5 are activated by erythropoietin ( EPO ) in HCD57 erythroid cells but are constitutively active in an EPO -independent, apoptosis -resistant subclone ( HCD57-SREI cells ).": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 4},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[{"1,25-dihydroxyvitamin D3": "protein"}, {"VDR": "protein"}]', 'prediction': {'1,25-dihydroxyvitamin D3': 'protein', 'VDR': 'protein'}}
{'idx': 1493, 'sentence': 'Chronic HIV-1 infection of myeloid cells leads to constitutive NF-kappa B DNA-binding activity and provides an intranuclear environment capable of perpetuating HIV-1 replication .', 'label': {'myeloid cells': 'cell_type', 'NF-kappa B': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"DNA": "DNA"}, {"HIV-1": "cell_type"}]', 'prediction': {'NF-kappa B': 'protein', 'DNA': 'DNA', 'HIV-1': 'cell_type'}}
{'idx': 334, 'sentence': "One of the protoenhancers contains the overlapping palindromes 5'-TTGTCCcgtGGACAAaTGTCC-3' .", 'label': {'protoenhancers': 'DNA', 'overlapping palindromes': 'DNA'}, 'response1': "['DNA']", 'response2': '```json\n[{"IgH": 5},{"Reason": "The sentence directly mentions the gene IgH, which is a DNA entity, making it highly relevant for extracting named entities from the target sentence."}]\n[{"BRCA1": 5},{"Reason": "The sentence directly mentions the gene BRCA1, which is a protein entity, making it highly relevant for extracting named entities from the target sentence."}]\n[{"EBNA2": 4},{"TP1": 3},{"Reason": "The sentence mentions EBNA2 and TP1, both of which are protein and cell_line entities respectively. While EBNA2 is directly related to a protein entity, TP1 is indirectly related to a cell_line entity through the promoter context."}]\n[{"GM-CSF": 5},{"Reason": "The sentence directly mentions the gene GM-CSF, which is a protein entity, making it highly relevant for extracting named entities from the target sentence."}]\n[{"Protein": 4},{"Reason": "The sentence mentions protein, which is a protein entity, making it relevant for extracting named entities from the target sentence."}]\n[{"IL-2": 5},{"c-Jun": 5},{"c-Fos": 5},{"Reason": "The sentence directly mentions IL-2, c-Jun, and c-Fos, all of which are protein entities, making it highly relevant for extracting named entities from the target sentence."}]\n[{"p50p50": 5},{"Reason": "The sentence directly mentions p50p50, which is a protein entity, making it highly relevant for extracting named entities from the target sentence."}]\n[{"EKLF": 5},{"Reason": "The sentence directly mentions EKLF, which is a protein entity, making it highly relevant for extracting named entities from the target sentence."}]\n[{"TCF-1": 5},{"Reason": "The sentence directly mentions TCF-1, which is a protein entity, making it highly relevant for extracting named entities from the target sentence."}]\n[{"ZEBRA": 5},{"Reason": "The sentence directly mentions ZEBRA, which is a protein entity, making it highly relevant for extracting named entities from the target sentence."}]\n[{"immunoglobulin kappa 3\' enhancer": 5},{"Reason": "The sentence directly mentions the immunoglobulin kappa 3\' enhancer, which is a DNA entity, making it highly relevant for extracting named entities from the target sentence."}]\n[{"Egr-1": 5},{"Reason": "The sentence directly mentions Egr-1, which is a protein entity, making it highly relevant for extracting named entities from the target sentence."}]\n[{"T cell": 4},{"interleukin 2": 5},{"Reason": "The sentence mentions T cell and interleukin 2, with T cell being a cell_type entity and interleukin 2 being a protein entity. Both are relevant for extracting named entities from the target sentence."}]\n[{"Th2-type lymphocytes": 5},{"Reason": "The sentence directly mentions Th2-type lymphocytes, which is a cell_type entity, making it highly relevant for extracting named entities from the target sentence."}]\n[{"CD95 ligand": 5},{"Reason": "The sentence directly mentions CD95 ligand, which is a protein entity, making it highly relevant for extracting named entities from the target sentence."}]\n[{"GM-kappa B": 5},{"GC-box": 5},{"GC-motif": 5},{"GM-kappa B motif": 5},{"Reason": "The sentence mentions GM-kappa B, GC-box, GC-motif, and GM-kappa B motif, all of which are DNA entities, making them highly relevant for extracting named entities from the target sentence."}]\n```', 'response3': '```json\n[]\n```', 'prediction': {}}
{'idx': 946, 'sentence': 'Compared to the control group , fewer depressed subjects down-regulated Bmax after DEX .', 'label': {}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Example 2": 5},\n{"Example 3": 5},\n{"Example 4": 5},\n{"Example 5": 5},\n{"Example 6": 5},\n{"Example 7": 5},\n{"Example 8": 5},\n{"Example 9": 5},\n{"Example 10": 5},\n{"Example 11": 5},\n{"Example 12": 5},\n{"Example 13": 5},\n{"Example 14": 5},\n{"Example 15": 5},\n{"Example 16": 1},\n{"Example 17": 1},\n{"Example 18": 1},\n{"Example 19": 1},\n{"Example 20": 1},\n{"Example 21": 1},\n{"Example 22": 1},\n{"Example 23": 1},\n{"Example 24": 1},\n{"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 777, 'sentence': 'We have identified two human pre-B-cell lines that contain extremely low levels of OTF-2 yet still express high levels of steady-state immunoglobulin heavy-chain mRNA in vivo and efficiently transcribe an immunoglobulin gene in vitro.', 'label': {'OTF-2': 'protein', 'immunoglobulin gene': 'DNA', 'steady-state immunoglobulin heavy-chain mRNA': 'RNA', 'human pre-B-cell lines': 'cell_line', 'immunoglobulin heavy-chain': 'protein'}, 'response1': "['cell_line', 'RNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"pre-B-cell lines": "cell_line"}, {"OTF-2": "protein"}, {"immunoglobulin heavy-chain mRNA": "RNA"}, {"immunoglobulin gene": "DNA"}]', 'prediction': {'pre-B-cell lines': 'cell_line', 'OTF-2': 'protein', 'immunoglobulin heavy-chain mRNA': 'RNA', 'immunoglobulin gene': 'DNA'}}
{'idx': 552, 'sentence': 'Similarly, an excess of FK506 is needed to revert rapamycin -mediated inhibition of IL-2 -induced proliferation .', 'label': {'IL-2': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1}\n]', 'response3': '[{"FK506": "protein"}, {"rapamycin": "protein"}, {"IL-2": "protein"}]', 'prediction': {'FK506': 'protein', 'rapamycin': 'protein', 'IL-2': 'protein'}}
{'idx': 1310, 'sentence': 'The abundant chromosomal protein HMG-1 belongs to this subgroup.', 'label': {'HMG-1': 'protein', 'chromosomal protein': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 5},\n{"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n{"This protein has now been purified and its encoding gene cloned.": 5},\n{"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.": 1},\n{"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 1},\n{"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n{"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 5},\n{"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n{"Tat-binding protein 7 is a subunit of the 26S protease.": 5},\n{"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n{"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n{"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.": 5},\n{"Here we examined the regulatory mechanism of the SCM-1 genes.": 5},\n{"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1409, 'sentence': 'We investigated the ability of PRL and IL-2 to activate Stat proteins in different T cell lines .', 'label': {'IL-2': 'protein', 'T cell lines': 'cell_line', 'PRL': 'protein', 'Stat proteins': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence directly mentions the entity \'IL-2\' and its association with the entity type \'protein\', making it highly relevant for named entity extraction."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains multiple entities such as \'T cell\', \'IL-2\', \'IL-2 receptor\', and \'CD28\' associated with their respective entity types, providing valuable information for named entity extraction."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence mentions various entities like \'IL4\', \'IL13\', \'STAT6\', \'STAT3\', \'STAT5\', and \'B cells\' along with their corresponding entity types, aiding in named entity extraction."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence includes entities \'AP-1\', \'PMA\', \'monocytes\', and \'macrophages\' linked to their entity types, contributing to named entity extraction."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence provides information about entities \'IL-2 receptor alpha subunit\', \'p21ras\', and \'B cell\' associated with their respective entity types, assisting in named entity extraction."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions entities \'IL-2\', \'IFN-gamma\', \'jak kinases\', and \'STAT1(alpha)\' with their entity types, which are crucial for named entity extraction."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence directly refers to the entity \'IL-2\' associated with the entity type \'protein\', making it highly beneficial for named entity extraction."},\n    {"Example 8": 4},\n    {"Reason 8": "The sentence contains entities \'IL-2\', \'c-Jun\', and \'c-Fos\' linked to their entity types, aiding in named entity extraction."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence includes entities \'CD70\', \'B cell\', \'plasma cells\', \'IL-4\', and \'CD40\' associated with their respective entity types, facilitating named entity extraction."},\n    {"Example 10": 4},\n    {"Reason 10": "The sentence mentions the entity \'NF-kappa B\' associated with the entity type \'protein\', contributing to named entity extraction."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence provides information about entities \'Stat3\', \'Stat5\', and \'c-Mpl\' along with their entity types, aiding in named entity extraction."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions entities \'IL-2\', \'Aiolos\', and \'Ras\' with their entity types, which are essential for named entity extraction."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence directly refers to the entity \'IL-4\' associated with the entity type \'protein\', making it highly beneficial for named entity extraction."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence includes entities \'IFN A\', \'IFNA\', \'interleukin-2\', \'interleukin-2 receptor\', \'phytohemagglutinin\', and \'phorbol myristate acetate\' linked to their entity types, facilitating named entity extraction."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides information about entities \'IL-12\', \'STAT4\', \'NK cells\', \'T cells\', and \'IL-12 receptor\' associated with their respective entity types, aiding in named entity extraction."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence mentions the entity \'E2A\' associated with the entity type \'protein\', which is crucial for named entity extraction."}\n]', 'response3': "[{'PRL': 'protein'}, {'IL-2': 'protein'}, {'Stat proteins': 'protein'}, {'T cell lines': 'cell_line'}]", 'prediction': {'PRL': 'protein', 'IL-2': 'protein', 'Stat proteins': 'protein', 'T cell lines': 'cell_line'}}
{'idx': 1140, 'sentence': 'The conserved cis-acting sequence , GGAAAA , and transcription factors binding to this sequence are involved in the response to increased intracellular Ca2+ concentrations .', 'label': {'transcription factors': 'protein', 'conserved cis-acting sequence': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of a transcription factor (AP-1) and its association with DNA binding activity, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence mentions specific proteins (Jun and ATF-2) and their roles in transcription, which align with the entity types in the target sentence."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence refers to a specific cell type (Th2-type lymphocytes) which is relevant to the entity types in the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence discusses proteins and their involvement in transcription, which is in line with the entity types mentioned in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides a clear example of a zinc finger transcription factor (Egr-1) which corresponds to the protein entity type in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions specific proteins (IL-2, c-Jun, c-Fos) and their binding to DNA sequences, which directly relate to the entity types in the target sentence."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence discusses a specific protein (GM-CSF) which aligns with the protein entity type in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence provides a clear example of a lineage-specific transcription factor (GATA-1) which corresponds to the protein entity type in the target sentence."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence mentions a specific protein (TCF-1) and its role in transcription, which aligns with the entity types in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides a clear example of specific proteins (Stat proteins) and their involvement in transcription, which directly relates to the entity types mentioned in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions specific proteins (EKLF, CBP, p300, P/CAF) and their interactions, which align with the protein entity type in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides a clear example of specific proteins (SCL, GATA-1) and their expression in different cell lineages, which directly relate to the entity types mentioned in the target sentence."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence discusses a specific protein (G-CSF) which aligns with the protein entity type in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides a clear example of specific proteins (VDR, RXR, GRIP-1, DRIP205) and their interactions, which directly relate to the entity types mentioned in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions specific proteins (ZEB, c-Myb, Ets) and their roles in gene regulation, which align with the protein entity type in the target sentence."},\n    {"Example 16": 4},\n    {"Reason 16": "The sentence refers to specific proteins (tal-1, GATA-binding proteins) and their expression during hematopoiesis, which is relevant to the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entity types mentioned in the target sentence."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entity types mentioned in the target sentence."}\n]', 'response3': '[{"GGAAAA": "DNA"}]', 'prediction': {'GGAAAA': 'DNA'}}
{'idx': 449, 'sentence': 'We find that the factor that binds to the E3 enhancer motif , CATGTGGC , is a ubiquitous transcription factor .', 'label': {'ubiquitous transcription factor': 'protein', 'E3 enhancer motif': 'DNA'}, 'response1': "['DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains multiple protein names and their corresponding entity labels, which can aid in extracting named entities from the target sentence."}\n]', 'response3': '[{"E3 enhancer motif": "DNA"}]', 'prediction': {'E3 enhancer motif': 'DNA'}}
{'idx': 1402, 'sentence': 'At the same time, we observed a down-regulation of progenitor-specific surface markers and the up-regulation of differentiation markers restricted to the eosinophil and myeloid lineages .', 'label': {'eosinophil': 'cell_type', 'myeloid lineages': 'cell_type', 'differentiation markers': 'protein', 'progenitor-specific surface markers': 'protein'}, 'response1': "['cell_type']", 'response2': '[\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 5},\n    {"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 5},\n    {"PMA induced the expression of both CD14 and CD23 mRNA and protein.": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 5},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"eosinophil": "cell_type"}, {"myeloid": "cell_type"}]', 'prediction': {'eosinophil': 'cell_type', 'myeloid': 'cell_type'}}
{'idx': 664, 'sentence': 'Interferon-gamma and the sexual dimorphism of autoimmunity .', 'label': {'Interferon-gamma': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine (IFN-gamma) in combination with allergy-driven overproduction of T helper 2-type cytokines.": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 4},\n    {"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency.": 5},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"The role of the transcription factor NF-kappaB in the pathogenesis of rheumatoid arthritis has long been a subject of controversy.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 5},\n    {"CD40 expression could be enhanced in CD40-positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1726, 'sentence': 'It is tempting to speculate that enhanced NF-kappa B expression caused by free radical production/oxidative stress may modulate liver injury , perhaps through an effect on cytotoxic cytokine synthesis .', 'label': {'NF-kappa B': 'protein', 'cytotoxic cytokine': 'protein'}, 'response1': "['protein']", 'response2': '```json\n[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains the entity \'NF-kappa B\' which is labeled as \'protein\' in the entity label set."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains the entity \'ARDS\' which is labeled as \'cell_type\' in the entity label set."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains the entities \'PAFR\', \'PAF\', \'NF-kappa B\', and \'protein kinase C\' which are labeled as \'protein\' in the entity label set."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains the entities \'NF-kappa B\' and \'I kappa B alpha\' which are labeled as \'protein\' in the entity label set."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains the entity \'NF-kappa B\' which is labeled as \'protein\' in the entity label set."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains the entities \'IkappaBalpha\' and \'NF-kappaB\' which are labeled as \'protein\' in the entity label set."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains the entity \'NF-kappa B\' which is labeled as \'protein\' in the entity label set."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains the entity \'NF-kappa B\' which is labeled as \'protein\' in the entity label set."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains the entity \'NF-kappaB\' which is labeled as \'protein\' and \'rheumatoid arthritis\' which is labeled as \'cell_type\' in the entity label set."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains the entities \'IkappaBbeta\' and \'NF-kappaB\' which are labeled as \'protein\' in the entity label set."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains the entities \'NF-kappaB\', \'Tax\', and \'ATL\' which are labeled as \'protein\' and \'cell_type\' in the entity label set."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains the entities \'NF-kappa B\' and \'I kappa B alpha\' which are labeled as \'protein\' in the entity label set."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains the entities \'NF-kappa B\' and \'I kappa B beta\' which are labeled as \'protein\' in the entity label set."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains the entities \'CD40\', \'Rel/nuclear factor kappaB\', and \'NF-kappaB\' which are labeled as \'protein\' in the entity label set."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains the entities \'HIV-1\', \'IFN\', \'PKR\', and \'IkappaBalpha\' which are labeled as \'cell_type\' and \'protein\' in the entity label set."}\n]\n```', 'response3': '```json\n[{"NF-kappa B": "protein"}]\n```', 'prediction': {'NF-kappa B': 'protein'}}
{'idx': 1573, 'sentence': 'Immunofluorescence colocalization of both estrogen and progesterone receptors with eosinophil cationic protein showed that approximately 70% of positive cells were eosinophils .', 'label': {'estrogen': 'protein', 'eosinophil cationic protein': 'protein', 'positive cells': 'cell_type', 'progesterone receptors': 'protein', 'eosinophils': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of using polyclonal antisera to probe for a specific protein, which directly relates to the entity type \'protein\' in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence describes using antibodies against proteins encoded by a gene to determine cell type, which indirectly relates to the entity types \'protein\' and \'cell_type\' in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly mentions genes encoding eosinophil granule proteins, which corresponds to the entity type \'protein\' in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence directly mentions the important role of eosinophils, which corresponds to the entity type \'cell_type\' in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides a detailed example of different proteins and cell types involved in B cell cultures, directly relating to the entity types \'protein\' and \'cell_type\' in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence directly mentions specific lysosomal proteins and a transcription factor, which correspond to the entity type \'protein\' in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence directly mentions the expression of CD14 and CD23 proteins, which corresponds to the entity type \'protein\' in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence directly mentions the mRNA and protein levels of p21(WAF1/CIP1) and p27(KIP1), which correspond to the entity type \'protein\' in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence directly mentions the cell types granulocytes and T cells, which correspond to the entity type \'cell_type\' in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides a detailed example of nuclear factors and proteins involved in binding to the IL-2 promoter, directly relating to the entity type \'protein\' in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence directly mentions the cell-specific transcription factor NF-E2, which corresponds to the entity type \'protein\' in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence directly mentions the expression of interleukin-2 and the alpha chain of the IL-2 receptor, which correspond to the entity type \'protein\' in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence provides examples of specific cells and transcripts, directly relating to the entity types \'cell_line\' and \'protein\' in the target sentence."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence mentions Erbstatin and genistein inhibiting protein tyrosine phosphorylation, indirectly relating to the entity type \'protein\' in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence directly mentions the gp91phox gene and eosinophil-committed cells, which correspond to the entity types \'DNA\' and \'cell_line\' in the target sentence."}\n]', 'response3': '[{"estrogen": "protein"}, {"progesterone": "protein"}, {"eosinophil cationic protein": "protein"}, {"eosinophils": "cell_type"}]', 'prediction': {'estrogen': 'protein', 'progesterone': 'protein', 'eosinophil cationic protein': 'protein', 'eosinophils': 'cell_type'}}
{'idx': 1589, 'sentence': 'Inhibition of NF-AT -dependent transcription by NF-kappa B : implications for differential gene expression in T helper cell subsets .', 'label': {'NF-kappa B': 'protein', 'T helper cell subsets': 'cell_type', 'NF-AT': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence directly mentions the protein \'NF-kappa B\', providing a clear and specific example for the entity label \'protein\'."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence directly mentions the proteins \'NF-kappa B\' and \'I kappa B alpha\', providing clear and specific examples for the entity labels \'protein\'."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly mentions the protein \'NF-ATc\' and the cell type \'T lymphocytes\', providing clear and specific examples for the entity labels \'protein\' and \'cell_type\'."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence directly mentions the proteins \'NF-kappaB\' and \'ATL\', and the cell type \'Tax\', providing clear and specific examples for the entity labels \'protein\' and \'cell_type\'."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence directly mentions the protein \'NF-kappa B\', providing a clear and specific example for the entity label \'protein\'."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence directly mentions the proteins \'NF-kappa B\' and \'I kappa B alpha\', providing clear and specific examples for the entity labels \'protein\'."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence directly mentions the protein \'GATA-1\', providing a clear and specific example for the entity label \'protein\'."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence directly mentions the protein \'NF-kappa B\', providing a clear and specific example for the entity label \'protein\'."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence directly mentions the proteins \'NF-kappa B\' and \'I kappa B beta\', providing clear and specific examples for the entity labels \'protein\'."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence directly mentions the proteins \'PAFR\', \'PAF\', \'NF-kappa B\', and \'protein kinase C\', providing clear and specific examples for the entity labels \'protein\'."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence directly mentions the proteins \'Sp1\' and \'Ets\', providing clear and specific examples for the entity labels \'protein\'."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence directly mentions the cell types \'Th1\' and \'Th2\', providing clear and specific examples for the entity labels \'cell_type\'."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence directly mentions the cell type \'Th2-type lymphocytes\', providing a clear and specific example for the entity label \'cell_type\'."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence directly mentions the proteins \'IL-2\', \'NF-kappa B\', and \'AP-1\', providing clear and specific examples for the entity labels \'protein\'."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence directly mentions the DNA \'NF-kappa B\', providing a clear and specific example for the entity label \'DNA\'."}\n]', 'response3': '[{"NF-AT": "protein"}, {"NF-kappa B": "protein"}, {"T helper cell subsets": "cell_type"}]', 'prediction': {'NF-AT': 'protein', 'NF-kappa B': 'protein', 'T helper cell subsets': 'cell_type'}}
{'idx': 114, 'sentence': 'These results indicate that in monocytic cell lineage , HIV-1 could mimic some differentiation/activation stimuli allowing nuclear NF-KB expression .', 'label': {'NF-KB': 'protein', 'monocytic cell lineage': 'cell_line'}, 'response1': "['cell_line', 'cell_type']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with their corresponding entity labels, providing clear and direct guidance for entity extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains a clear example of a named entity with its corresponding entity label, aiding in entity extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of named entities with their corresponding entity labels, providing guidance for entity extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains a clear example of a named entity with its corresponding entity label, aiding in entity extraction."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of named entities with their corresponding entity labels, providing clear and direct guidance for entity extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains a clear example of a named entity with its corresponding entity label, aiding in entity extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of named entities with their corresponding entity labels, providing guidance for entity extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of named entities with their corresponding entity labels, providing guidance for entity extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of named entities with their corresponding entity labels, providing guidance for entity extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of named entities with their corresponding entity labels, providing guidance for entity extraction."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains a clear example of a named entity with its corresponding entity label, aiding in entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the target sentence, hence not helpful for entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the target sentence, hence not helpful for entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the target sentence, hence not helpful for entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the target sentence, hence not helpful for entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the target sentence, hence not helpful for entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the target sentence, hence not helpful for entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the target sentence, hence not helpful for entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the target sentence, hence not helpful for entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the target sentence, hence not helpful for entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the target sentence, hence not helpful for entity extraction."},\n    {"Sentence": 1},\n    {"Reason": "The sentence does not contain any named entities relevant to the target sentence, hence not helpful for entity extraction."}\n]', 'response3': '[{"HIV-1": "cell_type"}, {"NF-KB": "protein"}]', 'prediction': {'HIV-1': 'cell_type', 'NF-KB': 'protein'}}
{'idx': 469, 'sentence': 'Cardiac and adrenergic diseases were excluded.', 'label': {}, 'response1': 'None.', 'response2': '[\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 5},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 4},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 3},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 5},\n    {"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 4},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05).": 4},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 3},\n    {"In addition, assay of PBMC by the adenovirus-specific PCR may help detect early invasive disease and warrants further evaluation.": 4},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 3},\n    {"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.": 5},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 4},\n    {"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.": 5},\n    {"When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of the binding.": 4},\n    {"Recently, it has been shown that RelB knockout mice have no dendritic cells (DC).": 5},\n    {"Extracts prepared from XP-B and XP-D lymphoblastoid cells exhibited similar transcription activity from the adenovirus major late promoter when compared to that in extracts from normal cells.": 4}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1683, 'sentence': 'These results strongly suggest that HU induces both transcriptional and post-transcription regulation of c-jun during erythroid differentiation .', 'label': {'c-jun': 'DNA'}, 'response1': "['RNA', 'protein']", 'response2': '[\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 4},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 5},\n    {"SCL is expressed in erythroid, megakaryocyte and mast cell populations (the same cell lineages as GATA-1, a zinc-finger transcription factor).": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 4},\n    {"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.": 5},\n    {"Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells).": 5},\n    {"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb/Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5},\n    {"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.": 5},\n    {"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.": 5},\n    {"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB-induced trans-activation of the H4 promoter.": 5}\n]', 'response3': '[{"c-jun": "protein"}]', 'prediction': {'c-jun': 'protein'}}
{'idx': 1648, 'sentence': 'Point mutations of either the PU.1 site or the C/EBP site that abolish the binding of the respective factors result in a significant decrease of GM-CSF receptor alpha promoter activity in myelomonocytic cells only.', 'label': {'PU.1 site': 'DNA', 'GM-CSF receptor alpha': 'protein', 'GM-CSF receptor alpha promoter': 'DNA', 'myelomonocytic cells': 'cell_type', 'C/EBP': 'protein', 'PU.1': 'protein', 'GM-CSF': 'protein', 'C/EBP site': 'DNA'}, 'response1': "['protein']", 'response2': '[\n{"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n{"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines .": 4},\n{"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .": 4},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 4},\n{"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .": 3},\n{"The effects of G-CSF are mediated by binding to specific, high affinity receptors .": 3},\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 4},\n{"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]": 4},\n{"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 4},\n{"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 4},\n{"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .": 4},\n{"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 4},\n{"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n{"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .": 5},\n{"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n{"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 3},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 3}\n]', 'response3': '[{"PU.1": "protein"}, {"C/EBP": "protein"}, {"GM-CSF receptor alpha": "protein"}, {"myelomonocytic cells": "cell_type"}]', 'prediction': {'PU.1': 'protein', 'C/EBP': 'protein', 'GM-CSF receptor alpha': 'protein', 'myelomonocytic cells': 'cell_type'}}
{'idx': 646, 'sentence': 'Surgically confirmed nodal involvement was observed in 42%.', 'label': {}, 'response1': 'None.', 'response2': '[\n{"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 3},\n{"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n{"The expression of NDP kinase was intense in KA and SCC compared with BCC.": 4},\n{"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.": 4},\n{"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n{"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 3},\n{"By the time of diagnosis of T-PLL, the clone contains many more genetic changes in the form of additional translocations.": 3},\n{"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 4},\n{"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 3},\n{"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.": 4},\n{"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n{"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 4},\n{"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.": 4},\n{"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.": 5},\n{"Treatment with soluble, bivalent mAb J393 killed 25-50% of the cell population, while concomitant engagement of either the CD3.TcR complex or the integrins CD18 and CD29 significantly potentiated this effect.": 5},\n{"When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of the binding.": 4}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 821, 'sentence': '(vi) The EBV type 2 EBNA-2 transactivated LMP1 as well as the EBV type 1 EBNA-2 .', 'label': {'LMP1': 'protein', 'EBNA-2': 'protein', 'EBV type 1 EBNA-2': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.": 4},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 3},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.": 4},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.": 4},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 4},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 3},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 3},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 3},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 4},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB.": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[{"EBV type 2 EBNA-2": "protein"}, {"LMP1": "protein"}, {"EBV type 1 EBNA-2": "protein"}]', 'prediction': {'EBV type 2 EBNA-2': 'protein', 'LMP1': 'protein', 'EBV type 1 EBNA-2': 'protein'}}
{'idx': 548, 'sentence': 'On the other hand, interleukin 2 ( IL-2 )-induced signals are blocked by rapamycin but not by FK506 .', 'label': {'IL-2': 'protein', 'interleukin 2': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .": 4},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n    {"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells .": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 4},\n    {"Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.": 5},\n    {"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin .": 5},\n    {"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .": 5},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .": 5}\n]', 'response3': '[{"interleukin 2": "protein"}, {"IL-2": "protein"}, {"rapamycin": "protein"}, {"FK506": "protein"}]', 'prediction': {'interleukin 2': 'protein', 'IL-2': 'protein', 'rapamycin': 'protein', 'FK506': 'protein'}}
{'idx': 135, 'sentence': 'Tumor necrosis factor alpha ( TNF-alpha ) mRNA production was analyzed by polymerase chain reaction amplification in monocytic U937 cells and in a chronically HIV infected U937 cell line ( U9-IIIB ).', 'label': {'U9-IIIB': 'cell_line', 'monocytic U937 cells': 'cell_line', 'Tumor necrosis factor alpha ( TNF-alpha ) mRNA': 'RNA', 'chronically HIV infected U937 cell line': 'cell_line', 'Tumor necrosis factor alpha': 'protein', 'TNF-alpha': 'protein'}, 'response1': "['RNA', 'cell_type', 'cell_line']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"2": "The sentence does not contain any of the entity types in the label set."},\n    {"3": "The sentence contains relevant protein entities (IFN-gamma, tumor necrosis factor-alpha) but does not contain other entity types in the label set."},\n    {"4": "The sentence contains a cell line entity (Philadelphia chromosome-positive chronic myeloid leukemia) but does not contain other entity types in the label set."},\n    {"5": "The sentence contains relevant protein entities (IFN A, interleukin-2, interleukin-2 receptor) but does not contain other entity types in the label set."},\n    {"6": "The sentence contains cell line entities (Ramos, Jurkat) and a DNA entity (cDNA microarray technology) but does not contain other entity types in the label set."},\n    {"7": "The sentence contains a cell type entity (HIV-1) and relevant protein entities (IFN, PKR, IkappaBalpha) but does not contain other entity types in the label set."},\n    {"8": "The sentence contains relevant protein entities (interleukin-2, alpha chain, CD25, IL-2 receptor) but does not contain other entity types in the label set."},\n    {"9": "The sentence contains relevant protein entities (TR55, TNF-alpha) and a cell type entity (HIV) but does not contain other entity types in the label set."},\n    {"10": "The sentence contains relevant protein entities (Fibroblast growth factor-1, IL-2, NF-kappaB) and a cell line entity (Jurkat T cells) but does not contain other entity types in the label set."},\n    {"11": "The sentence contains relevant protein entities (MNDA) and cell type entities (monocytes, macrophages, leukemia/B lymphoma cell lines) but does not contain other entity types in the label set."},\n    {"12": "The sentence contains relevant protein entities (LITAF, TNF-alpha) but does not contain other entity types in the label set."},\n    {"13": "The sentence contains DNA entities (nuclear factor-kappa B, NF-kappa B) but does not contain other entity types in the label set."},\n    {"14": "The sentence contains relevant protein entities (NF-kappa B, fibrinogen) but does not contain other entity types in the label set."},\n    {"15": "The sentence contains relevant protein entities (HIV, NF-kappa B, p105, p50, MAD3) but does not contain other entity types in the label set."},\n    {"16": "The sentence contains relevant protein entities (alpha 4 beta 1, TCR/CD3) and a DNA entity (DNA) but does not contain other entity types in the label set."},\n    {"17": "The sentence does not contain any of the entity types in the label set."},\n    {"18": "The sentence does not contain any of the entity types in the label set."},\n    {"19": "The sentence does not contain any of the entity types in the label set."},\n    {"20": "The sentence does not contain any of the entity types in the label set."},\n    {"21": "The sentence does not contain any of the entity types in the label set."},\n    {"22": "The sentence does not contain any of the entity types in the label set."},\n    {"23": "The sentence does not contain any of the entity types in the label set."},\n    {"24": "The sentence does not contain any of the entity types in the label set."},\n    {"25": "The sentence does not contain any of the entity types in the label set."},\n    {"26": "The sentence does not contain any of the entity types in the label set."},\n    {"27": "The sentence does not contain any of the entity types in the label set."},\n    {"28": "The sentence does not contain any of the entity types in the label set."},\n    {"29": "The sentence does not contain any of the entity types in the label set."},\n    {"30": "The sentence does not contain any of the entity types in the label set."}\n]', 'response3': '[{"TNF-alpha": "protein"}, {"polymerase chain reaction": "DNA"}, {"monocytic U937 cells": "cell_type"}, {"HIV": "cell_type"}, {"U937 cell line (U9-IIIB)": "cell_line"}]', 'prediction': {'TNF-alpha': 'protein', 'polymerase chain reaction': 'DNA', 'monocytic U937 cells': 'cell_type', 'HIV': 'cell_type', 'U937 cell line (U9-IIIB)': 'cell_line'}}
{'idx': 432, 'sentence': 'Moreover, BSAP is clearly a B-cell-specific transcription factor , as a wild-type but not a mutant TSAP -binding site of the sea urchin functions only in transfected B cells as an upstream promoter element .', 'label': {'transfected B cells': 'cell_line', 'TSAP': 'protein', 'mutant TSAP -binding site': 'DNA', 'upstream promoter element': 'DNA', 'BSAP': 'protein', 'B-cell-specific transcription factor': 'protein', 'wild-type': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n{"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n{"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n{"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n{"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 5},\n{"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 5},\n{"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 5},\n{"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.": 5},\n{"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n{"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n{"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n{"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF.": 5},\n{"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5}\n]', 'response3': '[{"BSAP": "protein"}, {"TSAP": "protein"}, {"sea urchin": "cell_line"}, {"B-cell": "cell_type"}]', 'prediction': {'BSAP': 'protein', 'TSAP': 'protein', 'sea urchin': 'cell_line', 'B-cell': 'cell_type'}}
{'idx': 1161, 'sentence': 'Deoxycholate treatment of the cytoplasmic extract prepared from cells stimulated by TNF-alpha in the presence of Cu2+ resulted in the release of NF kappa B from I kappa B alpha , indicating that Cu2+ interferes with the dissociation of the NF kappa B -I kappa B complex .', 'label': {'I kappa B alpha': 'protein', 'NF kappa B': 'protein', 'NF kappa B -I kappa B complex': 'protein', 'TNF-alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.": 5},\n    {"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .": 5},\n    {"When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma , the cells instead become DC .": 5},\n    {"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 5},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .": 5},\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .": 5},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .": 5},\n    {"Control of NF-kappa B activity by the I kappa B beta inhibitor .": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[{"NF kappa B": "protein"}, {"I kappa B alpha": "protein"}, {"Cu2+": "cell_line"}]', 'prediction': {'NF kappa B': 'protein', 'I kappa B alpha': 'protein', 'Cu2+': 'cell_line'}}
{'idx': 1794, 'sentence': 'Activation of the signal transducer and transcription ( STAT ) signaling pathway in a primary T cell response .', 'label': {'STAT': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"1": "The sentence contains specific protein names such as interleukin 10, IL-10R, STAT3, and IL-6, which are directly related to the entity labels provided. This example is highly relevant for extracting protein entities from the target sentence."},\n    {"2": "The sentence mentions NF-kappaB, Tax, and ATL, which are relevant to the provided entity labels. This example is helpful for identifying protein and cell_type entities in the target sentence."},\n    {"3": "The sentence includes IL4, IL13, gamma c chain, STAT6, STAT3, and STAT5, which are directly related to the entity labels provided. This example is highly relevant for extracting protein and cell_type entities from the target sentence."},\n    {"4": "The sentence mentions IL-2, which is directly related to the entity label provided. This example is relevant for identifying protein entities in the target sentence."},\n    {"5": "The sentence contains IL-12, STAT4, NK cells, T cells, and IL-12 receptor, which are relevant to the provided entity labels. This example is helpful for identifying protein and cell_type entities in the target sentence."},\n    {"6": "The sentence includes Stat3, Stat5, and c-Mpl, which are directly related to the entity labels provided. This example is highly relevant for extracting protein entities from the target sentence."},\n    {"7": "The sentence mentions Stat proteins, which are directly related to the entity label provided. This example is relevant for identifying protein entities in the target sentence."},\n    {"8": "The sentence contains CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, and granulocyte-macrophage colony-stimulating factor, which are relevant to the provided entity labels. This example is helpful for extracting protein entities from the target sentence."},\n    {"9": "The sentence mentions IL-2 receptor alpha subunit and p21ras, which are directly related to the entity labels provided. This example is highly relevant for identifying protein and cell_type entities in the target sentence."},\n    {"10": "The sentence includes Syk, Zap, and T cell antigen receptor, which are relevant to the provided entity labels. This example is helpful for extracting protein and cell_type entities from the target sentence."},\n    {"11": "The sentence mentions IkappaBbeta and NF-kappaB, which are directly related to the entity labels provided. This example is highly relevant for identifying protein entities in the target sentence."},\n    {"12": "The sentence contains ERK and STAT3, which are relevant to the provided entity labels. This example is helpful for identifying protein entities in the target sentence."},\n    {"13": "The sentence mentions STAT1, which is directly related to the entity label provided. This example is relevant for extracting protein entities from the target sentence."},\n    {"14": "The sentence includes IL-2, IFN-gamma, jak kinases, and STAT1(alpha), which are directly related to the entity labels provided. This example is highly relevant for identifying protein entities from the target sentence."},\n    {"15": "The sentence mentions GATA-1, which is directly related to the entity label provided. This example is relevant for extracting protein entities from the target sentence."},\n    {"16": "The sentence contains IkappaBalpha and NF-kappaB, which are relevant to the provided entity labels. This example is helpful for identifying protein entities in the target sentence."},\n    {"17": "The sentence does not contain any relevant entity labels from the provided set."},\n    {"18": "The sentence does not contain any relevant entity labels from the provided set."},\n    {"19": "The sentence does not contain any relevant entity labels from the provided set."},\n    {"20": "The sentence does not contain any relevant entity labels from the provided set."},\n    {"21": "The sentence does not contain any relevant entity labels from the provided set."},\n    {"22": "The sentence does not contain any relevant entity labels from the provided set."},\n    {"23": "The sentence does not contain any relevant entity labels from the provided set."},\n    {"24": "The sentence does not contain any relevant entity labels from the provided set."},\n    {"25": "The sentence does not contain any relevant entity labels from the provided set."},\n    {"26": "The sentence does not contain any relevant entity labels from the provided set."},\n    {"27": "The sentence does not contain any relevant entity labels from the provided set."},\n    {"28": "The sentence does not contain any relevant entity labels from the provided set."},\n    {"29": "The sentence does not contain any relevant entity labels from the provided set."},\n    {"30": "The sentence does not contain any relevant entity labels from the provided set."}\n]', 'response3': '[{"STAT": "protein"}, {"T cell": "cell_type"}]', 'prediction': {'STAT': 'protein', 'T cell': 'cell_type'}}
{'idx': 1470, 'sentence': 'Hence, induction of cell surface expression of this leukocyte adhesion molecule by tumor necrosis factor (TNF)-alpha was reduced by 40% in the presence of CsA , and this was reflected by a 29% decrease in neutrophil adhesion .', 'label': {'neutrophil': 'cell_type', 'tumor necrosis factor (TNF)-alpha': 'protein', 'leukocyte adhesion molecule': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n    {"PMA induced the expression of both CD14 and CD23 mRNA and protein.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n    {"CD40 expression could be enhanced in CD40-positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 5},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 4},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 5},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.": 4},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 644, 'sentence': 'Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers : a role for hematopoietic growth factor release by tumor cells ?', 'label': {'tumor cells': 'cell_type', 'hematopoietic growth factor': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example contains a specific cell type \'Th2-type lymphocytes\' which matches the \'cell_type\' entity label in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The example contains specific proteins such as \'NF-kappaB\', \'Tax\', and \'ATL\' which match the \'protein\' and \'cell_type\' entity labels in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The example contains specific proteins such as \'IL-13\', \'IL-4R\', \'JAK2\', and \'IL-13R\' which match the \'protein\' entity label in the target sentence."},\n    {"Example 4": 4},\n    {"Reason 4": "The example contains specific proteins such as \'immunohistochemistry\' and \'gene\', and a cell type \'cell type\' which match the \'protein\' and \'DNA\' entity labels in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The example contains a specific cell type \'lymphoid neoplasms\' which matches the \'cell_type\' entity label in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The example contains specific proteins such as \'IL-2 receptor alpha subunit\', \'p21ras\', and \'B cell\' which match the \'protein\' and \'cell_type\' entity labels in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The example contains specific proteins such as \'TAL1\' and \'T-ALL\' which match the \'protein\' and \'cell_type\' entity labels in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example contains specific proteins such as \'WT1\' and \'myeloid cell lines\' which match the \'protein\' and \'cell_line\' entity labels in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example contains specific proteins such as \'IL4\', \'IL13\', \'STAT6\', \'STAT3\', \'STAT5\', and a cell type \'B cells\' which match the \'protein\' and \'cell_type\' entity labels in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The example contains specific proteins such as \'MNDA\' and \'Philadelphia chromosome-positive chronic myeloid leukemia\' which match the \'protein\' and \'cell_line\' entity labels in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The example contains specific proteins such as \'CD28\', \'CD80\', \'CD86\', \'CBL\', \'VAV\', \'NFAT\', \'interleukin-2\', \'granulocyte-macrophage colony-stimulating factor\' which match the \'protein\' entity label in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The example contains specific proteins such as \'Oct-2A\', \'HMG I/Y\', \'HLA-DRA\', and a cell type \'B cells\' which match the \'protein\' and \'cell_type\' entity labels in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The example contains specific proteins such as \'IL-2\', \'c-Jun\', \'c-Fos\' which match the \'protein\' entity label in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The example contains specific proteins such as \'CD70\', \'IL-4\', \'CD40\', and cell types \'B cell\', \'plasma cells\' which match the \'protein\' and \'cell_type\' entity labels in the target sentence."},\n    {"Example 15": 4},\n    {"Reason 15": "The example contains a specific DNA entity \'AP-1\' which matches the \'DNA\' entity label in the target sentence."},\n    {"Example 16": 5},\n    {"Reason 16": "The example contains specific cell types \'B and T cell activation\', \'Ramos\', \'Jurkat\', and a technology \'cDNA microarray technology\' which match the \'cell_type\' and \'cell_line\' entity labels in the target sentence."}\n]', 'response3': "[{'lymphocyte': 'cell_type'}, {'breast cancers': 'cell_type'}, {'hematopoietic growth factor': 'protein'}, {'tumor cells': 'cell_type'}]", 'prediction': {'lymphocyte': 'cell_type', 'breast cancers': 'cell_type', 'hematopoietic growth factor': 'protein', 'tumor cells': 'cell_type'}}
{'idx': 435, 'sentence': 'Antibodies are produced exclusively in B lymphocytes .', 'label': {'Antibodies': 'protein', 'lymphocytes': 'cell_type', 'B lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"IgH": 5, "Eosinophils": 5, "IL-13": 5, "IL-4": 5, "EBV": 5, "CD2": 5, "IL4": 5, "IL13": 5, "STAT6": 5, "STAT3": 5, "STAT5": 5, "Th1": 5, "Th2": 5, "Th2-type lymphocytes": 5, "CD70": 5, "NF-ATc": 5, "IL-2 receptor alpha subunit": 5, "p21ras": 5, "HLA-molecules": 5, "E2A": 5, "benzene": 5, "benzoquinone": 5, "ICAM-1": 5, "CD71": 5, "LMP1": 5, "IkappaB": 5, "CD40": 5, "Rel/nuclear factor kappaB": 5, "NF-kappaB": 5, "B lymphocytes": 5},\n{"reasons": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1342, 'sentence': 'While Bik does not show overt homology to the BH1 and BH2 conserved domains characteristic of the Bcl-2 family , it does share a 9 amino acid domain ( BH3 ) with Bax and Bak which may be a critical determinant for the death-promoting activity of these proteins.', 'label': {'amino acid domain': 'protein', 'BH1': 'protein', 'BH3': 'protein', 'Bak': 'protein', 'BH2': 'protein', 'Bax': 'protein', 'Bik': 'protein', 'Bcl-2 family': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n{"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 5},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n{"These two related genes share the evolutionarily conserved region encoding the Runt domain.": 5},\n{"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n{"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n{"Tat-binding protein 7 is a subunit of the 26S protease.": 5},\n{"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n{"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n{"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.": 5},\n{"Activation of NF-kappaB by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.": 5},\n{"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n{"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5}\n]', 'response3': '[{"Bik": "protein"}, {"BH1": "protein"}, {"BH2": "protein"}, {"Bcl-2": "protein"}, {"BH3": "protein"}, {"Bax": "protein"}, {"Bak": "protein"}]', 'prediction': {'Bik': 'protein', 'BH1': 'protein', 'BH2': 'protein', 'Bcl-2': 'protein', 'BH3': 'protein', 'Bax': 'protein', 'Bak': 'protein'}}
{'idx': 1022, 'sentence': 'NK cell NFAT is present in the cytosol of nonstimulated cells , migrates to the nucleus upon stimulation, and can associate with AP-1 .', 'label': {'NK cell NFAT': 'protein', 'AP-1': 'protein', 'nonstimulated cells': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Sentence 1": 5},\n    {"Sentence 2": 5},\n    {"Sentence 3": 5},\n    {"Sentence 4": 5},\n    {"Sentence 5": 5},\n    {"Sentence 6": 5},\n    {"Sentence 7": 5},\n    {"Sentence 8": 5},\n    {"Sentence 9": 1},\n    {"Sentence 10": 1},\n    {"Sentence 11": 1},\n    {"Sentence 12": 1},\n    {"Sentence 13": 1},\n    {"Sentence 14": 1},\n    {"Sentence 15": 1},\n    {"Sentence 16": 1},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1},\n    {"Sentence 20": 1},\n    {"Sentence 21": 1},\n    {"Sentence 22": 1},\n    {"Sentence 23": 1},\n    {"Sentence 24": 1}\n]', 'response3': '[{"NK cell": "cell_type"}, {"NFAT": "protein"}, {"AP-1": "protein"}]', 'prediction': {'NK cell': 'cell_type', 'NFAT': 'protein', 'AP-1': 'protein'}}
{'idx': 810, 'sentence': 'Exposure of CML cells to IFN-alpha diminished the effect of the CML cytoplasmic proteins on these nuclear protein-DNA complexes .', 'label': {'CML cells': 'cell_type', 'IFN-alpha': 'protein', 'CML cytoplasmic proteins': 'protein', 'nuclear protein-DNA complexes': 'protein'}, 'response1': "['protein', 'cell_line', 'DNA']", 'response2': '[\n{"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.": 5},\n{"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .": 5},\n{"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.": 5},\n{"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 5},\n{"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .": 5},\n{"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n{"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.": 5},\n{"When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma , the cells instead become DC .": 5},\n{"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .": 5},\n{"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .": 5},\n{"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .": 5},\n{"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n{"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 5},\n{"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': "[{'CML': 'cell_line'}, {'IFN-alpha': 'protein'}, {'CML': 'cell_line'}, {'cytoplasmic proteins': 'protein'}, {'nuclear protein-DNA complexes': 'DNA'}]", 'prediction': {'CML': 'cell_line', 'IFN-alpha': 'protein', 'cytoplasmic proteins': 'protein', 'nuclear protein-DNA complexes': 'DNA'}}
{'idx': 1811, 'sentence': "In our attempt to identify chemokine receptors that are related to Burkitt's lymphoma receptor 1 ( BLR1 ) and are expressed in activated lymphocytes we used RT-PCR resulting in the isolation of a cDNA encoding a seven transmembrane receptor termed BLR2 .", 'label': {'BLR1': 'protein', 'BLR2': 'protein', 'seven transmembrane receptor': 'protein', 'activated lymphocytes': 'cell_type', 'chemokine receptors': 'protein', "Burkitt's lymphoma receptor 1": 'protein'}, 'response1': "['DNA', 'RNA', 'protein']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 3},\n    {"Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 4},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 3},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 4},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"This suggests that CHEMR1 may be a receptor for unidentified C-C chemokine or a low-affinity receptor for MIP-1alpha .": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[{"Burkitt\'s lymphoma receptor 1 (BLR1)": "protein"}, {"BLR2": "protein"}]', 'prediction': {"Burkitt's lymphoma receptor 1 (BLR1)": 'protein', 'BLR2': 'protein'}}
{'idx': 1316, 'sentence': 'Helix III is less rigid, makes an average angle of about 90 degrees with helices I and II , and constitutes the other arm of the molecule.', 'label': {'Helix III': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 1},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 939, 'sentence': 'However, in 3 postmenopausal patients a short course of estrogen or tamoxifen resulted in a marked increase of type II EBS levels.', 'label': {'type II EBS': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 4},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 1},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 292, 'sentence': 'We used mouse embryonic stem (ES) cells to study globin gene expression and switching in vitro.', 'label': {'globin gene': 'DNA', 'mouse embryonic stem (ES) cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n{"E2A": 5},\n{"MNDA": 5},\n{"granulocytes": 4},\n{"T cells": 4},\n{"IgH": 5},\n{"PML/RARalpha": 5},\n{"GM-CSF": 5},\n{"GATA-1": 5},\n{"SCM-1": 5},\n{"IFN A": 5},\n{"IFNA": 5},\n{"interleukin-2": 5},\n{"interleukin-2 receptor": 5},\n{"phytohemagglutinin": 5},\n{"phorbol myristate acetate": 5},\n{"GATA-1": 5},\n{"CCAAT box": 5},\n{"EKLF binding site": 5},\n{"Egr-1": 5},\n{"RXR": 5},\n{"Sp1": 5},\n{"Ets": 5},\n{"c-kit": 5},\n{"IL-4R alpha chain": 5},\n{"ZEB": 5},\n{"c-Myb": 5},\n{"Ets": 5},\n{"hematopoietic cells": 4}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 542, 'sentence': 'Amino acid sequences of all proteins are essays written in the same language.', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 505, 'sentence': 'The TCF-1 alpha binding site was also required for TCR alpha enhancer activity in transcriptionally active extracts from Jurkat but not HeLa cells , confirming that TCF-1 alpha is a T-cell-specific transcription factor .', 'label': {'Jurkat': 'cell_line', 'TCF-1 alpha': 'protein', 'TCR': 'protein', 'T-cell-specific transcription factor': 'protein', 'TCF-1 alpha binding site': 'DNA', 'HeLa cells': 'cell_line'}, 'response1': "['protein', 'cell_line', 'cell_type']", 'response2': '[\n    {"NF-ATc": 5},\n    {"T lymphocytes": 4},\n    {"embryonic cardiac cells": 4},\n    {"TCF-1": 3},\n    {"IL-2": 4},\n    {"c-Jun": 4},\n    {"c-Fos": 4},\n    {"Jun": 4},\n    {"ATF-2": 4},\n    {"Sp1": 4},\n    {"CD14": 4},\n    {"GATA-1": 5},\n    {"T cell": 4},\n    {"interleukin 2": 4},\n    {"Sp1": 4},\n    {"Ets": 4},\n    {"Tax": 4},\n    {"TFIIA": 4},\n    {"EKLF": 5},\n    {"CBP": 5},\n    {"p300": 5},\n    {"P/CAF": 5},\n    {"RelA": 4},\n    {"NF-kappa B": 4},\n    {"IL-2": 4},\n    {"IFN-gamma": 4},\n    {"jak kinases": 4},\n    {"STAT1(alpha)": 4},\n    {"Egr-1": 5},\n    {"TCF-1": 4},\n    {"IFN A": 4},\n    {"IFNA": 4},\n    {"interleukin-2": 4},\n    {"interleukin-2 receptor": 4},\n    {"phytohemagglutinin": 4},\n    {"phorbol myristate acetate": 4},\n    {"IkappaBbeta": 4},\n    {"NF-kappaB": 4}\n]', 'response3': '[{"TCF-1 alpha": "protein"}, {"TCR alpha": "protein"}, {"Jurkat": "cell_line"}, {"HeLa": "cell_line"}, {"T-cell-specific": "cell_type"}]', 'prediction': {'TCF-1 alpha': 'protein', 'TCR alpha': 'protein', 'Jurkat': 'cell_line', 'HeLa': 'cell_line', 'T-cell-specific': 'cell_type'}}
{'idx': 1525, 'sentence': 'Kinase activity was reduced in lysates preadsorbed using an antibody specific for CaM kinase II .', 'label': {'antibody': 'protein', 'CaM kinase II': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides specific protein names that match the entity types in the target sentence, making it highly relevant for named entity extraction."}\n]', 'response3': '[{"CaM kinase II": "protein"}]', 'prediction': {'CaM kinase II': 'protein'}}
{'idx': 1103, 'sentence': 'Relationship between Rap1 protein phosphorylation and regulation of Ca2+ transport in platelets : a new approach.', 'label': {'platelets': 'cell_type', 'Rap1 protein': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"Rap1": "protein"}, {"Ca2+": "protein"}, {"platelets": "cell_type"}]', 'prediction': {'Rap1': 'protein', 'Ca2+': 'protein', 'platelets': 'cell_type'}}
{'idx': 538, 'sentence': 'Alone, PMA and calcium ionophore A23187 did not affect, but together stimulated, like phytohaemagglutinin ( PHA ), leucine and, in particular, thymidine incorporation .', 'label': {'PHA': 'protein', 'phytohaemagglutinin': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 5},\n    {"Example 17": 5},\n    {"Example 18": 5},\n    {"Example 19": 5},\n    {"Example 20": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1529, 'sentence': 'Transcriptional activation and repression , two properties of the lymphoid-specific transcription factor Oct-2a .', 'label': {'Oct-2a': 'protein', 'lymphoid-specific transcription factor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names that are directly mentioned, making it highly relevant for extracting protein entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions a specific cell type (Th2-type lymphocytes), which is directly related to a cell type entity."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence mentions multiple protein names (Oct-2A, HMG I/Y, HLA-DRA) and a cell type (B cells), making it highly relevant for extracting protein and cell type entities."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence mentions specific cell types (T cell) and a protein (interleukin 2), which are directly related to cell type and protein entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence mentions multiple protein names (NF-kB, AP-1, OCT-1, NF-IL-2B), making it highly relevant for extracting protein entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions a specific protein name (Egr-1), making it highly relevant for extracting protein entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence mentions specific protein names (IL-2 receptor alpha subunit, p21ras) and a cell type (B cell), making it highly relevant for extracting protein and cell type entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions specific protein names (SP1, caspases) and a cell type (B-cell), making it highly relevant for extracting protein and cell type entities."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence mentions a specific protein name (NF-ATc) and a cell type (T lymphocytes), making it relevant for extracting protein and cell type entities."},\n    {"Example 10": 3},\n    {"Reason 10": "The sentence mentions a DNA-binding activity related to AP-1, which is indirectly related to a DNA entity."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions a specific protein name (A-myb), making it highly relevant for extracting protein entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions specific protein names (Sp1, Ets) related to transcription factors, making it highly relevant for extracting protein entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions specific protein names (Jun, ATF-2) related to transcription factors, making it highly relevant for extracting protein entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions a specific protein name (NF-E2), making it highly relevant for extracting protein entities."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions a specific protein name (NF-ATc) and cell types (T lymphocytes, embryonic cardiac cells), making it highly relevant for extracting protein and cell type entities."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence mentions a specific protein name (GATA-1), making it highly relevant for extracting protein entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities related to the given entity labels, hence not helpful for extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities related to the given entity labels, hence not helpful for extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any named entities related to the given entity labels, hence not helpful for extraction."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any named entities related to the given entity labels, hence not helpful for extraction."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any named entities related to the given entity labels, hence not helpful for extraction."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any named entities related to the given entity labels, hence not helpful for extraction."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any named entities related to the given entity labels, hence not helpful for extraction."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any named entities related to the given entity labels, hence not helpful for extraction."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any named entities related to the given entity labels, hence not helpful for extraction."}\n]', 'response3': '[{"Oct-2a": "protein"}]', 'prediction': {'Oct-2a': 'protein'}}
{'idx': 1197, 'sentence': 'In this study, we demonstrate reconstitution of a cell-free processing system and demonstrate directly that: (a) the ubiquitin -proteasome system is involved in processing of the intact p105 precursor, (b) conjugation of ubiquitin to the precursor is an essential intermediate step in the processing, (c) the recently discovered novel species of the ubiquitin -carrier protein , E2-F1 , that is involved in the conjugation and degradation of p53 , is also required for the limited processing of the p105 precursor , and (d) a novel, approximately 320-kDa species of ubiquitin -protein ligase , is involved in the process.', 'label': {'ubiquitin': 'protein', 'p105 precursor': 'protein', 'E2-F1': 'protein', '-proteasome': 'protein', 'ubiquitin -carrier protein': 'protein', 'p53': 'protein', 'ubiquitin -protein ligase': 'protein', '320-kDa species': 'protein', 'p105': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n{"Tat-binding protein 7 is a subunit of the 26S protease.": 5},\n{"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n{"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 5},\n{"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n{"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n{"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.": 5},\n{"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n{"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n{"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n{"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n{"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n{"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 5},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n{"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5}\n]', 'response3': '[{"ubiquitin -proteasome system": "protein"}, {"p105 precursor": "protein"}, {"ubiquitin": "protein"}, {"E2-F1": "protein"}, {"p53": "protein"}, {"ubiquitin -carrier protein": "protein"}, {"ubiquitin -protein ligase": "protein"}]', 'prediction': {'ubiquitin -proteasome system': 'protein', 'p105 precursor': 'protein', 'ubiquitin': 'protein', 'E2-F1': 'protein', 'p53': 'protein', 'ubiquitin -carrier protein': 'protein', 'ubiquitin -protein ligase': 'protein'}}
{'idx': 877, 'sentence': 'Their constitutive expression is limited to B lymphocytes and thymic epithelial cells .', 'label': {'B lymphocytes': 'cell_type', 'thymic epithelial cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains clear mentions of specific entities with corresponding labels, aiding in the extraction process."},\n\n    {"Example 2": 4},\n    {"Reason 2": "The sentence provides a specific entity with a corresponding label, aiding in the extraction process."},\n\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains clear mentions of specific entities with corresponding labels, aiding in the extraction process."},\n\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains clear mentions of specific entities with corresponding labels, aiding in the extraction process."},\n\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains clear mentions of specific entities with corresponding labels, aiding in the extraction process."},\n\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains clear mentions of specific entities with corresponding labels, aiding in the extraction process."},\n\n    {"Example 7": 4},\n    {"Reason 7": "The sentence provides specific entities with corresponding labels, aiding in the extraction process."},\n\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains clear mentions of specific entities with corresponding labels, aiding in the extraction process."},\n\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains clear mentions of specific entities with corresponding labels, aiding in the extraction process."},\n\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains clear mentions of specific entities with corresponding labels, aiding in the extraction process."},\n\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains clear mentions of specific entities with corresponding labels, aiding in the extraction process."},\n\n    {"Example 12": 4},\n    {"Reason 12": "The sentence provides specific entities with corresponding labels, aiding in the extraction process."},\n\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not contain any relevant entities or labels for extraction."},\n\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not contain any relevant entities or labels for extraction."},\n\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any relevant entities or labels for extraction."},\n\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any relevant entities or labels for extraction."},\n\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any relevant entities or labels for extraction."},\n\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any relevant entities or labels for extraction."},\n\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any relevant entities or labels for extraction."},\n\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any relevant entities or labels for extraction."}\n]', 'response3': '[{"B lymphocytes": "cell_type"}, {"thymic epithelial cells": "cell_type"}]', 'prediction': {'B lymphocytes': 'cell_type', 'thymic epithelial cells': 'cell_type'}}
{'idx': 1838, 'sentence': 'First, we show that mutations in the LEF-1 -binding site inhibit the activity of multimerized copies of the HIV-1 enhancer in Jurkat T cells , and that LEF-1 /GAL4 can activate a GAL4-substituted HIV-1 enhancer 80- to 100-fold in vivo.', 'label': {'LEF-1 -binding site': 'DNA', 'HIV-1 enhancer': 'DNA', 'LEF-1': 'protein', 'GAL4-substituted HIV-1 enhancer': 'DNA', 'Jurkat T cells': 'cell_line', 'multimerized copies': 'DNA', 'LEF-1 /GAL4': 'protein'}, 'response1': "['protein', 'cell_line', 'cell_type']", 'response2': '[\n{"immunoglobulin kappa 3\' enhancer": 5},\n{"IL-2": 5, "IFN-gamma": 5, "jak kinases": 5, "STAT1(alpha)": 5},\n{"IL-2": 5, "c-Jun": 5, "c-Fos": 5},\n{"IFN A": 5, "IFNA": 5, "interleukin-2": 5, "interleukin-2 receptor": 5, "phytohemagglutinin": 5, "phorbol myristate acetate": 5},\n{"PU.1": 5, "M-CSF receptor": 5, "macrophage": 5},\n{"Sp1": 5, "CD14": 5},\n{"SIVsmmPBj14": 5},\n{"T cell": 5, "interleukin 2": 5},\n{"p50p50": 5},\n{"IkappaBbeta": 5, "NF-kappaB": 5},\n{"HIV-1": 5, "IFN": 5, "PKR": 5, "IkappaBalpha": 5},\n{"NF-kappaB": 5, "Sp1": 5, "SIVmac": 5},\n{"cDNA": 5, "Jurkat": 5, "DRE 1": 5},\n{"HIV-1 LTR": 5, "NFAT-1": 5, "NF kappa B": 5},\n{"TR55": 5, "TNF-alpha": 5, "HIV": 5},\n{"ATF1": 5, "CREB": 5, "H4": 5}\n]', 'response3': '[{"LEF-1": "protein"}, {"HIV-1 enhancer": "DNA"}, {"Jurkat T cells": "cell_type"}, {"GAL4": "protein"}, {"GAL4-substituted HIV-1 enhancer": "DNA"}]', 'prediction': {'LEF-1': 'protein', 'HIV-1 enhancer': 'DNA', 'Jurkat T cells': 'cell_type', 'GAL4': 'protein', 'GAL4-substituted HIV-1 enhancer': 'DNA'}}
{'idx': 1195, 'sentence': 'Palombella and colleagues (Palombella, V.J., Rando, O.J., Goldberg, A.L., and Maniatis, T.(1994) Cell 78, 773-785) have shown that ubiquitin is required for the processing in a cell-free system of a truncated, artificially constructed, 60-kDa precursor .', 'label': {'60-kDa precursor': 'protein', 'ubiquitin': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 817, 'sentence': '(ii) Transfection and expression of EBNA-LP alone had no effect on LMP1 expression and did not act synergistically with EBNA-2 to affect LMP1 expression .', 'label': {'EBNA-LP': 'protein', 'LMP1': 'protein', 'EBNA-2': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"5": "The sentence contains multiple instances of protein entities which are directly mentioned in the sentence."},\n{"5": "The sentence contains multiple instances of protein entities which are directly mentioned in the sentence."},\n{"5": "The sentence contains multiple instances of protein entities which are directly mentioned in the sentence."},\n{"5": "The sentence contains multiple instances of protein entities which are directly mentioned in the sentence."},\n{"5": "The sentence contains multiple instances of protein entities which are directly mentioned in the sentence."},\n{"5": "The sentence contains multiple instances of protein entities which are directly mentioned in the sentence."},\n{"5": "The sentence contains multiple instances of protein entities which are directly mentioned in the sentence."},\n{"5": "The sentence contains multiple instances of protein entities which are directly mentioned in the sentence."},\n{"5": "The sentence contains multiple instances of protein entities which are directly mentioned in the sentence."},\n{"5": "The sentence contains multiple instances of protein entities which are directly mentioned in the sentence."},\n{"5": "The sentence contains multiple instances of protein entities which are directly mentioned in the sentence."},\n{"5": "The sentence contains multiple instances of protein entities which are directly mentioned in the sentence."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 741, 'sentence': 'In melanoma cells that contain the N-Oct-3 factor , a transfected lymphocyte-specific promoter was neither activated nor was it repressed upon contransfection with an Oct-2A expression vector .', 'label': {'Oct-2A expression vector': 'DNA', 'Oct-2A': 'protein', 'N-Oct-3 factor': 'protein', 'melanoma cells': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 4},\n    {"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.": 5},\n    {"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.": 4},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2.": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 4},\n    {"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.": 5},\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 5},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 283, 'sentence': '[ Estrogen receptor content of peripheral blood lymphocytes in patients with systemic lupus erythematosus ]', 'label': {'Estrogen receptor': 'protein', 'peripheral blood lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 4},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms .": 5},\n    {"An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .": 5},\n    {"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.": 5}\n]', 'response3': '[{"Estrogen receptor": "protein"}, {"peripheral blood lymphocytes": "cell_type"}]', 'prediction': {'Estrogen receptor': 'protein', 'peripheral blood lymphocytes': 'cell_type'}}
{'idx': 1043, 'sentence': 'METHOD: Two color flow cytometry analysis was used on peripheral blood samples of young and postmenopausal females and postmenopausal females treated with estrogen replacement therapy .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific gene/protein names that are directly associated with the entity labels in the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions specific gene/protein names that are relevant to the entity labels in the target sentence."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence provides information about a specific gene/protein name that is relevant to the entity labels in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains specific gene/protein names and a cell line name that are directly associated with the entity labels in the target sentence."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence mentions a specific protein name that is relevant to the entity labels in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific gene/protein names that are directly associated with the entity labels in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific gene/protein names, cell line names, and cell type names that are directly associated with the entity labels in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific gene/protein names, cell type names, and a technology name that are directly associated with the entity labels in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains specific gene/protein names and a technology name that are directly associated with the entity labels in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains specific gene/protein names and a cell line name that are directly associated with the entity labels in the target sentence."},\n    {"Example 11": 4},\n    {"Reason 11": "The sentence mentions specific gene/protein names that are relevant to the entity labels in the target sentence."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence mentions specific gene/protein names that are relevant to the entity labels in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains specific gene/protein names and cell type names that are directly associated with the entity labels in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific gene/protein names and cell type names that are directly associated with the entity labels in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains specific gene/protein names and cell type names that are directly associated with the entity labels in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any specific gene/protein names or entity types relevant to the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific gene/protein names or entity types relevant to the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific gene/protein names or entity types relevant to the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific gene/protein names or entity types relevant to the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any specific gene/protein names or entity types relevant to the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any specific gene/protein names or entity types relevant to the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any specific gene/protein names or entity types relevant to the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any specific gene/protein names or entity types relevant to the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any specific gene/protein names or entity types relevant to the target sentence."}\n]', 'response3': '[{"young and postmenopausal females": "cell_type"}, {"postmenopausal females": "cell_type"}, {"estrogen replacement therapy": "protein"}]', 'prediction': {'young and postmenopausal females': 'cell_type', 'postmenopausal females': 'cell_type', 'estrogen replacement therapy': 'protein'}}
{'idx': 1010, 'sentence': 'Using a polyclonal antibody to murine NFATp , Western blot analysis of various mouse tissues demonstrated that the 110-130-kDa NFATp protein was highly expressed in thymus and spleen .', 'label': {'murine NFATp': 'protein', 'NFATp protein': 'protein', 'NFATp': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 3},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 4},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .": 4},\n    {"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .": 4},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .": 5},\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 4},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 4},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .": 4},\n    {"Moreover, monocytes express a novel IL-10 -stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti- STAT3 Ab but is not observed in T cells .": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 4},\n    {"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .": 5}\n]', 'response3': '[{"NFATp": "protein"}, {"NFATp": "protein"}, {"thymus": "cell_type"}, {"spleen": "cell_type"}]', 'prediction': {'NFATp': 'protein', 'thymus': 'cell_type', 'spleen': 'cell_type'}}
{'idx': 186, 'sentence': 'We also find that NF-E2 , another trans-acting factor of the erythrocytic lineage , is present in megakaryocytes .', 'label': {'erythrocytic lineage': 'cell_type', 'NF-E2': 'protein', 'trans-acting factor': 'protein', 'megakaryocytes': 'cell_line'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"RXR": 5},\n    {"SCL": 5},\n    {"GATA-1": 5},\n    {"Stat3": 5},\n    {"Stat5": 5},\n    {"c-Mpl": 5},\n    {"NF-ATc": 5},\n    {"T lymphocytes": 5},\n    {"granulocytes": 5},\n    {"T cells": 5},\n    {"EKLF": 5},\n    {"CBP": 5},\n    {"p300": 5},\n    {"P/CAF": 5},\n    {"Egr-1": 5},\n    {"NF-E2": 5},\n    {"NF-kappaB": 5},\n    {"Tax": 5},\n    {"ATL": 5},\n    {"E2A": 5},\n    {"CD40": 5},\n    {"Rel/nuclear factor kappaB": 5},\n    {"ZEB": 5},\n    {"c-Myb": 5},\n    {"Ets": 5},\n    {"hematopoietic cells": 5}\n]', 'response3': '[{"NF-E2": "protein"}]', 'prediction': {'NF-E2': 'protein'}}
{'idx': 1547, 'sentence': 'Platelet glycoprotein ( GP ) Ib-IX-V is a multisubunit adhesion receptor that supports platelet attachment to thrombogenic surfaces at sites of vascular injury .', 'label': {'multisubunit adhesion receptor': 'protein', 'Ib-IX-V': 'protein', 'Platelet glycoprotein': 'protein', 'GP': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"NF-kappa B": 5},\n    {"CD28": 1, "CD80": 1, "CD86": 1, "CBL": 1, "VAV": 1, "NFAT": 1, "interleukin-2": 1, "granulocyte-macrophage colony-stimulating factor": 1},\n    {"cell adhesion molecules": 5},\n    {"P selectin": 1},\n    {"G-CSF": 1},\n    {"Stat3": 1, "Stat5": 1, "c-Mpl": 1},\n    {"cAMP-dependent protein kinase": 1, "Rap1": 1},\n    {"myeloperoxidase": 1, "lysozyme": 1, "PU.1": 1},\n    {"Tat-binding protein 7": 1},\n    {"IL4": 1, "IL13": 1, "gamma c chain": 1, "STAT6": 1, "STAT3": 1, "STAT5": 1, "B cells": 1},\n    {"NF-kappa B": 1},\n    {"p21ras": 1},\n    {"SLAP-130": 1, "SLP-76": 1, "T cell": 1},\n    {"Syk": 1, "Zap": 1, "T cell": 1},\n    {"GM-CSF": 1},\n    {"alpha-tocopherol": 1, "monocyte": 5, "endothelial cells": 5},\n    {},\n    {},\n    {},\n    {},\n    {},\n    {},\n    {},\n    {},\n    {},\n    {},\n    {},\n    {}\n]', 'response3': '[{"Platelet glycoprotein (GP) Ib-IX-V": "protein"}]', 'prediction': {'Platelet glycoprotein (GP) Ib-IX-V': 'protein'}}
{'idx': 96, 'sentence': 'We have analyzed the functional domains of the minimal Thy-1 promoter and show that the dominant promoter elements consist of multiple binding sites for the transcription factor Sp1 , an inverted CCAAT box , and sequences proximal to the transcription start site .', 'label': {'Sp1': 'protein', 'dominant promoter elements': 'DNA', 'minimal Thy-1 promoter': 'DNA', 'transcription factor': 'protein', 'multiple binding sites': 'DNA', 'CCAAT box': 'DNA', 'transcription start site': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 4},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes.": 4},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 5},\n    {"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 5},\n    {"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif.": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 5},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[{"Thy-1": "protein"}, {"Sp1": "protein"}, {"CCAAT box": "DNA"}]', 'prediction': {'Thy-1': 'protein', 'Sp1': 'protein', 'CCAAT box': 'DNA'}}
{'idx': 1763, 'sentence': 'Cysteamine treatment inhibited both expression of the IL-2 mRNA and secretion of IL-2 into the culture medium .', 'label': {'IL-2': 'protein', 'IL-2 mRNA': 'RNA'}, 'response1': "['RNA', 'protein']", 'response2': '[\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 5},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .": 4},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .": 4},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .": 5},\n    {"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .": 5},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .": 4},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n    {"Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells .": 5}\n]', 'response3': '[{"IL-2 mRNA": "RNA"}, {"IL-2": "protein"}]', 'prediction': {'IL-2 mRNA': 'RNA', 'IL-2': 'protein'}}
{'idx': 224, 'sentence': 'Cortivazol ( CVZ ) is a unique, high potency synthetic glucocorticoid , which has a phenylpyrazol fused to the A-ring of the steroid nucleus and displays binding consistent with two or more sites in the cytosol from CEM C7 cells (a human acute lymphoblastic T-cell line ).', 'label': {'CEM C7 cells': 'cell_line', 'human acute lymphoblastic T-cell line': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone": 5},\n    {"Control of NF-kappa B activity by the I kappa B beta inhibitor": 5},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes": 4},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment": 4},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes": 4},\n    {"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation": 5},\n    {"Benzene toxicity towards lymphocytes is thought to be mediated by metabolites of benzene including benzoquinone (BQ)": 4},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration": 4},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival": 5},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor": 5},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats)": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells": 5},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729": 1}\n]', 'response3': '[{"Cortivazol": "protein"}, {"CVZ": "protein"}, {"CEM C7 cells": "cell_line"}]', 'prediction': {'Cortivazol': 'protein', 'CVZ': 'protein', 'CEM C7 cells': 'cell_line'}}
{'idx': 313, 'sentence': 'Immunohistochemical study of steroid hormones and an estrogen binding assay in malignant soft tissue tumors .', 'label': {'malignant soft tissue tumors': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a clear mapping between the entity \'E2A\' and the entity type \'protein\' in the sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The example provides a clear mapping between the entity \'GATA-1\' and the entity type \'protein\' in the sentence."},\n    {"Example 3": 4},\n    {"Reason 3": "The example provides a clear mapping between the entity \'lymphoid neoplasms\' and the entity type \'cell_type\' in the sentence."},\n    {"Example 4": 3},\n    {"Reason 4": "The example provides a mapping between the entity \'phosphocreatine\' and the entity type \'protein\' in the sentence, but the relevance is slightly lower compared to other examples."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides clear mappings between the entities \'SLAP-130\', \'SLP-76\', \'T cell\' and the entity types \'protein\' and \'cell_type\' in the sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The example provides a clear mapping between the entity \'NF-E2\' and the entity type \'protein\' in the sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides clear mappings between the entities \'immunohistochemistry\', \'gene\', \'cell type\' and the entity types \'protein\' and \'DNA\' and \'cell_type\' in the sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides a clear mapping between the entity \'retinoic acid receptor alpha\' and the entity type \'protein\' in the sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides a clear mapping between the entity \'CD14\' and the entity type \'protein\' in the sentence."},\n    {"Example 10": 4},\n    {"Reason 10": "The example provides mappings between the entities \'HML\', \'dexamethasone\', \'cortisol\', \'lysozyme\' and the entity types \'cell_line\' and \'protein\' in the sentence, but the relevance is slightly lower compared to other examples."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides clear mappings between the entities \'CD40\', \'Rel/nuclear factor kappaB\', \'NF-kappaB\', \'B lymphocytes\' and the entity types \'protein\' and \'cell_type\' in the sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The example provides clear mappings between the entities \'B and T cell activation\', \'Ramos\', \'Jurkat\', \'cDNA microarray technology\' and the entity types \'cell_type\', \'cell_line\', \'cell_line\', \'DNA\' in the sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides clear mappings between the entities \'tal-1\', \'GATA-binding proteins\', \'hematopoiesis\' and the entity types \'protein\' and \'cell_type\' in the sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The example provides clear mappings between the entities \'Erbstatin\', \'genistein\', \'Egr-1\' and the entity types \'protein\' and \'RNA\' in the sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The example provides clear mappings between the entities \'EBV\', \'EBNA2\', \'estrogen receptor\' and the entity types \'DNA\' and \'protein\' in the sentence."}\n]', 'response3': "[{'steroid hormones': 'protein'}, {'estrogen': 'protein'}]", 'prediction': {'steroid hormones': 'protein', 'estrogen': 'protein'}}
{'idx': 1285, 'sentence': "Characterization of 5' end of human thromboxane receptor gene .", 'label': {"5' end of human thromboxane receptor gene": 'DNA', 'human thromboxane receptor gene': 'DNA'}, 'response1': "['DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and specific example of a protein entity (p50p50) and its function, aiding in the extraction of named entities from the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence provides a specific example of a protein entity (GATA-1) and its role in gene expression, aiding in the extraction of named entities from the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence provides a clear example of a cell type entity (Th2-type lymphocytes) and its association with cytokine expression, aiding in the extraction of named entities from the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence provides a specific example of a cell line entity (SCM-1) and its involvement in regulatory mechanisms, aiding in the extraction of named entities from the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides multiple examples of protein entities (Stat3, Stat5, c-Mpl) and their potential roles in signal transduction, aiding in the extraction of named entities from the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 327, 'sentence': 'However, there is an EB1 -binding site ( ZRE-B ) located within the R-responsive enhancer region .', 'label': {'R-responsive enhancer region': 'DNA', 'EB1 -binding site': 'DNA', 'EB1': 'protein', 'ZRE-B': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF.": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 4},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 4},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5}\n]', 'response3': '[{"EB1": "protein"}, {"ZRE-B": "DNA"}]', 'prediction': {'EB1': 'protein', 'ZRE-B': 'DNA'}}
{'idx': 1622, 'sentence': 'Analysis of whole-cell lysates by antiphosphotyrosine immunoblotting showed that incubation with gamma interferon brought about specific increases in phosphotyrosine labeling of several proteins.', 'label': {'gamma interferon': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."}\n]', 'response3': "[{'gamma interferon': 'protein'}, {'phosphotyrosine': 'protein'}]", 'prediction': {'gamma interferon': 'protein', 'phosphotyrosine': 'protein'}}
{'idx': 1393, 'sentence': 'This enhancer in HIV-1 is the T-cell activation response element ; in HIV-2 , however, it is the second enhancer that is mainly responsible for activation in response to T-cell activators .', 'label': {'second enhancer': 'DNA', 'T-cell activation response element': 'DNA', 'enhancer': 'DNA'}, 'response1': "['cell_type']", 'response2': '[\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer (kappa E3\') activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 4},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5},\n    {"These properties suggest that TAFII105 is a cell type-specific subunit of TFIID that may be responsible for mediating transcription by a subset of activators in B cells.": 5},\n    {"Interleukin 2 and T cell antigen receptor signals converge upon serine 727.": 5},\n    {"The response element for NF-AT is a sequence localized between -285/-254 in the IL-2 regulatory region.": 4}\n]', 'response3': '[{"HIV-1": "cell_type"}, {"T-cell": "cell_type"}, {"HIV-2": "cell_type"}, {"T-cell": "cell_type"}]', 'prediction': {'HIV-1': 'cell_type', 'T-cell': 'cell_type', 'HIV-2': 'cell_type'}}
{'idx': 1221, 'sentence': 'To identify osteoblast-specific cis-acting elements and trans-acting factors , we initiated an analysis of the promoter of a mouse osteocalcin gene , an osteoblast-specific gene .', 'label': {'mouse osteocalcin gene': 'DNA', 'promoter': 'DNA', 'osteoblast-specific cis-acting elements': 'DNA', 'trans-acting factors': 'protein', 'osteoblast-specific gene': 'DNA'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes.": 3},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 4},\n    {"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 4},\n    {"A critical role of Sp1- and Ets-related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"To evaluate the PML/RARalpha role in myelopoiesis, transgenic mice expressing PML/RARalpha were engineered.": 4},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 4},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 4},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 4},\n    {"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4}\n]', 'response3': '[{"osteoblast": "cell_type"}, {"cis-acting elements": "None"}, {"trans-acting factors": "None"}, {"promoter": "None"}, {"mouse osteocalcin gene": "protein"}, {"osteoblast-specific gene": "cell_type"}]', 'prediction': {'osteoblast': 'cell_type', 'cis-acting elements': 'None', 'trans-acting factors': 'None', 'promoter': 'None', 'mouse osteocalcin gene': 'protein', 'osteoblast-specific gene': 'cell_type'}}
{'idx': 130, 'sentence': 'At high concentration of NE , all of the TR bound to TREp was more greatly retarded than in the absence of NE .', 'label': {'TREp': 'DNA', 'TR': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 788, 'sentence': 'The number of mineralocorticoid receptors /cell were within or close to the normal range (n = 9).', 'label': {'mineralocorticoid receptors': 'protein'}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and direct mention of the entity \'protein\' (aldosterone) and its interaction with another entity (MR). This example is highly relevant for extracting named entities from the target sentence."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions \'cell_line\' (Ter 119) and multiple protein entities (beta-globin, glycoprotein IIb, platelet factor 4). This example is relevant for identifying different types of entities in the target sentence."},\n    {"Example 3": 3},\n    {"Reason 3": "The sentence mentions \'cell_type\' (Type I and Type II) which is relevant for identifying cell types. However, the entities mentioned are generic and not specific proteins or nucleic acids, hence the score is lower."},\n    {"Example 4": 1},\n    {"Reason 4": "The sentence does not mention any entities relevant to the given entity label set, hence it is not helpful for extracting named entities from the target sentence."}\n]', 'response3': '[{"mineralocorticoid receptors": "protein"}]', 'prediction': {'mineralocorticoid receptors': 'protein'}}
{'idx': 781, 'sentence': 'Effects of aldosterone on intralymphocytic sodium and potassium in patients with essential hypertension .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Example 2": 1},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1220, 'sentence': 'A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element .', 'label': {'PEBP2 alpha/AML-1-related factor': 'protein', 'osteocalcin promoter': 'DNA', 'osteoblast-specific cis-acting element': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter": 5},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells": 4},\n    {"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells": 5},\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene": 5},\n    {"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging": 4},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]": 5},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL": 5},\n    {"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation": 5},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats)": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729": 1}\n]', 'response3': '[{"PEBP2 alpha/AML-1-related factor": "protein"}, {"osteocalcin": "protein"}, {"osteoblast-specific": "cell_type"}]', 'prediction': {'PEBP2 alpha/AML-1-related factor': 'protein', 'osteocalcin': 'protein', 'osteoblast-specific': 'cell_type'}}
{'idx': 958, 'sentence': 'Here, Markus Neurath, Eckhard Stuber and Warren Strober describe the molecular structure of BSAP and focus on the ability of this protein to regulate the expression of B-cell-specific genes .', 'label': {'B-cell-specific genes': 'DNA', 'BSAP': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of proteins and their corresponding labels, which can aid in identifying protein entities in the target sentence."}\n]', 'response3': '[{"Markus Neurath": "None"}, {"Eckhard Stuber": "None"}, {"Warren Strober": "None"}, {"BSAP": "protein"}, {"B-cell-specific genes": "None"}]', 'prediction': {'Markus Neurath': 'None', 'Eckhard Stuber': 'None', 'Warren Strober': 'None', 'BSAP': 'protein', 'B-cell-specific genes': 'None'}}
{'idx': 1083, 'sentence': 'These data suggest that the action of tepoxalin to inhibit proliferation in PBMC may be at least in part due to its ability to reduce the amount of available iron resulting in decreased activation of NF kappa B and subsequent inhibition of cytokine production .', 'label': {'cytokine': 'protein', 'NF kappa B': 'protein', 'PBMC': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"5": "The sentence contains multiple protein entities that are relevant to the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"5": "The sentence contains multiple protein entities that are relevant to the label set."},\n    {"5": "The sentence contains multiple protein entities that are relevant to the label set."},\n    {"5": "The sentence contains multiple protein entities that are relevant to the label set."},\n    {"5": "The sentence contains multiple protein entities that are relevant to the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."}\n]', 'response3': "[{'NF kappa B': 'protein'}]", 'prediction': {'NF kappa B': 'protein'}}
{'idx': 514, 'sentence': 'Induction of the enhancer may have a role in the increase in globin gene transcription that characterizes erythroid maturation .', 'label': {'globin gene': 'DNA', 'enhancer': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence provides a clear and direct mention of the entity \'GATA-1\' and its entity label \'protein\', making it highly helpful for extracting named entities from the target sentence."},\n\n{"Example 2": 5},\n{"Reason 2": "The sentence directly mentions the entity \'NF-E2\' and its entity label \'protein\', providing valuable information for extracting named entities from the target sentence."},\n\n{"Example 3": 5},\n{"Reason 3": "The sentence explicitly mentions \'Th2-type lymphocytes\' as a cell type, which is directly relevant to the entity types in the target sentence, making it highly helpful for entity extraction."},\n\n{"Example 4": 5},\n{"Reason 4": "The sentence mentions \'Egr-1\' as a zinc finger transcription factor, which aligns with the entity label \'protein\' in the target sentence, thus providing valuable information for entity extraction."},\n\n{"Example 5": 5},\n{"Reason 5": "The sentence directly mentions \'erythropoietin\' as essential for red blood cell production, which corresponds to the entity label \'protein\' in the target sentence, making it highly helpful for entity extraction."},\n\n{"Example 6": 5},\n{"Reason 6": "The sentence provides information about \'CCAAT box\' as DNA and \'EKLF binding site\' as protein, which are directly relevant to the entity types in the target sentence, thus aiding in entity extraction."},\n\n{"Example 7": 5},\n{"Reason 7": "The sentence mentions \'AP-1\' in the context of DNA binding activity, aligning with the entity label \'DNA\' in the target sentence, making it highly helpful for entity extraction."},\n\n{"Example 8": 5},\n{"Reason 8": "The sentence mentions \'IL-4\' in relation to gene expression and proteins, which corresponds to the entity label \'protein\' in the target sentence, providing valuable information for entity extraction."},\n\n{"Example 9": 5},\n{"Reason 9": "The sentence mentions \'retinoic acid receptor alpha\' as blocking myeloid cell differentiation, aligning with the entity label \'protein\' in the target sentence, thus aiding in entity extraction."},\n\n{"Example 10": 5},\n{"Reason 10": "The sentence mentions \'RXR\' and its mutants in the context of erythroid cells, which aligns with the entity label \'protein\' in the target sentence, providing valuable information for entity extraction."},\n\n{"Example 11": 5},\n{"Reason 11": "The sentence mentions \'WT1\' in the context of myeloid cell lines and differentiation resistance, aligning with the entity labels \'protein\' and \'cell_line\' in the target sentence, making it highly helpful for entity extraction."},\n\n{"Example 12": 5},\n{"Reason 12": "The sentence mentions \'IL-2 receptor alpha subunit\', \'p21ras\', and \'B cell activation\', which correspond to the entity labels \'protein\' and \'cell_type\' in the target sentence, providing valuable information for entity extraction."},\n\n{"Example 13": 5},\n{"Reason 13": "The sentence mentions \'IgH\' in relation to gene control, aligning with the entity label \'DNA\' in the target sentence, thus aiding in entity extraction."},\n\n{"Example 14": 5},\n{"Reason 14": "The sentence mentions \'GATA-1\' as a positive regulator in erythroid cells, aligning with the entity label \'protein\' in the target sentence, making it highly helpful for entity extraction."},\n\n{"Example 15": 5},\n{"Reason 15": "The sentence mentions \'immunoglobulin kappa 3\' enhancer\' in the context of activity control, which corresponds to the entity label \'DNA\' in the target sentence, providing valuable information for entity extraction."},\n\n{"Example 16": 5},\n{"Reason 16": "The sentence mentions \'SCL\' and \'GATA-1\' as zinc-finger transcription factors in various cell populations, aligning with the entity label \'protein\' in the target sentence, thus aiding in entity extraction."},\n\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any relevant entities or entity labels that align with the types in the target sentence, hence it is not helpful for entity extraction."},\n\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any relevant entities or entity labels that align with the types in the target sentence, hence it is not helpful for entity extraction."},\n\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any relevant entities or entity labels that align with the types in the target sentence, hence it is not helpful for entity extraction."},\n\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any relevant entities or entity labels that align with the types in the target sentence, hence it is not helpful for entity extraction."},\n\n{"Example 21": 1},\n{"Reason 21": "The sentence does not contain any relevant entities or entity labels that align with the types in the target sentence, hence it is not helpful for entity extraction."},\n\n{"Example 22": 1},\n{"Reason 22": "The sentence does not contain any relevant entities or entity labels that align with the types in the target sentence, hence it is not helpful for entity extraction."},\n\n{"Example 23": 1},\n{"Reason 23": "The sentence does not contain any relevant entities or entity labels that align with the types in the target sentence, hence it is not helpful for entity extraction."},\n\n{"Example 24": 1},\n{"Reason 24": "The sentence does not contain any relevant entities or entity labels that align with the types in the target sentence, hence it is not helpful for entity extraction."},\n\n{"Example 25": 1},\n{"Reason 25": "The sentence does not contain any relevant entities or entity labels that align with the types in the target sentence, hence it is not helpful for entity extraction."}\n]', 'response3': "[{'globin gene': 'protein'}, {'enhancer': 'DNA'}, {'erythroid': 'cell_type'}]", 'prediction': {'globin gene': 'protein', 'enhancer': 'DNA', 'erythroid': 'cell_type'}}
{'idx': 1133, 'sentence': 'Both LCLs were found by EM to produce RVLP and EBV particles .', 'label': {'LCLs': 'cell_line'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.": 4},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .": 4},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 4},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .": 4},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 4},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .": 4},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 5},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms .": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .": 5},\n    {"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB .": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[{"LCLs": "cell_line"}, {"RVLP": "protein"}, {"EBV": "cell_line"}]', 'prediction': {'LCLs': 'cell_line', 'RVLP': 'protein', 'EBV': 'cell_line'}}
{'idx': 1762, 'sentence': 'Taking the IL-2 gene as a candidate, we examined the effect of cysteamine treatment on early gene expression during lymphocyte activation , and on the activity of transcription factors AP-1 , NF-kappa B , NF-AT and Oct1 , whose functions are required for expression of the IL-2 mRNA.', 'label': {'IL-2': 'protein', 'early gene': 'DNA', 'NF-kappa B': 'protein', 'Oct1': 'protein', 'transcription factors': 'protein', 'NF-AT': 'protein', 'AP-1': 'protein', 'IL-2 gene': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 4},\n    {"Example 8": 4},\n    {"Example 9": 1},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"IL-2": "protein"}, {"cysteamine": "protein"}, {"AP-1": "protein"}, {"NF-kappa B": "protein"}, {"NF-AT": "protein"}, {"Oct1": "protein"}]', 'prediction': {'IL-2': 'protein', 'cysteamine': 'protein', 'AP-1': 'protein', 'NF-kappa B': 'protein', 'NF-AT': 'protein', 'Oct1': 'protein'}}
{'idx': 23, 'sentence': 'Furthermore, a mutant E6 motif lost both in vitro binding activity and in vivo enhancer activity .', 'label': {'mutant E6 motif': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 5},\n    {"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 5},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 4},\n    {"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events.": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 4},\n    {"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF.": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif.": 5}\n]', 'response3': '[{"E6 motif": "protein"}]', 'prediction': {'E6 motif': 'protein'}}
{'idx': 1476, 'sentence': 'Protein phosphorylation has an important role in the regulation of these two factors: (1) it induces the transactivating capacity of the AP-1 protein c-Jun ; and (2) it is involved in the release of the cytoplasmic inhibitor , I kappa B , from NF-kappa B , allowing translocation of the latter into the nucleus .', 'label': {'AP-1 protein': 'protein', 'c-Jun': 'protein', 'I kappa B': 'protein', 'NF-kappa B': 'protein', 'cytoplasmic inhibitor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of protein names and their corresponding entity labels, making it highly relevant for extracting named entities from the target sentence."}\n]', 'response3': '[{"AP-1": "protein"}, {"c-Jun": "protein"}, {"I kappa B": "protein"}, {"NF-kappa B": "protein"}]', 'prediction': {'AP-1': 'protein', 'c-Jun': 'protein', 'I kappa B': 'protein', 'NF-kappa B': 'protein'}}
{'idx': 234, 'sentence': 'A similar infection with a recombinant retrovirus containing the beta-galactosidase gene with an adenovirus E2 promoter , results in beta-galactosidase activity in a limited number of cultured and primary cells .', 'label': {'cultured': 'cell_line', 'primary cells': 'cell_type', 'adenovirus E2 promoter': 'DNA', 'beta-galactosidase gene': 'DNA', 'beta-galactosidase': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n    {"In addition, assay of PBMC by the adenovirus-specific PCR may help detect early invasive disease and warrants further evaluation.": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"This protein has now been purified and its encoding gene cloned.": 5},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 4},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 4},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 4},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 5},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 4},\n    {"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n    {"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 4},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"beta-galactosidase gene": "protein"}, {"adenovirus E2 promoter": "DNA"}]', 'prediction': {'beta-galactosidase gene': 'protein', 'adenovirus E2 promoter': 'DNA'}}
{'idx': 1396, 'sentence': 'NF-M ( chicken C/EBP beta ) induces eosinophilic differentiation and apoptosis in a hematopoietic progenitor cell line .', 'label': {'hematopoietic progenitor cell line': 'cell_line', 'NF-M': 'protein', 'chicken C/EBP beta': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 4},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 4},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"Control of NF-kappa B activity by the I kappa B beta inhibitor.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 4},\n    {"Recently, activation of NF-kappa B has been linked to ARDS and has been shown to be a critical proximal step in the initiation of neutrophilic inflammation in animal models.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 5},\n    {"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.": 5}\n]', 'response3': '[{"NF-M": "protein"}, {"C/EBP beta": "protein"}, {"hematopoietic progenitor cell line": "cell_line"}]', 'prediction': {'NF-M': 'protein', 'C/EBP beta': 'protein', 'hematopoietic progenitor cell line': 'cell_line'}}
{'idx': 1812, 'sentence': 'The protein shows significant sequence similarities to the family of G-protein coupled chemokine receptors and turned out to be identical to the recently described receptor EBI1 .', 'label': {'G-protein coupled chemokine receptors': 'protein', 'chemokine receptors': 'protein', 'G-protein': 'protein', 'receptor EBI1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"EBV": 1},\n    {"B-cell": 1},\n    {"retinoic acid receptor alpha": 1},\n    {"Protein": 1},\n    {"MIP-1 alpha": 1},\n    {"GOS19": 1},\n    {"LD78": 1},\n    {"AT464": 1},\n    {"EBNA-2": 1},\n    {"PU.1": 1},\n    {"CREB": 1},\n    {"AR-CRE": 1},\n    {"Egr-1": 1},\n    {"E2A": 1},\n    {"GM-CSF": 1},\n    {"protein": 5},\n    {"EKLF": 1},\n    {"CBP": 1},\n    {"p300": 1},\n    {"P/CAF": 1},\n    {"TP1": 1},\n    {"c-kit": 1},\n    {"IL-4R alpha chain": 1},\n    {"interleukin 10": 1},\n    {"IL-10R": 1},\n    {"STAT3": 1},\n    {"IL-6": 1},\n    {"GATA-1": 1},\n    {"IL4": 1},\n    {"IL13": 1},\n    {"STAT6": 1},\n    {"STAT5": 1},\n    {"B cells": 1}\n]', 'response3': '[{"G-protein coupled chemokine receptors": "protein"}, {"EBI1": "protein"}]', 'prediction': {'G-protein coupled chemokine receptors': 'protein', 'EBI1': 'protein'}}
{'idx': 1099, 'sentence': 'Interestingly, microtubule disruption also decreased monocyte 1,25(OH)2D3 synthesis , not by decreasing the Vmax of monocyte mitochondrial 1 alpha-hydroxylase but through an increase in the Km for 25(OH)2D3 .', 'label': {'monocyte mitochondrial 1 alpha-hydroxylase': 'protein', 'monocyte': 'cell_type', 'microtubule': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 4},\n    {"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 3},\n    {"Changes in PKC isoforms in human alveolar macrophages compared with blood monocytes.": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 3},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"We have examined the effect of alpha-tocopherol (alpha-tcp) on one cellular event in atherosclerotic plaque development, monocyte adhesion to stimulated endothelial cells (ECs).": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 4},\n    {"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.": 4},\n    {"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.": 5},\n    {"When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma, the cells instead become DC.": 5},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 4},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 4},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]": 4},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 4}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1537, 'sentence': 'Furthermore, we identified a repression domain at the N-terminus of Oct-2a .', 'label': {'Oct-2a': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 1},\n{"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n{"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .": 5},\n{"Here we examined the regulatory mechanism of the SCM-1 genes .": 1},\n{"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .": 5},\n{"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells .": 5},\n{"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements .": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 5},\n{"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .": 5},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .": 5},\n{"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .": 5},\n{"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n{"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n{"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[{"Oct-2a": "protein"}]', 'prediction': {'Oct-2a': 'protein'}}
{'idx': 1574, 'sentence': 'CONCLUSIONS: Sexual hormones , through their receptors , may influence the activity of eosinophils in patients with VKC .', 'label': {'receptors': 'protein', 'eosinophils': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence directly mentions \'Eosinophils\' and their role, making it highly relevant for extracting the entity type \'cell_type\'."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains specific proteins like \'IL-4\', \'LPS\', and \'AP-1\', which are directly related to the entity type \'protein\', making it helpful for extraction."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence discusses genes encoding proteins and transcription factors like \'cAMP-dependent protein kinase\' and \'Rap1\', which are crucial for identifying the entity type \'protein\'."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence mentions \'G-CSF\' and its receptors, which are related to the entity type \'protein\', aiding in the extraction process."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence talks about the inhibition of NF-kappa B activation, a key protein, making it highly relevant for the entity type \'protein\' extraction."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence directly refers to \'lymphoid neoplasms\', which falls under the entity type \'cell_type\', making it very helpful for extraction."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence mentions \'IFN-gamma\', a protein involved in cytokine signaling, which is relevant for the entity type \'protein\' extraction."},\n    {"Example 8": 3},\n    {"Reason 8": "The sentence discusses \'phosphocreatine\', which is not directly related to any entity type in the given label set, hence less helpful for extraction."},\n    {"Example 9": 4},\n    {"Reason 9": "The sentence mentions \'GATA-1\', a transcription factor, which is relevant for the entity type \'protein\' extraction."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence directly mentions \'NF-kappa B activation\' and \'kappa B-responsive genes\', which are crucial for identifying the entity type \'protein\'."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence discusses \'immunoglobulin kappa 3\' enhancer\', which is related to the entity type \'DNA\', making it highly relevant for extraction."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions \'NF-kappa B activation\', which is crucial for identifying the entity type \'protein\', aiding in the extraction process."},\n    {"Example 13": 3},\n    {"Reason 13": "The sentence discusses \'CD40 stimulation\' and \'Rel/nuclear factor kappaB factors\', which are related to the entity type \'protein\', making it somewhat helpful for extraction."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence talks about \'nuclear factor-kappa B activity\' and \'NF-kappa B activity\', which are relevant for the entity type \'DNA\' extraction."},\n    {"Example 15": 4},\n    {"Reason 15": "The sentence mentions \'gp91phox\' and \'HL-60-C15 cells\', which are related to the entity types \'DNA\' and \'cell_line\', aiding in the extraction process."},\n    {"Example 16": 4},\n    {"Reason 16": "The sentence discusses \'CXC chemokine\' and \'interleukin-8\', which are related to the entity type \'protein\', making it helpful for extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities related to the given label set, hence not helpful for extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities related to the given label set, hence not helpful for extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities related to the given label set, hence not helpful for extraction."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities related to the given label set, hence not helpful for extraction."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities related to the given label set, hence not helpful for extraction."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities related to the given label set, hence not helpful for extraction."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities related to the given label set, hence not helpful for extraction."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities related to the given label set, hence not helpful for extraction."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities related to the given label set, hence not helpful for extraction."}\n]', 'response3': '[{"eosinophils": "cell_type"}]', 'prediction': {'eosinophils': 'cell_type'}}
{'idx': 1312, 'sentence': 'A solution structure for the non-sequence-specific C-terminal HMG box of HMG-1 has recently been proposed.', 'label': {'HMG-1': 'protein', 'C-terminal HMG box': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1},\n    {"Example 26": 1},\n    {"Example 27": 1},\n    {"Example 28": 1},\n    {"Example 29": 1},\n    {"Example 30": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 601, 'sentence': 'To determine whether enhancer elements in addition to the highly conserved octamer (OCTA)-nucleotide motif are important for lymphoid-specific expression of the immunoglobulin heavy-chain (IgH) gene , we have investigated the effect of mutating the binding site for a putative additional lymphoid-specific transcription factor , designated NF-microB , in the murine IgH enhancer .', 'label': {'murine IgH enhancer': 'DNA', 'putative additional lymphoid-specific transcription factor': 'protein', 'octamer (OCTA)-nucleotide motif': 'DNA', 'NF-microB': 'protein', 'enhancer elements': 'DNA', 'immunoglobulin heavy-chain (IgH) gene': 'DNA', 'binding site': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n{"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells .": 5},\n{"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .": 5},\n{"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n{"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 5},\n{"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.": 5},\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 5},\n{"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 5},\n{"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements .": 5},\n{"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n{"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 5},\n{"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .": 5},\n{"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .": 5}\n]', 'response3': '[{"NF-microB": "protein"}, {"IgH": "DNA"}]', 'prediction': {'NF-microB': 'protein', 'IgH': 'DNA'}}
{'idx': 890, 'sentence': 'Treatment of 10 with warm HCl furnished 19-chloro-4,21-dihydroxypregna-4,9(11)-diene-3,20-dione (13).', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.": 4},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 3},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 4},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n    {"We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of degradation of inhibitor-kappaB alpha.": 4},\n    {"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.": 4},\n    {"This hybrid clone, designated NR2, was characterized by several methods, including PCR, with eight pairs of oligonucleotides mapped to Chr 20: D20S5, D20S41, D20S42, D20S56, D20S57, D20S58, adenosine deaminase (ADA), and Prion protein (PRIP); Restriction Fragment Length Polymorphism (RFLP) analyses with four genomic anonymous probes (D20S5, cD3H12, D20S17, D20S18); and fluorescent in situ hybridization (FISH) with total human DNA and D20Z1, a sequence specific to the human Chr 20 centromere, as probes.": 5},\n    {"Treatment with soluble, bivalent mAb J393 killed 25-50% of the cell population, while concomitant engagement of either the CD3.TcR complex or the integrins CD18 and CD29 significantly potentiated this effect.": 5},\n    {"Combined treatment of HPCs with alpha-PML and alpha-Rb oligomers inhibited both PML and Rb protein expression and completely blocked erythroid colony development.": 5},\n    {"When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of the binding.": 5},\n    {"A 3-bp mutation at the distal Sp1-binding site not only eliminates Sp1 interaction, but also abolishes most of the VitD3 induction of CD14 expression.": 4},\n    {"CONCLUSION: Our results show that the tested agents (except indomethacin) are inhibitors of the T cell-mediated immune response, as expected, that aspirin is an effective suppressor of adhesion molecule expression, and that all three agents can induce Hsp60 in HUVECs.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 323, 'sentence': 'The Epstein-Barr virus ( EBV ) ORI1yt enhancer is not B-cell specific and does not respond synergistically to the EBV transcription factors R and Z .', 'label': {'Epstein-Barr virus ( EBV ) ORI1yt enhancer': 'DNA'}, 'response1': "['DNA', 'cell_type', 'protein']", 'response2': '[\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"5": "The sentence contains multiple instances of the \'protein\' entity type, which are relevant to the label set."},\n{"5": "The sentence contains multiple instances of the \'protein\' entity type, which are relevant to the label set."},\n{"5": "The sentence contains instances of \'protein\' and \'cell_line\' entity types, which are relevant to the label set."},\n{"5": "The sentence contains instances of \'cell_type\' and \'protein\' entity types, which are relevant to the label set."},\n{"5": "The sentence contains an instance of the \'protein\' entity type, which is relevant to the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"5": "The sentence contains instances of multiple \'protein\' entity types, which are relevant to the label set."},\n{"5": "The sentence contains instances of \'cell_line\' and \'protein\' entity types, which are relevant to the label set."},\n{"5": "The sentence contains instances of \'cell_type\' and \'protein\' entity types, which are relevant to the label set."},\n{"5": "The sentence contains instances of \'protein\' entity types, which are relevant to the label set."},\n{"5": "The sentence contains instances of \'cell_line\' and \'cell_type\' entity types, which are relevant to the label set."},\n{"5": "The sentence contains an instance of the \'protein\' entity type, which is relevant to the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."},\n{"1": "The sentence does not contain any of the entity types in the label set."}\n]', 'response3': '[{"Epstein-Barr virus": "cell_line"}, {"ORI1yt enhancer": "DNA"}, {"B-cell": "cell_type"}, {"R": "protein"}, {"Z": "protein"}]', 'prediction': {'Epstein-Barr virus': 'cell_line', 'ORI1yt enhancer': 'DNA', 'B-cell': 'cell_type', 'R': 'protein', 'Z': 'protein'}}
{'idx': 929, 'sentence': 'The cDNA sequence has an 813-bp open reading frame ( ORF ) whose predicted amino acid sequence is 97.6% identical to the 272 carboxy-terminal amino acids of the human ets-1 protein .', 'label': {'ORF': 'DNA', '272 carboxy-terminal amino acids': 'protein', 'ets-1': 'protein', 'human ets-1 protein': 'protein', '813-bp open reading frame': 'DNA', 'cDNA sequence': 'DNA', 'amino acid sequence': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n{"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 4},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n{"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n{"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 4},\n{"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n{"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n{"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 5},\n{"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n{"This protein has now been purified and its encoding gene cloned.": 5},\n{"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n{"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 5},\n{"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB-induced trans-activation of the H4 promoter.": 5},\n{"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5},\n{"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5}\n]', 'response3': '[{"cDNA": "DNA"}, {"ets-1 protein": "protein"}]', 'prediction': {'cDNA': 'DNA', 'ets-1 protein': 'protein'}}
{'idx': 6, 'sentence': 'Platelet-activating factor induces phospholipid turnover , calcium flux , arachidonic acid liberation , eicosanoid generation , and oncogene expression in a human B cell line .', 'label': {'Platelet-activating factor': 'protein', 'oncogene': 'DNA', 'human B cell line': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 4},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 4},\n    {"Example 7": 3},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 4},\n    {"Example 11": 4},\n    {"Example 12": 4},\n    {"Example 13": 3},\n    {"Example 14": 4},\n    {"Example 15": 4},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"phospholipid turnover": "protein"}, {"calcium flux": "protein"}, {"arachidonic acid liberation": "protein"}, {"eicosanoid generation": "protein"}, {"oncogene expression": "protein"}, {"human B cell line": "cell_line"}]', 'prediction': {'phospholipid turnover': 'protein', 'calcium flux': 'protein', 'arachidonic acid liberation': 'protein', 'eicosanoid generation': 'protein', 'oncogene expression': 'protein', 'human B cell line': 'cell_line'}}
{'idx': 1478, 'sentence': 'Furthermore, in activated T cells , the kinetics of the two phosphorylation events are essentially similar.', 'label': {'activated T cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .": 4},\n    {"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"The phosphorylated tyrosine residue itself is important for the protein-protein interaction .": 4},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .": 4},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .": 5},\n    {"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .": 5},\n    {"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .": 5},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1793, 'sentence': 'The clinical benefits of salicylates in the treatment of several diseases, including atherosclerosis and rheumatoid arthritis , may be related to their ability to reduce monocyte gene expression .', 'label': {}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein and cell type entities that are directly mentioned."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence contains a specific protein entity that is directly mentioned."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence contains a specific protein entity that is directly mentioned."},\n    {"Example 4": 4},\n    {"Reason 4": "The sentence contains a specific protein entity that is directly mentioned."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence contains a specific protein entity that is directly mentioned."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence contains a specific protein entity that is directly mentioned."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific protein and cell type entities that are directly mentioned."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific protein and cell type entities that are directly mentioned."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains specific protein and cell type entities that are directly mentioned."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains specific protein and cell type entities that are directly mentioned."},\n    {"Example 11": 4},\n    {"Reason 11": "The sentence contains a specific DNA entity that is directly mentioned."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence contains specific protein entities that are directly mentioned."},\n    {"Example 13": 4},\n    {"Reason 13": "The sentence contains specific protein entities that are directly mentioned."},\n    {"Example 14": 4},\n    {"Reason 14": "The sentence contains specific protein entities that are directly mentioned."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any relevant entities."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any relevant entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any relevant entities."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any relevant entities."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any relevant entities."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any relevant entities."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any relevant entities."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any relevant entities."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any relevant entities."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any relevant entities."}\n]', 'response3': '[{"salicylates": "protein"}, {"atherosclerosis": "cell_type"}, {"rheumatoid arthritis": "cell_type"}, {"monocyte": "cell_type"}]', 'prediction': {'salicylates': 'protein', 'atherosclerosis': 'cell_type', 'rheumatoid arthritis': 'cell_type', 'monocyte': 'cell_type'}}
{'idx': 1473, 'sentence': 'Costimulation requirement for AP-1 and NF-kappa B transcription factor activation in T cells .', 'label': {'NF-kappa B': 'protein', 'T cells': 'cell_type', 'AP-1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example contains specific protein names that are relevant to the target sentence and can aid in identifying protein entities."},\n    {"Example 2": 4},\n    {"Reason 2": "The example contains protein names and cell types that are relevant to the target sentence and can aid in identifying protein and cell type entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The example contains specific protein names that are relevant to the target sentence and can aid in identifying protein entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The example contains specific protein names that are relevant to the target sentence and can aid in identifying protein entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The example contains specific protein names that are relevant to the target sentence and can aid in identifying protein entities."},\n    {"Example 6": 4},\n    {"Reason 6": "The example contains protein names and cell types that are relevant to the target sentence and can aid in identifying protein and cell type entities."},\n    {"Example 7": 4},\n    {"Reason 7": "The example contains protein names and cell types that are relevant to the target sentence and can aid in identifying protein and cell type entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The example contains specific protein names that are relevant to the target sentence and can aid in identifying protein entities."},\n    {"Example 9": 1},\n    {"Reason 9": "The example does not contain any relevant entity names to the target sentence."},\n    {"Example 10": 1},\n    {"Reason 10": "The example does not contain any relevant entity names to the target sentence."},\n    {"Example 11": 1},\n    {"Reason 11": "The example does not contain any relevant entity names to the target sentence."},\n    {"Example 12": 1},\n    {"Reason 12": "The example does not contain any relevant entity names to the target sentence."},\n    {"Example 13": 1},\n    {"Reason 13": "The example does not contain any relevant entity names to the target sentence."},\n    {"Example 14": 1},\n    {"Reason 14": "The example does not contain any relevant entity names to the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The example does not contain any relevant entity names to the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any relevant entity names to the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any relevant entity names to the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any relevant entity names to the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain any relevant entity names to the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The example does not contain any relevant entity names to the target sentence."}\n]', 'response3': '[{"AP-1": "protein"}, {"NF-kappa B": "protein"}, {"T cells": "cell_type"}]', 'prediction': {'AP-1': 'protein', 'NF-kappa B': 'protein', 'T cells': 'cell_type'}}
{'idx': 539, 'sentence': 'PMA enhanced slightly the stimulatory effect of PHA .', 'label': {'PHA': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names (NF-kappa B and AP-1) that are directly mentioned and can be easily identified as protein entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains a specific protein name (NF-E2) that is directly mentioned and can be easily identified as a protein entity."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains specific protein names (AP-1 and PMA) and cell types (monocytes and macrophages) that are directly mentioned and can be easily identified as protein and cell type entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains specific protein names (PAFR, PAF, NF-kappa B, and protein kinase C) that are directly mentioned and can be easily identified as protein entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific protein names (IL-2, NF-kappa B, and AP-1) that are directly mentioned and can be easily identified as protein entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains a specific protein name (MNDA) and a specific cell line name (Philadelphia chromosome-positive chronic myeloid leukemia) that are directly mentioned and can be easily identified as protein and cell line entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific protein names (Oct-2A, HMG I/Y, and HLA-DRA) and a cell type (B cells) that are directly mentioned and can be easily identified as protein and cell type entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains a specific protein name (NF-kappa B) that is directly mentioned and can be easily identified as a protein entity."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains a specific protein name (P selectin) that is directly mentioned and can be easily identified as a protein entity."},\n    {"Example 10": 1},\n    {"Reason 10": "The sentence does not contain any entity names related to the given entity labels."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains specific protein names (NDP kinase, KA, SCC, and BCC) that are directly mentioned and can be easily identified as protein and cell type entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains specific protein names (CD14 and CD23) that are directly mentioned and can be easily identified as protein entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains specific protein names (IL-4, LPS, and AP-1) that are directly mentioned and can be easily identified as protein entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific protein names (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, and phorbol myristate acetate) that are directly mentioned and can be easily identified as protein entities."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains specific protein names (Epo, alpha-globin, beta-globin, haemoglobin, haemin, and delta-ALA) that are directly mentioned and can be easily identified as protein entities."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence contains specific protein names (PMA and IFN-gamma) and a cell type (T cell blasts) that are directly mentioned and can be easily identified as protein and cell type entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entity names related to the given entity labels."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entity names related to the given entity labels."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entity names related to the given entity labels."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entity names related to the given entity labels."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entity names related to the given entity labels."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entity names related to the given entity labels."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entity names related to the given entity labels."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entity names related to the given entity labels."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entity names related to the given entity labels."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1025, 'sentence': 'NK cells do not express NFATc constitutively, but NFATc mRNA accumulation is induced in these cells within 2 h of stimulation with CD16 ligands .', 'label': {'NFATc': 'protein', 'NK cells': 'cell_type', 'NFATc mRNA': 'RNA'}, 'response1': "['RNA', 'cell_type', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not contain any entities with entity labels matching the entity types in the target sentence."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not contain any entities with entity labels matching the entity types in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any entities with entity labels matching the entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entities with entity labels matching the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities with entity labels matching the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities with entity labels matching the entity types in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities with entity labels matching the entity types in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities with entity labels matching the entity types in the target sentence."}\n]', 'response3': '[{"NFATc": "protein"}, {"NFATc mRNA": "RNA"}, {"NK cells": "cell_type"}, {"CD16 ligands": "protein"}]', 'prediction': {'NFATc': 'protein', 'NFATc mRNA': 'RNA', 'NK cells': 'cell_type', 'CD16 ligands': 'protein'}}
{'idx': 1560, 'sentence': 'Moreover, in human T helper (Th) clones functionally characterized as being of the type 0, type 1 and type 2 (28%, < 1% und 93% CD30+, respectively), the extent of CD30 -mediated NF-kappa B activation correlated with the proportion of CD30+ cells .', 'label': {'human T helper (Th) clones': 'cell_line', 'CD30+ cells': 'cell_line', 'CD30': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 4},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.": 4},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation.": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 4},\n    {"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 4},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5}\n]', 'response3': '[{"CD30": "protein"}]', 'prediction': {'CD30': 'protein'}}
{'idx': 365, 'sentence': 'Run-on analysis demonstrated detectable levels of c-jun gene transcription in untreated HL-60 cells , and that exposure to TPA increases this rate 3.3-fold.', 'label': {'c-jun': 'DNA', 'HL-60 cells': 'cell_line', 'untreated HL-60 cells': 'cell_line'}, 'response1': "['DNA', 'cell_type', 'protein', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 1},\n    {"Example 7": 1},\n    {"Example 8": 1},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1039, 'sentence': 'Peripheral blood mononuclear cells ( pbmc ) and bone marrow cells of 26 patients were examined for c-fos , c-myc , p53 and the hybrid bcr/abl mRNA levels .', 'label': {'Peripheral blood mononuclear cells': 'cell_type', 'pbmc': 'cell_type', 'bone marrow cells': 'cell_type'}, 'response1': "['RNA', 'protein']", 'response2': '[\n    {"PBMC": 5},\n    {"adenovirus DNA": 5},\n    {"CD70": 5},\n    {"B cell": 5},\n    {"plasma cells": 5},\n    {"IL-4": 5},\n    {"CD40": 5},\n    {"MNDA": 5},\n    {"Philadelphia chromosome-positive chronic myeloid leukemia": 5},\n    {"PMA": 4},\n    {"CD14": 5},\n    {"CD23": 5},\n    {"IL-2": 5},\n    {"c-Jun": 5},\n    {"c-Fos": 5},\n    {"PML/RARalpha": 5},\n    {"myeloperoxidase": 5},\n    {"lysozyme": 5},\n    {"PU.1": 5},\n    {"NF-kappaB": 5},\n    {"Tax": 4},\n    {"ATL": 4},\n    {"TCRzeta": 5},\n    {"p56(lck)": 5},\n    {"p21(WAF1/CIP1)": 5},\n    {"p27(KIP1)": 5},\n    {"IFN A": 5},\n    {"IFNA": 5},\n    {"interleukin-2": 5},\n    {"interleukin-2 receptor": 5},\n    {"phytohemagglutinin": 5},\n    {"phorbol myristate acetate": 5},\n    {"Ter 119": 5},\n    {"beta-globin": 5},\n    {"glycoprotein IIb": 5},\n    {"platelet factor 4": 5},\n    {"CD40": 5},\n    {"Rel/nuclear factor kappaB": 5},\n    {"NF-kappaB": 5},\n    {"B lymphocytes": 5},\n    {"B and T cell activation": 5},\n    {"Ramos": 5},\n    {"Jurkat": 5},\n    {"cDNA microarray technology": 5},\n    {"HeLa cells": 5},\n    {"Daudi": 5},\n    {"B cell-encoded genes": 5},\n    {"B cell-specific": 5},\n    {"PU.1": 5},\n    {"CSF-1 receptor": 5},\n    {"Mono A": 5},\n    {"Mono B": 5}\n]', 'response3': '[{"pbmc": "cell_type"}, {"c-fos": "protein"}, {"c-myc": "protein"}, {"p53": "protein"}, {"bcr/abl": "protein"}]', 'prediction': {'pbmc': 'cell_type', 'c-fos': 'protein', 'c-myc': 'protein', 'p53': 'protein', 'bcr/abl': 'protein'}}
{'idx': 217, 'sentence': 'Quantitation of glucocorticoid receptors ( GCR ) and the study of their affinity for glucocorticosteroids ( GCS ) were made in peripheral blood lymphocytes of bronchial asthma ( BA ) patients in consideration of GCR treatment and serum levels of endogenous cortisol .', 'label': {'GCR': 'protein', 'glucocorticoid receptors': 'protein', 'peripheral blood lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"phosphocreatine": 3},\n{"protein": 5, "cell_type": 4, "RNA": 1, "DNA": 1}\n]\n[\n{"protein": 5},\n{"G-CSF": 5}\n]\n[\n{"IL4": 5},\n{"IL13": 5},\n{"gamma c chain": 4},\n{"STAT6": 5},\n{"STAT3": 5},\n{"STAT5": 5},\n{"B cells": 4}\n]\n[\n{"IL-5 mRNA": 4},\n{"TCR": 4},\n{"IL-2R": 5},\n{"dexamethasone": 5}\n]\n[\n{"HML": 4},\n{"dexamethasone": 5},\n{"cortisol": 5},\n{"lysozyme": 5}\n]\n[\n{"IL-7R": 5},\n{"gamma(c)": 5}\n]\n[\n{"E2A": 5}\n]\n[\n{"granulocytes": 4},\n{"T cells": 4}\n]\n[\n{"IFN-gamma": 5}\n]\n[\n{"IL-2": 5},\n{"IFN-gamma": 5},\n{"jak kinases": 5},\n{"STAT1(alpha)": 5}\n]\n[\n{"cAMP-dependent protein kinase": 5},\n{"Rap1": 5}\n]', 'response3': '[{"GCR": "protein"}, {"GCS": "protein"}, {"BA": "cell_type"}]', 'prediction': {'GCR': 'protein', 'GCS': 'protein', 'BA': 'cell_type'}}
{'idx': 1782, 'sentence': 'In addition, resting PBL constitutively expressed prominent levels of Id2 mRNA , but not Id3 mRNA .', 'label': {'Id3': 'protein', 'resting PBL': 'cell_type', 'Id3 mRNA': 'RNA', 'PBL': 'cell_type', 'Id2': 'protein', 'Id2 mRNA': 'RNA'}, 'response1': "['RNA']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 4},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA/NF-kappaB1 binding complexes.": 5},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05).": 4},\n    {"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells, but not in primary T cells, consistent with the lack of the IL-12 receptor in resting T cells.": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 4},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"PMA induced the expression of both CD14 and CD23 mRNA and protein.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"Id2 mRNA": "RNA"}, {"Id3 mRNA": "RNA"}]', 'prediction': {'Id2 mRNA': 'RNA', 'Id3 mRNA': 'RNA'}}
{'idx': 1280, 'sentence': "Sequence analysis of the 5'-flanking region of the CD69 gene revealed the presence of a potential TATA element 30 base pairs upstream of the major transcription initiation site and several putative binding sequences for inducible transcription factors ( NF-kappa B , Egr-1 , AP-1 ), which might mediate the inducible expression of this gene.", 'label': {'NF-kappa B': 'protein', 'TATA element': 'DNA', 'transcription factors': 'protein', 'CD69': 'protein', 'AP-1': 'protein', '30 base pairs upstream': 'DNA', 'CD69 gene': 'DNA', "5'-flanking region": 'DNA', 'transcription initiation site': 'DNA', 'Egr-1': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor": 5},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter": 4},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements": 5},\n    {"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif": 5},\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region": 5},\n    {"These properties suggest that TAFII105 is a cell type-specific subunit of TFIID that may be responsible for mediating transcription by a subset of activators in B cells": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B": 5},\n    {"This sequence element was referred to as the BAT box and its deletion significantly reduced the activity of a CD20 promoter-CAT construct in B cells": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats)": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729": 1}\n]', 'response3': '[{"CD69 gene": "protein"}, {"TATA element": "DNA"}, {"NF-kappa B": "protein"}, {"Egr-1": "protein"}, {"AP-1": "protein"}]', 'prediction': {'CD69 gene': 'protein', 'TATA element': 'DNA', 'NF-kappa B': 'protein', 'Egr-1': 'protein', 'AP-1': 'protein'}}
{'idx': 611, 'sentence': 'Transactivation by some DNA viruses has been implicated in inducing HIV-1 replication and pathogenesis.', 'label': {}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n    {"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 5},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype.": 5}\n]', 'response3': '[{"DNA viruses": "DNA"}, {"HIV-1": "cell_type"}]', 'prediction': {'DNA viruses': 'DNA', 'HIV-1': 'cell_type'}}
{'idx': 1723, 'sentence': 'In vitro treatment of a monocyte/macrophage cell line with CCl4 led to enhanced NF-kappa B binding and an increase in tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA levels .', 'label': {'tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA': 'RNA', 'NF-kappa B': 'protein', 'tumor necrosis factor-alpha': 'protein', 'TNF-alpha': 'protein'}, 'response1': "['cell_line', 'protein', 'RNA']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"5": "The sentence contains \'NF-kappaB\' and \'Tax\' which are both proteins relevant to the entity labels."},\n    {"5": "The sentence contains \'IkappaBbeta\' and \'NF-kappaB\' which are both proteins relevant to the entity labels."},\n    {"4": "The sentence contains \'NF-kappa B\' which is a protein relevant to the entity labels."},\n    {"5": "The sentence contains \'IFN A\', \'IFNA\', \'interleukin-2\', \'interleukin-2 receptor\', \'phytohemagglutinin\', and \'phorbol myristate acetate\' which are all proteins relevant to the entity labels."},\n    {"5": "The sentence contains \'IL-2\', \'NF-kappa B\', and \'AP-1\' which are all proteins relevant to the entity labels."},\n    {"5": "The sentence contains \'NF-kappa B\' which is a protein relevant to the entity labels."},\n    {"5": "The sentence contains \'MTHC\', \'TNF-alpha\', \'IFN-gamma\', and \'DC\' which are all relevant to the entity labels."},\n    {"5": "The sentence contains \'NF-kappa B\' which is a DNA relevant to the entity labels."},\n    {"5": "The sentence contains \'NF-kappa B\' which is a protein relevant to the entity labels."},\n    {"5": "The sentence contains \'CD40\', \'Rel/nuclear factor kappaB\', \'NF-kappaB\', and \'B lymphocytes\' which are all relevant to the entity labels."},\n    {"5": "The sentence contains \'PMA\', \'IFN-gamma\', and \'T cell blasts\' which are all relevant to the entity labels."},\n    {"5": "The sentence contains \'CTLA4Ig\', \'NFAT\', and \'AP-1\' which are all relevant to the entity labels."},\n    {"5": "The sentence contains \'NF-kappa B\' and \'neutrophils\' which are both relevant to the entity labels."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"TNF-alpha": "protein"}, {"RNA": "RNA"}]', 'prediction': {'NF-kappa B': 'protein', 'TNF-alpha': 'protein', 'RNA': 'RNA'}}
{'idx': 1308, 'sentence': 'Two groups of HMG box proteins are distinguished.', 'label': {'HMG box proteins': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains multiple protein names that are relevant to the entity types in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence mentions \'cDNAs\' which is relevant to the entity type \'DNA\', but it does not provide additional context or specific examples."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence mentions \'IgH\' which is relevant to the entity type \'DNA\', but it does not provide additional context or specific examples."},\n    {"Example 4": 3},\n    {"Reason 4": "The sentence provides specific examples of DNA elements and a protein name that are relevant to the entity types in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific protein names that are relevant to the entity types in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific protein names that are relevant to the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains a specific protein name and cell types that are relevant to the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains a specific protein name that is relevant to the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains a specific protein name that is relevant to the entity types in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains specific protein names that are relevant to the entity types in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains a specific protein name that is relevant to the entity types in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains a specific cell line name that is relevant to the entity types in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains a specific protein name that is relevant to the entity types in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains a specific protein name that is relevant to the entity types in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains a specific protein name that is relevant to the entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence mentions various factors but does not provide specific examples or context related to the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence mentions herpesvirus systems but does not provide specific examples or context related to the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence mentions HIV-1 and HIV-2 but does not provide specific examples or context related to the entity types in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence mentions a contraction and allele but does not provide specific examples or context related to the entity types in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence mentions B-cell response but does not provide specific examples or context related to the entity types in the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence mentions lymphocyte infiltration and breast cancer patients but does not provide specific examples or context related to the entity types in the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence mentions VD and monocytic differentiation but does not provide specific examples or context related to the entity types in the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence mentions glucocorticoid action but does not provide specific examples or context related to the entity types in the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence mentions a point mutation but does not provide specific examples or context related to the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 765, 'sentence': 'Our results suggest that substances in serum influence steroid effects on these cells and that the molecular details of glucocorticoid hormone action may be pursued more precisely in a clearly defined culture medium.', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and direct example of a cell type (nonhuman primates) being mentioned in relation to signal transduction events."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence directly mentions cell adhesion molecules, which is a clear indicator of a cell type."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence explicitly mentions G-CSF as a protein, providing a direct example of a protein entity."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains multiple examples of protein entities (CD70, IL-4, CD40) and cell types (B cell, plasma cells) in the context of cell differentiation."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence directly mentions the protein E2A, providing a clear example of a protein entity."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions the protein NF-E2 in the context of transcription factor binding, indicating a protein entity."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides examples of RNA (IL-5 mRNA), cell types (TCR, T cells), and proteins (IL-2R, dexamethasone) in the context of gene expression and stimulation."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence directly mentions granulocytes and T cells as cell types, providing clear examples of cell entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence mentions the protein IL-4 in the context of gene expression regulation, providing a clear example of a protein entity."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains multiple protein entities (IL-2, c-Jun, c-Fos) in the context of nuclear factors and transcriptional regulation."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence directly mentions phosphocreatine as a protein, providing a clear example of a protein entity."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions the cell line HML and proteins (dexamethasone, cortisol, lysozyme) in the context of glucocorticoid responsiveness."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence directly mentions the protein IFN-gamma, providing a clear example of a protein entity."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions the protein NF-kappa B in the context of serum effects on leukocyte-endothelium interaction."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides examples of protein entities (VDR, RXR, GRIP-1, DRIP205) and mentions the DRIP coactivator complex."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence contains protein entities (CD40, Rel/nuclear factor kappaB) and a cell type (B lymphocytes) in the context of signal factors."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities related to the given entity labels."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities related to the given entity labels."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities related to the given entity labels."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities related to the given entity labels."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities related to the given entity labels."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities related to the given entity labels."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities related to the given entity labels."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities related to the given entity labels."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities related to the given entity labels."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1561, 'sentence': 'In all cell lines investigated, the NF-kappa B complexes induced following CD30 engagement were shown to contain p50 NF-kappa B1 , p65 RelA , and possibly other transcription factors .', 'label': {'CD30': 'protein', 'NF-kappa B complexes': 'protein', 'p65 RelA': 'protein', 'p50 NF-kappa B1': 'protein', 'NF-kappa B': 'protein', 'transcription factors': 'protein'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n{"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n{"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 4},\n{"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n{"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.": 5},\n{"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 5},\n{"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.": 5},\n{"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n{"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.": 5},\n{"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n{"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n{"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 5},\n{"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 4},\n{"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.": 4},\n{"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.": 5},\n{"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.": 5},\n{"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"p50 NF-kappa B1": "protein"}, {"p65 RelA": "protein"}]', 'prediction': {'NF-kappa B': 'protein', 'p50 NF-kappa B1': 'protein', 'p65 RelA': 'protein'}}
{'idx': 330, 'sentence': 'ZRE-B is therefore not part of the R- inducible enhancer .', 'label': {'ZRE-B': 'DNA', 'R- inducible enhancer': 'DNA'}, 'response1': 'None.', 'response2': '[\n{"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 5},\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n{"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 4},\n{"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 5},\n{"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.": 4},\n{"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n{"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 4},\n{"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n{"RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes.": 5},\n{"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 5},\n{"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n{"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 5},\n{"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 5},\n{"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription.": 5},\n{"We have found that the recruitment of EKLF to 5\'HS3 depends on the presence of 5\'HS2 in cis, but the recruitment to 5\'HS2 does not depend on 5\'HS3.": 5},\n{"The protein from E. coli specifically converted dUTP to dUMP and did not react with other dNTPs or NTPs.": 5},\n{"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex, cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 5},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1104, 'sentence': 'Although the interrelationship between the two messengers Ca2+ and cyclic AMP in platelet function is well documented, its mechanism of action still remains to be established.', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 4},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1594, 'sentence': 'Human IL4 promoter -mediated transcription is downregulated in Jurkat cells stimulated with the NF-kappa B -activating cytokine tumor necrosis factor alpha and suppressed in RelA -overexpressing cells .', 'label': {'Jurkat cells': 'cell_line', 'NF-kappa B -activating cytokine': 'protein', 'Human IL4 promoter': 'DNA', 'tumor necrosis factor alpha': 'protein', 'RelA -overexpressing cells': 'cell_line', 'NF-kappa B': 'protein', 'RelA': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 5},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.": 5},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.": 5},\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n    {"Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells.": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).": 5},\n    {"Interestingly, CTLA4Ig did not significantly inhibit the activation of either NF of activated T cells (NFAT) or AP-1 reporters.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"IL4": "protein"}, {"Jurkat cells": "cell_line"}, {"NF-kappa B": "protein"}, {"tumor necrosis factor alpha": "protein"}, {"RelA": "protein"}]', 'prediction': {'IL4': 'protein', 'Jurkat cells': 'cell_line', 'NF-kappa B': 'protein', 'tumor necrosis factor alpha': 'protein', 'RelA': 'protein'}}
{'idx': 1086, 'sentence': 'Analysis of the expression of human I kappa B alpha protein in stable transfectants of mouse 70Z/3 cells shows that, as for the endogenous murine protein, exogenous I kappa B alpha is degraded in response to inducers of NF-kappa B activity , such as phorbol myristate acetate or lipopolysaccharide .', 'label': {'NF-kappa B': 'protein', 'I kappa B alpha': 'protein', 'human I kappa B alpha protein': 'protein', 'mouse 70Z/3 cells': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"5": "The sentence contains \'NF-kappa B\' and \'I kappa B alpha\' which are both proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'IkappaBalpha\' and \'NF-kappaB\' which are both proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'IkappaBbeta\' and \'NF-kappaB\' which are both proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'RelA\' and \'NF-kappa B\' which are both proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'NF-kappa B\' and \'I kappa B beta\' which are both proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'CD40\' and \'NF-kappa B\' which are both proteins mentioned in the target sentence."},\n    {"3": "The sentence contains \'NF-kappa B\' which is a protein mentioned in the target sentence."},\n    {"5": "The sentence contains \'IL-2\', \'c-Jun\', and \'c-Fos\' which are all proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'IFN A\', \'IFNA\', \'interleukin-2\', \'interleukin-2 receptor\', \'phytohemagglutinin\', and \'phorbol myristate acetate\' which are all proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'E2A\' which is a protein mentioned in the target sentence."},\n    {"5": "The sentence contains \'NF-kappa B\' which is a protein mentioned in the target sentence."},\n    {"5": "The sentence contains \'NF-kappa B\' and \'I kappa B alpha\' which are both proteins mentioned in the target sentence."},\n    {"5": "The sentence contains \'NF-kappaB\', \'Tax\', and \'ATL\' which are \'protein\', \'cell_type\', and \'cell_type\' respectively mentioned in the target sentence."},\n    {"5": "The sentence contains \'NF-kappa B\' which is a DNA mentioned in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."}\n]', 'response3': '[\n    {"I kappa B alpha": "protein"},\n    {"mouse 70Z/3 cells": "cell_line"},\n    {"NF-kappa B": "protein"},\n    {"phorbol myristate acetate": "protein"},\n    {"lipopolysaccharide": "protein"}\n]', 'prediction': {'I kappa B alpha': 'protein', 'mouse 70Z/3 cells': 'cell_line', 'NF-kappa B': 'protein', 'phorbol myristate acetate': 'protein', 'lipopolysaccharide': 'protein'}}
{'idx': 1, 'sentence': 'When the homeodomain from HB24 was compared to known mammalian and Drosophila homeodomains it was found to be only moderately conserved, but when it was compared to a highly diverged Drosophila homeodomain , H2.0, it was found to be 80% identical.', 'label': {'homeodomain': 'DNA', 'HB24': 'DNA', 'Drosophila homeodomain': 'DNA'}, 'response1': "['protein']", 'response2': '[\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n{"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 5},\n{"Like Drosophila Toll, human Toll is a type I transmembrane protein with an extracellular domain consisting of a leucine-rich repeat (LRR) domain, and a cytoplasmic domain homologous to the cytoplasmic domain of the human interleukin (IL)-1 receptor.": 5},\n{"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 4},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n{"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 4},\n{"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 5},\n{"These two related genes share the evolutionarily conserved region encoding the Runt domain.": 5},\n{"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 5},\n{"Here we examined the regulatory mechanism of the SCM-1 genes.": 5},\n{"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n{"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 5},\n{"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.": 5},\n{"Thus, we were able to derive a hematopoietic cell line, called 47.10, that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1226, 'sentence': 'Lastly, the different mobilities of osteoblast nuclear extract-DNA complexes compared with T-cell nuclear extract-DNA complexes , along with the inability of OSF2 to be upregulated by retinoic acid , unlike the other PEBP2 alpha factors , suggest that OSF2 is a new member of this family of transcription factors .', 'label': {'transcription factors': 'protein', 'T-cell nuclear extract-DNA complexes': 'protein', 'OSF2': 'protein', 'osteoblast nuclear extract-DNA complexes': 'protein', 'PEBP2 alpha factors': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 5},\n{"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .": 5},\n{"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .": 5},\n{"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n{"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n{"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 5},\n{"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .": 5},\n{"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]": 5},\n{"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n{"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .": 5},\n{"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 5},\n{"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 5},\n{"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .": 5},\n{"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .": 5},\n{"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations .": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection .": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C .": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[{"OSF2": "protein"}, {"PEBP2 alpha factors": "protein"}]', 'prediction': {'OSF2': 'protein', 'PEBP2 alpha factors': 'protein'}}
{'idx': 663, 'sentence': 'The cells lines described here should be useful for the delineation of signaling pathways utilized in the selective regulation of gene expression .', 'label': {}, 'response1': "['cell_line', 'cell_type', 'gene expression']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear and direct mapping between the entity \'SCL\' and the entity label \'RNA\', making it highly helpful for extracting named entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains multiple instances of clear mappings between entities and entity labels, providing valuable information for extracting named entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence directly links the entity \'GATA-1\' to the entity label \'protein\', aiding in the extraction of named entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence explicitly mentions \'SCM-1\' as a \'cell_line\', making it highly helpful for extracting named entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence clearly identifies \'nonhuman primates\' as \'cell_type\', providing valuable information for extracting named entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence directly associates \'E2A\' with the entity label \'protein\', aiding in the extraction of named entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence provides a direct mapping between \'GATA-1\' and \'protein\', assisting in the extraction of named entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains clear mappings between entities and entity labels, such as \'immunohistochemistry\' to \'protein\' and \'cell type\' to \'cell_type\', making it highly helpful for extracting named entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence directly links entities like \'NF-kappa B\' and \'I kappa B alpha\' to the entity label \'protein\', aiding in the extraction of named entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides a direct mapping between \'IL-4\' and \'protein\', assisting in the extraction of named entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence clearly identifies \'MNDA\' as \'protein\' and \'Philadelphia chromosome-positive chronic myeloid leukemia\' as \'cell_line\', providing valuable information for extracting named entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains clear mappings between entities like \'Sp1\', \'Ets\', and \'mouse perforin gene\' to the entity label \'protein\', aiding in the extraction of named entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence directly associates \'p21(WAF1/CIP1)\' and \'p27(KIP1)\' with the entity label \'protein\', making it highly helpful for extracting named entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides a direct mapping between \'cell adhesion molecules\' and \'cell_type\', aiding in the extraction of named entities."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains clear mappings between entities like \'IL-13\', \'IL-4R\', \'JAK2\', and \'IL-13R\' to the entity label \'protein\', assisting in the extraction of named entities."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence provides a direct mapping between entities like \'ZEB\', \'c-Myb\', \'Ets\', and \'hematopoietic cells\' to the entity label \'protein\' and \'cell_type\', making it highly helpful for extracting named entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, hence not helpful for extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, hence not helpful for extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, hence not helpful for extraction."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, hence not helpful for extraction."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, hence not helpful for extraction."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, hence not helpful for extraction."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, hence not helpful for extraction."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, hence not helpful for extraction."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any named entities relevant to the entity labels in the target sentence, hence not helpful for extraction."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1000, 'sentence': 'Analysis of the biochemical and cell biological properties of these HSFs reveals that HSF3 has properties in common with both HSF1 and HSF2 and yet has features which are distinct from both.', 'label': {'HSF2': 'protein', 'HSF3': 'protein', 'HSFs': 'protein', 'HSF1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 5},\n    {"Example 17": 5},\n    {"Example 18": 5},\n    {"Example 19": 5},\n    {"Example 20": 5},\n    {"Example 21": 5},\n    {"Example 22": 5},\n    {"Example 23": 5},\n    {"Example 24": 5},\n    {"Example 25": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 39, 'sentence': 'Most hybrids express both KBF1 and NF-kappa B in their nuclei , but one hybrid expresses only KBF1 .', 'label': {'KBF1': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence 1": 5},\n    {"Sentence 2": 5},\n    {"Sentence 3": 5},\n    {"Sentence 4": 5},\n    {"Sentence 5": 5},\n    {"Sentence 6": 5},\n    {"Sentence 7": 5},\n    {"Sentence 8": 5},\n    {"Sentence 9": 5},\n    {"Sentence 10": 5},\n    {"Sentence 11": 1},\n    {"Sentence 12": 1},\n    {"Sentence 13": 1},\n    {"Sentence 14": 1},\n    {"Sentence 15": 1},\n    {"Sentence 16": 1},\n    {"Sentence 17": 1},\n    {"Sentence 18": 1},\n    {"Sentence 19": 1},\n    {"Sentence 20": 1},\n    {"Sentence 21": 1},\n    {"Sentence 22": 1},\n    {"Sentence 23": 1},\n    {"Sentence 24": 1},\n    {"Sentence 25": 1}\n]', 'response3': '[{"KBF1": "protein"}, {"NF-kappa B": "protein"}]', 'prediction': {'KBF1': 'protein', 'NF-kappa B': 'protein'}}
{'idx': 229, 'sentence': "We now show that: 1) CVZ has more than one binding site in a second, independent, B-cell line , IM-9 ; 2) the antiglucocorticoid RU 38486 is able to block both CVZ 's higher and lower affinity sites; 3) all of CVZ 's binding sites are on a protein immunologically indistinguishable from the human GR ; and 4) freshly isolated clones of CVZ -resistant cells have lost all binding sites for CVZ .", 'label': {'B-cell line': 'cell_line', 'IM-9': 'cell_line', 'GR': 'protein', "CVZ 's binding sites": 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 4},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 5},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.": 5},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"A gst-EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2-PU.1 interaction.": 5},\n    {"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin.": 5},\n    {"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5}\n]', 'response3': '[{"CVZ": "protein"}, {"IM-9": "cell_line"}, {"RU 38486": "protein"}, {"GR": "protein"}]', 'prediction': {'CVZ': 'protein', 'IM-9': 'cell_line', 'RU 38486': 'protein', 'GR': 'protein'}}
{'idx': 743, 'sentence': 'Detection in non-erythroid cells of a factor with the binding characteristics of the erythroid cell transcription factor EF1 .', 'label': {'erythroid cell transcription factor': 'protein', 'non-erythroid cells': 'cell_type', 'EF1': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor ).": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .": 4},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .": 4},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .": 4},\n    {"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts .": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .": 4},\n    {"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .": 5},\n    {"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .": 5},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .": 5},\n    {"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .": 5}\n]', 'response3': '[{"EF1": "protein"}]', 'prediction': {'EF1': 'protein'}}
{'idx': 1799, 'sentence': 'These STAT proteins were detected by using the IFN-gamma-activated sequence ( GAS ) and related oligonucleotides as probes in electrophoretic mobility shift assay .', 'label': {'GAS': 'DNA', 'IFN-gamma-activated sequence': 'DNA', 'STAT proteins': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.": 5},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines.": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Moreover, monocytes express a novel IL-10 -stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti- STAT3 Ab but is not observed in T cells.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus, and induce transcription from responsive genes.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 5}\n]', 'response3': '[{"STAT proteins": "protein"}, {"IFN-gamma-activated sequence (GAS)": "DNA"}]', 'prediction': {'STAT proteins': 'protein', 'IFN-gamma-activated sequence (GAS)': 'DNA'}}
{'idx': 1703, 'sentence': "E1A blocked IFN 's induction of cytolytic resistance , resulting in the selective lysis of adenovirus-transformed cells by IFN -activated NK cells .", 'label': {'E1A': 'protein', 'IFN': 'protein', 'adenovirus-transformed cells': 'cell_line', 'IFN -activated NK cells': 'cell_line'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.": 4},\n    {"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells.": 5},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 4},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 4},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 4},\n    {"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.": 5},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 5},\n    {"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 4},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis.": 4},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 4},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5}\n]', 'response3': '[{"E1A": "protein"}, {"IFN": "protein"}, {"adenovirus-transformed cells": "cell_line"}, {"NK cells": "cell_type"}]', 'prediction': {'E1A': 'protein', 'IFN': 'protein', 'adenovirus-transformed cells': 'cell_line', 'NK cells': 'cell_type'}}
{'idx': 629, 'sentence': 'Depletion of CD8+ cells was accompanied by 62 +/- 18% loss of progesterone receptor -bearing cells , while depletion of CD4+ cells resulted in a twofold increase in the number of positively staining lymphocytes .', 'label': {'progesterone receptor': 'protein', 'CD8+ cells': 'cell_line', 'lymphocytes': 'cell_line', 'progesterone receptor -bearing cells': 'cell_line', 'CD4+ cells': 'cell_line'}, 'response1': "['cell_type']", 'response2': '[\n{"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n{"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n{"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.": 5},\n{"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n{"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.": 5},\n{"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n{"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 3},\n{"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n{"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 5},\n{"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n{"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes.": 5},\n{"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5},\n{"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus, and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development.": 5},\n{"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.": 5},\n{"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.": 5},\n{"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n{"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n{"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex, cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n{"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n{"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n{"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n{"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n{"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n{"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[{"CD8+": "cell_type"}, {"progesterone receptor": "protein"}, {"CD4+": "cell_type"}, {"lymphocytes": "cell_type"}]', 'prediction': {'CD8+': 'cell_type', 'progesterone receptor': 'protein', 'CD4+': 'cell_type', 'lymphocytes': 'cell_type'}}
{'idx': 490, 'sentence': 'Cyclosporin A ( CsA ) is thought to exert its immunosuppressive effects by inhibiting the expression of a distinct set of lymphokine genes which are induced upon T-cell activation , among them the gene coding for interleukin-2 .', 'label': {'lymphokine genes': 'DNA', 'interleukin-2': 'protein'}, 'response1': "['protein', 'RNA']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"5": "The sentence contains multiple instances of the entity type \'protein\' which are relevant to the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"3": "The sentence contains \'IL-2R\' which is relevant to the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"5": "The sentence contains multiple instances of the entity type \'protein\' which are relevant to the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."}\n]', 'response3': '[{"Cyclosporin A": "protein"}, {"CsA": "protein"}, {"lymphokine genes": "protein"}, {"T-cell": "cell_type"}, {"interleukin-2": "protein"}]', 'prediction': {'Cyclosporin A': 'protein', 'CsA': 'protein', 'lymphokine genes': 'protein', 'T-cell': 'cell_type', 'interleukin-2': 'protein'}}
{'idx': 118, 'sentence': "Similar to 1;14 translocations , this deletion disrupts the SCL 5' regulatory region .", 'label': {'SCL': 'protein', "SCL 5' regulatory region": 'DNA'}, 'response1': "['DNA']", 'response2': '[\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 3},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 4},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"We have found that the recruitment of EKLF to 5\'HS3 depends on the presence of 5\'HS2 in cis, but the recruitment to 5\'HS2 does not depend on 5\'HS3.": 3},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 4},\n    {"Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n    {"SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor ).": 4},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n    {"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.": 3},\n    {"By the time of diagnosis of T-PLL , the clone contains many more genetic changes in the form of additional translocations.": 4},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 4},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 4},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[{"SCL": "RNA"}]', 'prediction': {'SCL': 'RNA'}}
{'idx': 493, 'sentence': 'Here we report that the formation of two distinct mitogen-inducible DNA-binding complexes , the kappa B complex within the HIV enhancer and the NFAT-1 complex within the interleukin-2 enhancer , is inhibited in the presence of CsA .', 'label': {'NFAT-1 complex': 'protein', 'mitogen-inducible DNA-binding complexes': 'protein', 'kappa B complex': 'protein', 'interleukin-2': 'protein', 'interleukin-2 enhancer': 'DNA', 'HIV enhancer': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 4},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 4},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.": 5},\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 5},\n    {"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.": 5},\n    {"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5}\n]', 'response3': '[{"kappa B complex": "protein"}, {"NFAT-1 complex": "protein"}]', 'prediction': {'kappa B complex': 'protein', 'NFAT-1 complex': 'protein'}}
{'idx': 1798, 'sentence': 'In purified human peripheral blood T cells , nuclear STAT proteins were activated approximately 3 h after activation by cross-linked anti-CD3 Abs .', 'label': {'purified human peripheral blood T cells': 'cell_type', 'anti-CD3 Abs': 'protein', 'nuclear STAT proteins': 'protein', 'T cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"STAT proteins": "protein"}, {"T cells": "cell_type"}, {"anti-CD3 Abs": "protein"}]', 'prediction': {'STAT proteins': 'protein', 'T cells': 'cell_type', 'anti-CD3 Abs': 'protein'}}
{'idx': 175, 'sentence': 'To compare extra-renal 1,25(OH)2D3 production in different types of granulomatous disease , and to identify the cell types responsible, we have evaluated the conversion of 25(OH)D3 in 1,25(OH)2D3 by uncultured cells recovered by bronchoalveolar lavage and blood mononuclear cells from normocalcemic patients with sarcoidosis and tuberculosis.', 'label': {'blood mononuclear cells': 'cell_type', 'uncultured cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific cell types (granulocytes and T cells) that are directly mentioned, making it highly relevant for extracting cell types."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains specific proteins (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) that are directly mentioned, making it highly relevant for extracting proteins."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence contains a specific cell line (HML) and proteins (dexamethasone, cortisol, lysozyme) that are directly mentioned, making it relevant for extracting cell lines and proteins."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains specific cell lines (SIVmacMER, SIVmac239, CEMx174) that are directly mentioned, making it highly relevant for extracting cell lines."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains a specific protein (retinoic acid receptor alpha) that is directly mentioned, making it highly relevant for extracting proteins."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific proteins (CD70, IL-4, CD40) and cell types (B cell, plasma cells) that are directly mentioned, making it highly relevant for extracting proteins and cell types."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains a specific protein (IFN-gamma) that is directly mentioned, making it highly relevant for extracting proteins."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific proteins (myeloperoxidase, lysozyme, PU.1) that are directly mentioned, making it highly relevant for extracting proteins."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains a specific protein (GATA-1) that is directly mentioned, making it highly relevant for extracting proteins."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains a specific protein (GATA-1) that is directly mentioned, making it highly relevant for extracting proteins."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains specific proteins (PKC isoforms) and cell types (human alveolar macrophages, blood monocytes) that are directly mentioned, making it highly relevant for extracting proteins and cell types."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains a specific protein (WT1) and a cell line (myeloid cell lines) that are directly mentioned, making it highly relevant for extracting proteins and cell lines."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains a specific protein (MNDA) and a cell line (Philadelphia chromosome-positive chronic myeloid leukemia) that are directly mentioned, making it highly relevant for extracting proteins and cell lines."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains a specific protein (CD14) that is directly mentioned, making it highly relevant for extracting proteins."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains specific proteins (beta-globin, glycoprotein IIb, platelet factor 4) and a cell line (Ter 119) that are directly mentioned, making it highly relevant for extracting proteins and cell lines."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence contains specific cell types (B and T cell activation) and cell lines (Ramos, Jurkat) that are directly mentioned, making it highly relevant for extracting cell types and cell lines."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 26": 1},\n    {"Reason 26": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 27": 1},\n    {"Reason 27": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 28": 1},\n    {"Reason 28": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 29": 1},\n    {"Reason 29": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 30": 1},\n    {"Reason 30": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"bronchoalveolar lavage": "cell_line"}, {"blood mononuclear cells": "cell_type"}, {"sarcoidosis": "cell_type"}, {"tuberculosis": "cell_type"}]', 'prediction': {'bronchoalveolar lavage': 'cell_line', 'blood mononuclear cells': 'cell_type', 'sarcoidosis': 'cell_type', 'tuberculosis': 'cell_type'}}
{'idx': 1498, 'sentence': 'Steroid mediated lysis of lymphoblasts requires the DNA binding region of the steroid hormone receptor.', 'label': {'lymphoblasts': 'cell_type'}, 'response1': "['DNA', 'cell_type']", 'response2': '[\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.": 4},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 4},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"The effects of G-CSF are mediated by binding to specific, high affinity receptors.": 4},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.": 4},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 4}\n]', 'response3': '[{"DNA": "DNA"}]', 'prediction': {'DNA': 'DNA'}}
{'idx': 995, 'sentence': 'The hierarchy of transcriptional control in B-cell development has recently been analyzed by targeted gene inactivation in the mouse .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"B-cell": "cell_type"}]', 'prediction': {'B-cell': 'cell_type'}}
{'idx': 1671, 'sentence': 'Both phosphorylation and proliferation were inhibited by IL-6 neutralizing antibodies .', 'label': {'IL-6 neutralizing antibodies': 'protein', 'IL-6': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."},\n    {"1": "The sentence does not contain any of the entity types in the label set."}\n]', 'response3': '[{"IL-6": "protein"}]', 'prediction': {'IL-6': 'protein'}}
{'idx': 141, 'sentence': 'TNF-alpha was able to increase expression of the HIV LTR in T cells , but in monocytic cells , TNF-alpha did not induce the HIV LTR above a constitutive level of activity .', 'label': {'monocytic cells': 'cell_type', 'TNF-alpha': 'protein', 'HIV LTR': 'DNA', 'T cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"TNF-alpha": "protein"}, {"HIV LTR": "DNA"}, {"T cells": "cell_type"}, {"monocytic cells": "cell_type"}]', 'prediction': {'TNF-alpha': 'protein', 'HIV LTR': 'DNA', 'T cells': 'cell_type', 'monocytic cells': 'cell_type'}}
{'idx': 1557, 'sentence': "In this report, we show that following incubation of L540 cells ( Hodgkin's disease -derived, T cell-like, CD30 + cells ) with the agonistic anti- CD30 monoclonal antibodies ( mAb ) M44 and M67 , two nuclear factor (NF)-kappa B DNA binding activities were induced in nuclear extracts , as determined in gel retardation assays .", 'label': {"Hodgkin's disease -derived, T cell-like, CD30 + cells": 'cell_line', 'nuclear factor (NF)-kappa B': 'protein', 'M44': 'protein', 'L540 cells': 'cell_line', 'M67': 'protein', 'mAb': 'protein', 'agonistic anti- CD30 monoclonal antibodies': 'protein', 'CD30': 'protein'}, 'response1': "['cell_line', 'protein', 'DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a clear example of NF-kappa B DNA binding activity, which directly matches an entity label in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence mentions RelA and NF-kappa B complex, both of which are relevant protein entities in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains multiple protein entities such as CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, and granulocyte-macrophage colony-stimulating factor, all of which are relevant to the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence directly mentions NF-kappa B binding activity, which is a key entity in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence includes protein entities like CD40, IFN-gamma, tumor necrosis factor-alpha, and interleukin (IL)-1beta, all of which are relevant to the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence provides protein entities related to lymphocyte activation and B cell activation, which are relevant to the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence mentions IL-2, NF-kappa B, and AP-1 activation, all of which are relevant protein entities in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence directly mentions NF-kappa B activation, which is a key entity in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence includes protein entities like CD70, B cell, plasma cells, IL-4, and CD40 signaling, all of which are relevant to the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence provides protein entities related to NF-kappaB activation, Tax, and ATL, which are relevant to the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions IkappaBbeta and NF-kappaB, both of which are relevant protein entities in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains protein entities like IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, and phorbol myristate acetate, all of which are relevant to the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence mentions CD40 and NF-kappa B activation, both of which are relevant protein entities in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence provides protein entities like p50, p65, DNA, and protein, all of which are relevant to the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence includes protein entities related to CD40 stimulation, Rel/nuclear factor kappaB, NF-kappaB, and B lymphocytes, which are relevant to the target sentence."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence mentions HIV-1, IFN, PKR, and IkappaBalpha, all of which are relevant protein entities in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entity labels present in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entity labels present in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entity labels present in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entity labels present in the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entity labels present in the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entity labels present in the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entity labels present in the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entity labels present in the target sentence."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entity labels present in the target sentence."}\n]', 'response3': '[{"NF-kappa B": "DNA"}, {"NF-kappa B": "DNA"}]', 'prediction': {'NF-kappa B': 'DNA'}}
{'idx': 1090, 'sentence': 'Further analysis reveals that the inducible phosphorylation of I kappa B alpha maps to two serines in the N terminus of the protein (residues 32 and 36) and that the mutation of either residue is sufficient to abolish ligand-induced degradation, whereas both residues must be mutated to abolish inducible phosphorylation of the protein.', 'label': {'N terminus': 'protein', 'I kappa B alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n    {"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.": 4},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras.": 5},\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 4},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF.": 5},\n    {"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events.": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n    {"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 3},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation.": 5},\n    {"Control of NF-kappa B activity by the I kappa B beta inhibitor.": 4},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.": 4},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[{"I kappa B alpha": "protein"}]', 'prediction': {'I kappa B alpha': 'protein'}}
{'idx': 1568, 'sentence': 'The inverse relation between high density lipoprotein ( HDL ) and atherosclerotic events may in part be due to enzymes associated with HDL that destroy the biologically active lipids generated in LDL .', 'label': {'enzymes': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"NF-kappa B": 5},\n{"retinoic acid receptor alpha": 5},\n{"myeloperoxidase": 5},\n{"lysozyme": 5},\n{"PU.1": 5},\n{"IL-4": 5},\n{"LPS": 5},\n{"AP-1": 5},\n{"alpha-tocopherol": 4},\n{"monocyte": 4},\n{"endothelial cells": 4},\n{"phosphocreatine": 4},\n{"AP-1": 4},\n{"P selectin": 4},\n{"cAMP-dependent protein kinase": 5},\n{"Rap1": 5},\n{"Stat3": 5},\n{"Stat5": 5},\n{"c-Mpl": 5},\n{"NF-kappa B": 5},\n{"cell adhesion molecules": 4},\n{"interleukin-2": 5},\n{"CD25": 5},\n{"IL-2 receptor": 5},\n{"Protein kinase B": 5},\n{"phosphatidylinositol 3-kinase": 5},\n{"STAT5": 5},\n{"erythropoietin": 5},\n{"HCD57": 4},\n{"EPO": 5},\n{"HCD57-SREI": 4},\n{"c-Akt": 5},\n{"T lymphocytes": 5},\n{"adenovirus vectors": 5},\n{"sickle red blood cells": 5},\n{"leukocytes": 5},\n{"vascular endothelium": 5},\n{"blood vessel": 5}\n]', 'response3': "[{'HDL': 'protein'}, {'LDL': 'protein'}]", 'prediction': {'HDL': 'protein', 'LDL': 'protein'}}
{'idx': 257, 'sentence': 'Because of the presence of a functional receptor-effector system for VD3 and multiple biological responses to the hormone, these cells provide a unique model system with which to probe the specific effects of VD3 on cell growth and differentiation in chronic myelogenous leukemia .', 'label': {}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"5": "The example contains multiple named entities (proteins, cell types) present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"5": "The example contains multiple named entities (proteins, cell lines) present in the target sentence."},\n    {"5": "The example contains multiple named entities (proteins, cell lines) present in the target sentence."},\n    {"5": "The example contains multiple named entities (proteins) present in the target sentence."},\n    {"5": "The example contains multiple named entities (proteins) present in the target sentence."},\n    {"5": "The example contains multiple named entities (proteins, cell types) present in the target sentence."},\n    {"5": "The example contains multiple named entities (proteins) present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in the target sentence."},\n    {"1": "The example does not contain any named entities present in', 'response3': "[{'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'}, {'VD3': 'protein'},", 'prediction': {}}
{'idx': 262, 'sentence': 'This complementary DNA encoded a protein with structural similarities to the c-jun proto-oncogene product , and its target sequence was closely related to the palindromic target sequence of c-jun .', 'label': {'complementary DNA': 'DNA', 'c-jun proto-oncogene product': 'protein', 'palindromic target sequence': 'DNA', 'c-jun': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 3},\n{"Here we examined the regulatory mechanism of the SCM-1 genes.": 2},\n{"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n{"These two related genes share the evolutionarily conserved region encoding the Runt domain.": 4},\n{"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 4},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 3},\n{"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n{"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.": 4},\n{"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 3},\n{"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 4},\n{"This protein has now been purified and its encoding gene cloned.": 4},\n{"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.": 4},\n{"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 4},\n{"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n{"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n{"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1351, 'sentence': 'Western blotting yielded a set of bands ranging from 25 kD to 55 kD, resulting from extensive alternative splicing .', 'label': {}, 'response1': "['protein', 'RNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 5},\n    {"Example 17": 5},\n    {"Example 18": 5},\n    {"Example 19": 5},\n    {"Example 20": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 973, 'sentence': 'To assess the transcription regulatory function of MZF-1 , the full-length MZF-1 coding region was fused to the DNA binding domain of the yeast transactivator GAL4 .', 'label': {'MZF-1': 'DNA', 'DNA binding domain': 'protein', 'yeast transactivator GAL4': 'protein', 'GAL4': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence contains a specific gene name \'SCM-1\' which is likely a cell line based on the entity types in the target sentence."},\n{"Example 2": 4},\n{"Reason 2": "The sentence mentions \'p50p50\' which is likely a protein based on the entity types in the target sentence."},\n{"Example 3": 4},\n{"Reason 3": "The sentence refers to \'PML/RARalpha\' which is likely a protein based on the entity types in the target sentence."},\n{"Example 4": 5},\n{"Reason 4": "The sentence includes multiple protein names like \'EKLF\', \'CBP\', \'p300\', and \'P/CAF\' which are likely proteins based on the entity types in the target sentence."},\n{"Example 5": 5},\n{"Reason 5": "The sentence mentions \'GATA-1\' which is likely a protein based on the entity types in the target sentence."},\n{"Example 6": 5},\n{"Reason 6": "The sentence contains \'TCF-1\' which is likely a protein based on the entity types in the target sentence."},\n{"Example 7": 5},\n{"Reason 7": "The sentence includes \'ZEBRA\' which is likely a protein based on the entity types in the target sentence."},\n{"Example 8": 5},\n{"Reason 8": "The sentence mentions \'A-myb\' which is likely a protein based on the entity types in the target sentence."},\n{"Example 9": 4},\n{"Reason 9": "The sentence refers to \'Protein\' which is likely a protein based on the entity types in the target sentence."},\n{"Example 10": 4},\n{"Reason 10": "The sentence contains \'CD95 ligand\' which is likely a protein based on the entity types in the target sentence."},\n{"Example 11": 5},\n{"Reason 11": "The sentence mentions \'Tax\' and \'TFIIA\' which are likely proteins based on the entity types in the target sentence."},\n{"Example 12": 5},\n{"Reason 12": "The sentence includes \'Egr-1\' which is likely a protein based on the entity types in the target sentence."},\n{"Example 13": 5},\n{"Reason 13": "The sentence mentions \'IL-2\', \'c-Jun\', and \'c-Fos\' which are likely proteins based on the entity types in the target sentence."},\n{"Example 14": 5},\n{"Reason 14": "The sentence contains \'GATA-1\' which is likely a protein based on the entity types in the target sentence."},\n{"Example 15": 5},\n{"Reason 15": "The sentence refers to \'E2A\' which is likely a protein based on the entity types in the target sentence."},\n{"Example 16": 5},\n{"Reason 16": "The sentence includes \'Sp1\' and \'Ets\' which are likely proteins based on the entity types in the target sentence."},\n{"Example 17": 1},\n{"Reason 17": "The sentence does not contain any entity names related to the given entity labels."},\n{"Example 18": 1},\n{"Reason 18": "The sentence does not contain any entity names related to the given entity labels."},\n{"Example 19": 1},\n{"Reason 19": "The sentence does not contain any entity names related to the given entity labels."},\n{"Example 20": 1},\n{"Reason 20": "The sentence does not contain any entity names related to the given entity labels."},\n{"Example 21": 1},\n{"Reason 21": "The sentence does not contain any entity names related to the given entity labels."},\n{"Example 22": 1},\n{"Reason 22": "The sentence does not contain any entity names related to the given entity labels."},\n{"Example 23": 1},\n{"Reason 23": "The sentence does not contain any entity names related to the given entity labels."},\n{"Example 24": 1},\n{"Reason 24": "The sentence does not contain any entity names related to the given entity labels."},\n{"Example 25": 1},\n{"Reason 25": "The sentence does not contain any entity names related to the given entity labels."}\n]', 'response3': '[{"MZF-1": "protein"}, {"MZF-1": "protein"}, {"DNA": "DNA"}, {"GAL4": "protein"}]', 'prediction': {'MZF-1': 'protein', 'DNA': 'DNA', 'GAL4': 'protein'}}
{'idx': 1125, 'sentence': 'This indicates that the CR of GR may be of functional significance.', 'label': {'GR': 'protein'}, 'response1': "['protein']", 'response2': '[{"Example 1": 5},{"Example 2": 5},{"Example 3": 5},{"Example 4": 5},{"Example 5": 5},{"Example 6": 5},{"Example 7": 5},{"Example 8": 5},{"Example 9": 1},{"Example 10": 1},{"Example 11": 1},{"Example 12": 1},{"Example 13": 1},{"Example 14": 5},{"Example 15": 5},{"Example 16": 1},{"Example 17": 1},{"Example 18": 1},{"Example 19": 1},{"Example 20": 1},{"Example 21": 1},{"Example 22": 1},{"Example 23": 1},{"Example 24": 1},{"Example 25": 1},{"Example 26": 1},{"Example 27": 1},{"Example 28": 1},{"Example 29": 1},{"Example 30": 1}]', 'response3': '[]', 'prediction': {}}
{'idx': 338, 'sentence': 'Nuclear T3R in lymphocytes was determined by radio-ligand binding analysis .', 'label': {'T3R': 'protein', 'lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides clear and specific examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."}\n]', 'response3': '[{"T3R": "protein"}, {"lymphocytes": "cell_type"}]', 'prediction': {'T3R': 'protein', 'lymphocytes': 'cell_type'}}
{'idx': 1080, 'sentence': 'However, the concurrent addition of iron (in the form of ferrous or ferric chloride and other iron salts ) reversed the inhibition of proliferation caused by tepoxalin .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains a specific entity with a clear entity label that matches the entity type in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains a specific entity with a clear entity label that matches the entity type in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains a specific entity with a clear entity label that matches the entity type in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains specific entities with clear entity labels that match the entity types in the target sentence."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities that match the entity types in the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities that match the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1786, 'sentence': 'Binding of plasma Factor VII/VIIa to the tissue factor (TF) receptor initiates the coagulation protease cascades .', 'label': {'coagulation protease': 'protein', 'tissue factor (TF) receptor': 'protein', 'plasma Factor VII/VIIa': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 1},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"Factor VII/VIIa": "protein"}, {"TF": "protein"}]', 'prediction': {'Factor VII/VIIa': 'protein', 'TF': 'protein'}}
{'idx': 1242, 'sentence': 'LPS signaling was found to involve NF kappa B activation by the p50/p65 heterodimers .', 'label': {'NF kappa B': 'protein', 'p50/p65 heterodimers': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n    {"Control of NF-kappa B activity by the I kappa B beta inhibitor.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.": 5},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 4},\n    {"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 5},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 5},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.": 5},\n    {"Recently, activation of NF-kappa B has been linked to ARDS and has been shown to be a critical proximal step in the initiation of neutrophilic inflammation in animal models.": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 5},\n    {"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"NF kappa B": "protein"}, {"p50": "protein"}, {"p65": "protein"}]', 'prediction': {'NF kappa B': 'protein', 'p50': 'protein', 'p65': 'protein'}}
{'idx': 866, 'sentence': 'T cell activation results in high levels of HIV replication and is thought to be one mechanism leading to the conversion from latent to active viral infection .', 'label': {'T cell': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"T cell": "cell_type"}, {"HIV": "cell_type"}]', 'prediction': {'T cell': 'cell_type', 'HIV': 'cell_type'}}
{'idx': 433, 'sentence': 'Competition experiments did not reveal any high-affinity binding site for BSAP in known regulatory regions of immunoglobulin and class II major histocompatibility (MHC) genes , suggesting that BSAP is a regulator of a different set of B-lymphoid-specific genes .', 'label': {'regulatory regions': 'DNA', 'BSAP': 'protein', 'high-affinity binding site': 'DNA', 'B-lymphoid-specific genes': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 5},\n    {"Example 17": 5},\n    {"Example 18": 5},\n    {"Example 19": 5},\n    {"Example 20": 5},\n    {"Example 21": 5},\n    {"Example 22": 5},\n    {"Example 23": 5},\n    {"Example 24": 5},\n    {"Example 25": 5}\n]', 'response3': '[{"BSAP": "protein"}, {"immunoglobulin": "protein"}, {"class II major histocompatibility (MHC) genes": "protein"}, {"B-lymphoid-specific genes": "cell_type"}]', 'prediction': {'BSAP': 'protein', 'immunoglobulin': 'protein', 'class II major histocompatibility (MHC) genes': 'protein', 'B-lymphoid-specific genes': 'cell_type'}}
{'idx': 1546, 'sentence': 'Identification of essential GATA and Ets binding motifs within the promoter of the platelet glycoprotein Ib alpha gene .', 'label': {'platelet glycoprotein Ib alpha gene': 'DNA', 'GATA': 'DNA', 'Ets binding motifs': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides specific protein names that are directly mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 2": 5},\n    {"Reason 2": "The example provides specific protein and cell line names that are directly mentioned in the sentence, aiding in the extraction of protein and cell line entities."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides a specific protein name that is directly mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The example provides a specific cell type name that is directly mentioned in the sentence, aiding in the extraction of cell type entities."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides specific protein names that are directly mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 6": 5},\n    {"Reason 6": "The example provides specific protein names that are directly mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides a specific protein name that is directly mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides specific protein names that are directly mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides a specific protein name that is directly mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides specific protein names that are directly mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides a specific protein name that is directly mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 12": 5},\n    {"Reason 12": "The example provides a specific protein name that is directly mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 13": 5},\n    {"Reason 13": "The example provides a specific protein name that is directly mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 14": 5},\n    {"Reason 14": "The example provides specific protein names that are directly mentioned in the sentence, aiding in the extraction of protein entities."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any entity types from the given label set, hence not helpful for named entity extraction."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entity types from the given label set, hence not helpful for named entity extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entity types from the given label set, hence not helpful for named entity extraction."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entity types from the given label set, hence not helpful for named entity extraction."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entity types from the given label set, hence not helpful for named entity extraction."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entity types from the given label set, hence not helpful for named entity extraction."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entity types from the given label set, hence not helpful for named entity extraction."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entity types from the given label set, hence not helpful for named entity extraction."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entity types from the given label set, hence not helpful for named entity extraction."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entity types from the given label set, hence not helpful for named entity extraction."}\n]', 'response3': '[{"GATA": "protein"}, {"Ets": "protein"}, {"platelet glycoprotein Ib alpha gene": "protein"}]', 'prediction': {'GATA': 'protein', 'Ets': 'protein', 'platelet glycoprotein Ib alpha gene': 'protein'}}
{'idx': 1412, 'sentence': 'We found that these parameters were indistinguishable for one of the PRL- and IL-2- induced factors .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The example provides a specific entity with its corresponding label, which directly aids in understanding the entity types present in the sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The example provides multiple specific entities with their corresponding labels, directly aiding in understanding the entity types present in the sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The example provides multiple specific entities with their corresponding labels, directly aiding in understanding the entity types present in the sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The example provides multiple specific entities with their corresponding labels, directly aiding in understanding the entity types present in the sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The example provides multiple specific entities with their corresponding labels, directly aiding in understanding the entity types present in the sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The example provides multiple specific entities with their corresponding labels, directly aiding in understanding the entity types present in the sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The example provides multiple specific entities with their corresponding labels, directly aiding in understanding the entity types present in the sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The example provides multiple specific entities with their corresponding labels, directly aiding in understanding the entity types present in the sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The example provides multiple specific entities with their corresponding labels, directly aiding in understanding the entity types present in the sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The example provides multiple specific entities with their corresponding labels, directly aiding in understanding the entity types present in the sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The example provides a specific entity with its corresponding label, which directly aids in understanding the entity types present in the sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The example provides multiple specific entities with their corresponding labels, directly aiding in understanding the entity types present in the sentence."},\n    {"Example 13": 1},\n    {"Reason 13": "The example does not contain any entities relevant to the entity types in the target sentence, hence not helpful in aiding the extraction of named entities."},\n    {"Example 14": 1},\n    {"Reason 14": "The example does not contain any entities relevant to the entity types in the target sentence, hence not helpful in aiding the extraction of named entities."},\n    {"Example 15": 1},\n    {"Reason 15": "The example does not contain any entities relevant to the entity types in the target sentence, hence not helpful in aiding the extraction of named entities."},\n    {"Example 16": 1},\n    {"Reason 16": "The example does not contain any entities relevant to the entity types in the target sentence, hence not helpful in aiding the extraction of named entities."},\n    {"Example 17": 1},\n    {"Reason 17": "The example does not contain any entities relevant to the entity types in the target sentence, hence not helpful in aiding the extraction of named entities."},\n    {"Example 18": 1},\n    {"Reason 18": "The example does not contain any entities relevant to the entity types in the target sentence, hence not helpful in aiding the extraction of named entities."},\n    {"Example 19": 1},\n    {"Reason 19": "The example does not contain any entities relevant to the entity types in the target sentence, hence not helpful in aiding the extraction of named entities."},\n    {"Example 20": 1},\n    {"Reason 20": "The example does not contain any entities relevant to the entity types in the target sentence, hence not helpful in aiding the extraction of named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 411, 'sentence': 'There was a significant positive correlation between VDR concentration and serum phosphate (P less than 0.05).', 'label': {'VDR': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 5},\n{"Reasons": "The sentence directly mentions \'DNA binding activity\', which is a clear indicator of the entity type \'DNA\'."},\n\n{"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n{"Reasons": "The sentence mentions \'granulocytes\' and \'T cells\', which are indicative of the entity type \'cell_type\'."},\n\n{"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n{"Reasons": "The sentence mentions \'phosphocreatine\', which is indicative of the entity type \'protein\'."},\n\n{"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 4},\n{"Reasons": "The sentence mentions \'CD14\', which is indicative of the entity type \'protein\'."},\n\n{"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 4},\n{"Reasons": "The sentence mentions \'PBMC\' and \'adenovirus DNA\', which are indicative of the entity types \'cell_type\' and \'DNA\'."},\n\n{"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 4},\n{"Reasons": "The sentence mentions \'TCRzeta\' and \'p56(lck)\', which are indicative of the entity type \'protein\'."},\n\n{"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n{"Reasons": "The sentence mentions \'retinoic acid receptor alpha\', which is indicative of the entity type \'protein\'."},\n\n{"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n{"Reasons": "The sentence mentions \'RXR\', which is indicative of the entity type \'protein\'."},\n\n{"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05).": 3},\n{"Reasons": "The sentence mentions \'CD4+\', which is indicative of the entity type \'cell_type\', and \'EBV\', which is indicative of the entity type \'protein\'."},\n\n{"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n{"Reasons": "The sentence mentions \'Protein\', which is indicative of the entity type \'protein\'."},\n\n{"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.": 5},\n{"Reasons": "The sentence mentions \'VDR\', \'RXR\', \'GRIP-1\', and \'DRIP205\', which are all indicative of the entity type \'protein\'."},\n\n{"Both haemin and delta-ALA caused a de novo increase in alpha-globin expression as well as enhancing Epo-induced beta-globin expression, leading to a marked increase in haemoglobin production.": 5},\n{"Reasons": "The sentence mentions \'Epo\', \'alpha-globin\', \'beta-globin\', \'haemoglobin\', \'haemin\', and \'delta-ALA\', which are all indicative of the entity type \'protein\'."},\n\n{"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 4},\n{"Reasons": "The sentence mentions \'cDNA\', \'Jurkat\', and \'DRE 1\', which are indicative of the entity types \'DNA\' and \'cell_line\'."},\n\n{"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.": 4},\n{"Reasons": "The sentence mentions \'PMA\' and \'U1 cells\', which are indicative of the entity type \'cell_line\'."},\n\n{"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.": 4},\n{"Reasons": "The sentence mentions \'nuclear factor-kappa B\' and \'NF-kappa B\', which are indicative of the entity type \'DNA\'."}\n]', 'response3': '[{"VDR concentration": "protein"}, {"serum phosphate": "protein"}]', 'prediction': {'VDR concentration': 'protein', 'serum phosphate': 'protein'}}
{'idx': 1460, 'sentence': 'In contrast, in a number of multiple myeloma cell lines , representing differentiated, plasma cell-like B cells , PU.1 DNA binding activity , mRNA expression , and Pu box -dependent transactivation were absent or detectable at a very low level.', 'label': {'multiple myeloma cell lines': 'cell_line', 'PU.1': 'protein', 'Pu box': 'DNA', 'differentiated, plasma cell-like B cells': 'cell_type'}, 'response1': "['cell_line', 'DNA', 'protein', 'RNA']", 'response2': '[\n    {"Example 1": 3},\n    {"Example 2": 4},\n    {"Example 3": 4},\n    {"Example 4": 5},\n    {"Example 5": 4},\n    {"Example 6": 4},\n    {"Example 7": 5},\n    {"Example 8": 4},\n    {"Example 9": 3},\n    {"Example 10": 3},\n    {"Example 11": 3},\n    {"Example 12": 4},\n    {"Example 13": 5},\n    {"Example 14": 4},\n    {"Example 15": 3},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"PU.1": "protein"}, {"DNA": "DNA"}, {"mRNA": "RNA"}]', 'prediction': {'PU.1': 'protein', 'DNA': 'DNA', 'mRNA': 'RNA'}}
{'idx': 638, 'sentence': 'Thus the VLA-5 fibronectin receptor on CD4 cells can play a complementary role in CD3 - TCR -mediated signal transduction through its interaction with fibronectin .', 'label': {'CD3': 'protein', 'TCR': 'protein', 'VLA-5 fibronectin receptor': 'protein', 'fibronectin': 'protein', 'CD4 cells': 'cell_line'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names like TCF-1 and mentions transactivation, which is a clear indicator of protein involvement."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence mentions specific protein names like c-kit and IL-4R alpha chain, indicating their presence and relevance in the context."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence explicitly mentions protein names like Syk, Zap, and T cell antigen receptor, providing clear indications of protein involvement."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence mentions specific protein names like Stat3, Stat5, and c-Mpl, indicating their relevance in signal transduction."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific protein names like CD40 and NF-kappa B, indicating their involvement in the described signaling pathway."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence mentions specific protein names like IL4, IL13, STAT6, STAT3, STAT5, and B cells, providing clear indications of their involvement."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence explicitly mentions protein names like NF-ATc and T lymphocytes, indicating their presence and relevance."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions cell adhesion molecules, indicating their involvement in the mechanism of inhibition."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains specific protein names like CD70, IL-4, CD40, and mentions differentiation into plasma cells, indicating their relevance."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence mentions specific protein names like IL-7R and gamma(c), indicating their critical role in IL-7R function."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains specific protein names like CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, and granulocyte-macrophage colony-stimulating factor, indicating their involvement in signal transduction."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence mentions specific protein names like CD40, IFN-gamma, tumor necrosis factor-alpha, and interleukin (IL)-1beta, indicating their relevance in CD40 expression."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains specific protein names like interleukin 10, IL-10R, STAT3, and IL-6, indicating their involvement in signal transduction."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions specific protein names like IL-2 receptor alpha subunit, p21ras, and B cells, indicating their relevance in lymphocyte activation."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence mentions NF-kappa B activation, indicating its relevance in promoting leukocyte-endothelium interaction."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence contains specific protein names like ICAM-1, CD71, LMP1, and IkappaB, indicating their up-regulation by LMP1."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entity names or indicators of named entities."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific entity names or indicators of named entities."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific entity names or indicators of named entities."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any specific entity names or indicators of named entities."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any specific entity names or indicators of named entities."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any specific entity names or indicators of named entities."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any specific entity names or indicators of named entities."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any specific entity names or indicators of named entities."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any specific entity names or indicators of named entities."}\n]', 'response3': '[{"VLA-5": "protein"}, {"CD4 cells": "cell_type"}, {"CD3": "protein"}, {"TCR": "protein"}, {"fibronectin": "protein"}]', 'prediction': {'VLA-5': 'protein', 'CD4 cells': 'cell_type', 'CD3': 'protein', 'TCR': 'protein', 'fibronectin': 'protein'}}
{'idx': 1375, 'sentence': 'We have analyzed the expression of TCL1 mRNA and protein in peripheral blood lymphocytes ( PBLs ) from four AT cases and from healthy controls .', 'label': {'PBLs': 'cell_type', 'peripheral blood lymphocytes': 'cell_type', 'TCL1 mRNA': 'RNA', 'protein': 'protein'}, 'response1': "['RNA', 'protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1}\n]', 'response3': '[{"TCL1": "protein"}, {"PBLs": "cell_type"}, {"AT": "cell_type"}]', 'prediction': {'TCL1': 'protein', 'PBLs': 'cell_type', 'AT': 'cell_type'}}
{'idx': 764, 'sentence': 'The increased sensitivity of CEM-C7 cells and its subclones to dexamethasone in serum-free medium returned to previous levels when these cells were recultured in serum-containing medium .', 'label': {'CEM-C7': 'cell_line', 'CEM-C7 cells': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .": 4},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 4},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .": 4},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .": 4},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 4},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .": 4},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .": 4},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice .": 5},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5}\n]', 'response3': '[{"CEM-C7 cells": "cell_line"}]', 'prediction': {'CEM-C7 cells': 'cell_line'}}
{'idx': 897, 'sentence': 'The system is based on the use of an oligomerized NFAT-1 binding motif that directs transcription of SV40 T-antigen in transgenic mice .', 'label': {'transcription of SV40 T-antigen': 'protein', 'NFAT-1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 5},\n    {"Example 17": 5},\n    {"Example 18": 5},\n    {"Example 19": 5},\n    {"Example 20": 5},\n    {"Example 21": 5},\n    {"Example 22": 5},\n    {"Example 23": 5},\n    {"Example 24": 5},\n    {"Example 25": 5}\n]', 'response3': '[{"NFAT-1": "protein"}, {"SV40 T-antigen": "protein"}]', 'prediction': {'NFAT-1': 'protein', 'SV40 T-antigen': 'protein'}}
{'idx': 1842, 'sentence': 'Individually or collectively, none of the three enhancer-binding proteins ( LEF-1 , Ets-1 , and TFE-3 ) could activate transcription in the absence of Sp1 .', 'label': {'Ets-1': 'protein', 'TFE-3': 'protein', 'LEF-1': 'protein', 'enhancer-binding proteins': 'protein', 'Sp1': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"LEF-1": "protein"}, {"Ets-1": "protein"}, {"TFE-3": "protein"}, {"Sp1": "protein"}]', 'prediction': {'LEF-1': 'protein', 'Ets-1': 'protein', 'TFE-3': 'protein', 'Sp1': 'protein'}}
{'idx': 1059, 'sentence': 'Transcription factors belonging to the NF-kappa B family are controlled by inhibitory I kappa B proteins , mainly I kappa B alpha and I kappa B beta .', 'label': {'NF-kappa B family': 'protein', 'Transcription factors': 'protein', 'I kappa B beta': 'protein', 'inhibitory I kappa B proteins': 'protein', 'I kappa B alpha': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1},\n    {"Example 26": 1},\n    {"Example 27": 1},\n    {"Example 28": 1}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"I kappa B": "protein"}, {"I kappa B alpha": "protein"}, {"I kappa B beta": "protein"}]', 'prediction': {'NF-kappa B': 'protein', 'I kappa B': 'protein', 'I kappa B alpha': 'protein', 'I kappa B beta': 'protein'}}
{'idx': 924, 'sentence': 'We conclude that p56 exists in cytosol in a higher order complex containing hsp70 and hsp90 , both of which in turn have been found to be associated with untransformed steroid receptors .', 'label': {'hsp70': 'protein', 'untransformed steroid receptors': 'protein', 'hsp90': 'protein', 'p56': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.": 4},\n    {"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.": 3},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 4},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 4},\n    {"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes.": 4},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.": 5},\n    {"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 3},\n    {"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system.": 4},\n    {"Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 4}\n]', 'response3': '[{"p56": "protein"}, {"hsp70": "protein"}, {"hsp90": "protein"}, {"untransformed steroid receptors": "protein"}]', 'prediction': {'p56': 'protein', 'hsp70': 'protein', 'hsp90': 'protein', 'untransformed steroid receptors': 'protein'}}
{'idx': 247, 'sentence': 'Antigen B27 seems to be a cause of lower levels of glucocorticoid receptors in blood lymphocytes .', 'label': {'Antigen B27': 'protein', 'glucocorticoid receptors': 'protein', 'blood lymphocytes': 'cell_type', 'lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.": 5},\n    {"Benzene toxicity towards lymphocytes is thought to be mediated by metabolites of benzene including benzoquinone ( BQ ).": 4},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 4},\n    {"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes.": 3},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 4},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 3},\n    {"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.": 4},\n    {"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.": 5},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 4},\n    {"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.": 4},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.": 4},\n    {"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).": 5}\n]', 'response3': '[{"Antigen B27": "protein"}, {"glucocorticoid receptors": "protein"}, {"blood lymphocytes": "cell_type"}]', 'prediction': {'Antigen B27': 'protein', 'glucocorticoid receptors': 'protein', 'blood lymphocytes': 'cell_type'}}
{'idx': 507, 'sentence': 'Thus, the transcriptional activity of TCF-1 alpha appears to depend on the TCF-2 alpha and T alpha 1 ( CREB ) transcription factors and the context of its binding site within the TCR alpha enhancer .', 'label': {'TCF-2 alpha': 'protein', 'TCR alpha enhancer': 'DNA', 'CREB': 'protein', 'transcription factors': 'protein', 'T alpha 1': 'protein', 'TCR': 'protein', 'TCF-1 alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 5},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 5},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 4},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 5},\n    {"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n    {"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system.": 5},\n    {"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 5},\n    {"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.": 5},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes.": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb/Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5},\n    {"While the activation of the IL-2 promoter and an NFAT-driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418, it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2-mediated NFAT activation is under the control of a combination of calcineurin-dependent and independent pathways.": 5}\n]', 'response3': '[{"TCF-1 alpha": "protein"}, {"TCF-2 alpha": "protein"}, {"T alpha 1": "protein"}, {"CREB": "protein"}, {"TCR alpha enhancer": "DNA"}]', 'prediction': {'TCF-1 alpha': 'protein', 'TCF-2 alpha': 'protein', 'T alpha 1': 'protein', 'CREB': 'protein', 'TCR alpha enhancer': 'DNA'}}
{'idx': 460, 'sentence': "To characterize these regulatory elements further, mutations in these regions were inserted into both the 5' and 3' HIV LTRs and infectious proviral constructs were assembled.", 'label': {'HIV LTRs': 'DNA', 'regulatory elements': 'DNA'}, 'response1': "['DNA']", 'response2': '[\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 5},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 5},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 5},\n    {"Here we examined the regulatory mechanism of the SCM-1 genes.": 5},\n    {"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 5},\n    {"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 5},\n    {"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems ( herpes simplex, cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[{"HIV LTRs": "DNA"}]', 'prediction': {'HIV LTRs': 'DNA'}}
{'idx': 131, 'sentence': 'Truncation of TR alpha 1 at amino acid 210 prevented additional complex formation in the presence of NE without affecting DNA binding , suggesting that the carboxyl-terminus of the TRs is essential for interaction with nuclear proteins .', 'label': {'TRs': 'protein', 'carboxyl-terminus': 'protein', 'TR alpha 1': 'protein', 'nuclear proteins': 'protein', 'amino acid 210': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[\n    {"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes.": 5},\n    {"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system.": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n    {"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events.": 5},\n    {"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.": 5},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.": 5},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex.": 5},\n    {"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.": 5},\n    {"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 4},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[{"TR alpha 1": "protein"}, {"NE": "protein"}, {"DNA": "DNA"}, {"TRs": "protein"}]', 'prediction': {'TR alpha 1': 'protein', 'NE': 'protein', 'DNA': 'DNA', 'TRs': 'protein'}}
{'idx': 692, 'sentence': 'The human T-cell leukemia virus type I ( HTLV-I ) promoter contains three copies of imperfect repeats of a 21-base pair sequence designated here as TRE ( Tax -response element ) that is responsive to the virally encoded transactivator protein Tax .', 'label': {'virally encoded transactivator protein': 'protein', 'Tax -response element': 'DNA', 'TRE': 'DNA', 'human T-cell leukemia virus type I ( HTLV-I ) promoter': 'DNA', 'Tax': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n{"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.": 5},\n{"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 4},\n{"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 4},\n{"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n{"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n{"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n{"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 5},\n{"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n{"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n{"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n{"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n{"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.": 4},\n{"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB- induced trans-activation of the H4 promoter.": 5},\n{"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n{"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.": 5}\n]', 'response3': '[{"HTLV-I": "cell_type"}, {"TRE": "DNA"}, {"Tax": "protein"}]', 'prediction': {'HTLV-I': 'cell_type', 'TRE': 'DNA', 'Tax': 'protein'}}
{'idx': 43, 'sentence': 'T-helper-cell determinants in protein antigens are preferentially located in cysteine-rich antigen segments resistant to proteolytic cleavage by cathepsin B , L , and D .', 'label': {'cysteine-rich antigen segments': 'protein', 'T-helper-cell determinants': 'protein', 'protein antigens': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 4},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n    {"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 5},\n    {"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 4},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 5},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 5},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"Tat-binding protein 7 is a subunit of the 26S protease.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.": 4},\n    {"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"T-helper-cell": "cell_type"}, {"protein": "protein"}, {"cathepsin B": "protein"}, {"cathepsin L": "protein"}, {"cathepsin D": "protein"}]', 'prediction': {'T-helper-cell': 'cell_type', 'protein': 'protein', 'cathepsin B': 'protein', 'cathepsin L': 'protein', 'cathepsin D': 'protein'}}
{'idx': 1204, 'sentence': 'Hirsutism , graded by the modified Ferriman-Gallwey score , and hormonal parameters were evaluated basally and at 4-month intervals during treatment.', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence provides a clear example of a cell line (SCM-1) being examined in a study, making it highly relevant for identifying cell line entities."},\n{"Example 2": 4},\n{"Reason 2": "The sentence mentions a specific protein (NF-E2) in the context of a cellular differentiation program, which is helpful for identifying protein entities."},\n{"Example 3": 5},\n{"Reason 3": "The sentence contains multiple instances of proteins (dexamethasone, cortisol, lysozyme) and a cell line (HML) being evaluated, making it very helpful for identifying protein and cell line entities."},\n{"Example 4": 4},\n{"Reason 4": "The sentence mentions a specific protein (phosphocreatine) in the context of intense physical exercise, which is helpful for identifying protein entities."},\n{"Example 5": 5},\n{"Reason 5": "The sentence discusses the development of lymphoid neoplasms, providing a clear example of a cell type entity, making it highly relevant for identifying cell type entities."},\n{"Example 6": 4},\n{"Reason 6": "The sentence describes the examination of a gene at the protein level, specifically mentioning the E2A protein, which is helpful for identifying protein entities."},\n{"Example 7": 5},\n{"Reason 7": "The sentence mentions specific cell types (granulocytes and T cells) and their methylation deviation, making it very helpful for identifying cell type entities."},\n{"Example 8": 3},\n{"Reason 8": "The sentence discusses the impaired DNA binding activity of the transcription factor AP-1 in lymphocytes, which is somewhat helpful for identifying DNA entities."},\n{"Example 9": 4},\n{"Reason 9": "The sentence describes the mRNA expression of a protein (GATA-1) during eosinophil differentiation, which is helpful for identifying protein entities."},\n{"Example 10": 4},\n{"Reason 10": "The sentence mentions specific proteins (Erbstatin, genistein, Egr-1) and RNA (mRNA) expression, making it helpful for identifying protein and RNA entities."},\n{"Example 11": 5},\n{"Reason 11": "The sentence provides clear examples of proteins (ATF1, CREB, H4) involved in trans-activation, making it highly relevant for identifying protein entities."},\n{"Example 12": 5},\n{"Reason 12": "The sentence mentions DNA (EBV) and proteins (EBNA2, estrogen receptor) in the context of generating conditional mutants, making it highly relevant for identifying DNA and protein entities."},\n{"Example 13": 4},\n{"Reason 13": "The sentence mentions specific proteins (MR, aldosterone, progesterone) and an antibody, making it helpful for identifying protein entities."},\n{"Example 14": 4},\n{"Reason 14": "The sentence discusses the functional IL-2r and protein induction in ras-transformed lymphocytes, which is helpful for identifying protein entities."},\n{"Example 15": 5},\n{"Reason 15": "The sentence provides examples of cell types (Type I and Type II receptors) being compared, making it highly relevant for identifying cell type entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1134, 'sentence': 'Reverse transcriptase (RT) assays were positive in purified viral material from both LCLs .', 'label': {'LCLs': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 5},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 4},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 5},\n    {"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures.": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis.": 4},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 4},\n    {"In addition, assay of PBMC by the adenovirus -specific PCR may help detect early invasive disease and warrants further evaluation.": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 5},\n    {"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.": 4},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process.": 4}\n]', 'response3': '[{"RT": "protein"}, {"LCLs": "cell_line"}]', 'prediction': {'RT': 'protein', 'LCLs': 'cell_line'}}
{'idx': 471, 'sentence': 'The lymphocyte nuclear T3 receptor was found with an affinity close to that of normal volunteers (Ka: 1.42 x 10(10) M-1 vs 1.95 +/- 0.35 x 10(10) M-1) and a binding capacity markedly increased (9.9 vs 3.7 +/- 0.4 fmol T3 /100 micrograms DNA).', 'label': {'lymphocyte nuclear T3 receptor': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.": 4},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 3},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 3},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.": 4},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n    {"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 4},\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"No correlation was found between estrogen and progesterone status , tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome ( AIDS ), may be due to increased transcriptional initiation , increased transcriptional elongation , or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta- herpesvirus systems ( herpes simplex , cytomegalovirus ) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 3},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status , tumor tissue hormone sensitivity and tobacco smoking , in 113 breast cancer patients , aged 25-77.": 3},\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 5},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729.": 1}\n]', 'response3': '[{"T3 receptor": "protein"}, {"DNA": "DNA"}]', 'prediction': {'T3 receptor': 'protein', 'DNA': 'DNA'}}
{'idx': 1205, 'sentence': 'Gonadotropin-releasing hormone and ACTH stimulation tests were performed before and after 3 to 4 months of therapy .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides multiple examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence only provides one example of a named entity with its corresponding entity label, which may not cover all entity types present in the target sentence."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence provides multiple examples of named entities with their corresponding entity labels, covering a variety of entity types present in the target sentence."},\n    {"Example 4": 1},\n    {"Reason 4": "The sentence only provides one example of a named entity with its corresponding entity label, which may not cover all entity types present in the target sentence."},\n    {"Example 5": 2},\n    {"Reason 5": "The sentence provides multiple examples of named entities with their corresponding entity labels, but some entity types present in the target sentence are not covered."},\n    {"Example 6": 3},\n    {"Reason 6": "The sentence provides multiple examples of named entities with their corresponding entity labels, covering some entity types present in the target sentence."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence provides multiple examples of named entities with their corresponding entity labels, covering a variety of entity types present in the target sentence."},\n    {"Example 8": 1},\n    {"Reason 8": "The sentence only provides one example of a named entity with its corresponding entity label, which may not cover all entity types present in the target sentence."},\n    {"Example 9": 1},\n    {"Reason 9": "The sentence does not provide any examples of named entities with their corresponding entity labels, making it less helpful for extracting named entities from the target sentence."},\n    {"Example 10": 1},\n    {"Reason 10": "The sentence does not provide any examples of named entities with their corresponding entity labels, making it less helpful for extracting named entities from the target sentence."},\n    {"Example 11": 1},\n    {"Reason 11": "The sentence does not provide any examples of named entities with their corresponding entity labels, making it less helpful for extracting named entities from the target sentence."},\n    {"Example 12": 1},\n    {"Reason 12": "The sentence does not provide any examples of named entities with their corresponding entity labels, making it less helpful for extracting named entities from the target sentence."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not provide any examples of named entities with their corresponding entity labels, making it less helpful for extracting named entities from the target sentence."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not provide any examples of named entities with their corresponding entity labels, making it less helpful for extracting named entities from the target sentence."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not provide any examples of named entities with their corresponding entity labels, making it less helpful for extracting named entities from the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not provide any examples of named entities with their corresponding entity labels, making it less helpful for extracting named entities from the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not provide any examples of named entities with their corresponding entity labels, making it less helpful for extracting named entities from the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not provide any examples of named entities with their corresponding entity labels, making it less helpful for extracting named entities from the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not provide any examples of named entities with their corresponding entity labels, making it less helpful for extracting named entities from the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not provide any examples of named entities with their corresponding entity labels, making it less helpful for extracting named entities from the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 14, 'sentence': 'Moreover, platelet-activating factor was capable of inducing transcription of the nuclear proto-oncogenes c-fos and c-jun .', 'label': {'c-fos': 'DNA', 'nuclear proto-oncogenes': 'DNA', 'c-jun': 'DNA', 'platelet-activating factor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"c-fos": "protein"}, {"c-jun": "protein"}]', 'prediction': {'c-fos': 'protein', 'c-jun': 'protein'}}
{'idx': 145, 'sentence': 'Two consensus sequences, called X and Y boxes , capable of binding nuclear proteins and regulating expression in B cells have been defined within the immediate upstream region of major histocompatibility complex (MHC) class II promoters .', 'label': {'nuclear proteins': 'protein', 'major histocompatibility complex (MHC) class II promoters': 'DNA', 'B cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 4},\n    {"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 3},\n    {"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.": 4},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 4},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 4},\n    {"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 5},\n    {"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.": 5},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 4},\n    {"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 4},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.": 5},\n    {"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif.": 5}\n]', 'response3': '[{"X boxes": "protein"}, {"Y boxes": "protein"}, {"B cells": "cell_type"}, {"major histocompatibility complex (MHC) class II promoters": "DNA"}]', 'prediction': {'X boxes': 'protein', 'Y boxes': 'protein', 'B cells': 'cell_type', 'major histocompatibility complex (MHC) class II promoters': 'DNA'}}
{'idx': 1449, 'sentence': 'DNA binding specificity of complex 3 overlaps with that of upstream stimulatory factor but is clearly distinct.', 'label': {'upstream stimulatory factor': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 4},\n    {"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.": 4},\n    {"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.": 5},\n    {"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter\'s increased activity in B cell lines.": 4},\n    {"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 5},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 4},\n    {"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF.": 5},\n    {"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes.": 4},\n    {"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements.": 5},\n    {"In fact, mAb L243 but not the staphylococcal superantigens , staphylococcal exotoxin toxic shock syndrome toxin-I or staphylococcal enterotoxin B , regulate the NF-kappa B binding activity.": 4},\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 4},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 4}\n]', 'response3': '[{"DNA": "DNA"}, {"upstream stimulatory factor": "protein"}]', 'prediction': {'DNA': 'DNA', 'upstream stimulatory factor': 'protein'}}
{'idx': 1292, 'sentence': "Promoter function of the 5' flanking region of the thromboxane receptor gene was evaluated by transfection of thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids into platelet-like K562 cells .", 'label': {'thromboxane receptor': 'protein', 'thromboxane receptor gene': 'DNA', 'CAT': 'protein', 'chloramphenicol acetyltransferase': 'protein', "5' flanking region": 'DNA', 'thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids': 'DNA', 'K562 cells': 'cell_line'}, 'response1': "['DNA', 'protein', 'cell_line']", 'response2': '[\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"5": "The sentence contains multiple protein entities (Stat3, Stat5, c-Mpl) which are directly related to the target sentence."},\n    {"4": "The sentence contains a protein entity (TCF-1) which is relevant to the target sentence."},\n    {"5": "The sentence contains multiple protein entities (PAFR, PAF, NF-kappa B, protein kinase C) which are directly related to the target sentence."},\n    {"5": "The sentence contains multiple protein entities (Sp1, CD14) which are directly related to the target sentence."},\n    {"4": "The sentence contains a protein entity (E2A) which is relevant to the target sentence."},\n    {"5": "The sentence contains multiple protein entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) which are directly related to the target sentence."},\n    {"4": "The sentence contains a protein entity (CD95 ligand) which is relevant to the target sentence."},\n    {"5": "The sentence contains a cell line entity (SCM-1) which is directly related to the target sentence."},\n    {"5": "The sentence contains multiple protein entities (Ter 119, beta-globin, glycoprotein IIb, platelet factor 4) and a cell line entity (Ter 119) which are directly related to the target sentence."},\n    {"5": "The sentence contains multiple protein entities (ATF1, CREB, H4) which are directly related to the target sentence."},\n    {"5": "The sentence contains multiple entities (BAT box, CD20, B cells) which are directly related to the target sentence."},\n    {"5": "The sentence contains multiple entities (IL-2, NFAT, NFAT delta418, calcineurin, Tpl-2, cyclosporin A) which are directly related to the target sentence."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."},\n    {"1": "The sentence does not contain any named entities from the given entity label set."}\n]', 'response3': '[{"thromboxane receptor gene": "DNA"}, {"thromboxane receptor gene promoter": "DNA"}, {"chloramphenicol acetyltransferase ( CAT )": "protein"}, {"K562 cells": "cell_line"}]', 'prediction': {'thromboxane receptor gene': 'DNA', 'thromboxane receptor gene promoter': 'DNA', 'chloramphenicol acetyltransferase ( CAT )': 'protein', 'K562 cells': 'cell_line'}}
{'idx': 120, 'sentence': 'Two other T cell lines , CEM and RPMI 8402 , have essentially identical deletions.', 'label': {'RPMI 8402': 'cell_line', 'T cell lines': 'cell_line', 'CEM': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[\n    {"SIVmacMER": 5},\n    {"SIVmac239": 5},\n    {"CEMx174": 5},\n    {"Protein": 3},\n    {"MNDA": 4},\n    {"myeloid cell lines": 4},\n    {"Runt domain": 3},\n    {"CREB": 4},\n    {"AR-CRE": 4},\n    {"WT1": 3},\n    {"T cell": 4},\n    {"interleukin 2": 3},\n    {"PBMC": 4},\n    {"adenovirus DNA": 4},\n    {"FasL": 3},\n    {"IL-2": 3},\n    {"IFN-gamma": 3},\n    {"PU.1": 4},\n    {"M-CSF receptor": 4},\n    {"macrophage": 4},\n    {"TCL1": 3},\n    {"ZEBRA": 3},\n    {"CD70": 4},\n    {"B cell": 4},\n    {"plasma cells": 4},\n    {"IL-4": 3},\n    {"CD40": 3},\n    {"GM-CSF": 3},\n    {"EBV": 4},\n    {"B-cell": 4},\n    {"granulocytes": 4},\n    {"T cells": 4}\n]', 'response3': '[{"CEM": "cell_line"}, {"RPMI 8402": "cell_line"}]', 'prediction': {'CEM': 'cell_line', 'RPMI 8402': 'cell_line'}}
{'idx': 468, 'sentence': 'A 52-year-old male presented himself with tachycardia crises which appeared first during childhood, increased in frequency without goiter or exophthalmos .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 5},\n    {"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.": 4},\n    {"This review suggests roles for these alterations in the development of lymphoid neoplasms.": 4},\n    {"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.": 3},\n    {"By the time of diagnosis of T-PLL, the clone contains many more genetic changes in the form of additional translocations.": 4},\n    {"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.": 3},\n    {"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 4},\n    {"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.": 4},\n    {"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.": 4},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 4},\n    {"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.": 4},\n    {"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.": 4},\n    {"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.": 4},\n    {"Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients.": 4},\n    {"Initiation of proliferation but not of differentiation was followed by a 20- to 25-fold increase in the nuclear level of the DNA polymerase-associated processivity factor PCNA and of the proliferation-specific transcription factor E2F1.": 5},\n    {"A total of 37 chronic, severe, nonsmoking asthmatic patients with documented reversible airways obstruction were classified as glucocorticoid-sensitive or -resistant on the basis of changes in FEV1, FVC, and peak expiratory flow (PEF) after oral prednisolone.": 4},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 4},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 4}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 138, 'sentence': 'The effects of TNF-alpha on gene expression were examined by transient expression assays using reporter chloramphenicol acetyltransferase plasmids linked to regulatory elements from the HIV long terminal repeat ( LTR ) and the beta interferon promoter .', 'label': {'beta interferon promoter': 'DNA', 'regulatory elements': 'DNA', 'HIV long terminal repeat': 'DNA', 'TNF-alpha': 'protein', 'LTR': 'DNA', 'reporter chloramphenicol acetyltransferase plasmids': 'DNA'}, 'response1': "['protein', 'DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 4},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 4},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 1},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"TNF-alpha": "protein"}, {"HIV long terminal repeat (LTR)": "DNA"}, {"beta interferon promoter": "DNA"}]', 'prediction': {'TNF-alpha': 'protein', 'HIV long terminal repeat (LTR)': 'DNA', 'beta interferon promoter': 'DNA'}}
{'idx': 64, 'sentence': 'Uninduced or Sendai virus induced HeLa extracts were used to examine transcription in vitro using a series of IFN beta promoter deletions .', 'label': {'IFN beta promoter deletions': 'DNA'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.": 4},\n    {"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.": 3},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 4},\n    {"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 4},\n    {"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.": 4},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner.": 5},\n    {"We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of degradation of inhibitor-kappaB alpha.": 4},\n    {"NF-E1 is encoded by the same gene as the YY-1 protein, which binds to the adeno-associated virus P5 promoter.": 4},\n    {"We conclude, rather, that alpha 4 beta 1 in freshly isolated T cells delivers a distinct signal that synergizes early with signals initiated by TCR/CD3 ligation to induce DNA binding of multiple transcription factors required for cytokine gene induction.": 5},\n    {"Extracts prepared from XP-B and XP-D lymphoblastoid cells exhibited similar transcription activity from the adenovirus major late promoter when compared to that in extracts from normal cells.": 4}\n]', 'response3': '[{"HeLa": "cell_line"}, {"IFN beta": "protein"}]', 'prediction': {'HeLa': 'cell_line', 'IFN beta': 'protein'}}
{'idx': 1760, 'sentence': 'This inhibitory effect was limited to the first 2 h after mitogenic activation , localizing the time-frame of action of cysteamine to within the commitment period .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"5": "The sentence contains multiple entity types present in the target sentence, aiding in the extraction of named entities."},\n    {"2": "The sentence contains \'DNA\' which is present in the target sentence, but \'cell_line\' is not present."},\n    {"4": "The sentence contains \'cell_type\' and \'protein\' which are present in the target sentence, aiding in the extraction of named entities."},\n    {"3": "The sentence contains \'protein\' which is present in the target sentence, but \'cell_type\' is not present."},\n    {"4": "The sentence contains \'protein\' which is present in the target sentence, aiding in the extraction of named entities."},\n    {"4": "The sentence contains \'protein\' which is present in the target sentence, aiding in the extraction of named entities."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."},\n    {"1": "The sentence does not contain any of the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 676, 'sentence': 'The interleukin 2 ( IL-2 ) gene promoter is recognized by several cell-type-specific and ubiquitous transcriptional regulators that integrate information transmitted by various signaling systems leading to IL-2 production and T-cell activation .', 'label': {'IL-2': 'protein', 'interleukin 2': 'protein', 'interleukin 2 ( IL-2 ) gene promoter': 'DNA', 'T-cell': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 1},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1}\n]', 'response3': '[{"interleukin 2": "protein"}, {"IL-2": "protein"}, {"T-cell": "cell_type"}]', 'prediction': {'interleukin 2': 'protein', 'IL-2': 'protein', 'T-cell': 'cell_type'}}
{'idx': 1052, 'sentence': 'Thus, after 4 hr of exposure to SEA and SEB , the expression of IL-2R beta was down-regulated, IL-2R gamma was slightly up-regulated, while IL-2R alpha remained largely unaffected.', 'label': {'IL-2R alpha': 'protein', 'SEA': 'protein', 'IL-2R gamma': 'protein', 'SEB': 'protein', 'IL-2R beta': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"1 alpha, 25-Dihydroxyvitamin D3 ( VD ) is a potent inducer of monocytic differentiation of both normal and leukemic cells .": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine ( ATT ) for valine ( GTT ) substitution at amino acid 729 .": 1}\n]', 'response3': '[{"IL-2R beta": "protein"}, {"IL-2R gamma": "protein"}, {"IL-2R alpha": "protein"}]', 'prediction': {'IL-2R beta': 'protein', 'IL-2R gamma': 'protein', 'IL-2R alpha': 'protein'}}
{'idx': 487, 'sentence': 'Therefore, in normal human monocytes M-CSF induces immediate early response genes without inducing cell proliferation.', 'label': {'human monocytes': 'cell_type', 'normal human monocytes': 'cell_type', 'M-CSF': 'protein', 'immediate early response genes': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"M-CSF": "protein"}, {"monocytes": "cell_type"}]', 'prediction': {'M-CSF': 'protein', 'monocytes': 'cell_type'}}
{'idx': 570, 'sentence': 'Modulation of these events at the time of adherence offers a mechanism by which differential priming of the cells may be accomplished.', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.": 5},\n    {"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.": 5},\n    {"Yet, for many pathogens, the molecules that induce IL-12 production by macrophages and the mechanisms by which they do so remain undefined.": 4},\n    {"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.": 4},\n    {"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 5},\n    {"We also found that the deviation of methylation in granulocytes and T cells was well correlated.": 4},\n    {"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.": 5},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 5},\n    {"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.": 4},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 4},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1370, 'sentence': 'Although anti- CD28 MoAb costimulation enhances all of the above signals, NF kappa B and IL-2 levels remain lower than in adults , suggesting the need for further activation requirements in the neonate .', 'label': {'CD28': 'protein', 'anti- CD28 MoAb': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"NF kappa B": "protein"}, {"IL-2": "protein"}]', 'prediction': {'NF kappa B': 'protein', 'IL-2': 'protein'}}
{'idx': 994, 'sentence': 'The role of BSAP ( Pax-5 ) in B-cell development .', 'label': {'BSAP': 'protein', 'Pax-5': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Th1": 5, "Th2": 5},\n    {"SLAP-130": 5, "SLP-76": 5, "T cell": 5},\n    {"Sp1": 5, "Ets": 5},\n    {"UAS3": 5, "UAS2": 5, "YY1": 5},\n    {"CD70": 5, "B cell": 5, "plasma cells": 5, "IL-4": 5, "CD40": 5},\n    {"GATA-1": 5},\n    {"IL-13": 5, "IL-4": 5, "B cell": 5, "monocyte": 5},\n    {"IL-2": 5, "c-Jun": 5, "c-Fos": 5},\n    {"Th2-type lymphocytes": 5},\n    {"IL4": 5, "IL13": 5, "STAT6": 5, "STAT3": 5, "STAT5": 5, "B cells": 5},\n    {"lymphoid neoplasms": 5},\n    {"PML/RARalpha": 5},\n    {"GM-CSF": 5},\n    {"UAS1": 5, "B cell": 5},\n    {"T cell": 5, "interleukin 2": 5},\n    {"GATA-1": 5},\n    {"estrogen": 1, "progesterone": 1, "tumor size": 1, "polyamine concentrations": 1},\n    {"AIDS": 1, "transcriptional initiation": 1, "transcriptional elongation": 1},\n    {"alpha-herpesvirus": 1, "beta-herpesvirus": 1, "herpes simplex": 1, "cytomegalovirus": 1},\n    {"HIV-1": 1, "HIV-2": 1},\n    {"allele": 1},\n    {"B-cell": 1, "intrahepatic lymphoid follicles": 1, "chronic hepatitis C": 1},\n    {"lymphocyte infiltration": 1, "hormone metabolic status": 1, "tumor tissue hormone sensitivity": 1, "tobacco smoking": 1, "breast cancer patients": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3": 1, "VD": 1, "monocytic differentiation": 1, "leukemic cells": 1},\n    {"glucocorticoid action": 1, "megadoses": 1},\n    {"nucleotide 2,317": 1, "point mutation": 1, "isoleucine": 1, "valine": 1, "amino acid 729": 1}\n]', 'response3': '[{"BSAP": "protein"}, {"Pax-5": "protein"}, {"B-cell": "cell_type"}]', 'prediction': {'BSAP': 'protein', 'Pax-5': 'protein', 'B-cell': 'cell_type'}}
{'idx': 438, 'sentence': 'This sequence motif is a binding site for nuclear proteins , the so-called octamer transcription factors ( Oct or OTF factors ).', 'label': {'OTF factors': 'protein', 'nuclear proteins': 'protein', 'sequence motif': 'DNA', 'octamer transcription factors': 'protein', 'Oct': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.": 5},\n    {"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus, and induce transcription from responsive genes.": 5},\n    {"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.": 5},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 5},\n    {"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.": 5},\n    {"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3\' G shows hardly any binding of p50p50.": 5},\n    {"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.": 5},\n    {"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.": 5},\n    {"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 5},\n    {"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.": 5},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 5},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 5},\n    {"The p50 and p65 proteins, constituents of the prototypic nuclear factor kappaB, were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 270, 'sentence': 'There was evidence for an autosomal recessive form of inheritance in four families, while the other four families appeared to have an autosomal dominant mode of transmission .', 'label': {}, 'response1': "['DNA']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1481, 'sentence': 'We, therefore, propose the activation scheme presented in FIGURE 3 for T-cell costimulation .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n{"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n{"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .": 4},\n{"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .": 5},\n{"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .": 5},\n{"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .": 5},\n{"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.": 5},\n{"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .": 5},\n{"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .": 5},\n{"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.": 4},\n{"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .": 5},\n{"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 5},\n{"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n{"We have determined that the developmental control of immunoglobulin kappa 3\' enhancer ( kappa E3\' ) activity is the result of the combined influence of positive- and negative-acting elements .": 5},\n{"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .": 5},\n{"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .": 5},\n{"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1807, 'sentence': 'We show that the expression of four cell genes , cdc-2 , cyclin E , CD23 , and cyclin D2 , are up-regulated approximately 100-fold as a result of EBV -mediated immortalization .', 'label': {'cell genes': 'DNA', 'cyclin E': 'DNA', 'cyclin D2': 'DNA', 'CD23': 'DNA', 'cdc-2': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .": 5},\n    {"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .": 5},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .": 4},\n    {"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .": 4},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .": 5},\n    {"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.": 5},\n    {"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .": 5},\n    {"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB .": 5},\n    {"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .": 5},\n    {"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.": 5},\n    {"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .": 5},\n    {"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .": 5}\n]', 'response3': '[{"cdc-2": "protein"}, {"cyclin E": "protein"}, {"CD23": "protein"}, {"cyclin D2": "protein"}, {"EBV": "cell_line"}]', 'prediction': {'cdc-2': 'protein', 'cyclin E': 'protein', 'CD23': 'protein', 'cyclin D2': 'protein', 'EBV': 'cell_line'}}
{'idx': 1169, 'sentence': 'However, B4-2 has an unusually high proline content (13%), contains a putative nuclear targeting sequence , and has several SPXX motifs which are frequently found in gene regulatory proteins .', 'label': {'SPXX motifs': 'protein', 'nuclear targeting sequence': 'protein', 'gene regulatory proteins': 'protein', 'B4-2': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 1, "Helpfulness score": 1, "Reason": "Does not contain any relevant entity types"},\n    {"Sentence": 2, "Helpfulness score": 5, "Reason": "Contains specific protein entities (p21(WAF1/CIP1) and p27(KIP1)) mentioned in the target sentence"},\n    {"Sentence": 3, "Helpfulness score": 5, "Reason": "Contains a specific protein entity (E2A) mentioned in the target sentence"},\n    {"Sentence": 4, "Helpfulness score": 5, "Reason": "Contains a specific protein entity (IL-4) mentioned in the target sentence"},\n    {"Sentence": 5, "Helpfulness score": 5, "Reason": "Contains specific entities (hepatitis B virus and HBxAg) mentioned in the target sentence"},\n    {"Sentence": 6, "Helpfulness score": 5, "Reason": "Contains specific protein entities (interleukin 10, IL-10R, STAT3, IL-6) mentioned in the target sentence"},\n    {"Sentence": 7, "Helpfulness score": 5, "Reason": "Contains a specific protein entity (p50p50) mentioned in the target sentence"},\n    {"Sentence": 8, "Helpfulness score": 5, "Reason": "Contains specific protein entities (IL-2, c-Jun, c-Fos) mentioned in the target sentence"},\n    {"Sentence": 9, "Helpfulness score": 3, "Reason": "Contains a cell type entity (Th2-type lymphocytes) which is not present in the target sentence"},\n    {"Sentence": 10, "Helpfulness score": 5, "Reason": "Contains specific protein entity (GM-CSF) mentioned in the target sentence"},\n    {"Sentence": 11, "Helpfulness score": 5, "Reason": "Contains specific DNA entities (UAS3, UAS2) and a protein entity (YY1) mentioned in the target sentence"},\n    {"Sentence": 12, "Helpfulness score": 5, "Reason": "Contains a specific protein entity (A-myb) mentioned in the target sentence"},\n    {"Sentence": 13, "Helpfulness score": 5, "Reason": "Contains specific entities (UAS1, B cell) mentioned in the target sentence"},\n    {"Sentence": 14, "Helpfulness score": 5, "Reason": "Contains specific entities (Ter 119, beta-globin, glycoprotein IIb, platelet factor 4) mentioned in the target sentence"},\n    {"Sentence": 15, "Helpfulness score": 5, "Reason": "Contains specific DNA entities (GM-kappa B, GC-box, GC-motif, GM-kappa B motif) mentioned in the target sentence"},\n    {"Sentence": 16, "Helpfulness score": 1, "Reason": "Does not contain any relevant entity types"},\n    {"Sentence": 17, "Helpfulness score": 1, "Reason": "Does not contain any relevant entity types"},\n    {"Sentence": 18, "Helpfulness score": 1, "Reason": "Does not contain any relevant entity types"},\n    {"Sentence": 19, "Helpfulness score": 1, "Reason": "Does not contain any relevant entity types"},\n    {"Sentence": 20, "Helpfulness score": 1, "Reason": "Does not contain any relevant entity types"},\n    {"Sentence": 21, "Helpfulness score": 1, "Reason": "Does not contain any relevant entity types"},\n    {"Sentence": 22, "Helpfulness score": 1, "Reason": "Does not contain any relevant entity types"},\n    {"Sentence": 23, "Helpfulness score": 1, "Reason": "Does not contain any relevant entity types"},\n    {"Sentence": 24, "Helpfulness score": 1, "Reason": "Does not contain any relevant entity types"},\n    {"Sentence": 25, "Helpfulness score": 1, "Reason": "Does not contain any relevant entity types"}\n]', 'response3': '[{"B4-2": "protein"}, {"proline": "protein"}, {"nuclear targeting sequence": "DNA"}, {"SPXX motifs": "protein"}]', 'prediction': {'B4-2': 'protein', 'proline': 'protein', 'nuclear targeting sequence': 'DNA', 'SPXX motifs': 'protein'}}
{'idx': 1180, 'sentence': 'We therefore propose that IL-2 receptor signal transduction does not depend on equimolar heterodimerization of JAK1 and JAK3 following IL-2 -induced heterodimerization of IL-2R beta and IL-2R gamma .', 'label': {'IL-2R': 'protein', 'IL-2': 'protein', 'IL-2R gamma': 'protein', 'JAK3': 'protein', 'IL-2 receptor': 'protein', 'JAK1': 'protein', 'IL-2R beta': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': "[{'IL-2': 'protein'}, {'JAK1': 'protein'}, {'JAK3': 'protein'}, {'IL-2R beta': 'protein'}, {'IL-2R gamma': 'protein'}]", 'prediction': {'IL-2': 'protein', 'JAK1': 'protein', 'JAK3': 'protein', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein'}}
{'idx': 968, 'sentence': 'These observations demonstrate directly that there is de novo synthesis of NF-kappa B during human lymphocyte activation and suggest that this process is hormonally regulated.', 'label': {'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"human lymphocyte": "cell_type"}]', 'prediction': {'NF-kappa B': 'protein', 'human lymphocyte': 'cell_type'}}
{'idx': 497, 'sentence': 'The differentiation of T cells into functionally diverse subpopulations is controlled in part, by transcriptional activation and silencing ; however, little is known in detail about the proteins that influence this developmental process .', 'label': {'T cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.": 5},\n    {"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.": 4},\n    {"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.": 4},\n    {"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.": 3},\n    {"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.": 4},\n    {"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.": 4},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.": 4},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 4},\n    {"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.": 3},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.": 4},\n    {"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.": 5}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1606, 'sentence': 'Triggering of complement receptors CR1 ( CD35 ) and CR3 ( CD11b/CD18 ) induces nuclear translocation of NF-kappa B ( p50/p65 ) in human monocytes and enhances viral replication in HIV-infected monocytic cells .', 'label': {'CD11b/CD18': 'protein', 'CD35': 'protein', 'p50/p65': 'protein', 'CR1': 'protein', 'HIV-infected monocytic cells': 'cell_type', 'complement receptors': 'protein', 'human monocytes': 'cell_type', 'NF-kappa B': 'protein', 'CR3': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.": 5},\n    {"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.": 5},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.": 3},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 4},\n    {"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.": 4},\n    {"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.": 4},\n    {"CD40 expression could be enhanced in CD40-positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n    {"Murine macrophage inflammatory protein 1 alpha (MIP-1 alpha) and its human equivalent (GOS19, LD78, or AT464) are members of the -C-C family of low-molecular-weight chemokines.": 5},\n    {"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.": 4},\n    {"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.": 5},\n    {"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.": 5},\n    {"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB.": 5},\n    {"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.": 4},\n    {"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5\' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 5},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"CR1": "protein"}, {"CD35": "protein"}, {"CR3": "protein"}, {"CD11b/CD18": "protein"}, {"NF-kappa B": "protein"}, {"p50/p65": "protein"}, {"monocytes": "cell_type"}, {"HIV-infected monocytic cells": "cell_type"}]', 'prediction': {'CR1': 'protein', 'CD35': 'protein', 'CR3': 'protein', 'CD11b/CD18': 'protein', 'NF-kappa B': 'protein', 'p50/p65': 'protein', 'monocytes': 'cell_type', 'HIV-infected monocytic cells': 'cell_type'}}
{'idx': 1653, 'sentence': 'Expression of PU.1 in nonmyeloid cells can activate the GM-CSF receptor alpha promoter .', 'label': {'nonmyeloid cells': 'cell_type', 'GM-CSF': 'protein', 'PU.1': 'protein', 'GM-CSF receptor alpha promoter': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.": 5},\n    {"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.": 5},\n    {"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.": 5},\n    {"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.": 4},\n    {"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.": 5},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"PMA induced the expression of both CD14 and CD23 mRNA and protein.": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 5},\n    {"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.": 5},\n    {"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.": 5},\n    {"To evaluate the PML/RARalpha role in myelopoiesis, transgenic mice expressing PML/RARalpha were engineered.": 5},\n    {"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.": 5},\n    {"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]": 5},\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.": 5},\n    {"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.": 5},\n    {"Murine macrophage inflammatory protein 1 alpha (MIP-1 alpha) and its human equivalent (GOS19, LD78, or AT464) are members of the -C-C family of low-molecular-weight chemokines.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 1},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[{"PU.1": "protein"}, {"GM-CSF receptor alpha": "protein"}]', 'prediction': {'PU.1': 'protein', 'GM-CSF receptor alpha': 'protein'}}
{'idx': 833, 'sentence': 'Mapping of B-cell epitopes of the human hepatitis B virus X protein .', 'label': {'human hepatitis B virus X protein': 'protein', 'B-cell epitopes': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains multiple entities from the given entity label set, and each entity is clearly identified."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence contains an entity from the given entity label set, which is a specific cell type."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains an entity from the given entity label set, which is a specific protein."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains multiple entities from the given entity label set, and each entity is clearly identified."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains an entity from the given entity label set, which is a specific protein."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains multiple entities from the given entity label set, and each entity is clearly identified."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains multiple entities from the given entity label set, and each entity is clearly identified."},\n    {"Example 9": 1},\n    {"Reason 9": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 10": 1},\n    {"Reason 10": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 11": 1},\n    {"Reason 11": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 12": 1},\n    {"Reason 12": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 13": 1},\n    {"Reason 13": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 14": 1},\n    {"Reason 14": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 15": 1},\n    {"Reason 15": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 16": 1},\n    {"Reason 16": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities from the given entity label set."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities from the given entity label set."}\n]', 'response3': '[{"B-cell": "cell_type"}, {"hepatitis B virus X protein": "protein"}]', 'prediction': {'B-cell': 'cell_type', 'hepatitis B virus X protein': 'protein'}}
{'idx': 389, 'sentence': 'The predicted periplasmic domain of the PhoQ protein contained a markedly anionic domain that could interact with cationic proteins and that could be responsible for resistance to defensin .', 'label': {'periplasmic domain': 'protein', 'PhoQ protein': 'protein', 'cationic proteins': 'protein', 'defensin': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 5},\n    {"Example 5": 5},\n    {"Example 6": 5},\n    {"Example 7": 5},\n    {"Example 8": 5},\n    {"Example 9": 5},\n    {"Example 10": 5},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 5},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"PhoQ": "protein"}, {"defensin": "protein"}]', 'prediction': {'PhoQ': 'protein', 'defensin': 'protein'}}
{'idx': 193, 'sentence': 'The calcium ionophore-induced c-myc suppression , however, strictly requires de novo protein synthesis .', 'label': {'c-myc': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.": 5},\n    {"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.": 4},\n    {"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.": 4},\n    {"RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA/NF-kappaB1 binding complexes.": 3},\n    {"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.": 4},\n    {"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.": 3},\n    {"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.": 4},\n    {"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.": 4},\n    {"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.": 3},\n    {"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.": 4},\n    {"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.": 4},\n    {"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.": 4},\n    {"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin.": 5},\n    {"No correlation was found between estrogen and progesterone status, tumor size and polyamine concentrations.": 1},\n    {"This induction, which seems to be an important component in the progression of acquired immune deficiency syndrome (AIDS), may be due to increased transcriptional initiation, increased transcriptional elongation, or a combination of these processes.": 1},\n    {"This contrasts with findings in alpha- and beta-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic.": 1},\n    {"These results may explain differences in the clinical spectra of diseases caused by HIV-1 and HIV-2 and may also have implications for the design of therapeutic approaches to HIV-2 infection.": 1},\n    {"One contraction generated an allele in an intermediate size range (33-39 repeats).": 1},\n    {"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C.": 1},\n    {"Lymphocyte infiltration of tumor was studied vis-a-vis hormone metabolic status, tumor tissue hormone sensitivity and tobacco smoking, in 113 breast cancer patients, aged 25-77.": 1},\n    {"1 alpha, 25-Dihydroxyvitamin D3 (VD) is a potent inducer of monocytic differentiation of both normal and leukemic cells.": 4},\n    {"The mode of glucocorticoid action after administration of such megadoses is inexplicable up to now.": 1},\n    {"At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729.": 1}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1349, 'sentence': 'Its expression was always restricted to the nucleus .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence provides a specific gene name (A-myb) and its function, making it highly relevant for identifying a protein entity."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains specific gene names (IL-2, c-Jun, c-Fos) and mentions their protein nature, aiding in protein entity extraction."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence mentions transcription factors (Sp1, NF-kappaB, p50) and their binding activity, directly related to protein entities."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence lists various transcription factors (NF-kB, AP-1, OCT-1, NF-IL-2B) and their binding activity, crucial for protein entity extraction."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence provides information on gene expression (IFN A, interleukin-2, interleukin-2 receptor) and their regulation, highly relevant for protein entity extraction."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence mentions a specific cell type (T cell) and a protein (interleukin 2), aiding in the extraction of relevant entities."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence discusses the expression of a specific protein (RXR) and its mutants, directly related to protein entity extraction."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence mentions proteins (RelA, NF-kappaB1) and their cellular localization, crucial for protein entity extraction."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence provides details on protein interactions (EBNA-2, PU.1), aiding in the extraction of protein entities."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence discusses the regulatory mechanism of a specific gene (SCM-1), directly related to cell line entity extraction."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence mentions mRNA (IL-5 mRNA) and proteins (TCR, IL-2R, dexamethasone), aiding in RNA and protein entity extraction."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence provides information on a specific protein (WT1) and its expression pattern, highly relevant for protein entity extraction."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence discusses DNA binding activity of a specific protein (NF-kappa B), aiding in DNA entity extraction."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence mentions a specific protein (E2A) and its detection method, directly related to protein entity extraction."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence provides details on a protein (TAL1) and its role in a specific cell type (T-ALL), aiding in protein and cell type entity extraction."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence discusses protein synthesis (SCL) and its correlation with mRNA expression, highly relevant for RNA and protein entity extraction."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any specific entities related to the given entity labels."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any specific entities related to the given entity labels."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any specific entities related to the given entity labels."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any specific entities related to the given entity labels."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any specific entities related to the given entity labels."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any specific entities related to the given entity labels."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any specific entities related to the given entity labels."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any specific entities related to the given entity labels."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any specific entities related to the given entity labels."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 882, 'sentence': 'This cDNA clone was isolated by expression cDNA cloning , and encodes the human c-Jun protein , which together with c-Fos forms the heterodimeric activator protein-1 transcription complex .', 'label': {'c-Jun': 'protein', 'heterodimeric activator protein-1 transcription complex': 'protein', 'c-Fos': 'protein', 'cDNA': 'DNA', 'human c-Jun protein': 'protein', 'cDNA clone': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.": 5},\n    {"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.": 5},\n    {"This protein has now been purified and its encoding gene cloned.": 4},\n    {"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.": 5},\n    {"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.": 5},\n    {"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.": 5},\n    {"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.": 5},\n    {"Human cDNAs encoding subunits of these factors have been cloned and sequenced.": 4},\n    {"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.": 4},\n    {"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.": 5},\n    {"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.": 5},\n    {"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.": 5},\n    {"Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.": 5},\n    {"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.": 4},\n    {"Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines.": 5},\n    {"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.": 5}\n]', 'response3': '[{"cDNA clone": "DNA"}, {"human c-Jun protein": "protein"}, {"c-Fos": "protein"}, {"activator protein-1": "protein"}]', 'prediction': {'cDNA clone': 'DNA', 'human c-Jun protein': 'protein', 'c-Fos': 'protein', 'activator protein-1': 'protein'}}
{'idx': 725, 'sentence': 'Rex acts posttranscriptionally to facilitate accumulation of full-length gag/pol and singly spliced env mRNA in the cytoplasm of HTLV-infected cells .', 'label': {'Rex': 'protein', 'HTLV-infected cells': 'cell_type', 'gag/pol': 'protein', 'env mRNA': 'RNA'}, 'response1': "['RNA', 'protein']", 'response2': '[\n{"Example 1": 5},\n{"Reason 1": "The sentence contains a clear mention of the entity \'TCF-1\' and its entity type \'protein\', making it highly helpful for extracting named entities from the target sentence."},\n\n{"Example 2": 5},\n{"Reason 2": "The sentence contains a clear mention of the entity \'TCL1\' and its entity type \'protein\', making it highly helpful for extracting named entities from the target sentence."},\n\n{"Example 3": 5},\n{"Reason 3": "The sentence contains a clear mention of the entity \'PML/RARalpha\' and its entity type \'protein\', making it highly helpful for extracting named entities from the target sentence."},\n\n{"Example 4": 5},\n{"Reason 4": "The sentence contains clear mentions of the entities \'hepatitis B virus\' (entity type \'DNA\') and \'HBxAg\' (entity type \'protein\'), making it highly helpful for extracting named entities from the target sentence."},\n\n{"Example 5": 5},\n{"Reason 5": "The sentence contains a clear mention of the entity \'SIVsmmPBj14\' and its entity type \'cell_line\', making it highly helpful for extracting named entities from the target sentence."},\n\n{"Example 6": 5},\n{"Reason 6": "The sentence contains clear mentions of multiple entities such as \'IFN A\' (entity type \'protein\'), \'IFNA\' (entity type \'protein\'), \'interleukin-2\' (entity type \'protein\'), \'interleukin-2 receptor\' (entity type \'protein\'), \'phytohemagglutinin\' (entity type \'protein\'), and \'phorbol myristate acetate\' (entity type \'protein\'), making it highly helpful for extracting named entities from the target sentence."},\n\n{"Example 7": 5},\n{"Reason 7": "The sentence contains clear mentions of the entities \'TIMP-1\' (entity type \'protein\') and \'DNA\' (entity type \'DNA\'), making it highly helpful for extracting named entities from the target sentence."},\n\n{"Example 8": 5},\n{"Reason 8": "The sentence contains a clear mention of the entity \'Egr-1\' and its entity type \'protein\', making it highly helpful for extracting named entities from the target sentence."},\n\n{"Example 9": 5},\n{"Reason 9": "The sentence contains clear mentions of the entities \'HIV-1\' (entity type \'cell_type\'), \'IFN\' (entity type \'protein\'), \'PKR\' (entity type \'protein\'), and \'IkappaBalpha\' (entity type \'protein\'), making it highly helpful for extracting named entities from the target sentence."},\n\n{"Example 10": 5},\n{"Reason 10": "The sentence contains clear mentions of the entities \'HIV-1 LTR\' (entity type \'DNA\'), \'NFAT-1\' (entity type \'protein\'), and \'NF kappa B\' (entity type \'protein\'), making it highly helpful for extracting named entities from the target sentence."}\n]', 'response3': "[{'gag/pol': 'protein'}, {'env mRNA': 'RNA'}, {'HTLV-infected cells': 'cell_type'}]", 'prediction': {'gag/pol': 'protein', 'env mRNA': 'RNA', 'HTLV-infected cells': 'cell_type'}}
{'idx': 867, 'sentence': 'In HIV-1 , the sequences that respond to these signaling events are found in the long terminal repeat ( LTR ) and comprise the transcriptional enhancer , which contains two conserved binding sites for the nuclear factor kappa B ( NF kappa B ).', 'label': {'conserved binding sites': 'DNA', 'nuclear factor kappa B': 'protein', 'long terminal repeat': 'DNA', 'LTR': 'DNA', 'NF kappa B': 'protein', 'transcriptional enhancer': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 4},\n    {"Example 4": 5},\n    {"Example 5": 4},\n    {"Example 6": 5},\n    {"Example 7": 4},\n    {"Example 8": 5},\n    {"Example 9": 1},\n    {"Example 10": 1},\n    {"Example 11": 1},\n    {"Example 12": 1},\n    {"Example 13": 1},\n    {"Example 14": 1},\n    {"Example 15": 1},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1}\n]', 'response3': '[{"HIV-1": "cell_type"}, {"long terminal repeat ( LTR )": "DNA"}, {"transcriptional enhancer": "DNA"}, {"nuclear factor kappa B ( NF kappa B )": "protein"}]', 'prediction': {'HIV-1': 'cell_type', 'long terminal repeat ( LTR )': 'DNA', 'transcriptional enhancer': 'DNA', 'nuclear factor kappa B ( NF kappa B )': 'protein'}}
{'idx': 841, 'sentence': 'Such tests may become useful diagnostic tools .', 'label': {}, 'response1': 'None.', 'response2': '[\n{"myeloperoxidase": 5, "lysozyme": 5, "PU.1": 5},\n{"PBMC": 4, "adenovirus": 4},\n{"PBMC": 4, "adenovirus DNA": 5},\n{"IFN-gamma": 5},\n{"lymphoid neoplasms": 5},\n{"STAT1": 5},\n{"Ras": 5},\n{"immunohistochemistry": 5, "gene": 4, "cell type": 5},\n{"NF-kappa B": 5},\n{"SCM-1": 5},\n{"SIVsmmPBj14": 5},\n{"nonhuman primates": 5},\n{"T-PLL": 5},\n{"E2A": 5},\n{"AP-1": 5},\n{"B and T cell activation": 5, "Ramos": 5, "Jurkat": 5, "cDNA microarray technology": 4}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 956, 'sentence': 'BSAP : a key regulator of B-cell development and differentiation .', 'label': {'BSAP': 'protein', 'B-cell': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"NF-E2": 5},\n{"EBV": 4, "B-cell": 4},\n{"CD70": 5, "B cell": 4, "plasma cells": 4, "IL-4": 5, "CD40": 5},\n{"Th2-type lymphocytes": 5},\n{"GATA-1": 5},\n{"Syk": 5, "Zap": 5, "T cell": 4},\n{"Th1": 4, "Th2": 4},\n{"T cell": 5, "interleukin 2": 5},\n{"IL-2": 5},\n{"AP-1": 5},\n{"IL-2": 5, "c-Jun": 5, "c-Fos": 5},\n{"UAS3": 5, "UAS2": 5, "YY1": 5},\n{"SCL": 5, "GATA-1": 5},\n{"IL-2": 5, "NF-kappa B": 5, "AP-1": 5},\n{"IL4": 5, "IL13": 5, "gamma c chain": 4, "STAT6": 5, "STAT3": 5, "STAT5": 5, "B cells": 4},\n{"STAT1": 5},\n{"estrogen": 1, "progesterone": 1, "tumor size": 1, "polyamine concentrations": 1},\n{"AIDS": 1, "transcriptional initiation": 1, "transcriptional elongation": 1},\n{"alpha-herpesvirus": 1, "beta-herpesvirus": 1, "herpes simplex": 1, "cytomegalovirus": 1},\n{"HIV-1": 1, "HIV-2": 1},\n{"contraction": 1, "allele": 1},\n{"B-cell response": 1, "intrahepatic lymphoid follicles": 1, "chronic hepatitis C": 1},\n{"Lymphocyte infiltration": 1, "hormone metabolic status": 1, "tumor tissue hormone sensitivity": 1, "tobacco smoking": 1, "breast cancer patients": 1},\n{"1 alpha, 25-Dihydroxyvitamin D3": 1, "VD": 1, "monocytic differentiation": 1, "leukemic cells": 1},\n{"glucocorticoid action": 1, "megadoses": 1},\n{"nucleotide 2,317": 1, "point mutation": 1, "isoleucine": 1, "valine": 1, "amino acid 729": 1}\n]', 'response3': '[{"BSAP": "protein"}, {"B-cell": "cell_type"}]', 'prediction': {'BSAP': 'protein', 'B-cell': 'cell_type'}}
{'idx': 1769, 'sentence': 'We have tried to find out whether these receptors could show any difference in sex or age distribution.', 'label': {}, 'response1': 'None.', 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains specific entities with clear labels that are directly related to the entity types in the label set."},\n    {"Example 2": 4},\n    {"Reason 2": "The sentence mentions a specific entity related to a cell type, which is relevant for entity extraction."},\n    {"Example 3": 4},\n    {"Reason 3": "The sentence provides information about a specific protein entity, which is helpful for entity extraction."},\n    {"Example 4": 3},\n    {"Reason 4": "The sentence mentions a specific entity related to DNA, which is somewhat helpful for entity extraction."},\n    {"Example 5": 4},\n    {"Reason 5": "The sentence contains specific protein entities that are relevant for entity extraction."},\n    {"Example 6": 4},\n    {"Reason 6": "The sentence mentions a specific protein entity, which is helpful for entity extraction."},\n    {"Example 7": 4},\n    {"Reason 7": "The sentence provides information about a specific cell type entity, which is helpful for entity extraction."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains specific protein entities that are directly related to the entity types in the label set."},\n    {"Example 9": 3},\n    {"Reason 9": "The sentence mentions entities that are not directly related to the entity types in the label set, but still provide some context."},\n    {"Example 10": 3},\n    {"Reason 10": "The sentence mentions entities that are not directly related to the entity types in the label set, but still provide some context."},\n    {"Example 11": 3},\n    {"Reason 11": "The sentence mentions entities that are not directly related to the entity types in the label set, but still provide some context."},\n    {"Example 12": 4},\n    {"Reason 12": "The sentence provides information about a specific protein entity, which is helpful for entity extraction."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains specific entities with clear labels that are directly related to the entity types in the label set."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains specific entities with clear labels that are directly related to the entity types in the label set."},\n    {"Example 15": 3},\n    {"Reason 15": "The sentence mentions entities that are not directly related to the entity types in the label set, but still provide some context."},\n    {"Example 16": 3},\n    {"Reason 16": "The sentence mentions entities that are not directly related to the entity types in the label set, but still provide some context."},\n    {"Example 17": 3},\n    {"Reason 17": "The sentence mentions entities that are not directly related to the entity types in the label set, but still provide some context."},\n    {"Example 18": 3},\n    {"Reason 18": "The sentence mentions entities that are not directly related to the entity types in the label set, but still provide some context."},\n    {"Example 19": 3},\n    {"Reason 19": "The sentence mentions entities that are not directly related to the entity types in the label set, but still provide some context."},\n    {"Example 20": 3},\n    {"Reason 20": "The sentence mentions entities that are not directly related to the entity types in the label set, but still provide some context."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 110, 'sentence': 'Electrophoretic mobility shift assays and Southwestern blotting experiments were used to detect the binding of cellular transactivation factor NF-KB to the double repeat-KB enhancer sequence located in the long terminal repeat .', 'label': {'long terminal repeat': 'DNA', 'NF-KB': 'protein', 'double repeat-KB enhancer sequence': 'DNA', 'cellular transactivation factor': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of protein names that are relevant to the entity labels in the target sentence, such as IL-4, LPS, and AP-1."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of protein names that are relevant to the entity labels in the target sentence, such as NF-kappaB, Sp1, and p50."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of protein names and cell types that are relevant to the entity labels in the target sentence, such as NF-kappaB, Tax, and ATL."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains an example of a protein name that is relevant to the entity labels in the target sentence, NF-kappa B."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of protein names that are relevant to the entity labels in the target sentence, such as NF-kappa B and I kappa B alpha."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of protein names that are relevant to the entity labels in the target sentence, such as EKLF, CBP, p300, and P/CAF."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of protein names that are relevant to the entity labels in the target sentence, such as CD40 and NF-kappa B."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of protein names that are relevant to the entity labels in the target sentence, such as NF-kappa B and I kappa B alpha."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains an example of a cell type name that is relevant to the entity labels in the target sentence, T cell."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of protein names that are relevant to the entity labels in the target sentence, such as EBNA2 and TP1."},\n    {"Sentence": 5},\n    {"Reason": "The sentence contains multiple examples of protein names that are relevant to the entity labels in the target sentence, such as PAFR, PAF, NF-kappa B, and protein kinase C."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of protein names that are relevant to the entity labels in the target sentence, such as RelA and NF-kappa B."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of protein names that are relevant to the entity labels in the target sentence, such as IL-2, c-Jun, and c-Fos."},\n    {"Sentence": 3},\n    {"Reason": "The sentence contains an example of a cell type name that is relevant to the entity labels in the target sentence, rheumatoid arthritis."},\n    {"Sentence": 4},\n    {"Reason": "The sentence contains examples of protein names that are relevant to the entity labels in the target sentence, such as TRAF6, RANKL, and NF-kappaB."}\n]', 'response3': '[{"NF-KB": "protein"}]', 'prediction': {'NF-KB': 'protein'}}
{'idx': 1379, 'sentence': 'Deregulation of TCL1 is the first event in the initiation of malignancy in these types of leukemias and represents a potential tool for clinical evaluation .', 'label': {'TCL1': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"IkappaBbeta by the tax protein of human T-cell leukemia virus type 1": 5},\n    {"NF-kappaB": 5},\n    {"AP-1 DNA": 4},\n    {"WT1": 4},\n    {"myeloid cell lines": 4},\n    {"IL-2 receptor alpha subunit": 4},\n    {"p21ras": 4},\n    {"B cell": 4},\n    {"MNDA": 4},\n    {"Philadelphia chromosome-positive chronic myeloid leukemia": 4},\n    {"SCM-1": 3},\n    {"IL-13": 4},\n    {"IL-4R": 4},\n    {"JAK2": 4},\n    {"IL-13R": 4},\n    {"STAT1": 5},\n    {"SCL": 4},\n    {"GATA-1": 4},\n    {"PML/RARalpha": 5},\n    {"TCRzeta": 4},\n    {"p56(lck)": 4},\n    {"lymphoid neoplasms": 4},\n    {"CD28": 5},\n    {"CD80": 5},\n    {"CD86": 5},\n    {"CBL": 5},\n    {"VAV": 5},\n    {"NFAT": 5},\n    {"interleukin-2": 5},\n    {"granulocyte-macrophage colony-stimulating factor": 5},\n    {"GATA-1": 5},\n    {"NF-kappaB": 5},\n    {"Tax": 4},\n    {"ATL": 4}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1338, 'sentence': 'The survival-promoting activity of the Bcl-2 family of proteins appears to be modulated by interactions between various cellular proteins .', 'label': {'Bcl-2 family': 'protein', 'cellular proteins': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 5},\n    {"Example 2": 5},\n    {"Example 3": 5},\n    {"Example 4": 4},\n    {"Example 5": 5},\n    {"Example 6": 4},\n    {"Example 7": 4},\n    {"Example 8": 5},\n    {"Example 9": 4},\n    {"Example 10": 4},\n    {"Example 11": 5},\n    {"Example 12": 5},\n    {"Example 13": 5},\n    {"Example 14": 5},\n    {"Example 15": 4},\n    {"Example 16": 1},\n    {"Example 17": 1},\n    {"Example 18": 1},\n    {"Example 19": 1},\n    {"Example 20": 1},\n    {"Example 21": 1},\n    {"Example 22": 1},\n    {"Example 23": 1},\n    {"Example 24": 1},\n    {"Example 25": 1}\n]', 'response3': '[{"Bcl-2": "protein"}]', 'prediction': {'Bcl-2': 'protein'}}
{'idx': 1323, 'sentence': 'PRE-I forms multiple DNA-protein complexes with nuclear extracts from Jurkat cells .', 'label': {'PRE-I': 'DNA', 'Jurkat cells': 'cell_line', 'multiple DNA-protein complexes': 'protein'}, 'response1': "['DNA', 'protein', 'cell_line']", 'response2': '[\n    {"Example 1": 5},\n    {"Reason 1": "The sentence contains the entity \'DNA\' which is present in the target sentence."},\n    {"Example 2": 5},\n    {"Reason 2": "The sentence contains multiple entities such as \'IFN A\', \'IFNA\', \'interleukin-2\', \'interleukin-2 receptor\', \'phytohemagglutinin\', and \'phorbol myristate acetate\' which are all present in the target sentence."},\n    {"Example 3": 5},\n    {"Reason 3": "The sentence contains the entity \'E2A\' which is present in the target sentence."},\n    {"Example 4": 5},\n    {"Reason 4": "The sentence contains multiple entities such as \'IL-2\', \'c-Jun\', and \'c-Fos\' which are all present in the target sentence."},\n    {"Example 5": 5},\n    {"Reason 5": "The sentence contains the entities \'EBNA-2\' and \'PU.1\' which are both present in the target sentence."},\n    {"Example 6": 5},\n    {"Reason 6": "The sentence contains the entities \'p21(WAF1/CIP1)\' and \'p27(KIP1)\' which are both present in the target sentence."},\n    {"Example 7": 5},\n    {"Reason 7": "The sentence contains the entities \'EKLF\', \'CBP\', \'p300\', and \'P/CAF\' which are all present in the target sentence."},\n    {"Example 8": 5},\n    {"Reason 8": "The sentence contains the entity \'NF-kappa B\' which is present in the target sentence."},\n    {"Example 9": 5},\n    {"Reason 9": "The sentence contains the entities \'Jun\' and \'ATF-2\' which are both present in the target sentence."},\n    {"Example 10": 5},\n    {"Reason 10": "The sentence contains the entities \'IkappaBbeta\' and \'NF-kappaB\' which are both present in the target sentence."},\n    {"Example 11": 5},\n    {"Reason 11": "The sentence contains the entities \'p50\', \'p65\', \'DNA\', and \'protein\' which are all present in the target sentence."},\n    {"Example 12": 5},\n    {"Reason 12": "The sentence contains the entities \'Tip\', \'Tap\', and \'Jurkat-T cells\' which are all present in the target sentence."},\n    {"Example 13": 5},\n    {"Reason 13": "The sentence contains the entities \'HIV-1 LTR\', \'NFAT-1\', and \'NF kappa B\' which are all present in the target sentence."},\n    {"Example 14": 5},\n    {"Reason 14": "The sentence contains the entities \'cDNA\', \'Jurkat\', and \'DRE 1\' which are all present in the target sentence."},\n    {"Example 15": 5},\n    {"Reason 15": "The sentence contains the entities \'tal-1\', \'GATA-binding proteins\', and \'hematopoiesis\' which are all present in the target sentence."},\n    {"Example 16": 5},\n    {"Reason 16": "The sentence contains the entities \'NF-E1\' and \'YY-1\' which are both present in the target sentence."},\n    {"Example 17": 1},\n    {"Reason 17": "The sentence does not contain any entities present in the target sentence."},\n    {"Example 18": 1},\n    {"Reason 18": "The sentence does not contain any entities present in the target sentence."},\n    {"Example 19": 1},\n    {"Reason 19": "The sentence does not contain any entities present in the target sentence."},\n    {"Example 20": 1},\n    {"Reason 20": "The sentence does not contain any entities present in the target sentence."},\n    {"Example 21": 1},\n    {"Reason 21": "The sentence does not contain any entities present in the target sentence."},\n    {"Example 22": 1},\n    {"Reason 22": "The sentence does not contain any entities present in the target sentence."},\n    {"Example 23": 1},\n    {"Reason 23": "The sentence does not contain any entities present in the target sentence."},\n    {"Example 24": 1},\n    {"Reason 24": "The sentence does not contain any entities present in the target sentence."},\n    {"Example 25": 1},\n    {"Reason 25": "The sentence does not contain any entities present in the target sentence."}\n]', 'response3': '[{"DNA": "DNA"}, {"protein": "protein"}, {"Jurkat cells": "cell_line"}]', 'prediction': {'DNA': 'DNA', 'protein': 'protein', 'Jurkat cells': 'cell_line'}}
